data_2l04_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2l04 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.903 0.382 . . . . 75.329999999999998 111.051 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -127.6 24.34 6.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 70.310000000000002 111.155 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 151.54 99.08 0.18 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.776 -0.726 . . . . 74.120000000000005 112.551 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 43.8 ttp -113.13 125.5 54.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.846 0.355 . . . . 72.420000000000002 110.901 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 51.6 p -114.47 103.62 11.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 74.420000000000002 111.153 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 21.4 t -99.7 130.48 48.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.256 -0.429 . . . . 73.349999999999994 111.117 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.3 m -125.0 92.88 46.81 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.593 0.711 . . . . 73.200000000000003 111.113 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -168.85 0.29 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.668 2.245 . . . . 65.010000000000005 112.381 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -86.73 -40.84 14.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.279 -0.419 . . . . 74.430000000000007 111.104 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 93.6 p 46.43 79.06 0.06 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.245 -0.434 . . . . 51.329999999999998 110.851 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.5 t -175.09 -174.89 0.8 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.126 -0.488 . . . . 75.439999999999998 111.118 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 89.4 p -98.8 164.06 12.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 73.400000000000006 110.849 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 3.5 p -146.31 154.02 12.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 74.219999999999999 111.111 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 66.7 t -87.35 145.31 7.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 75.510000000000005 111.071 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -49.03 122.56 5.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.134 -0.484 . . . . 71.120000000000005 110.923 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.38 -14.59 60.83 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.75 -0.738 . . . . 74.120000000000005 112.476 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 17.4 mm100 -90.82 -178.22 5.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.83 0.347 . . . . 73.420000000000002 110.927 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 35.1 p -161.51 148.49 14.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.224 -0.444 . . . . 74.430000000000007 110.85 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 6.7 t -106.81 -173.55 2.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.075 -0.511 . . . . 63.109999999999999 111.151 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.29 132.31 27.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.231 -0.44 . . . . 75.5 111.133 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.7 mp -105.21 143.05 33.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 74.510000000000005 110.951 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 21.9 m -110.06 142.36 41.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.217 -0.447 . . . . 72.519999999999996 111.118 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 18.4 t -129.34 140.24 49.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 73.329999999999998 111.13 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -130.11 152.12 49.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.143 -0.48 . . . . 73.319999999999993 111.098 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -145.76 126.88 14.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 74.409999999999997 110.865 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.58 66.71 77.33 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.542 0.687 . . . . 73.120000000000005 110.921 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo . . . . . 0 N--CA 1.465 -0.155 0 C-N-CA 122.676 2.251 . . . . 74.019999999999996 112.377 179.975 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 7.2 t0 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.865 0.364 . . . . 65.530000000000001 110.876 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.12 92.43 0.11 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 71.439999999999998 110.913 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 1.6 m -105.78 -7.08 18.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 60.32 110.831 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 19.2 p90 -91.34 176.35 6.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.098 -0.501 . . . . 72.430000000000007 110.913 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -163.05 171.16 16.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.459 . . . . 75.340000000000003 110.839 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -120.31 168.0 11.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 74.430000000000007 111.078 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 11.3 p -175.21 151.45 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 75.0 111.108 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.7 t -77.31 150.15 35.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.126 -0.488 . . . . 54.219999999999999 110.858 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -86.32 -23.79 26.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 64.450000000000003 111.138 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -127.7 -52.52 1.35 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.19 -0.459 . . . . 64.340000000000003 110.831 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.24 24.39 14.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.2 -0.455 . . . . 74.439999999999998 110.91 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 35.5 p -113.37 -2.73 13.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.246 -0.433 . . . . 71.409999999999997 111.138 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 8.8 mtmm -152.59 18.53 0.62 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.251 -0.432 . . . . 75.209999999999994 110.878 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -177.22 146.61 0.5 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 73.129999999999995 111.089 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 11.9 p -107.22 159.04 16.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.174 -0.467 . . . . 74.209999999999994 111.117 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 11.2 m -141.23 141.72 30.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 64.5 111.141 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 4.3 m -148.76 108.46 4.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 72.299999999999997 110.843 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . 0.421 ' HA ' ' HA ' ' A' ' 214' ' ' ILE . 3.5 p -87.96 143.1 11.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.132 -0.485 . . . . 74.299999999999997 111.132 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 16.7 t -172.08 123.45 0.5 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 73.329999999999998 110.841 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 55.86 47.16 80.96 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.745 -0.74 . . . . 75.140000000000001 112.488 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 2.1 mtp 63.74 16.01 9.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.853 0.359 . . . . 73.109999999999999 110.896 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 7.0 m -126.0 113.59 17.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 63.420000000000002 111.146 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.421 ' HA ' ' HA ' ' A' ' 209' ' ' VAL . 2.9 mp -110.23 113.96 45.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 75.109999999999999 111.125 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 5.0 m -88.1 132.16 34.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.45 . . . . 74.310000000000002 111.123 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 3.3 t -117.21 124.47 73.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 64.510000000000005 111.082 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -106.19 139.33 40.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 73.430000000000007 110.907 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -94.22 79.57 0.96 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.782 -0.723 . . . . 64.129999999999995 112.495 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 19.6 t -50.29 -55.96 4.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.792 0.329 . . . . 71.140000000000001 111.175 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -128.71 161.4 29.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 74.319999999999993 111.095 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -61.06 140.31 57.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.215 -0.448 . . . . 71.219999999999999 111.121 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 139.41 171.21 12.15 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.743 -0.741 . . . . 74.409999999999997 112.488 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 14.3 mttt -99.46 124.56 44.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.821 0.343 . . . . 71.340000000000003 110.941 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 7.0 p -120.96 127.37 75.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 73.329999999999998 111.169 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 21.3 m120 -90.81 151.81 21.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 74.400000000000006 110.906 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 4.4 mp -138.06 93.12 12.0 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.622 0.725 . . . . 74.140000000000001 111.125 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -178.3 2.29 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.708 2.272 . . . . 71.219999999999999 112.34 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 90.5 t -150.09 134.78 9.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 72.109999999999999 111.137 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 80.4 t -117.08 135.59 56.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.147 -0.478 . . . . 65.230000000000004 111.161 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 31.0 t -122.12 116.65 24.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 74.120000000000005 110.871 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 66.48 -115.04 6.98 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.729 -0.748 . . . . 71.120000000000005 112.464 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -110.54 19.23 18.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.874 0.369 . . . . 73.019999999999996 110.888 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 117.33 2.72 17.69 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.748 -0.739 . . . . 75.439999999999998 112.485 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -51.06 -70.36 0.09 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.866 0.365 . . . . 71.109999999999999 110.902 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -107.38 159.66 16.22 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.172 -0.467 . . . . 74.430000000000007 110.852 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -160.75 165.19 30.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.103 -0.499 . . . . 74.409999999999997 111.091 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -146.2 163.18 36.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 73.109999999999999 111.135 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 24.1 t -137.18 137.02 46.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.215 -0.448 . . . . 62.039999999999999 111.11 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -139.08 165.29 27.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.173 -0.467 . . . . 73.530000000000001 111.134 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -144.95 132.51 20.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.244 -0.434 . . . . 74.140000000000001 110.851 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 23.5 mm -126.87 115.09 40.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.134 -0.485 . . . . 72.25 111.174 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 2.0 m -82.43 141.24 32.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.152 -0.476 . . . . 75.420000000000002 111.162 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 17.8 t -119.71 121.54 66.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 74.510000000000005 111.128 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 7.1 p -82.28 133.0 35.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 73.420000000000002 111.17 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -58.33 -22.52 53.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 53.43 111.113 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 1.4 p . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.197 -0.456 . . . . 73.299999999999997 110.866 -179.77 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.859 0.361 . . . . 73.120000000000005 111.093 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -129.25 24.09 5.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.24 -0.436 . . . . 75.209999999999994 111.088 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 153.28 99.85 0.18 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.734 -0.746 . . . . 74.030000000000001 112.448 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 21.3 ttp -113.85 124.6 52.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.85 0.357 . . . . 75.409999999999997 110.872 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 51.6 p -114.58 103.32 10.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.257 -0.429 . . . . 70.420000000000002 111.147 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 21.7 t -97.97 131.72 44.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.192 -0.458 . . . . 75.540000000000006 111.153 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.4 m -126.46 92.38 45.39 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.545 0.688 . . . . 72.530000000000001 111.143 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 -167.2 0.22 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.67 2.247 . . . . 74.150000000000006 112.321 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -85.94 -40.26 16.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 61.299999999999997 111.15 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 87.9 p 46.41 77.29 0.08 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.213 -0.449 . . . . 75.030000000000001 110.877 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.5 t -175.72 -174.82 0.71 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.12 -0.491 . . . . 75.129999999999995 111.128 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 34.6 p -100.56 162.91 12.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 72.239999999999995 110.862 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 3.3 p -144.27 153.03 15.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 72.25 111.12 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 63.2 t -86.58 145.26 7.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 73.420000000000002 111.152 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.1 122.3 5.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.191 -0.459 . . . . 75.239999999999995 110.899 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 100.19 -14.35 59.79 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.758 -0.734 . . . . 61.210000000000001 112.484 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -90.03 -177.66 5.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.81 0.338 . . . . 65.420000000000002 110.935 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 2.2 p -160.9 148.82 15.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 63.130000000000003 110.836 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 7.5 t -109.65 -176.82 3.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 74.140000000000001 111.128 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -139.47 127.51 22.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 72.310000000000002 111.148 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.9 mp -99.89 145.71 27.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.221 -0.445 . . . . 75.540000000000006 110.902 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -114.1 143.21 45.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 72.329999999999998 111.173 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 25.4 t -129.47 141.9 45.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 65.510000000000005 111.146 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -129.81 150.66 51.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 75.25 111.095 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -144.5 127.8 16.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 65.5 110.901 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.39 66.76 71.3 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.642 0.734 . . . . 74.219999999999999 110.877 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo . . . . . 0 C--N 1.342 0.21 0 C-N-CA 122.657 2.238 . . . . 74.209999999999994 112.367 179.943 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 2.7 t70 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.854 0.359 . . . . 73.310000000000002 110.86 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.37 104.53 0.51 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 74.530000000000001 110.932 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 1.2 m -115.42 -6.14 12.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 65.200000000000003 110.843 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -90.31 174.45 7.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.125 -0.489 . . . . 74.319999999999993 110.878 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -165.7 151.64 9.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 73.150000000000006 110.863 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -104.2 158.91 16.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 75.439999999999998 111.116 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 6.4 m -153.04 -178.05 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 75.340000000000003 111.16 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 11.9 p -108.1 132.27 53.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 73.310000000000002 110.887 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -75.35 -26.01 58.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.122 -0.49 . . . . 42.310000000000002 111.14 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -129.01 -60.02 1.1 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.454 . . . . 75.409999999999997 110.884 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 63.88 35.45 10.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 72.049999999999997 110.922 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 32.7 p -118.44 -4.73 10.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.165 -0.47 . . . . 75.150000000000006 111.064 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 9.4 mtmm -152.84 18.63 0.59 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.255 -0.43 . . . . 71.099999999999994 110.907 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -171.26 144.91 2.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 71.310000000000002 111.128 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 17.0 p -107.37 130.85 54.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.249 -0.432 . . . . 64.150000000000006 111.17 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 4.8 m -118.86 138.99 47.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 71.450000000000003 111.145 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 5.7 t -145.29 109.09 4.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 72.420000000000002 110.849 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 4.2 p -89.4 143.61 10.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.104 -0.498 . . . . 71.430000000000007 111.091 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 3.4 t -144.79 96.28 2.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.138 -0.483 . . . . 62.119999999999997 110.885 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 70.29 -81.04 0.38 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.78 -0.724 . . . . 73.120000000000005 112.507 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -138.43 8.09 2.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.882 0.373 . . . . 73.120000000000005 110.911 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -129.24 121.82 28.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 63.119999999999997 111.168 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 2.6 mp -115.3 131.79 66.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 74.329999999999998 111.131 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 1.5 m -100.63 125.71 47.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.139 -0.482 . . . . 75.340000000000003 111.152 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 2.4 t -116.64 126.66 74.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 74.200000000000003 111.165 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -112.19 138.96 48.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 63.030000000000001 110.86 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -93.4 80.98 1.04 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.768 -0.729 . . . . 54.200000000000003 112.469 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 19.3 t -50.26 -51.18 18.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.855 0.36 . . . . 71.120000000000005 111.099 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -137.78 162.36 34.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 73.109999999999999 111.132 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -57.25 143.45 39.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 74.329999999999998 111.132 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 137.18 167.95 11.23 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.748 -0.739 . . . . 71.310000000000002 112.482 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 6.1 mttp -102.47 133.93 46.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.83 0.348 . . . . 74.219999999999999 110.893 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 13.1 p -130.49 131.66 65.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 75.400000000000006 111.118 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -91.33 152.45 20.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.464 . . . . 63.420000000000002 110.905 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 4.3 mp -137.43 92.44 13.47 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.611 0.719 . . . . 74.209999999999994 111.124 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.71 -179.55 2.97 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.689 2.26 . . . . 75.430000000000007 112.367 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 85.9 t -150.4 134.84 9.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 62.5 111.125 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 86.9 t -116.94 136.07 55.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 74.099999999999994 111.147 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -119.77 108.83 14.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 62.549999999999997 110.844 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 56.99 -116.05 7.32 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.767 -0.73 . . . . 44.509999999999998 112.503 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 17.9 p30 -95.04 19.3 10.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.836 0.351 . . . . 74.120000000000005 110.842 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 101.09 8.28 47.98 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.72 -0.752 . . . . 70.109999999999999 112.486 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -52.0 -33.81 39.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.814 0.34 . . . . 71.150000000000006 110.835 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -144.21 153.21 41.85 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.202 -0.454 . . . . 74.310000000000002 110.894 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -154.28 165.53 36.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.174 -0.466 . . . . 65.510000000000005 111.097 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -145.78 163.16 35.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.464 . . . . 64.340000000000003 111.115 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 23.3 t -136.6 135.83 48.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.251 -0.431 . . . . 75.319999999999993 111.131 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.6 165.29 27.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 73.319999999999993 111.123 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -145.81 132.37 19.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 75.219999999999999 110.862 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 24.5 mm -125.79 113.59 35.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.194 -0.457 . . . . 74.439999999999998 111.151 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 1.7 m -83.17 141.63 31.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 63.530000000000001 111.146 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 11.3 t -119.78 122.78 69.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.44 . . . . 73.019999999999996 111.17 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 4.2 p -84.75 132.56 34.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 74.439999999999998 111.141 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -58.18 -23.48 55.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 62.549999999999997 111.097 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 58.8 m . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 72.439999999999998 110.884 -179.792 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.869 0.366 . . . . 72.209999999999994 111.131 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 1.9 m -128.26 24.13 5.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.261 -0.427 . . . . 71.239999999999995 111.165 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 153.41 99.04 0.17 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.701 -0.762 . . . . 73.329999999999998 112.476 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 27.9 ttp -113.18 125.34 54.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.862 0.363 . . . . 74.209999999999994 110.851 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 48.5 p -114.72 104.01 11.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 71.310000000000002 111.142 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 21.7 t -100.41 130.98 48.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 72.230000000000004 111.117 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 19.2 m -125.1 92.48 47.36 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.551 0.691 . . . . 75.439999999999998 111.085 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 -166.75 0.2 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.649 2.233 . . . . 74.420000000000002 112.355 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -86.59 -40.59 15.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.436 . . . . 74.299999999999997 111.063 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 88.2 p 46.72 76.3 0.1 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 61.340000000000003 110.875 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.5 t -174.23 -174.9 0.93 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 73.340000000000003 111.152 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 24.5 p -100.37 162.24 13.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 73.230000000000004 110.824 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 2.8 p -144.27 154.06 15.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.117 -0.492 . . . . 73.450000000000003 111.127 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 79.5 t -89.29 144.48 9.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 74.450000000000003 111.142 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.78 123.76 6.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.451 . . . . 74.239999999999995 110.92 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.84 -16.14 58.84 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.788 -0.72 . . . . 61.409999999999997 112.498 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 9.7 mm100 -89.41 -177.89 5.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.846 0.355 . . . . 75.530000000000001 110.914 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 11.9 p -161.98 147.09 12.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.212 -0.449 . . . . 62.310000000000002 110.884 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 7.3 t -108.12 -174.69 2.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 73.120000000000005 111.132 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -140.42 132.31 27.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 75.129999999999995 111.189 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.6 mp -105.12 142.14 35.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 73.329999999999998 110.919 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 24.9 m -110.01 141.99 42.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 72.209999999999994 111.179 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 21.5 t -129.32 139.87 50.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.293 -0.412 . . . . 71.109999999999999 111.127 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -130.11 151.91 50.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.124 -0.489 . . . . 75.400000000000006 111.126 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -144.24 128.69 17.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 75.420000000000002 110.889 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.25 66.69 71.66 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.582 0.706 . . . . 75.230000000000004 110.912 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo . . . . . 0 C--N 1.341 0.162 0 C-N-CA 122.68 2.253 . . . . 65.349999999999994 112.355 179.999 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 13.5 t0 . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.877 0.37 . . . . 64.439999999999998 110.883 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 9.5 mtmt -63.24 96.78 0.11 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 74.530000000000001 110.914 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 2.0 m -109.84 -6.25 15.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 73.219999999999999 110.877 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -90.71 175.9 6.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.073 -0.512 . . . . 62.219999999999999 110.845 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 3.1 ptt-85 -158.25 173.71 16.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.132 -0.486 . . . . 73.219999999999999 110.89 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -124.65 167.16 14.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 62.200000000000003 111.086 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 10.0 p -174.77 152.73 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 75.239999999999995 111.131 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.7 126.75 36.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.156 -0.475 . . . . 72.150000000000006 110.878 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -61.68 -17.94 57.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.115 -0.493 . . . . 74.129999999999995 111.093 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -156.99 92.43 1.27 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.213 -0.449 . . . . 72.299999999999997 110.913 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 8.0 tttp -83.65 55.18 3.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 75.049999999999997 110.931 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 20.0 p -130.66 2.67 4.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.246 -0.434 . . . . 74.129999999999995 111.144 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 10.8 mtmm -153.99 18.23 0.51 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 74.040000000000006 110.881 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -179.47 153.4 0.57 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.449 . . . . 74.430000000000007 111.113 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 8.4 p -117.49 131.23 56.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 73.340000000000003 111.142 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 4.9 m -120.1 140.33 44.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.184 -0.462 . . . . 74.510000000000005 111.112 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.16 109.0 4.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 72.420000000000002 110.868 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . 0.427 ' HA ' ' HA ' ' A' ' 214' ' ' ILE . 3.7 p -85.45 143.08 12.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.138 -0.483 . . . . 71.150000000000006 111.173 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 17.2 p -172.19 123.85 0.5 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 74.230000000000004 110.839 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 55.4 48.05 72.15 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.752 -0.737 . . . . 51.020000000000003 112.476 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 2.4 mtp 62.5 16.47 8.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.884 0.373 . . . . 75.540000000000006 110.853 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 1.4 m -128.15 114.23 16.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.26 -0.427 . . . . 65.310000000000002 111.153 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.427 ' HA ' ' HA ' ' A' ' 209' ' ' VAL . 3.4 mp -110.24 115.61 50.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 75.25 111.076 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 1.3 m -89.99 126.91 35.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 75.430000000000007 111.118 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 4.8 t -112.74 128.28 69.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.216 -0.447 . . . . 72.530000000000001 111.135 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -109.56 135.69 50.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 75.409999999999997 110.921 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -84.41 66.81 3.82 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.731 -0.747 . . . . 71.200000000000003 112.507 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 1.9 t -48.75 -53.58 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.817 0.341 . . . . 74.540000000000006 111.146 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -123.96 155.33 38.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.146 -0.479 . . . . 72.400000000000006 111.114 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -67.82 138.03 55.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 74.239999999999995 111.054 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 140.46 174.68 14.05 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.769 -0.729 . . . . 52.039999999999999 112.478 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 6.0 mttp -99.38 121.51 41.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.827 0.346 . . . . 74.25 110.885 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 7.6 p -120.35 128.67 76.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 74.530000000000001 111.132 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 36.1 m120 -90.52 150.2 21.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.145 -0.479 . . . . 74.030000000000001 110.863 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 4.7 mp -133.19 92.39 25.17 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.675 0.75 . . . . 75.510000000000005 111.135 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.7 -179.67 3.05 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.687 2.258 . . . . 74.319999999999993 112.375 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 96.2 t -149.46 136.13 12.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 74.400000000000006 111.142 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 82.6 t -118.26 135.52 58.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.186 -0.461 . . . . 73.349999999999994 111.134 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.21 108.8 14.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 72.200000000000003 110.856 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 74.06 -111.44 3.43 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.763 -0.732 . . . . 54.32 112.485 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -111.09 8.31 21.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.907 0.384 . . . . 75.349999999999994 110.948 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 127.78 3.24 6.0 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.709 -0.758 . . . . 60.149999999999999 112.456 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -51.66 -73.21 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.853 0.358 . . . . 75.329999999999998 110.899 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -102.94 156.37 17.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.468 . . . . 74.140000000000001 110.872 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -157.24 165.18 36.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.148 -0.478 . . . . 74.319999999999993 111.068 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -144.83 163.5 33.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 74.299999999999997 111.096 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 58.8 t -137.02 136.46 47.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.226 -0.443 . . . . 70.310000000000002 111.126 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.72 165.26 27.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 72.319999999999993 111.103 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -143.15 131.49 22.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 75.109999999999999 110.888 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 25.8 mm -127.28 112.05 27.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.13 -0.486 . . . . 71.420000000000002 111.089 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 1.7 m -82.5 139.28 34.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.189 -0.46 . . . . 63.340000000000003 111.132 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 22.1 t -120.49 119.48 59.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.23 -0.441 . . . . 74.219999999999999 111.142 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 6.8 p -81.91 132.9 35.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 74.430000000000007 111.169 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -55.2 -26.19 37.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 73.030000000000001 111.051 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 9.3 t . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.234 -0.439 . . . . 73.540000000000006 110.846 -179.785 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.835 0.35 . . . . 75.319999999999993 111.106 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -125.02 32.28 5.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 65.329999999999998 111.093 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 136.87 99.7 0.55 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.72 -0.752 . . . . 65.430000000000007 112.501 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 11.6 ttp -109.75 133.04 53.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.83 0.348 . . . . 71.099999999999994 110.898 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 33.4 p -121.65 108.17 13.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 74.319999999999993 111.147 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 26.3 t -102.23 132.29 48.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 70.530000000000001 111.122 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.7 m -124.33 92.49 48.05 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.599 0.714 . . . . 72.5 111.143 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -166.43 0.19 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.709 2.273 . . . . 75.030000000000001 112.329 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -89.03 -39.49 13.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 74.329999999999998 111.133 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 98.2 p 46.32 79.33 0.06 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 63.210000000000001 110.829 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.1 t -175.55 -174.59 0.71 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.093 -0.503 . . . . 71.030000000000001 111.121 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 97.2 p -99.89 163.19 12.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.262 -0.426 . . . . 74.420000000000002 110.886 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 3.1 p -144.95 153.6 14.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.134 -0.484 . . . . 64.129999999999995 111.099 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 58.7 t -87.53 145.67 7.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 70.540000000000006 111.13 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.34 122.37 6.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.459 . . . . 72.329999999999998 110.919 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.7 -12.54 61.14 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.761 -0.733 . . . . 61.130000000000003 112.489 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -92.64 -178.06 4.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.779 0.323 . . . . 73.400000000000006 110.928 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 23.8 p -161.5 148.83 14.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 62.219999999999999 110.878 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 9.1 t -108.74 -175.4 2.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.124 -0.489 . . . . 73.010000000000005 111.137 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -138.9 132.98 31.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 65.400000000000006 111.143 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.4 mp -106.52 143.59 34.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 74.230000000000004 110.946 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 2.2 m -111.75 142.5 44.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.462 . . . . 75.109999999999999 111.11 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 22.6 t -129.75 140.52 48.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 71.400000000000006 111.141 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -132.38 152.49 51.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 71.25 111.097 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -143.77 128.7 18.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.455 . . . . 75.530000000000001 110.866 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.77 67.11 76.81 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.577 0.704 . . . . 73.109999999999999 110.896 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo . . . . . 0 C--N 1.342 0.185 0 C-N-CA 122.675 2.25 . . . . 71.349999999999994 112.357 179.95 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.877 0.37 . . . . 74.109999999999999 110.881 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 6.1 mtmt -52.94 105.55 0.13 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 75.140000000000001 110.888 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 59.8 m -116.76 -6.69 11.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 74.329999999999998 110.857 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -90.75 176.5 6.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.101 -0.499 . . . . 72.340000000000003 110.857 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.28 157.34 15.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.122 -0.49 . . . . 71.439999999999998 110.862 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -105.48 167.78 9.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.47 . . . . 71.409999999999997 111.115 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 11.6 p -164.32 151.06 2.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 72.150000000000006 111.153 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.56 121.17 29.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 70.120000000000005 110.874 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -65.34 -19.49 65.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.103 -0.499 . . . . 75.099999999999994 111.107 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -163.81 91.4 0.65 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.17 -0.468 . . . . 55.009999999999998 110.845 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 7.8 ttpt -83.19 55.59 3.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 70.420000000000002 110.909 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 25.0 p -128.06 -0.23 5.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.236 -0.438 . . . . 75.019999999999996 111.153 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 6.1 mtmt -156.42 19.45 0.35 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.18 -0.463 . . . . 71.239999999999995 110.9 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -179.64 149.85 0.39 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 75.120000000000005 111.162 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 4.0 p -108.51 156.22 19.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 73.109999999999999 111.12 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 15.7 m -141.27 137.56 33.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 74.310000000000002 111.161 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 60.4 p -146.04 108.01 4.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 72.530000000000001 110.879 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . 0.418 ' HA ' ' HA ' ' A' ' 214' ' ' ILE . 3.3 p -91.18 140.94 15.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 73.299999999999997 111.147 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 17.5 p -172.38 126.71 0.53 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 75.0 110.832 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 56.49 45.44 89.58 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.782 -0.723 . . . . 74.510000000000005 112.476 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 4.2 mtp 63.51 16.15 9.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.871 0.367 . . . . 74.340000000000003 110.867 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 22.2 m -127.05 115.04 18.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.229 -0.441 . . . . 75.25 111.088 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.418 ' HA ' ' HA ' ' A' ' 209' ' ' VAL . 3.4 mp -110.44 120.25 60.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 73.209999999999994 111.141 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 1.2 m -92.18 128.84 38.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.211 -0.449 . . . . 60.310000000000002 111.168 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 3.5 t -115.34 125.58 72.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 74.329999999999998 111.125 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -110.79 138.72 46.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 74.219999999999999 110.908 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -94.99 78.53 0.88 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.765 -0.731 . . . . 73.329999999999998 112.474 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 19.1 t -49.71 -53.0 11.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.827 0.346 . . . . 74.120000000000005 111.11 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -131.33 161.95 31.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.461 . . . . 74.239999999999995 111.113 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -60.74 138.62 58.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.235 -0.439 . . . . 63.310000000000002 111.085 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 142.77 171.18 13.21 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.705 -0.759 . . . . 74.129999999999995 112.486 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 13.6 mttt -101.56 125.15 48.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.84 0.352 . . . . 72.140000000000001 110.936 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 7.1 p -122.07 126.17 74.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.242 -0.436 . . . . 73.230000000000004 111.122 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -90.96 155.48 18.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 73.230000000000004 110.878 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 4.6 mp -139.88 92.65 9.8 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.603 0.716 . . . . 70.219999999999999 111.133 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.75 -178.14 2.2 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.67 2.247 . . . . 73.409999999999997 112.365 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 80.4 t -150.3 143.02 17.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 71.540000000000006 111.094 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 94.8 t -123.77 134.09 67.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.182 -0.463 . . . . 72.310000000000002 111.119 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -122.3 133.68 54.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 73.430000000000007 110.846 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 52.25 -116.15 4.86 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.78 -0.724 . . . . 73.439999999999998 112.464 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -108.73 21.17 17.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.83 0.348 . . . . 73.109999999999999 110.86 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 110.41 5.87 27.77 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.7 -0.762 . . . . 52.340000000000003 112.514 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -52.9 -60.32 3.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.924 0.392 . . . . 71.450000000000003 110.885 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -113.04 166.69 11.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.103 -0.499 . . . . 75.430000000000007 110.89 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -165.06 162.2 20.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.151 -0.477 . . . . 74.239999999999995 111.129 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -140.09 163.26 33.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 73.010000000000005 111.125 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.2 p -140.17 131.66 31.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 75.420000000000002 111.191 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -132.71 165.2 25.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.191 -0.459 . . . . 72.549999999999997 111.093 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -144.55 132.28 21.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.225 -0.443 . . . . 74.010000000000005 110.916 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 27.2 mm -127.21 112.49 28.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 75.430000000000007 111.096 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 2.2 m -81.76 141.21 33.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.117 -0.492 . . . . 75.549999999999997 111.123 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 19.7 t -120.12 121.31 65.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.213 -0.448 . . . . 75.230000000000004 111.106 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 6.2 p -83.69 132.77 34.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.138 -0.483 . . . . 73.099999999999994 111.126 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -53.45 -28.26 29.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 72.299999999999997 111.117 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 7.9 t . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.44 . . . . 74.129999999999995 110.86 -179.766 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.874 0.369 . . . . 63.32 111.111 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 1.6 m -134.33 30.79 3.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 65.209999999999994 111.139 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 137.27 104.97 0.71 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.739 -0.743 . . . . 72.209999999999994 112.503 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 1.5 ttp -115.84 138.5 51.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.837 0.351 . . . . 74.230000000000004 110.855 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 37.5 p -125.34 106.67 10.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 63.140000000000001 111.152 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 16.4 t -97.62 135.92 30.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 74.239999999999995 111.099 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.3 m -128.78 92.22 40.83 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.574 0.702 . . . . 74.0 111.157 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 -165.03 0.14 Allowed 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.695 2.263 . . . . 73.239999999999995 112.365 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -93.0 -37.01 12.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.433 . . . . 65.209999999999994 111.124 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 88.0 p 46.85 76.92 0.09 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 71.430000000000007 110.838 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.4 t -171.22 -174.5 1.48 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 63.32 111.18 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 18.4 p -100.35 163.66 12.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 65.230000000000004 110.833 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 3.0 p -144.4 153.4 15.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.079 -0.51 . . . . 65.409999999999997 111.173 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 23.2 t -86.38 145.09 8.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 62.299999999999997 111.139 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.42 122.23 5.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 74.010000000000005 110.91 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 98.87 -11.08 62.49 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.696 -0.764 . . . . 64.5 112.505 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 19.2 mm100 -92.82 -177.53 4.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.769 0.319 . . . . 75.120000000000005 110.945 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 59.8 p -160.56 151.65 19.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.246 -0.434 . . . . 74.310000000000002 110.854 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 11.0 t -113.74 -178.71 3.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.119 -0.491 . . . . 73.430000000000007 111.16 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.02 129.71 32.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.22 -0.445 . . . . 74.329999999999998 111.12 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.7 mp -103.57 146.23 28.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 70.409999999999997 110.901 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 7.1 m -111.1 144.36 40.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 74.040000000000006 111.133 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 21.8 t -129.5 142.26 44.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 73.439999999999998 111.155 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -129.08 152.83 48.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 63.210000000000001 111.106 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -145.77 129.23 16.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.458 . . . . 72.340000000000003 110.852 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.6 66.81 75.42 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.592 0.71 . . . . 71.420000000000002 110.878 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--N 1.342 0.197 0 C-N-CA 122.636 2.224 . . . . 75.299999999999997 112.358 179.97 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.919 0.39 . . . . 71.319999999999993 110.862 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -66.33 90.51 0.15 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.451 . . . . 75.430000000000007 110.906 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 1.8 t -105.5 -6.64 19.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 74.040000000000006 110.836 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -91.08 168.85 11.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.465 . . . . 72.230000000000004 110.905 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.08 168.8 25.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 73.430000000000007 110.889 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -119.53 163.06 17.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.446 . . . . 64.25 111.144 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.9 m -153.79 -178.74 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.272 -0.422 . . . . 73.25 111.121 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -119.53 127.35 52.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.161 -0.472 . . . . 70.450000000000003 110.921 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -70.82 -9.73 58.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.474 . . . . 62.310000000000002 111.153 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -166.22 99.12 0.62 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 64.319999999999993 110.867 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 14.9 tttt -91.52 41.71 1.08 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.176 -0.465 . . . . 74.299999999999997 110.892 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 4.2 p -124.93 -5.22 7.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 54.329999999999998 111.188 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 8.5 mtmm -148.05 15.09 1.04 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 74.329999999999998 110.922 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -179.67 150.11 0.39 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.44 . . . . 64.109999999999999 111.081 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 9.3 p -115.95 151.85 34.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 73.200000000000003 111.133 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 6.2 m -138.03 141.64 37.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 74.349999999999994 111.082 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -147.05 109.02 4.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 75.349999999999994 110.906 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . 0.424 ' HA ' ' HA ' ' A' ' 214' ' ' ILE . 3.6 p -86.23 143.21 11.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.128 -0.487 . . . . 72.239999999999995 111.114 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 7.7 p -171.98 124.11 0.53 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 71.450000000000003 110.869 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 55.64 47.19 79.09 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.781 -0.723 . . . . 73.510000000000005 112.47 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 2.0 mtp 63.26 16.08 9.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.844 0.354 . . . . 72.420000000000002 110.884 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 1.9 m -127.4 114.81 18.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.24 -0.436 . . . . 71.430000000000007 111.143 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.424 ' HA ' ' HA ' ' A' ' 209' ' ' VAL . 3.0 mp -110.15 116.26 51.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 73.329999999999998 111.107 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -89.34 126.15 35.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 64.120000000000005 111.125 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 2.8 t -111.43 129.91 65.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 74.310000000000002 111.172 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -113.55 139.03 49.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.439 . . . . 70.239999999999995 110.887 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -96.73 78.02 0.71 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.738 -0.744 . . . . 73.109999999999999 112.526 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 17.0 t -50.22 -54.96 6.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.846 0.355 . . . . 73.140000000000001 111.151 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -128.0 160.8 30.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 74.200000000000003 111.115 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -61.07 140.05 57.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 62.439999999999998 111.051 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 142.56 170.83 12.94 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.802 -0.713 . . . . 71.329999999999998 112.535 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 12.8 mttt -100.85 121.33 41.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.818 0.342 . . . . 73.120000000000005 110.877 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 7.4 p -120.57 126.96 75.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.262 -0.426 . . . . 71.540000000000006 111.139 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -90.67 155.97 18.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.464 . . . . 74.319999999999993 110.864 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . 0.4 ' HA ' ' HD2' ' A' ' 227' ' ' PRO . 3.9 mp -135.91 92.34 16.6 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.629 0.728 . . . . 73.340000000000003 111.072 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 226' ' ' ILE . 53.8 Cg_endo -69.77 179.78 3.47 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.66 2.24 . . . . 75.329999999999998 112.352 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 64.3 t -150.29 144.11 17.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.236 -0.438 . . . . 75.329999999999998 111.108 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 86.8 t -132.55 135.74 57.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.136 -0.484 . . . . 73.319999999999993 111.156 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 82.6 p -115.03 106.7 14.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.452 . . . . 64.430000000000007 110.882 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 59.33 -100.26 0.18 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.746 -0.74 . . . . 75.430000000000007 112.475 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 18.0 p30 -95.09 -7.68 38.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.897 0.379 . . . . 74.239999999999995 110.899 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 112.45 13.24 11.97 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.738 -0.744 . . . . 71.140000000000001 112.462 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -52.54 -28.73 21.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.865 0.364 . . . . 75.230000000000004 110.887 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -144.66 132.53 21.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 74.299999999999997 110.85 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -134.26 164.86 26.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 72.340000000000003 111.049 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -135.38 162.98 31.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 73.019999999999996 111.088 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 58.3 t -135.82 121.94 31.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.205 -0.452 . . . . 74.209999999999994 111.114 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -129.4 165.08 22.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 74.109999999999999 111.057 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -146.74 132.7 19.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 65.109999999999999 110.864 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 23.7 mm -126.76 111.92 27.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 72.530000000000001 111.11 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 2.7 m -79.8 141.22 36.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 70.230000000000004 111.148 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 16.6 t -119.9 120.7 63.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.28 -0.418 . . . . 73.420000000000002 111.113 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 7.2 p -82.36 132.85 35.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.164 -0.471 . . . . 73.209999999999994 111.117 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -57.97 -23.88 55.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 75.129999999999995 111.086 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 80.4 p . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.242 -0.435 . . . . 72.140000000000001 110.875 -179.805 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.836 0.351 . . . . 75.209999999999994 111.142 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 1.1 m -124.81 32.82 5.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.263 -0.426 . . . . 75.439999999999998 111.157 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 137.28 98.68 0.5 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.751 -0.738 . . . . 65.109999999999999 112.493 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 3.8 ttp -110.23 130.29 55.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.827 0.346 . . . . 74.319999999999993 110.846 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 43.9 p -118.67 104.01 10.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 75.530000000000001 111.118 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 34.7 t -97.86 132.78 41.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.264 -0.425 . . . . 73.420000000000002 111.104 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.6 m -126.76 92.53 44.54 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.571 0.701 . . . . 73.140000000000001 111.179 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -166.13 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.689 2.259 . . . . 71.530000000000001 112.317 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -87.99 -39.22 14.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 54.25 111.079 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 96.1 p 46.46 78.06 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.274 -0.421 . . . . 54.399999999999999 110.844 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.6 t -175.18 -174.81 0.78 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.493 . . . . 74.549999999999997 111.212 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 94.7 p -99.78 163.25 12.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.254 -0.43 . . . . 73.129999999999995 110.841 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 2.8 p -144.41 152.76 15.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.125 -0.489 . . . . 75.519999999999996 111.122 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 32.2 t -85.49 145.04 8.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.179 -0.464 . . . . 74.310000000000002 111.114 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.28 121.98 5.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.18 -0.464 . . . . 74.140000000000001 110.896 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.16 -11.87 62.0 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.701 -0.761 . . . . 65.040000000000006 112.471 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 21.5 mm100 -91.05 -177.39 4.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.78 0.324 . . . . 75.430000000000007 110.944 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -159.3 149.99 19.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.262 -0.427 . . . . 65.230000000000004 110.84 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 11.5 t -110.99 179.64 3.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.486 . . . . 72.540000000000006 111.139 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -136.02 126.12 26.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 74.319999999999993 111.185 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.7 mp -100.32 149.35 23.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 71.510000000000005 110.88 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 2.4 m -117.54 143.55 45.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.16 -0.473 . . . . 73.439999999999998 111.149 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 22.0 t -129.56 140.95 47.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 72.319999999999993 111.079 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -129.04 151.95 49.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.474 . . . . 52.420000000000002 111.088 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -146.65 130.05 16.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 74.200000000000003 110.895 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.24 66.63 75.55 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.612 0.72 . . . . 72.109999999999999 110.946 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--N 1.341 0.169 0 C-N-CA 122.722 2.281 . . . . 72.340000000000003 112.307 -179.988 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 18.3 t70 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.899 0.381 . . . . 73.329999999999998 110.893 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.27 91.68 3.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.179 -0.464 . . . . 65.219999999999999 110.907 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.82 -6.48 21.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 74.310000000000002 110.838 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 26.9 p90 -90.74 179.32 5.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.469 . . . . 74.530000000000001 110.897 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 2.2 ptt180 -166.45 174.48 8.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 72.099999999999994 110.867 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -119.45 154.77 33.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.458 . . . . 53.109999999999999 111.118 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 12.7 t -144.85 154.8 14.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.234 -0.439 . . . . 73.430000000000007 111.082 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.95 115.97 28.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.145 -0.48 . . . . 73.099999999999994 110.857 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -59.73 -22.14 61.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 63.420000000000002 111.133 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -161.16 92.17 0.9 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.221 -0.445 . . . . 65.219999999999999 110.895 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 5.8 tttp -85.07 54.39 3.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 71.510000000000005 110.888 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 19.1 p -129.51 1.28 5.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 71.049999999999997 111.16 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 9.0 mtmt -155.53 18.28 0.4 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 74.340000000000003 110.924 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -179.9 148.39 0.31 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 72.420000000000002 111.104 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 5.9 p -104.71 154.15 20.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 74.319999999999993 111.13 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 17.1 m -140.8 134.31 32.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.464 . . . . 74.329999999999998 111.114 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 10.7 m -145.3 109.09 4.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 75.239999999999995 110.867 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 4.3 p -92.69 142.43 13.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 72.010000000000005 111.113 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 4.1 t -143.23 98.9 3.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.134 -0.485 . . . . 72.25 110.866 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 69.89 -81.9 0.32 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.714 -0.755 . . . . 75.230000000000004 112.489 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 1.1 mtp -139.0 9.55 2.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.851 0.358 . . . . 74.200000000000003 110.853 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 7.3 m -130.21 123.25 29.76 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.243 -0.435 . . . . 64.230000000000004 111.17 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 2.2 mp -115.26 141.19 33.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.221 -0.445 . . . . 70.340000000000003 111.17 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.41 125.4 51.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.237 -0.438 . . . . 72.430000000000007 111.139 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 2.6 t -115.33 130.77 69.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 75.209999999999994 111.085 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -116.95 138.42 51.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 75.530000000000001 110.926 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -95.21 79.72 0.85 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.768 -0.729 . . . . 71.319999999999993 112.509 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 16.3 t -50.82 -53.46 13.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.792 0.33 . . . . 74.129999999999995 111.129 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -130.81 162.48 29.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.447 . . . . 72.200000000000003 111.073 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -60.92 140.45 57.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 72.120000000000005 111.12 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 142.34 171.25 13.06 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.79 -0.719 . . . . 74.349999999999994 112.528 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 5.5 mttp -103.74 121.85 43.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.85 0.357 . . . . 70.340000000000003 110.864 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 7.2 p -120.36 126.04 74.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 75.510000000000005 111.179 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 35.3 m120 -90.8 153.33 20.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 72.019999999999996 110.871 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 4.1 mp -137.21 93.08 13.33 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.608 0.718 . . . . 75.230000000000004 111.132 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -178.37 2.3 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.66 2.24 . . . . 71.530000000000001 112.37 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 47.0 t -147.37 139.62 18.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 72.349999999999994 111.111 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 99.8 t -120.53 135.19 61.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 74.319999999999993 111.152 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -121.46 122.51 39.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 74.439999999999998 110.878 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 56.14 -119.87 16.69 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.757 -0.735 . . . . 72.25 112.485 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -92.36 14.09 17.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.818 0.342 . . . . 74.010000000000005 110.878 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 108.17 8.6 29.1 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.705 -0.759 . . . . 63.219999999999999 112.471 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -51.97 -65.76 0.5 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.887 0.375 . . . . 74.420000000000002 110.939 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -100.54 158.98 15.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 74.120000000000005 110.904 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -157.73 160.52 37.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.165 -0.471 . . . . 74.219999999999999 111.108 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -136.97 163.61 30.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 71.5 111.102 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 57.7 t -137.34 130.39 43.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 74.109999999999999 111.17 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.54 163.33 31.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 73.109999999999999 111.09 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -147.35 130.37 16.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.203 -0.453 . . . . 73.329999999999998 110.903 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 26.5 mm -124.4 112.18 31.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.13 -0.486 . . . . 71.120000000000005 111.106 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 1.9 m -80.66 141.51 34.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.164 -0.471 . . . . 75.299999999999997 111.151 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 15.9 t -119.98 121.84 66.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 64.430000000000007 111.134 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 6.8 p -83.04 132.95 35.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 61.240000000000002 111.154 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -57.11 -23.82 49.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.23 -0.441 . . . . 73.510000000000005 111.089 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 4.4 t . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.26 -0.427 . . . . 62.5 110.837 -179.79 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.824 0.345 . . . . 73.420000000000002 111.161 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -125.56 33.74 5.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.276 -0.42 . . . . 70.5 111.176 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 134.66 99.63 0.63 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.724 -0.75 . . . . 74.030000000000001 112.481 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 11.6 ttp -114.76 133.08 56.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.861 0.363 . . . . 70.239999999999995 110.918 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 28.2 p -122.26 110.88 16.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 75.409999999999997 111.124 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 21.5 t -100.88 134.99 39.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 73.219999999999999 111.156 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.3 m -124.98 91.77 48.78 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.56 0.695 . . . . 75.040000000000006 111.136 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -165.16 0.14 Allowed 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.696 2.264 . . . . 73.450000000000003 112.336 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -91.14 -38.13 12.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.452 . . . . 73.120000000000005 111.079 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 90.5 p 46.85 77.31 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 74.030000000000001 110.88 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.2 t -174.32 -174.34 0.86 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.101 -0.499 . . . . 63.439999999999998 111.12 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 90.4 p -100.33 161.75 13.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 73.120000000000005 110.866 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 2.9 p -142.39 153.05 17.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.131 -0.486 . . . . 73.310000000000002 111.103 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 32.3 t -85.53 145.08 8.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 74.409999999999997 111.142 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.72 122.17 6.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.47 . . . . 73.040000000000006 110.897 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.12 -10.92 62.01 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.753 -0.737 . . . . 74.430000000000007 112.49 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 20.3 mm100 -91.83 -177.31 4.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.836 0.35 . . . . 74.120000000000005 110.911 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.52 152.36 19.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 73.019999999999996 110.89 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 13.2 t -115.66 179.13 4.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.454 . . . . 74.310000000000002 111.124 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.05 126.16 27.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 70.439999999999998 111.131 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.4 mp -100.28 142.77 31.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 75.209999999999994 110.916 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 14.1 m -108.74 143.81 37.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 73.239999999999995 111.196 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 21.0 t -129.65 141.22 47.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 63.439999999999998 111.071 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -130.04 149.55 51.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 72.230000000000004 111.119 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -139.79 130.6 26.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 73.439999999999998 110.863 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.73 67.0 80.03 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.564 0.697 . . . . 71.420000000000002 110.864 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--N 1.341 0.177 0 C-N-CA 122.696 2.264 . . . . 72.030000000000001 112.332 179.966 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 7.9 t70 . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.853 0.359 . . . . 74.310000000000002 110.876 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 11.7 mtpt -61.4 95.91 0.05 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 75.030000000000001 110.875 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.35 -6.99 17.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.216 -0.447 . . . . 62.030000000000001 110.828 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -91.04 178.46 6.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 72.340000000000003 110.882 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.9 171.47 12.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.121 -0.491 . . . . 75.439999999999998 110.854 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -122.89 163.42 20.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 72.319999999999993 111.106 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 5.8 m -153.1 -178.27 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 72.329999999999998 111.127 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.65 114.88 24.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 72.219999999999999 110.884 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -59.79 -20.86 59.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 71.230000000000004 111.083 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -162.24 96.73 0.99 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 62.219999999999999 110.85 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -87.95 47.85 1.56 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.485 . . . . 73.439999999999998 110.902 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 12.4 p -125.59 -4.35 7.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 74.099999999999994 111.09 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 9.0 mtmm -149.82 16.08 0.86 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.436 . . . . 73.540000000000006 110.902 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -179.67 151.24 0.44 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.448 . . . . 73.540000000000006 111.078 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 7.2 p -112.29 152.59 28.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.215 -0.448 . . . . 75.329999999999998 111.157 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 12.9 m -141.02 137.72 34.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.265 -0.425 . . . . 75.230000000000004 111.114 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.54 109.35 4.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 75.340000000000003 110.879 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . 0.434 ' HA ' ' HA ' ' A' ' 214' ' ' ILE . 3.5 p -87.93 134.7 27.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 72.340000000000003 111.157 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 2.9 m -161.53 124.08 3.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 63.100000000000001 110.83 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 55.34 47.74 73.6 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.74 -0.743 . . . . 71.109999999999999 112.48 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 3.4 mtp 63.24 16.1 9.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.851 0.358 . . . . 74.420000000000002 110.85 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 15.9 m -126.93 110.64 13.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 75.420000000000002 111.167 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.434 ' HA ' ' HA ' ' A' ' 209' ' ' VAL . 3.1 mp -105.7 117.35 51.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 64.5 111.126 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.26 127.02 36.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 74.329999999999998 111.107 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 2.8 t -113.0 131.53 64.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 74.109999999999999 111.107 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -117.25 136.62 52.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 72.329999999999998 110.905 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -94.15 79.22 0.97 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.777 -0.725 . . . . 73.319999999999993 112.46 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 18.5 t -50.98 -52.25 18.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.871 0.367 . . . . 71.040000000000006 111.144 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -131.97 161.42 33.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 64.230000000000004 111.116 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -59.96 139.12 57.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 65.219999999999999 111.122 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 142.44 170.45 12.7 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.746 -0.74 . . . . 74.230000000000004 112.522 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 13.4 mttt -99.36 123.5 43.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.819 0.343 . . . . 75.120000000000005 110.852 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 6.7 p -118.96 124.72 73.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 63.130000000000003 111.093 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -90.78 152.83 20.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.152 -0.476 . . . . 75.150000000000006 110.87 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 4.3 mp -137.77 93.17 12.41 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.594 0.712 . . . . 74.400000000000006 111.136 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 179.74 3.51 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.676 2.251 . . . . 74.219999999999999 112.336 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 90.3 t -150.23 136.31 11.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 74.420000000000002 111.128 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 91.3 t -117.67 134.71 60.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 73.25 111.167 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -120.94 127.57 51.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 73.430000000000007 110.893 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 58.85 -117.81 12.05 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.723 -0.751 . . . . 65.349999999999994 112.496 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -108.62 21.04 17.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.878 0.37 . . . . 71.439999999999998 110.862 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 113.4 3.69 23.97 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.759 -0.734 . . . . 61.020000000000003 112.485 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -54.12 -64.39 0.84 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.907 0.384 . . . . 74.120000000000005 110.881 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -111.42 156.74 21.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 75.319999999999993 110.831 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -156.57 164.54 38.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.095 -0.502 . . . . 72.129999999999995 111.131 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -143.2 163.29 33.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.269 -0.423 . . . . 63.210000000000001 111.113 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 13.5 p -140.49 138.72 36.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 72.349999999999994 111.154 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -136.95 165.33 26.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 74.209999999999994 111.09 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -141.88 131.17 23.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.23 -0.441 . . . . 71.140000000000001 110.876 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 25.9 mm -127.32 110.63 23.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.123 -0.49 . . . . 73.549999999999997 111.147 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 1.8 m -80.13 141.33 35.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.206 -0.452 . . . . 74.150000000000006 111.158 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 17.1 t -119.91 121.92 67.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 74.319999999999993 111.124 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 7.3 p -83.36 132.86 34.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 74.310000000000002 111.136 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -57.46 -24.46 55.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 71.140000000000001 111.106 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 5.2 m . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 72.109999999999999 110.836 -179.837 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.885 0.374 . . . . 54.25 111.077 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -131.91 18.53 4.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.184 -0.462 . . . . 61.039999999999999 111.074 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 166.8 97.91 0.12 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.746 -0.74 . . . . 51.539999999999999 112.466 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 41.7 ttp -111.98 129.96 56.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.815 0.341 . . . . 60.140000000000001 110.886 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 46.6 p -118.82 103.03 9.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.249 -0.432 . . . . 73.400000000000006 111.141 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 22.8 t -97.82 132.72 42.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.208 -0.451 . . . . 74.230000000000004 111.107 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.2 m -125.11 92.9 46.58 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 121.598 0.713 . . . . 60.439999999999998 111.119 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 -168.62 0.28 Allowed 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.685 2.257 . . . . 71.510000000000005 112.377 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -86.99 -39.82 15.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 74.040000000000006 111.062 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 95.3 p 46.43 78.5 0.07 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 74.239999999999995 110.847 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.1 t -173.86 -174.79 0.98 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.088 -0.505 . . . . 74.409999999999997 111.141 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 27.3 p -99.34 163.56 12.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.445 . . . . 55.310000000000002 110.875 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 3.1 p -146.38 154.32 12.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.115 -0.493 . . . . 74.230000000000004 111.135 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 57.6 t -88.39 145.43 7.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.48 . . . . 74.239999999999995 111.153 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -48.93 122.67 6.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 74.109999999999999 110.887 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.72 -14.2 60.55 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.733 -0.746 . . . . 74.340000000000003 112.463 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -91.16 -177.88 5.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.836 0.35 . . . . 71.109999999999999 110.93 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 20.4 p -161.43 149.51 15.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 73.219999999999999 110.829 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 7.5 t -108.52 -173.87 2.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.113 -0.494 . . . . 64.310000000000002 111.188 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.01 131.23 26.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.45 . . . . 65.530000000000001 111.195 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.5 mp -104.87 144.25 32.04 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.244 -0.435 . . . . 74.439999999999998 110.946 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 31.3 m -111.46 144.92 39.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 73.230000000000004 111.15 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 21.3 t -129.32 140.07 50.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 73.409999999999997 111.112 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -129.6 154.95 46.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.466 . . . . 73.439999999999998 111.048 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -145.28 133.8 22.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 74.120000000000005 110.879 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.83 66.33 26.28 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.596 0.712 . . . . 74.400000000000006 110.907 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--N 1.341 0.172 0 C-N-CA 122.679 2.253 . . . . 74.109999999999999 112.388 179.94 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.886 0.374 . . . . 75.25 110.854 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 1.9 ttpp -79.62 61.67 3.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 70.239999999999995 110.866 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 1.7 t -73.08 -7.93 53.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 62.399999999999999 110.843 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -91.49 163.43 14.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 75.540000000000006 110.922 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.27 172.21 18.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.471 . . . . 73.420000000000002 110.867 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -117.18 168.11 10.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 73.209999999999994 111.088 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 10.6 p -173.12 152.04 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.443 . . . . 75.049999999999997 111.126 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.3 t -78.27 151.51 32.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 74.200000000000003 110.849 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -88.43 -23.89 23.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 73.0 111.146 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.77 -53.51 1.23 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 75.230000000000004 110.841 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.28 28.48 15.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 71.129999999999995 110.919 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 71.9 p -114.65 -3.17 12.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 75.420000000000002 111.134 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 7.6 mtmt -152.05 18.52 0.67 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 64.439999999999998 110.888 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -177.11 146.84 0.52 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 74.549999999999997 111.052 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 18.8 p -106.93 157.47 17.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 74.219999999999999 111.158 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 9.8 m -140.9 141.08 32.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.184 -0.462 . . . . 74.430000000000007 111.108 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -148.6 108.81 4.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 72.310000000000002 110.881 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . 0.429 ' HA ' ' HA ' ' A' ' 214' ' ' ILE . 3.8 p -87.36 143.42 11.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.491 . . . . 71.329999999999998 111.158 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -171.83 123.27 0.52 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 74.140000000000001 110.855 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 55.76 47.4 78.68 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.773 -0.727 . . . . 51.340000000000003 112.471 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 1.7 mtp 63.5 15.83 9.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.867 0.365 . . . . 70.140000000000001 110.869 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 1.1 m -126.51 113.72 17.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.434 . . . . 72.230000000000004 111.178 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.429 ' HA ' ' HA ' ' A' ' 209' ' ' VAL . 3.2 mp -110.16 115.48 49.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.241 -0.436 . . . . 73.209999999999994 111.145 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 3.8 m -88.3 131.05 34.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.459 . . . . 74.420000000000002 111.116 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 2.8 t -116.88 124.56 73.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 74.510000000000005 111.136 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -107.9 137.92 45.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 64.310000000000002 110.922 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -93.22 80.74 1.06 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.767 -0.73 . . . . 74.219999999999999 112.445 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 19.7 t -50.49 -54.83 7.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.882 0.372 . . . . 74.109999999999999 111.116 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -130.01 162.88 27.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 74.340000000000003 111.09 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -62.09 140.19 58.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 74.329999999999998 111.068 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 140.1 171.2 12.28 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.676 -0.773 . . . . 73.150000000000006 112.473 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 14.0 mttt -99.5 124.24 44.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.826 0.346 . . . . 64.5 110.871 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 7.0 p -121.02 127.08 75.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 73.109999999999999 111.149 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 33.2 m120 -90.88 151.72 21.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 75.099999999999994 110.851 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 4.0 mp -136.52 93.27 14.46 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.618 0.723 . . . . 74.400000000000006 111.156 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 179.89 3.38 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.689 2.259 . . . . 73.349999999999994 112.325 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 97.2 t -150.31 141.41 16.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 72.439999999999998 111.201 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 46.5 t -124.51 138.31 54.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 75.329999999999998 111.144 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 1.7 t -122.18 108.76 13.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 61.229999999999997 110.88 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 69.27 -119.35 9.37 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.732 -0.747 . . . . 75.400000000000006 112.505 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -104.56 21.14 17.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.807 0.336 . . . . 74.129999999999995 110.866 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 112.35 5.63 24.49 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.741 -0.742 . . . . 33.530000000000001 112.521 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -51.28 -44.03 61.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.867 0.365 . . . . 74.420000000000002 110.863 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -138.56 167.04 22.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 72.329999999999998 110.886 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -163.53 164.72 24.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 75.120000000000005 111.122 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -143.84 163.18 34.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.436 . . . . 72.129999999999995 111.145 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 10.5 p -137.94 136.69 45.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 75.019999999999996 111.115 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -139.16 165.17 27.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 63.450000000000003 111.102 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -143.87 132.13 21.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 73.420000000000002 110.898 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 24.7 mm -127.2 113.93 34.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.205 -0.452 . . . . 74.209999999999994 111.145 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 2.8 m -82.81 141.23 32.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 75.200000000000003 111.146 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 17.0 t -120.06 120.95 64.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 75.230000000000004 111.173 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 5.4 p -82.33 132.79 35.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 63.509999999999998 111.118 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -57.41 -23.42 49.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 74.230000000000004 111.095 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 2.1 t . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 73.219999999999999 110.859 -179.769 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.175 0 CA-C-O 120.896 0.379 . . . . 74.140000000000001 111.082 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -131.68 27.09 4.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.236 -0.438 . . . . 72.530000000000001 111.106 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 145.92 101.93 0.32 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.778 -0.725 . . . . 62.229999999999997 112.484 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 42.9 ttp -114.49 126.16 54.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.863 0.364 . . . . 73.200000000000003 110.829 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 43.4 p -115.65 105.69 13.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 74.409999999999997 111.154 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 21.5 t -101.52 130.76 50.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 64.519999999999996 111.102 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.3 m -123.82 92.42 48.54 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.549 0.69 . . . . 73.230000000000004 111.121 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -167.2 0.21 Allowed 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.66 2.24 . . . . 75.030000000000001 112.361 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -90.2 -40.85 11.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 62.549999999999997 111.126 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 93.0 p 46.74 79.6 0.06 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 74.030000000000001 110.839 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.5 t -175.33 -175.63 0.84 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 74.409999999999997 111.137 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 41.7 p -98.75 163.63 12.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 71.409999999999997 110.831 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 3.0 p -145.6 153.57 13.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.124 -0.489 . . . . 70.099999999999994 111.107 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 99.1 t -87.24 144.71 8.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 74.230000000000004 111.134 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -47.95 122.57 5.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.216 -0.447 . . . . 75.310000000000002 110.891 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.75 -13.5 60.86 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.759 -0.734 . . . . 75.409999999999997 112.473 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 11.0 mm100 -93.38 -179.58 5.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.776 0.322 . . . . 63.399999999999999 110.913 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 57.4 p -162.09 148.09 13.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 70.049999999999997 110.849 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 6.9 t -105.26 -173.72 2.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.136 -0.484 . . . . 74.329999999999998 111.158 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -140.11 130.53 25.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 62.43 111.165 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.6 mp -103.53 142.39 34.36 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.245 -0.434 . . . . 74.540000000000006 110.93 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 10.9 m -109.46 142.72 40.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.262 -0.426 . . . . 74.409999999999997 111.166 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 21.9 t -129.45 141.53 46.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.231 -0.44 . . . . 71.239999999999995 111.154 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -132.28 151.86 51.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.463 . . . . 63.030000000000001 111.132 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -145.33 126.73 14.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.275 -0.42 . . . . 72.120000000000005 110.882 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.97 66.69 79.65 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.57 0.7 . . . . 72.109999999999999 110.889 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--N 1.341 0.138 0 C-N-CA 122.668 2.245 . . . . 74.040000000000006 112.328 -179.993 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.903 0.382 . . . . 73.239999999999995 110.838 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -65.63 90.08 0.11 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 74.439999999999998 110.897 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 47.3 t -105.4 -6.66 19.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.254 -0.43 . . . . 70.540000000000006 110.848 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 17.1 p90 -90.82 177.68 6.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 65.129999999999995 110.878 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.44 175.29 9.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 75.430000000000007 110.908 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -122.57 168.08 12.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 73.109999999999999 111.102 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 8.7 p -173.61 153.61 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.214 -0.448 . . . . 71.430000000000007 111.121 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.66 133.42 33.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 75.150000000000006 110.908 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -69.26 -21.11 63.92 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.154 -0.476 . . . . 74.150000000000006 111.074 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -132.61 -46.15 0.89 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 71.129999999999995 110.858 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.11 27.45 7.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 74.230000000000004 110.93 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 53.3 p -112.13 -13.66 13.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 73.510000000000005 111.155 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? -139.26 24.88 2.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 72.439999999999998 110.87 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . 179.06 143.3 0.13 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 73.319999999999993 111.137 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 7.8 p -106.99 131.23 54.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.231 -0.441 . . . . 74.140000000000001 111.121 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 5.0 m -118.34 143.33 29.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 72.030000000000001 111.153 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 3.3 m -149.3 108.7 3.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.466 . . . . 53.530000000000001 110.854 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . 0.437 ' HA ' ' HA ' ' A' ' 214' ' ' ILE . 4.1 p -83.82 143.97 10.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 73.010000000000005 111.144 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 5.3 t -171.75 122.58 0.51 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 60.210000000000001 110.878 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 54.19 50.41 55.89 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.732 -0.747 . . . . 73.549999999999997 112.464 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 1.8 mtp 61.05 17.41 7.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.834 0.35 . . . . 75.109999999999999 110.831 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 12.7 m -129.44 113.1 14.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.253 -0.43 . . . . 74.040000000000006 111.139 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.437 ' HA ' ' HA ' ' A' ' 209' ' ' VAL . 2.9 mp -108.92 114.92 48.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 74.140000000000001 111.102 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 10.2 m -88.0 128.09 35.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 71.209999999999994 111.141 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 2.8 t -114.46 121.93 67.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.46 . . . . 74.129999999999995 111.109 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -106.0 144.43 32.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 73.019999999999996 110.861 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -96.64 66.26 0.99 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.693 -0.765 . . . . 75.109999999999999 112.478 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -50.13 -42.08 19.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.863 0.363 . . . . 74.219999999999999 111.142 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -125.2 154.04 42.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.454 . . . . 54.32 111.106 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -73.47 131.89 42.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.232 -0.44 . . . . 70.299999999999997 111.085 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 143.93 177.31 18.72 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.722 -0.752 . . . . 72.540000000000006 112.494 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 12.6 mttt -98.89 136.26 39.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.84 0.352 . . . . 73.239999999999995 110.885 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 7.6 p -137.58 133.61 45.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.223 -0.444 . . . . 74.349999999999994 111.125 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 36.7 m120 -90.94 154.05 19.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 73.129999999999995 110.885 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . 0.404 ' HA ' ' HD2' ' A' ' 227' ' ' PRO . 4.1 mp -136.83 92.54 14.44 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.58 0.705 . . . . 73.510000000000005 111.162 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 226' ' ' ILE . 53.6 Cg_endo -69.79 179.05 3.99 Favored 'Trans proline' 0 C--O 1.231 0.141 0 C-N-CA 122.671 2.248 . . . . 73.540000000000006 112.353 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 57.9 t -149.26 137.19 14.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.252 -0.431 . . . . 71.430000000000007 111.165 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 98.6 t -117.55 138.65 47.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 75.129999999999995 111.124 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -121.66 106.96 11.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 74.420000000000002 110.87 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 56.93 -115.04 5.95 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.722 -0.751 . . . . 65.319999999999993 112.486 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -94.56 21.08 7.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.848 0.356 . . . . 74.420000000000002 110.853 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 97.49 9.19 55.44 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.756 -0.735 . . . . 63.100000000000001 112.485 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -51.94 -30.52 24.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.896 0.379 . . . . 72.540000000000006 110.871 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -145.59 163.41 34.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.153 -0.476 . . . . 74.239999999999995 110.907 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -161.71 165.26 28.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 73.219999999999999 111.078 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -143.86 163.24 33.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 75.510000000000005 111.13 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 59.2 t -136.52 132.84 48.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.264 -0.425 . . . . 71.120000000000005 111.114 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.71 165.39 27.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 75.430000000000007 111.074 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -144.52 131.76 20.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 71.239999999999995 110.856 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 34.8 mm -127.25 114.95 38.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.123 -0.49 . . . . 74.439999999999998 111.123 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 3.0 m -86.42 140.7 29.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.13 -0.487 . . . . 73.510000000000005 111.157 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 19.8 t -120.5 120.04 61.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 73.510000000000005 111.145 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 6.4 p -81.56 132.96 35.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 64.040000000000006 111.203 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -57.46 -26.67 61.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.281 -0.418 . . . . 74.540000000000006 111.138 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 15.1 m . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 73.430000000000007 110.893 -179.814 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.888 0.375 . . . . 72.019999999999996 111.096 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -130.08 27.2 5.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 73.439999999999998 111.148 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 146.66 100.68 0.27 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.727 -0.749 . . . . 74.239999999999995 112.446 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 45.9 ttp -111.32 130.54 55.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.807 0.337 . . . . 54.32 110.919 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 50.1 p -119.65 102.4 8.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.251 -0.431 . . . . 73.439999999999998 111.131 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 21.1 t -97.82 133.14 40.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 75.310000000000002 111.119 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.1 m -126.11 92.22 46.28 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.57 0.7 . . . . 72.120000000000005 111.173 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.8 -166.14 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.698 2.265 . . . . 62.340000000000003 112.335 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -89.03 -42.64 11.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 61.119999999999997 111.117 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 22.9 t 49.29 79.14 0.08 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.241 -0.436 . . . . 73.549999999999997 110.899 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.5 t -175.44 -175.54 0.81 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 73.239999999999995 111.146 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 38.1 p -98.8 163.88 12.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 73.329999999999998 110.849 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 2.6 p -145.81 152.56 14.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 73.420000000000002 111.158 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 38.8 t -85.76 145.28 8.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 74.409999999999997 111.12 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.24 122.09 5.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 72.420000000000002 110.881 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.18 -11.18 61.95 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.745 -0.741 . . . . 74.310000000000002 112.448 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 20.9 mm100 -91.37 -177.21 4.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.826 0.346 . . . . 75.140000000000001 110.883 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -160.56 149.31 16.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 51.340000000000003 110.858 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 7.7 t -111.3 -177.27 3.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.124 -0.489 . . . . 75.420000000000002 111.12 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -138.07 133.62 33.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.211 -0.45 . . . . 74.319999999999993 111.176 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.8 mp -107.7 146.4 32.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.233 -0.44 . . . . 74.099999999999994 110.918 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 2.1 m -113.94 143.53 44.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.459 . . . . 74.430000000000007 111.119 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 21.3 t -129.33 138.18 55.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 73.239999999999995 111.163 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -126.22 151.38 47.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 74.329999999999998 111.087 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -144.9 131.76 20.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.221 -0.445 . . . . 74.219999999999999 110.907 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.9 66.38 47.53 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.605 0.717 . . . . 70.299999999999997 110.952 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo . . . . . 0 C--N 1.342 0.186 0 C-N-CA 122.653 2.235 . . . . 55.520000000000003 112.355 -179.991 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 37.5 t0 . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.881 0.372 . . . . 71.25 110.867 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.72 87.1 6.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 65.310000000000002 110.898 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 14.4 m -102.3 -5.43 24.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 74.349999999999994 110.88 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -89.78 172.89 8.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 73.409999999999997 110.854 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.82 171.44 16.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.104 -0.498 . . . . 75.209999999999994 110.848 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -114.86 168.04 10.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 72.209999999999994 111.089 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 9.6 p -159.88 152.85 5.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.25 -0.432 . . . . 73.510000000000005 111.12 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.77 119.0 28.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 74.209999999999994 110.844 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -62.89 -18.62 63.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 74.409999999999997 111.108 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -163.49 89.55 0.61 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 73.439999999999998 110.858 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 9.1 tmtt? -82.63 55.45 2.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.446 . . . . 74.319999999999993 110.907 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 25.9 p -129.44 1.18 5.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 74.310000000000002 111.139 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 10.6 mtmt -157.38 19.48 0.29 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 75.519999999999996 110.895 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . 179.65 148.45 0.27 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 72.510000000000005 111.112 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 9.4 p -105.68 153.94 21.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.194 -0.457 . . . . 73.230000000000004 111.125 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 18.9 m -140.77 135.14 33.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.448 . . . . 75.230000000000004 111.172 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 4.6 m -144.32 109.31 5.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 61.119999999999997 110.8 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 5.5 p -92.47 144.44 9.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 75.310000000000002 111.168 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 2.7 m -146.56 99.42 3.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 73.519999999999996 110.859 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 70.17 -81.43 0.36 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.745 -0.74 . . . . 61.140000000000001 112.482 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -139.71 9.01 2.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.826 0.346 . . . . 64.400000000000006 110.844 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 56.9 m -128.52 124.42 35.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.242 -0.435 . . . . 72.120000000000005 111.141 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 2.5 mp -117.87 135.27 58.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 72.120000000000005 111.113 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.21 128.25 51.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.461 . . . . 70.120000000000005 111.108 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 6.8 t -118.05 131.39 70.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.227 -0.442 . . . . 75.420000000000002 111.137 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -116.45 139.22 50.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 62.200000000000003 110.905 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -94.88 78.95 0.88 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.734 -0.745 . . . . 74.420000000000002 112.492 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 17.2 t -49.56 -54.24 7.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.827 0.346 . . . . 75.329999999999998 111.149 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -129.6 162.92 27.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 65.219999999999999 111.105 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -61.83 138.36 58.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.447 . . . . 74.430000000000007 111.09 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 144.25 170.33 13.57 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.74 -0.743 . . . . 52.210000000000001 112.488 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 13.3 mttt -100.19 124.0 45.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.793 0.33 . . . . 75.129999999999995 110.921 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 6.3 p -123.76 122.98 66.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 73.140000000000001 111.091 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -91.19 156.27 17.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.466 . . . . 75.230000000000004 110.923 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 4.7 mp -138.63 92.86 11.27 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.554 0.692 . . . . 74.25 111.114 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.88 -178.93 2.62 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.672 2.248 . . . . 74.430000000000007 112.31 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 23.5 t -146.52 149.24 16.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.455 . . . . 74.349999999999994 111.146 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 86.9 t -138.17 138.38 43.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 74.319999999999993 111.082 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -121.98 119.97 33.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 74.120000000000005 110.848 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 58.08 -112.2 3.7 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.714 -0.755 . . . . 54.439999999999998 112.5 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -99.81 7.42 44.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.874 0.368 . . . . 73.109999999999999 110.892 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 114.46 16.09 7.83 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.691 -0.766 . . . . 73.430000000000007 112.495 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -51.13 -38.42 51.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.891 0.377 . . . . 71.209999999999994 110.863 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -143.07 167.04 23.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 64.140000000000001 110.911 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -162.23 165.32 26.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.113 -0.494 . . . . 74.430000000000007 111.1 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -139.11 163.61 31.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.441 . . . . 71.319999999999993 111.135 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 61.2 t -132.46 127.2 56.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.233 -0.44 . . . . 64.439999999999998 111.095 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -134.38 161.15 35.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.169 -0.469 . . . . 75.150000000000006 111.065 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -145.31 132.68 20.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 74.549999999999997 110.874 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 28.8 mm -126.95 112.85 30.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 72.299999999999997 111.129 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 1.9 m -83.06 141.49 32.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 75.129999999999995 111.179 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 14.0 t -119.92 121.6 66.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 75.040000000000006 111.156 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 8.1 p -83.65 132.37 34.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.145 -0.479 . . . . 72.420000000000002 111.14 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -53.72 -27.64 29.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 70.540000000000006 111.099 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 11.5 m . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 65.010000000000005 110.812 -179.726 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.855 0.36 . . . . 74.0 111.118 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 1.1 p -119.55 3.92 11.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 73.439999999999998 111.167 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 173.74 101.73 0.15 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.741 -0.742 . . . . 73.010000000000005 112.447 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 16.3 ttp -111.84 125.17 53.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.86 0.362 . . . . 41.049999999999997 110.88 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 59.2 p -113.98 103.07 10.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.446 . . . . 72.200000000000003 111.129 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 20.7 t -99.83 131.29 47.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.215 -0.448 . . . . 73.230000000000004 111.11 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.8 m -126.81 92.57 44.37 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.565 0.697 . . . . 74.430000000000007 111.12 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 -167.7 0.24 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.686 2.257 . . . . 73.219999999999999 112.317 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -85.38 -41.66 15.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 75.420000000000002 111.121 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 88.7 p 46.46 75.08 0.13 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.461 . . . . 63.229999999999997 110.85 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.4 t -172.32 -175.08 1.33 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.107 -0.497 . . . . 74.420000000000002 111.165 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 86.6 p -98.9 164.08 12.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.262 -0.427 . . . . 72.319999999999993 110.844 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 3.0 p -147.39 153.77 11.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.114 -0.494 . . . . 72.109999999999999 111.116 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 64.3 t -87.87 145.44 7.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 71.439999999999998 111.132 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.98 122.75 6.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 71.319999999999993 110.864 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 100.08 -15.33 59.33 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.782 -0.723 . . . . 42.439999999999998 112.517 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -89.64 -177.97 5.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.807 0.337 . . . . 73.209999999999994 110.941 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 15.1 p -161.6 148.87 14.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 75.409999999999997 110.859 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 7.3 t -108.95 -173.86 2.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 73.109999999999999 111.133 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.41 131.87 26.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 74.219999999999999 111.13 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.6 mp -104.21 141.72 35.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 74.329999999999998 110.954 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.9 m -110.0 141.49 42.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.212 -0.449 . . . . 73.409999999999997 111.158 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 32.5 t -129.62 141.04 47.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.242 -0.435 . . . . 74.010000000000005 111.143 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -131.53 151.46 51.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 72.450000000000003 111.114 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -143.72 129.81 19.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.249 -0.432 . . . . 74.420000000000002 110.862 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.54 66.91 58.76 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.616 0.722 . . . . 75.129999999999995 110.907 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--N 1.341 0.163 0 C-N-CA 122.684 2.256 . . . . 72.25 112.362 179.986 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.859 0.362 . . . . 74.400000000000006 110.897 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.67 104.09 0.98 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 72.5 110.919 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -117.38 -6.21 11.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 73.209999999999994 110.834 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -90.45 178.59 6.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 72.409999999999997 110.886 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.14 172.01 11.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 71.340000000000003 110.897 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -128.02 144.56 51.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 72.329999999999998 111.092 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 59.7 t -150.64 146.65 16.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 71.099999999999994 111.145 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 26.6 t -70.58 136.83 49.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.19 -0.459 . . . . 61.109999999999999 110.909 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -76.35 -8.41 57.06 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.149 -0.478 . . . . 71.439999999999998 111.092 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -142.85 -56.33 0.42 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.248 -0.433 . . . . 55.340000000000003 110.871 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 64.39 26.27 13.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.446 . . . . 74.200000000000003 110.91 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 80.6 p -114.24 -3.21 13.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 74.010000000000005 111.101 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 8.7 mtmm -149.19 16.4 0.93 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.274 -0.421 . . . . 75.109999999999999 110.859 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -177.69 146.78 0.46 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.259 -0.428 . . . . 75.349999999999994 111.139 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 15.9 p -104.81 153.37 21.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 65.5 111.136 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 35.5 m -136.88 140.96 41.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 75.040000000000006 111.115 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.98 108.3 4.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 74.140000000000001 110.865 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . 0.422 ' HA ' ' HA ' ' A' ' 214' ' ' ILE . 3.7 p -87.95 143.46 11.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.064 -0.516 . . . . 73.230000000000004 111.139 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 3.8 t -172.13 123.14 0.49 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 64.129999999999995 110.851 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 55.71 47.8 75.73 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.773 -0.727 . . . . 64.129999999999995 112.452 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 3.8 mtp 63.19 16.27 9.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.833 0.349 . . . . 73.040000000000006 110.867 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 21.0 m -126.47 113.48 16.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.261 -0.427 . . . . 73.219999999999999 111.114 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.422 ' HA ' ' HA ' ' A' ' 209' ' ' VAL . 3.1 mp -110.46 115.54 50.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.463 . . . . 63.219999999999999 111.121 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 2.6 m -88.88 132.66 34.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.24 -0.436 . . . . 74.200000000000003 111.169 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 3.5 t -118.0 125.69 74.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.257 -0.429 . . . . 75.510000000000005 111.104 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -109.12 136.87 47.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.104 -0.498 . . . . 75.120000000000005 110.873 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -91.16 83.56 1.27 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.734 -0.746 . . . . 73.310000000000002 112.499 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 20.3 t -53.99 -52.52 35.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.857 0.36 . . . . 75.530000000000001 111.151 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -134.34 163.18 30.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 73.319999999999993 111.129 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -56.64 144.84 30.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 75.310000000000002 111.107 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 129.92 166.29 11.81 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.791 -0.719 . . . . 71.239999999999995 112.535 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 2.6 mtmm -101.32 129.67 47.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.833 0.349 . . . . 74.200000000000003 110.907 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 7.4 p -118.58 129.68 74.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.263 -0.426 . . . . 72.209999999999994 111.149 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 35.2 m120 -89.71 147.4 23.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 70.219999999999999 110.889 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 4.3 mp -137.75 93.35 12.33 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.633 0.73 . . . . 74.540000000000006 111.161 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -176.9 1.65 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.729 2.286 . . . . 74.25 112.297 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 48.2 t -147.3 134.72 14.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 74.420000000000002 111.082 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 93.7 t -117.95 133.08 65.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.177 -0.465 . . . . 73.25 111.109 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.23 116.28 23.85 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.128 -0.487 . . . . 73.049999999999997 110.845 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 61.18 -121.13 25.44 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.743 -0.742 . . . . 73.109999999999999 112.469 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -95.78 15.43 20.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.871 0.367 . . . . 74.120000000000005 110.904 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 111.13 9.96 21.3 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.747 -0.739 . . . . 65.409999999999997 112.459 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -51.11 -65.08 0.62 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.906 0.384 . . . . 72.319999999999993 110.907 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -110.78 156.03 21.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 74.109999999999999 110.894 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -153.16 164.69 37.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 63.149999999999999 111.053 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -144.86 163.88 32.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.456 . . . . 75.310000000000002 111.119 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 14.1 p -137.91 134.65 45.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 75.140000000000001 111.105 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -139.31 164.37 30.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.119 -0.491 . . . . 73.019999999999996 111.116 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -147.56 131.14 16.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.249 -0.432 . . . . 63.310000000000002 110.879 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 30.7 mm -122.83 115.0 44.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 71.420000000000002 111.064 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -83.0 141.28 32.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.179 -0.464 . . . . 74.409999999999997 111.149 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 19.5 t -120.39 120.32 62.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.225 -0.443 . . . . 73.409999999999997 111.161 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 4.9 p -82.61 132.95 35.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 75.349999999999994 111.133 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -58.71 -21.67 55.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.439 . . . . 72.120000000000005 111.086 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 4.5 m . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.443 . . . . 71.430000000000007 110.883 -179.807 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.889 0.376 . . . . 70.329999999999998 111.073 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -125.14 32.11 5.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 74.319999999999993 111.183 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 138.46 99.58 0.48 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.775 -0.726 . . . . 75.239999999999995 112.473 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 41.2 ttp -111.11 129.07 56.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.882 0.372 . . . . 73.319999999999993 110.841 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 40.4 p -118.0 105.86 12.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.194 -0.457 . . . . 75.230000000000004 111.13 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 21.5 t -99.87 133.64 42.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 75.200000000000003 111.167 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.3 m -126.2 92.49 45.56 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.593 0.711 . . . . 73.109999999999999 111.145 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -167.88 0.25 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.7 2.267 . . . . 75.019999999999996 112.338 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -87.15 -38.13 16.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 75.420000000000002 111.121 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 94.4 p 46.21 79.54 0.05 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 53.229999999999997 110.87 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.4 t -175.39 -174.6 0.74 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.17 -0.468 . . . . 74.329999999999998 111.164 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 33.0 p -101.06 162.0 13.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 72.219999999999999 110.875 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 2.6 p -144.83 154.25 14.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 74.450000000000003 111.133 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 93.2 t -89.91 144.9 8.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 75.099999999999994 111.137 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -47.75 124.11 6.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 74.439999999999998 110.922 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.69 -17.22 57.79 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.756 -0.735 . . . . 52.109999999999999 112.465 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 10.7 mm100 -87.99 -177.77 5.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.768 0.318 . . . . 75.430000000000007 110.956 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 1.7 p -161.86 148.91 14.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.237 -0.438 . . . . 74.409999999999997 110.875 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 9.2 t -111.04 -174.86 2.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.14 -0.482 . . . . 72.439999999999998 111.112 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.21 132.46 29.89 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.174 -0.466 . . . . 74.329999999999998 111.139 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.6 mp -106.36 143.3 34.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 74.349999999999994 110.904 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 16.3 m -110.31 143.91 39.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.451 . . . . 64.219999999999999 111.129 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 22.9 t -129.69 142.36 44.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.214 -0.448 . . . . 73.409999999999997 111.143 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -131.55 150.92 51.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 70.349999999999994 111.081 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -144.47 126.45 15.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 72.109999999999999 110.881 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.22 67.23 79.61 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.565 0.698 . . . . 74.549999999999997 110.892 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--N 1.341 0.174 0 C-N-CA 122.674 2.249 . . . . 72.140000000000001 112.387 179.962 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.886 0.374 . . . . 70.319999999999993 110.854 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 5.1 mtmt -54.39 101.45 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 74.400000000000006 110.918 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 23.0 t -115.22 -5.99 12.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 70.329999999999998 110.837 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -90.31 172.15 8.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.127 -0.488 . . . . 63.409999999999997 110.873 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.58 158.89 36.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 74.329999999999998 110.886 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -112.83 165.97 11.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.445 . . . . 73.450000000000003 111.094 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 10.7 p -175.18 151.84 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 72.530000000000001 111.132 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.6 t -79.25 144.49 34.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 72.239999999999995 110.866 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -78.57 -22.6 46.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 75.519999999999996 111.073 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -127.63 -54.87 1.33 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 60.5 110.814 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 1.7 ttpm? 63.43 27.92 15.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.469 . . . . 72.400000000000006 110.885 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 44.8 p -115.76 -1.77 12.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.265 -0.425 . . . . 71.200000000000003 111.149 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 11.2 mtmm -149.61 16.48 0.89 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 73.109999999999999 110.919 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -174.9 150.68 1.27 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 72.040000000000006 111.078 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 23.9 p -112.88 134.65 54.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 71.200000000000003 111.145 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 5.3 m -122.4 139.65 48.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.221 -0.445 . . . . 72.200000000000003 111.108 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -144.1 108.87 4.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 75.540000000000006 110.848 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . 0.429 ' HA ' ' HA ' ' A' ' 214' ' ' ILE . 4.3 p -84.84 143.76 11.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 64.420000000000002 111.142 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 11.8 t -172.12 124.47 0.52 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 74.439999999999998 110.865 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 52.87 52.0 41.81 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.728 -0.749 . . . . 55.43 112.478 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 2.2 mtp 58.75 19.61 7.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.885 0.374 . . . . 74.209999999999994 110.914 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 1.6 m -131.56 113.21 13.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.229 -0.441 . . . . 73.439999999999998 111.164 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.429 ' HA ' ' HA ' ' A' ' 209' ' ' VAL . 3.1 mp -109.71 116.78 53.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 74.409999999999997 111.118 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 1.1 m -89.86 129.91 36.16 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.148 -0.478 . . . . 72.010000000000005 111.118 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 3.5 t -115.75 129.6 71.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 74.540000000000006 111.063 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -112.32 135.12 53.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.119 -0.491 . . . . 63.229999999999997 110.875 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -82.1 67.04 3.76 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.752 -0.737 . . . . 70.299999999999997 112.519 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 1.4 t -48.4 -51.05 11.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.848 0.356 . . . . 74.010000000000005 111.153 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -127.86 154.87 44.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 54.409999999999997 111.093 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -66.63 136.36 55.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 73.420000000000002 111.078 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 139.21 171.91 12.41 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.726 -0.749 . . . . 71.129999999999995 112.487 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 8.3 mttm -96.02 125.19 40.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.806 0.336 . . . . 74.349999999999994 110.918 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 7.7 p -121.42 131.25 73.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.268 -0.423 . . . . 75.400000000000006 111.141 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 34.3 m120 -90.54 151.41 21.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 64.400000000000006 110.859 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 4.3 mp -136.71 92.71 14.55 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.633 0.73 . . . . 64.340000000000003 111.136 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.82 179.92 3.39 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.664 2.243 . . . . 62.43 112.339 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 96.7 t -150.63 137.54 13.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 73.230000000000004 111.161 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 92.7 t -122.38 134.55 65.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 73.049999999999997 111.115 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -122.22 125.02 45.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.15 -0.477 . . . . 75.420000000000002 110.869 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 56.77 -117.74 10.21 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.74 -0.743 . . . . 70.120000000000005 112.468 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -94.44 8.46 42.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.865 0.364 . . . . 75.230000000000004 110.85 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 106.94 9.61 29.83 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.717 -0.754 . . . . 63.229999999999997 112.473 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -51.67 -40.66 60.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.886 0.374 . . . . 74.230000000000004 110.884 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -127.68 167.25 16.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.481 . . . . 75.400000000000006 110.873 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -166.26 165.34 17.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 73.200000000000003 111.081 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -139.33 163.19 33.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.222 -0.445 . . . . 73.450000000000003 111.103 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.0 p -135.32 127.71 47.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.441 . . . . 74.519999999999996 111.112 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -130.52 163.07 27.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.13 -0.486 . . . . 64.129999999999995 111.086 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -144.31 128.29 17.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.439 . . . . 73.319999999999993 110.876 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 26.0 mm -124.92 111.2 27.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 74.129999999999995 111.127 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 4.0 m -81.63 139.94 34.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 73.310000000000002 111.131 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 30.5 t -120.26 119.06 58.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 71.319999999999993 111.142 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 5.1 p -81.12 132.87 35.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.151 -0.477 . . . . 73.420000000000002 111.102 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -54.06 -27.66 33.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 64.430000000000007 111.113 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 10.2 m . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.237 -0.438 . . . . 73.519999999999996 110.875 -179.783 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.842 0.354 . . . . 75.430000000000007 111.115 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 1.1 m -137.55 27.58 2.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 75.239999999999995 111.138 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 147.01 105.65 0.43 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.801 -0.714 . . . . 72.430000000000007 112.522 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 1.5 ttp -120.0 140.52 50.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.875 0.369 . . . . 71.430000000000007 110.886 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 32.8 p -126.43 109.83 12.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.445 . . . . 71.510000000000005 111.167 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 21.7 t -97.57 134.98 33.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 74.200000000000003 111.102 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 4.3 m -126.94 92.59 44.1 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.631 0.729 . . . . 75.349999999999994 111.168 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -167.65 0.23 Allowed 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.686 2.257 . . . . 73.400000000000006 112.373 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -89.88 -43.16 10.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 73.140000000000001 111.093 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 12.2 t 49.7 80.98 0.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 72.409999999999997 110.835 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.5 t -175.13 -175.46 0.85 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 75.209999999999994 111.199 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 83.3 p -98.45 161.69 13.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.436 . . . . 71.040000000000006 110.893 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 3.1 p -144.24 153.92 15.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 73.439999999999998 111.132 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 64.7 t -87.5 144.99 8.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 74.329999999999998 111.159 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.6 122.55 5.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.451 . . . . 74.209999999999994 110.883 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.59 -14.2 60.73 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.753 -0.737 . . . . 65.209999999999994 112.475 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -91.61 -178.23 5.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.802 0.334 . . . . 75.439999999999998 110.915 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 54.3 p -161.55 146.24 13.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 75.209999999999994 110.862 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 7.0 t -103.34 -173.85 2.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.083 -0.508 . . . . 75.109999999999999 111.158 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.51 132.86 28.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.219 -0.446 . . . . 74.540000000000006 111.14 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.5 mp -106.63 145.25 32.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 72.400000000000006 110.943 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 2.2 m -113.81 145.56 41.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.238 -0.437 . . . . 63.210000000000001 111.13 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 21.9 t -129.48 142.18 44.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 72.340000000000003 111.124 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -128.74 152.94 47.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 72.319999999999993 111.088 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -143.99 128.25 17.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 73.040000000000006 110.852 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' GLN . . . . . 0.405 ' N ' HE21 ' A' ' 186' ' ' GLN . 0.0 OUTLIER -132.72 66.93 77.6 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.606 0.717 . . . . 64.310000000000002 110.9 -179.935 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--N 1.341 0.159 0 C-N-CA 122.694 2.263 . . . . 72.540000000000006 112.387 179.972 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 37.6 t70 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.918 0.389 . . . . 75.420000000000002 110.86 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 24.8 mtmt -74.31 74.68 1.85 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 73.519999999999996 110.894 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -75.55 -6.25 49.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 74.010000000000005 110.826 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -90.03 151.81 21.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 74.129999999999995 110.898 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.59 154.04 43.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.144 -0.48 . . . . 75.299999999999997 110.923 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -103.81 167.77 9.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 75.209999999999994 111.103 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 9.3 p -173.25 152.99 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 75.400000000000006 111.171 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 73.4 p -76.6 152.86 35.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 71.010000000000005 110.866 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -93.86 -19.54 20.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.126 -0.488 . . . . 73.040000000000006 111.135 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.84 -55.28 0.93 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 73.519999999999996 110.864 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.54 26.41 14.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 72.219999999999999 110.881 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 41.5 p -112.9 -3.92 14.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 65.430000000000007 111.152 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 10.2 mtmm -154.21 19.87 0.49 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 72.549999999999997 110.898 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -177.46 147.6 0.53 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 73.430000000000007 111.105 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 15.0 p -108.65 159.67 16.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 75.519999999999996 111.159 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 7.7 m -141.37 141.97 29.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.246 -0.434 . . . . 74.219999999999999 111.107 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 69.8 m -149.1 108.66 3.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 73.430000000000007 110.888 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . 0.428 ' HA ' ' HA ' ' A' ' 214' ' ' ILE . 3.6 p -88.97 143.15 11.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.1 -0.5 . . . . 73.030000000000001 111.119 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 18.8 t -172.16 123.48 0.49 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.47 . . . . 75.239999999999995 110.864 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 56.04 47.02 83.24 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.719 -0.753 . . . . 64.430000000000007 112.524 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 2.4 mtp 63.85 15.94 9.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.904 0.383 . . . . 75.310000000000002 110.908 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 6.5 m -125.6 113.14 17.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.459 . . . . 75.5 111.128 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.428 ' HA ' ' HA ' ' A' ' 209' ' ' VAL . 3.0 mp -110.43 113.98 45.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 75.219999999999999 111.127 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 7.3 m -88.95 132.78 34.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.129 -0.487 . . . . 71.420000000000002 111.184 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 4.4 t -117.94 123.54 71.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.257 -0.429 . . . . 61.340000000000003 111.124 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -104.94 140.0 38.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 73.219999999999999 110.901 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -95.41 79.31 0.83 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.726 -0.749 . . . . 73.239999999999995 112.478 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 18.3 t -49.54 -54.67 6.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.821 0.343 . . . . 65.099999999999994 111.12 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -130.85 162.07 30.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 71.530000000000001 111.075 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -60.36 141.82 55.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 73.329999999999998 111.141 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 139.4 172.05 12.5 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.757 -0.735 . . . . 51.229999999999997 112.471 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 5.0 mttt -99.74 120.84 40.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.824 0.345 . . . . 74.409999999999997 110.89 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 6.4 p -117.46 122.88 70.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.213 -0.448 . . . . 74.400000000000006 111.133 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -90.99 152.74 20.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.163 -0.472 . . . . 73.439999999999998 110.908 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 3.9 mp -137.74 92.72 12.76 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.632 0.729 . . . . 64.120000000000005 111.13 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 177.1 5.88 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.67 2.247 . . . . 65.310000000000002 112.376 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 34.6 t -146.18 139.11 20.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.257 -0.429 . . . . 74.120000000000005 111.102 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 91.4 t -129.25 143.79 40.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.15 -0.477 . . . . 71.200000000000003 111.178 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 6.0 p -92.4 176.0 6.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 71.140000000000001 110.832 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -51.16 -45.97 51.41 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.761 -0.733 . . . . 73.349999999999994 112.499 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 20.2 t30 -111.48 21.08 16.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.873 0.368 . . . . 65.010000000000005 110.885 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 61.7 16.02 49.69 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.724 -0.75 . . . . 72.129999999999995 112.469 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -66.36 -44.45 83.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.894 0.378 . . . . 75.299999999999997 110.902 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -117.3 144.93 44.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.146 -0.479 . . . . 74.209999999999994 110.909 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -144.71 163.23 34.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 72.319999999999993 111.101 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -142.65 163.4 32.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 63.299999999999997 111.052 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 57.3 t -139.6 136.6 40.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.215 -0.448 . . . . 74.120000000000005 111.132 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.17 165.08 27.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.466 . . . . 72.140000000000001 111.075 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -143.79 132.25 22.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 74.120000000000005 110.862 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 24.1 mm -127.27 113.28 31.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 74.409999999999997 111.156 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 1.7 m -81.42 141.06 34.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 72.540000000000006 111.134 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 17.2 t -119.95 122.13 67.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 73.439999999999998 111.144 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 7.2 p -82.57 133.05 35.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 73.239999999999995 111.159 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -59.14 -21.87 60.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 75.040000000000006 111.088 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 52.3 p . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 72.140000000000001 110.856 -179.782 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.905 0.384 . . . . 60.229999999999997 111.078 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -124.6 31.96 5.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 74.409999999999997 111.109 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 138.28 99.17 0.48 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.743 -0.741 . . . . 70.450000000000003 112.486 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 35.2 ttp -109.71 130.91 55.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.822 0.344 . . . . 71.409999999999997 110.888 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 36.5 p -120.48 105.1 10.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.44 . . . . 74.349999999999994 111.182 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 21.1 t -98.26 136.11 30.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 64.510000000000005 111.171 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.3 m -127.7 91.86 44.29 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.593 0.711 . . . . 54.409999999999997 111.127 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 -165.7 0.16 Allowed 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.709 2.273 . . . . 74.120000000000005 112.346 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -91.84 -39.25 11.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 74.409999999999997 111.089 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 88.5 p 46.73 79.82 0.05 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 65.420000000000002 110.897 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.6 t -175.56 -175.06 0.75 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.121 -0.491 . . . . 72.040000000000006 111.131 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 25.5 p -99.84 163.28 12.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 73.349999999999994 110.853 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 3.0 p -143.91 153.4 15.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.123 -0.489 . . . . 75.319999999999993 111.12 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 80.6 t -87.76 143.58 10.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 73.549999999999997 111.099 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.35 122.41 4.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 75.340000000000003 110.872 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.34 -9.88 61.18 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.735 -0.745 . . . . 72.310000000000002 112.482 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -97.17 -178.68 4.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.792 0.329 . . . . 75.420000000000002 110.946 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 15.2 p -161.55 147.67 14.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 63.299999999999997 110.898 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 7.7 t -104.9 -175.82 2.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.476 . . . . 63.329999999999998 111.131 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -137.38 130.11 30.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 75.230000000000004 111.16 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 8.0 mp -105.43 140.39 38.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 72.209999999999994 110.937 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -109.92 145.57 36.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 75.329999999999998 111.163 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 52.1 t -129.58 142.61 43.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.453 . . . . 74.400000000000006 111.141 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -130.13 150.76 51.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.198 -0.455 . . . . 71.510000000000005 111.084 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -144.83 126.74 15.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 74.400000000000006 110.884 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.89 67.61 80.92 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.612 0.72 . . . . 70.109999999999999 110.903 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--N 1.342 0.202 0 C-N-CA 122.67 2.247 . . . . 73.530000000000001 112.372 -179.996 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.889 0.376 . . . . 75.0 110.844 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.35 99.82 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 73.120000000000005 110.87 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 3.3 t -111.16 -7.33 14.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 72.540000000000006 110.892 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -91.36 -176.29 4.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.108 -0.496 . . . . 72.200000000000003 110.878 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -166.3 175.27 8.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 72.400000000000006 110.926 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -125.24 167.16 15.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 74.319999999999993 111.098 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 13.9 p -170.54 149.52 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 71.230000000000004 111.133 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.2 p -92.22 125.3 36.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 71.099999999999994 110.833 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -60.77 -18.62 56.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 73.400000000000006 111.076 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -164.25 103.52 0.86 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 73.420000000000002 110.878 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -89.61 46.78 1.4 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.169 -0.469 . . . . 72.209999999999994 110.891 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 11.9 p -120.9 -9.17 9.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 72.209999999999994 111.165 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 11.3 mtmm -143.09 17.1 1.92 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 71.420000000000002 110.908 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . 178.91 143.12 0.12 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 71.129999999999995 111.106 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 2.1 p -104.6 161.68 13.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.437 . . . . 75.239999999999995 111.165 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 17.2 m -140.85 150.17 20.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.239 -0.437 . . . . 75.319999999999993 111.138 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 22.8 m -157.69 109.71 2.35 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.474 . . . . 73.319999999999993 110.843 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 90.5 t -79.45 145.18 9.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.116 -0.493 . . . . 74.409999999999997 111.162 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 59.2 p -165.84 111.56 0.87 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.197 -0.456 . . . . 72.200000000000003 110.848 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 47.66 63.33 3.52 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.736 -0.745 . . . . 70.430000000000007 112.458 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 3.1 mtp 55.75 20.48 4.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.875 0.369 . . . . 72.540000000000006 110.891 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 1.4 m -130.97 106.5 8.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.23 -0.441 . . . . 72.25 111.14 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -101.64 122.01 53.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.264 -0.426 . . . . 73.299999999999997 111.166 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 7.3 m -92.22 123.15 35.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 74.099999999999994 111.112 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 2.4 t -108.65 123.18 64.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 72.109999999999999 111.101 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -107.63 145.1 33.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 63.530000000000001 110.87 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -99.72 64.24 0.65 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.776 -0.726 . . . . 64.319999999999993 112.526 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -48.23 -41.59 10.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.809 0.338 . . . . 74.400000000000006 111.092 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -127.3 151.02 49.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 73.209999999999994 111.074 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -66.68 138.05 57.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 55.240000000000002 111.1 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 137.72 170.15 11.81 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.747 -0.739 . . . . 70.310000000000002 112.542 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 7.9 mttm -93.32 127.61 39.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.846 0.355 . . . . 74.530000000000001 110.95 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 7.3 p -122.05 129.36 75.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.239 -0.437 . . . . 72.439999999999998 111.15 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -90.95 148.54 22.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 75.099999999999994 110.851 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 4.3 mp -135.72 92.57 16.76 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.622 0.725 . . . . 74.129999999999995 111.096 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 178.63 4.38 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.66 2.24 . . . . 63.420000000000002 112.358 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 54.4 t -148.29 136.78 15.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.237 -0.438 . . . . 75.019999999999996 111.18 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 98.3 t -118.15 136.63 54.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.453 . . . . 72.129999999999995 111.133 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 22.7 t -122.17 135.51 54.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 63.420000000000002 110.87 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 52.53 -113.72 2.9 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.738 -0.744 . . . . 71.439999999999998 112.471 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -111.8 20.66 16.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.873 0.368 . . . . 74.0 110.887 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 113.14 1.94 25.02 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.719 -0.753 . . . . 74.400000000000006 112.478 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -52.92 -62.58 1.56 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.878 0.37 . . . . 74.510000000000005 110.892 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -108.37 166.13 10.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 74.209999999999994 110.867 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -166.1 165.15 17.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.128 -0.487 . . . . 73.319999999999993 111.087 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -143.41 163.27 33.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 73.010000000000005 111.061 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 14.8 p -138.25 137.64 43.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 75.329999999999998 111.157 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.95 164.82 28.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 61.100000000000001 111.138 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -143.99 130.48 19.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 75.120000000000005 110.94 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 32.7 mm -127.12 114.77 38.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 74.530000000000001 111.134 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 3.2 m -84.28 141.0 31.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 73.010000000000005 111.169 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 25.9 t -120.39 120.1 61.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.446 . . . . 72.329999999999998 111.134 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 7.1 p -81.1 132.83 35.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.485 . . . . 73.200000000000003 111.145 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -58.51 -25.16 62.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 75.150000000000006 111.073 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 40.3 t . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 71.109999999999999 110.83 -179.753 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.174 0 CA-C-O 120.825 0.345 . . . . 70.5 111.155 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 1.2 m -125.07 32.68 5.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.271 -0.422 . . . . 74.430000000000007 111.153 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 140.55 97.99 0.34 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.765 -0.731 . . . . 72.209999999999994 112.48 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -112.95 138.1 50.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.905 0.383 . . . . 75.349999999999994 110.86 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 34.4 p -121.52 109.8 15.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.236 -0.438 . . . . 75.219999999999999 111.18 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 33.5 t -98.45 132.91 42.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.429 . . . . 75.540000000000006 111.155 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.5 m -123.43 92.09 49.16 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.619 0.723 . . . . 74.010000000000005 111.179 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -168.41 0.27 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.666 2.244 . . . . 64.230000000000004 112.348 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -89.75 -42.7 11.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.446 . . . . 74.219999999999999 111.105 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 12.3 t 49.88 80.57 0.07 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.236 -0.438 . . . . 64.340000000000003 110.869 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.5 t -174.72 -175.09 0.87 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 75.299999999999997 111.142 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 1.5 m -98.7 162.41 13.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.444 . . . . 74.140000000000001 110.893 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 3.6 p -144.5 153.32 15.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.129 -0.487 . . . . 73.129999999999995 111.124 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 61.8 t -86.73 145.55 7.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 73.140000000000001 111.1 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.23 122.22 5.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.468 . . . . 73.0 110.914 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.18 -11.54 61.95 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.76 -0.734 . . . . 72.439999999999998 112.467 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -94.2 -178.62 4.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.818 0.342 . . . . 75.230000000000004 110.909 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 52.2 p -161.74 148.09 13.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 74.319999999999993 110.861 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 7.0 t -106.01 -173.61 2.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.13 -0.487 . . . . 73.120000000000005 111.097 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -139.93 132.2 28.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.456 . . . . 64.109999999999999 111.166 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.6 mp -105.83 145.19 31.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.247 -0.433 . . . . 74.439999999999998 110.904 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 5.3 m -111.55 145.12 39.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.144 -0.48 . . . . 73.120000000000005 111.123 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 22.5 t -129.31 140.62 48.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.256 -0.429 . . . . 75.099999999999994 111.11 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -129.11 153.1 48.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.486 . . . . 71.299999999999997 111.082 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -143.91 129.28 18.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.251 -0.432 . . . . 75.219999999999999 110.864 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' GLN . . . . . 0.405 ' N ' HE21 ' A' ' 186' ' ' GLN . 0.0 OUTLIER -132.86 66.78 77.09 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.634 0.73 . . . . 64.549999999999997 110.925 -179.975 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo . . . . . 0 C--N 1.342 0.219 0 C-N-CA 122.693 2.262 . . . . 74.439999999999998 112.36 179.986 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.881 0.372 . . . . 74.209999999999994 110.841 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 13.9 mtpp -81.9 74.44 8.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 72.5 110.923 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 2.2 m -78.48 -7.28 57.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 73.049999999999997 110.862 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -91.31 164.38 13.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 65.049999999999997 110.838 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.04 167.52 30.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.116 -0.493 . . . . 73.310000000000002 110.88 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -115.64 160.05 20.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 64.230000000000004 111.103 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 5.1 m -153.43 163.04 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.206 -0.452 . . . . 64.099999999999994 111.114 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.61 118.68 35.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 72.329999999999998 110.9 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -59.87 -21.0 60.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.141 -0.481 . . . . 63.439999999999998 111.11 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.97 96.79 1.36 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 73.329999999999998 110.84 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.89 50.18 1.92 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 72.040000000000006 110.904 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 12.0 p -128.73 -1.45 5.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.211 -0.45 . . . . 73.530000000000001 111.176 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 7.5 mtmt -154.57 18.47 0.47 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.196 -0.457 . . . . 75.549999999999997 110.829 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -179.88 153.79 0.54 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.251 -0.431 . . . . 64.349999999999994 111.085 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 11.7 p -117.32 156.05 28.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.214 -0.448 . . . . 75.120000000000005 111.131 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 33.8 m -137.19 141.17 40.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 65.349999999999994 111.136 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 50.9 m -147.86 107.87 4.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 74.109999999999999 110.845 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . 0.418 ' HA ' ' HA ' ' A' ' 214' ' ' ILE . 3.0 p -88.31 142.87 12.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 64.109999999999999 111.11 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.2 m -171.56 122.89 0.53 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.188 -0.46 . . . . 71.340000000000003 110.861 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 55.6 47.23 78.55 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.726 -0.75 . . . . 72.510000000000005 112.481 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 3.3 mtp 64.06 16.38 9.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.848 0.356 . . . . 70.040000000000006 110.854 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 18.8 m -125.67 112.65 16.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 63.43 111.151 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.418 ' HA ' ' HA ' ' A' ' 209' ' ' VAL . 2.6 mp -109.69 113.75 45.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 64.239999999999995 111.105 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 6.3 m -87.45 133.92 33.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.206 -0.452 . . . . 55.210000000000001 111.181 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 2.9 t -118.18 123.17 71.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.27 -0.423 . . . . 63.399999999999999 111.09 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -106.33 139.57 40.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.474 . . . . 75.109999999999999 110.857 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -96.9 78.3 0.69 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.719 -0.753 . . . . 63.109999999999999 112.48 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 16.2 t -50.13 -55.29 5.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.83 0.347 . . . . 74.400000000000006 111.112 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -126.38 161.63 27.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 72.140000000000001 111.122 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -62.61 139.97 58.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.243 -0.435 . . . . 73.510000000000005 111.104 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 142.24 172.84 13.86 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.732 -0.747 . . . . 61.130000000000003 112.503 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 12.7 mttt -102.18 120.81 41.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.837 0.351 . . . . 75.140000000000001 110.886 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 7.3 p -119.13 126.89 75.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 72.109999999999999 111.143 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -90.55 156.05 18.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 72.409999999999997 110.864 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 4.4 mp -138.13 92.43 12.33 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.634 0.731 . . . . 75.310000000000002 111.127 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 -179.26 2.79 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.679 2.253 . . . . 53.399999999999999 112.345 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 61.3 t -150.11 140.6 16.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 74.510000000000005 111.16 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 89.9 t -124.06 138.53 53.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 72.219999999999999 111.137 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 1.5 m -118.94 106.67 12.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.191 -0.459 . . . . 72.209999999999994 110.862 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 57.74 -110.86 2.59 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.701 -0.761 . . . . 74.209999999999994 112.486 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -81.01 -7.39 59.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.865 0.364 . . . . 65.310000000000002 110.889 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 109.76 10.01 23.76 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.743 -0.741 . . . . 61.43 112.424 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -50.72 -47.1 59.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.874 0.369 . . . . 74.530000000000001 110.879 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -117.51 147.52 42.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 63.549999999999997 110.884 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -149.72 165.23 33.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 73.230000000000004 111.11 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -136.95 163.3 31.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.441 . . . . 73.420000000000002 111.109 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.4 p -136.36 125.59 38.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.188 -0.46 . . . . 73.430000000000007 111.139 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -132.79 162.13 32.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 72.510000000000005 111.15 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -144.16 132.1 21.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.268 -0.424 . . . . 75.129999999999995 110.886 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 26.3 mm -126.81 112.73 30.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.124 -0.489 . . . . 75.340000000000003 111.142 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 2.7 m -80.82 141.28 34.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 65.239999999999995 111.165 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 17.1 t -120.08 121.0 64.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.236 -0.438 . . . . 73.329999999999998 111.116 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 7.3 p -82.28 132.75 35.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.144 -0.48 . . . . 74.439999999999998 111.146 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -56.92 -24.63 53.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.462 . . . . 74.239999999999995 111.113 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.26 -0.427 . . . . 71.430000000000007 110.847 -179.791 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.922 0.391 . . . . 73.239999999999995 111.07 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -124.9 30.85 5.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.161 -0.472 . . . . 75.430000000000007 111.096 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 146.24 96.7 0.19 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.722 -0.751 . . . . 73.150000000000006 112.466 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 2.1 tmm? -106.09 143.71 33.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.845 0.355 . . . . 65.010000000000005 110.897 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 44.7 p -133.87 103.33 5.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.274 -0.421 . . . . 71.340000000000003 111.169 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 89.0 t -97.19 133.98 36.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 74.409999999999997 111.103 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 40.8 m -123.86 92.01 48.99 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.517 0.675 . . . . 74.540000000000006 111.115 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -167.33 0.22 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.636 2.224 . . . . 73.299999999999997 112.331 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -90.75 -43.75 9.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.459 . . . . 71.349999999999994 111.089 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 8.0 t 49.48 80.12 0.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 75.140000000000001 110.861 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.6 t -173.68 -176.11 1.2 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.135 -0.484 . . . . 75.319999999999993 111.128 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 10.0 p -97.27 162.19 13.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 70.430000000000007 110.837 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 3.3 p -145.37 153.18 14.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.479 . . . . 64.340000000000003 111.142 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 66.6 t -87.52 145.21 7.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.116 -0.493 . . . . 73.010000000000005 111.12 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.64 122.42 5.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 73.420000000000002 110.837 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.81 -12.87 61.0 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.741 -0.742 . . . . 73.239999999999995 112.501 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -92.91 -178.32 4.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.811 0.339 . . . . 64.420000000000002 110.931 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 39.1 p -161.37 149.45 15.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.214 -0.448 . . . . 74.040000000000006 110.894 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 6.8 t -107.11 -173.92 2.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 73.319999999999993 111.186 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.73 132.39 27.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.258 -0.428 . . . . 72.120000000000005 111.184 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.6 mp -106.56 145.54 31.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 74.299999999999997 110.873 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 4.1 m -113.75 146.42 39.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 72.310000000000002 111.144 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 47.4 t -128.7 140.84 48.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 75.129999999999995 111.136 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -129.9 155.98 45.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 72.319999999999993 111.123 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -148.93 131.28 15.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.257 -0.428 . . . . 74.209999999999994 110.9 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.05 67.35 73.52 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.634 0.73 . . . . 74.010000000000005 110.919 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--N 1.342 0.22 0 C-N-CA 122.703 2.268 . . . . 65.0 112.343 -179.983 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 1.4 p30 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.863 0.364 . . . . 64.129999999999995 110.882 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 6.1 mtpm? -91.4 67.58 5.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 71.540000000000006 110.907 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 21.8 t -74.51 -7.24 52.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 71.430000000000007 110.864 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -91.28 163.64 14.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.131 -0.486 . . . . 70.439999999999998 110.897 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.9 173.19 16.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 74.239999999999995 110.878 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -112.66 168.14 9.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 75.040000000000006 111.068 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 14.5 p -167.62 149.7 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 75.319999999999993 111.101 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.03 130.03 36.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.139 -0.482 . . . . 74.319999999999993 110.881 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -68.08 -17.61 64.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.095 -0.502 . . . . 72.010000000000005 111.106 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -162.93 95.7 0.88 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.224 -0.443 . . . . 64.239999999999995 110.891 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 18.6 tttt -84.99 53.06 2.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 73.340000000000003 110.935 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 18.0 p -128.82 0.37 5.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 73.450000000000003 111.142 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 3.7 mtmm -155.29 18.24 0.41 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 74.299999999999997 110.887 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -179.96 149.16 0.33 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.277 -0.419 . . . . 73.319999999999993 111.107 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 7.0 p -109.92 156.69 20.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.166 -0.47 . . . . 74.239999999999995 111.118 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 17.6 m -140.42 140.86 33.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 74.439999999999998 111.112 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -148.15 109.0 4.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 72.540000000000006 110.879 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . 0.419 ' HA ' ' HA ' ' A' ' 214' ' ' ILE . 3.6 p -89.21 143.01 12.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.465 . . . . 74.340000000000003 111.106 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.7 m -171.82 123.43 0.52 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 72.0 110.91 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 56.2 46.67 85.33 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.715 -0.755 . . . . 74.230000000000004 112.466 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 4.1 mtp 64.2 15.78 9.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.827 0.346 . . . . 64.430000000000007 110.892 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 13.6 m -125.13 113.01 17.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.246 -0.434 . . . . 74.430000000000007 111.112 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.419 ' HA ' ' HA ' ' A' ' 209' ' ' VAL . 3.1 mp -110.48 113.8 45.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 75.219999999999999 111.154 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 5.8 m -88.93 132.05 34.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 74.129999999999995 111.12 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 3.9 t -117.02 124.28 72.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.187 -0.46 . . . . 55.100000000000001 111.101 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -106.03 138.67 41.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 75.319999999999993 110.95 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -94.73 78.55 0.91 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.676 -0.773 . . . . 72.319999999999993 112.505 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 20.6 t -49.75 -55.52 4.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.823 0.344 . . . . 72.439999999999998 111.134 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -127.19 161.75 27.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 72.219999999999999 111.111 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -62.22 139.93 58.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 70.239999999999995 111.068 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 142.27 171.72 13.27 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.752 -0.737 . . . . 73.230000000000004 112.496 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 2.1 mttt -101.12 121.19 41.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.783 0.325 . . . . 75.420000000000002 110.929 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 7.1 p -120.46 125.46 74.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.259 -0.428 . . . . 64.230000000000004 111.102 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -90.98 152.45 20.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.468 . . . . 72.329999999999998 110.888 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 4.3 mp -135.24 92.71 17.59 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.667 0.746 . . . . 75.329999999999998 111.166 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -176.44 1.49 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.689 2.26 . . . . 74.25 112.329 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 59.5 t -149.4 137.04 13.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.444 . . . . 72.439999999999998 111.127 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 84.0 t -118.4 133.18 66.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.158 -0.474 . . . . 75.409999999999997 111.135 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 5.7 t -122.32 126.21 47.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 72.319999999999993 110.881 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 55.53 -121.86 24.43 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.717 -0.754 . . . . 75.120000000000005 112.519 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -98.17 21.03 11.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.87 0.367 . . . . 75.439999999999998 110.911 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 106.77 6.9 34.54 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.702 -0.761 . . . . 73.120000000000005 112.507 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -53.26 -62.66 1.51 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.85 0.357 . . . . 74.319999999999993 110.887 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -105.99 166.02 10.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 74.340000000000003 110.879 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -167.15 165.41 15.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 70.040000000000006 111.053 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -142.33 163.16 33.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 75.109999999999999 111.099 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 8.0 p -136.58 131.15 47.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.243 -0.435 . . . . 74.409999999999997 111.149 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -139.3 165.22 27.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 63.219999999999999 111.157 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -147.7 133.32 18.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 74.219999999999999 110.919 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 25.1 mm -126.7 115.13 40.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.475 . . . . 74.040000000000006 111.11 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 2.4 m -82.91 141.11 32.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 73.450000000000003 111.146 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 21.2 t -120.01 121.06 64.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.243 -0.435 . . . . 75.439999999999998 111.121 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 9.2 p -82.92 132.78 35.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.138 -0.483 . . . . 75.540000000000006 111.124 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -54.39 -27.18 34.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 71.219999999999999 111.089 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 46.9 t . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 62.119999999999997 110.906 -179.811 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.885 0.374 . . . . 70.310000000000002 111.081 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 10.8 t -127.24 15.99 7.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 60.310000000000002 111.132 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -176.71 81.28 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.764 -0.731 . . . . 74.109999999999999 112.493 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 30.5 ttp -102.95 123.19 46.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.895 0.378 . . . . 74.030000000000001 110.867 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 51.6 p -111.52 104.97 13.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.236 -0.438 . . . . 72.349999999999994 111.159 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 60.9 t -97.2 131.92 42.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.455 . . . . 74.439999999999998 111.141 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 38.5 m -124.55 92.29 48.18 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.534 0.683 . . . . 63.149999999999999 111.147 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 -167.26 0.22 Allowed 'Trans proline' 0 C--N 1.341 0.132 0 C-N-CA 122.674 2.249 . . . . 75.420000000000002 112.35 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -90.92 -39.27 12.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.444 . . . . 72.530000000000001 111.114 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 4.8 p 45.86 79.96 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 74.439999999999998 110.87 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.6 t -175.44 -175.69 0.83 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.477 . . . . 72.310000000000002 111.126 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 1.7 m -97.42 164.42 12.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.443 . . . . 65.120000000000005 110.908 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 3.4 p -146.22 153.18 13.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.469 . . . . 70.200000000000003 111.137 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 59.2 t -86.1 145.48 7.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 64.310000000000002 111.125 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.27 122.32 5.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.443 . . . . 75.010000000000005 110.905 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.15 -12.79 62.06 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.771 -0.728 . . . . 72.450000000000003 112.53 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 17.9 mm100 -92.35 -178.8 5.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.796 0.331 . . . . 74.299999999999997 110.914 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 60.6 p -161.69 148.63 14.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 74.140000000000001 110.879 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 6.7 t -105.75 -174.46 2.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 75.310000000000002 111.145 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -140.29 127.09 20.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.256 -0.429 . . . . 75.530000000000001 111.139 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.5 mp -100.81 141.01 34.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.183 -0.462 . . . . 71.530000000000001 110.93 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 6.1 m -109.17 144.61 37.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 71.530000000000001 111.152 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 23.1 t -129.43 141.56 46.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 75.540000000000006 111.104 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -130.89 156.87 44.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 74.439999999999998 111.111 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -147.09 133.37 19.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 74.140000000000001 110.894 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.62 67.18 23.96 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.634 0.731 . . . . 70.049999999999997 110.915 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--N 1.341 0.169 0 C-N-CA 122.676 2.251 . . . . 73.329999999999998 112.369 179.99 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.858 0.361 . . . . 72.109999999999999 110.868 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 10.3 mtmm -85.31 73.11 10.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.474 . . . . 72.510000000000005 110.87 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.45 -3.98 43.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.253 -0.431 . . . . 70.120000000000005 110.831 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -88.05 168.58 12.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.074 -0.512 . . . . 65.409999999999997 110.858 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -164.38 162.07 21.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 70.140000000000001 110.868 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -104.03 157.69 16.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.467 . . . . 75.030000000000001 111.107 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 91.9 t -150.25 145.14 17.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.257 -0.429 . . . . 74.230000000000004 111.126 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -83.83 122.78 29.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 74.109999999999999 110.826 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.98 -8.25 54.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 74.150000000000006 111.088 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -164.21 98.58 0.83 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.259 -0.428 . . . . 63.119999999999997 110.899 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.64 41.4 1.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 70.340000000000003 110.89 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 4.3 p -124.51 -5.3 7.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.249 -0.432 . . . . 71.010000000000005 111.144 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 9.7 mtmm -148.45 16.27 1.02 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.462 . . . . 75.129999999999995 110.921 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -179.2 154.35 0.65 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 74.409999999999997 111.124 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 11.2 p -117.62 158.42 24.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.209 -0.45 . . . . 74.239999999999995 111.153 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 10.7 m -134.74 144.4 34.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 71.120000000000005 111.093 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 1.9 t -150.93 109.21 3.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 74.239999999999995 110.886 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 80.9 t -84.16 145.71 7.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 75.409999999999997 111.123 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 3.3 t -171.09 117.58 0.46 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.147 -0.479 . . . . 53.420000000000002 110.849 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 48.52 61.32 5.19 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.738 -0.744 . . . . 53.020000000000003 112.496 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 2.3 mtp 54.09 21.97 3.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.887 0.375 . . . . 74.109999999999999 110.904 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 1.7 m -130.59 110.33 11.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 74.200000000000003 111.2 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -104.65 121.36 56.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.253 -0.43 . . . . 74.030000000000001 111.158 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 21.0 m -91.9 129.19 37.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.146 -0.479 . . . . 70.150000000000006 111.16 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 2.3 t -115.54 120.94 66.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 75.420000000000002 111.15 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -105.47 140.33 38.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 73.409999999999997 110.872 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -96.47 78.54 0.73 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.767 -0.73 . . . . 52.240000000000002 112.491 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 19.5 t -50.81 -56.67 3.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.837 0.351 . . . . 70.219999999999999 111.115 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -123.86 161.21 25.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.148 -0.478 . . . . 74.540000000000006 111.103 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -63.15 138.7 58.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.256 -0.429 . . . . 73.420000000000002 111.099 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 141.37 168.49 11.53 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.713 -0.756 . . . . 63.299999999999997 112.458 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 5.6 mttp -95.68 120.2 35.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.804 0.335 . . . . 73.340000000000003 110.915 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 6.6 p -117.99 123.15 71.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.272 -0.422 . . . . 72.140000000000001 111.177 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -90.72 153.18 20.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.458 . . . . 71.329999999999998 110.864 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 4.2 mp -138.38 93.19 11.47 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.645 0.736 . . . . 62.229999999999997 111.139 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -177.41 1.85 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.73 2.287 . . . . 74.409999999999997 112.339 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 62.4 t -149.01 142.04 18.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 65.230000000000004 111.126 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 91.0 t -121.42 137.09 56.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.157 -0.474 . . . . 73.010000000000005 111.141 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.34 130.09 52.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 71.439999999999998 110.884 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 53.37 -114.09 3.53 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.74 -0.743 . . . . 72.129999999999995 112.513 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -111.17 21.22 16.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.807 0.337 . . . . 74.349999999999994 110.831 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 114.39 1.76 23.23 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.76 -0.733 . . . . 62.329999999999998 112.512 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 44.1 mm-40 -51.75 -62.96 1.3 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.9 0.381 . . . . 61.399999999999999 110.899 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -112.46 162.93 15.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 75.519999999999996 110.929 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -165.71 164.8 18.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 74.349999999999994 111.065 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -143.01 163.05 33.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 63.009999999999998 111.084 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 10.9 p -137.77 136.34 45.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 75.430000000000007 111.172 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -139.23 165.51 26.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 65.310000000000002 111.086 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -145.11 132.34 20.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 71.120000000000005 110.88 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 36.3 mm -127.21 116.89 45.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 75.319999999999993 111.155 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 2.1 m -84.22 141.68 30.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.192 -0.458 . . . . 62.240000000000002 111.138 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 21.5 t -120.0 121.5 66.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.243 -0.435 . . . . 60.100000000000001 111.127 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 7.6 p -82.58 132.8 35.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 70.310000000000002 111.166 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -55.78 -25.29 40.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 62.409999999999997 111.082 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 9.7 t . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 74.310000000000002 110.857 -179.774 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.892 0.377 . . . . 70.310000000000002 111.089 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 2.3 m -124.89 13.93 8.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.243 -0.435 . . . . 74.519999999999996 111.139 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 163.26 104.71 0.19 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.715 -0.755 . . . . 53.329999999999998 112.504 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 21.5 ttp -110.62 134.48 52.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.839 0.352 . . . . 74.129999999999995 110.9 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 1.8 p -119.62 95.44 4.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.256 -0.429 . . . . 71.109999999999999 111.173 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 21.8 t -97.21 117.9 42.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.439 . . . . 73.409999999999997 111.168 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 60.8 m -112.72 91.61 17.93 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.574 0.702 . . . . 74.140000000000001 111.17 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 -168.23 0.26 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.638 2.226 . . . . 71.540000000000006 112.361 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -86.6 -44.57 11.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.438 . . . . 70.299999999999997 111.104 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 37.8 t 49.82 76.93 0.12 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.257 -0.429 . . . . 64.319999999999993 110.887 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.4 t -175.05 -174.91 0.8 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.111 -0.495 . . . . 71.430000000000007 111.14 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 33.3 p -99.15 158.42 15.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 71.450000000000003 110.856 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 3.3 p -140.22 152.37 21.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.103 -0.499 . . . . 73.150000000000006 111.096 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 95.5 t -84.6 143.66 11.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.166 -0.47 . . . . 73.319999999999993 111.093 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -48.04 122.5 5.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 73.549999999999997 110.917 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.85 -14.6 60.15 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.712 -0.756 . . . . 53.530000000000001 112.473 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 16.7 mm100 -90.63 -178.31 5.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.824 0.345 . . . . 74.400000000000006 110.889 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 27.4 p -161.52 149.14 14.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 55.530000000000001 110.825 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 7.3 t -108.21 -173.68 2.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.481 . . . . 74.540000000000006 111.136 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -140.47 132.1 27.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.451 . . . . 52.240000000000002 111.161 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.3 mp -105.37 142.02 35.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.246 -0.434 . . . . 75.030000000000001 110.918 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 3.6 m -108.42 142.12 39.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 74.319999999999993 111.128 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 16.5 t -129.79 136.37 59.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 65.329999999999998 111.13 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -124.33 155.86 37.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.243 -0.435 . . . . 72.219999999999999 111.076 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -142.83 125.25 15.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 72.310000000000002 110.884 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.48 63.06 46.34 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.557 0.694 . . . . 73.25 110.903 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--N 1.342 0.194 0 C-N-CA 122.668 2.245 . . . . 74.340000000000003 112.317 179.99 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.856 0.36 . . . . 75.409999999999997 110.848 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.17 70.71 7.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 73.310000000000002 110.866 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 1.1 m -93.79 -5.3 48.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 75.5 110.886 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -89.77 171.87 9.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.107 -0.497 . . . . 75.329999999999998 110.873 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.68 167.17 17.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.141 -0.481 . . . . 75.219999999999999 110.852 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -113.19 167.84 10.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.178 -0.464 . . . . 74.340000000000003 111.077 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 10.5 p -173.65 151.52 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 75.230000000000004 111.168 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.8 t -78.44 152.55 32.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 75.319999999999993 110.852 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -89.97 -21.61 22.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 63.450000000000003 111.122 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -129.14 -54.63 1.19 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 74.209999999999994 110.906 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 3.0 ttpp 63.63 25.52 14.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 75.340000000000003 110.915 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 32.3 p -112.59 -4.85 14.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.469 . . . . 52.520000000000003 111.11 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 9.1 mtmm -151.94 18.28 0.68 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 71.530000000000001 110.947 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -174.91 147.36 0.97 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 65.430000000000007 111.122 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 16.7 p -108.59 157.78 18.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 71.25 111.101 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 12.3 m -140.6 140.85 33.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 73.329999999999998 111.133 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 10.0 m -148.68 108.77 4.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 70.519999999999996 110.863 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . 0.433 ' HA ' ' HA ' ' A' ' 214' ' ' ILE . 3.2 p -87.07 135.43 25.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.154 -0.475 . . . . 70.5 111.148 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 3.3 m -161.31 121.96 2.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 74.319999999999993 110.858 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 54.72 49.08 62.95 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.752 -0.737 . . . . 64.540000000000006 112.511 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER 63.3 16.38 9.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.853 0.359 . . . . 74.239999999999995 110.877 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 3.3 m -126.46 109.41 12.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 73.230000000000004 111.167 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.433 ' HA ' ' HA ' ' A' ' 209' ' ' VAL . 2.1 mp -105.18 114.09 43.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 75.329999999999998 111.11 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 6.2 m -87.9 130.51 34.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 75.219999999999999 111.124 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 2.8 t -115.93 123.91 71.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.449 . . . . 73.510000000000005 111.144 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -106.78 139.74 40.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 75.530000000000001 110.864 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -94.79 79.8 0.89 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.804 -0.712 . . . . 63.399999999999999 112.45 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 18.5 t -50.75 -55.63 6.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.858 0.361 . . . . 74.239999999999995 111.112 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -129.36 163.87 24.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 73.140000000000001 111.125 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -63.17 142.26 58.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 65.510000000000005 111.085 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 139.04 171.56 12.23 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.78 -0.724 . . . . 70.420000000000002 112.495 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 14.9 mttt -100.73 121.57 41.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.788 0.328 . . . . 74.140000000000001 110.88 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 7.4 p -120.62 126.23 75.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 74.510000000000005 111.124 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -90.66 154.3 19.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.127 -0.488 . . . . 73.150000000000006 110.908 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 4.1 mp -137.02 93.16 13.55 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.619 0.723 . . . . 74.120000000000005 111.102 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.81 -178.61 2.44 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.723 2.282 . . . . 74.540000000000006 112.305 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 99.4 t -150.29 138.32 14.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.169 -0.468 . . . . 72.230000000000004 111.069 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 66.6 t -121.47 139.39 48.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.166 -0.47 . . . . 74.409999999999997 111.124 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 7.4 m -122.45 125.53 46.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 73.129999999999995 110.851 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 55.54 -115.35 5.75 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.716 -0.754 . . . . 72.129999999999995 112.474 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -103.29 17.42 24.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.896 0.379 . . . . 72.219999999999999 110.897 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 114.01 9.73 15.37 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.778 -0.725 . . . . 72.319999999999993 112.513 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -52.01 -73.44 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.874 0.368 . . . . 72.430000000000007 110.921 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -104.15 162.48 13.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 72.230000000000004 110.879 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -158.93 165.1 34.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.469 . . . . 72.439999999999998 111.097 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -144.1 163.36 33.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 54.539999999999999 111.099 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 11.5 p -138.0 135.38 45.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.201 -0.454 . . . . 72.219999999999999 111.125 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.84 164.26 30.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 71.420000000000002 111.071 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -141.55 131.85 25.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 74.450000000000003 110.921 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 23.9 mm -127.43 110.64 22.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.154 -0.476 . . . . 74.450000000000003 111.161 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 1.4 m -81.32 141.43 34.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 74.430000000000007 111.139 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 15.7 t -120.13 122.78 69.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 73.349999999999994 111.137 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 14.6 p -82.41 133.62 35.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 70.239999999999995 111.14 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -59.16 -21.88 60.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 74.310000000000002 111.058 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 67.0 m . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.239 -0.437 . . . . 74.420000000000002 110.859 -179.732 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.182 0 CA-C-O 120.902 0.382 . . . . 73.310000000000002 111.075 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.88 32.94 5.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.233 -0.44 . . . . 73.219999999999999 111.148 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 135.27 99.63 0.6 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.721 -0.752 . . . . 53.399999999999999 112.51 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 18.8 ttp -110.88 128.15 55.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.824 0.345 . . . . 72.430000000000007 110.907 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 38.9 p -116.29 107.4 14.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 73.140000000000001 111.116 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 21.2 t -102.24 131.1 50.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.246 -0.434 . . . . 74.230000000000004 111.141 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -123.58 91.86 49.3 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.554 0.693 . . . . 75.200000000000003 111.189 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 -167.05 0.21 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.653 2.235 . . . . 74.430000000000007 112.34 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -92.55 -45.19 8.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.45 . . . . 70.299999999999997 111.117 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 73.1 m 48.08 85.42 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 75.140000000000001 110.905 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 8.4 t -176.0 -176.01 0.78 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 75.129999999999995 111.173 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 75.8 p -97.07 153.49 17.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 70.329999999999998 110.852 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 3.3 p -139.07 153.54 24.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.139 -0.482 . . . . 71.510000000000005 111.127 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 67.2 t -87.6 145.05 8.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.167 -0.47 . . . . 73.409999999999997 111.151 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -48.42 122.66 5.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 72.319999999999993 110.914 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.98 -15.35 59.45 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.756 -0.735 . . . . 71.310000000000002 112.487 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -90.62 -178.63 5.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.781 0.324 . . . . 73.439999999999998 110.943 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 65.4 p -161.96 149.7 14.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 63.340000000000003 110.838 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 7.8 t -107.19 -173.89 2.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.105 -0.498 . . . . 74.329999999999998 111.115 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.76 132.25 28.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.201 -0.454 . . . . 74.530000000000001 111.111 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.6 mp -105.8 143.66 33.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.186 -0.461 . . . . 74.0 110.933 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 4.0 m -111.35 142.98 42.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.444 . . . . 74.200000000000003 111.133 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 21.8 t -129.69 143.41 41.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.255 -0.429 . . . . 71.329999999999998 111.185 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -134.48 152.06 51.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 61.32 111.106 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -144.88 126.53 15.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 70.420000000000002 110.878 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.81 67.77 68.93 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.594 0.712 . . . . 75.030000000000001 110.877 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo . . . . . 0 C--N 1.342 0.187 0 C-N-CA 122.657 2.238 . . . . 70.030000000000001 112.333 179.983 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 2.2 t70 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.849 0.357 . . . . 73.349999999999994 110.887 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt -58.15 98.43 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.44 . . . . 71.510000000000005 110.874 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 2.6 t -111.61 -6.8 14.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 74.420000000000002 110.878 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -90.97 174.58 7.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.15 -0.477 . . . . 74.519999999999996 110.899 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -165.81 154.95 11.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 65.219999999999999 110.861 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -103.89 165.63 10.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 73.030000000000001 111.076 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 10.4 p -169.17 152.17 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 73.109999999999999 111.122 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.4 p -81.93 140.22 34.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 74.430000000000007 110.863 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -76.52 -23.34 53.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.107 -0.497 . . . . 75.109999999999999 111.069 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -134.82 -53.61 0.81 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.436 . . . . 74.340000000000003 110.845 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 2.8 ttpp 63.66 33.85 12.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.44 . . . . 75.519999999999996 110.918 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 50.8 p -116.65 -3.26 11.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.196 -0.456 . . . . 74.340000000000003 111.121 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 8.0 mtmm -153.19 18.75 0.57 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 73.349999999999994 110.854 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -172.42 148.09 2.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 72.519999999999996 111.083 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 17.1 p -111.69 142.37 44.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 74.099999999999994 111.192 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 16.2 m -126.7 140.15 49.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.267 -0.424 . . . . 75.129999999999995 111.146 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 28.4 m -146.68 108.99 4.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 74.329999999999998 110.846 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . 0.427 ' HA ' ' HA ' ' A' ' 214' ' ' ILE . 3.7 p -86.87 143.27 11.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.08 -0.509 . . . . 75.310000000000002 111.112 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 43.7 t -171.45 123.57 0.56 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.152 -0.477 . . . . 75.230000000000004 110.881 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 55.14 48.29 69.05 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.73 -0.748 . . . . 72.400000000000006 112.479 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 1.8 mtp 62.5 16.59 8.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.834 0.35 . . . . 64.409999999999997 110.889 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 2.3 m -127.55 113.55 16.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 74.209999999999994 111.175 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.427 ' HA ' ' HA ' ' A' ' 209' ' ' VAL . 3.0 mp -109.9 115.96 51.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.241 -0.436 . . . . 74.530000000000001 111.15 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 3.4 m -89.1 130.83 35.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.439 . . . . 65.420000000000002 111.127 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 3.0 t -116.24 121.06 66.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.24 -0.436 . . . . 74.409999999999997 111.124 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -104.79 139.83 38.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 73.129999999999995 110.863 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -94.28 79.65 0.95 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.729 -0.748 . . . . 42.329999999999998 112.502 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 19.7 t -49.95 -56.39 3.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.837 0.351 . . . . 75.430000000000007 111.154 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -127.77 163.35 24.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 72.319999999999993 111.07 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -63.45 137.75 58.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 62.240000000000002 111.092 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 142.4 167.53 11.42 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.74 -0.743 . . . . 74.340000000000003 112.515 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 6.2 mttp -98.72 124.58 43.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.876 0.369 . . . . 65.319999999999993 110.874 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 7.4 p -121.96 129.76 75.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.218 -0.446 . . . . 71.430000000000007 111.119 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 27.4 m120 -90.62 152.48 20.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 73.439999999999998 110.876 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 4.2 mp -138.2 92.83 11.97 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.611 0.72 . . . . 74.329999999999998 111.12 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 -177.79 2.03 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.658 2.239 . . . . 53.119999999999997 112.379 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 99.7 t -150.08 137.82 13.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 73.319999999999993 111.084 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 88.1 t -117.94 132.82 66.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 73.450000000000003 111.12 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -121.72 137.52 54.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 75.519999999999996 110.858 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 51.91 -118.88 7.78 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.707 -0.758 . . . . 73.420000000000002 112.51 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -105.5 21.09 17.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.918 0.39 . . . . 72.340000000000003 110.933 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 107.27 12.01 24.41 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.706 -0.759 . . . . 73.030000000000001 112.49 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -63.14 -58.97 5.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.842 0.353 . . . . 73.430000000000007 110.901 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -105.58 167.22 9.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.464 . . . . 74.329999999999998 110.89 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -166.13 165.04 17.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.165 -0.471 . . . . 65.109999999999999 111.115 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -139.52 163.2 33.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 73.420000000000002 111.064 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 52.4 t -137.52 132.11 44.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.441 . . . . 71.420000000000002 111.137 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -139.23 162.48 34.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 74.010000000000005 111.094 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -145.51 124.37 12.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 75.219999999999999 110.898 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 29.6 mm -119.1 109.13 25.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.12 -0.491 . . . . 73.530000000000001 111.135 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 4.2 m -80.31 141.83 35.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 74.239999999999995 111.12 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 18.5 t -119.22 121.1 65.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 75.540000000000006 111.18 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 6.7 p -81.67 132.85 35.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.188 -0.46 . . . . 72.439999999999998 111.185 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -58.46 -21.7 52.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.226 -0.443 . . . . 73.400000000000006 111.076 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 76.5 p . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.224 -0.444 . . . . 70.150000000000006 110.83 -179.769 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.826 0.346 . . . . 75.439999999999998 111.105 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 4.7 t -120.69 22.37 11.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 75.329999999999998 111.171 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 147.23 100.38 0.25 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.775 -0.726 . . . . 74.209999999999994 112.524 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -110.04 136.5 49.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.88 0.371 . . . . 74.420000000000002 110.876 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 68.6 p -116.11 105.65 12.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 72.310000000000002 111.147 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 45.7 t -98.48 130.14 47.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.198 -0.456 . . . . 74.219999999999999 111.094 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 8.9 m -126.66 92.72 44.26 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.537 0.684 . . . . 74.439999999999998 111.128 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 -166.07 0.17 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.67 2.246 . . . . 74.319999999999993 112.352 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -87.05 -40.13 14.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 73.099999999999994 111.114 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 99.5 p 46.47 78.81 0.06 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.439 . . . . 70.439999999999998 110.876 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.5 t -175.27 -174.96 0.78 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.11 -0.496 . . . . 75.150000000000006 111.174 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 99.1 p -99.79 162.94 12.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.261 -0.427 . . . . 63.32 110.85 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 1.9 p -147.06 151.68 13.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 73.319999999999993 111.114 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 69.3 t -87.62 145.35 7.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.475 . . . . 73.230000000000004 111.116 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.31 123.1 6.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 74.200000000000003 110.92 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 100.49 -15.87 58.34 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.758 -0.734 . . . . 65.409999999999997 112.526 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 12.9 mm100 -86.51 -177.09 6.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.819 0.343 . . . . 63.210000000000001 110.921 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 1.4 p -161.02 149.31 15.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 71.340000000000003 110.838 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 8.9 t -113.26 -178.25 3.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.09 -0.504 . . . . 71.430000000000007 111.113 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -138.61 128.89 25.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.203 -0.453 . . . . 73.120000000000005 111.16 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.6 mp -101.69 147.96 25.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 73.400000000000006 110.866 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 7.4 m -115.23 142.79 46.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.198 -0.456 . . . . 73.129999999999995 111.135 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 30.0 t -129.72 142.56 43.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 71.420000000000002 111.139 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -130.41 152.94 49.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 52.140000000000001 111.078 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -146.4 131.85 18.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 62.100000000000001 110.885 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.71 68.05 73.95 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.544 0.688 . . . . 72.420000000000002 110.931 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 C--O 1.231 0.136 0 C-N-CA 122.692 2.262 . . . . 64.209999999999994 112.345 -179.983 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 15.2 t0 . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.9 0.381 . . . . 74.219999999999999 110.865 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.16 76.6 6.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.197 -0.456 . . . . 74.010000000000005 110.918 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 4.9 m -86.07 -6.48 59.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.258 -0.428 . . . . 72.200000000000003 110.86 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -90.74 173.4 8.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.129 -0.487 . . . . 73.010000000000005 110.867 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 23.4 ptt180 -163.04 172.56 14.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.138 -0.483 . . . . 75.530000000000001 110.874 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -121.38 167.86 12.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 75.450000000000003 111.074 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 8.3 p -174.05 153.82 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 74.530000000000001 111.089 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.49 129.14 38.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.121 -0.491 . . . . 72.319999999999993 110.834 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -65.92 -21.86 66.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.114 -0.494 . . . . 64.349999999999994 111.078 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -155.45 86.85 1.09 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.245 -0.434 . . . . 52.310000000000002 110.869 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 24.4 ttmt -79.23 58.46 2.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.44 . . . . 72.299999999999997 110.905 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 27.6 p -132.89 3.68 3.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 74.400000000000006 111.123 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 12.9 mtmm -154.22 16.51 0.48 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.238 -0.437 . . . . 73.450000000000003 110.918 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -179.96 152.96 0.49 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.436 . . . . 72.340000000000003 111.068 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 12.1 p -107.9 154.13 22.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 74.329999999999998 111.17 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 13.3 m -140.58 136.36 35.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 74.340000000000003 111.124 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 1.2 t -144.99 108.44 4.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.459 . . . . 65.409999999999997 110.85 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 4.4 p -91.01 143.68 10.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 72.519999999999996 111.139 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 7.8 t -144.97 98.16 3.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 70.510000000000005 110.843 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 70.24 -81.63 0.36 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.748 -0.739 . . . . 74.120000000000005 112.497 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -138.78 7.68 2.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.838 0.351 . . . . 63.43 110.86 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 1.6 m -129.16 123.03 31.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.444 . . . . 74.140000000000001 111.185 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 2.4 mp -114.6 140.49 35.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 73.129999999999995 111.17 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.0 128.59 54.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 74.420000000000002 111.087 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 2.6 t -118.72 134.24 62.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 73.450000000000003 111.125 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -119.27 137.19 53.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 65.400000000000006 110.923 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -85.7 68.88 3.32 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.778 -0.725 . . . . 54.520000000000003 112.491 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 1.9 t -49.45 -53.98 7.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.812 0.339 . . . . 75.230000000000004 111.116 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -123.71 155.2 38.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 73.310000000000002 111.134 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -67.27 137.11 55.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.238 -0.437 . . . . 65.430000000000007 111.106 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 141.32 175.09 14.67 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.703 -0.76 . . . . 74.140000000000001 112.503 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 5.1 mttp -98.86 122.24 41.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.787 0.327 . . . . 73.230000000000004 110.926 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 6.4 p -119.15 127.35 75.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 71.430000000000007 111.123 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 30.6 m120 -90.7 145.4 24.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 64.030000000000001 110.916 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 4.8 mp -131.12 92.56 32.8 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.657 0.742 . . . . 72.349999999999994 111.126 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 179.21 3.85 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.705 2.27 . . . . 74.200000000000003 112.338 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 58.0 t -148.36 137.27 15.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 74.349999999999994 111.155 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 46.1 t -116.93 135.91 55.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 74.129999999999995 111.123 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.25 107.37 12.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 74.019999999999996 110.844 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 74.94 -118.23 5.6 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.752 -0.737 . . . . 71.200000000000003 112.492 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -108.06 19.95 19.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.851 0.357 . . . . 74.549999999999997 110.867 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 116.49 2.87 19.29 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.733 -0.746 . . . . 55.009999999999998 112.52 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -51.47 -71.47 0.06 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.876 0.37 . . . . 71.430000000000007 110.88 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -109.32 151.63 26.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 73.530000000000001 110.86 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -149.46 161.73 41.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 74.299999999999997 111.138 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -139.61 163.15 33.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.246 -0.434 . . . . 73.540000000000006 111.149 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 43.0 t -136.58 139.58 44.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.281 -0.418 . . . . 73.510000000000005 111.117 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -139.26 164.37 29.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.237 -0.438 . . . . 74.200000000000003 111.109 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -143.71 128.72 18.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.239 -0.437 . . . . 54.530000000000001 110.861 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 29.1 mm -125.2 110.85 25.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 72.519999999999996 111.156 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 1.5 m -80.75 138.82 36.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 73.349999999999994 111.191 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 18.3 t -120.07 117.82 54.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.24 -0.436 . . . . 73.239999999999995 111.152 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 4.3 p -81.86 132.94 35.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 62.140000000000001 111.149 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -53.24 -28.52 27.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 71.030000000000001 111.106 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 1.4 t . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 63.229999999999997 110.845 -179.789 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 N-CA-C 112.507 -0.237 . . . . 71.340000000000003 112.507 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -95.23 90.48 5.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.744 0.306 . . . . 74.120000000000005 111.059 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 7.7 mtt -151.26 174.43 13.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.235 -0.439 . . . . 74.230000000000004 110.903 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -122.54 128.15 50.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.255 -0.43 . . . . 65.310000000000002 111.104 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -64.08 -70.01 0.25 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.251 -0.431 . . . . 75.450000000000003 111.119 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -178.55 -169.16 0.17 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.449 . . . . 75.329999999999998 111.051 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -127.6 24.34 6.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 70.310000000000002 111.155 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 151.54 99.08 0.18 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.776 -0.726 . . . . 74.120000000000005 112.551 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 43.8 ttp -113.13 125.5 54.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.846 0.355 . . . . 72.420000000000002 110.901 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 51.6 p -114.47 103.62 11.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 74.420000000000002 111.153 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 21.4 t -99.7 130.48 48.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.256 -0.429 . . . . 73.349999999999994 111.117 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.3 m -125.0 92.88 46.81 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.593 0.711 . . . . 73.200000000000003 111.113 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -168.85 0.29 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.668 2.245 . . . . 65.010000000000005 112.381 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -86.73 -40.84 14.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.279 -0.419 . . . . 74.430000000000007 111.104 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 93.6 p 46.43 79.06 0.06 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.245 -0.434 . . . . 51.329999999999998 110.851 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.5 t -175.09 -174.89 0.8 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.126 -0.488 . . . . 75.439999999999998 111.118 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 89.4 p -98.8 164.06 12.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 73.400000000000006 110.849 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 3.5 p -146.31 154.02 12.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 74.219999999999999 111.111 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 66.7 t -87.35 145.31 7.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 75.510000000000005 111.071 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -49.03 122.56 5.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.134 -0.484 . . . . 71.120000000000005 110.923 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.38 -14.59 60.83 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.75 -0.738 . . . . 74.120000000000005 112.476 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 17.4 mm100 -90.82 -178.22 5.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.83 0.347 . . . . 73.420000000000002 110.927 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 35.1 p -161.51 148.49 14.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.224 -0.444 . . . . 74.430000000000007 110.85 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 6.7 t -106.81 -173.55 2.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.075 -0.511 . . . . 63.109999999999999 111.151 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.29 132.31 27.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.231 -0.44 . . . . 75.5 111.133 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.7 mp -105.21 143.05 33.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 74.510000000000005 110.951 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 21.9 m -110.06 142.36 41.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.217 -0.447 . . . . 72.519999999999996 111.118 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 18.4 t -129.34 140.24 49.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 73.329999999999998 111.13 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -130.11 152.12 49.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.143 -0.48 . . . . 73.319999999999993 111.098 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -145.76 126.88 14.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 74.409999999999997 110.865 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.58 66.71 77.33 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.542 0.687 . . . . 73.120000000000005 110.921 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -38.37 7.91 Favored 'Trans proline' 0 N--CA 1.465 -0.155 0 C-N-CA 122.676 2.251 . . . . 74.019999999999996 112.377 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 66.92 45.68 1.77 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 74.540000000000006 110.892 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 163.74 -24.13 0.18 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.744 -0.741 . . . . 75.450000000000003 112.467 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 3.4 t -93.36 -58.99 3.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.918 0.39 . . . . 71.519999999999996 111.15 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 70.3 p 47.42 70.5 0.41 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 71.140000000000001 111.119 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -167.8 119.41 0.86 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 65.530000000000001 110.876 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.12 92.43 0.11 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 71.439999999999998 110.913 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 1.6 m -105.78 -7.08 18.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 60.32 110.831 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 19.2 p90 -91.34 176.35 6.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.098 -0.501 . . . . 72.430000000000007 110.913 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -163.05 171.16 16.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.459 . . . . 75.340000000000003 110.839 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -120.31 168.0 11.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 74.430000000000007 111.078 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 11.3 p -175.21 151.45 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 75.0 111.108 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.7 t -77.31 150.15 35.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.126 -0.488 . . . . 54.219999999999999 110.858 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -86.32 -23.79 26.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 64.450000000000003 111.138 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -127.7 -52.52 1.35 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.19 -0.459 . . . . 64.340000000000003 110.831 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.24 24.39 14.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.2 -0.455 . . . . 74.439999999999998 110.91 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 35.5 p -113.37 -2.73 13.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.246 -0.433 . . . . 71.409999999999997 111.138 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 8.8 mtmm -152.59 18.53 0.62 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.251 -0.432 . . . . 75.209999999999994 110.878 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -177.22 146.61 0.5 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 73.129999999999995 111.089 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 11.9 p -107.22 159.04 16.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.174 -0.467 . . . . 74.209999999999994 111.117 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 11.2 m -141.23 141.72 30.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 64.5 111.141 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 4.3 m -148.76 108.46 4.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 72.299999999999997 110.843 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . 0.421 ' HA ' ' HA ' ' A' ' 214' ' ' ILE . 3.5 p -87.96 143.1 11.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.132 -0.485 . . . . 74.299999999999997 111.132 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 16.7 t -172.08 123.45 0.5 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 73.329999999999998 110.841 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 55.86 47.16 80.96 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.745 -0.74 . . . . 75.140000000000001 112.488 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 2.1 mtp 63.74 16.01 9.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.853 0.359 . . . . 73.109999999999999 110.896 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 7.0 m -126.0 113.59 17.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 63.420000000000002 111.146 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.421 ' HA ' ' HA ' ' A' ' 209' ' ' VAL . 2.9 mp -110.23 113.96 45.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 75.109999999999999 111.125 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 5.0 m -88.1 132.16 34.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.45 . . . . 74.310000000000002 111.123 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 3.3 t -117.21 124.47 73.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 64.510000000000005 111.082 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -106.19 139.33 40.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 73.430000000000007 110.907 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -94.22 79.57 0.96 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.782 -0.723 . . . . 64.129999999999995 112.495 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 19.6 t -50.29 -55.96 4.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.792 0.329 . . . . 71.140000000000001 111.175 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -128.71 161.4 29.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 74.319999999999993 111.095 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -61.06 140.31 57.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.215 -0.448 . . . . 71.219999999999999 111.121 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 139.41 171.21 12.15 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.743 -0.741 . . . . 74.409999999999997 112.488 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 14.3 mttt -99.46 124.56 44.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.821 0.343 . . . . 71.340000000000003 110.941 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 7.0 p -120.96 127.37 75.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 73.329999999999998 111.169 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 21.3 m120 -90.81 151.81 21.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 74.400000000000006 110.906 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 4.4 mp -138.06 93.12 12.0 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.622 0.725 . . . . 74.140000000000001 111.125 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -178.3 2.29 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.708 2.272 . . . . 71.219999999999999 112.34 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 90.5 t -150.09 134.78 9.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 72.109999999999999 111.137 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 80.4 t -117.08 135.59 56.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.147 -0.478 . . . . 65.230000000000004 111.161 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 31.0 t -122.12 116.65 24.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 74.120000000000005 110.871 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 66.48 -115.04 6.98 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.729 -0.748 . . . . 71.120000000000005 112.464 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -110.54 19.23 18.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.874 0.369 . . . . 73.019999999999996 110.888 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 117.33 2.72 17.69 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.748 -0.739 . . . . 75.439999999999998 112.485 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -51.06 -70.36 0.09 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.866 0.365 . . . . 71.109999999999999 110.902 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -107.38 159.66 16.22 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.172 -0.467 . . . . 74.430000000000007 110.852 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -160.75 165.19 30.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.103 -0.499 . . . . 74.409999999999997 111.091 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -146.2 163.18 36.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 73.109999999999999 111.135 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 24.1 t -137.18 137.02 46.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.215 -0.448 . . . . 62.039999999999999 111.11 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -139.08 165.29 27.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.173 -0.467 . . . . 73.530000000000001 111.134 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -144.95 132.51 20.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.244 -0.434 . . . . 74.140000000000001 110.851 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 23.5 mm -126.87 115.09 40.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.134 -0.485 . . . . 72.25 111.174 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 2.0 m -82.43 141.24 32.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.152 -0.476 . . . . 75.420000000000002 111.162 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 17.8 t -119.71 121.54 66.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 74.510000000000005 111.128 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 7.1 p -82.28 133.0 35.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 73.420000000000002 111.17 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -58.33 -22.52 53.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 53.43 111.113 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 1.4 p . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.197 -0.456 . . . . 73.299999999999997 110.866 -179.77 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 N-CA-C 112.539 -0.224 . . . . 62.399999999999999 112.539 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -112.3 159.2 18.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.821 0.343 . . . . 74.340000000000003 111.09 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 4.1 mmt -134.4 178.92 6.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 73.439999999999998 110.9 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -137.33 142.62 41.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.249 -0.432 . . . . 73.310000000000002 111.129 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -60.67 -64.75 0.84 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 74.019999999999996 111.09 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -177.78 -169.6 0.22 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 73.120000000000005 111.093 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -129.25 24.09 5.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.24 -0.436 . . . . 75.209999999999994 111.088 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 153.28 99.85 0.18 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.734 -0.746 . . . . 74.030000000000001 112.448 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 21.3 ttp -113.85 124.6 52.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.85 0.357 . . . . 75.409999999999997 110.872 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 51.6 p -114.58 103.32 10.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.257 -0.429 . . . . 70.420000000000002 111.147 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 21.7 t -97.97 131.72 44.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.192 -0.458 . . . . 75.540000000000006 111.153 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.4 m -126.46 92.38 45.39 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.545 0.688 . . . . 72.530000000000001 111.143 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 -167.2 0.22 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.67 2.247 . . . . 74.150000000000006 112.321 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -85.94 -40.26 16.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 61.299999999999997 111.15 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 87.9 p 46.41 77.29 0.08 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.213 -0.449 . . . . 75.030000000000001 110.877 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.5 t -175.72 -174.82 0.71 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.12 -0.491 . . . . 75.129999999999995 111.128 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 34.6 p -100.56 162.91 12.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 72.239999999999995 110.862 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 3.3 p -144.27 153.03 15.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 72.25 111.12 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 63.2 t -86.58 145.26 7.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 73.420000000000002 111.152 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.1 122.3 5.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.191 -0.459 . . . . 75.239999999999995 110.899 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 100.19 -14.35 59.79 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.758 -0.734 . . . . 61.210000000000001 112.484 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -90.03 -177.66 5.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.81 0.338 . . . . 65.420000000000002 110.935 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 2.2 p -160.9 148.82 15.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 63.130000000000003 110.836 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 7.5 t -109.65 -176.82 3.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 74.140000000000001 111.128 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -139.47 127.51 22.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 72.310000000000002 111.148 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.9 mp -99.89 145.71 27.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.221 -0.445 . . . . 75.540000000000006 110.902 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -114.1 143.21 45.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 72.329999999999998 111.173 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 25.4 t -129.47 141.9 45.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 65.510000000000005 111.146 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -129.81 150.66 51.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 75.25 111.095 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -144.5 127.8 16.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 65.5 110.901 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.39 66.76 71.3 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.642 0.734 . . . . 74.219999999999999 110.877 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 -35.76 12.11 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.657 2.238 . . . . 74.209999999999994 112.367 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 65.61 43.8 3.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 73.549999999999997 110.885 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 166.26 -38.74 0.26 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.719 -0.753 . . . . 60.100000000000001 112.503 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 2.6 t -76.99 -56.9 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.859 0.361 . . . . 71.019999999999996 111.111 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 50.2 p 47.43 66.02 1.12 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 72.109999999999999 111.147 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -167.2 116.81 0.85 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.205 -0.452 . . . . 73.310000000000002 110.86 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.37 104.53 0.51 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 74.530000000000001 110.932 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 1.2 m -115.42 -6.14 12.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 65.200000000000003 110.843 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -90.31 174.45 7.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.125 -0.489 . . . . 74.319999999999993 110.878 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -165.7 151.64 9.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 73.150000000000006 110.863 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -104.2 158.91 16.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 75.439999999999998 111.116 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 6.4 m -153.04 -178.05 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 75.340000000000003 111.16 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 11.9 p -108.1 132.27 53.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 73.310000000000002 110.887 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -75.35 -26.01 58.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.122 -0.49 . . . . 42.310000000000002 111.14 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -129.01 -60.02 1.1 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.454 . . . . 75.409999999999997 110.884 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 63.88 35.45 10.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 72.049999999999997 110.922 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 32.7 p -118.44 -4.73 10.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.165 -0.47 . . . . 75.150000000000006 111.064 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 9.4 mtmm -152.84 18.63 0.59 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.255 -0.43 . . . . 71.099999999999994 110.907 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -171.26 144.91 2.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 71.310000000000002 111.128 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 17.0 p -107.37 130.85 54.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.249 -0.432 . . . . 64.150000000000006 111.17 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 4.8 m -118.86 138.99 47.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 71.450000000000003 111.145 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 5.7 t -145.29 109.09 4.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 72.420000000000002 110.849 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 4.2 p -89.4 143.61 10.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.104 -0.498 . . . . 71.430000000000007 111.091 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 3.4 t -144.79 96.28 2.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.138 -0.483 . . . . 62.119999999999997 110.885 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 70.29 -81.04 0.38 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.78 -0.724 . . . . 73.120000000000005 112.507 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -138.43 8.09 2.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.882 0.373 . . . . 73.120000000000005 110.911 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -129.24 121.82 28.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 63.119999999999997 111.168 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 2.6 mp -115.3 131.79 66.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 74.329999999999998 111.131 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 1.5 m -100.63 125.71 47.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.139 -0.482 . . . . 75.340000000000003 111.152 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 2.4 t -116.64 126.66 74.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 74.200000000000003 111.165 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -112.19 138.96 48.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 63.030000000000001 110.86 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -93.4 80.98 1.04 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.768 -0.729 . . . . 54.200000000000003 112.469 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 19.3 t -50.26 -51.18 18.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.855 0.36 . . . . 71.120000000000005 111.099 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -137.78 162.36 34.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 73.109999999999999 111.132 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -57.25 143.45 39.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 74.329999999999998 111.132 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 137.18 167.95 11.23 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.748 -0.739 . . . . 71.310000000000002 112.482 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 6.1 mttp -102.47 133.93 46.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.83 0.348 . . . . 74.219999999999999 110.893 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 13.1 p -130.49 131.66 65.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 75.400000000000006 111.118 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -91.33 152.45 20.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.464 . . . . 63.420000000000002 110.905 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 4.3 mp -137.43 92.44 13.47 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.611 0.719 . . . . 74.209999999999994 111.124 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.71 -179.55 2.97 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.689 2.26 . . . . 75.430000000000007 112.367 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 85.9 t -150.4 134.84 9.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 62.5 111.125 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 86.9 t -116.94 136.07 55.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 74.099999999999994 111.147 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -119.77 108.83 14.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 62.549999999999997 110.844 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 56.99 -116.05 7.32 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.767 -0.73 . . . . 44.509999999999998 112.503 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 17.9 p30 -95.04 19.3 10.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.836 0.351 . . . . 74.120000000000005 110.842 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 101.09 8.28 47.98 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.72 -0.752 . . . . 70.109999999999999 112.486 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -52.0 -33.81 39.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.814 0.34 . . . . 71.150000000000006 110.835 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -144.21 153.21 41.85 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.202 -0.454 . . . . 74.310000000000002 110.894 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -154.28 165.53 36.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.174 -0.466 . . . . 65.510000000000005 111.097 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -145.78 163.16 35.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.464 . . . . 64.340000000000003 111.115 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 23.3 t -136.6 135.83 48.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.251 -0.431 . . . . 75.319999999999993 111.131 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.6 165.29 27.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 73.319999999999993 111.123 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -145.81 132.37 19.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 75.219999999999999 110.862 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 24.5 mm -125.79 113.59 35.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.194 -0.457 . . . . 74.439999999999998 111.151 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 1.7 m -83.17 141.63 31.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 63.530000000000001 111.146 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 11.3 t -119.78 122.78 69.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.44 . . . . 73.019999999999996 111.17 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 4.2 p -84.75 132.56 34.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 74.439999999999998 111.141 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -58.18 -23.48 55.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 62.549999999999997 111.097 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 58.8 m . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 72.439999999999998 110.884 -179.792 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.3 0 N-CA-C 112.489 -0.245 . . . . 74.230000000000004 112.489 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -64.06 153.52 37.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.845 0.355 . . . . 73.329999999999998 111.049 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 2.0 tpt -68.14 150.48 48.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.21 -0.45 . . . . 72.040000000000006 110.907 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -114.98 123.89 50.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.269 -0.423 . . . . 75.099999999999994 111.128 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -82.15 -65.74 0.97 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 71.150000000000006 111.095 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -178.28 -169.14 0.18 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.251 -0.431 . . . . 72.209999999999994 111.131 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 1.9 m -128.26 24.13 5.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.261 -0.427 . . . . 71.239999999999995 111.165 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 153.41 99.04 0.17 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.701 -0.762 . . . . 73.329999999999998 112.476 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 27.9 ttp -113.18 125.34 54.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.862 0.363 . . . . 74.209999999999994 110.851 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 48.5 p -114.72 104.01 11.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 71.310000000000002 111.142 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 21.7 t -100.41 130.98 48.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 72.230000000000004 111.117 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 19.2 m -125.1 92.48 47.36 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.551 0.691 . . . . 75.439999999999998 111.085 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 -166.75 0.2 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.649 2.233 . . . . 74.420000000000002 112.355 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -86.59 -40.59 15.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.436 . . . . 74.299999999999997 111.063 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 88.2 p 46.72 76.3 0.1 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 61.340000000000003 110.875 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.5 t -174.23 -174.9 0.93 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 73.340000000000003 111.152 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 24.5 p -100.37 162.24 13.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 73.230000000000004 110.824 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 2.8 p -144.27 154.06 15.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.117 -0.492 . . . . 73.450000000000003 111.127 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 79.5 t -89.29 144.48 9.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 74.450000000000003 111.142 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.78 123.76 6.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.451 . . . . 74.239999999999995 110.92 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.84 -16.14 58.84 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.788 -0.72 . . . . 61.409999999999997 112.498 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 9.7 mm100 -89.41 -177.89 5.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.846 0.355 . . . . 75.530000000000001 110.914 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 11.9 p -161.98 147.09 12.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.212 -0.449 . . . . 62.310000000000002 110.884 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 7.3 t -108.12 -174.69 2.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 73.120000000000005 111.132 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -140.42 132.31 27.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 75.129999999999995 111.189 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.6 mp -105.12 142.14 35.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 73.329999999999998 110.919 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 24.9 m -110.01 141.99 42.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 72.209999999999994 111.179 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 21.5 t -129.32 139.87 50.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.293 -0.412 . . . . 71.109999999999999 111.127 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -130.11 151.91 50.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.124 -0.489 . . . . 75.400000000000006 111.126 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -144.24 128.69 17.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 75.420000000000002 110.889 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.25 66.69 71.66 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.582 0.706 . . . . 75.230000000000004 110.912 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 -37.38 9.22 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.68 2.253 . . . . 65.349999999999994 112.355 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 66.31 43.7 2.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 75.540000000000006 110.84 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 166.63 -29.7 0.19 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.722 -0.751 . . . . 71.150000000000006 112.468 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 2.9 t -87.16 -57.86 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.914 0.387 . . . . 75.230000000000004 111.129 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 65.2 p 47.53 69.94 0.47 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 74.049999999999997 111.135 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -170.22 118.65 0.57 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 64.439999999999998 110.883 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 9.5 mtmt -63.24 96.78 0.11 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 74.530000000000001 110.914 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 2.0 m -109.84 -6.25 15.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 73.219999999999999 110.877 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -90.71 175.9 6.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.073 -0.512 . . . . 62.219999999999999 110.845 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 3.1 ptt-85 -158.25 173.71 16.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.132 -0.486 . . . . 73.219999999999999 110.89 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -124.65 167.16 14.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 62.200000000000003 111.086 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 10.0 p -174.77 152.73 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 75.239999999999995 111.131 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.7 126.75 36.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.156 -0.475 . . . . 72.150000000000006 110.878 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -61.68 -17.94 57.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.115 -0.493 . . . . 74.129999999999995 111.093 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -156.99 92.43 1.27 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.213 -0.449 . . . . 72.299999999999997 110.913 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 8.0 tttp -83.65 55.18 3.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 75.049999999999997 110.931 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 20.0 p -130.66 2.67 4.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.246 -0.434 . . . . 74.129999999999995 111.144 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 10.8 mtmm -153.99 18.23 0.51 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 74.040000000000006 110.881 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -179.47 153.4 0.57 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.449 . . . . 74.430000000000007 111.113 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 8.4 p -117.49 131.23 56.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 73.340000000000003 111.142 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 4.9 m -120.1 140.33 44.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.184 -0.462 . . . . 74.510000000000005 111.112 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.16 109.0 4.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 72.420000000000002 110.868 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . 0.427 ' HA ' ' HA ' ' A' ' 214' ' ' ILE . 3.7 p -85.45 143.08 12.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.138 -0.483 . . . . 71.150000000000006 111.173 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 17.2 p -172.19 123.85 0.5 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 74.230000000000004 110.839 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 55.4 48.05 72.15 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.752 -0.737 . . . . 51.020000000000003 112.476 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 2.4 mtp 62.5 16.47 8.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.884 0.373 . . . . 75.540000000000006 110.853 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 1.4 m -128.15 114.23 16.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.26 -0.427 . . . . 65.310000000000002 111.153 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.427 ' HA ' ' HA ' ' A' ' 209' ' ' VAL . 3.4 mp -110.24 115.61 50.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 75.25 111.076 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 1.3 m -89.99 126.91 35.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 75.430000000000007 111.118 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 4.8 t -112.74 128.28 69.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.216 -0.447 . . . . 72.530000000000001 111.135 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -109.56 135.69 50.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 75.409999999999997 110.921 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -84.41 66.81 3.82 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.731 -0.747 . . . . 71.200000000000003 112.507 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 1.9 t -48.75 -53.58 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.817 0.341 . . . . 74.540000000000006 111.146 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -123.96 155.33 38.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.146 -0.479 . . . . 72.400000000000006 111.114 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -67.82 138.03 55.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 74.239999999999995 111.054 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 140.46 174.68 14.05 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.769 -0.729 . . . . 52.039999999999999 112.478 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 6.0 mttp -99.38 121.51 41.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.827 0.346 . . . . 74.25 110.885 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 7.6 p -120.35 128.67 76.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 74.530000000000001 111.132 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 36.1 m120 -90.52 150.2 21.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.145 -0.479 . . . . 74.030000000000001 110.863 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 4.7 mp -133.19 92.39 25.17 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.675 0.75 . . . . 75.510000000000005 111.135 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.7 -179.67 3.05 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.687 2.258 . . . . 74.319999999999993 112.375 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 96.2 t -149.46 136.13 12.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 74.400000000000006 111.142 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 82.6 t -118.26 135.52 58.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.186 -0.461 . . . . 73.349999999999994 111.134 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.21 108.8 14.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 72.200000000000003 110.856 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 74.06 -111.44 3.43 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.763 -0.732 . . . . 54.32 112.485 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -111.09 8.31 21.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.907 0.384 . . . . 75.349999999999994 110.948 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 127.78 3.24 6.0 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.709 -0.758 . . . . 60.149999999999999 112.456 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -51.66 -73.21 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.853 0.358 . . . . 75.329999999999998 110.899 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -102.94 156.37 17.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.468 . . . . 74.140000000000001 110.872 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -157.24 165.18 36.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.148 -0.478 . . . . 74.319999999999993 111.068 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -144.83 163.5 33.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 74.299999999999997 111.096 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 58.8 t -137.02 136.46 47.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.226 -0.443 . . . . 70.310000000000002 111.126 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.72 165.26 27.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 72.319999999999993 111.103 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -143.15 131.49 22.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 75.109999999999999 110.888 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 25.8 mm -127.28 112.05 27.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.13 -0.486 . . . . 71.420000000000002 111.089 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 1.7 m -82.5 139.28 34.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.189 -0.46 . . . . 63.340000000000003 111.132 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 22.1 t -120.49 119.48 59.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.23 -0.441 . . . . 74.219999999999999 111.142 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 6.8 p -81.91 132.9 35.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 74.430000000000007 111.169 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -55.2 -26.19 37.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 73.030000000000001 111.051 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 9.3 t . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.234 -0.439 . . . . 73.540000000000006 110.846 -179.785 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 N-CA-C 112.48 -0.248 . . . . 53.020000000000003 112.48 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -77.98 -56.14 4.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.756 0.312 . . . . 75.129999999999995 111.109 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 20.8 mmt -90.19 130.98 36.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.242 -0.435 . . . . 71.430000000000007 110.846 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -169.19 -169.71 1.0 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 73.540000000000006 111.111 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -175.15 129.36 0.29 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 74.530000000000001 111.088 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.65 -167.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 75.319999999999993 111.106 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -125.02 32.28 5.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 65.329999999999998 111.093 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 136.87 99.7 0.55 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.72 -0.752 . . . . 65.430000000000007 112.501 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 11.6 ttp -109.75 133.04 53.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.83 0.348 . . . . 71.099999999999994 110.898 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 33.4 p -121.65 108.17 13.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 74.319999999999993 111.147 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 26.3 t -102.23 132.29 48.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 70.530000000000001 111.122 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.7 m -124.33 92.49 48.05 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.599 0.714 . . . . 72.5 111.143 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -166.43 0.19 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.709 2.273 . . . . 75.030000000000001 112.329 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -89.03 -39.49 13.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 74.329999999999998 111.133 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 98.2 p 46.32 79.33 0.06 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 63.210000000000001 110.829 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.1 t -175.55 -174.59 0.71 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.093 -0.503 . . . . 71.030000000000001 111.121 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 97.2 p -99.89 163.19 12.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.262 -0.426 . . . . 74.420000000000002 110.886 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 3.1 p -144.95 153.6 14.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.134 -0.484 . . . . 64.129999999999995 111.099 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 58.7 t -87.53 145.67 7.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 70.540000000000006 111.13 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.34 122.37 6.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.459 . . . . 72.329999999999998 110.919 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.7 -12.54 61.14 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.761 -0.733 . . . . 61.130000000000003 112.489 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -92.64 -178.06 4.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.779 0.323 . . . . 73.400000000000006 110.928 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 23.8 p -161.5 148.83 14.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 62.219999999999999 110.878 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 9.1 t -108.74 -175.4 2.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.124 -0.489 . . . . 73.010000000000005 111.137 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -138.9 132.98 31.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 65.400000000000006 111.143 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.4 mp -106.52 143.59 34.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 74.230000000000004 110.946 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 2.2 m -111.75 142.5 44.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.462 . . . . 75.109999999999999 111.11 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 22.6 t -129.75 140.52 48.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 71.400000000000006 111.141 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -132.38 152.49 51.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 71.25 111.097 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -143.77 128.7 18.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.455 . . . . 75.530000000000001 110.866 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.77 67.11 76.81 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.577 0.704 . . . . 73.109999999999999 110.896 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 -35.45 12.72 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.675 2.25 . . . . 71.349999999999994 112.357 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 65.89 38.25 5.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.241 -0.436 . . . . 73.319999999999993 110.904 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 171.65 -44.91 0.18 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.71 -0.757 . . . . 72.420000000000002 112.488 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 2.9 t -69.05 -58.18 6.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.897 0.379 . . . . 73.349999999999994 111.1 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 41.4 p 48.23 61.7 2.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 73.150000000000006 111.11 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -164.7 112.51 1.06 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.241 -0.436 . . . . 74.109999999999999 110.881 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 6.1 mtmt -52.94 105.55 0.13 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 75.140000000000001 110.888 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 59.8 m -116.76 -6.69 11.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 74.329999999999998 110.857 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -90.75 176.5 6.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.101 -0.499 . . . . 72.340000000000003 110.857 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.28 157.34 15.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.122 -0.49 . . . . 71.439999999999998 110.862 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -105.48 167.78 9.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.47 . . . . 71.409999999999997 111.115 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 11.6 p -164.32 151.06 2.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 72.150000000000006 111.153 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.56 121.17 29.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 70.120000000000005 110.874 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -65.34 -19.49 65.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.103 -0.499 . . . . 75.099999999999994 111.107 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -163.81 91.4 0.65 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.17 -0.468 . . . . 55.009999999999998 110.845 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 7.8 ttpt -83.19 55.59 3.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 70.420000000000002 110.909 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 25.0 p -128.06 -0.23 5.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.236 -0.438 . . . . 75.019999999999996 111.153 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 6.1 mtmt -156.42 19.45 0.35 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.18 -0.463 . . . . 71.239999999999995 110.9 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -179.64 149.85 0.39 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 75.120000000000005 111.162 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 4.0 p -108.51 156.22 19.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 73.109999999999999 111.12 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 15.7 m -141.27 137.56 33.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 74.310000000000002 111.161 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 60.4 p -146.04 108.01 4.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 72.530000000000001 110.879 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . 0.418 ' HA ' ' HA ' ' A' ' 214' ' ' ILE . 3.3 p -91.18 140.94 15.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 73.299999999999997 111.147 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 17.5 p -172.38 126.71 0.53 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 75.0 110.832 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 56.49 45.44 89.58 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.782 -0.723 . . . . 74.510000000000005 112.476 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 4.2 mtp 63.51 16.15 9.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.871 0.367 . . . . 74.340000000000003 110.867 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 22.2 m -127.05 115.04 18.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.229 -0.441 . . . . 75.25 111.088 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.418 ' HA ' ' HA ' ' A' ' 209' ' ' VAL . 3.4 mp -110.44 120.25 60.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 73.209999999999994 111.141 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 1.2 m -92.18 128.84 38.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.211 -0.449 . . . . 60.310000000000002 111.168 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 3.5 t -115.34 125.58 72.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 74.329999999999998 111.125 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -110.79 138.72 46.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 74.219999999999999 110.908 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -94.99 78.53 0.88 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.765 -0.731 . . . . 73.329999999999998 112.474 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 19.1 t -49.71 -53.0 11.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.827 0.346 . . . . 74.120000000000005 111.11 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -131.33 161.95 31.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.461 . . . . 74.239999999999995 111.113 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -60.74 138.62 58.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.235 -0.439 . . . . 63.310000000000002 111.085 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 142.77 171.18 13.21 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.705 -0.759 . . . . 74.129999999999995 112.486 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 13.6 mttt -101.56 125.15 48.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.84 0.352 . . . . 72.140000000000001 110.936 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 7.1 p -122.07 126.17 74.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.242 -0.436 . . . . 73.230000000000004 111.122 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -90.96 155.48 18.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 73.230000000000004 110.878 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 4.6 mp -139.88 92.65 9.8 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.603 0.716 . . . . 70.219999999999999 111.133 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.75 -178.14 2.2 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.67 2.247 . . . . 73.409999999999997 112.365 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 80.4 t -150.3 143.02 17.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 71.540000000000006 111.094 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 94.8 t -123.77 134.09 67.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.182 -0.463 . . . . 72.310000000000002 111.119 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -122.3 133.68 54.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 73.430000000000007 110.846 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 52.25 -116.15 4.86 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.78 -0.724 . . . . 73.439999999999998 112.464 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -108.73 21.17 17.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.83 0.348 . . . . 73.109999999999999 110.86 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 110.41 5.87 27.77 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.7 -0.762 . . . . 52.340000000000003 112.514 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -52.9 -60.32 3.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.924 0.392 . . . . 71.450000000000003 110.885 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -113.04 166.69 11.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.103 -0.499 . . . . 75.430000000000007 110.89 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -165.06 162.2 20.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.151 -0.477 . . . . 74.239999999999995 111.129 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -140.09 163.26 33.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 73.010000000000005 111.125 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.2 p -140.17 131.66 31.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 75.420000000000002 111.191 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -132.71 165.2 25.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.191 -0.459 . . . . 72.549999999999997 111.093 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -144.55 132.28 21.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.225 -0.443 . . . . 74.010000000000005 110.916 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 27.2 mm -127.21 112.49 28.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 75.430000000000007 111.096 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 2.2 m -81.76 141.21 33.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.117 -0.492 . . . . 75.549999999999997 111.123 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 19.7 t -120.12 121.31 65.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.213 -0.448 . . . . 75.230000000000004 111.106 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 6.2 p -83.69 132.77 34.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.138 -0.483 . . . . 73.099999999999994 111.126 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -53.45 -28.26 29.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 72.299999999999997 111.117 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 7.9 t . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.44 . . . . 74.129999999999995 110.86 -179.766 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 N-CA-C 112.441 -0.264 . . . . 64.329999999999998 112.441 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -78.61 151.92 32.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.753 0.311 . . . . 71.109999999999999 111.091 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 15.2 ptp -113.8 66.71 0.67 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.264 -0.425 . . . . 72.319999999999993 110.873 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -135.04 177.93 7.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.266 -0.425 . . . . 70.209999999999994 111.143 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -108.99 -62.8 1.43 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.258 -0.428 . . . . 72.329999999999998 111.119 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -178.74 -168.6 0.14 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.246 -0.434 . . . . 63.32 111.111 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 1.6 m -134.33 30.79 3.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 65.209999999999994 111.139 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 137.27 104.97 0.71 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.739 -0.743 . . . . 72.209999999999994 112.503 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 1.5 ttp -115.84 138.5 51.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.837 0.351 . . . . 74.230000000000004 110.855 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 37.5 p -125.34 106.67 10.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 63.140000000000001 111.152 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 16.4 t -97.62 135.92 30.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 74.239999999999995 111.099 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.3 m -128.78 92.22 40.83 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.574 0.702 . . . . 74.0 111.157 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 -165.03 0.14 Allowed 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.695 2.263 . . . . 73.239999999999995 112.365 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -93.0 -37.01 12.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.433 . . . . 65.209999999999994 111.124 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 88.0 p 46.85 76.92 0.09 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 71.430000000000007 110.838 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.4 t -171.22 -174.5 1.48 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 63.32 111.18 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 18.4 p -100.35 163.66 12.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 65.230000000000004 110.833 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 3.0 p -144.4 153.4 15.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.079 -0.51 . . . . 65.409999999999997 111.173 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 23.2 t -86.38 145.09 8.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 62.299999999999997 111.139 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.42 122.23 5.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 74.010000000000005 110.91 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 98.87 -11.08 62.49 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.696 -0.764 . . . . 64.5 112.505 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 19.2 mm100 -92.82 -177.53 4.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.769 0.319 . . . . 75.120000000000005 110.945 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 59.8 p -160.56 151.65 19.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.246 -0.434 . . . . 74.310000000000002 110.854 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 11.0 t -113.74 -178.71 3.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.119 -0.491 . . . . 73.430000000000007 111.16 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.02 129.71 32.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.22 -0.445 . . . . 74.329999999999998 111.12 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.7 mp -103.57 146.23 28.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 70.409999999999997 110.901 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 7.1 m -111.1 144.36 40.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 74.040000000000006 111.133 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 21.8 t -129.5 142.26 44.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 73.439999999999998 111.155 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -129.08 152.83 48.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 63.210000000000001 111.106 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -145.77 129.23 16.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.458 . . . . 72.340000000000003 110.852 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.6 66.81 75.42 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.592 0.71 . . . . 71.420000000000002 110.878 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -37.73 8.74 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.636 2.224 . . . . 75.299999999999997 112.358 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 65.39 31.33 10.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 73.150000000000006 110.92 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 175.7 -49.13 0.12 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.766 -0.73 . . . . 60.020000000000003 112.497 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 2.3 t -63.79 -56.61 15.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.889 0.376 . . . . 73.209999999999994 111.156 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 39.6 p 47.45 61.41 2.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.193 -0.458 . . . . 73.129999999999995 111.177 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -159.24 124.65 4.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 71.319999999999993 110.862 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -66.33 90.51 0.15 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.451 . . . . 75.430000000000007 110.906 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 1.8 t -105.5 -6.64 19.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 74.040000000000006 110.836 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -91.08 168.85 11.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.465 . . . . 72.230000000000004 110.905 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.08 168.8 25.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 73.430000000000007 110.889 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -119.53 163.06 17.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.446 . . . . 64.25 111.144 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.9 m -153.79 -178.74 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.272 -0.422 . . . . 73.25 111.121 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -119.53 127.35 52.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.161 -0.472 . . . . 70.450000000000003 110.921 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -70.82 -9.73 58.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.474 . . . . 62.310000000000002 111.153 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -166.22 99.12 0.62 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 64.319999999999993 110.867 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 14.9 tttt -91.52 41.71 1.08 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.176 -0.465 . . . . 74.299999999999997 110.892 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 4.2 p -124.93 -5.22 7.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 54.329999999999998 111.188 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 8.5 mtmm -148.05 15.09 1.04 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 74.329999999999998 110.922 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -179.67 150.11 0.39 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.44 . . . . 64.109999999999999 111.081 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 9.3 p -115.95 151.85 34.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 73.200000000000003 111.133 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 6.2 m -138.03 141.64 37.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 74.349999999999994 111.082 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -147.05 109.02 4.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 75.349999999999994 110.906 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . 0.424 ' HA ' ' HA ' ' A' ' 214' ' ' ILE . 3.6 p -86.23 143.21 11.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.128 -0.487 . . . . 72.239999999999995 111.114 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 7.7 p -171.98 124.11 0.53 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 71.450000000000003 110.869 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 55.64 47.19 79.09 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.781 -0.723 . . . . 73.510000000000005 112.47 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 2.0 mtp 63.26 16.08 9.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.844 0.354 . . . . 72.420000000000002 110.884 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 1.9 m -127.4 114.81 18.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.24 -0.436 . . . . 71.430000000000007 111.143 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.424 ' HA ' ' HA ' ' A' ' 209' ' ' VAL . 3.0 mp -110.15 116.26 51.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 73.329999999999998 111.107 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -89.34 126.15 35.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 64.120000000000005 111.125 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 2.8 t -111.43 129.91 65.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 74.310000000000002 111.172 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -113.55 139.03 49.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.439 . . . . 70.239999999999995 110.887 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -96.73 78.02 0.71 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.738 -0.744 . . . . 73.109999999999999 112.526 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 17.0 t -50.22 -54.96 6.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.846 0.355 . . . . 73.140000000000001 111.151 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -128.0 160.8 30.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 74.200000000000003 111.115 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -61.07 140.05 57.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 62.439999999999998 111.051 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 142.56 170.83 12.94 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.802 -0.713 . . . . 71.329999999999998 112.535 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 12.8 mttt -100.85 121.33 41.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.818 0.342 . . . . 73.120000000000005 110.877 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 7.4 p -120.57 126.96 75.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.262 -0.426 . . . . 71.540000000000006 111.139 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -90.67 155.97 18.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.464 . . . . 74.319999999999993 110.864 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . 0.4 ' HA ' ' HD2' ' A' ' 227' ' ' PRO . 3.9 mp -135.91 92.34 16.6 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.629 0.728 . . . . 73.340000000000003 111.072 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 226' ' ' ILE . 53.8 Cg_endo -69.77 179.78 3.47 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.66 2.24 . . . . 75.329999999999998 112.352 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 64.3 t -150.29 144.11 17.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.236 -0.438 . . . . 75.329999999999998 111.108 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 86.8 t -132.55 135.74 57.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.136 -0.484 . . . . 73.319999999999993 111.156 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 82.6 p -115.03 106.7 14.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.452 . . . . 64.430000000000007 110.882 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 59.33 -100.26 0.18 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.746 -0.74 . . . . 75.430000000000007 112.475 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 18.0 p30 -95.09 -7.68 38.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.897 0.379 . . . . 74.239999999999995 110.899 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 112.45 13.24 11.97 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.738 -0.744 . . . . 71.140000000000001 112.462 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -52.54 -28.73 21.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.865 0.364 . . . . 75.230000000000004 110.887 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -144.66 132.53 21.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 74.299999999999997 110.85 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -134.26 164.86 26.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 72.340000000000003 111.049 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -135.38 162.98 31.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 73.019999999999996 111.088 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 58.3 t -135.82 121.94 31.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.205 -0.452 . . . . 74.209999999999994 111.114 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -129.4 165.08 22.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 74.109999999999999 111.057 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -146.74 132.7 19.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 65.109999999999999 110.864 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 23.7 mm -126.76 111.92 27.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 72.530000000000001 111.11 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 2.7 m -79.8 141.22 36.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 70.230000000000004 111.148 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 16.6 t -119.9 120.7 63.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.28 -0.418 . . . . 73.420000000000002 111.113 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 7.2 p -82.36 132.85 35.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.164 -0.471 . . . . 73.209999999999994 111.117 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -57.97 -23.88 55.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 75.129999999999995 111.086 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 80.4 p . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.242 -0.435 . . . . 72.140000000000001 110.875 -179.805 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.389 0 N-CA-C 112.514 -0.235 . . . . 73.430000000000007 112.514 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . 56.78 25.54 10.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.79 0.329 . . . . 73.530000000000001 111.126 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 9.0 mmt -83.74 80.54 9.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 70.209999999999994 110.912 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -171.38 -172.47 1.08 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.226 -0.443 . . . . 71.519999999999996 111.09 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -174.34 129.08 0.36 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 73.319999999999993 111.133 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.5 -168.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 75.209999999999994 111.142 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 1.1 m -124.81 32.82 5.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.263 -0.426 . . . . 75.439999999999998 111.157 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 137.28 98.68 0.5 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.751 -0.738 . . . . 65.109999999999999 112.493 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 3.8 ttp -110.23 130.29 55.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.827 0.346 . . . . 74.319999999999993 110.846 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 43.9 p -118.67 104.01 10.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 75.530000000000001 111.118 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 34.7 t -97.86 132.78 41.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.264 -0.425 . . . . 73.420000000000002 111.104 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.6 m -126.76 92.53 44.54 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.571 0.701 . . . . 73.140000000000001 111.179 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -166.13 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.689 2.259 . . . . 71.530000000000001 112.317 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -87.99 -39.22 14.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 54.25 111.079 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 96.1 p 46.46 78.06 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.274 -0.421 . . . . 54.399999999999999 110.844 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.6 t -175.18 -174.81 0.78 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.493 . . . . 74.549999999999997 111.212 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 94.7 p -99.78 163.25 12.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.254 -0.43 . . . . 73.129999999999995 110.841 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 2.8 p -144.41 152.76 15.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.125 -0.489 . . . . 75.519999999999996 111.122 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 32.2 t -85.49 145.04 8.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.179 -0.464 . . . . 74.310000000000002 111.114 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.28 121.98 5.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.18 -0.464 . . . . 74.140000000000001 110.896 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.16 -11.87 62.0 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.701 -0.761 . . . . 65.040000000000006 112.471 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 21.5 mm100 -91.05 -177.39 4.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.78 0.324 . . . . 75.430000000000007 110.944 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -159.3 149.99 19.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.262 -0.427 . . . . 65.230000000000004 110.84 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 11.5 t -110.99 179.64 3.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.486 . . . . 72.540000000000006 111.139 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -136.02 126.12 26.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 74.319999999999993 111.185 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.7 mp -100.32 149.35 23.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 71.510000000000005 110.88 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 2.4 m -117.54 143.55 45.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.16 -0.473 . . . . 73.439999999999998 111.149 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 22.0 t -129.56 140.95 47.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 72.319999999999993 111.079 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -129.04 151.95 49.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.474 . . . . 52.420000000000002 111.088 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -146.65 130.05 16.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 74.200000000000003 110.895 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.24 66.63 75.55 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.612 0.72 . . . . 72.109999999999999 110.946 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -36.03 11.59 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.722 2.281 . . . . 72.340000000000003 112.307 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 66.18 43.07 2.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.254 -0.43 . . . . 74.400000000000006 110.902 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 166.28 -41.46 0.27 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.77 -0.729 . . . . 43.539999999999999 112.479 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 2.5 t -73.44 -55.57 12.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.927 0.394 . . . . 74.239999999999995 111.146 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER 47.29 66.45 1.01 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.175 -0.466 . . . . 63.530000000000001 111.16 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -165.75 131.34 2.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.212 -0.449 . . . . 73.329999999999998 110.893 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.27 91.68 3.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.179 -0.464 . . . . 65.219999999999999 110.907 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.82 -6.48 21.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 74.310000000000002 110.838 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 26.9 p90 -90.74 179.32 5.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.469 . . . . 74.530000000000001 110.897 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 2.2 ptt180 -166.45 174.48 8.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 72.099999999999994 110.867 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -119.45 154.77 33.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.458 . . . . 53.109999999999999 111.118 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 12.7 t -144.85 154.8 14.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.234 -0.439 . . . . 73.430000000000007 111.082 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.95 115.97 28.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.145 -0.48 . . . . 73.099999999999994 110.857 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -59.73 -22.14 61.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 63.420000000000002 111.133 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -161.16 92.17 0.9 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.221 -0.445 . . . . 65.219999999999999 110.895 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 5.8 tttp -85.07 54.39 3.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 71.510000000000005 110.888 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 19.1 p -129.51 1.28 5.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 71.049999999999997 111.16 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 9.0 mtmt -155.53 18.28 0.4 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 74.340000000000003 110.924 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -179.9 148.39 0.31 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 72.420000000000002 111.104 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 5.9 p -104.71 154.15 20.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 74.319999999999993 111.13 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 17.1 m -140.8 134.31 32.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.464 . . . . 74.329999999999998 111.114 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 10.7 m -145.3 109.09 4.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 75.239999999999995 110.867 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 4.3 p -92.69 142.43 13.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 72.010000000000005 111.113 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 4.1 t -143.23 98.9 3.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.134 -0.485 . . . . 72.25 110.866 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 69.89 -81.9 0.32 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.714 -0.755 . . . . 75.230000000000004 112.489 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 1.1 mtp -139.0 9.55 2.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.851 0.358 . . . . 74.200000000000003 110.853 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 7.3 m -130.21 123.25 29.76 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.243 -0.435 . . . . 64.230000000000004 111.17 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 2.2 mp -115.26 141.19 33.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.221 -0.445 . . . . 70.340000000000003 111.17 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.41 125.4 51.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.237 -0.438 . . . . 72.430000000000007 111.139 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 2.6 t -115.33 130.77 69.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 75.209999999999994 111.085 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -116.95 138.42 51.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 75.530000000000001 110.926 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -95.21 79.72 0.85 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.768 -0.729 . . . . 71.319999999999993 112.509 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 16.3 t -50.82 -53.46 13.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.792 0.33 . . . . 74.129999999999995 111.129 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -130.81 162.48 29.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.447 . . . . 72.200000000000003 111.073 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -60.92 140.45 57.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 72.120000000000005 111.12 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 142.34 171.25 13.06 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.79 -0.719 . . . . 74.349999999999994 112.528 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 5.5 mttp -103.74 121.85 43.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.85 0.357 . . . . 70.340000000000003 110.864 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 7.2 p -120.36 126.04 74.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 75.510000000000005 111.179 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 35.3 m120 -90.8 153.33 20.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 72.019999999999996 110.871 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 4.1 mp -137.21 93.08 13.33 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.608 0.718 . . . . 75.230000000000004 111.132 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -178.37 2.3 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.66 2.24 . . . . 71.530000000000001 112.37 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 47.0 t -147.37 139.62 18.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 72.349999999999994 111.111 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 99.8 t -120.53 135.19 61.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 74.319999999999993 111.152 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -121.46 122.51 39.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 74.439999999999998 110.878 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 56.14 -119.87 16.69 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.757 -0.735 . . . . 72.25 112.485 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -92.36 14.09 17.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.818 0.342 . . . . 74.010000000000005 110.878 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 108.17 8.6 29.1 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.705 -0.759 . . . . 63.219999999999999 112.471 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -51.97 -65.76 0.5 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.887 0.375 . . . . 74.420000000000002 110.939 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -100.54 158.98 15.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 74.120000000000005 110.904 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -157.73 160.52 37.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.165 -0.471 . . . . 74.219999999999999 111.108 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -136.97 163.61 30.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 71.5 111.102 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 57.7 t -137.34 130.39 43.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 74.109999999999999 111.17 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -137.54 163.33 31.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 73.109999999999999 111.09 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -147.35 130.37 16.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.203 -0.453 . . . . 73.329999999999998 110.903 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 26.5 mm -124.4 112.18 31.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.13 -0.486 . . . . 71.120000000000005 111.106 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 1.9 m -80.66 141.51 34.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.164 -0.471 . . . . 75.299999999999997 111.151 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 15.9 t -119.98 121.84 66.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 64.430000000000007 111.134 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 6.8 p -83.04 132.95 35.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 61.240000000000002 111.154 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -57.11 -23.82 49.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.23 -0.441 . . . . 73.510000000000005 111.089 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 4.4 t . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.26 -0.427 . . . . 62.5 110.837 -179.79 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 N-CA-C 112.494 -0.243 . . . . 74.319999999999993 112.494 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -107.88 145.72 33.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.798 0.332 . . . . 74.329999999999998 111.097 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 14.6 ptt? -118.02 79.58 1.39 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 73.299999999999997 110.843 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -160.64 -169.8 2.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.445 . . . . 71.239999999999995 111.135 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -177.19 129.65 0.16 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 63.009999999999998 111.112 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -59.95 -168.76 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.455 . . . . 73.420000000000002 111.161 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -125.56 33.74 5.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.276 -0.42 . . . . 70.5 111.176 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 134.66 99.63 0.63 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.724 -0.75 . . . . 74.030000000000001 112.481 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 11.6 ttp -114.76 133.08 56.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.861 0.363 . . . . 70.239999999999995 110.918 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 28.2 p -122.26 110.88 16.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 75.409999999999997 111.124 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 21.5 t -100.88 134.99 39.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 73.219999999999999 111.156 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.3 m -124.98 91.77 48.78 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.56 0.695 . . . . 75.040000000000006 111.136 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -165.16 0.14 Allowed 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.696 2.264 . . . . 73.450000000000003 112.336 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -91.14 -38.13 12.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.452 . . . . 73.120000000000005 111.079 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 90.5 p 46.85 77.31 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 74.030000000000001 110.88 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.2 t -174.32 -174.34 0.86 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.101 -0.499 . . . . 63.439999999999998 111.12 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 90.4 p -100.33 161.75 13.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 73.120000000000005 110.866 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 2.9 p -142.39 153.05 17.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.131 -0.486 . . . . 73.310000000000002 111.103 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 32.3 t -85.53 145.08 8.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 74.409999999999997 111.142 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.72 122.17 6.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.47 . . . . 73.040000000000006 110.897 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.12 -10.92 62.01 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.753 -0.737 . . . . 74.430000000000007 112.49 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 20.3 mm100 -91.83 -177.31 4.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.836 0.35 . . . . 74.120000000000005 110.911 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.52 152.36 19.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 73.019999999999996 110.89 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 13.2 t -115.66 179.13 4.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.454 . . . . 74.310000000000002 111.124 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.05 126.16 27.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 70.439999999999998 111.131 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.4 mp -100.28 142.77 31.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 75.209999999999994 110.916 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 14.1 m -108.74 143.81 37.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 73.239999999999995 111.196 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 21.0 t -129.65 141.22 47.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 63.439999999999998 111.071 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -130.04 149.55 51.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 72.230000000000004 111.119 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -139.79 130.6 26.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 73.439999999999998 110.863 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.73 67.0 80.03 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.564 0.697 . . . . 71.420000000000002 110.864 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -36.97 9.78 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.696 2.264 . . . . 72.030000000000001 112.332 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 65.85 26.52 11.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 73.030000000000001 110.909 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -178.81 -51.13 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.735 -0.745 . . . . 52.200000000000003 112.487 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 2.2 t -60.83 -54.39 35.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.91 0.385 . . . . 75.109999999999999 111.143 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 40.0 p 47.81 62.02 2.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.166 -0.47 . . . . 73.120000000000005 111.137 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -165.7 122.21 1.39 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.192 -0.458 . . . . 74.310000000000002 110.876 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 11.7 mtpt -61.4 95.91 0.05 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 75.030000000000001 110.875 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.35 -6.99 17.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.216 -0.447 . . . . 62.030000000000001 110.828 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -91.04 178.46 6.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 72.340000000000003 110.882 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.9 171.47 12.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.121 -0.491 . . . . 75.439999999999998 110.854 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -122.89 163.42 20.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 72.319999999999993 111.106 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 5.8 m -153.1 -178.27 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 72.329999999999998 111.127 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.65 114.88 24.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 72.219999999999999 110.884 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -59.79 -20.86 59.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 71.230000000000004 111.083 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -162.24 96.73 0.99 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 62.219999999999999 110.85 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -87.95 47.85 1.56 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.485 . . . . 73.439999999999998 110.902 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 12.4 p -125.59 -4.35 7.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 74.099999999999994 111.09 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 9.0 mtmm -149.82 16.08 0.86 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.436 . . . . 73.540000000000006 110.902 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -179.67 151.24 0.44 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.448 . . . . 73.540000000000006 111.078 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 7.2 p -112.29 152.59 28.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.215 -0.448 . . . . 75.329999999999998 111.157 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 12.9 m -141.02 137.72 34.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.265 -0.425 . . . . 75.230000000000004 111.114 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.54 109.35 4.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 75.340000000000003 110.879 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . 0.434 ' HA ' ' HA ' ' A' ' 214' ' ' ILE . 3.5 p -87.93 134.7 27.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 72.340000000000003 111.157 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 2.9 m -161.53 124.08 3.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 63.100000000000001 110.83 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 55.34 47.74 73.6 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.74 -0.743 . . . . 71.109999999999999 112.48 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 3.4 mtp 63.24 16.1 9.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.851 0.358 . . . . 74.420000000000002 110.85 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 15.9 m -126.93 110.64 13.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 75.420000000000002 111.167 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.434 ' HA ' ' HA ' ' A' ' 209' ' ' VAL . 3.1 mp -105.7 117.35 51.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 64.5 111.126 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.26 127.02 36.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 74.329999999999998 111.107 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 2.8 t -113.0 131.53 64.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 74.109999999999999 111.107 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -117.25 136.62 52.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 72.329999999999998 110.905 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -94.15 79.22 0.97 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.777 -0.725 . . . . 73.319999999999993 112.46 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 18.5 t -50.98 -52.25 18.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.871 0.367 . . . . 71.040000000000006 111.144 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -131.97 161.42 33.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 64.230000000000004 111.116 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -59.96 139.12 57.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 65.219999999999999 111.122 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 142.44 170.45 12.7 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.746 -0.74 . . . . 74.230000000000004 112.522 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 13.4 mttt -99.36 123.5 43.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.819 0.343 . . . . 75.120000000000005 110.852 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 6.7 p -118.96 124.72 73.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 63.130000000000003 111.093 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -90.78 152.83 20.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.152 -0.476 . . . . 75.150000000000006 110.87 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 4.3 mp -137.77 93.17 12.41 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.594 0.712 . . . . 74.400000000000006 111.136 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 179.74 3.51 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.676 2.251 . . . . 74.219999999999999 112.336 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 90.3 t -150.23 136.31 11.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 74.420000000000002 111.128 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 91.3 t -117.67 134.71 60.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 73.25 111.167 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -120.94 127.57 51.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 73.430000000000007 110.893 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 58.85 -117.81 12.05 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.723 -0.751 . . . . 65.349999999999994 112.496 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -108.62 21.04 17.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.878 0.37 . . . . 71.439999999999998 110.862 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 113.4 3.69 23.97 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.759 -0.734 . . . . 61.020000000000003 112.485 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -54.12 -64.39 0.84 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.907 0.384 . . . . 74.120000000000005 110.881 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -111.42 156.74 21.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 75.319999999999993 110.831 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -156.57 164.54 38.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.095 -0.502 . . . . 72.129999999999995 111.131 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -143.2 163.29 33.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.269 -0.423 . . . . 63.210000000000001 111.113 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 13.5 p -140.49 138.72 36.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 72.349999999999994 111.154 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -136.95 165.33 26.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 74.209999999999994 111.09 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -141.88 131.17 23.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.23 -0.441 . . . . 71.140000000000001 110.876 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 25.9 mm -127.32 110.63 23.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.123 -0.49 . . . . 73.549999999999997 111.147 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 1.8 m -80.13 141.33 35.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.206 -0.452 . . . . 74.150000000000006 111.158 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 17.1 t -119.91 121.92 67.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 74.319999999999993 111.124 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 7.3 p -83.36 132.86 34.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 74.310000000000002 111.136 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -57.46 -24.46 55.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 71.140000000000001 111.106 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 5.2 m . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 72.109999999999999 110.836 -179.837 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 N-CA-C 112.517 -0.233 . . . . 63.520000000000003 112.517 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . 57.17 26.53 12.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.793 0.33 . . . . 73.120000000000005 111.08 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 55.4 mtp -113.76 -179.84 3.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 75.239999999999995 110.889 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -111.69 130.67 55.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 73.439999999999998 111.097 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -109.38 -73.09 0.7 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.244 -0.434 . . . . 61.229999999999997 111.054 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -173.82 -169.37 0.49 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 54.25 111.077 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -131.91 18.53 4.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.184 -0.462 . . . . 61.039999999999999 111.074 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 166.8 97.91 0.12 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.746 -0.74 . . . . 51.539999999999999 112.466 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 41.7 ttp -111.98 129.96 56.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.815 0.341 . . . . 60.140000000000001 110.886 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 46.6 p -118.82 103.03 9.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.249 -0.432 . . . . 73.400000000000006 111.141 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 22.8 t -97.82 132.72 42.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.208 -0.451 . . . . 74.230000000000004 111.107 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.2 m -125.11 92.9 46.58 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 121.598 0.713 . . . . 60.439999999999998 111.119 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 -168.62 0.28 Allowed 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.685 2.257 . . . . 71.510000000000005 112.377 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -86.99 -39.82 15.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 74.040000000000006 111.062 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 95.3 p 46.43 78.5 0.07 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 74.239999999999995 110.847 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.1 t -173.86 -174.79 0.98 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.088 -0.505 . . . . 74.409999999999997 111.141 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 27.3 p -99.34 163.56 12.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.445 . . . . 55.310000000000002 110.875 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 3.1 p -146.38 154.32 12.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.115 -0.493 . . . . 74.230000000000004 111.135 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 57.6 t -88.39 145.43 7.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.48 . . . . 74.239999999999995 111.153 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -48.93 122.67 6.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 74.109999999999999 110.887 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.72 -14.2 60.55 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.733 -0.746 . . . . 74.340000000000003 112.463 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -91.16 -177.88 5.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.836 0.35 . . . . 71.109999999999999 110.93 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 20.4 p -161.43 149.51 15.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 73.219999999999999 110.829 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 7.5 t -108.52 -173.87 2.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.113 -0.494 . . . . 64.310000000000002 111.188 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.01 131.23 26.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.45 . . . . 65.530000000000001 111.195 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.5 mp -104.87 144.25 32.04 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.244 -0.435 . . . . 74.439999999999998 110.946 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 31.3 m -111.46 144.92 39.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 73.230000000000004 111.15 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 21.3 t -129.32 140.07 50.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 73.409999999999997 111.112 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -129.6 154.95 46.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.466 . . . . 73.439999999999998 111.048 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -145.28 133.8 22.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 74.120000000000005 110.879 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.83 66.33 26.28 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.596 0.712 . . . . 74.400000000000006 110.907 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -23.83 30.28 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.679 2.253 . . . . 74.109999999999999 112.388 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 70.91 33.83 2.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.453 . . . . 74.239999999999995 110.876 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 167.55 -25.42 0.13 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.719 -0.753 . . . . 75.329999999999998 112.452 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 78.3 t -100.38 150.11 5.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.882 0.373 . . . . 75.430000000000007 111.131 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 12.7 p -143.89 35.22 1.25 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 73.239999999999995 111.167 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -113.79 127.64 56.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.254 -0.43 . . . . 75.25 110.854 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 1.9 ttpp -79.62 61.67 3.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 70.239999999999995 110.866 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 1.7 t -73.08 -7.93 53.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 62.399999999999999 110.843 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -91.49 163.43 14.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 75.540000000000006 110.922 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.27 172.21 18.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.471 . . . . 73.420000000000002 110.867 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -117.18 168.11 10.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 73.209999999999994 111.088 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 10.6 p -173.12 152.04 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.443 . . . . 75.049999999999997 111.126 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.3 t -78.27 151.51 32.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 74.200000000000003 110.849 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -88.43 -23.89 23.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 73.0 111.146 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.77 -53.51 1.23 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 75.230000000000004 110.841 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.28 28.48 15.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 71.129999999999995 110.919 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 71.9 p -114.65 -3.17 12.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 75.420000000000002 111.134 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 7.6 mtmt -152.05 18.52 0.67 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 64.439999999999998 110.888 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -177.11 146.84 0.52 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 74.549999999999997 111.052 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 18.8 p -106.93 157.47 17.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 74.219999999999999 111.158 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 9.8 m -140.9 141.08 32.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.184 -0.462 . . . . 74.430000000000007 111.108 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -148.6 108.81 4.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 72.310000000000002 110.881 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . 0.429 ' HA ' ' HA ' ' A' ' 214' ' ' ILE . 3.8 p -87.36 143.42 11.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.491 . . . . 71.329999999999998 111.158 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -171.83 123.27 0.52 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 74.140000000000001 110.855 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 55.76 47.4 78.68 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.773 -0.727 . . . . 51.340000000000003 112.471 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 1.7 mtp 63.5 15.83 9.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.867 0.365 . . . . 70.140000000000001 110.869 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 1.1 m -126.51 113.72 17.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.434 . . . . 72.230000000000004 111.178 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.429 ' HA ' ' HA ' ' A' ' 209' ' ' VAL . 3.2 mp -110.16 115.48 49.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.241 -0.436 . . . . 73.209999999999994 111.145 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 3.8 m -88.3 131.05 34.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.459 . . . . 74.420000000000002 111.116 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 2.8 t -116.88 124.56 73.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 74.510000000000005 111.136 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -107.9 137.92 45.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 64.310000000000002 110.922 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -93.22 80.74 1.06 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.767 -0.73 . . . . 74.219999999999999 112.445 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 19.7 t -50.49 -54.83 7.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.882 0.372 . . . . 74.109999999999999 111.116 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -130.01 162.88 27.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 74.340000000000003 111.09 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -62.09 140.19 58.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 74.329999999999998 111.068 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 140.1 171.2 12.28 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.676 -0.773 . . . . 73.150000000000006 112.473 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 14.0 mttt -99.5 124.24 44.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.826 0.346 . . . . 64.5 110.871 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 7.0 p -121.02 127.08 75.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 73.109999999999999 111.149 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 33.2 m120 -90.88 151.72 21.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 75.099999999999994 110.851 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 4.0 mp -136.52 93.27 14.46 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.618 0.723 . . . . 74.400000000000006 111.156 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 179.89 3.38 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.689 2.259 . . . . 73.349999999999994 112.325 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 97.2 t -150.31 141.41 16.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 72.439999999999998 111.201 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 46.5 t -124.51 138.31 54.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 75.329999999999998 111.144 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 1.7 t -122.18 108.76 13.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 61.229999999999997 110.88 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 69.27 -119.35 9.37 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.732 -0.747 . . . . 75.400000000000006 112.505 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -104.56 21.14 17.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.807 0.336 . . . . 74.129999999999995 110.866 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 112.35 5.63 24.49 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.741 -0.742 . . . . 33.530000000000001 112.521 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -51.28 -44.03 61.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.867 0.365 . . . . 74.420000000000002 110.863 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -138.56 167.04 22.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 72.329999999999998 110.886 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -163.53 164.72 24.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 75.120000000000005 111.122 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -143.84 163.18 34.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.436 . . . . 72.129999999999995 111.145 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 10.5 p -137.94 136.69 45.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 75.019999999999996 111.115 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -139.16 165.17 27.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 63.450000000000003 111.102 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -143.87 132.13 21.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 73.420000000000002 110.898 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 24.7 mm -127.2 113.93 34.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.205 -0.452 . . . . 74.209999999999994 111.145 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 2.8 m -82.81 141.23 32.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 75.200000000000003 111.146 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 17.0 t -120.06 120.95 64.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 75.230000000000004 111.173 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 5.4 p -82.33 132.79 35.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 63.509999999999998 111.118 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -57.41 -23.42 49.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 74.230000000000004 111.095 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 2.1 t . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 73.219999999999999 110.859 -179.769 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.475 -0.25 . . . . 74.019999999999996 112.475 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -85.42 131.57 34.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.837 0.351 . . . . 73.430000000000007 111.107 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 5.7 tpt -111.34 57.05 0.63 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 72.230000000000004 110.867 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -158.54 163.63 36.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 73.340000000000003 111.131 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -76.32 -66.89 0.74 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 65.439999999999998 111.103 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -178.31 -169.34 0.18 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 74.140000000000001 111.082 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -131.68 27.09 4.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.236 -0.438 . . . . 72.530000000000001 111.106 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 145.92 101.93 0.32 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.778 -0.725 . . . . 62.229999999999997 112.484 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 42.9 ttp -114.49 126.16 54.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.863 0.364 . . . . 73.200000000000003 110.829 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 43.4 p -115.65 105.69 13.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 74.409999999999997 111.154 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 21.5 t -101.52 130.76 50.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 64.519999999999996 111.102 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.3 m -123.82 92.42 48.54 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.549 0.69 . . . . 73.230000000000004 111.121 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -167.2 0.21 Allowed 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.66 2.24 . . . . 75.030000000000001 112.361 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -90.2 -40.85 11.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 62.549999999999997 111.126 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 93.0 p 46.74 79.6 0.06 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 74.030000000000001 110.839 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.5 t -175.33 -175.63 0.84 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 74.409999999999997 111.137 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 41.7 p -98.75 163.63 12.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 71.409999999999997 110.831 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 3.0 p -145.6 153.57 13.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.124 -0.489 . . . . 70.099999999999994 111.107 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 99.1 t -87.24 144.71 8.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 74.230000000000004 111.134 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -47.95 122.57 5.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.216 -0.447 . . . . 75.310000000000002 110.891 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.75 -13.5 60.86 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.759 -0.734 . . . . 75.409999999999997 112.473 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 11.0 mm100 -93.38 -179.58 5.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.776 0.322 . . . . 63.399999999999999 110.913 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 57.4 p -162.09 148.09 13.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 70.049999999999997 110.849 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 6.9 t -105.26 -173.72 2.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.136 -0.484 . . . . 74.329999999999998 111.158 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -140.11 130.53 25.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 62.43 111.165 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.6 mp -103.53 142.39 34.36 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.245 -0.434 . . . . 74.540000000000006 110.93 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 10.9 m -109.46 142.72 40.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.262 -0.426 . . . . 74.409999999999997 111.166 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 21.9 t -129.45 141.53 46.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.231 -0.44 . . . . 71.239999999999995 111.154 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -132.28 151.86 51.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.463 . . . . 63.030000000000001 111.132 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -145.33 126.73 14.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.275 -0.42 . . . . 72.120000000000005 110.882 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.97 66.69 79.65 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.57 0.7 . . . . 72.109999999999999 110.889 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -38.07 8.33 Favored 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.668 2.245 . . . . 74.040000000000006 112.328 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 66.32 41.85 3.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.22 -0.446 . . . . 71.319999999999993 110.881 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 168.39 -33.52 0.19 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.741 -0.742 . . . . 71.150000000000006 112.5 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 3.2 t -82.88 -58.36 3.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.927 0.394 . . . . 73.310000000000002 111.174 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 47.7 p 47.63 67.51 0.8 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.136 -0.484 . . . . 74.450000000000003 111.163 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -164.38 122.31 1.75 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 73.239999999999995 110.838 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -65.63 90.08 0.11 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 74.439999999999998 110.897 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 47.3 t -105.4 -6.66 19.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.254 -0.43 . . . . 70.540000000000006 110.848 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 17.1 p90 -90.82 177.68 6.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 65.129999999999995 110.878 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.44 175.29 9.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 75.430000000000007 110.908 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -122.57 168.08 12.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 73.109999999999999 111.102 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 8.7 p -173.61 153.61 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.214 -0.448 . . . . 71.430000000000007 111.121 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.66 133.42 33.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 75.150000000000006 110.908 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -69.26 -21.11 63.92 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.154 -0.476 . . . . 74.150000000000006 111.074 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -132.61 -46.15 0.89 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 71.129999999999995 110.858 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.11 27.45 7.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 74.230000000000004 110.93 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 53.3 p -112.13 -13.66 13.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 73.510000000000005 111.155 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? -139.26 24.88 2.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 72.439999999999998 110.87 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . 179.06 143.3 0.13 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 73.319999999999993 111.137 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 7.8 p -106.99 131.23 54.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.231 -0.441 . . . . 74.140000000000001 111.121 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 5.0 m -118.34 143.33 29.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 72.030000000000001 111.153 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 3.3 m -149.3 108.7 3.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.466 . . . . 53.530000000000001 110.854 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . 0.437 ' HA ' ' HA ' ' A' ' 214' ' ' ILE . 4.1 p -83.82 143.97 10.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 73.010000000000005 111.144 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 5.3 t -171.75 122.58 0.51 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 60.210000000000001 110.878 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 54.19 50.41 55.89 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.732 -0.747 . . . . 73.549999999999997 112.464 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 1.8 mtp 61.05 17.41 7.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.834 0.35 . . . . 75.109999999999999 110.831 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 12.7 m -129.44 113.1 14.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.253 -0.43 . . . . 74.040000000000006 111.139 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.437 ' HA ' ' HA ' ' A' ' 209' ' ' VAL . 2.9 mp -108.92 114.92 48.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 74.140000000000001 111.102 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 10.2 m -88.0 128.09 35.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 71.209999999999994 111.141 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 2.8 t -114.46 121.93 67.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.46 . . . . 74.129999999999995 111.109 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -106.0 144.43 32.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 73.019999999999996 110.861 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -96.64 66.26 0.99 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.693 -0.765 . . . . 75.109999999999999 112.478 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -50.13 -42.08 19.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.863 0.363 . . . . 74.219999999999999 111.142 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -125.2 154.04 42.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.454 . . . . 54.32 111.106 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -73.47 131.89 42.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.232 -0.44 . . . . 70.299999999999997 111.085 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 143.93 177.31 18.72 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.722 -0.752 . . . . 72.540000000000006 112.494 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 12.6 mttt -98.89 136.26 39.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.84 0.352 . . . . 73.239999999999995 110.885 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 7.6 p -137.58 133.61 45.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.223 -0.444 . . . . 74.349999999999994 111.125 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 36.7 m120 -90.94 154.05 19.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 73.129999999999995 110.885 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . 0.404 ' HA ' ' HD2' ' A' ' 227' ' ' PRO . 4.1 mp -136.83 92.54 14.44 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.58 0.705 . . . . 73.510000000000005 111.162 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 226' ' ' ILE . 53.6 Cg_endo -69.79 179.05 3.99 Favored 'Trans proline' 0 C--O 1.231 0.141 0 C-N-CA 122.671 2.248 . . . . 73.540000000000006 112.353 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 57.9 t -149.26 137.19 14.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.252 -0.431 . . . . 71.430000000000007 111.165 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 98.6 t -117.55 138.65 47.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 75.129999999999995 111.124 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -121.66 106.96 11.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 74.420000000000002 110.87 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 56.93 -115.04 5.95 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.722 -0.751 . . . . 65.319999999999993 112.486 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -94.56 21.08 7.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.848 0.356 . . . . 74.420000000000002 110.853 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 97.49 9.19 55.44 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.756 -0.735 . . . . 63.100000000000001 112.485 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -51.94 -30.52 24.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.896 0.379 . . . . 72.540000000000006 110.871 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -145.59 163.41 34.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.153 -0.476 . . . . 74.239999999999995 110.907 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -161.71 165.26 28.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 73.219999999999999 111.078 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -143.86 163.24 33.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 75.510000000000005 111.13 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 59.2 t -136.52 132.84 48.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.264 -0.425 . . . . 71.120000000000005 111.114 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.71 165.39 27.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 75.430000000000007 111.074 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -144.52 131.76 20.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 71.239999999999995 110.856 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 34.8 mm -127.25 114.95 38.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.123 -0.49 . . . . 74.439999999999998 111.123 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 3.0 m -86.42 140.7 29.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.13 -0.487 . . . . 73.510000000000005 111.157 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 19.8 t -120.5 120.04 61.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 73.510000000000005 111.145 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 6.4 p -81.56 132.96 35.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 64.040000000000006 111.203 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -57.46 -26.67 61.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.281 -0.418 . . . . 74.540000000000006 111.138 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 15.1 m . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 73.430000000000007 110.893 -179.814 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 N-CA-C 112.485 -0.246 . . . . 73.040000000000006 112.485 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -63.43 135.06 56.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.775 0.321 . . . . 54.409999999999997 111.148 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 14.7 mmt -73.18 160.87 31.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 75.200000000000003 110.858 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -115.92 -2.0 12.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 65.040000000000006 111.114 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -147.0 -45.56 0.18 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.455 . . . . 73.239999999999995 111.111 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -179.58 -169.12 0.13 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.448 . . . . 72.019999999999996 111.096 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -130.08 27.2 5.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 73.439999999999998 111.148 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 146.66 100.68 0.27 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.727 -0.749 . . . . 74.239999999999995 112.446 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 45.9 ttp -111.32 130.54 55.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.807 0.337 . . . . 54.32 110.919 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 50.1 p -119.65 102.4 8.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.251 -0.431 . . . . 73.439999999999998 111.131 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 21.1 t -97.82 133.14 40.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 75.310000000000002 111.119 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.1 m -126.11 92.22 46.28 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.57 0.7 . . . . 72.120000000000005 111.173 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.8 -166.14 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.698 2.265 . . . . 62.340000000000003 112.335 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -89.03 -42.64 11.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 61.119999999999997 111.117 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 22.9 t 49.29 79.14 0.08 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.241 -0.436 . . . . 73.549999999999997 110.899 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.5 t -175.44 -175.54 0.81 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 73.239999999999995 111.146 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 38.1 p -98.8 163.88 12.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 73.329999999999998 110.849 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 2.6 p -145.81 152.56 14.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 73.420000000000002 111.158 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 38.8 t -85.76 145.28 8.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 74.409999999999997 111.12 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.24 122.09 5.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 72.420000000000002 110.881 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.18 -11.18 61.95 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.745 -0.741 . . . . 74.310000000000002 112.448 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 20.9 mm100 -91.37 -177.21 4.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.826 0.346 . . . . 75.140000000000001 110.883 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -160.56 149.31 16.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 51.340000000000003 110.858 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 7.7 t -111.3 -177.27 3.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.124 -0.489 . . . . 75.420000000000002 111.12 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -138.07 133.62 33.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.211 -0.45 . . . . 74.319999999999993 111.176 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.8 mp -107.7 146.4 32.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.233 -0.44 . . . . 74.099999999999994 110.918 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 2.1 m -113.94 143.53 44.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.459 . . . . 74.430000000000007 111.119 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 21.3 t -129.33 138.18 55.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 73.239999999999995 111.163 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -126.22 151.38 47.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 74.329999999999998 111.087 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -144.9 131.76 20.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.221 -0.445 . . . . 74.219999999999999 110.907 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.9 66.38 47.53 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.605 0.717 . . . . 70.299999999999997 110.952 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -33.58 16.35 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.653 2.235 . . . . 55.520000000000003 112.355 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 66.48 42.03 3.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.221 -0.445 . . . . 74.329999999999998 110.91 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 167.12 -46.17 0.25 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.763 -0.732 . . . . 71.329999999999998 112.474 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 2.3 t -67.58 -55.93 15.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.895 0.379 . . . . 65.219999999999999 111.147 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 44.7 p 47.96 63.61 1.97 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 71.439999999999998 111.133 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -160.89 132.43 5.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.238 -0.437 . . . . 71.25 110.867 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.72 87.1 6.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 65.310000000000002 110.898 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 14.4 m -102.3 -5.43 24.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 74.349999999999994 110.88 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -89.78 172.89 8.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 73.409999999999997 110.854 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.82 171.44 16.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.104 -0.498 . . . . 75.209999999999994 110.848 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -114.86 168.04 10.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 72.209999999999994 111.089 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 9.6 p -159.88 152.85 5.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.25 -0.432 . . . . 73.510000000000005 111.12 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.77 119.0 28.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 74.209999999999994 110.844 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -62.89 -18.62 63.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 74.409999999999997 111.108 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -163.49 89.55 0.61 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 73.439999999999998 110.858 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 9.1 tmtt? -82.63 55.45 2.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.446 . . . . 74.319999999999993 110.907 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 25.9 p -129.44 1.18 5.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 74.310000000000002 111.139 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 10.6 mtmt -157.38 19.48 0.29 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 75.519999999999996 110.895 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . 179.65 148.45 0.27 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 72.510000000000005 111.112 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 9.4 p -105.68 153.94 21.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.194 -0.457 . . . . 73.230000000000004 111.125 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 18.9 m -140.77 135.14 33.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.448 . . . . 75.230000000000004 111.172 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 4.6 m -144.32 109.31 5.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 61.119999999999997 110.8 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 5.5 p -92.47 144.44 9.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 75.310000000000002 111.168 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 2.7 m -146.56 99.42 3.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 73.519999999999996 110.859 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 70.17 -81.43 0.36 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.745 -0.74 . . . . 61.140000000000001 112.482 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -139.71 9.01 2.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.826 0.346 . . . . 64.400000000000006 110.844 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 56.9 m -128.52 124.42 35.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.242 -0.435 . . . . 72.120000000000005 111.141 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 2.5 mp -117.87 135.27 58.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 72.120000000000005 111.113 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.21 128.25 51.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.461 . . . . 70.120000000000005 111.108 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 6.8 t -118.05 131.39 70.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.227 -0.442 . . . . 75.420000000000002 111.137 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -116.45 139.22 50.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 62.200000000000003 110.905 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -94.88 78.95 0.88 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.734 -0.745 . . . . 74.420000000000002 112.492 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 17.2 t -49.56 -54.24 7.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.827 0.346 . . . . 75.329999999999998 111.149 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -129.6 162.92 27.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 65.219999999999999 111.105 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -61.83 138.36 58.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.447 . . . . 74.430000000000007 111.09 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 144.25 170.33 13.57 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.74 -0.743 . . . . 52.210000000000001 112.488 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 13.3 mttt -100.19 124.0 45.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.793 0.33 . . . . 75.129999999999995 110.921 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 6.3 p -123.76 122.98 66.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 73.140000000000001 111.091 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -91.19 156.27 17.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.466 . . . . 75.230000000000004 110.923 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 4.7 mp -138.63 92.86 11.27 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.554 0.692 . . . . 74.25 111.114 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.88 -178.93 2.62 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.672 2.248 . . . . 74.430000000000007 112.31 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 23.5 t -146.52 149.24 16.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.455 . . . . 74.349999999999994 111.146 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 86.9 t -138.17 138.38 43.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 74.319999999999993 111.082 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -121.98 119.97 33.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 74.120000000000005 110.848 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 58.08 -112.2 3.7 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.714 -0.755 . . . . 54.439999999999998 112.5 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -99.81 7.42 44.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.874 0.368 . . . . 73.109999999999999 110.892 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 114.46 16.09 7.83 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.691 -0.766 . . . . 73.430000000000007 112.495 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -51.13 -38.42 51.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.891 0.377 . . . . 71.209999999999994 110.863 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -143.07 167.04 23.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 64.140000000000001 110.911 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -162.23 165.32 26.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.113 -0.494 . . . . 74.430000000000007 111.1 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -139.11 163.61 31.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.441 . . . . 71.319999999999993 111.135 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 61.2 t -132.46 127.2 56.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.233 -0.44 . . . . 64.439999999999998 111.095 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -134.38 161.15 35.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.169 -0.469 . . . . 75.150000000000006 111.065 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -145.31 132.68 20.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 74.549999999999997 110.874 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 28.8 mm -126.95 112.85 30.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 72.299999999999997 111.129 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 1.9 m -83.06 141.49 32.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 75.129999999999995 111.179 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 14.0 t -119.92 121.6 66.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 75.040000000000006 111.156 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 8.1 p -83.65 132.37 34.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.145 -0.479 . . . . 72.420000000000002 111.14 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -53.72 -27.64 29.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 70.540000000000006 111.099 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 11.5 m . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 65.010000000000005 110.812 -179.726 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.491 -0.244 . . . . 64.310000000000002 112.491 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -121.46 163.64 18.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.792 0.33 . . . . 74.230000000000004 111.104 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 5.8 mmm -103.84 171.43 7.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 65.019999999999996 110.884 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -141.24 156.6 45.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.262 -0.426 . . . . 74.5 111.07 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -105.51 -66.99 0.94 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 74.439999999999998 111.125 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -178.46 -171.19 0.24 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.438 . . . . 74.0 111.118 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 1.1 p -119.55 3.92 11.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 73.439999999999998 111.167 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 173.74 101.73 0.15 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.741 -0.742 . . . . 73.010000000000005 112.447 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 16.3 ttp -111.84 125.17 53.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.86 0.362 . . . . 41.049999999999997 110.88 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 59.2 p -113.98 103.07 10.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.446 . . . . 72.200000000000003 111.129 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 20.7 t -99.83 131.29 47.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.215 -0.448 . . . . 73.230000000000004 111.11 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.8 m -126.81 92.57 44.37 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.565 0.697 . . . . 74.430000000000007 111.12 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 -167.7 0.24 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.686 2.257 . . . . 73.219999999999999 112.317 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -85.38 -41.66 15.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 75.420000000000002 111.121 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 88.7 p 46.46 75.08 0.13 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.461 . . . . 63.229999999999997 110.85 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.4 t -172.32 -175.08 1.33 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.107 -0.497 . . . . 74.420000000000002 111.165 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 86.6 p -98.9 164.08 12.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.262 -0.427 . . . . 72.319999999999993 110.844 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 3.0 p -147.39 153.77 11.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.114 -0.494 . . . . 72.109999999999999 111.116 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 64.3 t -87.87 145.44 7.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 71.439999999999998 111.132 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.98 122.75 6.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 71.319999999999993 110.864 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 100.08 -15.33 59.33 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.782 -0.723 . . . . 42.439999999999998 112.517 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -89.64 -177.97 5.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.807 0.337 . . . . 73.209999999999994 110.941 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 15.1 p -161.6 148.87 14.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 75.409999999999997 110.859 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 7.3 t -108.95 -173.86 2.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 73.109999999999999 111.133 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.41 131.87 26.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 74.219999999999999 111.13 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.6 mp -104.21 141.72 35.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 74.329999999999998 110.954 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.9 m -110.0 141.49 42.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.212 -0.449 . . . . 73.409999999999997 111.158 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 32.5 t -129.62 141.04 47.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.242 -0.435 . . . . 74.010000000000005 111.143 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -131.53 151.46 51.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 72.450000000000003 111.114 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -143.72 129.81 19.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.249 -0.432 . . . . 74.420000000000002 110.862 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.54 66.91 58.76 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.616 0.722 . . . . 75.129999999999995 110.907 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 -38.31 8.07 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.684 2.256 . . . . 72.25 112.362 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 67.17 47.89 1.28 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.181 -0.463 . . . . 74.310000000000002 110.869 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 160.9 -23.08 0.24 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.785 -0.721 . . . . 73.329999999999998 112.482 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 2.9 t -94.22 -58.65 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.916 0.388 . . . . 72.150000000000006 111.142 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 65.7 p 47.24 71.63 0.31 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.47 . . . . 74.530000000000001 111.145 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -169.68 118.23 0.62 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 74.400000000000006 110.897 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.67 104.09 0.98 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 72.5 110.919 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -117.38 -6.21 11.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 73.209999999999994 110.834 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -90.45 178.59 6.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 72.409999999999997 110.886 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.14 172.01 11.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 71.340000000000003 110.897 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -128.02 144.56 51.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 72.329999999999998 111.092 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 59.7 t -150.64 146.65 16.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 71.099999999999994 111.145 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 26.6 t -70.58 136.83 49.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.19 -0.459 . . . . 61.109999999999999 110.909 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -76.35 -8.41 57.06 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.149 -0.478 . . . . 71.439999999999998 111.092 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -142.85 -56.33 0.42 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.248 -0.433 . . . . 55.340000000000003 110.871 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 64.39 26.27 13.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.446 . . . . 74.200000000000003 110.91 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 80.6 p -114.24 -3.21 13.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 74.010000000000005 111.101 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 8.7 mtmm -149.19 16.4 0.93 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.274 -0.421 . . . . 75.109999999999999 110.859 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -177.69 146.78 0.46 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.259 -0.428 . . . . 75.349999999999994 111.139 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 15.9 p -104.81 153.37 21.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 65.5 111.136 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 35.5 m -136.88 140.96 41.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 75.040000000000006 111.115 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.98 108.3 4.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 74.140000000000001 110.865 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . 0.422 ' HA ' ' HA ' ' A' ' 214' ' ' ILE . 3.7 p -87.95 143.46 11.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.064 -0.516 . . . . 73.230000000000004 111.139 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 3.8 t -172.13 123.14 0.49 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 64.129999999999995 110.851 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 55.71 47.8 75.73 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.773 -0.727 . . . . 64.129999999999995 112.452 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 3.8 mtp 63.19 16.27 9.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.833 0.349 . . . . 73.040000000000006 110.867 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 21.0 m -126.47 113.48 16.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.261 -0.427 . . . . 73.219999999999999 111.114 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.422 ' HA ' ' HA ' ' A' ' 209' ' ' VAL . 3.1 mp -110.46 115.54 50.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.463 . . . . 63.219999999999999 111.121 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 2.6 m -88.88 132.66 34.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.24 -0.436 . . . . 74.200000000000003 111.169 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 3.5 t -118.0 125.69 74.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.257 -0.429 . . . . 75.510000000000005 111.104 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -109.12 136.87 47.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.104 -0.498 . . . . 75.120000000000005 110.873 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -91.16 83.56 1.27 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.734 -0.746 . . . . 73.310000000000002 112.499 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 20.3 t -53.99 -52.52 35.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.857 0.36 . . . . 75.530000000000001 111.151 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -134.34 163.18 30.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 73.319999999999993 111.129 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -56.64 144.84 30.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 75.310000000000002 111.107 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 129.92 166.29 11.81 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.791 -0.719 . . . . 71.239999999999995 112.535 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 2.6 mtmm -101.32 129.67 47.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.833 0.349 . . . . 74.200000000000003 110.907 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 7.4 p -118.58 129.68 74.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.263 -0.426 . . . . 72.209999999999994 111.149 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 35.2 m120 -89.71 147.4 23.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 70.219999999999999 110.889 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 4.3 mp -137.75 93.35 12.33 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.633 0.73 . . . . 74.540000000000006 111.161 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -176.9 1.65 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.729 2.286 . . . . 74.25 112.297 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 48.2 t -147.3 134.72 14.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 74.420000000000002 111.082 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 93.7 t -117.95 133.08 65.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.177 -0.465 . . . . 73.25 111.109 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.23 116.28 23.85 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.128 -0.487 . . . . 73.049999999999997 110.845 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 61.18 -121.13 25.44 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.743 -0.742 . . . . 73.109999999999999 112.469 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -95.78 15.43 20.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.871 0.367 . . . . 74.120000000000005 110.904 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 111.13 9.96 21.3 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.747 -0.739 . . . . 65.409999999999997 112.459 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -51.11 -65.08 0.62 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.906 0.384 . . . . 72.319999999999993 110.907 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -110.78 156.03 21.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 74.109999999999999 110.894 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -153.16 164.69 37.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 63.149999999999999 111.053 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -144.86 163.88 32.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.456 . . . . 75.310000000000002 111.119 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 14.1 p -137.91 134.65 45.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 75.140000000000001 111.105 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -139.31 164.37 30.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.119 -0.491 . . . . 73.019999999999996 111.116 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -147.56 131.14 16.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.249 -0.432 . . . . 63.310000000000002 110.879 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 30.7 mm -122.83 115.0 44.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 71.420000000000002 111.064 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -83.0 141.28 32.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.179 -0.464 . . . . 74.409999999999997 111.149 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 19.5 t -120.39 120.32 62.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.225 -0.443 . . . . 73.409999999999997 111.161 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 4.9 p -82.61 132.95 35.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 75.349999999999994 111.133 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -58.71 -21.67 55.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.439 . . . . 72.120000000000005 111.086 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 4.5 m . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.443 . . . . 71.430000000000007 110.883 -179.807 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 112.481 -0.247 . . . . 72.049999999999997 112.481 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -89.82 -33.16 16.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.806 0.336 . . . . 62.210000000000001 111.132 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 35.6 mtm -52.77 129.6 30.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 73.310000000000002 110.831 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -177.17 -169.37 0.24 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 62.329999999999998 111.069 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -176.67 129.61 0.19 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 73.0 111.078 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.36 -168.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 70.329999999999998 111.073 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -125.14 32.11 5.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 74.319999999999993 111.183 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 138.46 99.58 0.48 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.775 -0.726 . . . . 75.239999999999995 112.473 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 41.2 ttp -111.11 129.07 56.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.882 0.372 . . . . 73.319999999999993 110.841 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 40.4 p -118.0 105.86 12.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.194 -0.457 . . . . 75.230000000000004 111.13 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 21.5 t -99.87 133.64 42.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 75.200000000000003 111.167 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.3 m -126.2 92.49 45.56 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.593 0.711 . . . . 73.109999999999999 111.145 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -167.88 0.25 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.7 2.267 . . . . 75.019999999999996 112.338 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -87.15 -38.13 16.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 75.420000000000002 111.121 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 94.4 p 46.21 79.54 0.05 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 53.229999999999997 110.87 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.4 t -175.39 -174.6 0.74 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.17 -0.468 . . . . 74.329999999999998 111.164 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 33.0 p -101.06 162.0 13.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 72.219999999999999 110.875 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 2.6 p -144.83 154.25 14.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 74.450000000000003 111.133 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 93.2 t -89.91 144.9 8.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 75.099999999999994 111.137 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -47.75 124.11 6.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 74.439999999999998 110.922 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.69 -17.22 57.79 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.756 -0.735 . . . . 52.109999999999999 112.465 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 10.7 mm100 -87.99 -177.77 5.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.768 0.318 . . . . 75.430000000000007 110.956 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 1.7 p -161.86 148.91 14.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.237 -0.438 . . . . 74.409999999999997 110.875 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 9.2 t -111.04 -174.86 2.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.14 -0.482 . . . . 72.439999999999998 111.112 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.21 132.46 29.89 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.174 -0.466 . . . . 74.329999999999998 111.139 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.6 mp -106.36 143.3 34.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 74.349999999999994 110.904 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 16.3 m -110.31 143.91 39.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.451 . . . . 64.219999999999999 111.129 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 22.9 t -129.69 142.36 44.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.214 -0.448 . . . . 73.409999999999997 111.143 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -131.55 150.92 51.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 70.349999999999994 111.081 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -144.47 126.45 15.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 72.109999999999999 110.881 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.22 67.23 79.61 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.565 0.698 . . . . 74.549999999999997 110.892 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -37.22 9.58 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.674 2.249 . . . . 72.140000000000001 112.387 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 66.31 40.97 3.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 71.329999999999998 110.864 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 169.29 -37.99 0.2 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.777 -0.725 . . . . 54.109999999999999 112.52 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 2.9 t -77.43 -57.75 5.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.883 0.373 . . . . 71.310000000000002 111.09 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 1.1 p 47.21 66.56 0.98 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 73.209999999999994 111.16 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -168.49 113.63 0.62 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 70.319999999999993 110.854 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 5.1 mtmt -54.39 101.45 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 74.400000000000006 110.918 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 23.0 t -115.22 -5.99 12.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 70.329999999999998 110.837 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -90.31 172.15 8.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.127 -0.488 . . . . 63.409999999999997 110.873 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.58 158.89 36.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 74.329999999999998 110.886 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -112.83 165.97 11.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.445 . . . . 73.450000000000003 111.094 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 10.7 p -175.18 151.84 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 72.530000000000001 111.132 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.6 t -79.25 144.49 34.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 72.239999999999995 110.866 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -78.57 -22.6 46.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 75.519999999999996 111.073 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -127.63 -54.87 1.33 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 60.5 110.814 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 1.7 ttpm? 63.43 27.92 15.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.469 . . . . 72.400000000000006 110.885 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 44.8 p -115.76 -1.77 12.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.265 -0.425 . . . . 71.200000000000003 111.149 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 11.2 mtmm -149.61 16.48 0.89 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 73.109999999999999 110.919 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -174.9 150.68 1.27 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 72.040000000000006 111.078 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 23.9 p -112.88 134.65 54.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 71.200000000000003 111.145 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 5.3 m -122.4 139.65 48.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.221 -0.445 . . . . 72.200000000000003 111.108 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -144.1 108.87 4.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 75.540000000000006 110.848 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . 0.429 ' HA ' ' HA ' ' A' ' 214' ' ' ILE . 4.3 p -84.84 143.76 11.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 64.420000000000002 111.142 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 11.8 t -172.12 124.47 0.52 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 74.439999999999998 110.865 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 52.87 52.0 41.81 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.728 -0.749 . . . . 55.43 112.478 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 2.2 mtp 58.75 19.61 7.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.885 0.374 . . . . 74.209999999999994 110.914 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 1.6 m -131.56 113.21 13.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.229 -0.441 . . . . 73.439999999999998 111.164 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.429 ' HA ' ' HA ' ' A' ' 209' ' ' VAL . 3.1 mp -109.71 116.78 53.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 74.409999999999997 111.118 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 1.1 m -89.86 129.91 36.16 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.148 -0.478 . . . . 72.010000000000005 111.118 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 3.5 t -115.75 129.6 71.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 74.540000000000006 111.063 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -112.32 135.12 53.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.119 -0.491 . . . . 63.229999999999997 110.875 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -82.1 67.04 3.76 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.752 -0.737 . . . . 70.299999999999997 112.519 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 1.4 t -48.4 -51.05 11.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.848 0.356 . . . . 74.010000000000005 111.153 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -127.86 154.87 44.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 54.409999999999997 111.093 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -66.63 136.36 55.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 73.420000000000002 111.078 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 139.21 171.91 12.41 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.726 -0.749 . . . . 71.129999999999995 112.487 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 8.3 mttm -96.02 125.19 40.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.806 0.336 . . . . 74.349999999999994 110.918 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 7.7 p -121.42 131.25 73.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.268 -0.423 . . . . 75.400000000000006 111.141 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 34.3 m120 -90.54 151.41 21.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 64.400000000000006 110.859 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 4.3 mp -136.71 92.71 14.55 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.633 0.73 . . . . 64.340000000000003 111.136 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.82 179.92 3.39 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.664 2.243 . . . . 62.43 112.339 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 96.7 t -150.63 137.54 13.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 73.230000000000004 111.161 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 92.7 t -122.38 134.55 65.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 73.049999999999997 111.115 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -122.22 125.02 45.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.15 -0.477 . . . . 75.420000000000002 110.869 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 56.77 -117.74 10.21 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.74 -0.743 . . . . 70.120000000000005 112.468 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -94.44 8.46 42.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.865 0.364 . . . . 75.230000000000004 110.85 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 106.94 9.61 29.83 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.717 -0.754 . . . . 63.229999999999997 112.473 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -51.67 -40.66 60.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.886 0.374 . . . . 74.230000000000004 110.884 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -127.68 167.25 16.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.481 . . . . 75.400000000000006 110.873 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -166.26 165.34 17.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 73.200000000000003 111.081 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -139.33 163.19 33.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.222 -0.445 . . . . 73.450000000000003 111.103 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.0 p -135.32 127.71 47.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.441 . . . . 74.519999999999996 111.112 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -130.52 163.07 27.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.13 -0.486 . . . . 64.129999999999995 111.086 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -144.31 128.29 17.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.439 . . . . 73.319999999999993 110.876 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 26.0 mm -124.92 111.2 27.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 74.129999999999995 111.127 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 4.0 m -81.63 139.94 34.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 73.310000000000002 111.131 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 30.5 t -120.26 119.06 58.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 71.319999999999993 111.142 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 5.1 p -81.12 132.87 35.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.151 -0.477 . . . . 73.420000000000002 111.102 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -54.06 -27.66 33.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 64.430000000000007 111.113 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 10.2 m . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.237 -0.438 . . . . 73.519999999999996 110.875 -179.783 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.289 0 N-CA-C 112.455 -0.258 . . . . 72.400000000000006 112.455 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -81.02 114.6 20.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.769 0.319 . . . . 70.140000000000001 111.091 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 8.0 mmt -119.29 139.08 52.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.444 . . . . 73.239999999999995 110.907 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -136.38 146.3 46.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.244 -0.435 . . . . 62.539999999999999 111.132 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -76.03 -75.15 0.19 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.252 -0.431 . . . . 62.009999999999998 111.107 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -174.02 -167.78 0.37 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 75.430000000000007 111.115 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 1.1 m -137.55 27.58 2.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 75.239999999999995 111.138 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 147.01 105.65 0.43 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.801 -0.714 . . . . 72.430000000000007 112.522 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 1.5 ttp -120.0 140.52 50.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.875 0.369 . . . . 71.430000000000007 110.886 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 32.8 p -126.43 109.83 12.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.445 . . . . 71.510000000000005 111.167 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 21.7 t -97.57 134.98 33.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 74.200000000000003 111.102 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 4.3 m -126.94 92.59 44.1 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.631 0.729 . . . . 75.349999999999994 111.168 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -167.65 0.23 Allowed 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.686 2.257 . . . . 73.400000000000006 112.373 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -89.88 -43.16 10.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 73.140000000000001 111.093 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 12.2 t 49.7 80.98 0.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 72.409999999999997 110.835 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.5 t -175.13 -175.46 0.85 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 75.209999999999994 111.199 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 83.3 p -98.45 161.69 13.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.436 . . . . 71.040000000000006 110.893 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 3.1 p -144.24 153.92 15.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 73.439999999999998 111.132 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 64.7 t -87.5 144.99 8.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 74.329999999999998 111.159 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.6 122.55 5.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.451 . . . . 74.209999999999994 110.883 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.59 -14.2 60.73 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.753 -0.737 . . . . 65.209999999999994 112.475 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -91.61 -178.23 5.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.802 0.334 . . . . 75.439999999999998 110.915 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 54.3 p -161.55 146.24 13.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 75.209999999999994 110.862 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 7.0 t -103.34 -173.85 2.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.083 -0.508 . . . . 75.109999999999999 111.158 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.51 132.86 28.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.219 -0.446 . . . . 74.540000000000006 111.14 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.5 mp -106.63 145.25 32.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 72.400000000000006 110.943 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 2.2 m -113.81 145.56 41.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.238 -0.437 . . . . 63.210000000000001 111.13 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 21.9 t -129.48 142.18 44.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 72.340000000000003 111.124 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -128.74 152.94 47.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 72.319999999999993 111.088 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -143.99 128.25 17.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 73.040000000000006 110.852 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . 0.405 ' N ' HE21 ' A' ' 186' ' ' GLN . 0.0 OUTLIER -132.72 66.93 77.6 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.606 0.717 . . . . 64.310000000000002 110.9 -179.935 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -26.16 27.96 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.694 2.263 . . . . 72.540000000000006 112.387 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 70.31 33.43 2.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.195 -0.457 . . . . 74.319999999999993 110.878 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 167.88 -25.66 0.13 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.713 -0.756 . . . . 45.020000000000003 112.442 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 71.7 t -101.18 149.64 6.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.913 0.387 . . . . 74.239999999999995 111.132 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 12.4 p -140.45 38.63 1.88 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 74.219999999999999 111.158 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -125.02 119.74 29.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.215 -0.448 . . . . 75.420000000000002 110.86 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 24.8 mtmt -74.31 74.68 1.85 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 73.519999999999996 110.894 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -75.55 -6.25 49.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 74.010000000000005 110.826 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -90.03 151.81 21.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 74.129999999999995 110.898 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.59 154.04 43.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.144 -0.48 . . . . 75.299999999999997 110.923 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -103.81 167.77 9.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 75.209999999999994 111.103 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 9.3 p -173.25 152.99 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 75.400000000000006 111.171 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 73.4 p -76.6 152.86 35.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 71.010000000000005 110.866 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -93.86 -19.54 20.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.126 -0.488 . . . . 73.040000000000006 111.135 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.84 -55.28 0.93 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 73.519999999999996 110.864 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.54 26.41 14.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 72.219999999999999 110.881 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 41.5 p -112.9 -3.92 14.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 65.430000000000007 111.152 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 10.2 mtmm -154.21 19.87 0.49 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 72.549999999999997 110.898 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -177.46 147.6 0.53 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 73.430000000000007 111.105 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 15.0 p -108.65 159.67 16.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 75.519999999999996 111.159 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 7.7 m -141.37 141.97 29.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.246 -0.434 . . . . 74.219999999999999 111.107 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 69.8 m -149.1 108.66 3.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 73.430000000000007 110.888 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . 0.428 ' HA ' ' HA ' ' A' ' 214' ' ' ILE . 3.6 p -88.97 143.15 11.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.1 -0.5 . . . . 73.030000000000001 111.119 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 18.8 t -172.16 123.48 0.49 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.47 . . . . 75.239999999999995 110.864 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 56.04 47.02 83.24 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.719 -0.753 . . . . 64.430000000000007 112.524 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 2.4 mtp 63.85 15.94 9.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.904 0.383 . . . . 75.310000000000002 110.908 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 6.5 m -125.6 113.14 17.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.459 . . . . 75.5 111.128 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.428 ' HA ' ' HA ' ' A' ' 209' ' ' VAL . 3.0 mp -110.43 113.98 45.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 75.219999999999999 111.127 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 7.3 m -88.95 132.78 34.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.129 -0.487 . . . . 71.420000000000002 111.184 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 4.4 t -117.94 123.54 71.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.257 -0.429 . . . . 61.340000000000003 111.124 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -104.94 140.0 38.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 73.219999999999999 110.901 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -95.41 79.31 0.83 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.726 -0.749 . . . . 73.239999999999995 112.478 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 18.3 t -49.54 -54.67 6.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.821 0.343 . . . . 65.099999999999994 111.12 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -130.85 162.07 30.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 71.530000000000001 111.075 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -60.36 141.82 55.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 73.329999999999998 111.141 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 139.4 172.05 12.5 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.757 -0.735 . . . . 51.229999999999997 112.471 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 5.0 mttt -99.74 120.84 40.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.824 0.345 . . . . 74.409999999999997 110.89 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 6.4 p -117.46 122.88 70.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.213 -0.448 . . . . 74.400000000000006 111.133 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -90.99 152.74 20.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.163 -0.472 . . . . 73.439999999999998 110.908 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 3.9 mp -137.74 92.72 12.76 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.632 0.729 . . . . 64.120000000000005 111.13 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 177.1 5.88 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.67 2.247 . . . . 65.310000000000002 112.376 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 34.6 t -146.18 139.11 20.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.257 -0.429 . . . . 74.120000000000005 111.102 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 91.4 t -129.25 143.79 40.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.15 -0.477 . . . . 71.200000000000003 111.178 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 6.0 p -92.4 176.0 6.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 71.140000000000001 110.832 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -51.16 -45.97 51.41 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.761 -0.733 . . . . 73.349999999999994 112.499 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 20.2 t30 -111.48 21.08 16.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.873 0.368 . . . . 65.010000000000005 110.885 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 61.7 16.02 49.69 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.724 -0.75 . . . . 72.129999999999995 112.469 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -66.36 -44.45 83.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.894 0.378 . . . . 75.299999999999997 110.902 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -117.3 144.93 44.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.146 -0.479 . . . . 74.209999999999994 110.909 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -144.71 163.23 34.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 72.319999999999993 111.101 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -142.65 163.4 32.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 63.299999999999997 111.052 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 57.3 t -139.6 136.6 40.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.215 -0.448 . . . . 74.120000000000005 111.132 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.17 165.08 27.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.466 . . . . 72.140000000000001 111.075 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -143.79 132.25 22.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 74.120000000000005 110.862 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 24.1 mm -127.27 113.28 31.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 74.409999999999997 111.156 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 1.7 m -81.42 141.06 34.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 72.540000000000006 111.134 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 17.2 t -119.95 122.13 67.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 73.439999999999998 111.144 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 7.2 p -82.57 133.05 35.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 73.239999999999995 111.159 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -59.14 -21.87 60.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 75.040000000000006 111.088 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 52.3 p . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 72.140000000000001 110.856 -179.782 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 N-CA-C 112.449 -0.26 . . . . 65.5 112.449 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -163.67 164.16 24.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.773 0.32 . . . . 72.409999999999997 111.096 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.26 -177.31 3.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 75.319999999999993 110.839 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -171.22 -169.55 0.75 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 73.209999999999994 111.092 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -176.48 129.38 0.2 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.441 . . . . 75.010000000000005 111.096 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.5 -168.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.242 -0.435 . . . . 60.229999999999997 111.078 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -124.6 31.96 5.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 74.409999999999997 111.109 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 138.28 99.17 0.48 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.743 -0.741 . . . . 70.450000000000003 112.486 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 35.2 ttp -109.71 130.91 55.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.822 0.344 . . . . 71.409999999999997 110.888 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 36.5 p -120.48 105.1 10.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.44 . . . . 74.349999999999994 111.182 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 21.1 t -98.26 136.11 30.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 64.510000000000005 111.171 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.3 m -127.7 91.86 44.29 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.593 0.711 . . . . 54.409999999999997 111.127 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 -165.7 0.16 Allowed 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.709 2.273 . . . . 74.120000000000005 112.346 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -91.84 -39.25 11.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 74.409999999999997 111.089 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 88.5 p 46.73 79.82 0.05 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 65.420000000000002 110.897 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.6 t -175.56 -175.06 0.75 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.121 -0.491 . . . . 72.040000000000006 111.131 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 25.5 p -99.84 163.28 12.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 73.349999999999994 110.853 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 3.0 p -143.91 153.4 15.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.123 -0.489 . . . . 75.319999999999993 111.12 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 80.6 t -87.76 143.58 10.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 73.549999999999997 111.099 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.35 122.41 4.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 75.340000000000003 110.872 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.34 -9.88 61.18 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.735 -0.745 . . . . 72.310000000000002 112.482 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -97.17 -178.68 4.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.792 0.329 . . . . 75.420000000000002 110.946 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 15.2 p -161.55 147.67 14.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 63.299999999999997 110.898 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 7.7 t -104.9 -175.82 2.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.476 . . . . 63.329999999999998 111.131 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -137.38 130.11 30.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 75.230000000000004 111.16 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 8.0 mp -105.43 140.39 38.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 72.209999999999994 110.937 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -109.92 145.57 36.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 75.329999999999998 111.163 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 52.1 t -129.58 142.61 43.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.453 . . . . 74.400000000000006 111.141 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -130.13 150.76 51.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.198 -0.455 . . . . 71.510000000000005 111.084 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -144.83 126.74 15.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 74.400000000000006 110.884 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.89 67.61 80.92 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.612 0.72 . . . . 70.109999999999999 110.903 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 -33.55 16.22 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.67 2.247 . . . . 73.530000000000001 112.372 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 65.75 32.54 8.85 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.212 -0.449 . . . . 72.510000000000005 110.857 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 177.66 -50.0 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.724 -0.75 . . . . 60.240000000000002 112.457 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 2.6 t -62.72 -56.26 18.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.918 0.389 . . . . 70.510000000000005 111.155 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 38.2 p 48.21 61.7 2.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 71.230000000000004 111.114 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -166.8 120.76 1.04 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.256 -0.429 . . . . 75.0 110.844 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.35 99.82 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 73.120000000000005 110.87 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 3.3 t -111.16 -7.33 14.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 72.540000000000006 110.892 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -91.36 -176.29 4.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.108 -0.496 . . . . 72.200000000000003 110.878 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -166.3 175.27 8.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 72.400000000000006 110.926 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -125.24 167.16 15.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 74.319999999999993 111.098 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 13.9 p -170.54 149.52 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 71.230000000000004 111.133 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.2 p -92.22 125.3 36.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 71.099999999999994 110.833 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -60.77 -18.62 56.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 73.400000000000006 111.076 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -164.25 103.52 0.86 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 73.420000000000002 110.878 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -89.61 46.78 1.4 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.169 -0.469 . . . . 72.209999999999994 110.891 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 11.9 p -120.9 -9.17 9.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 72.209999999999994 111.165 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 11.3 mtmm -143.09 17.1 1.92 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 71.420000000000002 110.908 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . 178.91 143.12 0.12 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 71.129999999999995 111.106 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 2.1 p -104.6 161.68 13.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.437 . . . . 75.239999999999995 111.165 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 17.2 m -140.85 150.17 20.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.239 -0.437 . . . . 75.319999999999993 111.138 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 22.8 m -157.69 109.71 2.35 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.474 . . . . 73.319999999999993 110.843 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 90.5 t -79.45 145.18 9.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.116 -0.493 . . . . 74.409999999999997 111.162 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 59.2 p -165.84 111.56 0.87 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.197 -0.456 . . . . 72.200000000000003 110.848 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 47.66 63.33 3.52 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.736 -0.745 . . . . 70.430000000000007 112.458 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 3.1 mtp 55.75 20.48 4.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.875 0.369 . . . . 72.540000000000006 110.891 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 1.4 m -130.97 106.5 8.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.23 -0.441 . . . . 72.25 111.14 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -101.64 122.01 53.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.264 -0.426 . . . . 73.299999999999997 111.166 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 7.3 m -92.22 123.15 35.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 74.099999999999994 111.112 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 2.4 t -108.65 123.18 64.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 72.109999999999999 111.101 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -107.63 145.1 33.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 63.530000000000001 110.87 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -99.72 64.24 0.65 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.776 -0.726 . . . . 64.319999999999993 112.526 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -48.23 -41.59 10.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.809 0.338 . . . . 74.400000000000006 111.092 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -127.3 151.02 49.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 73.209999999999994 111.074 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -66.68 138.05 57.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 55.240000000000002 111.1 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 137.72 170.15 11.81 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.747 -0.739 . . . . 70.310000000000002 112.542 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 7.9 mttm -93.32 127.61 39.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.846 0.355 . . . . 74.530000000000001 110.95 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 7.3 p -122.05 129.36 75.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.239 -0.437 . . . . 72.439999999999998 111.15 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -90.95 148.54 22.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 75.099999999999994 110.851 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 4.3 mp -135.72 92.57 16.76 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.622 0.725 . . . . 74.129999999999995 111.096 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 178.63 4.38 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.66 2.24 . . . . 63.420000000000002 112.358 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 54.4 t -148.29 136.78 15.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.237 -0.438 . . . . 75.019999999999996 111.18 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 98.3 t -118.15 136.63 54.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.453 . . . . 72.129999999999995 111.133 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 22.7 t -122.17 135.51 54.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 63.420000000000002 110.87 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 52.53 -113.72 2.9 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.738 -0.744 . . . . 71.439999999999998 112.471 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -111.8 20.66 16.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.873 0.368 . . . . 74.0 110.887 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 113.14 1.94 25.02 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.719 -0.753 . . . . 74.400000000000006 112.478 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -52.92 -62.58 1.56 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.878 0.37 . . . . 74.510000000000005 110.892 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -108.37 166.13 10.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 74.209999999999994 110.867 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -166.1 165.15 17.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.128 -0.487 . . . . 73.319999999999993 111.087 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -143.41 163.27 33.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 73.010000000000005 111.061 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 14.8 p -138.25 137.64 43.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 75.329999999999998 111.157 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.95 164.82 28.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 61.100000000000001 111.138 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -143.99 130.48 19.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 75.120000000000005 110.94 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 32.7 mm -127.12 114.77 38.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 74.530000000000001 111.134 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 3.2 m -84.28 141.0 31.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 73.010000000000005 111.169 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 25.9 t -120.39 120.1 61.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.446 . . . . 72.329999999999998 111.134 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 7.1 p -81.1 132.83 35.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.485 . . . . 73.200000000000003 111.145 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -58.51 -25.16 62.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 75.150000000000006 111.073 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 40.3 t . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 71.109999999999999 110.83 -179.753 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.286 0 N-CA-C 112.516 -0.234 . . . . 61.32 112.516 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -125.43 143.62 50.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.773 0.321 . . . . 64.519999999999996 111.108 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 16.2 tpp -53.74 156.9 2.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 74.230000000000004 110.861 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -167.41 -169.88 1.33 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 73.120000000000005 111.116 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -174.38 129.75 0.36 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 74.420000000000002 111.108 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -59.83 -168.68 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 70.5 111.155 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 1.2 m -125.07 32.68 5.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.271 -0.422 . . . . 74.430000000000007 111.153 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 140.55 97.99 0.34 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.765 -0.731 . . . . 72.209999999999994 112.48 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -112.95 138.1 50.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.905 0.383 . . . . 75.349999999999994 110.86 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 34.4 p -121.52 109.8 15.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.236 -0.438 . . . . 75.219999999999999 111.18 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 33.5 t -98.45 132.91 42.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.429 . . . . 75.540000000000006 111.155 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.5 m -123.43 92.09 49.16 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.619 0.723 . . . . 74.010000000000005 111.179 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -168.41 0.27 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.666 2.244 . . . . 64.230000000000004 112.348 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -89.75 -42.7 11.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.446 . . . . 74.219999999999999 111.105 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 12.3 t 49.88 80.57 0.07 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.236 -0.438 . . . . 64.340000000000003 110.869 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.5 t -174.72 -175.09 0.87 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 75.299999999999997 111.142 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 1.5 m -98.7 162.41 13.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.444 . . . . 74.140000000000001 110.893 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 3.6 p -144.5 153.32 15.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.129 -0.487 . . . . 73.129999999999995 111.124 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 61.8 t -86.73 145.55 7.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 73.140000000000001 111.1 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.23 122.22 5.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.468 . . . . 73.0 110.914 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.18 -11.54 61.95 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.76 -0.734 . . . . 72.439999999999998 112.467 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -94.2 -178.62 4.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.818 0.342 . . . . 75.230000000000004 110.909 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 52.2 p -161.74 148.09 13.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 74.319999999999993 110.861 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 7.0 t -106.01 -173.61 2.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.13 -0.487 . . . . 73.120000000000005 111.097 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -139.93 132.2 28.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.456 . . . . 64.109999999999999 111.166 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.6 mp -105.83 145.19 31.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.247 -0.433 . . . . 74.439999999999998 110.904 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 5.3 m -111.55 145.12 39.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.144 -0.48 . . . . 73.120000000000005 111.123 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 22.5 t -129.31 140.62 48.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.256 -0.429 . . . . 75.099999999999994 111.11 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -129.11 153.1 48.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.486 . . . . 71.299999999999997 111.082 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -143.91 129.28 18.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.251 -0.432 . . . . 75.219999999999999 110.864 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . 0.405 ' N ' HE21 ' A' ' 186' ' ' GLN . 0.0 OUTLIER -132.86 66.78 77.09 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.634 0.73 . . . . 64.549999999999997 110.925 -179.975 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.405 ' CB ' ' HB ' ' A' ' 190' ' ' VAL . 53.5 Cg_endo -69.77 -25.75 28.23 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.693 2.262 . . . . 74.439999999999998 112.36 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 70.21 31.51 3.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 74.450000000000003 110.873 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 169.82 -26.18 0.11 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.753 -0.736 . . . . 62.350000000000001 112.5 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . 0.405 ' HB ' ' CB ' ' A' ' 187' ' ' PRO . 76.4 t -99.16 149.43 5.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.96 0.409 . . . . 74.239999999999995 111.125 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 9.5 p -140.33 37.12 1.89 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.132 -0.485 . . . . 65.230000000000004 111.133 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -122.01 131.23 53.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.261 -0.427 . . . . 74.209999999999994 110.841 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 13.9 mtpp -81.9 74.44 8.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 72.5 110.923 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 2.2 m -78.48 -7.28 57.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 73.049999999999997 110.862 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -91.31 164.38 13.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 65.049999999999997 110.838 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.04 167.52 30.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.116 -0.493 . . . . 73.310000000000002 110.88 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -115.64 160.05 20.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 64.230000000000004 111.103 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 5.1 m -153.43 163.04 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.206 -0.452 . . . . 64.099999999999994 111.114 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.61 118.68 35.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 72.329999999999998 110.9 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -59.87 -21.0 60.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.141 -0.481 . . . . 63.439999999999998 111.11 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.97 96.79 1.36 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 73.329999999999998 110.84 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.89 50.18 1.92 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 72.040000000000006 110.904 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 12.0 p -128.73 -1.45 5.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.211 -0.45 . . . . 73.530000000000001 111.176 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 7.5 mtmt -154.57 18.47 0.47 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.196 -0.457 . . . . 75.549999999999997 110.829 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -179.88 153.79 0.54 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.251 -0.431 . . . . 64.349999999999994 111.085 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 11.7 p -117.32 156.05 28.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.214 -0.448 . . . . 75.120000000000005 111.131 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 33.8 m -137.19 141.17 40.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 65.349999999999994 111.136 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 50.9 m -147.86 107.87 4.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 74.109999999999999 110.845 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . 0.418 ' HA ' ' HA ' ' A' ' 214' ' ' ILE . 3.0 p -88.31 142.87 12.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 64.109999999999999 111.11 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.2 m -171.56 122.89 0.53 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.188 -0.46 . . . . 71.340000000000003 110.861 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 55.6 47.23 78.55 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.726 -0.75 . . . . 72.510000000000005 112.481 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 3.3 mtp 64.06 16.38 9.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.848 0.356 . . . . 70.040000000000006 110.854 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 18.8 m -125.67 112.65 16.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 63.43 111.151 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.418 ' HA ' ' HA ' ' A' ' 209' ' ' VAL . 2.6 mp -109.69 113.75 45.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 64.239999999999995 111.105 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 6.3 m -87.45 133.92 33.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.206 -0.452 . . . . 55.210000000000001 111.181 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 2.9 t -118.18 123.17 71.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.27 -0.423 . . . . 63.399999999999999 111.09 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -106.33 139.57 40.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.474 . . . . 75.109999999999999 110.857 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -96.9 78.3 0.69 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.719 -0.753 . . . . 63.109999999999999 112.48 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 16.2 t -50.13 -55.29 5.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.83 0.347 . . . . 74.400000000000006 111.112 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -126.38 161.63 27.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 72.140000000000001 111.122 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -62.61 139.97 58.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.243 -0.435 . . . . 73.510000000000005 111.104 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 142.24 172.84 13.86 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.732 -0.747 . . . . 61.130000000000003 112.503 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 12.7 mttt -102.18 120.81 41.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.837 0.351 . . . . 75.140000000000001 110.886 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 7.3 p -119.13 126.89 75.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 72.109999999999999 111.143 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -90.55 156.05 18.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 72.409999999999997 110.864 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 4.4 mp -138.13 92.43 12.33 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.634 0.731 . . . . 75.310000000000002 111.127 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 -179.26 2.79 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.679 2.253 . . . . 53.399999999999999 112.345 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 61.3 t -150.11 140.6 16.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 74.510000000000005 111.16 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 89.9 t -124.06 138.53 53.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 72.219999999999999 111.137 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 1.5 m -118.94 106.67 12.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.191 -0.459 . . . . 72.209999999999994 110.862 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 57.74 -110.86 2.59 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.701 -0.761 . . . . 74.209999999999994 112.486 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -81.01 -7.39 59.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.865 0.364 . . . . 65.310000000000002 110.889 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 109.76 10.01 23.76 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.743 -0.741 . . . . 61.43 112.424 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -50.72 -47.1 59.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.874 0.369 . . . . 74.530000000000001 110.879 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -117.51 147.52 42.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 63.549999999999997 110.884 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -149.72 165.23 33.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 73.230000000000004 111.11 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -136.95 163.3 31.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.441 . . . . 73.420000000000002 111.109 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.4 p -136.36 125.59 38.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.188 -0.46 . . . . 73.430000000000007 111.139 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -132.79 162.13 32.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 72.510000000000005 111.15 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -144.16 132.1 21.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.268 -0.424 . . . . 75.129999999999995 110.886 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 26.3 mm -126.81 112.73 30.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.124 -0.489 . . . . 75.340000000000003 111.142 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 2.7 m -80.82 141.28 34.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 65.239999999999995 111.165 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 17.1 t -120.08 121.0 64.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.236 -0.438 . . . . 73.329999999999998 111.116 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 7.3 p -82.28 132.75 35.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.144 -0.48 . . . . 74.439999999999998 111.146 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -56.92 -24.63 53.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.462 . . . . 74.239999999999995 111.113 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.26 -0.427 . . . . 71.430000000000007 110.847 -179.791 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.266 0 N-CA-C 112.493 -0.243 . . . . 72.019999999999996 112.493 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . 62.19 24.8 14.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.789 0.328 . . . . 74.120000000000005 111.084 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.87 75.58 1.62 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 51.149999999999999 110.873 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -128.45 -169.46 2.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.268 -0.424 . . . . 74.25 111.097 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -172.48 129.48 0.55 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.449 . . . . 64.129999999999995 111.101 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.05 -168.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 73.239999999999995 111.07 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -124.9 30.85 5.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.161 -0.472 . . . . 75.430000000000007 111.096 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 146.24 96.7 0.19 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.722 -0.751 . . . . 73.150000000000006 112.466 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 2.1 tmm? -106.09 143.71 33.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.845 0.355 . . . . 65.010000000000005 110.897 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 44.7 p -133.87 103.33 5.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.274 -0.421 . . . . 71.340000000000003 111.169 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 89.0 t -97.19 133.98 36.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 74.409999999999997 111.103 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 40.8 m -123.86 92.01 48.99 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.517 0.675 . . . . 74.540000000000006 111.115 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -167.33 0.22 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.636 2.224 . . . . 73.299999999999997 112.331 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -90.75 -43.75 9.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.459 . . . . 71.349999999999994 111.089 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 8.0 t 49.48 80.12 0.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 75.140000000000001 110.861 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.6 t -173.68 -176.11 1.2 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.135 -0.484 . . . . 75.319999999999993 111.128 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 10.0 p -97.27 162.19 13.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 70.430000000000007 110.837 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 3.3 p -145.37 153.18 14.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.479 . . . . 64.340000000000003 111.142 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 66.6 t -87.52 145.21 7.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.116 -0.493 . . . . 73.010000000000005 111.12 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.64 122.42 5.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 73.420000000000002 110.837 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.81 -12.87 61.0 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.741 -0.742 . . . . 73.239999999999995 112.501 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -92.91 -178.32 4.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.811 0.339 . . . . 64.420000000000002 110.931 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 39.1 p -161.37 149.45 15.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.214 -0.448 . . . . 74.040000000000006 110.894 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 6.8 t -107.11 -173.92 2.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 73.319999999999993 111.186 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.73 132.39 27.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.258 -0.428 . . . . 72.120000000000005 111.184 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.6 mp -106.56 145.54 31.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 74.299999999999997 110.873 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 4.1 m -113.75 146.42 39.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 72.310000000000002 111.144 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 47.4 t -128.7 140.84 48.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 75.129999999999995 111.136 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -129.9 155.98 45.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 72.319999999999993 111.123 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -148.93 131.28 15.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.257 -0.428 . . . . 74.209999999999994 110.9 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.05 67.35 73.52 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.634 0.73 . . . . 74.010000000000005 110.919 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -25.38 28.72 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.703 2.268 . . . . 65.0 112.343 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 70.66 30.45 3.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.21 -0.45 . . . . 72.510000000000005 110.885 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 171.16 -27.11 0.1 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.761 -0.733 . . . . 74.129999999999995 112.491 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 76.8 t -98.14 149.14 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.898 0.38 . . . . 71.439999999999998 111.11 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 7.0 p -140.98 35.13 1.75 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 72.540000000000006 111.129 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -115.88 136.29 53.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.236 -0.438 . . . . 64.129999999999995 110.882 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 6.1 mtpm? -91.4 67.58 5.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 71.540000000000006 110.907 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 21.8 t -74.51 -7.24 52.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 71.430000000000007 110.864 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -91.28 163.64 14.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.131 -0.486 . . . . 70.439999999999998 110.897 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.9 173.19 16.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 74.239999999999995 110.878 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -112.66 168.14 9.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 75.040000000000006 111.068 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 14.5 p -167.62 149.7 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 75.319999999999993 111.101 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.03 130.03 36.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.139 -0.482 . . . . 74.319999999999993 110.881 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -68.08 -17.61 64.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.095 -0.502 . . . . 72.010000000000005 111.106 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -162.93 95.7 0.88 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.224 -0.443 . . . . 64.239999999999995 110.891 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 18.6 tttt -84.99 53.06 2.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 73.340000000000003 110.935 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 18.0 p -128.82 0.37 5.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 73.450000000000003 111.142 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 3.7 mtmm -155.29 18.24 0.41 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 74.299999999999997 110.887 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -179.96 149.16 0.33 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.277 -0.419 . . . . 73.319999999999993 111.107 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 7.0 p -109.92 156.69 20.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.166 -0.47 . . . . 74.239999999999995 111.118 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 17.6 m -140.42 140.86 33.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 74.439999999999998 111.112 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -148.15 109.0 4.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 72.540000000000006 110.879 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . 0.419 ' HA ' ' HA ' ' A' ' 214' ' ' ILE . 3.6 p -89.21 143.01 12.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.465 . . . . 74.340000000000003 111.106 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.7 m -171.82 123.43 0.52 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 72.0 110.91 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 56.2 46.67 85.33 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.715 -0.755 . . . . 74.230000000000004 112.466 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 4.1 mtp 64.2 15.78 9.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.827 0.346 . . . . 64.430000000000007 110.892 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 13.6 m -125.13 113.01 17.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.246 -0.434 . . . . 74.430000000000007 111.112 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.419 ' HA ' ' HA ' ' A' ' 209' ' ' VAL . 3.1 mp -110.48 113.8 45.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 75.219999999999999 111.154 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 5.8 m -88.93 132.05 34.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 74.129999999999995 111.12 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 3.9 t -117.02 124.28 72.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.187 -0.46 . . . . 55.100000000000001 111.101 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -106.03 138.67 41.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 75.319999999999993 110.95 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -94.73 78.55 0.91 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.676 -0.773 . . . . 72.319999999999993 112.505 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 20.6 t -49.75 -55.52 4.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.823 0.344 . . . . 72.439999999999998 111.134 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -127.19 161.75 27.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 72.219999999999999 111.111 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -62.22 139.93 58.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 70.239999999999995 111.068 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 142.27 171.72 13.27 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.752 -0.737 . . . . 73.230000000000004 112.496 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 2.1 mttt -101.12 121.19 41.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.783 0.325 . . . . 75.420000000000002 110.929 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 7.1 p -120.46 125.46 74.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.259 -0.428 . . . . 64.230000000000004 111.102 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -90.98 152.45 20.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.468 . . . . 72.329999999999998 110.888 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 4.3 mp -135.24 92.71 17.59 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.667 0.746 . . . . 75.329999999999998 111.166 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -176.44 1.49 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.689 2.26 . . . . 74.25 112.329 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 59.5 t -149.4 137.04 13.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.444 . . . . 72.439999999999998 111.127 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 84.0 t -118.4 133.18 66.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.158 -0.474 . . . . 75.409999999999997 111.135 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 5.7 t -122.32 126.21 47.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 72.319999999999993 110.881 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 55.53 -121.86 24.43 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.717 -0.754 . . . . 75.120000000000005 112.519 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -98.17 21.03 11.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.87 0.367 . . . . 75.439999999999998 110.911 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 106.77 6.9 34.54 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.702 -0.761 . . . . 73.120000000000005 112.507 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -53.26 -62.66 1.51 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.85 0.357 . . . . 74.319999999999993 110.887 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -105.99 166.02 10.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 74.340000000000003 110.879 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -167.15 165.41 15.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 70.040000000000006 111.053 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -142.33 163.16 33.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 75.109999999999999 111.099 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 8.0 p -136.58 131.15 47.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.243 -0.435 . . . . 74.409999999999997 111.149 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -139.3 165.22 27.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 63.219999999999999 111.157 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -147.7 133.32 18.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 74.219999999999999 110.919 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 25.1 mm -126.7 115.13 40.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.475 . . . . 74.040000000000006 111.11 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 2.4 m -82.91 141.11 32.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 73.450000000000003 111.146 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 21.2 t -120.01 121.06 64.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.243 -0.435 . . . . 75.439999999999998 111.121 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 9.2 p -82.92 132.78 35.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.138 -0.483 . . . . 75.540000000000006 111.124 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -54.39 -27.18 34.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 71.219999999999999 111.089 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 46.9 t . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 62.119999999999997 110.906 -179.811 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 N-CA-C 112.499 -0.24 . . . . 72.109999999999999 112.499 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -64.06 165.87 8.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.792 0.33 . . . . 74.019999999999996 111.126 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 67.5 mmm -104.78 177.01 4.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.247 -0.433 . . . . 60.25 110.887 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -126.19 129.06 48.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 75.400000000000006 111.106 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -73.62 -71.06 0.34 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.211 -0.449 . . . . 74.239999999999995 111.072 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -178.48 -174.45 0.39 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.205 -0.452 . . . . 70.310000000000002 111.081 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 10.8 t -127.24 15.99 7.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 60.310000000000002 111.132 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -176.71 81.28 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.764 -0.731 . . . . 74.109999999999999 112.493 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 30.5 ttp -102.95 123.19 46.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.895 0.378 . . . . 74.030000000000001 110.867 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 51.6 p -111.52 104.97 13.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.236 -0.438 . . . . 72.349999999999994 111.159 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 60.9 t -97.2 131.92 42.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.455 . . . . 74.439999999999998 111.141 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 38.5 m -124.55 92.29 48.18 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.534 0.683 . . . . 63.149999999999999 111.147 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 -167.26 0.22 Allowed 'Trans proline' 0 C--N 1.341 0.132 0 C-N-CA 122.674 2.249 . . . . 75.420000000000002 112.35 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -90.92 -39.27 12.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.444 . . . . 72.530000000000001 111.114 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 4.8 p 45.86 79.96 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 74.439999999999998 110.87 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.6 t -175.44 -175.69 0.83 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.477 . . . . 72.310000000000002 111.126 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 1.7 m -97.42 164.42 12.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.443 . . . . 65.120000000000005 110.908 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 3.4 p -146.22 153.18 13.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.469 . . . . 70.200000000000003 111.137 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 59.2 t -86.1 145.48 7.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 64.310000000000002 111.125 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.27 122.32 5.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.443 . . . . 75.010000000000005 110.905 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.15 -12.79 62.06 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.771 -0.728 . . . . 72.450000000000003 112.53 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 17.9 mm100 -92.35 -178.8 5.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.796 0.331 . . . . 74.299999999999997 110.914 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 60.6 p -161.69 148.63 14.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 74.140000000000001 110.879 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 6.7 t -105.75 -174.46 2.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 75.310000000000002 111.145 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -140.29 127.09 20.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.256 -0.429 . . . . 75.530000000000001 111.139 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.5 mp -100.81 141.01 34.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.183 -0.462 . . . . 71.530000000000001 110.93 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 6.1 m -109.17 144.61 37.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 71.530000000000001 111.152 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 23.1 t -129.43 141.56 46.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 75.540000000000006 111.104 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -130.89 156.87 44.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 74.439999999999998 111.111 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -147.09 133.37 19.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 74.140000000000001 110.894 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.62 67.18 23.96 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.634 0.731 . . . . 70.049999999999997 110.915 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -23.87 30.39 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.676 2.251 . . . . 73.329999999999998 112.369 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 71.58 38.07 1.04 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 65.420000000000002 110.865 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 163.32 -23.36 0.18 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.754 -0.736 . . . . 75.140000000000001 112.478 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 73.0 t -104.07 148.34 9.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.877 0.37 . . . . 74.030000000000001 111.109 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 16.6 p -139.72 38.0 2.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 64.340000000000003 111.134 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -121.14 123.12 41.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 72.109999999999999 110.868 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 10.3 mtmm -85.31 73.11 10.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.474 . . . . 72.510000000000005 110.87 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.45 -3.98 43.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.253 -0.431 . . . . 70.120000000000005 110.831 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -88.05 168.58 12.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.074 -0.512 . . . . 65.409999999999997 110.858 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -164.38 162.07 21.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 70.140000000000001 110.868 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -104.03 157.69 16.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.467 . . . . 75.030000000000001 111.107 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 91.9 t -150.25 145.14 17.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.257 -0.429 . . . . 74.230000000000004 111.126 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -83.83 122.78 29.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 74.109999999999999 110.826 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.98 -8.25 54.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 74.150000000000006 111.088 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -164.21 98.58 0.83 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.259 -0.428 . . . . 63.119999999999997 110.899 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.64 41.4 1.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 70.340000000000003 110.89 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 4.3 p -124.51 -5.3 7.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.249 -0.432 . . . . 71.010000000000005 111.144 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 9.7 mtmm -148.45 16.27 1.02 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.462 . . . . 75.129999999999995 110.921 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -179.2 154.35 0.65 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 74.409999999999997 111.124 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 11.2 p -117.62 158.42 24.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.209 -0.45 . . . . 74.239999999999995 111.153 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 10.7 m -134.74 144.4 34.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 71.120000000000005 111.093 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 1.9 t -150.93 109.21 3.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 74.239999999999995 110.886 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 80.9 t -84.16 145.71 7.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 75.409999999999997 111.123 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 3.3 t -171.09 117.58 0.46 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.147 -0.479 . . . . 53.420000000000002 110.849 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 48.52 61.32 5.19 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.738 -0.744 . . . . 53.020000000000003 112.496 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 2.3 mtp 54.09 21.97 3.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.887 0.375 . . . . 74.109999999999999 110.904 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 1.7 m -130.59 110.33 11.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 74.200000000000003 111.2 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -104.65 121.36 56.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.253 -0.43 . . . . 74.030000000000001 111.158 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 21.0 m -91.9 129.19 37.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.146 -0.479 . . . . 70.150000000000006 111.16 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 2.3 t -115.54 120.94 66.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 75.420000000000002 111.15 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -105.47 140.33 38.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 73.409999999999997 110.872 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -96.47 78.54 0.73 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.767 -0.73 . . . . 52.240000000000002 112.491 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 19.5 t -50.81 -56.67 3.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.837 0.351 . . . . 70.219999999999999 111.115 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -123.86 161.21 25.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.148 -0.478 . . . . 74.540000000000006 111.103 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -63.15 138.7 58.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.256 -0.429 . . . . 73.420000000000002 111.099 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 141.37 168.49 11.53 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.713 -0.756 . . . . 63.299999999999997 112.458 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 5.6 mttp -95.68 120.2 35.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.804 0.335 . . . . 73.340000000000003 110.915 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 6.6 p -117.99 123.15 71.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.272 -0.422 . . . . 72.140000000000001 111.177 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -90.72 153.18 20.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.458 . . . . 71.329999999999998 110.864 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 4.2 mp -138.38 93.19 11.47 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.645 0.736 . . . . 62.229999999999997 111.139 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -177.41 1.85 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.73 2.287 . . . . 74.409999999999997 112.339 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 62.4 t -149.01 142.04 18.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 65.230000000000004 111.126 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 91.0 t -121.42 137.09 56.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.157 -0.474 . . . . 73.010000000000005 111.141 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.34 130.09 52.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 71.439999999999998 110.884 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 53.37 -114.09 3.53 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.74 -0.743 . . . . 72.129999999999995 112.513 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -111.17 21.22 16.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.807 0.337 . . . . 74.349999999999994 110.831 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 114.39 1.76 23.23 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.76 -0.733 . . . . 62.329999999999998 112.512 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 44.1 mm-40 -51.75 -62.96 1.3 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.9 0.381 . . . . 61.399999999999999 110.899 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -112.46 162.93 15.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 75.519999999999996 110.929 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -165.71 164.8 18.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 74.349999999999994 111.065 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -143.01 163.05 33.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 63.009999999999998 111.084 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 10.9 p -137.77 136.34 45.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 75.430000000000007 111.172 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -139.23 165.51 26.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 65.310000000000002 111.086 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -145.11 132.34 20.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 71.120000000000005 110.88 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 36.3 mm -127.21 116.89 45.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 75.319999999999993 111.155 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 2.1 m -84.22 141.68 30.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.192 -0.458 . . . . 62.240000000000002 111.138 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 21.5 t -120.0 121.5 66.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.243 -0.435 . . . . 60.100000000000001 111.127 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 7.6 p -82.58 132.8 35.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 70.310000000000002 111.166 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -55.78 -25.29 40.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 62.409999999999997 111.082 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 9.7 t . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 74.310000000000002 110.857 -179.774 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 N-CA-C 112.448 -0.261 . . . . 61.340000000000003 112.448 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -86.49 -33.97 20.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.801 0.334 . . . . 74.209999999999994 111.098 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 14.5 mtm -135.85 176.62 8.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 73.120000000000005 110.86 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -151.36 176.42 11.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 75.299999999999997 111.152 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -110.05 -70.14 0.83 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.255 -0.43 . . . . 63.130000000000003 111.132 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -179.28 -174.46 0.32 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.469 . . . . 70.310000000000002 111.089 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 2.3 m -124.89 13.93 8.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.243 -0.435 . . . . 74.519999999999996 111.139 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 163.26 104.71 0.19 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.715 -0.755 . . . . 53.329999999999998 112.504 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 21.5 ttp -110.62 134.48 52.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.839 0.352 . . . . 74.129999999999995 110.9 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 1.8 p -119.62 95.44 4.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.256 -0.429 . . . . 71.109999999999999 111.173 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 21.8 t -97.21 117.9 42.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.439 . . . . 73.409999999999997 111.168 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 60.8 m -112.72 91.61 17.93 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.574 0.702 . . . . 74.140000000000001 111.17 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 -168.23 0.26 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.638 2.226 . . . . 71.540000000000006 112.361 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -86.6 -44.57 11.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.438 . . . . 70.299999999999997 111.104 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 37.8 t 49.82 76.93 0.12 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.257 -0.429 . . . . 64.319999999999993 110.887 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.4 t -175.05 -174.91 0.8 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.111 -0.495 . . . . 71.430000000000007 111.14 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 33.3 p -99.15 158.42 15.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 71.450000000000003 110.856 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 3.3 p -140.22 152.37 21.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.103 -0.499 . . . . 73.150000000000006 111.096 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 95.5 t -84.6 143.66 11.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.166 -0.47 . . . . 73.319999999999993 111.093 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -48.04 122.5 5.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 73.549999999999997 110.917 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.85 -14.6 60.15 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.712 -0.756 . . . . 53.530000000000001 112.473 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 16.7 mm100 -90.63 -178.31 5.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.824 0.345 . . . . 74.400000000000006 110.889 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 27.4 p -161.52 149.14 14.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 55.530000000000001 110.825 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 7.3 t -108.21 -173.68 2.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.481 . . . . 74.540000000000006 111.136 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -140.47 132.1 27.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.451 . . . . 52.240000000000002 111.161 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.3 mp -105.37 142.02 35.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.246 -0.434 . . . . 75.030000000000001 110.918 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 3.6 m -108.42 142.12 39.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 74.319999999999993 111.128 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 16.5 t -129.79 136.37 59.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 65.329999999999998 111.13 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -124.33 155.86 37.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.243 -0.435 . . . . 72.219999999999999 111.076 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -142.83 125.25 15.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 72.310000000000002 110.884 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.48 63.06 46.34 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.557 0.694 . . . . 73.25 110.903 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 -43.16 2.85 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.668 2.245 . . . . 74.340000000000003 112.317 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 69.77 49.39 0.53 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 72.230000000000004 110.871 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 157.53 -20.67 0.39 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.716 -0.754 . . . . 52.009999999999998 112.495 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 2.7 t -98.16 -59.68 3.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.928 0.394 . . . . 74.439999999999998 111.125 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 48.26 72.34 0.28 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.181 -0.463 . . . . 73.530000000000001 111.131 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -157.26 138.68 13.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 75.409999999999997 110.848 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.17 70.71 7.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 73.310000000000002 110.866 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 1.1 m -93.79 -5.3 48.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 75.5 110.886 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -89.77 171.87 9.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.107 -0.497 . . . . 75.329999999999998 110.873 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.68 167.17 17.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.141 -0.481 . . . . 75.219999999999999 110.852 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -113.19 167.84 10.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.178 -0.464 . . . . 74.340000000000003 111.077 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 10.5 p -173.65 151.52 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 75.230000000000004 111.168 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.8 t -78.44 152.55 32.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 75.319999999999993 110.852 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -89.97 -21.61 22.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 63.450000000000003 111.122 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -129.14 -54.63 1.19 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 74.209999999999994 110.906 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 3.0 ttpp 63.63 25.52 14.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 75.340000000000003 110.915 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 32.3 p -112.59 -4.85 14.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.469 . . . . 52.520000000000003 111.11 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 9.1 mtmm -151.94 18.28 0.68 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 71.530000000000001 110.947 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -174.91 147.36 0.97 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 65.430000000000007 111.122 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 16.7 p -108.59 157.78 18.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 71.25 111.101 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 12.3 m -140.6 140.85 33.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 73.329999999999998 111.133 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 10.0 m -148.68 108.77 4.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 70.519999999999996 110.863 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . 0.433 ' HA ' ' HA ' ' A' ' 214' ' ' ILE . 3.2 p -87.07 135.43 25.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.154 -0.475 . . . . 70.5 111.148 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 3.3 m -161.31 121.96 2.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 74.319999999999993 110.858 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 54.72 49.08 62.95 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.752 -0.737 . . . . 64.540000000000006 112.511 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER 63.3 16.38 9.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.853 0.359 . . . . 74.239999999999995 110.877 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 3.3 m -126.46 109.41 12.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 73.230000000000004 111.167 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.433 ' HA ' ' HA ' ' A' ' 209' ' ' VAL . 2.1 mp -105.18 114.09 43.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 75.329999999999998 111.11 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 6.2 m -87.9 130.51 34.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 75.219999999999999 111.124 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 2.8 t -115.93 123.91 71.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.449 . . . . 73.510000000000005 111.144 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -106.78 139.74 40.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 75.530000000000001 110.864 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -94.79 79.8 0.89 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.804 -0.712 . . . . 63.399999999999999 112.45 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 18.5 t -50.75 -55.63 6.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.858 0.361 . . . . 74.239999999999995 111.112 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -129.36 163.87 24.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 73.140000000000001 111.125 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -63.17 142.26 58.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 65.510000000000005 111.085 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 139.04 171.56 12.23 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.78 -0.724 . . . . 70.420000000000002 112.495 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 14.9 mttt -100.73 121.57 41.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.788 0.328 . . . . 74.140000000000001 110.88 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 7.4 p -120.62 126.23 75.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 74.510000000000005 111.124 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -90.66 154.3 19.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.127 -0.488 . . . . 73.150000000000006 110.908 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 4.1 mp -137.02 93.16 13.55 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.619 0.723 . . . . 74.120000000000005 111.102 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.81 -178.61 2.44 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.723 2.282 . . . . 74.540000000000006 112.305 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 99.4 t -150.29 138.32 14.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.169 -0.468 . . . . 72.230000000000004 111.069 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 66.6 t -121.47 139.39 48.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.166 -0.47 . . . . 74.409999999999997 111.124 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 7.4 m -122.45 125.53 46.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 73.129999999999995 110.851 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 55.54 -115.35 5.75 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.716 -0.754 . . . . 72.129999999999995 112.474 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -103.29 17.42 24.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.896 0.379 . . . . 72.219999999999999 110.897 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 114.01 9.73 15.37 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.778 -0.725 . . . . 72.319999999999993 112.513 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -52.01 -73.44 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.874 0.368 . . . . 72.430000000000007 110.921 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -104.15 162.48 13.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 72.230000000000004 110.879 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -158.93 165.1 34.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.469 . . . . 72.439999999999998 111.097 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -144.1 163.36 33.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 54.539999999999999 111.099 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 11.5 p -138.0 135.38 45.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.201 -0.454 . . . . 72.219999999999999 111.125 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.84 164.26 30.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 71.420000000000002 111.071 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -141.55 131.85 25.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 74.450000000000003 110.921 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 23.9 mm -127.43 110.64 22.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.154 -0.476 . . . . 74.450000000000003 111.161 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 1.4 m -81.32 141.43 34.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 74.430000000000007 111.139 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 15.7 t -120.13 122.78 69.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 73.349999999999994 111.137 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 14.6 p -82.41 133.62 35.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 70.239999999999995 111.14 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -59.16 -21.88 60.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 74.310000000000002 111.058 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 67.0 m . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.239 -0.437 . . . . 74.420000000000002 110.859 -179.732 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 N-CA-C 112.466 -0.253 . . . . 62.299999999999997 112.466 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -118.35 -66.61 1.06 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.797 0.332 . . . . 63.5 111.095 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 8.7 mtt -114.08 119.64 37.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 73.239999999999995 110.851 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -176.62 -170.15 0.32 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 72.140000000000001 111.112 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -173.21 129.09 0.46 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 74.200000000000003 111.11 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.32 -168.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.438 . . . . 73.310000000000002 111.075 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.88 32.94 5.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.233 -0.44 . . . . 73.219999999999999 111.148 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 135.27 99.63 0.6 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.721 -0.752 . . . . 53.399999999999999 112.51 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 18.8 ttp -110.88 128.15 55.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.824 0.345 . . . . 72.430000000000007 110.907 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 38.9 p -116.29 107.4 14.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 73.140000000000001 111.116 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 21.2 t -102.24 131.1 50.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.246 -0.434 . . . . 74.230000000000004 111.141 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -123.58 91.86 49.3 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.554 0.693 . . . . 75.200000000000003 111.189 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 -167.05 0.21 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.653 2.235 . . . . 74.430000000000007 112.34 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -92.55 -45.19 8.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.45 . . . . 70.299999999999997 111.117 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 73.1 m 48.08 85.42 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 75.140000000000001 110.905 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 8.4 t -176.0 -176.01 0.78 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 75.129999999999995 111.173 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 75.8 p -97.07 153.49 17.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 70.329999999999998 110.852 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 3.3 p -139.07 153.54 24.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.139 -0.482 . . . . 71.510000000000005 111.127 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 67.2 t -87.6 145.05 8.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.167 -0.47 . . . . 73.409999999999997 111.151 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -48.42 122.66 5.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 72.319999999999993 110.914 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.98 -15.35 59.45 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.756 -0.735 . . . . 71.310000000000002 112.487 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -90.62 -178.63 5.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.781 0.324 . . . . 73.439999999999998 110.943 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 65.4 p -161.96 149.7 14.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 63.340000000000003 110.838 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 7.8 t -107.19 -173.89 2.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.105 -0.498 . . . . 74.329999999999998 111.115 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.76 132.25 28.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.201 -0.454 . . . . 74.530000000000001 111.111 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.6 mp -105.8 143.66 33.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.186 -0.461 . . . . 74.0 110.933 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 4.0 m -111.35 142.98 42.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.444 . . . . 74.200000000000003 111.133 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 21.8 t -129.69 143.41 41.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.255 -0.429 . . . . 71.329999999999998 111.185 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -134.48 152.06 51.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 61.32 111.106 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -144.88 126.53 15.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 70.420000000000002 110.878 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.81 67.77 68.93 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.594 0.712 . . . . 75.030000000000001 110.877 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.79 -40.44 5.27 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.657 2.238 . . . . 70.030000000000001 112.333 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 67.01 42.35 2.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 73.219999999999999 110.896 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 163.11 -40.56 0.34 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.807 -0.711 . . . . 62.329999999999998 112.507 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . 0.423 ' O ' ' C ' ' A' ' 191' ' ' THR . 2.2 t -78.02 -48.2 23.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.864 0.364 . . . . 73.430000000000007 111.165 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' THR . . . . . 0.423 ' C ' ' O ' ' A' ' 190' ' ' VAL . 1.6 t 35.82 71.96 0.11 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 74.439999999999998 111.139 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -164.52 116.75 1.29 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.205 -0.452 . . . . 73.349999999999994 110.887 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt -58.15 98.43 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.44 . . . . 71.510000000000005 110.874 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 2.6 t -111.61 -6.8 14.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 74.420000000000002 110.878 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -90.97 174.58 7.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.15 -0.477 . . . . 74.519999999999996 110.899 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -165.81 154.95 11.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 65.219999999999999 110.861 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -103.89 165.63 10.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 73.030000000000001 111.076 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 10.4 p -169.17 152.17 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 73.109999999999999 111.122 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.4 p -81.93 140.22 34.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 74.430000000000007 110.863 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -76.52 -23.34 53.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.107 -0.497 . . . . 75.109999999999999 111.069 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -134.82 -53.61 0.81 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.436 . . . . 74.340000000000003 110.845 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 2.8 ttpp 63.66 33.85 12.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.44 . . . . 75.519999999999996 110.918 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 50.8 p -116.65 -3.26 11.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.196 -0.456 . . . . 74.340000000000003 111.121 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 8.0 mtmm -153.19 18.75 0.57 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 73.349999999999994 110.854 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -172.42 148.09 2.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 72.519999999999996 111.083 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 17.1 p -111.69 142.37 44.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 74.099999999999994 111.192 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 16.2 m -126.7 140.15 49.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.267 -0.424 . . . . 75.129999999999995 111.146 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 28.4 m -146.68 108.99 4.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 74.329999999999998 110.846 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . 0.427 ' HA ' ' HA ' ' A' ' 214' ' ' ILE . 3.7 p -86.87 143.27 11.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.08 -0.509 . . . . 75.310000000000002 111.112 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 43.7 t -171.45 123.57 0.56 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.152 -0.477 . . . . 75.230000000000004 110.881 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 55.14 48.29 69.05 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.73 -0.748 . . . . 72.400000000000006 112.479 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 1.8 mtp 62.5 16.59 8.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.834 0.35 . . . . 64.409999999999997 110.889 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 2.3 m -127.55 113.55 16.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 74.209999999999994 111.175 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.427 ' HA ' ' HA ' ' A' ' 209' ' ' VAL . 3.0 mp -109.9 115.96 51.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.241 -0.436 . . . . 74.530000000000001 111.15 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 3.4 m -89.1 130.83 35.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.439 . . . . 65.420000000000002 111.127 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 3.0 t -116.24 121.06 66.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.24 -0.436 . . . . 74.409999999999997 111.124 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -104.79 139.83 38.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 73.129999999999995 110.863 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -94.28 79.65 0.95 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.729 -0.748 . . . . 42.329999999999998 112.502 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 19.7 t -49.95 -56.39 3.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.837 0.351 . . . . 75.430000000000007 111.154 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -127.77 163.35 24.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 72.319999999999993 111.07 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -63.45 137.75 58.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 62.240000000000002 111.092 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 142.4 167.53 11.42 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.74 -0.743 . . . . 74.340000000000003 112.515 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 6.2 mttp -98.72 124.58 43.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.876 0.369 . . . . 65.319999999999993 110.874 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 7.4 p -121.96 129.76 75.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.218 -0.446 . . . . 71.430000000000007 111.119 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 27.4 m120 -90.62 152.48 20.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 73.439999999999998 110.876 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 4.2 mp -138.2 92.83 11.97 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.611 0.72 . . . . 74.329999999999998 111.12 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 -177.79 2.03 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.658 2.239 . . . . 53.119999999999997 112.379 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 99.7 t -150.08 137.82 13.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 73.319999999999993 111.084 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 88.1 t -117.94 132.82 66.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 73.450000000000003 111.12 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -121.72 137.52 54.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 75.519999999999996 110.858 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 51.91 -118.88 7.78 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.707 -0.758 . . . . 73.420000000000002 112.51 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -105.5 21.09 17.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.918 0.39 . . . . 72.340000000000003 110.933 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 107.27 12.01 24.41 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.706 -0.759 . . . . 73.030000000000001 112.49 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -63.14 -58.97 5.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.842 0.353 . . . . 73.430000000000007 110.901 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -105.58 167.22 9.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.464 . . . . 74.329999999999998 110.89 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -166.13 165.04 17.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.165 -0.471 . . . . 65.109999999999999 111.115 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -139.52 163.2 33.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 73.420000000000002 111.064 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 52.4 t -137.52 132.11 44.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.441 . . . . 71.420000000000002 111.137 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -139.23 162.48 34.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 74.010000000000005 111.094 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -145.51 124.37 12.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 75.219999999999999 110.898 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 29.6 mm -119.1 109.13 25.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.12 -0.491 . . . . 73.530000000000001 111.135 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 4.2 m -80.31 141.83 35.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 74.239999999999995 111.12 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 18.5 t -119.22 121.1 65.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 75.540000000000006 111.18 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 6.7 p -81.67 132.85 35.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.188 -0.46 . . . . 72.439999999999998 111.185 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -58.46 -21.7 52.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.226 -0.443 . . . . 73.400000000000006 111.076 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 76.5 p . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.224 -0.444 . . . . 70.150000000000006 110.83 -179.769 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 N-CA-C 112.475 -0.25 . . . . 73.530000000000001 112.475 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -165.05 110.49 0.93 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.804 0.335 . . . . 74.549999999999997 111.075 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 8.6 mtt -83.31 178.11 8.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 73.310000000000002 110.879 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -135.69 -175.26 3.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 74.450000000000003 111.062 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -175.3 129.53 0.28 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.15 -0.477 . . . . 75.340000000000003 111.101 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -59.81 -169.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 75.439999999999998 111.105 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 4.7 t -120.69 22.37 11.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 75.329999999999998 111.171 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 147.23 100.38 0.25 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.775 -0.726 . . . . 74.209999999999994 112.524 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -110.04 136.5 49.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.88 0.371 . . . . 74.420000000000002 110.876 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 68.6 p -116.11 105.65 12.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 72.310000000000002 111.147 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 45.7 t -98.48 130.14 47.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.198 -0.456 . . . . 74.219999999999999 111.094 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 8.9 m -126.66 92.72 44.26 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.537 0.684 . . . . 74.439999999999998 111.128 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 -166.07 0.17 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.67 2.246 . . . . 74.319999999999993 112.352 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -87.05 -40.13 14.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 73.099999999999994 111.114 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 99.5 p 46.47 78.81 0.06 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.439 . . . . 70.439999999999998 110.876 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.5 t -175.27 -174.96 0.78 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.11 -0.496 . . . . 75.150000000000006 111.174 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 99.1 p -99.79 162.94 12.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.261 -0.427 . . . . 63.32 110.85 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 1.9 p -147.06 151.68 13.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 73.319999999999993 111.114 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 69.3 t -87.62 145.35 7.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.475 . . . . 73.230000000000004 111.116 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.31 123.1 6.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 74.200000000000003 110.92 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 100.49 -15.87 58.34 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.758 -0.734 . . . . 65.409999999999997 112.526 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 12.9 mm100 -86.51 -177.09 6.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.819 0.343 . . . . 63.210000000000001 110.921 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 1.4 p -161.02 149.31 15.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 71.340000000000003 110.838 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 8.9 t -113.26 -178.25 3.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.09 -0.504 . . . . 71.430000000000007 111.113 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -138.61 128.89 25.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.203 -0.453 . . . . 73.120000000000005 111.16 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.6 mp -101.69 147.96 25.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 73.400000000000006 110.866 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 7.4 m -115.23 142.79 46.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.198 -0.456 . . . . 73.129999999999995 111.135 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 30.0 t -129.72 142.56 43.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 71.420000000000002 111.139 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -130.41 152.94 49.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 52.140000000000001 111.078 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -146.4 131.85 18.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 62.100000000000001 110.885 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.71 68.05 73.95 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.544 0.688 . . . . 72.420000000000002 110.931 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 -33.93 15.63 Favored 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.692 2.262 . . . . 64.209999999999994 112.345 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 60.31 19.84 9.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 73.129999999999995 110.871 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -177.92 -54.34 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.752 -0.737 . . . . 72.510000000000005 112.491 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 1.4 t -54.62 -50.4 59.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.947 0.403 . . . . 65.140000000000001 111.135 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 44.0 p 47.04 62.17 2.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.187 -0.46 . . . . 73.310000000000002 111.125 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -157.6 146.61 19.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 74.219999999999999 110.865 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.16 76.6 6.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.197 -0.456 . . . . 74.010000000000005 110.918 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 4.9 m -86.07 -6.48 59.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.258 -0.428 . . . . 72.200000000000003 110.86 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -90.74 173.4 8.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.129 -0.487 . . . . 73.010000000000005 110.867 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 23.4 ptt180 -163.04 172.56 14.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.138 -0.483 . . . . 75.530000000000001 110.874 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -121.38 167.86 12.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 75.450000000000003 111.074 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 8.3 p -174.05 153.82 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 74.530000000000001 111.089 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.49 129.14 38.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.121 -0.491 . . . . 72.319999999999993 110.834 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -65.92 -21.86 66.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.114 -0.494 . . . . 64.349999999999994 111.078 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -155.45 86.85 1.09 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.245 -0.434 . . . . 52.310000000000002 110.869 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 24.4 ttmt -79.23 58.46 2.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.44 . . . . 72.299999999999997 110.905 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 27.6 p -132.89 3.68 3.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 74.400000000000006 111.123 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 12.9 mtmm -154.22 16.51 0.48 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.238 -0.437 . . . . 73.450000000000003 110.918 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -179.96 152.96 0.49 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.436 . . . . 72.340000000000003 111.068 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 12.1 p -107.9 154.13 22.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 74.329999999999998 111.17 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 13.3 m -140.58 136.36 35.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 74.340000000000003 111.124 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 1.2 t -144.99 108.44 4.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.459 . . . . 65.409999999999997 110.85 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 4.4 p -91.01 143.68 10.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 72.519999999999996 111.139 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 7.8 t -144.97 98.16 3.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 70.510000000000005 110.843 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 70.24 -81.63 0.36 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.748 -0.739 . . . . 74.120000000000005 112.497 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -138.78 7.68 2.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.838 0.351 . . . . 63.43 110.86 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 1.6 m -129.16 123.03 31.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.444 . . . . 74.140000000000001 111.185 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 2.4 mp -114.6 140.49 35.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 73.129999999999995 111.17 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.0 128.59 54.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 74.420000000000002 111.087 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 2.6 t -118.72 134.24 62.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 73.450000000000003 111.125 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -119.27 137.19 53.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 65.400000000000006 110.923 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -85.7 68.88 3.32 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.778 -0.725 . . . . 54.520000000000003 112.491 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 1.9 t -49.45 -53.98 7.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.812 0.339 . . . . 75.230000000000004 111.116 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -123.71 155.2 38.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 73.310000000000002 111.134 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -67.27 137.11 55.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.238 -0.437 . . . . 65.430000000000007 111.106 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 141.32 175.09 14.67 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.703 -0.76 . . . . 74.140000000000001 112.503 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 5.1 mttp -98.86 122.24 41.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.787 0.327 . . . . 73.230000000000004 110.926 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 6.4 p -119.15 127.35 75.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 71.430000000000007 111.123 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 30.6 m120 -90.7 145.4 24.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 64.030000000000001 110.916 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 4.8 mp -131.12 92.56 32.8 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.657 0.742 . . . . 72.349999999999994 111.126 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 179.21 3.85 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.705 2.27 . . . . 74.200000000000003 112.338 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 58.0 t -148.36 137.27 15.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 74.349999999999994 111.155 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 46.1 t -116.93 135.91 55.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 74.129999999999995 111.123 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.25 107.37 12.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 74.019999999999996 110.844 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 74.94 -118.23 5.6 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.752 -0.737 . . . . 71.200000000000003 112.492 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -108.06 19.95 19.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.851 0.357 . . . . 74.549999999999997 110.867 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 116.49 2.87 19.29 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.733 -0.746 . . . . 55.009999999999998 112.52 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -51.47 -71.47 0.06 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.876 0.37 . . . . 71.430000000000007 110.88 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -109.32 151.63 26.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 73.530000000000001 110.86 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -149.46 161.73 41.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 74.299999999999997 111.138 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -139.61 163.15 33.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.246 -0.434 . . . . 73.540000000000006 111.149 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 43.0 t -136.58 139.58 44.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.281 -0.418 . . . . 73.510000000000005 111.117 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -139.26 164.37 29.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.237 -0.438 . . . . 74.200000000000003 111.109 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -143.71 128.72 18.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.239 -0.437 . . . . 54.530000000000001 110.861 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 29.1 mm -125.2 110.85 25.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 72.519999999999996 111.156 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 1.5 m -80.75 138.82 36.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 73.349999999999994 111.191 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 18.3 t -120.07 117.82 54.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.24 -0.436 . . . . 73.239999999999995 111.152 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 4.3 p -81.86 132.94 35.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 62.140000000000001 111.149 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -53.24 -28.52 27.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 71.030000000000001 111.106 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 1.4 t . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 63.229999999999997 110.845 -179.789 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.903 0.382 . . . . 75.33 111.051 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -127.6 24.34 6.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 51.12 111.155 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 151.54 99.08 0.18 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.776 -0.726 . . . . 42.12 112.551 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 43.8 ttp -113.13 125.5 54.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.846 0.355 . . . . 72.42 110.901 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.64 ' OG1' ' HB3' ' A' ' 184' ' ' ALA . 51.6 p -114.47 103.62 11.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 61.22 111.153 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 1.087 HG22 HG13 ' A' ' 183' ' ' VAL . 21.4 t -99.7 130.48 48.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.256 -0.429 . . . . 73.35 111.117 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.3 m -125.0 92.88 46.81 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.593 0.711 . . . . 73.2 111.113 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.473 ' HB3' HD23 ' A' ' 181' ' ' LEU . 53.7 Cg_endo -69.74 -168.85 0.29 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.668 2.245 . . . . 65.01 112.381 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -86.73 -40.84 14.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.279 -0.419 . . . . 74.43 111.104 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 93.6 p 46.43 79.06 0.06 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.245 -0.434 . . . . 51.33 110.851 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.5 t -175.09 -174.89 0.8 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.126 -0.488 . . . . 62.44 111.118 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 89.4 p -98.8 164.06 12.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 73.4 110.849 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.715 HG22 ' HB2' ' A' ' 177' ' ' GLN . 3.5 p -146.31 154.02 12.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 65.33 111.111 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 66.7 t -87.35 145.31 7.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 71.11 111.071 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -49.03 122.56 5.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.134 -0.484 . . . . 71.12 110.923 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.38 -14.59 60.83 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.75 -0.738 . . . . 74.12 112.476 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' GLN . . . . . 0.715 ' HB2' HG22 ' A' ' 173' ' ' VAL . 17.4 mm100 -90.82 -178.22 5.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.83 0.347 . . . . 72.52 110.927 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 35.1 p -161.51 148.49 14.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.224 -0.444 . . . . 74.43 110.85 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.484 HG21 HD12 ' A' ' 241' ' ' ILE . 6.7 t -106.81 -173.55 2.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.075 -0.511 . . . . 53.43 111.151 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.29 132.31 27.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.231 -0.44 . . . . 75.5 111.133 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.473 HD23 ' HB3' ' A' ' 168' ' ' PRO . 7.7 mp -105.21 143.05 33.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 72.44 110.951 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 21.9 m -110.06 142.36 41.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.217 -0.447 . . . . 72.52 111.118 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 1.087 HG13 HG22 ' A' ' 166' ' ' VAL . 18.4 t -129.34 140.24 49.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 73.33 111.13 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.64 ' HB3' ' OG1' ' A' ' 165' ' ' THR . . . -130.11 152.12 49.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.143 -0.48 . . . . 64.45 111.098 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -145.76 126.88 14.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 74.41 110.865 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.58 66.71 77.33 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.542 0.687 . . . . 73.12 110.921 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo . . . . . 0 N--CA 1.465 -0.155 0 C-N-CA 122.676 2.251 . . . . 73.45 112.377 179.975 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 7.2 t0 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.865 0.364 . . . . 65.53 110.876 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.12 92.43 0.11 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 54.42 110.913 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 1.6 m -105.78 -7.08 18.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 60.32 110.831 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.776 ' CE2' HG11 ' A' ' 183' ' ' VAL . 19.2 p90 -91.34 176.35 6.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.098 -0.501 . . . . 72.43 110.913 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -163.05 171.16 16.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.459 . . . . 73.43 110.839 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 197' ' ' ALA . . . . . 0.416 ' HB3' ' HB ' ' A' ' 209' ' ' VAL . . . -120.31 168.0 11.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 72.43 111.078 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 11.3 p -175.21 151.45 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 75.0 111.108 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.7 t -77.31 150.15 35.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.126 -0.488 . . . . 53.03 110.858 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.522 ' HB2' ' HD3' ' A' ' 227' ' ' PRO . . . -86.32 -23.79 26.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 63.15 111.138 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -127.7 -52.52 1.35 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.19 -0.459 . . . . 64.34 110.831 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.24 24.39 14.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.2 -0.455 . . . . 74.44 110.91 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 35.5 p -113.37 -2.73 13.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.246 -0.433 . . . . 71.41 111.138 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 8.8 mtmm -152.59 18.53 0.62 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.251 -0.432 . . . . 74.34 110.878 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.629 ' HA ' HG23 ' A' ' 219' ' ' VAL . . . -177.22 146.61 0.5 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 73.13 111.089 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 11.9 p -107.22 159.04 16.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.174 -0.467 . . . . 50.12 111.117 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.769 HG12 HG22 ' A' ' 216' ' ' VAL . 11.2 m -141.23 141.72 30.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 53.1 111.141 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 4.3 m -148.76 108.46 4.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 72.3 110.843 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.494 HG23 HG13 ' A' ' 214' ' ' ILE . 3.5 p -87.96 143.1 11.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.132 -0.485 . . . . 74.3 111.132 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 16.7 t -172.08 123.45 0.5 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 73.33 110.841 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 55.86 47.16 80.96 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.745 -0.74 . . . . 75.14 112.488 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 2.1 mtp 63.74 16.01 9.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.853 0.359 . . . . 71.52 110.896 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 7.0 m -126.0 113.59 17.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 63.42 111.146 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.494 HG13 HG23 ' A' ' 209' ' ' VAL . 2.9 mp -110.23 113.96 45.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 75.11 111.125 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 5.0 m -88.1 132.16 34.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.45 . . . . 74.31 111.123 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.769 HG22 HG12 ' A' ' 207' ' ' VAL . 3.3 t -117.21 124.47 73.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 64.51 111.082 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -106.19 139.33 40.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 73.31 110.907 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -94.22 79.57 0.96 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.782 -0.723 . . . . 60.34 112.495 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.629 HG23 ' HA ' ' A' ' 205' ' ' ALA . 19.6 t -50.29 -55.96 4.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.792 0.329 . . . . 63.53 111.175 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -128.71 161.4 29.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 54.44 111.095 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 221' ' ' ALA . . . . . 0.684 ' HB2' ' HA ' ' A' ' 245' ' ' ALA . . . -61.06 140.31 57.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.215 -0.448 . . . . 71.22 111.121 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 139.41 171.21 12.15 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.743 -0.741 . . . . 74.41 112.488 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 223' ' ' LYS . . . . . 0.495 ' HG3' HG23 ' A' ' 242' ' ' THR . 14.3 mttt -99.46 124.56 44.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.821 0.343 . . . . 54.4 110.941 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.593 HG11 ' CB ' ' A' ' 205' ' ' ALA . 7.0 p -120.96 127.37 75.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 72.11 111.169 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 225' ' ' ASN . . . . . 0.606 ' C ' HD12 ' A' ' 226' ' ' ILE . 21.3 m120 -90.81 151.81 21.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 64.31 110.906 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.606 HD12 ' C ' ' A' ' 225' ' ' ASN . 4.4 mp -138.06 93.12 12.0 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.622 0.725 . . . . 71.12 111.125 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 227' ' ' PRO . . . . . 0.522 ' HD3' ' HB2' ' A' ' 200' ' ' ALA . 53.6 Cg_endo -69.79 -178.3 2.29 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.708 2.272 . . . . 71.22 112.34 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 90.5 t -150.09 134.78 9.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 61.21 111.137 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 80.4 t -117.08 135.59 56.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.147 -0.478 . . . . 65.23 111.161 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 31.0 t -122.12 116.65 24.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 74.12 110.871 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 66.48 -115.04 6.98 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.729 -0.748 . . . . 63.11 112.464 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -110.54 19.23 18.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.874 0.369 . . . . 65.22 110.888 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 117.33 2.72 17.69 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.748 -0.739 . . . . 75.44 112.485 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -51.06 -70.36 0.09 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.866 0.365 . . . . 70.22 110.902 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -107.38 159.66 16.22 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.172 -0.467 . . . . 72.53 110.852 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -160.75 165.19 30.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.103 -0.499 . . . . 74.41 111.091 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -146.2 163.18 36.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 71.44 111.135 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 24.1 t -137.18 137.02 46.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.215 -0.448 . . . . 62.04 111.11 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -139.08 165.29 27.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.173 -0.467 . . . . 73.53 111.134 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 240' ' ' GLU . . . . . 0.419 ' O ' HD13 ' A' ' 241' ' ' ILE . 5.8 pt-20 -144.95 132.51 20.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.244 -0.434 . . . . 74.14 110.851 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 241' ' ' ILE . . . . . 0.587 HG13 HG11 ' A' ' 216' ' ' VAL . 23.5 mm -126.87 115.09 40.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.134 -0.485 . . . . 72.25 111.174 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 242' ' ' THR . . . . . 0.495 HG23 ' HG3' ' A' ' 223' ' ' LYS . 2.0 m -82.43 141.24 32.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.152 -0.476 . . . . 62.0 111.162 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 17.8 t -119.71 121.54 66.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 52.4 111.128 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 244' ' ' THR . . . . . 0.529 HG23 ' O ' ' A' ' 173' ' ' VAL . 7.1 p -82.28 133.0 35.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 73.42 111.17 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 245' ' ' ALA . . . . . 0.684 ' HA ' ' HB2' ' A' ' 221' ' ' ALA . . . -58.33 -22.52 53.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 34.23 111.113 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 1.4 p . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.197 -0.456 . . . . 73.3 110.866 -179.77 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.859 0.361 . . . . 71.22 111.093 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -129.25 24.09 5.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.24 -0.436 . . . . 64.44 111.088 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 153.28 99.85 0.18 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.734 -0.746 . . . . 74.03 112.448 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 21.3 ttp -113.85 124.6 52.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.85 0.357 . . . . 64.55 110.872 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.648 ' OG1' ' HB3' ' A' ' 184' ' ' ALA . 51.6 p -114.58 103.32 10.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.257 -0.429 . . . . 70.42 111.147 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 1.037 HG22 HG13 ' A' ' 183' ' ' VAL . 21.7 t -97.97 131.72 44.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.192 -0.458 . . . . 75.54 111.153 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.4 m -126.46 92.38 45.39 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.545 0.688 . . . . 72.53 111.143 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.472 ' HG3' ' HB2' ' A' ' 239' ' ' ALA . 53.5 Cg_endo -69.82 -167.2 0.22 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.67 2.247 . . . . 74.11 112.321 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -85.94 -40.26 16.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 61.3 111.15 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 87.9 p 46.41 77.29 0.08 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.213 -0.449 . . . . 75.03 110.877 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.5 t -175.72 -174.82 0.71 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.12 -0.491 . . . . 73.11 111.128 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 34.6 p -100.56 162.91 12.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 72.24 110.862 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.732 HG22 ' HB2' ' A' ' 177' ' ' GLN . 3.3 p -144.27 153.03 15.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 64.53 111.12 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 63.2 t -86.58 145.26 7.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 73.42 111.152 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.1 122.3 5.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.191 -0.459 . . . . 73.34 110.899 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 100.19 -14.35 59.79 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.758 -0.734 . . . . 61.21 112.484 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' GLN . . . . . 0.732 ' HB2' HG22 ' A' ' 173' ' ' VAL . 11.7 mm100 -90.03 -177.66 5.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.81 0.338 . . . . 60.41 110.935 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 2.2 p -160.9 148.82 15.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 43.14 110.836 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.494 HG21 HD12 ' A' ' 241' ' ' ILE . 7.5 t -109.65 -176.82 3.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 50.25 111.128 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -139.47 127.51 22.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 60.23 111.148 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.466 HD23 ' HB3' ' A' ' 168' ' ' PRO . 7.9 mp -99.89 145.71 27.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.221 -0.445 . . . . 75.54 110.902 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -114.1 143.21 45.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 64.22 111.173 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 1.037 HG13 HG22 ' A' ' 166' ' ' VAL . 25.4 t -129.47 141.9 45.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 61.24 111.146 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.648 ' HB3' ' OG1' ' A' ' 165' ' ' THR . . . -129.81 150.66 51.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 75.25 111.095 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -144.5 127.8 16.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 65.5 110.901 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.39 66.76 71.3 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.642 0.734 . . . . 74.22 110.877 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo . . . . . 0 C--N 1.342 0.21 0 C-N-CA 122.657 2.238 . . . . 74.21 112.367 179.943 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 2.7 t70 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.854 0.359 . . . . 73.31 110.86 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.37 104.53 0.51 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 74.1 110.932 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 1.2 m -115.42 -6.14 12.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 65.2 110.843 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.777 ' CE2' HG11 ' A' ' 183' ' ' VAL . 21.9 p90 -90.31 174.45 7.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.125 -0.489 . . . . 74.32 110.878 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -165.7 151.64 9.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 73.15 110.863 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 197' ' ' ALA . . . . . 0.759 ' HB3' ' HB ' ' A' ' 209' ' ' VAL . . . -104.2 158.91 16.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 75.44 111.116 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.635 ' O ' HG23 ' A' ' 226' ' ' ILE . 6.4 m -153.04 -178.05 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 75.34 111.16 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 11.9 p -108.1 132.27 53.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 73.31 110.887 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.497 ' HB2' ' HD3' ' A' ' 227' ' ' PRO . . . -75.35 -26.01 58.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.122 -0.49 . . . . 40.01 111.14 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -129.01 -60.02 1.1 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.454 . . . . 75.41 110.884 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 63.88 35.45 10.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 45.31 110.922 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 32.7 p -118.44 -4.73 10.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.165 -0.47 . . . . 75.15 111.064 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 9.4 mtmm -152.84 18.63 0.59 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.255 -0.43 . . . . 61.53 110.907 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.663 ' HA ' HG23 ' A' ' 219' ' ' VAL . . . -171.26 144.91 2.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 71.31 111.128 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 17.0 p -107.37 130.85 54.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.249 -0.432 . . . . 64.15 111.17 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.913 HG12 HG22 ' A' ' 216' ' ' VAL . 4.8 m -118.86 138.99 47.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 71.45 111.145 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 208' ' ' SER . . . . . 0.496 ' C ' HG23 ' A' ' 214' ' ' ILE . 5.7 t -145.29 109.09 4.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 61.45 110.849 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.759 ' HB ' ' HB3' ' A' ' 197' ' ' ALA . 4.2 p -89.4 143.61 10.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.104 -0.498 . . . . 63.15 111.091 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 3.4 t -144.79 96.28 2.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.138 -0.483 . . . . 34.12 110.885 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 70.29 -81.04 0.38 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.78 -0.724 . . . . 72.43 112.507 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -138.43 8.09 2.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.882 0.373 . . . . 64.21 110.911 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -129.24 121.82 28.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 63.12 111.168 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.654 HG13 HG23 ' A' ' 209' ' ' VAL . 2.6 mp -115.3 131.79 66.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 71.24 111.131 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 1.5 m -100.63 125.71 47.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.139 -0.482 . . . . 74.22 111.152 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.913 HG22 HG12 ' A' ' 207' ' ' VAL . 2.4 t -116.64 126.66 74.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 74.2 111.165 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -112.19 138.96 48.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 63.03 110.86 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -93.4 80.98 1.04 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.768 -0.729 . . . . 54.2 112.469 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.663 HG23 ' HA ' ' A' ' 205' ' ' ALA . 19.3 t -50.26 -51.18 18.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.855 0.36 . . . . 71.12 111.099 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -137.78 162.36 34.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 53.21 111.132 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 221' ' ' ALA . . . . . 0.631 ' HB2' ' HA ' ' A' ' 245' ' ' ALA . . . -57.25 143.45 39.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 74.33 111.132 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 137.18 167.95 11.23 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.748 -0.739 . . . . 52.44 112.482 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 223' ' ' LYS . . . . . 0.618 ' HG3' HG23 ' A' ' 242' ' ' THR . 6.1 mttp -102.47 133.93 46.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.83 0.348 . . . . 73.55 110.893 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 13.1 p -130.49 131.66 65.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 50.55 111.118 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 225' ' ' ASN . . . . . 0.617 ' C ' HD12 ' A' ' 226' ' ' ILE . 33.3 m120 -91.33 152.45 20.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.464 . . . . 63.42 110.905 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.635 HG23 ' O ' ' A' ' 198' ' ' VAL . 4.3 mp -137.43 92.44 13.47 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.611 0.719 . . . . 61.1 111.124 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 227' ' ' PRO . . . . . 0.497 ' HD3' ' HB2' ' A' ' 200' ' ' ALA . 54.5 Cg_endo -69.71 -179.55 2.97 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.689 2.26 . . . . 75.43 112.367 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 85.9 t -150.4 134.84 9.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 34.54 111.125 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 86.9 t -116.94 136.07 55.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 74.1 111.147 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -119.77 108.83 14.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 55.43 110.844 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 56.99 -116.05 7.32 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.767 -0.73 . . . . 44.51 112.503 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 17.9 p30 -95.04 19.3 10.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.836 0.351 . . . . 64.31 110.842 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 101.09 8.28 47.98 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.72 -0.752 . . . . 42.15 112.486 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -52.0 -33.81 39.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.814 0.34 . . . . 62.33 110.835 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -144.21 153.21 41.85 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.202 -0.454 . . . . 74.31 110.894 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -154.28 165.53 36.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.174 -0.466 . . . . 42.42 111.097 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -145.78 163.16 35.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.464 . . . . 64.34 111.115 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 23.3 t -136.6 135.83 48.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.251 -0.431 . . . . 74.53 111.131 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 239' ' ' ALA . . . . . 0.472 ' HB2' ' HG3' ' A' ' 168' ' ' PRO . . . -138.6 165.29 27.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 73.32 111.123 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -145.81 132.37 19.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 75.22 110.862 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 241' ' ' ILE . . . . . 0.529 HG13 HG11 ' A' ' 216' ' ' VAL . 24.5 mm -125.79 113.59 35.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.194 -0.457 . . . . 72.54 111.151 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 242' ' ' THR . . . . . 0.618 HG23 ' HG3' ' A' ' 223' ' ' LYS . 1.7 m -83.17 141.63 31.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 63.51 111.146 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 11.3 t -119.78 122.78 69.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.44 . . . . 73.02 111.17 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 244' ' ' THR . . . . . 0.51 HG23 ' O ' ' A' ' 173' ' ' VAL . 4.2 p -84.75 132.56 34.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 63.23 111.141 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 245' ' ' ALA . . . . . 0.631 ' HA ' ' HB2' ' A' ' 221' ' ' ALA . . . -58.18 -23.48 55.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 62.55 111.097 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 58.8 m . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 72.44 110.884 -179.792 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.869 0.366 . . . . 72.21 111.131 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 1.9 m -128.26 24.13 5.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.261 -0.427 . . . . 61.11 111.165 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 153.41 99.04 0.17 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.701 -0.762 . . . . 73.33 112.476 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 27.9 ttp -113.18 125.34 54.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.862 0.363 . . . . 74.21 110.851 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.596 ' OG1' ' HB3' ' A' ' 184' ' ' ALA . 48.5 p -114.72 104.01 11.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 71.31 111.142 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 1.071 HG22 HG13 ' A' ' 183' ' ' VAL . 21.7 t -100.41 130.98 48.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 61.1 111.117 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 19.2 m -125.1 92.48 47.36 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.551 0.691 . . . . 75.44 111.085 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.481 ' HG3' ' HB2' ' A' ' 239' ' ' ALA . 53.7 Cg_endo -69.8 -166.75 0.2 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.649 2.233 . . . . 71.11 112.355 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -86.59 -40.59 15.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.436 . . . . 53.13 111.063 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 88.2 p 46.72 76.3 0.1 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 61.34 110.875 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.5 t -174.23 -174.9 0.93 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 73.34 111.152 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 24.5 p -100.37 162.24 13.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 51.42 110.824 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.725 HG22 ' HB2' ' A' ' 177' ' ' GLN . 2.8 p -144.27 154.06 15.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.117 -0.492 . . . . 64.21 111.127 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 79.5 t -89.29 144.48 9.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 63.05 111.142 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.78 123.76 6.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.451 . . . . 70.41 110.92 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.84 -16.14 58.84 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.788 -0.72 . . . . 60.31 112.498 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' GLN . . . . . 0.725 ' HB2' HG22 ' A' ' 173' ' ' VAL . 9.7 mm100 -89.41 -177.89 5.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.846 0.355 . . . . 75.53 110.914 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 11.9 p -161.98 147.09 12.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.212 -0.449 . . . . 62.31 110.884 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 7.3 t -108.12 -174.69 2.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 73.12 111.132 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -140.42 132.31 27.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 75.13 111.189 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.474 HD23 ' HB3' ' A' ' 168' ' ' PRO . 7.6 mp -105.12 142.14 35.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 73.33 110.919 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 24.9 m -110.01 141.99 42.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 65.43 111.179 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 1.071 HG13 HG22 ' A' ' 166' ' ' VAL . 21.5 t -129.32 139.87 50.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.293 -0.412 . . . . 64.22 111.127 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.596 ' HB3' ' OG1' ' A' ' 165' ' ' THR . . . -130.11 151.91 50.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.124 -0.489 . . . . 73.45 111.126 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -144.24 128.69 17.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 75.42 110.889 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.25 66.69 71.66 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.582 0.706 . . . . 75.23 110.912 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo . . . . . 0 C--N 1.341 0.162 0 C-N-CA 122.68 2.253 . . . . 65.35 112.355 179.999 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 13.5 t0 . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.877 0.37 . . . . 64.44 110.883 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 9.5 mtmt -63.24 96.78 0.11 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 74.53 110.914 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 2.0 m -109.84 -6.25 15.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 73.22 110.877 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.773 ' CE2' HG11 ' A' ' 183' ' ' VAL . 20.6 p90 -90.71 175.9 6.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.073 -0.512 . . . . 62.22 110.845 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 3.1 ptt-85 -158.25 173.71 16.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.132 -0.486 . . . . 73.22 110.89 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' ALA . . . . . 0.553 ' HB3' ' HB ' ' A' ' 209' ' ' VAL . . . -124.65 167.16 14.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 42.04 111.086 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 10.0 p -174.77 152.73 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 73.44 111.131 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.7 126.75 36.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.156 -0.475 . . . . 71.32 110.878 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.526 ' HB2' ' HD3' ' A' ' 227' ' ' PRO . . . -61.68 -17.94 57.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.115 -0.493 . . . . 74.13 111.093 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -156.99 92.43 1.27 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.213 -0.449 . . . . 61.41 110.913 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 8.0 tttp -83.65 55.18 3.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 75.05 110.931 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 20.0 p -130.66 2.67 4.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.246 -0.434 . . . . 54.1 111.144 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 204' ' ' LYS . . . . . 0.45 ' HA ' ' HB3' ' A' ' 220' ' ' ALA . 10.8 mtmm -153.99 18.23 0.51 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 65.23 110.881 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -179.47 153.4 0.57 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.449 . . . . 65.54 111.113 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 8.4 p -117.49 131.23 56.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 73.34 111.142 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 1.05 HG12 HG22 ' A' ' 216' ' ' VAL . 4.9 m -120.1 140.33 44.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.184 -0.462 . . . . 43.3 111.112 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.16 109.0 4.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 72.42 110.868 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.553 ' HB ' ' HB3' ' A' ' 197' ' ' ALA . 3.7 p -85.45 143.08 12.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.138 -0.483 . . . . 63.2 111.173 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 17.2 p -172.19 123.85 0.5 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 62.11 110.839 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 55.4 48.05 72.15 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.752 -0.737 . . . . 43.44 112.476 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 2.4 mtp 62.5 16.47 8.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.884 0.373 . . . . 72.51 110.853 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 1.4 m -128.15 114.23 16.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.26 -0.427 . . . . 54.21 111.153 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.537 HG13 HG23 ' A' ' 209' ' ' VAL . 3.4 mp -110.24 115.61 50.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 75.25 111.076 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 1.3 m -89.99 126.91 35.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 75.43 111.118 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 1.05 HG22 HG12 ' A' ' 207' ' ' VAL . 4.8 t -112.74 128.28 69.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.216 -0.447 . . . . 72.51 111.135 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -109.56 135.69 50.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 75.41 110.921 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -84.41 66.81 3.82 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.731 -0.747 . . . . 71.2 112.507 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.418 HG12 ' N ' ' A' ' 220' ' ' ALA . 1.9 t -48.75 -53.58 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.817 0.341 . . . . 70.24 111.146 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 220' ' ' ALA . . . . . 0.45 ' HB3' ' HA ' ' A' ' 204' ' ' LYS . . . -123.96 155.33 38.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.146 -0.479 . . . . 61.33 111.114 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 221' ' ' ALA . . . . . 0.662 ' HB2' ' HA ' ' A' ' 245' ' ' ALA . . . -67.82 138.03 55.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 74.24 111.054 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 140.46 174.68 14.05 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.769 -0.729 . . . . 52.04 112.478 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 223' ' ' LYS . . . . . 0.551 ' HG3' HG23 ' A' ' 242' ' ' THR . 6.0 mttp -99.38 121.51 41.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.827 0.346 . . . . 72.13 110.885 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 7.6 p -120.35 128.67 76.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 73.3 111.132 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 225' ' ' ASN . . . . . 0.456 ' C ' HD12 ' A' ' 226' ' ' ILE . 36.1 m120 -90.52 150.2 21.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.145 -0.479 . . . . 70.41 110.863 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.456 HD12 ' C ' ' A' ' 225' ' ' ASN . 4.7 mp -133.19 92.39 25.17 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.675 0.75 . . . . 75.51 111.135 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 227' ' ' PRO . . . . . 0.526 ' HD3' ' HB2' ' A' ' 200' ' ' ALA . 54.5 Cg_endo -69.7 -179.67 3.05 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.687 2.258 . . . . 63.4 112.375 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 96.2 t -149.46 136.13 12.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 74.4 111.142 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 82.6 t -118.26 135.52 58.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.186 -0.461 . . . . 73.35 111.134 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.21 108.8 14.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 72.2 110.856 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 74.06 -111.44 3.43 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.763 -0.732 . . . . 54.32 112.485 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -111.09 8.31 21.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.907 0.384 . . . . 75.35 110.948 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 127.78 3.24 6.0 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.709 -0.758 . . . . 52.22 112.456 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -51.66 -73.21 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.853 0.358 . . . . 75.33 110.899 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -102.94 156.37 17.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.468 . . . . 71.25 110.872 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -157.24 165.18 36.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.148 -0.478 . . . . 74.32 111.068 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -144.83 163.5 33.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 74.3 111.096 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 58.8 t -137.02 136.46 47.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.226 -0.443 . . . . 55.52 111.126 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 239' ' ' ALA . . . . . 0.481 ' HB2' ' HG3' ' A' ' 168' ' ' PRO . . . -138.72 165.26 27.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 72.32 111.103 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 240' ' ' GLU . . . . . 0.507 ' O ' HD13 ' A' ' 241' ' ' ILE . 1.8 pt-20 -143.15 131.49 22.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 75.11 110.888 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 241' ' ' ILE . . . . . 0.507 HD13 ' O ' ' A' ' 240' ' ' GLU . 25.8 mm -127.28 112.05 27.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.13 -0.486 . . . . 71.42 111.089 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 242' ' ' THR . . . . . 0.551 HG23 ' HG3' ' A' ' 223' ' ' LYS . 1.7 m -82.5 139.28 34.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.189 -0.46 . . . . 53.45 111.132 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 22.1 t -120.49 119.48 59.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.23 -0.441 . . . . 61.33 111.142 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 244' ' ' THR . . . . . 0.479 HG23 ' O ' ' A' ' 173' ' ' VAL . 6.8 p -81.91 132.9 35.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 74.43 111.169 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 245' ' ' ALA . . . . . 0.662 ' HA ' ' HB2' ' A' ' 221' ' ' ALA . . . -55.2 -26.19 37.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 73.03 111.051 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 9.3 t . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.234 -0.439 . . . . 62.25 110.846 -179.785 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.835 0.35 . . . . 75.32 111.106 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -125.02 32.28 5.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 61.34 111.093 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 136.87 99.7 0.55 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.72 -0.752 . . . . 65.43 112.501 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 11.6 ttp -109.75 133.04 53.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.83 0.348 . . . . 71.1 110.898 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.461 ' HG1' ' HB3' ' A' ' 184' ' ' ALA . 33.4 p -121.65 108.17 13.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 51.43 111.147 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 1.125 HG22 HG13 ' A' ' 183' ' ' VAL . 26.3 t -102.23 132.29 48.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 53.11 111.122 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.7 m -124.33 92.49 48.05 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.599 0.714 . . . . 72.5 111.143 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.483 ' HB3' HD23 ' A' ' 181' ' ' LEU . 53.7 Cg_endo -69.75 -166.43 0.19 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.709 2.273 . . . . 63.04 112.329 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -89.03 -39.49 13.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 71.0 111.133 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 98.2 p 46.32 79.33 0.06 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 53.32 110.829 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.1 t -175.55 -174.59 0.71 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.093 -0.503 . . . . 71.03 111.121 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 97.2 p -99.89 163.19 12.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.262 -0.426 . . . . 63.31 110.886 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.737 HG22 ' HB2' ' A' ' 177' ' ' GLN . 3.1 p -144.95 153.6 14.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.134 -0.484 . . . . 64.12 111.099 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 58.7 t -87.53 145.67 7.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 63.53 111.13 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.34 122.37 6.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.459 . . . . 61.3 110.919 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.7 -12.54 61.14 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.761 -0.733 . . . . 61.13 112.489 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' GLN . . . . . 0.737 ' HB2' HG22 ' A' ' 173' ' ' VAL . 13.9 mm100 -92.64 -178.06 4.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.779 0.323 . . . . 62.04 110.928 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 23.8 p -161.5 148.83 14.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 62.22 110.878 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.424 HG21 HD12 ' A' ' 241' ' ' ILE . 9.1 t -108.74 -175.4 2.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.124 -0.489 . . . . 73.01 111.137 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -138.9 132.98 31.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 65.4 111.143 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.483 HD23 ' HB3' ' A' ' 168' ' ' PRO . 7.4 mp -106.52 143.59 34.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 74.23 110.946 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 2.2 m -111.75 142.5 44.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.462 . . . . 75.11 111.11 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 1.125 HG13 HG22 ' A' ' 166' ' ' VAL . 22.6 t -129.75 140.52 48.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 71.4 111.141 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.461 ' HB3' ' HG1' ' A' ' 165' ' ' THR . . . -132.38 152.49 51.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 44.04 111.097 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -143.77 128.7 18.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.455 . . . . 65.5 110.866 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.77 67.11 76.81 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.577 0.704 . . . . 60.25 110.896 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo . . . . . 0 C--N 1.342 0.185 0 C-N-CA 122.675 2.25 . . . . 71.35 112.357 179.95 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.877 0.37 . . . . 73.05 110.881 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 6.1 mtmt -52.94 105.55 0.13 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 75.14 110.888 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 59.8 m -116.76 -6.69 11.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 64.4 110.857 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.755 ' CE2' HG11 ' A' ' 183' ' ' VAL . 23.6 p90 -90.75 176.5 6.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.101 -0.499 . . . . 61.53 110.857 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.28 157.34 15.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.122 -0.49 . . . . 71.44 110.862 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -105.48 167.78 9.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.47 . . . . 55.14 111.115 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 11.6 p -164.32 151.06 2.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 72.15 111.153 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.56 121.17 29.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 53.51 110.874 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.613 ' HB2' ' HD3' ' A' ' 227' ' ' PRO . . . -65.34 -19.49 65.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.103 -0.499 . . . . 73.33 111.107 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -163.81 91.4 0.65 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.17 -0.468 . . . . 32.34 110.845 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 7.8 ttpt -83.19 55.59 3.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 70.42 110.909 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 25.0 p -128.06 -0.23 5.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.236 -0.438 . . . . 75.02 111.153 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 6.1 mtmt -156.42 19.45 0.35 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.18 -0.463 . . . . 71.24 110.9 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.611 ' HA ' HG23 ' A' ' 219' ' ' VAL . . . -179.64 149.85 0.39 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 72.33 111.162 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 4.0 p -108.51 156.22 19.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 73.11 111.12 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.611 HG12 HG22 ' A' ' 216' ' ' VAL . 15.7 m -141.27 137.56 33.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 53.33 111.161 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 60.4 p -146.04 108.01 4.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 72.32 110.879 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.545 HG23 HG13 ' A' ' 214' ' ' ILE . 3.3 p -91.18 140.94 15.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 64.5 111.147 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 17.5 p -172.38 126.71 0.53 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 55.33 110.832 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 56.49 45.44 89.58 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.782 -0.723 . . . . 73.22 112.476 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 4.2 mtp 63.51 16.15 9.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.871 0.367 . . . . 74.34 110.867 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 22.2 m -127.05 115.04 18.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.229 -0.441 . . . . 75.25 111.088 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.545 HG13 HG23 ' A' ' 209' ' ' VAL . 3.4 mp -110.44 120.25 60.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 63.44 111.141 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 1.2 m -92.18 128.84 38.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.211 -0.449 . . . . 43.34 111.168 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.634 HG11 HG13 ' A' ' 241' ' ' ILE . 3.5 t -115.34 125.58 72.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 73.44 111.125 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -110.79 138.72 46.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 74.22 110.908 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -94.99 78.53 0.88 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.765 -0.731 . . . . 31.42 112.474 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.611 HG23 ' HA ' ' A' ' 205' ' ' ALA . 19.1 t -49.71 -53.0 11.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.827 0.346 . . . . 74.12 111.11 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -131.33 161.95 31.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.461 . . . . 74.24 111.113 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 221' ' ' ALA . . . . . 0.679 ' HB2' ' HA ' ' A' ' 245' ' ' ALA . . . -60.74 138.62 58.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.235 -0.439 . . . . 63.31 111.085 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 142.77 171.18 13.21 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.705 -0.759 . . . . 74.13 112.486 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 223' ' ' LYS . . . . . 0.507 ' HG3' HG23 ' A' ' 242' ' ' THR . 13.6 mttt -101.56 125.15 48.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.84 0.352 . . . . 72.14 110.936 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.472 HG11 ' CB ' ' A' ' 205' ' ' ALA . 7.1 p -122.07 126.17 74.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.242 -0.436 . . . . 73.23 111.122 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 225' ' ' ASN . . . . . 0.591 ' C ' HD12 ' A' ' 226' ' ' ILE . 0.3 OUTLIER -90.96 155.48 18.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 73.23 110.878 -179.977 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.591 HD12 ' C ' ' A' ' 225' ' ' ASN . 4.6 mp -139.88 92.65 9.8 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.603 0.716 . . . . 62.12 111.133 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 227' ' ' PRO . . . . . 0.613 ' HD3' ' HB2' ' A' ' 200' ' ' ALA . 54.3 Cg_endo -69.75 -178.14 2.2 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.67 2.247 . . . . 71.51 112.365 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 80.4 t -150.3 143.02 17.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 70.04 111.094 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 94.8 t -123.77 134.09 67.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.182 -0.463 . . . . 72.31 111.119 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -122.3 133.68 54.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 64.15 110.846 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 52.25 -116.15 4.86 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.78 -0.724 . . . . 73.44 112.464 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -108.73 21.17 17.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.83 0.348 . . . . 51.54 110.86 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 110.41 5.87 27.77 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.7 -0.762 . . . . 45.34 112.514 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -52.9 -60.32 3.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.924 0.392 . . . . 71.45 110.885 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -113.04 166.69 11.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.103 -0.499 . . . . 75.43 110.89 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -165.06 162.2 20.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.151 -0.477 . . . . 74.24 111.129 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -140.09 163.26 33.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 41.51 111.125 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.2 p -140.17 131.66 31.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 72.24 111.191 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 239' ' ' ALA . . . . . 0.407 ' HB2' ' HG3' ' A' ' 168' ' ' PRO . . . -132.71 165.2 25.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.191 -0.459 . . . . 62.43 111.093 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 240' ' ' GLU . . . . . 0.562 ' O ' HD13 ' A' ' 241' ' ' ILE . 4.4 pt-20 -144.55 132.28 21.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.225 -0.443 . . . . 70.3 110.916 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 241' ' ' ILE . . . . . 0.634 HG13 HG11 ' A' ' 216' ' ' VAL . 27.2 mm -127.21 112.49 28.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 73.34 111.096 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 242' ' ' THR . . . . . 0.507 HG23 ' HG3' ' A' ' 223' ' ' LYS . 2.2 m -81.76 141.21 33.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.117 -0.492 . . . . 75.55 111.123 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 19.7 t -120.12 121.31 65.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.213 -0.448 . . . . 75.23 111.106 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 244' ' ' THR . . . . . 0.49 HG23 ' O ' ' A' ' 173' ' ' VAL . 6.2 p -83.69 132.77 34.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.138 -0.483 . . . . 44.41 111.126 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 245' ' ' ALA . . . . . 0.679 ' HA ' ' HB2' ' A' ' 221' ' ' ALA . . . -53.45 -28.26 29.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 72.3 111.117 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 7.9 t . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.44 . . . . 74.13 110.86 -179.766 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.874 0.369 . . . . 63.32 111.111 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 1.6 m -134.33 30.79 3.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 63.42 111.139 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 137.27 104.97 0.71 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.739 -0.743 . . . . 72.21 112.503 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 1.5 ttp -115.84 138.5 51.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.837 0.351 . . . . 71.43 110.855 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.58 ' OG1' ' HB3' ' A' ' 184' ' ' ALA . 37.5 p -125.34 106.67 10.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 53.03 111.152 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.992 HG22 HG13 ' A' ' 183' ' ' VAL . 16.4 t -97.62 135.92 30.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 63.24 111.099 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.3 m -128.78 92.22 40.83 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.574 0.702 . . . . 63.2 111.157 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.542 ' HG3' ' HB2' ' A' ' 239' ' ' ALA . 53.5 Cg_endo -69.75 -165.03 0.14 Allowed 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.695 2.263 . . . . 73.24 112.365 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -93.0 -37.01 12.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.433 . . . . 65.21 111.124 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 88.0 p 46.85 76.92 0.09 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 71.43 110.838 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.4 t -171.22 -174.5 1.48 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 63.32 111.18 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 18.4 p -100.35 163.66 12.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 65.23 110.833 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.744 HG22 ' HB2' ' A' ' 177' ' ' GLN . 3.0 p -144.4 153.4 15.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.079 -0.51 . . . . 65.41 111.173 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 23.2 t -86.38 145.09 8.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 50.31 111.139 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.42 122.23 5.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 73.44 110.91 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 98.87 -11.08 62.49 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.696 -0.764 . . . . 64.5 112.505 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' GLN . . . . . 0.744 ' HB2' HG22 ' A' ' 173' ' ' VAL . 19.2 mm100 -92.82 -177.53 4.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.769 0.319 . . . . 75.12 110.945 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 59.8 p -160.56 151.65 19.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.246 -0.434 . . . . 72.41 110.854 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 11.0 t -113.74 -178.71 3.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.119 -0.491 . . . . 63.45 111.16 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.02 129.71 32.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.22 -0.445 . . . . 60.53 111.12 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.448 HD23 ' HB3' ' A' ' 168' ' ' PRO . 7.7 mp -103.57 146.23 28.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 61.12 110.901 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 7.1 m -111.1 144.36 40.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 71.44 111.133 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.992 HG13 HG22 ' A' ' 166' ' ' VAL . 21.8 t -129.5 142.26 44.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 73.44 111.155 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.58 ' HB3' ' OG1' ' A' ' 165' ' ' THR . . . -129.08 152.83 48.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 63.21 111.106 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -145.77 129.23 16.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.458 . . . . 72.02 110.852 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.6 66.81 75.42 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.592 0.71 . . . . 71.42 110.878 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--N 1.342 0.197 0 C-N-CA 122.636 2.224 . . . . 75.21 112.358 179.97 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.919 0.39 . . . . 71.32 110.862 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -66.33 90.51 0.15 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.451 . . . . 70.34 110.906 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 1.8 t -105.5 -6.64 19.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 74.04 110.836 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.756 ' CE2' HG11 ' A' ' 183' ' ' VAL . 18.8 p90 -91.08 168.85 11.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.465 . . . . 72.23 110.905 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.08 168.8 25.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 73.43 110.889 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 197' ' ' ALA . . . . . 0.621 ' HB3' ' HB ' ' A' ' 209' ' ' VAL . . . -119.53 163.06 17.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.446 . . . . 63.1 111.144 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.608 ' O ' HG23 ' A' ' 226' ' ' ILE . 3.9 m -153.79 -178.74 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.272 -0.422 . . . . 73.25 111.121 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 199' ' ' SER . . . . . 0.45 ' HB3' HG22 ' A' ' 207' ' ' VAL . 0.9 OUTLIER -119.53 127.35 52.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.161 -0.472 . . . . 54.01 110.921 -179.903 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.405 ' HB2' ' HD3' ' A' ' 227' ' ' PRO . . . -70.82 -9.73 58.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.474 . . . . 50.34 111.153 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -166.22 99.12 0.62 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 64.32 110.867 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 14.9 tttt -91.52 41.71 1.08 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.176 -0.465 . . . . 74.3 110.892 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 4.2 p -124.93 -5.22 7.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 52.31 111.188 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 8.5 mtmm -148.05 15.09 1.04 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 64.24 110.922 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.58 ' HA ' HG23 ' A' ' 219' ' ' VAL . . . -179.67 150.11 0.39 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.44 . . . . 44.55 111.081 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 9.3 p -115.95 151.85 34.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 64.21 111.133 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.862 HG12 HG22 ' A' ' 216' ' ' VAL . 6.2 m -138.03 141.64 37.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 55.02 111.082 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -147.05 109.02 4.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 75.35 110.906 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.621 ' HB ' ' HB3' ' A' ' 197' ' ' ALA . 3.6 p -86.23 143.21 11.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.128 -0.487 . . . . 72.24 111.114 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 7.7 p -171.98 124.11 0.53 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 71.45 110.869 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 55.64 47.19 79.09 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.781 -0.723 . . . . 73.51 112.47 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 2.0 mtp 63.26 16.08 9.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.844 0.354 . . . . 72.01 110.884 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 1.9 m -127.4 114.81 18.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.24 -0.436 . . . . 71.43 111.143 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.504 HG13 HG23 ' A' ' 209' ' ' VAL . 3.0 mp -110.15 116.26 51.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 73.33 111.107 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -89.34 126.15 35.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 62.12 111.125 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.862 HG22 HG12 ' A' ' 207' ' ' VAL . 2.8 t -111.43 129.91 65.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 73.33 111.172 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -113.55 139.03 49.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.439 . . . . 70.24 110.887 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -96.73 78.02 0.71 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.738 -0.744 . . . . 73.11 112.526 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.58 HG23 ' HA ' ' A' ' 205' ' ' ALA . 17.0 t -50.22 -54.96 6.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.846 0.355 . . . . 72.31 111.151 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -128.0 160.8 30.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 71.24 111.115 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 221' ' ' ALA . . . . . 0.67 ' HB2' ' HA ' ' A' ' 245' ' ' ALA . . . -61.07 140.05 57.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 62.44 111.051 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 142.56 170.83 12.94 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.802 -0.713 . . . . 71.33 112.535 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 223' ' ' LYS . . . . . 0.463 ' HG3' HG23 ' A' ' 242' ' ' THR . 12.8 mttt -100.85 121.33 41.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.818 0.342 . . . . 72.21 110.877 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.535 HG11 ' CB ' ' A' ' 205' ' ' ALA . 7.4 p -120.57 126.96 75.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.262 -0.426 . . . . 71.42 111.139 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 225' ' ' ASN . . . . . 0.627 ' C ' HD12 ' A' ' 226' ' ' ILE . 32.7 m120 -90.67 155.97 18.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.464 . . . . 64.43 110.864 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.627 HD12 ' C ' ' A' ' 225' ' ' ASN . 3.9 mp -135.91 92.34 16.6 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.629 0.728 . . . . 60.04 111.072 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 227' ' ' PRO . . . . . 0.595 ' HG2' HG23 ' A' ' 198' ' ' VAL . 53.8 Cg_endo -69.77 179.78 3.47 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.66 2.24 . . . . 75.33 112.352 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 64.3 t -150.29 144.11 17.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.236 -0.438 . . . . 73.33 111.108 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 86.8 t -132.55 135.74 57.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.136 -0.484 . . . . 73.15 111.156 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 82.6 p -115.03 106.7 14.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.452 . . . . 64.32 110.882 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 59.33 -100.26 0.18 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.746 -0.74 . . . . 74.32 112.475 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 18.0 p30 -95.09 -7.68 38.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.897 0.379 . . . . 74.0 110.899 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 112.45 13.24 11.97 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.738 -0.744 . . . . 65.43 112.462 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -52.54 -28.73 21.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.865 0.364 . . . . 74.33 110.887 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -144.66 132.53 21.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 74.24 110.85 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -134.26 164.86 26.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 72.34 111.049 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -135.38 162.98 31.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 73.02 111.088 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 58.3 t -135.82 121.94 31.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.205 -0.452 . . . . 73.35 111.114 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 239' ' ' ALA . . . . . 0.542 ' HB2' ' HG3' ' A' ' 168' ' ' PRO . . . -129.4 165.08 22.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 74.11 111.057 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 240' ' ' GLU . . . . . 0.504 ' O ' HD13 ' A' ' 241' ' ' ILE . 4.8 pt-20 -146.74 132.7 19.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 53.42 110.864 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 241' ' ' ILE . . . . . 0.598 HG13 HG11 ' A' ' 216' ' ' VAL . 23.7 mm -126.76 111.92 27.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 63.05 111.11 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 242' ' ' THR . . . . . 0.463 HG23 ' HG3' ' A' ' 223' ' ' LYS . 2.7 m -79.8 141.22 36.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 52.13 111.148 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 16.6 t -119.9 120.7 63.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.28 -0.418 . . . . 65.14 111.113 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 244' ' ' THR . . . . . 0.489 HG23 ' O ' ' A' ' 173' ' ' VAL . 7.2 p -82.36 132.85 35.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.164 -0.471 . . . . 61.14 111.117 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 245' ' ' ALA . . . . . 0.67 ' HA ' ' HB2' ' A' ' 221' ' ' ALA . . . -57.97 -23.88 55.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 51.42 111.086 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 80.4 p . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.242 -0.435 . . . . 70.44 110.875 -179.805 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.836 0.351 . . . . 61.55 111.142 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 1.1 m -124.81 32.82 5.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.263 -0.426 . . . . 74.25 111.157 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 137.28 98.68 0.5 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.751 -0.738 . . . . 32.04 112.493 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 3.8 ttp -110.23 130.29 55.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.827 0.346 . . . . 61.04 110.846 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.572 ' OG1' ' HB3' ' A' ' 184' ' ' ALA . 43.9 p -118.67 104.01 10.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 73.43 111.118 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 1.114 HG22 HG13 ' A' ' 183' ' ' VAL . 34.7 t -97.86 132.78 41.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.264 -0.425 . . . . 63.31 111.104 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.6 m -126.76 92.53 44.54 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.571 0.701 . . . . 73.14 111.179 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.517 ' HG3' ' HB2' ' A' ' 239' ' ' ALA . 53.7 Cg_endo -69.77 -166.13 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.689 2.259 . . . . 71.53 112.317 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -87.99 -39.22 14.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 54.25 111.079 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 96.1 p 46.46 78.06 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.274 -0.421 . . . . 54.4 110.844 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.6 t -175.18 -174.81 0.78 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.493 . . . . 74.55 111.212 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 94.7 p -99.78 163.25 12.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.254 -0.43 . . . . 63.03 110.841 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.768 HG22 ' HB2' ' A' ' 177' ' ' GLN . 2.8 p -144.41 152.76 15.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.125 -0.489 . . . . 75.52 111.122 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 32.2 t -85.49 145.04 8.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.179 -0.464 . . . . 64.13 111.114 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.28 121.98 5.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.18 -0.464 . . . . 74.14 110.896 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.16 -11.87 62.0 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.701 -0.761 . . . . 54.54 112.471 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' GLN . . . . . 0.768 ' HB2' HG22 ' A' ' 173' ' ' VAL . 21.5 mm100 -91.05 -177.39 4.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.78 0.324 . . . . 72.25 110.944 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -159.3 149.99 19.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.262 -0.427 . . . . 52.15 110.84 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 11.5 t -110.99 179.64 3.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.486 . . . . 72.54 111.139 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -136.02 126.12 26.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 74.32 111.185 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.466 HD23 ' HB3' ' A' ' 168' ' ' PRO . 7.7 mp -100.32 149.35 23.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 61.14 110.88 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 2.4 m -117.54 143.55 45.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.16 -0.473 . . . . 73.44 111.149 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 1.114 HG13 HG22 ' A' ' 166' ' ' VAL . 22.0 t -129.56 140.95 47.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 72.32 111.079 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.572 ' HB3' ' OG1' ' A' ' 165' ' ' THR . . . -129.04 151.95 49.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.474 . . . . 52.42 111.088 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -146.65 130.05 16.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 74.2 110.895 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.24 66.63 75.55 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.612 0.72 . . . . 72.11 110.946 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--N 1.341 0.169 0 C-N-CA 122.722 2.281 . . . . 64.0 112.307 -179.988 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 18.3 t70 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.899 0.381 . . . . 73.33 110.893 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.27 91.68 3.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.179 -0.464 . . . . 54.51 110.907 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.82 -6.48 21.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 74.24 110.838 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.77 ' CE2' HG11 ' A' ' 183' ' ' VAL . 26.9 p90 -90.74 179.32 5.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.469 . . . . 71.54 110.897 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 2.2 ptt180 -166.45 174.48 8.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 72.1 110.867 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 197' ' ' ALA . . . . . 0.525 ' HB3' ' HB ' ' A' ' 209' ' ' VAL . . . -119.45 154.77 33.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.458 . . . . 44.22 111.118 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.4 ' O ' HG23 ' A' ' 226' ' ' ILE . 12.7 t -144.85 154.8 14.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.234 -0.439 . . . . 33.41 111.082 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.95 115.97 28.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.145 -0.48 . . . . 71.31 110.857 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.459 ' HB2' ' HD3' ' A' ' 227' ' ' PRO . . . -59.73 -22.14 61.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 51.31 111.133 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -161.16 92.17 0.9 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.221 -0.445 . . . . 65.22 110.895 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 5.8 tttp -85.07 54.39 3.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 62.03 110.888 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 19.1 p -129.51 1.28 5.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 71.05 111.16 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 9.0 mtmt -155.53 18.28 0.4 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 63.12 110.924 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.624 ' HA ' HG23 ' A' ' 219' ' ' VAL . . . -179.9 148.39 0.31 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 70.2 111.104 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 5.9 p -104.71 154.15 20.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 71.21 111.13 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.655 HG12 HG22 ' A' ' 216' ' ' VAL . 17.1 m -140.8 134.31 32.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.464 . . . . 74.33 111.114 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 208' ' ' SER . . . . . 0.492 ' C ' HG23 ' A' ' 214' ' ' ILE . 10.7 m -145.3 109.09 4.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 75.24 110.867 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.628 HG23 HG13 ' A' ' 214' ' ' ILE . 4.3 p -92.69 142.43 13.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 62.23 111.113 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 4.1 t -143.23 98.9 3.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.134 -0.485 . . . . 72.25 110.866 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 69.89 -81.9 0.32 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.714 -0.755 . . . . 53.13 112.489 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 1.1 mtp -139.0 9.55 2.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.851 0.358 . . . . 61.41 110.853 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 7.3 m -130.21 123.25 29.76 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.243 -0.435 . . . . 51.24 111.17 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.628 HG13 HG23 ' A' ' 209' ' ' VAL . 2.2 mp -115.26 141.19 33.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.221 -0.445 . . . . 70.34 111.17 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.41 125.4 51.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.237 -0.438 . . . . 64.13 111.139 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.655 HG22 HG12 ' A' ' 207' ' ' VAL . 2.6 t -115.33 130.77 69.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 50.14 111.085 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -116.95 138.42 51.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 73.23 110.926 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -95.21 79.72 0.85 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.768 -0.729 . . . . 71.32 112.509 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.624 HG23 ' HA ' ' A' ' 205' ' ' ALA . 16.3 t -50.82 -53.46 13.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.792 0.33 . . . . 74.13 111.129 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -130.81 162.48 29.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.447 . . . . 72.2 111.073 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 221' ' ' ALA . . . . . 0.672 ' HB2' ' HA ' ' A' ' 245' ' ' ALA . . . -60.92 140.45 57.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 72.12 111.12 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 142.34 171.25 13.06 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.79 -0.719 . . . . 74.35 112.528 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 223' ' ' LYS . . . . . 0.558 ' HG3' HG23 ' A' ' 242' ' ' THR . 5.5 mttp -103.74 121.85 43.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.85 0.357 . . . . 54.53 110.864 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.475 HG11 ' CB ' ' A' ' 205' ' ' ALA . 7.2 p -120.36 126.04 74.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 75.51 111.179 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 225' ' ' ASN . . . . . 0.619 ' C ' HD12 ' A' ' 226' ' ' ILE . 35.3 m120 -90.8 153.33 20.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 72.02 110.871 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.619 HD12 ' C ' ' A' ' 225' ' ' ASN . 4.1 mp -137.21 93.08 13.33 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.608 0.718 . . . . 74.34 111.132 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 227' ' ' PRO . . . . . 0.459 ' HD3' ' HB2' ' A' ' 200' ' ' ALA . 54.1 Cg_endo -69.73 -178.37 2.3 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.66 2.24 . . . . 71.53 112.37 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.63 ' CG2' ' HB3' ' A' ' 237' ' ' ALA . 47.0 t -147.37 139.62 18.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 72.14 111.111 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 99.8 t -120.53 135.19 61.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 74.32 111.152 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -121.46 122.51 39.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 74.44 110.878 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 56.14 -119.87 16.69 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.757 -0.735 . . . . 72.25 112.485 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -92.36 14.09 17.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.818 0.342 . . . . 70.1 110.878 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 108.17 8.6 29.1 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.705 -0.759 . . . . 52.45 112.471 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -51.97 -65.76 0.5 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.887 0.375 . . . . 74.42 110.939 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -100.54 158.98 15.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 74.12 110.904 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -157.73 160.52 37.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.165 -0.471 . . . . 64.13 111.108 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 237' ' ' ALA . . . . . 0.63 ' HB3' ' CG2' ' A' ' 228' ' ' VAL . . . -136.97 163.61 30.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 71.5 111.102 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 57.7 t -137.34 130.39 43.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 63.14 111.17 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 239' ' ' ALA . . . . . 0.517 ' HB2' ' HG3' ' A' ' 168' ' ' PRO . . . -137.54 163.33 31.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 73.11 111.09 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 240' ' ' GLU . . . . . 0.464 ' O ' HD13 ' A' ' 241' ' ' ILE . 5.6 pt-20 -147.35 130.37 16.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.203 -0.453 . . . . 72.45 110.903 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 241' ' ' ILE . . . . . 0.574 HG13 HG11 ' A' ' 216' ' ' VAL . 26.5 mm -124.4 112.18 31.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.13 -0.486 . . . . 64.21 111.106 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 242' ' ' THR . . . . . 0.558 HG23 ' HG3' ' A' ' 223' ' ' LYS . 1.9 m -80.66 141.51 34.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.164 -0.471 . . . . 75.3 111.151 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 15.9 t -119.98 121.84 66.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 64.3 111.134 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 244' ' ' THR . . . . . 0.469 HG23 ' O ' ' A' ' 173' ' ' VAL . 6.8 p -83.04 132.95 35.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 34.4 111.154 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 245' ' ' ALA . . . . . 0.672 ' HA ' ' HB2' ' A' ' 221' ' ' ALA . . . -57.11 -23.82 49.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.23 -0.441 . . . . 73.51 111.089 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 4.4 t . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.26 -0.427 . . . . 60.2 110.837 -179.79 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.824 0.345 . . . . 62.21 111.161 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -125.56 33.74 5.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.276 -0.42 . . . . 52.03 111.176 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 134.66 99.63 0.63 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.724 -0.75 . . . . 74.03 112.481 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 11.6 ttp -114.76 133.08 56.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.861 0.363 . . . . 70.24 110.918 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 28.2 p -122.26 110.88 16.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 72.13 111.124 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 1.13 HG22 HG13 ' A' ' 183' ' ' VAL . 21.5 t -100.88 134.99 39.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 60.14 111.156 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.3 m -124.98 91.77 48.78 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.56 0.695 . . . . 74.35 111.136 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.476 ' HB3' HD23 ' A' ' 181' ' ' LEU . 53.9 Cg_endo -69.73 -165.16 0.14 Allowed 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.696 2.264 . . . . 73.45 112.336 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -91.14 -38.13 12.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.452 . . . . 65.33 111.079 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 90.5 p 46.85 77.31 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 55.45 110.88 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.2 t -174.32 -174.34 0.86 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.101 -0.499 . . . . 63.44 111.12 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 90.4 p -100.33 161.75 13.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 73.12 110.866 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.755 HG22 ' HB2' ' A' ' 177' ' ' GLN . 2.9 p -142.39 153.05 17.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.131 -0.486 . . . . 73.31 111.103 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 32.3 t -85.53 145.08 8.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 74.41 111.142 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.72 122.17 6.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.47 . . . . 73.04 110.897 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.12 -10.92 62.01 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.753 -0.737 . . . . 74.43 112.49 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' GLN . . . . . 0.755 ' HB2' HG22 ' A' ' 173' ' ' VAL . 20.3 mm100 -91.83 -177.31 4.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.836 0.35 . . . . 74.12 110.911 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.52 152.36 19.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 73.02 110.89 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 13.2 t -115.66 179.13 4.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.454 . . . . 74.31 111.124 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.05 126.16 27.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 51.14 111.131 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.476 HD23 ' HB3' ' A' ' 168' ' ' PRO . 7.4 mp -100.28 142.77 31.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 71.23 110.916 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 14.1 m -108.74 143.81 37.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 65.53 111.196 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 1.13 HG13 HG22 ' A' ' 166' ' ' VAL . 21.0 t -129.65 141.22 47.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 63.44 111.071 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -130.04 149.55 51.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 72.23 111.119 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -139.79 130.6 26.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 73.1 110.863 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -130.73 67.0 80.03 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.564 0.697 . . . . 71.42 110.864 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--N 1.341 0.177 0 C-N-CA 122.696 2.264 . . . . 72.03 112.332 179.966 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 7.9 t70 . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.853 0.359 . . . . 74.31 110.876 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 11.7 mtpt -61.4 95.91 0.05 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 75.03 110.875 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.35 -6.99 17.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.216 -0.447 . . . . 32.32 110.828 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.769 ' CE2' HG11 ' A' ' 183' ' ' VAL . 21.8 p90 -91.04 178.46 6.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 72.34 110.882 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.9 171.47 12.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.121 -0.491 . . . . 72.33 110.854 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 197' ' ' ALA . . . . . 0.64 ' HB3' ' HB ' ' A' ' 209' ' ' VAL . . . -122.89 163.42 20.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 72.32 111.106 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.533 ' O ' HG23 ' A' ' 226' ' ' ILE . 5.8 m -153.1 -178.27 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 64.21 111.127 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.65 114.88 24.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 72.14 110.884 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.435 ' HB2' ' HD3' ' A' ' 227' ' ' PRO . . . -59.79 -20.86 59.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 71.23 111.083 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -162.24 96.73 0.99 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 54.15 110.85 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -87.95 47.85 1.56 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.485 . . . . 70.22 110.902 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 12.4 p -125.59 -4.35 7.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 74.1 111.09 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 9.0 mtmm -149.82 16.08 0.86 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.436 . . . . 73.54 110.902 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.628 ' HA ' HG23 ' A' ' 219' ' ' VAL . . . -179.67 151.24 0.44 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.448 . . . . 73.54 111.078 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 7.2 p -112.29 152.59 28.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.215 -0.448 . . . . 75.33 111.157 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.786 HG12 HG22 ' A' ' 216' ' ' VAL . 12.9 m -141.02 137.72 34.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.265 -0.425 . . . . 74.5 111.114 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.54 109.35 4.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 75.34 110.879 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.64 ' HB ' ' HB3' ' A' ' 197' ' ' ALA . 3.5 p -87.93 134.7 27.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 72.05 111.157 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 2.9 m -161.53 124.08 3.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 63.1 110.83 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 55.34 47.74 73.6 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.74 -0.743 . . . . 71.11 112.48 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 3.4 mtp 63.24 16.1 9.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.851 0.358 . . . . 74.13 110.85 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 15.9 m -126.93 110.64 13.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 75.42 111.167 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.545 HG13 HG23 ' A' ' 209' ' ' VAL . 3.1 mp -105.7 117.35 51.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 64.5 111.126 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.26 127.02 36.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 74.33 111.107 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.786 HG22 HG12 ' A' ' 207' ' ' VAL . 2.8 t -113.0 131.53 64.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 74.11 111.107 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -117.25 136.62 52.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 72.33 110.905 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -94.15 79.22 0.97 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.777 -0.725 . . . . 22.13 112.46 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.628 HG23 ' HA ' ' A' ' 205' ' ' ALA . 18.5 t -50.98 -52.25 18.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.871 0.367 . . . . 71.04 111.144 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -131.97 161.42 33.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 64.23 111.116 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 221' ' ' ALA . . . . . 0.68 ' HB2' ' HA ' ' A' ' 245' ' ' ALA . . . -59.96 139.12 57.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 64.34 111.122 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 142.44 170.45 12.7 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.746 -0.74 . . . . 74.23 112.522 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 223' ' ' LYS . . . . . 0.478 ' HG3' HG23 ' A' ' 242' ' ' THR . 13.4 mttt -99.36 123.5 43.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.819 0.343 . . . . 75.12 110.852 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 6.7 p -118.96 124.72 73.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 63.13 111.093 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 225' ' ' ASN . . . . . 0.612 ' C ' HD12 ' A' ' 226' ' ' ILE . 16.8 m120 -90.78 152.83 20.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.152 -0.476 . . . . 73.02 110.87 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.612 HD12 ' C ' ' A' ' 225' ' ' ASN . 4.3 mp -137.77 93.17 12.41 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.594 0.712 . . . . 72.32 111.136 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 227' ' ' PRO . . . . . 0.465 ' HG2' HG23 ' A' ' 198' ' ' VAL . 53.3 Cg_endo -69.81 179.74 3.51 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.676 2.251 . . . . 64.13 112.336 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.428 ' HB ' ' HB3' ' A' ' 237' ' ' ALA . 90.3 t -150.23 136.31 11.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 60.15 111.128 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 91.3 t -117.67 134.71 60.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 71.24 111.167 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -120.94 127.57 51.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 73.43 110.893 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 58.85 -117.81 12.05 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.723 -0.751 . . . . 54.13 112.496 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -108.62 21.04 17.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.878 0.37 . . . . 71.44 110.862 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 113.4 3.69 23.97 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.759 -0.734 . . . . 61.02 112.485 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -54.12 -64.39 0.84 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.907 0.384 . . . . 74.12 110.881 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -111.42 156.74 21.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 75.32 110.831 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -156.57 164.54 38.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.095 -0.502 . . . . 65.04 111.131 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 237' ' ' ALA . . . . . 0.428 ' HB3' ' HB ' ' A' ' 228' ' ' VAL . . . -143.2 163.29 33.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.269 -0.423 . . . . 54.22 111.113 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 13.5 p -140.49 138.72 36.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 64.14 111.154 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 239' ' ' ALA . . . . . 0.428 ' HB2' ' HG3' ' A' ' 168' ' ' PRO . . . -136.95 165.33 26.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 74.21 111.09 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 240' ' ' GLU . . . . . 0.496 ' O ' HD13 ' A' ' 241' ' ' ILE . 3.3 pt-20 -141.88 131.17 23.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.23 -0.441 . . . . 71.14 110.876 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 241' ' ' ILE . . . . . 0.573 HG13 HG11 ' A' ' 216' ' ' VAL . 25.9 mm -127.32 110.63 23.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.123 -0.49 . . . . 64.4 111.147 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 242' ' ' THR . . . . . 0.478 HG23 ' HG3' ' A' ' 223' ' ' LYS . 1.8 m -80.13 141.33 35.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.206 -0.452 . . . . 65.32 111.158 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 17.1 t -119.91 121.92 67.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 74.32 111.124 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 244' ' ' THR . . . . . 0.466 HG23 ' O ' ' A' ' 173' ' ' VAL . 7.3 p -83.36 132.86 34.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 73.35 111.136 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 245' ' ' ALA . . . . . 0.68 ' HA ' ' HB2' ' A' ' 221' ' ' ALA . . . -57.46 -24.46 55.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 61.53 111.106 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 5.2 m . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 44.15 110.836 -179.837 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.437 ' HB1' ' HB3' ' A' ' 187' ' ' PRO . . . . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.885 0.374 . . . . 53.34 111.077 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -131.91 18.53 4.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.184 -0.462 . . . . 53.05 111.074 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 166.8 97.91 0.12 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.746 -0.74 . . . . 51.54 112.466 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 41.7 ttp -111.98 129.96 56.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.815 0.341 . . . . 54.12 110.886 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.592 ' OG1' ' HB3' ' A' ' 184' ' ' ALA . 46.6 p -118.82 103.03 9.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.249 -0.432 . . . . 73.4 111.141 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 1.084 HG22 HG13 ' A' ' 183' ' ' VAL . 22.8 t -97.82 132.72 42.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.208 -0.451 . . . . 74.23 111.107 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.2 m -125.11 92.9 46.58 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 121.598 0.713 . . . . 54.41 111.119 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.474 ' HB3' HD23 ' A' ' 181' ' ' LEU . 54.1 Cg_endo -69.72 -168.62 0.28 Allowed 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.685 2.257 . . . . 71.51 112.377 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -86.99 -39.82 15.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 74.04 111.062 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 95.3 p 46.43 78.5 0.07 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 70.35 110.847 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.1 t -173.86 -174.79 0.98 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.088 -0.505 . . . . 74.41 111.141 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 27.3 p -99.34 163.56 12.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.445 . . . . 55.31 110.875 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.723 HG22 ' HB2' ' A' ' 177' ' ' GLN . 3.1 p -146.38 154.32 12.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.115 -0.493 . . . . 73.53 111.135 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 57.6 t -88.39 145.43 7.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.48 . . . . 71.22 111.153 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -48.93 122.67 6.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 32.0 110.887 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.72 -14.2 60.55 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.733 -0.746 . . . . 44.13 112.463 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' GLN . . . . . 0.723 ' HB2' HG22 ' A' ' 173' ' ' VAL . 12.2 mm100 -91.16 -177.88 5.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.836 0.35 . . . . 71.11 110.93 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 20.4 p -161.43 149.51 15.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 73.22 110.829 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 7.5 t -108.52 -173.87 2.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.113 -0.494 . . . . 64.31 111.188 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.01 131.23 26.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.45 . . . . 65.53 111.195 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.474 HD23 ' HB3' ' A' ' 168' ' ' PRO . 7.5 mp -104.87 144.25 32.04 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.244 -0.435 . . . . 72.23 110.946 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 31.3 m -111.46 144.92 39.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 73.23 111.15 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 1.084 HG13 HG22 ' A' ' 166' ' ' VAL . 21.3 t -129.32 140.07 50.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 73.41 111.112 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.592 ' HB3' ' OG1' ' A' ' 165' ' ' THR . . . -129.6 154.95 46.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.466 . . . . 73.44 111.048 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -145.28 133.8 22.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 74.12 110.879 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.83 66.33 26.28 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.596 0.712 . . . . 74.4 110.907 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.437 ' HB3' ' HB1' ' A' ' 161' ' ' ALA . 53.7 Cg_endo . . . . . 0 C--N 1.341 0.172 0 C-N-CA 122.679 2.253 . . . . 65.52 112.388 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.886 0.374 . . . . 75.25 110.854 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 1.9 ttpp -79.62 61.67 3.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 53.31 110.866 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 1.7 t -73.08 -7.93 53.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 61.12 110.843 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.777 ' CE2' HG11 ' A' ' 183' ' ' VAL . 14.4 p90 -91.49 163.43 14.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 75.54 110.922 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.27 172.21 18.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.471 . . . . 73.42 110.867 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 197' ' ' ALA . . . . . 0.431 ' HB3' ' HB ' ' A' ' 209' ' ' VAL . . . -117.18 168.11 10.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 61.44 111.088 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 10.6 p -173.12 152.04 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.443 . . . . 75.05 111.126 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.3 t -78.27 151.51 32.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 74.2 110.849 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.607 ' HB2' ' HD3' ' A' ' 227' ' ' PRO . . . -88.43 -23.89 23.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 63.12 111.146 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.77 -53.51 1.23 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 75.23 110.841 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.28 28.48 15.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 65.44 110.919 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 71.9 p -114.65 -3.17 12.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 75.42 111.134 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 7.6 mtmt -152.05 18.52 0.67 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 60.12 110.888 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.667 ' HA ' HG23 ' A' ' 219' ' ' VAL . . . -177.11 146.84 0.52 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 60.45 111.052 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 18.8 p -106.93 157.47 17.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 73.54 111.158 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.784 HG12 HG22 ' A' ' 216' ' ' VAL . 9.8 m -140.9 141.08 32.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.184 -0.462 . . . . 54.53 111.108 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -148.6 108.81 4.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 45.34 110.881 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.544 HG23 HG13 ' A' ' 214' ' ' ILE . 3.8 p -87.36 143.42 11.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.491 . . . . 64.01 111.158 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -171.83 123.27 0.52 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 74.14 110.855 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 55.76 47.4 78.68 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.773 -0.727 . . . . 51.34 112.471 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 1.7 mtp 63.5 15.83 9.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.867 0.365 . . . . 70.14 110.869 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 1.1 m -126.51 113.72 17.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.434 . . . . 72.23 111.178 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.544 HG13 HG23 ' A' ' 209' ' ' VAL . 3.2 mp -110.16 115.48 49.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.241 -0.436 . . . . 61.31 111.145 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 3.8 m -88.3 131.05 34.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.459 . . . . 55.44 111.116 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.784 HG22 HG12 ' A' ' 207' ' ' VAL . 2.8 t -116.88 124.56 73.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 73.44 111.136 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -107.9 137.92 45.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 64.31 110.922 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -93.22 80.74 1.06 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.767 -0.73 . . . . 74.22 112.445 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.667 HG23 ' HA ' ' A' ' 205' ' ' ALA . 19.7 t -50.49 -54.83 7.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.882 0.372 . . . . 70.44 111.116 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -130.01 162.88 27.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 71.3 111.09 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 221' ' ' ALA . . . . . 0.68 ' HB2' ' HA ' ' A' ' 245' ' ' ALA . . . -62.09 140.19 58.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 62.42 111.068 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 140.1 171.2 12.28 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.676 -0.773 . . . . 73.15 112.473 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 223' ' ' LYS . . . . . 0.424 ' HG3' HG23 ' A' ' 242' ' ' THR . 14.0 mttt -99.5 124.24 44.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.826 0.346 . . . . 64.5 110.871 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.529 HG11 ' CB ' ' A' ' 205' ' ' ALA . 7.0 p -121.02 127.08 75.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 71.55 111.149 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 225' ' ' ASN . . . . . 0.637 ' C ' HD12 ' A' ' 226' ' ' ILE . 33.2 m120 -90.88 151.72 21.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 75.1 110.851 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.637 HD12 ' C ' ' A' ' 225' ' ' ASN . 4.0 mp -136.52 93.27 14.46 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.618 0.723 . . . . 73.55 111.156 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 227' ' ' PRO . . . . . 0.607 ' HD3' ' HB2' ' A' ' 200' ' ' ALA . 54.2 Cg_endo -69.75 179.89 3.38 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.689 2.259 . . . . 73.35 112.325 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.422 ' HB ' ' HB3' ' A' ' 237' ' ' ALA . 97.2 t -150.31 141.41 16.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 72.44 111.201 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 46.5 t -124.51 138.31 54.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 73.22 111.144 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 1.7 t -122.18 108.76 13.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 61.22 110.88 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 69.27 -119.35 9.37 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.732 -0.747 . . . . 75.4 112.505 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -104.56 21.14 17.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.807 0.336 . . . . 73.54 110.866 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 112.35 5.63 24.49 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.741 -0.742 . . . . 22.05 112.521 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -51.28 -44.03 61.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.867 0.365 . . . . 74.42 110.863 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -138.56 167.04 22.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 72.33 110.886 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -163.53 164.72 24.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 72.23 111.122 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 237' ' ' ALA . . . . . 0.422 ' HB3' ' HB ' ' A' ' 228' ' ' VAL . . . -143.84 163.18 34.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.436 . . . . 71.05 111.145 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 10.5 p -137.94 136.69 45.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 75.02 111.115 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 239' ' ' ALA . . . . . 0.427 ' HB2' ' HG3' ' A' ' 168' ' ' PRO . . . -139.16 165.17 27.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 63.45 111.102 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 240' ' ' GLU . . . . . 0.526 ' O ' HD13 ' A' ' 241' ' ' ILE . 4.3 pt-20 -143.87 132.13 21.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 73.42 110.898 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 241' ' ' ILE . . . . . 0.586 HG13 HG11 ' A' ' 216' ' ' VAL . 24.7 mm -127.2 113.93 34.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.205 -0.452 . . . . 74.21 111.145 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 242' ' ' THR . . . . . 0.424 HG23 ' HG3' ' A' ' 223' ' ' LYS . 2.8 m -82.81 141.23 32.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 54.45 111.146 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 17.0 t -120.06 120.95 64.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 75.23 111.173 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 244' ' ' THR . . . . . 0.516 HG23 ' O ' ' A' ' 173' ' ' VAL . 5.4 p -82.33 132.79 35.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 63.51 111.118 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 245' ' ' ALA . . . . . 0.68 ' HA ' ' HB2' ' A' ' 221' ' ' ALA . . . -57.41 -23.42 49.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 70.15 111.095 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 2.1 t . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 73.22 110.859 -179.769 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.175 0 CA-C-O 120.896 0.379 . . . . 74.14 111.082 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -131.68 27.09 4.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.236 -0.438 . . . . 72.53 111.106 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 145.92 101.93 0.32 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.778 -0.725 . . . . 62.23 112.484 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 42.9 ttp -114.49 126.16 54.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.863 0.364 . . . . 73.2 110.829 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.574 ' OG1' ' HB3' ' A' ' 184' ' ' ALA . 43.4 p -115.65 105.69 13.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 74.41 111.154 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 1.033 HG22 HG13 ' A' ' 183' ' ' VAL . 21.5 t -101.52 130.76 50.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 64.52 111.102 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.3 m -123.82 92.42 48.54 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.549 0.69 . . . . 73.23 111.121 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.48 ' HB3' HD23 ' A' ' 181' ' ' LEU . 53.9 Cg_endo -69.78 -167.2 0.21 Allowed 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.66 2.24 . . . . 75.03 112.361 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -90.2 -40.85 11.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 62.55 111.126 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 93.0 p 46.74 79.6 0.06 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 74.03 110.839 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.5 t -175.33 -175.63 0.84 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 65.21 111.137 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 41.7 p -98.75 163.63 12.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 64.44 110.831 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.732 HG22 ' HB2' ' A' ' 177' ' ' GLN . 3.0 p -145.6 153.57 13.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.124 -0.489 . . . . 61.44 111.107 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 99.1 t -87.24 144.71 8.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 64.54 111.134 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -47.95 122.57 5.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.216 -0.447 . . . . 75.31 110.891 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.75 -13.5 60.86 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.759 -0.734 . . . . 74.52 112.473 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' GLN . . . . . 0.732 ' HB2' HG22 ' A' ' 173' ' ' VAL . 11.0 mm100 -93.38 -179.58 5.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.776 0.322 . . . . 63.4 110.913 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 57.4 p -162.09 148.09 13.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 70.05 110.849 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.416 HG21 HD12 ' A' ' 241' ' ' ILE . 6.9 t -105.26 -173.72 2.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.136 -0.484 . . . . 74.33 111.158 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -140.11 130.53 25.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 54.51 111.165 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.48 HD23 ' HB3' ' A' ' 168' ' ' PRO . 7.6 mp -103.53 142.39 34.36 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.245 -0.434 . . . . 74.54 110.93 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 10.9 m -109.46 142.72 40.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.262 -0.426 . . . . 65.51 111.166 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 1.033 HG13 HG22 ' A' ' 166' ' ' VAL . 21.9 t -129.45 141.53 46.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.231 -0.44 . . . . 65.54 111.154 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.574 ' HB3' ' OG1' ' A' ' 165' ' ' THR . . . -132.28 151.86 51.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.463 . . . . 60.42 111.132 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -145.33 126.73 14.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.275 -0.42 . . . . 72.12 110.882 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.97 66.69 79.65 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.57 0.7 . . . . 71.15 110.889 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--N 1.341 0.138 0 C-N-CA 122.668 2.245 . . . . 54.15 112.328 -179.993 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.903 0.382 . . . . 54.03 110.838 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -65.63 90.08 0.11 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 70.11 110.897 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 47.3 t -105.4 -6.66 19.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.254 -0.43 . . . . 70.54 110.848 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.772 ' CE2' HG11 ' A' ' 183' ' ' VAL . 17.1 p90 -90.82 177.68 6.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 61.22 110.878 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.44 175.29 9.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 75.43 110.908 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 197' ' ' ALA . . . . . 0.408 ' HB3' ' HB ' ' A' ' 209' ' ' VAL . . . -122.57 168.08 12.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 73.11 111.102 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 8.7 p -173.61 153.61 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.214 -0.448 . . . . 54.03 111.121 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.66 133.42 33.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 73.44 110.908 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.664 ' HB2' ' HD3' ' A' ' 227' ' ' PRO . . . -69.26 -21.11 63.92 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.154 -0.476 . . . . 74.15 111.074 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 201' ' ' ASP . . . . . 0.607 ' O ' HG23 ' A' ' 203' ' ' THR . 0.6 OUTLIER -132.61 -46.15 0.89 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 71.13 110.858 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.11 27.45 7.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 74.23 110.93 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.607 HG23 ' O ' ' A' ' 201' ' ' ASP . 53.3 p -112.13 -13.66 13.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 73.51 111.155 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 204' ' ' LYS . . . . . 0.489 ' HA ' ' HB3' ' A' ' 220' ' ' ALA . 9.1 mtmp? -139.26 24.88 2.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 72.44 110.87 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.675 ' HA ' HG22 ' A' ' 219' ' ' VAL . . . 179.06 143.3 0.13 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 73.32 111.137 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 7.8 p -106.99 131.23 54.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.231 -0.441 . . . . 63.25 111.121 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.947 HG12 HG22 ' A' ' 216' ' ' VAL . 5.0 m -118.34 143.33 29.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 63.3 111.153 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 3.3 m -149.3 108.7 3.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.466 . . . . 50.35 110.854 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.511 HG23 HG13 ' A' ' 214' ' ' ILE . 4.1 p -83.82 143.97 10.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 62.24 111.144 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 5.3 t -171.75 122.58 0.51 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 60.21 110.878 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 54.19 50.41 55.89 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.732 -0.747 . . . . 73.55 112.464 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 1.8 mtp 61.05 17.41 7.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.834 0.35 . . . . 70.53 110.831 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 12.7 m -129.44 113.1 14.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.253 -0.43 . . . . 70.34 111.139 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.511 HG13 HG23 ' A' ' 209' ' ' VAL . 2.9 mp -108.92 114.92 48.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 73.02 111.102 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 10.2 m -88.0 128.09 35.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 71.21 111.141 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.947 HG22 HG12 ' A' ' 207' ' ' VAL . 2.8 t -114.46 121.93 67.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.46 . . . . 63.2 111.109 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -106.0 144.43 32.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 73.02 110.861 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -96.64 66.26 0.99 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.693 -0.765 . . . . 70.52 112.478 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.675 HG22 ' HA ' ' A' ' 205' ' ' ALA . 0.1 OUTLIER -50.13 -42.08 19.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.863 0.363 . . . . 71.15 111.142 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 220' ' ' ALA . . . . . 0.489 ' HB3' ' HA ' ' A' ' 204' ' ' LYS . . . -125.2 154.04 42.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.454 . . . . 54.32 111.106 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 221' ' ' ALA . . . . . 0.666 ' HB2' ' HA ' ' A' ' 245' ' ' ALA . . . -73.47 131.89 42.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.232 -0.44 . . . . 54.2 111.085 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 143.93 177.31 18.72 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.722 -0.752 . . . . 44.24 112.494 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 223' ' ' LYS . . . . . 0.53 ' HG3' HG23 ' A' ' 242' ' ' THR . 12.6 mttt -98.89 136.26 39.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.84 0.352 . . . . 65.34 110.885 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.589 HG11 ' HB3' ' A' ' 205' ' ' ALA . 7.6 p -137.58 133.61 45.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.223 -0.444 . . . . 74.35 111.125 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 225' ' ' ASN . . . . . 0.625 ' C ' HD12 ' A' ' 226' ' ' ILE . 36.7 m120 -90.94 154.05 19.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 71.41 110.885 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.625 HD12 ' C ' ' A' ' 225' ' ' ASN . 4.1 mp -136.83 92.54 14.44 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.58 0.705 . . . . 73.51 111.162 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 227' ' ' PRO . . . . . 0.664 ' HD3' ' HB2' ' A' ' 200' ' ' ALA . 53.6 Cg_endo -69.79 179.05 3.99 Favored 'Trans proline' 0 C--O 1.231 0.141 0 C-N-CA 122.671 2.248 . . . . 73.54 112.353 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 57.9 t -149.26 137.19 14.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.252 -0.431 . . . . 62.32 111.165 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 98.6 t -117.55 138.65 47.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 73.44 111.124 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -121.66 106.96 11.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 63.42 110.87 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 56.93 -115.04 5.95 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.722 -0.751 . . . . 60.42 112.486 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -94.56 21.08 7.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.848 0.356 . . . . 74.42 110.853 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 97.49 9.19 55.44 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.756 -0.735 . . . . 63.1 112.485 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -51.94 -30.52 24.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.896 0.379 . . . . 64.04 110.871 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -145.59 163.41 34.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.153 -0.476 . . . . 72.22 110.907 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -161.71 165.26 28.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 73.22 111.078 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -143.86 163.24 33.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 75.51 111.13 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 59.2 t -136.52 132.84 48.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.264 -0.425 . . . . 64.31 111.114 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 239' ' ' ALA . . . . . 0.44 ' HB2' ' HG3' ' A' ' 168' ' ' PRO . . . -138.71 165.39 27.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 40.33 111.074 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 240' ' ' GLU . . . . . 0.472 ' O ' HD13 ' A' ' 241' ' ' ILE . 2.9 pt-20 -144.52 131.76 20.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 71.24 110.856 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 241' ' ' ILE . . . . . 0.628 HG13 HG11 ' A' ' 216' ' ' VAL . 34.8 mm -127.25 114.95 38.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.123 -0.49 . . . . 71.3 111.123 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 242' ' ' THR . . . . . 0.53 HG23 ' HG3' ' A' ' 223' ' ' LYS . 3.0 m -86.42 140.7 29.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.13 -0.487 . . . . 73.51 111.157 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 19.8 t -120.5 120.04 61.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 73.51 111.145 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 244' ' ' THR . . . . . 0.495 HG23 ' O ' ' A' ' 173' ' ' VAL . 6.4 p -81.56 132.96 35.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 61.21 111.203 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 245' ' ' ALA . . . . . 0.666 ' HA ' ' HB2' ' A' ' 221' ' ' ALA . . . -57.46 -26.67 61.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.281 -0.418 . . . . 74.54 111.138 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 15.1 m . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 73.43 110.893 -179.814 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.888 0.375 . . . . 72.02 111.096 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -130.08 27.2 5.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 73.44 111.148 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 146.66 100.68 0.27 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.727 -0.749 . . . . 41.52 112.446 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 45.9 ttp -111.32 130.54 55.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.807 0.337 . . . . 54.32 110.919 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.612 ' OG1' ' HB3' ' A' ' 184' ' ' ALA . 50.1 p -119.65 102.4 8.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.251 -0.431 . . . . 70.05 111.131 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 1.022 HG22 HG13 ' A' ' 183' ' ' VAL . 21.1 t -97.82 133.14 40.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 74.42 111.119 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.1 m -126.11 92.22 46.28 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.57 0.7 . . . . 43.32 111.173 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.478 ' HB3' HD23 ' A' ' 181' ' ' LEU . 53.1 Cg_endo -69.8 -166.14 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.698 2.265 . . . . 52.53 112.335 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -89.03 -42.64 11.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 44.15 111.117 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 22.9 t 49.29 79.14 0.08 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.241 -0.436 . . . . 73.3 110.899 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.5 t -175.44 -175.54 0.81 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 71.33 111.146 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 38.1 p -98.8 163.88 12.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 62.43 110.849 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.778 HG22 ' HB2' ' A' ' 177' ' ' GLN . 2.6 p -145.81 152.56 14.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 62.01 111.158 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 38.8 t -85.76 145.28 8.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 71.2 111.12 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.24 122.09 5.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 72.42 110.881 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.18 -11.18 61.95 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.745 -0.741 . . . . 74.31 112.448 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' GLN . . . . . 0.778 ' HB2' HG22 ' A' ' 173' ' ' VAL . 20.9 mm100 -91.37 -177.21 4.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.826 0.346 . . . . 72.45 110.883 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -160.56 149.31 16.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 51.34 110.858 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 7.7 t -111.3 -177.27 3.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.124 -0.489 . . . . 61.22 111.12 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -138.07 133.62 33.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.211 -0.45 . . . . 53.32 111.176 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.478 HD23 ' HB3' ' A' ' 168' ' ' PRO . 7.8 mp -107.7 146.4 32.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.233 -0.44 . . . . 74.1 110.918 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 2.1 m -113.94 143.53 44.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.459 . . . . 61.02 111.119 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 1.022 HG13 HG22 ' A' ' 166' ' ' VAL . 21.3 t -129.33 138.18 55.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 70.23 111.163 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.612 ' HB3' ' OG1' ' A' ' 165' ' ' THR . . . -126.22 151.38 47.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 74.33 111.087 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -144.9 131.76 20.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.221 -0.445 . . . . 70.54 110.907 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.9 66.38 47.53 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.605 0.717 . . . . 70.3 110.952 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo . . . . . 0 C--N 1.342 0.186 0 C-N-CA 122.653 2.235 . . . . 43.11 112.355 -179.991 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 37.5 t0 . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.881 0.372 . . . . 63.22 110.867 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.72 87.1 6.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 54.12 110.898 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 14.4 m -102.3 -5.43 24.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 72.45 110.88 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.79 ' CE2' HG11 ' A' ' 183' ' ' VAL . 29.0 p90 -89.78 172.89 8.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 70.25 110.854 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.82 171.44 16.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.104 -0.498 . . . . 75.21 110.848 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 197' ' ' ALA . . . . . 0.468 ' HB3' ' HB ' ' A' ' 209' ' ' VAL . . . -114.86 168.04 10.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 60.21 111.089 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 9.6 p -159.88 152.85 5.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.25 -0.432 . . . . 73.51 111.12 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.77 119.0 28.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 74.21 110.844 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.565 ' HB2' ' HD3' ' A' ' 227' ' ' PRO . . . -62.89 -18.62 63.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 71.23 111.108 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -163.49 89.55 0.61 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 73.44 110.858 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 9.1 tmtt? -82.63 55.45 2.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.446 . . . . 74.32 110.907 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 25.9 p -129.44 1.18 5.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 45.32 111.139 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 10.6 mtmt -157.38 19.48 0.29 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 75.52 110.895 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.635 ' HA ' HG23 ' A' ' 219' ' ' VAL . . . 179.65 148.45 0.27 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 72.51 111.112 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 9.4 p -105.68 153.94 21.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.194 -0.457 . . . . 73.23 111.125 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.744 HG12 HG22 ' A' ' 216' ' ' VAL . 18.9 m -140.77 135.14 33.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.448 . . . . 73.34 111.172 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 208' ' ' SER . . . . . 0.438 ' C ' HG23 ' A' ' 214' ' ' ILE . 4.6 m -144.32 109.31 5.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 33.24 110.8 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.675 HG23 HG13 ' A' ' 214' ' ' ILE . 5.5 p -92.47 144.44 9.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 75.31 111.168 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 2.7 m -146.56 99.42 3.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 73.52 110.859 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 70.17 -81.43 0.36 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.745 -0.74 . . . . 61.14 112.482 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -139.71 9.01 2.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.826 0.346 . . . . 62.33 110.844 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 56.9 m -128.52 124.42 35.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.242 -0.435 . . . . 41.13 111.141 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.675 HG13 HG23 ' A' ' 209' ' ' VAL . 2.5 mp -117.87 135.27 58.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 71.14 111.113 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.21 128.25 51.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.461 . . . . 52.32 111.108 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.744 HG22 HG12 ' A' ' 207' ' ' VAL . 6.8 t -118.05 131.39 70.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.227 -0.442 . . . . 72.55 111.137 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -116.45 139.22 50.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 62.2 110.905 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -94.88 78.95 0.88 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.734 -0.745 . . . . 74.05 112.492 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.635 HG23 ' HA ' ' A' ' 205' ' ' ALA . 17.2 t -49.56 -54.24 7.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.827 0.346 . . . . 75.33 111.149 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -129.6 162.92 27.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 65.22 111.105 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 221' ' ' ALA . . . . . 0.681 ' HB2' ' HA ' ' A' ' 245' ' ' ALA . . . -61.83 138.36 58.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.447 . . . . 72.05 111.09 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 144.25 170.33 13.57 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.74 -0.743 . . . . 50.51 112.488 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 223' ' ' LYS . . . . . 0.567 ' HG3' HG23 ' A' ' 242' ' ' THR . 13.3 mttt -100.19 124.0 45.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.793 0.33 . . . . 73.01 110.921 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.485 HG11 ' CB ' ' A' ' 205' ' ' ALA . 6.3 p -123.76 122.98 66.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 53.22 111.091 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 225' ' ' ASN . . . . . 0.559 ' C ' HD12 ' A' ' 226' ' ' ILE . 21.2 m120 -91.19 156.27 17.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.466 . . . . 61.12 110.923 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.559 HD12 ' C ' ' A' ' 225' ' ' ASN . 4.7 mp -138.63 92.86 11.27 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.554 0.692 . . . . 65.31 111.114 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 227' ' ' PRO . . . . . 0.565 ' HD3' ' HB2' ' A' ' 200' ' ' ALA . 53.4 Cg_endo -69.88 -178.93 2.62 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.672 2.248 . . . . 74.42 112.31 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.484 ' CG2' ' HB3' ' A' ' 237' ' ' ALA . 23.5 t -146.52 149.24 16.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.455 . . . . 65.15 111.146 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 86.9 t -138.17 138.38 43.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 74.32 111.082 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -121.98 119.97 33.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 65.15 110.848 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 58.08 -112.2 3.7 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.714 -0.755 . . . . 44.35 112.5 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -99.81 7.42 44.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.874 0.368 . . . . 72.53 110.892 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 114.46 16.09 7.83 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.691 -0.766 . . . . 73.43 112.495 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -51.13 -38.42 51.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.891 0.377 . . . . 64.01 110.863 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -143.07 167.04 23.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 64.14 110.911 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -162.23 165.32 26.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.113 -0.494 . . . . 74.43 111.1 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 237' ' ' ALA . . . . . 0.484 ' HB3' ' CG2' ' A' ' 228' ' ' VAL . . . -139.11 163.61 31.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.441 . . . . 64.54 111.135 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 61.2 t -132.46 127.2 56.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.233 -0.44 . . . . 63.34 111.095 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 239' ' ' ALA . . . . . 0.468 ' HB2' ' HG3' ' A' ' 168' ' ' PRO . . . -134.38 161.15 35.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.169 -0.469 . . . . 74.4 111.065 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 240' ' ' GLU . . . . . 0.604 ' O ' HD13 ' A' ' 241' ' ' ILE . 5.1 pt-20 -145.31 132.68 20.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 74.55 110.874 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 241' ' ' ILE . . . . . 0.604 HD13 ' O ' ' A' ' 240' ' ' GLU . 28.8 mm -126.95 112.85 30.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 72.3 111.129 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 242' ' ' THR . . . . . 0.567 HG23 ' HG3' ' A' ' 223' ' ' LYS . 1.9 m -83.06 141.49 32.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 74.11 111.179 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 14.0 t -119.92 121.6 66.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 73.24 111.156 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 244' ' ' THR . . . . . 0.408 HG23 ' O ' ' A' ' 173' ' ' VAL . 8.1 p -83.65 132.37 34.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.145 -0.479 . . . . 72.42 111.14 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 245' ' ' ALA . . . . . 0.681 ' HA ' ' HB2' ' A' ' 221' ' ' ALA . . . -53.72 -27.64 29.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 62.34 111.099 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 11.5 m . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 65.01 110.812 -179.726 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.442 ' HB1' ' HB3' ' A' ' 187' ' ' PRO . . . . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.855 0.36 . . . . 64.23 111.118 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 1.1 p -119.55 3.92 11.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 65.44 111.167 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 173.74 101.73 0.15 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.741 -0.742 . . . . 73.01 112.447 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 16.3 ttp -111.84 125.17 53.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.86 0.362 . . . . 34.31 110.88 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.619 ' OG1' ' HB3' ' A' ' 184' ' ' ALA . 59.2 p -113.98 103.07 10.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.446 . . . . 72.2 111.129 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.998 HG22 HG13 ' A' ' 183' ' ' VAL . 20.7 t -99.83 131.29 47.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.215 -0.448 . . . . 73.23 111.11 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.8 m -126.81 92.57 44.37 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.565 0.697 . . . . 74.43 111.12 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.483 ' HB3' HD23 ' A' ' 181' ' ' LEU . 53.6 Cg_endo -69.81 -167.7 0.24 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.686 2.257 . . . . 73.22 112.317 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -85.38 -41.66 15.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 75.42 111.121 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 88.7 p 46.46 75.08 0.13 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.461 . . . . 55.53 110.85 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.4 t -172.32 -175.08 1.33 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.107 -0.497 . . . . 74.42 111.165 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 86.6 p -98.9 164.08 12.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.262 -0.427 . . . . 72.32 110.844 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.728 HG22 ' HB2' ' A' ' 177' ' ' GLN . 3.0 p -147.39 153.77 11.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.114 -0.494 . . . . 62.42 111.116 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 64.3 t -87.87 145.44 7.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 71.44 111.132 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.98 122.75 6.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 70.12 110.864 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 100.08 -15.33 59.33 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.782 -0.723 . . . . 42.44 112.517 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' GLN . . . . . 0.728 ' HB2' HG22 ' A' ' 173' ' ' VAL . 11.6 mm100 -89.64 -177.97 5.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.807 0.337 . . . . 53.44 110.941 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 15.1 p -161.6 148.87 14.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 72.54 110.859 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.513 HG21 HD12 ' A' ' 241' ' ' ILE . 7.3 t -108.95 -173.86 2.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 61.02 111.133 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.41 131.87 26.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 74.22 111.13 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.483 HD23 ' HB3' ' A' ' 168' ' ' PRO . 7.6 mp -104.21 141.72 35.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 71.31 110.954 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.9 m -110.0 141.49 42.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.212 -0.449 . . . . 72.22 111.158 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.998 HG13 HG22 ' A' ' 166' ' ' VAL . 32.5 t -129.62 141.04 47.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.242 -0.435 . . . . 74.01 111.143 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.619 ' HB3' ' OG1' ' A' ' 165' ' ' THR . . . -131.53 151.46 51.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 72.22 111.114 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -143.72 129.81 19.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.249 -0.432 . . . . 73.51 110.862 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.54 66.91 58.76 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.616 0.722 . . . . 73.21 110.907 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.442 ' HB3' ' HB1' ' A' ' 161' ' ' ALA . 53.7 Cg_endo . . . . . 0 C--N 1.341 0.163 0 C-N-CA 122.684 2.256 . . . . 55.51 112.362 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.859 0.362 . . . . 52.14 110.897 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.67 104.09 0.98 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 72.12 110.919 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -117.38 -6.21 11.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 73.21 110.834 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.764 ' CE2' HG11 ' A' ' 183' ' ' VAL . 24.7 p90 -90.45 178.59 6.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 72.21 110.886 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.14 172.01 11.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 71.34 110.897 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -128.02 144.56 51.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 72.33 111.092 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 59.7 t -150.64 146.65 16.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 71.1 111.145 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 26.6 t -70.58 136.83 49.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.19 -0.459 . . . . 61.11 110.909 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.53 ' HB2' ' HD3' ' A' ' 227' ' ' PRO . . . -76.35 -8.41 57.06 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.149 -0.478 . . . . 63.03 111.092 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -142.85 -56.33 0.42 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.248 -0.433 . . . . 55.34 110.871 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 64.39 26.27 13.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.446 . . . . 74.2 110.91 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 80.6 p -114.24 -3.21 13.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 55.32 111.101 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 8.7 mtmm -149.19 16.4 0.93 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.274 -0.421 . . . . 72.24 110.859 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.708 ' HA ' HG23 ' A' ' 219' ' ' VAL . . . -177.69 146.78 0.46 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.259 -0.428 . . . . 62.33 111.139 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 15.9 p -104.81 153.37 21.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 65.14 111.136 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.924 HG12 HG22 ' A' ' 216' ' ' VAL . 35.5 m -136.88 140.96 41.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 75.04 111.115 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.98 108.3 4.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 74.14 110.865 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.53 HG23 HG13 ' A' ' 214' ' ' ILE . 3.7 p -87.95 143.46 11.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.064 -0.516 . . . . 73.11 111.139 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 3.8 t -172.13 123.14 0.49 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 53.3 110.851 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 55.71 47.8 75.73 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.773 -0.727 . . . . 64.13 112.452 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 3.8 mtp 63.19 16.27 9.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.833 0.349 . . . . 63.51 110.867 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 21.0 m -126.47 113.48 16.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.261 -0.427 . . . . 73.22 111.114 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.53 HG13 HG23 ' A' ' 209' ' ' VAL . 3.1 mp -110.46 115.54 50.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.463 . . . . 63.22 111.121 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 2.6 m -88.88 132.66 34.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.24 -0.436 . . . . 74.2 111.169 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.924 HG22 HG12 ' A' ' 207' ' ' VAL . 3.5 t -118.0 125.69 74.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.257 -0.429 . . . . 64.2 111.104 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -109.12 136.87 47.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.104 -0.498 . . . . 75.12 110.873 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -91.16 83.56 1.27 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.734 -0.746 . . . . 73.31 112.499 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.708 HG23 ' HA ' ' A' ' 205' ' ' ALA . 20.3 t -53.99 -52.52 35.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.857 0.36 . . . . 72.31 111.151 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -134.34 163.18 30.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 65.44 111.129 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 221' ' ' ALA . . . . . 0.474 ' HB2' ' HA ' ' A' ' 245' ' ' ALA . . . -56.64 144.84 30.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 75.31 111.107 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 222' ' ' GLY . . . . . 0.441 ' O ' HG23 ' A' ' 243' ' ' VAL . . . 129.92 166.29 11.81 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.791 -0.719 . . . . 71.24 112.535 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 223' ' ' LYS . . . . . 0.77 ' HG3' HG23 ' A' ' 242' ' ' THR . 2.6 mtmm -101.32 129.67 47.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.833 0.349 . . . . 70.31 110.907 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.548 HG11 ' HB3' ' A' ' 205' ' ' ALA . 7.4 p -118.58 129.68 74.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.263 -0.426 . . . . 72.21 111.149 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 225' ' ' ASN . . . . . 0.609 ' C ' HD12 ' A' ' 226' ' ' ILE . 35.2 m120 -89.71 147.4 23.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 70.22 110.889 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.609 HD12 ' C ' ' A' ' 225' ' ' ASN . 4.3 mp -137.75 93.35 12.33 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.633 0.73 . . . . 74.54 111.161 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 227' ' ' PRO . . . . . 0.53 ' HD3' ' HB2' ' A' ' 200' ' ' ALA . 53.5 Cg_endo -69.79 -176.9 1.65 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.729 2.286 . . . . 74.25 112.297 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.557 ' CG2' ' HB3' ' A' ' 237' ' ' ALA . 48.2 t -147.3 134.72 14.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 62.3 111.082 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 93.7 t -117.95 133.08 65.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.177 -0.465 . . . . 61.02 111.109 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.23 116.28 23.85 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.128 -0.487 . . . . 73.05 110.845 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 61.18 -121.13 25.44 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.743 -0.742 . . . . 72.15 112.469 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -95.78 15.43 20.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.871 0.367 . . . . 72.14 110.904 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 111.13 9.96 21.3 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.747 -0.739 . . . . 52.35 112.459 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -51.11 -65.08 0.62 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.906 0.384 . . . . 64.13 110.907 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -110.78 156.03 21.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 74.11 110.894 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -153.16 164.69 37.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 63.15 111.053 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 237' ' ' ALA . . . . . 0.557 ' HB3' ' CG2' ' A' ' 228' ' ' VAL . . . -144.86 163.88 32.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.456 . . . . 75.31 111.119 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 14.1 p -137.91 134.65 45.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 75.14 111.105 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 239' ' ' ALA . . . . . 0.452 ' HB2' ' HG3' ' A' ' 168' ' ' PRO . . . -139.31 164.37 30.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.119 -0.491 . . . . 65.35 111.116 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -147.56 131.14 16.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.249 -0.432 . . . . 63.31 110.879 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 241' ' ' ILE . . . . . 0.645 HG13 HG11 ' A' ' 216' ' ' VAL . 30.7 mm -122.83 115.0 44.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 71.42 111.064 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 242' ' ' THR . . . . . 0.77 HG23 ' HG3' ' A' ' 223' ' ' LYS . 0.6 OUTLIER -83.0 141.28 32.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.179 -0.464 . . . . 63.1 111.149 179.926 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 222' ' ' GLY . 19.5 t -120.39 120.32 62.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.225 -0.443 . . . . 64.43 111.161 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 244' ' ' THR . . . . . 0.518 HG23 ' O ' ' A' ' 173' ' ' VAL . 4.9 p -82.61 132.95 35.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 75.35 111.133 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 245' ' ' ALA . . . . . 0.474 ' HA ' ' HB2' ' A' ' 221' ' ' ALA . . . -58.71 -21.67 55.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.439 . . . . 33.35 111.086 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 4.5 m . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.443 . . . . 71.43 110.883 -179.807 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.889 0.376 . . . . 61.02 111.073 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -125.14 32.11 5.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 72.43 111.183 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 138.46 99.58 0.48 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.775 -0.726 . . . . 75.24 112.473 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 41.2 ttp -111.11 129.07 56.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.882 0.372 . . . . 64.22 110.841 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.546 ' OG1' ' HB3' ' A' ' 184' ' ' ALA . 40.4 p -118.0 105.86 12.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.194 -0.457 . . . . 71.21 111.13 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 1.086 HG22 HG13 ' A' ' 183' ' ' VAL . 21.5 t -99.87 133.64 42.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 74.32 111.167 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.3 m -126.2 92.49 45.56 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.593 0.711 . . . . 73.11 111.145 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.497 ' HG3' ' HB2' ' A' ' 239' ' ' ALA . 53.5 Cg_endo -69.77 -167.88 0.25 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.7 2.267 . . . . 65.42 112.338 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -87.15 -38.13 16.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 72.51 111.121 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 94.4 p 46.21 79.54 0.05 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 31.31 110.87 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.4 t -175.39 -174.6 0.74 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.17 -0.468 . . . . 74.33 111.164 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 33.0 p -101.06 162.0 13.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 72.22 110.875 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.738 HG22 ' HB2' ' A' ' 177' ' ' GLN . 2.6 p -144.83 154.25 14.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 74.45 111.133 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 93.2 t -89.91 144.9 8.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 75.1 111.137 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -47.75 124.11 6.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 70.11 110.922 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.69 -17.22 57.79 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.756 -0.735 . . . . 52.11 112.465 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' GLN . . . . . 0.738 ' HB2' HG22 ' A' ' 173' ' ' VAL . 10.7 mm100 -87.99 -177.77 5.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.768 0.318 . . . . 73.33 110.956 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 1.7 p -161.86 148.91 14.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.237 -0.438 . . . . 74.41 110.875 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 9.2 t -111.04 -174.86 2.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.14 -0.482 . . . . 72.44 111.112 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.21 132.46 29.89 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.174 -0.466 . . . . 72.22 111.139 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.473 HD23 ' HB3' ' A' ' 168' ' ' PRO . 7.6 mp -106.36 143.3 34.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 73.52 110.904 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 16.3 m -110.31 143.91 39.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.451 . . . . 33.42 111.129 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 1.086 HG13 HG22 ' A' ' 166' ' ' VAL . 22.9 t -129.69 142.36 44.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.214 -0.448 . . . . 51.44 111.143 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.546 ' HB3' ' OG1' ' A' ' 165' ' ' THR . . . -131.55 150.92 51.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 70.35 111.081 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -144.47 126.45 15.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 72.11 110.881 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.22 67.23 79.61 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.565 0.698 . . . . 65.42 110.892 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--N 1.341 0.174 0 C-N-CA 122.674 2.249 . . . . 72.14 112.387 179.962 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.886 0.374 . . . . 70.32 110.854 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 5.1 mtmt -54.39 101.45 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 74.4 110.918 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 23.0 t -115.22 -5.99 12.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 54.22 110.837 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.772 ' CE2' HG11 ' A' ' 183' ' ' VAL . 22.7 p90 -90.31 172.15 8.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.127 -0.488 . . . . 63.41 110.873 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.58 158.89 36.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 74.24 110.886 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 197' ' ' ALA . . . . . 0.606 ' HB3' ' HB ' ' A' ' 209' ' ' VAL . . . -112.83 165.97 11.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.445 . . . . 54.51 111.094 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 10.7 p -175.18 151.84 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 34.4 111.132 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.6 t -79.25 144.49 34.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 71.11 110.866 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.581 ' HB2' ' HD3' ' A' ' 227' ' ' PRO . . . -78.57 -22.6 46.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 75.52 111.073 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -127.63 -54.87 1.33 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 60.5 110.814 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 1.7 ttpm? 63.43 27.92 15.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.469 . . . . 71.2 110.885 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 44.8 p -115.76 -1.77 12.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.265 -0.425 . . . . 71.2 111.149 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 204' ' ' LYS . . . . . 0.526 ' CB ' ' HB3' ' A' ' 220' ' ' ALA . 11.2 mtmm -149.61 16.48 0.89 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 73.11 110.919 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -174.9 150.68 1.27 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 72.04 111.078 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 23.9 p -112.88 134.65 54.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 70.33 111.145 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.924 HG12 HG22 ' A' ' 216' ' ' VAL . 5.3 m -122.4 139.65 48.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.221 -0.445 . . . . 72.2 111.108 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -144.1 108.87 4.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 45.43 110.848 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.606 ' HB ' ' HB3' ' A' ' 197' ' ' ALA . 4.3 p -84.84 143.76 11.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 63.53 111.142 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 11.8 t -172.12 124.47 0.52 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 74.44 110.865 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 52.87 52.0 41.81 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.728 -0.749 . . . . 51.12 112.478 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 2.2 mtp 58.75 19.61 7.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.885 0.374 . . . . 74.21 110.914 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 1.6 m -131.56 113.21 13.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.229 -0.441 . . . . 73.44 111.164 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.569 HG13 HG23 ' A' ' 209' ' ' VAL . 3.1 mp -109.71 116.78 53.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 64.21 111.118 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 1.1 m -89.86 129.91 36.16 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.148 -0.478 . . . . 62.04 111.118 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.924 HG22 HG12 ' A' ' 207' ' ' VAL . 3.5 t -115.75 129.6 71.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 73.34 111.063 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -112.32 135.12 53.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.119 -0.491 . . . . 52.0 110.875 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -82.1 67.04 3.76 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.752 -0.737 . . . . 65.42 112.519 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.423 HG12 ' N ' ' A' ' 220' ' ' ALA . 1.4 t -48.4 -51.05 11.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.848 0.356 . . . . 65.4 111.153 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 220' ' ' ALA . . . . . 0.526 ' HB3' ' CB ' ' A' ' 204' ' ' LYS . . . -127.86 154.87 44.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 45.24 111.093 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 221' ' ' ALA . . . . . 0.655 ' HB2' ' HA ' ' A' ' 245' ' ' ALA . . . -66.63 136.36 55.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 73.42 111.078 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 139.21 171.91 12.41 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.726 -0.749 . . . . 54.01 112.487 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 223' ' ' LYS . . . . . 0.441 ' HG3' HG23 ' A' ' 242' ' ' THR . 8.3 mttm -96.02 125.19 40.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.806 0.336 . . . . 74.35 110.918 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 7.7 p -121.42 131.25 73.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.268 -0.423 . . . . 75.4 111.141 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 225' ' ' ASN . . . . . 0.615 ' C ' HD12 ' A' ' 226' ' ' ILE . 34.3 m120 -90.54 151.41 21.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 62.22 110.859 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.615 HD12 ' C ' ' A' ' 225' ' ' ASN . 4.3 mp -136.71 92.71 14.55 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.633 0.73 . . . . 64.34 111.136 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 227' ' ' PRO . . . . . 0.581 ' HD3' ' HB2' ' A' ' 200' ' ' ALA . 53.9 Cg_endo -69.82 179.92 3.39 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.664 2.243 . . . . 62.43 112.339 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 96.7 t -150.63 137.54 13.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 73.23 111.161 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 92.7 t -122.38 134.55 65.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 51.02 111.115 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -122.22 125.02 45.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.15 -0.477 . . . . 62.11 110.869 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 56.77 -117.74 10.21 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.74 -0.743 . . . . 70.12 112.468 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -94.44 8.46 42.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.865 0.364 . . . . 62.44 110.85 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 106.94 9.61 29.83 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.717 -0.754 . . . . 63.23 112.473 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -51.67 -40.66 60.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.886 0.374 . . . . 74.23 110.884 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -127.68 167.25 16.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.481 . . . . 53.21 110.873 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -166.26 165.34 17.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 70.01 111.081 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -139.33 163.19 33.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.222 -0.445 . . . . 73.45 111.103 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.0 p -135.32 127.71 47.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.441 . . . . 52.45 111.112 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 239' ' ' ALA . . . . . 0.497 ' HB2' ' HG3' ' A' ' 168' ' ' PRO . . . -130.52 163.07 27.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.13 -0.486 . . . . 61.41 111.086 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 240' ' ' GLU . . . . . 0.439 ' O ' HD13 ' A' ' 241' ' ' ILE . 2.8 pt-20 -144.31 128.29 17.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.439 . . . . 44.21 110.876 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 241' ' ' ILE . . . . . 0.467 HG13 HG11 ' A' ' 216' ' ' VAL . 26.0 mm -124.92 111.2 27.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 63.2 111.127 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 242' ' ' THR . . . . . 0.441 HG23 ' HG3' ' A' ' 223' ' ' LYS . 4.0 m -81.63 139.94 34.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 73.31 111.131 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 30.5 t -120.26 119.06 58.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 53.31 111.142 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 244' ' ' THR . . . . . 0.503 HG23 ' O ' ' A' ' 173' ' ' VAL . 5.1 p -81.12 132.87 35.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.151 -0.477 . . . . 71.14 111.102 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 245' ' ' ALA . . . . . 0.655 ' HA ' ' HB2' ' A' ' 221' ' ' ALA . . . -54.06 -27.66 33.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 61.32 111.113 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 10.2 m . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.237 -0.438 . . . . 73.52 110.875 -179.783 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.842 0.354 . . . . 72.44 111.115 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 1.1 m -137.55 27.58 2.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 62.21 111.138 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 147.01 105.65 0.43 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.801 -0.714 . . . . 72.43 112.522 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 1.5 ttp -120.0 140.52 50.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.875 0.369 . . . . 63.51 110.886 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.407 ' OG1' ' HB3' ' A' ' 184' ' ' ALA . 32.8 p -126.43 109.83 12.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.445 . . . . 71.51 111.167 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 1.059 HG22 HG13 ' A' ' 183' ' ' VAL . 21.7 t -97.57 134.98 33.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 74.2 111.102 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 4.3 m -126.94 92.59 44.1 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.631 0.729 . . . . 70.51 111.168 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.468 ' HB3' HD23 ' A' ' 181' ' ' LEU . 53.8 Cg_endo -69.74 -167.65 0.23 Allowed 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.686 2.257 . . . . 73.4 112.373 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -89.88 -43.16 10.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 73.14 111.093 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 12.2 t 49.7 80.98 0.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 55.32 110.835 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.5 t -175.13 -175.46 0.85 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 75.21 111.199 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 83.3 p -98.45 161.69 13.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.436 . . . . 60.42 110.893 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.723 HG22 ' HB2' ' A' ' 177' ' ' GLN . 3.1 p -144.24 153.92 15.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 71.13 111.132 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 64.7 t -87.5 144.99 8.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 74.33 111.159 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.6 122.55 5.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.451 . . . . 74.21 110.883 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.59 -14.2 60.73 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.753 -0.737 . . . . 65.21 112.475 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' GLN . . . . . 0.723 ' HB2' HG22 ' A' ' 173' ' ' VAL . 15.7 mm100 -91.61 -178.23 5.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.802 0.334 . . . . 75.04 110.915 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 54.3 p -161.55 146.24 13.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 75.21 110.862 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.565 HG21 HD12 ' A' ' 241' ' ' ILE . 7.0 t -103.34 -173.85 2.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.083 -0.508 . . . . 75.11 111.158 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.51 132.86 28.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.219 -0.446 . . . . 74.42 111.14 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.468 HD23 ' HB3' ' A' ' 168' ' ' PRO . 7.5 mp -106.63 145.25 32.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 53.22 110.943 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 2.2 m -113.81 145.56 41.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.238 -0.437 . . . . 62.13 111.13 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 1.059 HG13 HG22 ' A' ' 166' ' ' VAL . 21.9 t -129.48 142.18 44.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 64.31 111.124 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.407 ' HB3' ' OG1' ' A' ' 165' ' ' THR . . . -128.74 152.94 47.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 72.32 111.088 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -143.99 128.25 17.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 73.04 110.852 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -132.72 66.93 77.6 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.606 0.717 . . . . 62.44 110.9 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--N 1.341 0.159 0 C-N-CA 122.694 2.263 . . . . 72.54 112.387 179.972 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 37.6 t70 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.918 0.389 . . . . 71.11 110.86 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 24.8 mtmt -74.31 74.68 1.85 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 52.1 110.894 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -75.55 -6.25 49.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 74.01 110.826 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.785 ' CE2' HG11 ' A' ' 183' ' ' VAL . 11.5 p90 -90.03 151.81 21.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 64.33 110.898 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.59 154.04 43.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.144 -0.48 . . . . 72.24 110.923 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -103.81 167.77 9.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 71.23 111.103 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 9.3 p -173.25 152.99 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 74.15 111.171 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 73.4 p -76.6 152.86 35.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 65.24 110.866 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.636 ' HB2' ' HD3' ' A' ' 227' ' ' PRO . . . -93.86 -19.54 20.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.126 -0.488 . . . . 71.43 111.135 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.84 -55.28 0.93 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 73.52 110.864 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.54 26.41 14.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 71.32 110.881 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 41.5 p -112.9 -3.92 14.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 65.43 111.152 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 10.2 mtmm -154.21 19.87 0.49 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 72.55 110.898 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.625 ' HA ' HG23 ' A' ' 219' ' ' VAL . . . -177.46 147.6 0.53 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 73.43 111.105 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 15.0 p -108.65 159.67 16.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 75.52 111.159 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.711 HG12 HG22 ' A' ' 216' ' ' VAL . 7.7 m -141.37 141.97 29.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.246 -0.434 . . . . 62.42 111.107 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 69.8 m -149.1 108.66 3.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 73.43 110.888 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.549 HG23 HG13 ' A' ' 214' ' ' ILE . 3.6 p -88.97 143.15 11.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.1 -0.5 . . . . 72.02 111.119 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 18.8 t -172.16 123.48 0.49 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.47 . . . . 64.41 110.864 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 56.04 47.02 83.24 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.719 -0.753 . . . . 64.43 112.524 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 2.4 mtp 63.85 15.94 9.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.904 0.383 . . . . 71.22 110.908 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 6.5 m -125.6 113.14 17.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.459 . . . . 51.54 111.128 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.549 HG13 HG23 ' A' ' 209' ' ' VAL . 3.0 mp -110.43 113.98 45.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 75.22 111.127 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 7.3 m -88.95 132.78 34.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.129 -0.487 . . . . 71.42 111.184 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.711 HG22 HG12 ' A' ' 207' ' ' VAL . 4.4 t -117.94 123.54 71.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.257 -0.429 . . . . 40.43 111.124 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -104.94 140.0 38.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 73.22 110.901 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -95.41 79.31 0.83 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.726 -0.749 . . . . 73.24 112.478 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.625 HG23 ' HA ' ' A' ' 205' ' ' ALA . 18.3 t -49.54 -54.67 6.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.821 0.343 . . . . 61.12 111.12 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -130.85 162.07 30.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 71.53 111.075 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 221' ' ' ALA . . . . . 0.672 ' HB2' ' HA ' ' A' ' 245' ' ' ALA . . . -60.36 141.82 55.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 73.33 111.141 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 139.4 172.05 12.5 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.757 -0.735 . . . . 51.23 112.471 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 223' ' ' LYS . . . . . 0.401 ' HG3' HG23 ' A' ' 242' ' ' THR . 5.0 mttt -99.74 120.84 40.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.824 0.345 . . . . 73.53 110.89 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.583 HG11 ' CB ' ' A' ' 205' ' ' ALA . 6.4 p -117.46 122.88 70.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.213 -0.448 . . . . 74.4 111.133 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 225' ' ' ASN . . . . . 0.652 ' C ' HD12 ' A' ' 226' ' ' ILE . 26.8 m120 -90.99 152.74 20.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.163 -0.472 . . . . 72.04 110.908 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.652 HD12 ' C ' ' A' ' 225' ' ' ASN . 3.9 mp -137.74 92.72 12.76 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.632 0.729 . . . . 64.12 111.13 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 227' ' ' PRO . . . . . 0.636 ' HD3' ' HB2' ' A' ' 200' ' ' ALA . 54.2 Cg_endo -69.7 177.1 5.88 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.67 2.247 . . . . 65.31 112.376 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.447 ' CG2' ' HB3' ' A' ' 237' ' ' ALA . 34.6 t -146.18 139.11 20.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.257 -0.429 . . . . 74.12 111.102 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 91.4 t -129.25 143.79 40.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.15 -0.477 . . . . 71.11 111.178 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 6.0 p -92.4 176.0 6.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 50.14 110.832 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -51.16 -45.97 51.41 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.761 -0.733 . . . . 73.35 112.499 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -111.48 21.08 16.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.873 0.368 . . . . 65.01 110.885 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 61.7 16.02 49.69 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.724 -0.75 . . . . 72.13 112.469 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -66.36 -44.45 83.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.894 0.378 . . . . 71.34 110.902 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -117.3 144.93 44.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.146 -0.479 . . . . 70.02 110.909 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -144.71 163.23 34.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 70.11 111.101 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 237' ' ' ALA . . . . . 0.447 ' HB3' ' CG2' ' A' ' 228' ' ' VAL . . . -142.65 163.4 32.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 63.3 111.052 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 57.3 t -139.6 136.6 40.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.215 -0.448 . . . . 55.33 111.132 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.17 165.08 27.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.466 . . . . 72.14 111.075 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 240' ' ' GLU . . . . . 0.405 ' O ' HD13 ' A' ' 241' ' ' ILE . 3.2 pt-20 -143.79 132.25 22.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 74.12 110.862 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 241' ' ' ILE . . . . . 0.565 HD12 HG21 ' A' ' 179' ' ' THR . 24.1 mm -127.27 113.28 31.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 64.41 111.156 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 242' ' ' THR . . . . . 0.401 HG23 ' HG3' ' A' ' 223' ' ' LYS . 1.7 m -81.42 141.06 34.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 52.34 111.134 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 17.2 t -119.95 122.13 67.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 73.44 111.144 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 244' ' ' THR . . . . . 0.525 HG23 ' O ' ' A' ' 173' ' ' VAL . 7.2 p -82.57 133.05 35.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 62.35 111.159 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 245' ' ' ALA . . . . . 0.672 ' HA ' ' HB2' ' A' ' 221' ' ' ALA . . . -59.14 -21.87 60.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 72.14 111.088 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 52.3 p . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 72.11 110.856 -179.782 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.905 0.384 . . . . 35.02 111.078 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -124.6 31.96 5.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 74.41 111.109 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 138.28 99.17 0.48 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.743 -0.741 . . . . 70.45 112.486 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 35.2 ttp -109.71 130.91 55.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.822 0.344 . . . . 70.01 110.888 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.552 ' OG1' ' HB3' ' A' ' 184' ' ' ALA . 36.5 p -120.48 105.1 10.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.44 . . . . 74.35 111.182 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.994 HG22 HG13 ' A' ' 183' ' ' VAL . 21.1 t -98.26 136.11 30.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 64.51 111.171 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.3 m -127.7 91.86 44.29 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.593 0.711 . . . . 54.41 111.127 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.465 ' HG3' ' HB2' ' A' ' 239' ' ' ALA . 53.9 Cg_endo -69.72 -165.7 0.16 Allowed 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.709 2.273 . . . . 65.04 112.346 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -91.84 -39.25 11.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 74.41 111.089 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 88.5 p 46.73 79.82 0.05 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 52.22 110.897 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.6 t -175.56 -175.06 0.75 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.121 -0.491 . . . . 72.04 111.131 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 25.5 p -99.84 163.28 12.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 73.35 110.853 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.726 HG22 ' HB2' ' A' ' 177' ' ' GLN . 3.0 p -143.91 153.4 15.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.123 -0.489 . . . . 75.32 111.12 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 80.6 t -87.76 143.58 10.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 73.55 111.099 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.35 122.41 4.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 75.05 110.872 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.34 -9.88 61.18 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.735 -0.745 . . . . 72.31 112.482 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' GLN . . . . . 0.726 ' HB2' HG22 ' A' ' 173' ' ' VAL . 11.9 mm100 -97.17 -178.68 4.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.792 0.329 . . . . 74.02 110.946 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 15.2 p -161.55 147.67 14.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 63.3 110.898 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 7.7 t -104.9 -175.82 2.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.476 . . . . 63.33 111.131 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -137.38 130.11 30.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 63.03 111.16 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.46 HD23 ' HB3' ' A' ' 168' ' ' PRO . 8.0 mp -105.43 140.39 38.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 72.21 110.937 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -109.92 145.57 36.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 75.33 111.163 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.994 HG13 HG22 ' A' ' 166' ' ' VAL . 52.1 t -129.58 142.61 43.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.453 . . . . 74.4 111.141 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.552 ' HB3' ' OG1' ' A' ' 165' ' ' THR . . . -130.13 150.76 51.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.198 -0.455 . . . . 71.51 111.084 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -144.83 126.74 15.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 74.4 110.884 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.89 67.61 80.92 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.612 0.72 . . . . 53.33 110.903 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--N 1.342 0.202 0 C-N-CA 122.67 2.247 . . . . 71.35 112.372 -179.996 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.889 0.376 . . . . 73.12 110.844 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.35 99.82 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 73.12 110.87 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 3.3 t -111.16 -7.33 14.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 65.43 110.892 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.789 ' CE2' HG11 ' A' ' 183' ' ' VAL . 21.1 p90 -91.36 -176.29 4.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.108 -0.496 . . . . 72.2 110.878 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -166.3 175.27 8.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 65.24 110.926 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 197' ' ' ALA . . . . . 0.684 ' HB3' ' CG2' ' A' ' 209' ' ' VAL . . . -125.24 167.16 15.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 74.32 111.098 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.419 HG13 ' HG2' ' A' ' 227' ' ' PRO . 13.9 p -170.54 149.52 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 71.23 111.133 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.2 p -92.22 125.3 36.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 71.1 110.833 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.483 ' HB2' ' HD3' ' A' ' 227' ' ' PRO . . . -60.77 -18.62 56.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 73.4 111.076 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -164.25 103.52 0.86 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 73.42 110.878 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -89.61 46.78 1.4 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.169 -0.469 . . . . 72.21 110.891 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 11.9 p -120.9 -9.17 9.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 72.21 111.165 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 204' ' ' LYS . . . . . 0.697 ' HA ' ' HB3' ' A' ' 220' ' ' ALA . 11.3 mtmm -143.09 17.1 1.92 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 71.42 110.908 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.63 ' CB ' HG11 ' A' ' 224' ' ' VAL . . . 178.91 143.12 0.12 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 45.51 111.106 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 2.1 p -104.6 161.68 13.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.437 . . . . 72.45 111.165 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.598 HG12 HG22 ' A' ' 216' ' ' VAL . 17.2 m -140.85 150.17 20.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.239 -0.437 . . . . 75.32 111.138 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 22.8 m -157.69 109.71 2.35 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.474 . . . . 73.32 110.843 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.684 ' CG2' ' HB3' ' A' ' 197' ' ' ALA . 90.5 t -79.45 145.18 9.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.116 -0.493 . . . . 61.3 111.162 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 59.2 p -165.84 111.56 0.87 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.197 -0.456 . . . . 72.2 110.848 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 47.66 63.33 3.52 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.736 -0.745 . . . . 70.43 112.458 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 3.1 mtp 55.75 20.48 4.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.875 0.369 . . . . 72.54 110.891 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 1.4 m -130.97 106.5 8.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.23 -0.441 . . . . 53.32 111.14 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.531 ' H ' HD12 ' A' ' 214' ' ' ILE . 0.8 OUTLIER -101.64 122.01 53.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.264 -0.426 . . . . 72.21 111.166 179.905 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 7.3 m -92.22 123.15 35.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 73.34 111.112 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.598 HG22 HG12 ' A' ' 207' ' ' VAL . 2.4 t -108.65 123.18 64.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 62.24 111.101 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -107.63 145.1 33.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 63.53 110.87 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -99.72 64.24 0.65 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.776 -0.726 . . . . 63.33 112.526 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.611 HG22 ' HA ' ' A' ' 205' ' ' ALA . 0.0 OUTLIER -48.23 -41.59 10.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.809 0.338 . . . . 60.02 111.092 -179.925 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 220' ' ' ALA . . . . . 0.697 ' HB3' ' HA ' ' A' ' 204' ' ' LYS . . . -127.3 151.02 49.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 73.21 111.074 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 221' ' ' ALA . . . . . 0.644 ' HB2' ' HA ' ' A' ' 245' ' ' ALA . . . -66.68 138.05 57.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 50.14 111.1 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 137.72 170.15 11.81 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.747 -0.739 . . . . 64.53 112.542 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 223' ' ' LYS . . . . . 0.527 ' HG3' HG23 ' A' ' 242' ' ' THR . 7.9 mttm -93.32 127.61 39.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.846 0.355 . . . . 74.53 110.95 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.63 HG11 ' CB ' ' A' ' 205' ' ' ALA . 7.3 p -122.05 129.36 75.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.239 -0.437 . . . . 72.44 111.15 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 225' ' ' ASN . . . . . 0.578 ' C ' HD12 ' A' ' 226' ' ' ILE . 19.3 m120 -90.95 148.54 22.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 73.41 110.851 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.578 HD12 ' C ' ' A' ' 225' ' ' ASN . 4.3 mp -135.72 92.57 16.76 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.622 0.725 . . . . 64.14 111.096 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 227' ' ' PRO . . . . . 0.483 ' HD3' ' HB2' ' A' ' 200' ' ' ALA . 54.1 Cg_endo -69.77 178.63 4.38 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.66 2.24 . . . . 63.42 112.358 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 54.4 t -148.29 136.78 15.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.237 -0.438 . . . . 75.02 111.18 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 98.3 t -118.15 136.63 54.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.453 . . . . 72.13 111.133 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 22.7 t -122.17 135.51 54.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 51.24 110.87 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 52.53 -113.72 2.9 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.738 -0.744 . . . . 71.44 112.471 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -111.8 20.66 16.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.873 0.368 . . . . 64.42 110.887 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 113.14 1.94 25.02 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.719 -0.753 . . . . 74.4 112.478 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -52.92 -62.58 1.56 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.878 0.37 . . . . 74.51 110.892 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -108.37 166.13 10.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 73.24 110.867 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -166.1 165.15 17.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.128 -0.487 . . . . 52.12 111.087 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -143.41 163.27 33.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 73.01 111.061 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 14.8 p -138.25 137.64 43.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 75.33 111.157 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 239' ' ' ALA . . . . . 0.465 ' HB2' ' HG3' ' A' ' 168' ' ' PRO . . . -138.95 164.82 28.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 61.1 111.138 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 240' ' ' GLU . . . . . 0.588 ' O ' HD13 ' A' ' 241' ' ' ILE . 4.6 pt-20 -143.99 130.48 19.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 75.12 110.94 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 241' ' ' ILE . . . . . 0.589 HG13 HG11 ' A' ' 216' ' ' VAL . 32.7 mm -127.12 114.77 38.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 74.53 111.134 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 242' ' ' THR . . . . . 0.527 HG23 ' HG3' ' A' ' 223' ' ' LYS . 3.2 m -84.28 141.0 31.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 70.25 111.169 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 25.9 t -120.39 120.1 61.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.446 . . . . 72.11 111.134 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 244' ' ' THR . . . . . 0.497 HG23 ' O ' ' A' ' 173' ' ' VAL . 7.1 p -81.1 132.83 35.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.485 . . . . 53.01 111.145 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 245' ' ' ALA . . . . . 0.644 ' HA ' ' HB2' ' A' ' 221' ' ' ALA . . . -58.51 -25.16 62.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 75.15 111.073 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 40.3 t . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 71.11 110.83 -179.753 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.472 ' HB1' ' HB3' ' A' ' 187' ' ' PRO . . . . . . . . 0 C--O 1.232 0.174 0 CA-C-O 120.825 0.345 . . . . 63.11 111.155 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 1.2 m -125.07 32.68 5.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.271 -0.422 . . . . 74.43 111.153 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 140.55 97.99 0.34 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.765 -0.731 . . . . 62.14 112.48 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.522 ' HE3' HG11 ' A' ' 228' ' ' VAL . 0.8 OUTLIER -112.95 138.1 50.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.905 0.383 . . . . 74.2 110.86 -179.965 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 34.4 p -121.52 109.8 15.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.236 -0.438 . . . . 53.3 111.18 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 1.083 HG22 HG13 ' A' ' 183' ' ' VAL . 33.5 t -98.45 132.91 42.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.429 . . . . 75.54 111.155 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.5 m -123.43 92.09 49.16 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.619 0.723 . . . . 64.3 111.179 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.463 ' HB3' HD23 ' A' ' 181' ' ' LEU . 53.6 Cg_endo -69.78 -168.41 0.27 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.666 2.244 . . . . 64.23 112.348 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -89.75 -42.7 11.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.446 . . . . 71.31 111.105 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 12.3 t 49.88 80.57 0.07 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.236 -0.438 . . . . 64.34 110.869 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.5 t -174.72 -175.09 0.87 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 75.3 111.142 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 1.5 m -98.7 162.41 13.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.444 . . . . 71.52 110.893 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.729 HG22 ' HB2' ' A' ' 177' ' ' GLN . 3.6 p -144.5 153.32 15.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.129 -0.487 . . . . 73.13 111.124 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 61.8 t -86.73 145.55 7.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 73.14 111.1 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.23 122.22 5.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.468 . . . . 73.0 110.914 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.18 -11.54 61.95 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.76 -0.734 . . . . 72.33 112.467 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' GLN . . . . . 0.729 ' HB2' HG22 ' A' ' 173' ' ' VAL . 16.3 mm100 -94.2 -178.62 4.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.818 0.342 . . . . 74.25 110.909 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 52.2 p -161.74 148.09 13.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 51.2 110.861 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.502 HG21 HD12 ' A' ' 241' ' ' ILE . 7.0 t -106.01 -173.61 2.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.13 -0.487 . . . . 53.2 111.097 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -139.93 132.2 28.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.456 . . . . 64.11 111.166 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.463 HD23 ' HB3' ' A' ' 168' ' ' PRO . 7.6 mp -105.83 145.19 31.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.247 -0.433 . . . . 74.44 110.904 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 5.3 m -111.55 145.12 39.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.144 -0.48 . . . . 73.12 111.123 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 1.083 HG13 HG22 ' A' ' 166' ' ' VAL . 22.5 t -129.31 140.62 48.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.256 -0.429 . . . . 75.1 111.11 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -129.11 153.1 48.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.486 . . . . 44.43 111.082 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -143.91 129.28 18.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.251 -0.432 . . . . 65.03 110.864 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -132.86 66.78 77.09 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.634 0.73 . . . . 64.55 110.925 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.472 ' HB3' ' HB1' ' A' ' 161' ' ' ALA . 53.5 Cg_endo . . . . . 0 C--N 1.342 0.219 0 C-N-CA 122.693 2.262 . . . . 74.44 112.36 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.881 0.372 . . . . 71.42 110.841 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 13.9 mtpp -81.9 74.44 8.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 71.31 110.923 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 2.2 m -78.48 -7.28 57.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 63.44 110.862 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.774 ' CE2' HG11 ' A' ' 183' ' ' VAL . 22.4 p90 -91.31 164.38 13.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 65.05 110.838 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.04 167.52 30.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.116 -0.493 . . . . 64.14 110.88 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -115.64 160.05 20.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 63.24 111.103 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.603 HG23 ' HG2' ' A' ' 227' ' ' PRO . 5.1 m -153.43 163.04 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.206 -0.452 . . . . 53.44 111.114 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.61 118.68 35.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 72.33 110.9 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.477 ' HB2' ' HD3' ' A' ' 227' ' ' PRO . . . -59.87 -21.0 60.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.141 -0.481 . . . . 63.44 111.11 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.97 96.79 1.36 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 64.24 110.84 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.89 50.18 1.92 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 72.04 110.904 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 12.0 p -128.73 -1.45 5.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.211 -0.45 . . . . 63.24 111.176 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 7.5 mtmt -154.57 18.47 0.47 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.196 -0.457 . . . . 72.53 110.829 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.589 ' HA ' HG23 ' A' ' 219' ' ' VAL . . . -179.88 153.79 0.54 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.251 -0.431 . . . . 55.12 111.085 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 11.7 p -117.32 156.05 28.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.214 -0.448 . . . . 71.12 111.131 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.817 HG12 HG22 ' A' ' 216' ' ' VAL . 33.8 m -137.19 141.17 40.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 63.23 111.136 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 50.9 m -147.86 107.87 4.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 71.43 110.845 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.446 ' HA ' ' HA ' ' A' ' 214' ' ' ILE . 3.0 p -88.31 142.87 12.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 63.23 111.11 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.2 m -171.56 122.89 0.53 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.188 -0.46 . . . . 64.03 110.861 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 55.6 47.23 78.55 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.726 -0.75 . . . . 44.51 112.481 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 3.3 mtp 64.06 16.38 9.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.848 0.356 . . . . 70.04 110.854 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 18.8 m -125.67 112.65 16.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 63.43 111.151 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.446 ' HA ' ' HA ' ' A' ' 209' ' ' VAL . 2.6 mp -109.69 113.75 45.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 64.12 111.105 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 6.3 m -87.45 133.92 33.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.206 -0.452 . . . . 55.21 111.181 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.817 HG22 HG12 ' A' ' 207' ' ' VAL . 2.9 t -118.18 123.17 71.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.27 -0.423 . . . . 53.51 111.09 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -106.33 139.57 40.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.474 . . . . 75.11 110.857 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -96.9 78.3 0.69 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.719 -0.753 . . . . 63.11 112.48 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.589 HG23 ' HA ' ' A' ' 205' ' ' ALA . 16.2 t -50.13 -55.29 5.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.83 0.347 . . . . 71.44 111.112 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -126.38 161.63 27.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 72.14 111.122 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 221' ' ' ALA . . . . . 0.677 ' HB2' ' HA ' ' A' ' 245' ' ' ALA . . . -62.61 139.97 58.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.243 -0.435 . . . . 73.35 111.104 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 142.24 172.84 13.86 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.732 -0.747 . . . . 45.43 112.503 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 223' ' ' LYS . . . . . 0.409 ' HG3' HG23 ' A' ' 242' ' ' THR . 12.7 mttt -102.18 120.81 41.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.837 0.351 . . . . 60.52 110.886 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.533 HG11 ' CB ' ' A' ' 205' ' ' ALA . 7.3 p -119.13 126.89 75.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 50.34 111.143 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 225' ' ' ASN . . . . . 0.597 ' C ' HD12 ' A' ' 226' ' ' ILE . 33.5 m120 -90.55 156.05 18.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 65.25 110.864 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.597 HD12 ' C ' ' A' ' 225' ' ' ASN . 4.4 mp -138.13 92.43 12.33 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.634 0.731 . . . . 75.31 111.127 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 227' ' ' PRO . . . . . 0.603 ' HG2' HG23 ' A' ' 198' ' ' VAL . 53.3 Cg_endo -69.77 -179.26 2.79 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.679 2.253 . . . . 45.21 112.345 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.522 HG11 ' HE3' ' A' ' 164' ' ' MET . 61.3 t -150.11 140.6 16.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 74.44 111.16 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 89.9 t -124.06 138.53 53.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 72.02 111.137 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 1.5 m -118.94 106.67 12.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.191 -0.459 . . . . 65.22 110.862 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 57.74 -110.86 2.59 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.701 -0.761 . . . . 74.21 112.486 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -81.01 -7.39 59.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.865 0.364 . . . . 65.31 110.889 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 109.76 10.01 23.76 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.743 -0.741 . . . . 61.43 112.424 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -50.72 -47.1 59.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.874 0.369 . . . . 64.22 110.879 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -117.51 147.52 42.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 63.55 110.884 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -149.72 165.23 33.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 73.23 111.11 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 237' ' ' ALA . . . . . 0.429 ' HB3' ' CG2' ' A' ' 228' ' ' VAL . . . -136.95 163.3 31.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.441 . . . . 73.42 111.109 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.4 p -136.36 125.59 38.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.188 -0.46 . . . . 73.43 111.139 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 239' ' ' ALA . . . . . 0.409 ' HB2' ' HG3' ' A' ' 168' ' ' PRO . . . -132.79 162.13 32.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 52.41 111.15 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 240' ' ' GLU . . . . . 0.413 ' O ' HD13 ' A' ' 241' ' ' ILE . 6.3 pt-20 -144.16 132.1 21.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.268 -0.424 . . . . 55.53 110.886 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 241' ' ' ILE . . . . . 0.621 HG13 HG11 ' A' ' 216' ' ' VAL . 26.3 mm -126.81 112.73 30.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.124 -0.489 . . . . 63.01 111.142 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 242' ' ' THR . . . . . 0.409 HG23 ' HG3' ' A' ' 223' ' ' LYS . 2.7 m -80.82 141.28 34.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 65.24 111.165 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 17.1 t -120.08 121.0 64.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.236 -0.438 . . . . 73.33 111.116 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 244' ' ' THR . . . . . 0.506 HG23 ' O ' ' A' ' 173' ' ' VAL . 7.3 p -82.28 132.75 35.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.144 -0.48 . . . . 73.01 111.146 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 245' ' ' ALA . . . . . 0.677 ' HA ' ' HB2' ' A' ' 221' ' ' ALA . . . -56.92 -24.63 53.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.462 . . . . 74.24 111.113 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.26 -0.427 . . . . 71.23 110.847 -179.791 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.494 ' HB1' ' HB3' ' A' ' 187' ' ' PRO . . . . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.922 0.391 . . . . 73.24 111.07 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -124.9 30.85 5.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.161 -0.472 . . . . 64.14 111.096 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 146.24 96.7 0.19 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.722 -0.751 . . . . 73.15 112.466 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.607 ' SD ' HG23 ' A' ' 166' ' ' VAL . 2.1 tmm? -106.09 143.71 33.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.845 0.355 . . . . 65.01 110.897 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.515 ' OG1' ' HB3' ' A' ' 184' ' ' ALA . 44.7 p -133.87 103.33 5.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.274 -0.421 . . . . 71.34 111.169 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 1.13 HG22 HG13 ' A' ' 183' ' ' VAL . 89.0 t -97.19 133.98 36.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 74.41 111.103 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 40.8 m -123.86 92.01 48.99 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.517 0.675 . . . . 74.54 111.115 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.465 ' HB3' HD23 ' A' ' 181' ' ' LEU . 53.9 Cg_endo -69.78 -167.33 0.22 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.636 2.224 . . . . 73.3 112.331 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -90.75 -43.75 9.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.459 . . . . 64.22 111.089 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 8.0 t 49.48 80.12 0.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 75.14 110.861 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.6 t -173.68 -176.11 1.2 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.135 -0.484 . . . . 75.32 111.128 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 10.0 p -97.27 162.19 13.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 54.15 110.837 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.734 HG22 ' HB2' ' A' ' 177' ' ' GLN . 3.3 p -145.37 153.18 14.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.479 . . . . 63.41 111.142 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 66.6 t -87.52 145.21 7.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.116 -0.493 . . . . 72.54 111.12 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.64 122.42 5.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 72.42 110.837 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.81 -12.87 61.0 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.741 -0.742 . . . . 73.24 112.501 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' GLN . . . . . 0.734 ' HB2' HG22 ' A' ' 173' ' ' VAL . 11.6 mm100 -92.91 -178.32 4.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.811 0.339 . . . . 61.11 110.931 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 39.1 p -161.37 149.45 15.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.214 -0.448 . . . . 74.04 110.894 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.533 HG21 HD12 ' A' ' 241' ' ' ILE . 6.8 t -107.11 -173.92 2.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 71.04 111.186 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.73 132.39 27.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.258 -0.428 . . . . 72.12 111.184 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.465 HD23 ' HB3' ' A' ' 168' ' ' PRO . 7.6 mp -106.56 145.54 31.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 74.3 110.873 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 4.1 m -113.75 146.42 39.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 72.31 111.144 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 1.13 HG13 HG22 ' A' ' 166' ' ' VAL . 47.4 t -128.7 140.84 48.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 75.13 111.136 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.515 ' HB3' ' OG1' ' A' ' 165' ' ' THR . . . -129.9 155.98 45.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 72.32 111.123 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -148.93 131.28 15.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.257 -0.428 . . . . 73.11 110.9 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.05 67.35 73.52 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.634 0.73 . . . . 74.01 110.919 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.494 ' HB3' ' HB1' ' A' ' 161' ' ' ALA . 53.6 Cg_endo . . . . . 0 C--N 1.342 0.22 0 C-N-CA 122.703 2.268 . . . . 65.0 112.343 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 1.4 p30 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.863 0.364 . . . . 62.43 110.882 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 6.1 mtpm? -91.4 67.58 5.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 52.43 110.907 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 21.8 t -74.51 -7.24 52.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 65.53 110.864 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.772 ' CE2' HG11 ' A' ' 183' ' ' VAL . 21.8 p90 -91.28 163.64 14.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.131 -0.486 . . . . 64.23 110.897 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.9 173.19 16.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 74.24 110.878 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -112.66 168.14 9.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 73.32 111.068 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.436 HG13 ' HG2' ' A' ' 227' ' ' PRO . 14.5 p -167.62 149.7 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 75.32 111.101 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.03 130.03 36.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.139 -0.482 . . . . 65.03 110.881 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.492 ' HB2' ' HD3' ' A' ' 227' ' ' PRO . . . -68.08 -17.61 64.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.095 -0.502 . . . . 72.01 111.106 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -162.93 95.7 0.88 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.224 -0.443 . . . . 64.11 110.891 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 18.6 tttt -84.99 53.06 2.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 71.13 110.935 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 18.0 p -128.82 0.37 5.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 73.32 111.142 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 204' ' ' LYS . . . . . 0.415 ' HG2' ' HB3' ' A' ' 220' ' ' ALA . 3.7 mtmm -155.29 18.24 0.41 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 74.3 110.887 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.613 ' HA ' HG23 ' A' ' 219' ' ' VAL . . . -179.96 149.16 0.33 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.277 -0.419 . . . . 73.32 111.107 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 7.0 p -109.92 156.69 20.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.166 -0.47 . . . . 74.24 111.118 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.856 HG12 HG22 ' A' ' 216' ' ' VAL . 17.6 m -140.42 140.86 33.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 72.12 111.112 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -148.15 109.0 4.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 72.54 110.879 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.544 HG23 HG13 ' A' ' 214' ' ' ILE . 3.6 p -89.21 143.01 12.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.465 . . . . 74.34 111.106 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.7 m -171.82 123.43 0.52 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 72.0 110.91 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 56.2 46.67 85.33 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.715 -0.755 . . . . 74.23 112.466 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 4.1 mtp 64.2 15.78 9.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.827 0.346 . . . . 64.43 110.892 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 13.6 m -125.13 113.01 17.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.246 -0.434 . . . . 71.03 111.112 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.544 HG13 HG23 ' A' ' 209' ' ' VAL . 3.1 mp -110.48 113.8 45.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 73.41 111.154 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 5.8 m -88.93 132.05 34.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 73.51 111.12 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.856 HG22 HG12 ' A' ' 207' ' ' VAL . 3.9 t -117.02 124.28 72.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.187 -0.46 . . . . 55.1 111.101 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -106.03 138.67 41.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 75.32 110.95 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -94.73 78.55 0.91 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.676 -0.773 . . . . 72.32 112.505 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.613 HG23 ' HA ' ' A' ' 205' ' ' ALA . 20.6 t -49.75 -55.52 4.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.823 0.344 . . . . 72.44 111.134 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 220' ' ' ALA . . . . . 0.415 ' HB3' ' HG2' ' A' ' 204' ' ' LYS . . . -127.19 161.75 27.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 64.05 111.111 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 221' ' ' ALA . . . . . 0.682 ' HB2' ' HA ' ' A' ' 245' ' ' ALA . . . -62.22 139.93 58.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 70.24 111.068 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 142.27 171.72 13.27 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.752 -0.737 . . . . 73.23 112.496 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 223' ' ' LYS . . . . . 0.464 ' HG3' HG23 ' A' ' 242' ' ' THR . 2.1 mttt -101.12 121.19 41.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.783 0.325 . . . . 75.42 110.929 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.501 HG11 ' CB ' ' A' ' 205' ' ' ALA . 7.1 p -120.46 125.46 74.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.259 -0.428 . . . . 64.23 111.102 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 225' ' ' ASN . . . . . 0.558 ' C ' HD12 ' A' ' 226' ' ' ILE . 21.0 m120 -90.98 152.45 20.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.468 . . . . 72.33 110.888 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.558 HD12 ' C ' ' A' ' 225' ' ' ASN . 4.3 mp -135.24 92.71 17.59 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.667 0.746 . . . . 75.33 111.166 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 227' ' ' PRO . . . . . 0.492 ' HD3' ' HB2' ' A' ' 200' ' ' ALA . 53.9 Cg_endo -69.76 -176.44 1.49 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.689 2.26 . . . . 74.25 112.329 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.505 ' CG2' ' HB3' ' A' ' 237' ' ' ALA . 59.5 t -149.4 137.04 13.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.444 . . . . 72.44 111.127 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 84.0 t -118.4 133.18 66.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.158 -0.474 . . . . 74.41 111.135 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 5.7 t -122.32 126.21 47.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 72.32 110.881 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 55.53 -121.86 24.43 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.717 -0.754 . . . . 75.12 112.519 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -98.17 21.03 11.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.87 0.367 . . . . 55.13 110.911 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 106.77 6.9 34.54 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.702 -0.761 . . . . 71.42 112.507 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -53.26 -62.66 1.51 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.85 0.357 . . . . 74.32 110.887 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -105.99 166.02 10.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 73.42 110.879 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -167.15 165.41 15.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 70.04 111.053 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 237' ' ' ALA . . . . . 0.505 ' HB3' ' CG2' ' A' ' 228' ' ' VAL . . . -142.33 163.16 33.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 75.11 111.099 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 8.0 p -136.58 131.15 47.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.243 -0.435 . . . . 74.41 111.149 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 239' ' ' ALA . . . . . 0.42 ' HB2' ' HG3' ' A' ' 168' ' ' PRO . . . -139.3 165.22 27.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 63.22 111.157 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -147.7 133.32 18.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 74.22 110.919 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 241' ' ' ILE . . . . . 0.533 HD12 HG21 ' A' ' 179' ' ' THR . 25.1 mm -126.7 115.13 40.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.475 . . . . 54.34 111.11 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 242' ' ' THR . . . . . 0.464 HG23 ' HG3' ' A' ' 223' ' ' LYS . 2.4 m -82.91 141.11 32.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 73.45 111.146 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 21.2 t -120.01 121.06 64.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.243 -0.435 . . . . 74.23 111.121 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 244' ' ' THR . . . . . 0.443 HG23 ' O ' ' A' ' 173' ' ' VAL . 9.2 p -82.92 132.78 35.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.138 -0.483 . . . . 75.54 111.124 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 245' ' ' ALA . . . . . 0.682 ' HA ' ' HB2' ' A' ' 221' ' ' ALA . . . -54.39 -27.18 34.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 71.22 111.089 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 46.9 t . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 54.13 110.906 -179.811 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.458 ' HB1' ' HB3' ' A' ' 187' ' ' PRO . . . . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.885 0.374 . . . . 70.12 111.081 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.508 HG22 ' HA ' ' A' ' 187' ' ' PRO . 10.8 t -127.24 15.99 7.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 60.31 111.132 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -176.71 81.28 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.764 -0.731 . . . . 74.11 112.493 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 30.5 ttp -102.95 123.19 46.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.895 0.378 . . . . 70.22 110.867 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.53 ' OG1' ' HB3' ' A' ' 184' ' ' ALA . 51.6 p -111.52 104.97 13.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.236 -0.438 . . . . 72.35 111.159 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 1.07 HG22 HG13 ' A' ' 183' ' ' VAL . 60.9 t -97.2 131.92 42.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.455 . . . . 74.44 111.141 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 38.5 m -124.55 92.29 48.18 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.534 0.683 . . . . 62.2 111.147 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.456 ' HB3' HD23 ' A' ' 181' ' ' LEU . 54.1 Cg_endo -69.74 -167.26 0.22 Allowed 'Trans proline' 0 C--N 1.341 0.132 0 C-N-CA 122.674 2.249 . . . . 75.42 112.35 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -90.92 -39.27 12.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.444 . . . . 63.45 111.114 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 4.8 p 45.86 79.96 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 71.11 110.87 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.6 t -175.44 -175.69 0.83 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.477 . . . . 63.35 111.126 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 1.7 m -97.42 164.42 12.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.443 . . . . 65.12 110.908 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.737 HG22 ' HB2' ' A' ' 177' ' ' GLN . 3.4 p -146.22 153.18 13.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.469 . . . . 62.34 111.137 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 59.2 t -86.1 145.48 7.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 64.31 111.125 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.27 122.32 5.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.443 . . . . 74.55 110.905 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.15 -12.79 62.06 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.771 -0.728 . . . . 44.4 112.53 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 177' ' ' GLN . . . . . 0.737 ' HB2' HG22 ' A' ' 173' ' ' VAL . 17.9 mm100 -92.35 -178.8 5.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.796 0.331 . . . . 74.3 110.914 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 60.6 p -161.69 148.63 14.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 71.32 110.879 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.466 HG21 HD12 ' A' ' 241' ' ' ILE . 6.7 t -105.75 -174.46 2.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 75.31 111.145 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -140.29 127.09 20.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.256 -0.429 . . . . 75.53 111.139 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.456 HD23 ' HB3' ' A' ' 168' ' ' PRO . 7.5 mp -100.81 141.01 34.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.183 -0.462 . . . . 71.53 110.93 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 6.1 m -109.17 144.61 37.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 65.02 111.152 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 1.07 HG13 HG22 ' A' ' 166' ' ' VAL . 23.1 t -129.43 141.56 46.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 75.54 111.104 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.53 ' HB3' ' OG1' ' A' ' 165' ' ' THR . . . -130.89 156.87 44.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 73.31 111.111 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -147.09 133.37 19.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 74.14 110.894 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.62 67.18 23.96 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.634 0.731 . . . . 70.05 110.915 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.508 ' HA ' HG22 ' A' ' 162' ' ' THR . 53.6 Cg_endo . . . . . 0 C--N 1.341 0.169 0 C-N-CA 122.676 2.251 . . . . 73.33 112.369 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.858 0.361 . . . . 72.11 110.868 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 10.3 mtmm -85.31 73.11 10.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.474 . . . . 72.51 110.87 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.45 -3.98 43.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.253 -0.431 . . . . 65.22 110.831 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.806 ' CE2' HG11 ' A' ' 183' ' ' VAL . 14.9 p90 -88.05 168.58 12.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.074 -0.512 . . . . 62.44 110.858 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -164.38 162.07 21.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 64.32 110.868 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 197' ' ' ALA . . . . . 0.684 ' HB3' ' CG2' ' A' ' 209' ' ' VAL . . . -104.03 157.69 16.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.467 . . . . 75.03 111.107 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 91.9 t -150.25 145.14 17.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.257 -0.429 . . . . 74.13 111.126 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -83.83 122.78 29.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 74.11 110.826 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.471 ' HB2' ' HD3' ' A' ' 227' ' ' PRO . . . -72.98 -8.25 54.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 74.15 111.088 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -164.21 98.58 0.83 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.259 -0.428 . . . . 63.12 110.899 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.64 41.4 1.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 61.32 110.89 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 4.3 p -124.51 -5.3 7.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.249 -0.432 . . . . 71.01 111.144 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 9.7 mtmm -148.45 16.27 1.02 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.462 . . . . 73.33 110.921 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.572 ' HA ' HG23 ' A' ' 219' ' ' VAL . . . -179.2 154.35 0.65 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 25.14 111.124 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 11.2 p -117.62 158.42 24.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.209 -0.45 . . . . 74.24 111.153 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 10.7 m -134.74 144.4 34.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 71.11 111.093 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 1.9 t -150.93 109.21 3.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 74.24 110.886 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.684 ' CG2' ' HB3' ' A' ' 197' ' ' ALA . 80.9 t -84.16 145.71 7.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 74.15 111.123 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 3.3 t -171.09 117.58 0.46 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.147 -0.479 . . . . 53.14 110.849 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 48.52 61.32 5.19 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.738 -0.744 . . . . 53.02 112.496 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 2.3 mtp 54.09 21.97 3.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.887 0.375 . . . . 74.11 110.904 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 1.7 m -130.59 110.33 11.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 71.45 111.2 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.493 HG23 HG22 ' A' ' 209' ' ' VAL . 0.8 OUTLIER -104.65 121.36 56.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.253 -0.43 . . . . 74.03 111.158 179.905 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 21.0 m -91.9 129.19 37.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.146 -0.479 . . . . 55.3 111.16 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.589 HG11 HG13 ' A' ' 241' ' ' ILE . 2.3 t -115.54 120.94 66.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 62.12 111.15 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -105.47 140.33 38.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 72.22 110.872 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -96.47 78.54 0.73 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.767 -0.73 . . . . 52.24 112.491 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.572 HG23 ' HA ' ' A' ' 205' ' ' ALA . 19.5 t -50.81 -56.67 3.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.837 0.351 . . . . 70.22 111.115 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -123.86 161.21 25.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.148 -0.478 . . . . 74.54 111.103 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 221' ' ' ALA . . . . . 0.669 ' HB2' ' HA ' ' A' ' 245' ' ' ALA . . . -63.15 138.7 58.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.256 -0.429 . . . . 72.54 111.099 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 141.37 168.49 11.53 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.713 -0.756 . . . . 62.4 112.458 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 223' ' ' LYS . . . . . 0.588 ' HG3' HG23 ' A' ' 242' ' ' THR . 5.6 mttp -95.68 120.2 35.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.804 0.335 . . . . 71.11 110.915 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.562 HG11 ' CB ' ' A' ' 205' ' ' ALA . 6.6 p -117.99 123.15 71.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.272 -0.422 . . . . 72.14 111.177 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 225' ' ' ASN . . . . . 0.634 ' C ' HD12 ' A' ' 226' ' ' ILE . 58.7 m-80 -90.72 153.18 20.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.458 . . . . 71.33 110.864 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.634 HD12 ' C ' ' A' ' 225' ' ' ASN . 4.2 mp -138.38 93.19 11.47 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.645 0.736 . . . . 53.43 111.139 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 227' ' ' PRO . . . . . 0.471 ' HD3' ' HB2' ' A' ' 200' ' ' ALA . 53.9 Cg_endo -69.73 -177.41 1.85 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.73 2.287 . . . . 70.34 112.339 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 62.4 t -149.01 142.04 18.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 65.23 111.126 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 91.0 t -121.42 137.09 56.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.157 -0.474 . . . . 73.01 111.141 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.34 130.09 52.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 70.22 110.884 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 53.37 -114.09 3.53 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.74 -0.743 . . . . 72.13 112.513 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -111.17 21.22 16.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.807 0.337 . . . . 74.35 110.831 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 114.39 1.76 23.23 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.76 -0.733 . . . . 62.33 112.512 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 44.1 mm-40 -51.75 -62.96 1.3 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.9 0.381 . . . . 61.4 110.899 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -112.46 162.93 15.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 75.52 110.929 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -165.71 164.8 18.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 74.35 111.065 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -143.01 163.05 33.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 50.01 111.084 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 10.9 p -137.77 136.34 45.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 70.34 111.172 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -139.23 165.51 26.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 65.31 111.086 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -145.11 132.34 20.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 64.34 110.88 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 241' ' ' ILE . . . . . 0.589 HG13 HG11 ' A' ' 216' ' ' VAL . 36.3 mm -127.21 116.89 45.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 73.23 111.155 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 242' ' ' THR . . . . . 0.588 HG23 ' HG3' ' A' ' 223' ' ' LYS . 2.1 m -84.22 141.68 30.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.192 -0.458 . . . . 53.53 111.138 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 21.5 t -120.0 121.5 66.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.243 -0.435 . . . . 42.32 111.127 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 244' ' ' THR . . . . . 0.502 HG23 ' O ' ' A' ' 173' ' ' VAL . 7.6 p -82.58 132.8 35.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 70.31 111.166 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 245' ' ' ALA . . . . . 0.669 ' HA ' ' HB2' ' A' ' 221' ' ' ALA . . . -55.78 -25.29 40.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 61.13 111.082 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 9.7 t . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 74.31 110.857 -179.774 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.892 0.377 . . . . 43.31 111.089 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 2.3 m -124.89 13.93 8.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.243 -0.435 . . . . 74.52 111.139 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 163.26 104.71 0.19 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.715 -0.755 . . . . 45.25 112.504 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 21.5 ttp -110.62 134.48 52.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.839 0.352 . . . . 74.13 110.9 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.651 ' OG1' ' HB3' ' A' ' 184' ' ' ALA . 1.8 p -119.62 95.44 4.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.256 -0.429 . . . . 64.33 111.173 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 1.02 HG22 HG13 ' A' ' 183' ' ' VAL . 21.8 t -97.21 117.9 42.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.439 . . . . 73.41 111.168 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 60.8 m -112.72 91.61 17.93 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.574 0.702 . . . . 74.14 111.17 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.472 ' HB3' HD23 ' A' ' 181' ' ' LEU . 53.7 Cg_endo -69.8 -168.23 0.26 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.638 2.226 . . . . 71.54 112.361 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -86.6 -44.57 11.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.438 . . . . 61.53 111.104 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 37.8 t 49.82 76.93 0.12 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.257 -0.429 . . . . 50.03 110.887 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.4 t -175.05 -174.91 0.8 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.111 -0.495 . . . . 71.04 111.14 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 33.3 p -99.15 158.42 15.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 64.13 110.856 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.738 HG22 ' HB2' ' A' ' 177' ' ' GLN . 3.3 p -140.22 152.37 21.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.103 -0.499 . . . . 73.15 111.096 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 95.5 t -84.6 143.66 11.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.166 -0.47 . . . . 72.41 111.093 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -48.04 122.5 5.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 73.55 110.917 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.85 -14.6 60.15 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.712 -0.756 . . . . 53.53 112.473 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' GLN . . . . . 0.738 ' HB2' HG22 ' A' ' 173' ' ' VAL . 16.7 mm100 -90.63 -178.31 5.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.824 0.345 . . . . 73.11 110.889 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 27.4 p -161.52 149.14 14.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 55.53 110.825 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 7.3 t -108.21 -173.68 2.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.481 . . . . 73.43 111.136 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -140.47 132.1 27.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.451 . . . . 42.13 111.161 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.472 HD23 ' HB3' ' A' ' 168' ' ' PRO . 7.3 mp -105.37 142.02 35.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.246 -0.434 . . . . 75.03 110.918 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 3.6 m -108.42 142.12 39.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 74.32 111.128 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 1.02 HG13 HG22 ' A' ' 166' ' ' VAL . 16.5 t -129.79 136.37 59.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 63.34 111.13 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.651 ' HB3' ' OG1' ' A' ' 165' ' ' THR . . . -124.33 155.86 37.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.243 -0.435 . . . . 70.44 111.076 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -142.83 125.25 15.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 71.21 110.884 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.48 63.06 46.34 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.557 0.694 . . . . 62.13 110.903 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--N 1.342 0.194 0 C-N-CA 122.668 2.245 . . . . 74.34 112.317 179.99 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.856 0.36 . . . . 75.41 110.848 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.17 70.71 7.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 64.34 110.866 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 1.1 m -93.79 -5.3 48.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 75.5 110.886 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.75 ' CE2' HG11 ' A' ' 183' ' ' VAL . 7.2 p90 -89.77 171.87 9.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.107 -0.497 . . . . 71.05 110.873 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.68 167.17 17.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.141 -0.481 . . . . 74.51 110.852 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 197' ' ' ALA . . . . . 0.421 ' HB3' ' HB ' ' A' ' 209' ' ' VAL . . . -113.19 167.84 10.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.178 -0.464 . . . . 73.55 111.077 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 10.5 p -173.65 151.52 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 75.23 111.168 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.8 t -78.44 152.55 32.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 71.43 110.852 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.567 ' HB2' ' HD3' ' A' ' 227' ' ' PRO . . . -89.97 -21.61 22.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 63.45 111.122 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -129.14 -54.63 1.19 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 74.21 110.906 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 3.0 ttpp 63.63 25.52 14.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 75.34 110.915 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 32.3 p -112.59 -4.85 14.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.469 . . . . 51.45 111.11 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 9.1 mtmm -151.94 18.28 0.68 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 71.53 110.947 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.63 ' HA ' HG23 ' A' ' 219' ' ' VAL . . . -174.91 147.36 0.97 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 65.05 111.122 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 16.7 p -108.59 157.78 18.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 71.25 111.101 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.779 HG12 HG22 ' A' ' 216' ' ' VAL . 12.3 m -140.6 140.85 33.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 54.45 111.133 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 10.0 m -148.68 108.77 4.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 52.12 110.863 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.463 ' HA ' ' HA ' ' A' ' 214' ' ' ILE . 3.2 p -87.07 135.43 25.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.154 -0.475 . . . . 70.5 111.148 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 3.3 m -161.31 121.96 2.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 32.51 110.858 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 54.72 49.08 62.95 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.752 -0.737 . . . . 64.42 112.511 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER 63.3 16.38 9.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.853 0.359 . . . . 70.5 110.877 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 3.3 m -126.46 109.41 12.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 72.04 111.167 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.463 ' HA ' ' HA ' ' A' ' 209' ' ' VAL . 2.1 mp -105.18 114.09 43.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 75.33 111.11 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 6.2 m -87.9 130.51 34.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 75.03 111.124 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.779 HG22 HG12 ' A' ' 207' ' ' VAL . 2.8 t -115.93 123.91 71.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.449 . . . . 71.54 111.144 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -106.78 139.74 40.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 75.53 110.864 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -94.79 79.8 0.89 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.804 -0.712 . . . . 63.4 112.45 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.63 HG23 ' HA ' ' A' ' 205' ' ' ALA . 18.5 t -50.75 -55.63 6.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.858 0.361 . . . . 74.24 111.112 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -129.36 163.87 24.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 60.41 111.125 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 221' ' ' ALA . . . . . 0.673 ' HB2' ' HA ' ' A' ' 245' ' ' ALA . . . -63.17 142.26 58.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 51.15 111.085 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 139.04 171.56 12.23 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.78 -0.724 . . . . 70.42 112.495 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 223' ' ' LYS . . . . . 0.614 ' HG3' HG23 ' A' ' 242' ' ' THR . 14.9 mttt -100.73 121.57 41.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.788 0.328 . . . . 62.11 110.88 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.6 HG11 ' CB ' ' A' ' 205' ' ' ALA . 7.4 p -120.62 126.23 75.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 74.13 111.124 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 225' ' ' ASN . . . . . 0.627 ' C ' HD12 ' A' ' 226' ' ' ILE . 30.0 m120 -90.66 154.3 19.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.127 -0.488 . . . . 71.05 110.908 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.627 HD12 ' C ' ' A' ' 225' ' ' ASN . 4.1 mp -137.02 93.16 13.55 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.619 0.723 . . . . 73.43 111.102 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 227' ' ' PRO . . . . . 0.567 ' HD3' ' HB2' ' A' ' 200' ' ' ALA . 54.1 Cg_endo -69.81 -178.61 2.44 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.723 2.282 . . . . 74.54 112.305 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 99.4 t -150.29 138.32 14.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.169 -0.468 . . . . 72.23 111.069 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 66.6 t -121.47 139.39 48.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.166 -0.47 . . . . 64.41 111.124 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 7.4 m -122.45 125.53 46.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 71.5 110.851 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 55.54 -115.35 5.75 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.716 -0.754 . . . . 72.13 112.474 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -103.29 17.42 24.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.896 0.379 . . . . 72.05 110.897 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 114.01 9.73 15.37 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.778 -0.725 . . . . 72.32 112.513 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -52.01 -73.44 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.874 0.368 . . . . 71.22 110.921 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -104.15 162.48 13.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 72.11 110.879 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -158.93 165.1 34.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.469 . . . . 44.04 111.097 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -144.1 163.36 33.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 45.25 111.099 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 11.5 p -138.0 135.38 45.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.201 -0.454 . . . . 54.12 111.125 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.84 164.26 30.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 71.42 111.071 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 240' ' ' GLU . . . . . 0.52 ' O ' HD13 ' A' ' 241' ' ' ILE . 2.3 pt-20 -141.55 131.85 25.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 74.45 110.921 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 241' ' ' ILE . . . . . 0.607 HG13 HG11 ' A' ' 216' ' ' VAL . 23.9 mm -127.43 110.64 22.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.154 -0.476 . . . . 43.53 111.161 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 242' ' ' THR . . . . . 0.614 HG23 ' HG3' ' A' ' 223' ' ' LYS . 1.4 m -81.32 141.43 34.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 62.52 111.139 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 15.7 t -120.13 122.78 69.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 53.22 111.137 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 14.6 p -82.41 133.62 35.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 52.05 111.14 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 245' ' ' ALA . . . . . 0.673 ' HA ' ' HB2' ' A' ' 221' ' ' ALA . . . -59.16 -21.88 60.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 72.42 111.058 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 67.0 m . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.239 -0.437 . . . . 74.42 110.859 -179.732 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.182 0 CA-C-O 120.902 0.382 . . . . 73.31 111.075 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.88 32.94 5.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.233 -0.44 . . . . 73.22 111.148 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 135.27 99.63 0.6 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.721 -0.752 . . . . 45.42 112.51 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 18.8 ttp -110.88 128.15 55.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.824 0.345 . . . . 70.24 110.907 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.481 ' OG1' ' HB3' ' A' ' 184' ' ' ALA . 38.9 p -116.29 107.4 14.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 71.31 111.116 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 1.063 HG22 HG13 ' A' ' 183' ' ' VAL . 21.2 t -102.24 131.1 50.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.246 -0.434 . . . . 71.2 111.141 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -123.58 91.86 49.3 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.554 0.693 . . . . 64.05 111.189 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.485 ' HB3' HD23 ' A' ' 181' ' ' LEU . 53.3 Cg_endo -69.77 -167.05 0.21 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.653 2.235 . . . . 74.43 112.34 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -92.55 -45.19 8.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.45 . . . . 42.4 111.117 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 73.1 m 48.08 85.42 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 75.14 110.905 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 8.4 t -176.0 -176.01 0.78 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 74.14 111.173 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 75.8 p -97.07 153.49 17.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 70.33 110.852 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.711 HG22 ' HB2' ' A' ' 177' ' ' GLN . 3.3 p -139.07 153.54 24.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.139 -0.482 . . . . 54.14 111.127 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 67.2 t -87.6 145.05 8.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.167 -0.47 . . . . 71.43 111.151 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -48.42 122.66 5.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 72.01 110.914 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.98 -15.35 59.45 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.756 -0.735 . . . . 71.31 112.487 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' GLN . . . . . 0.711 ' HB2' HG22 ' A' ' 173' ' ' VAL . 11.8 mm100 -90.62 -178.63 5.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.781 0.324 . . . . 72.44 110.943 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 65.4 p -161.96 149.7 14.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 63.34 110.838 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.409 HG21 HD12 ' A' ' 241' ' ' ILE . 7.8 t -107.19 -173.89 2.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.105 -0.498 . . . . 74.33 111.115 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.76 132.25 28.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.201 -0.454 . . . . 74.53 111.111 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.485 HD23 ' HB3' ' A' ' 168' ' ' PRO . 7.6 mp -105.8 143.66 33.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.186 -0.461 . . . . 72.14 110.933 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 4.0 m -111.35 142.98 42.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.444 . . . . 63.31 111.133 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 1.063 HG13 HG22 ' A' ' 166' ' ' VAL . 21.8 t -129.69 143.41 41.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.255 -0.429 . . . . 70.24 111.185 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.481 ' HB3' ' OG1' ' A' ' 165' ' ' THR . . . -134.48 152.06 51.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 44.44 111.106 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -144.88 126.53 15.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 70.42 110.878 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.81 67.77 68.93 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.594 0.712 . . . . 75.03 110.877 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo . . . . . 0 C--N 1.342 0.187 0 C-N-CA 122.657 2.238 . . . . 62.33 112.333 179.983 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 2.2 t70 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.849 0.357 . . . . 73.35 110.887 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt -58.15 98.43 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.44 . . . . 71.51 110.874 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 2.6 t -111.61 -6.8 14.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 74.42 110.878 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.769 ' CE2' HG11 ' A' ' 183' ' ' VAL . 20.0 p90 -90.97 174.58 7.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.15 -0.477 . . . . 74.52 110.899 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -165.81 154.95 11.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 65.22 110.861 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -103.89 165.63 10.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 73.03 111.076 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 10.4 p -169.17 152.17 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 65.24 111.122 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.4 p -81.93 140.22 34.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 74.43 110.863 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.506 ' HB2' ' HD3' ' A' ' 227' ' ' PRO . . . -76.52 -23.34 53.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.107 -0.497 . . . . 72.13 111.069 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -134.82 -53.61 0.81 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.436 . . . . 74.34 110.845 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 2.8 ttpp 63.66 33.85 12.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.44 . . . . 75.3 110.918 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 50.8 p -116.65 -3.26 11.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.196 -0.456 . . . . 74.34 111.121 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 204' ' ' LYS . . . . . 0.412 ' HG2' ' HB3' ' A' ' 220' ' ' ALA . 8.0 mtmm -153.19 18.75 0.57 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 73.35 110.854 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.642 ' HA ' HG23 ' A' ' 219' ' ' VAL . . . -172.42 148.09 2.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 72.52 111.083 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 17.1 p -111.69 142.37 44.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 74.1 111.192 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.905 HG12 HG22 ' A' ' 216' ' ' VAL . 16.2 m -126.7 140.15 49.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.267 -0.424 . . . . 71.42 111.146 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 28.4 m -146.68 108.99 4.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 74.33 110.846 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.535 HG23 HG13 ' A' ' 214' ' ' ILE . 3.7 p -86.87 143.27 11.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.08 -0.509 . . . . 74.2 111.112 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 43.7 t -171.45 123.57 0.56 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.152 -0.477 . . . . 75.23 110.881 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 55.14 48.29 69.05 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.73 -0.748 . . . . 71.34 112.479 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 1.8 mtp 62.5 16.59 8.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.834 0.35 . . . . 55.04 110.889 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 2.3 m -127.55 113.55 16.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 74.21 111.175 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.535 HG13 HG23 ' A' ' 209' ' ' VAL . 3.0 mp -109.9 115.96 51.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.241 -0.436 . . . . 73.52 111.15 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 3.4 m -89.1 130.83 35.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.439 . . . . 65.42 111.127 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.905 HG22 HG12 ' A' ' 207' ' ' VAL . 3.0 t -116.24 121.06 66.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.24 -0.436 . . . . 72.43 111.124 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -104.79 139.83 38.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 65.15 110.863 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -94.28 79.65 0.95 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.729 -0.748 . . . . 42.33 112.502 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.642 HG23 ' HA ' ' A' ' 205' ' ' ALA . 19.7 t -49.95 -56.39 3.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.837 0.351 . . . . 64.12 111.154 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 220' ' ' ALA . . . . . 0.412 ' HB3' ' HG2' ' A' ' 204' ' ' LYS . . . -127.77 163.35 24.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 42.02 111.07 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 221' ' ' ALA . . . . . 0.678 ' HB2' ' HA ' ' A' ' 245' ' ' ALA . . . -63.45 137.75 58.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 62.24 111.092 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 142.4 167.53 11.42 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.74 -0.743 . . . . 70.44 112.515 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 223' ' ' LYS . . . . . 0.606 ' HG3' HG23 ' A' ' 242' ' ' THR . 6.2 mttp -98.72 124.58 43.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.876 0.369 . . . . 62.22 110.874 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.497 HG11 ' CB ' ' A' ' 205' ' ' ALA . 7.4 p -121.96 129.76 75.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.218 -0.446 . . . . 71.43 111.119 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 225' ' ' ASN . . . . . 0.626 ' C ' HD12 ' A' ' 226' ' ' ILE . 27.4 m120 -90.62 152.48 20.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 61.5 110.876 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.626 HD12 ' C ' ' A' ' 225' ' ' ASN . 4.2 mp -138.2 92.83 11.97 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.611 0.72 . . . . 71.02 111.12 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 227' ' ' PRO . . . . . 0.506 ' HD3' ' HB2' ' A' ' 200' ' ' ALA . 53.6 Cg_endo -69.73 -177.79 2.03 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.658 2.239 . . . . 51.22 112.379 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.506 ' CG2' ' HB3' ' A' ' 237' ' ' ALA . 99.7 t -150.08 137.82 13.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 64.04 111.084 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 88.1 t -117.94 132.82 66.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 71.22 111.12 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -121.72 137.52 54.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 74.2 110.858 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 51.91 -118.88 7.78 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.707 -0.758 . . . . 42.32 112.51 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -105.5 21.09 17.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.918 0.39 . . . . 52.41 110.933 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 107.27 12.01 24.41 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.706 -0.759 . . . . 62.33 112.49 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -63.14 -58.97 5.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.842 0.353 . . . . 62.41 110.901 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -105.58 167.22 9.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.464 . . . . 74.33 110.89 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -166.13 165.04 17.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.165 -0.471 . . . . 51.34 111.115 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 237' ' ' ALA . . . . . 0.506 ' HB3' ' CG2' ' A' ' 228' ' ' VAL . . . -139.52 163.2 33.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 73.42 111.064 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 52.4 t -137.52 132.11 44.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.441 . . . . 61.42 111.137 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 239' ' ' ALA . . . . . 0.448 ' HB2' ' HG3' ' A' ' 168' ' ' PRO . . . -139.23 162.48 34.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 71.12 111.094 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -145.51 124.37 12.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 75.22 110.898 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 241' ' ' ILE . . . . . 0.662 HG13 HG11 ' A' ' 216' ' ' VAL . 29.6 mm -119.1 109.13 25.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.12 -0.491 . . . . 72.02 111.135 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 242' ' ' THR . . . . . 0.606 HG23 ' HG3' ' A' ' 223' ' ' LYS . 4.2 m -80.31 141.83 35.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 73.01 111.12 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 18.5 t -119.22 121.1 65.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 75.54 111.18 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 244' ' ' THR . . . . . 0.502 HG23 ' O ' ' A' ' 173' ' ' VAL . 6.7 p -81.67 132.85 35.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.188 -0.46 . . . . 70.35 111.185 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 245' ' ' ALA . . . . . 0.678 ' HA ' ' HB2' ' A' ' 221' ' ' ALA . . . -58.46 -21.7 52.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.226 -0.443 . . . . 70.54 111.076 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 76.5 p . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.224 -0.444 . . . . 40.52 110.83 -179.769 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.826 0.346 . . . . 75.44 111.105 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.735 HG22 ' HA ' ' A' ' 187' ' ' PRO . 4.7 t -120.69 22.37 11.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 71.23 111.171 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 147.23 100.38 0.25 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.775 -0.726 . . . . 74.21 112.524 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -110.04 136.5 49.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.88 0.371 . . . . 74.42 110.876 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.646 ' OG1' ' HB3' ' A' ' 184' ' ' ALA . 68.6 p -116.11 105.65 12.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 71.25 111.147 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 1.069 HG22 HG13 ' A' ' 183' ' ' VAL . 45.7 t -98.48 130.14 47.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.198 -0.456 . . . . 74.22 111.094 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 8.9 m -126.66 92.72 44.26 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.537 0.684 . . . . 72.01 111.128 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.532 ' HG3' ' HB2' ' A' ' 239' ' ' ALA . 54.1 Cg_endo -69.72 -166.07 0.17 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.67 2.246 . . . . 74.32 112.352 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -87.05 -40.13 14.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 64.42 111.114 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 99.5 p 46.47 78.81 0.06 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.439 . . . . 70.44 110.876 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.5 t -175.27 -174.96 0.78 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.11 -0.496 . . . . 64.35 111.174 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 99.1 p -99.79 162.94 12.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.261 -0.427 . . . . 42.32 110.85 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.79 HG22 ' HB2' ' A' ' 177' ' ' GLN . 1.9 p -147.06 151.68 13.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 73.32 111.114 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 69.3 t -87.62 145.35 7.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.475 . . . . 62.33 111.116 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.31 123.1 6.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 71.41 110.92 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 100.49 -15.87 58.34 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.758 -0.734 . . . . 65.41 112.526 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 177' ' ' GLN . . . . . 0.79 ' HB2' HG22 ' A' ' 173' ' ' VAL . 12.9 mm100 -86.51 -177.09 6.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.819 0.343 . . . . 63.21 110.921 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 1.4 p -161.02 149.31 15.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 63.2 110.838 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 8.9 t -113.26 -178.25 3.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.09 -0.504 . . . . 71.05 111.113 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -138.61 128.89 25.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.203 -0.453 . . . . 55.41 111.16 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.457 HD23 ' HB3' ' A' ' 168' ' ' PRO . 7.6 mp -101.69 147.96 25.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 73.4 110.866 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 7.4 m -115.23 142.79 46.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.198 -0.456 . . . . 71.41 111.135 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 1.069 HG13 HG22 ' A' ' 166' ' ' VAL . 30.0 t -129.72 142.56 43.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 71.42 111.139 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.646 ' HB3' ' OG1' ' A' ' 165' ' ' THR . . . -130.41 152.94 49.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 35.23 111.078 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -146.4 131.85 18.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 52.32 110.885 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -127.71 68.05 73.95 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.544 0.688 . . . . 72.42 110.931 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.735 ' HA ' HG22 ' A' ' 162' ' ' THR . 53.4 Cg_endo . . . . . 0 C--O 1.231 0.136 0 C-N-CA 122.692 2.262 . . . . 64.21 112.345 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 15.2 t0 . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.9 0.381 . . . . 74.22 110.865 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.16 76.6 6.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.197 -0.456 . . . . 73.33 110.918 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 4.9 m -86.07 -6.48 59.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.258 -0.428 . . . . 53.12 110.86 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.775 ' CE2' HG11 ' A' ' 183' ' ' VAL . 20.2 p90 -90.74 173.4 8.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.129 -0.487 . . . . 63.13 110.867 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 23.4 ptt180 -163.04 172.56 14.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.138 -0.483 . . . . 71.13 110.874 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 197' ' ' ALA . . . . . 0.549 ' HB3' ' HB ' ' A' ' 209' ' ' VAL . . . -121.38 167.86 12.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 75.45 111.074 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 8.3 p -174.05 153.82 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 74.15 111.089 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.49 129.14 38.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.121 -0.491 . . . . 72.32 110.834 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.445 ' HB2' ' HD3' ' A' ' 227' ' ' PRO . . . -65.92 -21.86 66.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.114 -0.494 . . . . 64.34 111.078 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -155.45 86.85 1.09 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.245 -0.434 . . . . 43.14 110.869 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 24.4 ttmt -79.23 58.46 2.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.44 . . . . 71.42 110.905 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 27.6 p -132.89 3.68 3.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 74.4 111.123 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 204' ' ' LYS . . . . . 0.444 ' HA ' ' HB3' ' A' ' 220' ' ' ALA . 12.9 mtmm -154.22 16.51 0.48 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.238 -0.437 . . . . 60.33 110.918 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.4 ' HA ' ' H ' ' A' ' 219' ' ' VAL . . . -179.96 152.96 0.49 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.436 . . . . 72.34 111.068 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 12.1 p -107.9 154.13 22.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 74.33 111.17 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.73 HG12 HG22 ' A' ' 216' ' ' VAL . 13.3 m -140.58 136.36 35.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 74.34 111.124 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 208' ' ' SER . . . . . 0.527 ' C ' HG23 ' A' ' 214' ' ' ILE . 1.2 t -144.99 108.44 4.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.459 . . . . 62.31 110.85 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.637 HG23 HG13 ' A' ' 214' ' ' ILE . 4.4 p -91.01 143.68 10.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 72.52 111.139 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 7.8 t -144.97 98.16 3.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 65.12 110.843 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 70.24 -81.63 0.36 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.748 -0.739 . . . . 74.12 112.497 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -138.78 7.68 2.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.838 0.351 . . . . 63.43 110.86 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 1.6 m -129.16 123.03 31.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.444 . . . . 74.14 111.185 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.637 HG13 HG23 ' A' ' 209' ' ' VAL . 2.4 mp -114.6 140.49 35.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 64.24 111.17 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.0 128.59 54.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 62.41 111.087 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.73 HG22 HG12 ' A' ' 207' ' ' VAL . 2.6 t -118.72 134.24 62.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 73.45 111.125 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -119.27 137.19 53.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 65.4 110.923 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -85.7 68.88 3.32 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.778 -0.725 . . . . 54.52 112.491 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.425 HG12 ' N ' ' A' ' 220' ' ' ALA . 1.9 t -49.45 -53.98 7.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.812 0.339 . . . . 63.1 111.116 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 220' ' ' ALA . . . . . 0.444 ' HB3' ' HA ' ' A' ' 204' ' ' LYS . . . -123.71 155.2 38.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 73.31 111.134 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 221' ' ' ALA . . . . . 0.664 ' HB2' ' HA ' ' A' ' 245' ' ' ALA . . . -67.27 137.11 55.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.238 -0.437 . . . . 65.43 111.106 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 141.32 175.09 14.67 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.703 -0.76 . . . . 70.12 112.503 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 223' ' ' LYS . . . . . 0.495 ' HG3' HG23 ' A' ' 242' ' ' THR . 5.1 mttp -98.86 122.24 41.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.787 0.327 . . . . 72.21 110.926 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 6.4 p -119.15 127.35 75.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 53.22 111.123 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 225' ' ' ASN . . . . . 0.418 ' C ' HD12 ' A' ' 226' ' ' ILE . 30.6 m120 -90.7 145.4 24.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 64.03 110.916 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.418 HD12 ' C ' ' A' ' 225' ' ' ASN . 4.8 mp -131.12 92.56 32.8 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.657 0.742 . . . . 72.35 111.126 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 227' ' ' PRO . . . . . 0.445 ' HD3' ' HB2' ' A' ' 200' ' ' ALA . 53.6 Cg_endo -69.75 179.21 3.85 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.705 2.27 . . . . 74.2 112.338 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.456 ' HB ' ' HB3' ' A' ' 237' ' ' ALA . 58.0 t -148.36 137.27 15.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 61.01 111.155 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 46.1 t -116.93 135.91 55.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 74.13 111.123 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.25 107.37 12.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 74.02 110.844 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 74.94 -118.23 5.6 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.752 -0.737 . . . . 52.21 112.492 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -108.06 19.95 19.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.851 0.357 . . . . 74.55 110.867 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 116.49 2.87 19.29 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.733 -0.746 . . . . 55.01 112.52 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -51.47 -71.47 0.06 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.876 0.37 . . . . 65.43 110.88 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -109.32 151.63 26.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 70.31 110.86 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -149.46 161.73 41.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 40.14 111.138 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 237' ' ' ALA . . . . . 0.456 ' HB3' ' HB ' ' A' ' 228' ' ' VAL . . . -139.61 163.15 33.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.246 -0.434 . . . . 73.54 111.149 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 43.0 t -136.58 139.58 44.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.281 -0.418 . . . . 73.21 111.117 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 239' ' ' ALA . . . . . 0.532 ' HB2' ' HG3' ' A' ' 168' ' ' PRO . . . -139.26 164.37 29.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.237 -0.438 . . . . 74.2 111.109 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 240' ' ' GLU . . . . . 0.448 ' O ' HD13 ' A' ' 241' ' ' ILE . 1.7 pt-20 -143.71 128.72 18.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.239 -0.437 . . . . 54.53 110.861 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 241' ' ' ILE . . . . . 0.448 HD13 ' O ' ' A' ' 240' ' ' GLU . 29.1 mm -125.2 110.85 25.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 72.52 111.156 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 242' ' ' THR . . . . . 0.495 HG23 ' HG3' ' A' ' 223' ' ' LYS . 1.5 m -80.75 138.82 36.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 73.35 111.191 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 18.3 t -120.07 117.82 54.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.24 -0.436 . . . . 65.24 111.152 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 244' ' ' THR . . . . . 0.481 HG23 ' O ' ' A' ' 173' ' ' VAL . 4.3 p -81.86 132.94 35.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 54.44 111.149 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 245' ' ' ALA . . . . . 0.664 ' HA ' ' HB2' ' A' ' 221' ' ' ALA . . . -53.24 -28.52 27.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 71.03 111.106 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 1.4 t . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 61.14 110.845 -179.789 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 N-CA-C 112.507 -0.237 . . . . 50.34 112.507 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -95.23 90.48 5.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.744 0.306 . . . . 74.12 111.059 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 7.7 mtt -151.26 174.43 13.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.235 -0.439 . . . . 74.23 110.903 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -122.54 128.15 50.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.255 -0.43 . . . . 65.31 111.104 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.718 ' HB2' ' HA3' ' A' ' 231' ' ' GLY . . . -64.08 -70.01 0.25 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.251 -0.431 . . . . 75.45 111.119 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -178.55 -169.16 0.17 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.449 . . . . 75.33 111.051 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -127.6 24.34 6.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 51.12 111.155 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 151.54 99.08 0.18 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.776 -0.726 . . . . 42.12 112.551 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 43.8 ttp -113.13 125.5 54.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.846 0.355 . . . . 72.42 110.901 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.64 ' OG1' ' HB3' ' A' ' 184' ' ' ALA . 51.6 p -114.47 103.62 11.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 61.22 111.153 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 1.087 HG22 HG13 ' A' ' 183' ' ' VAL . 21.4 t -99.7 130.48 48.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.256 -0.429 . . . . 73.35 111.117 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.3 m -125.0 92.88 46.81 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.593 0.711 . . . . 73.2 111.113 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.473 ' HB3' HD23 ' A' ' 181' ' ' LEU . 53.7 Cg_endo -69.74 -168.85 0.29 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.668 2.245 . . . . 65.01 112.381 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -86.73 -40.84 14.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.279 -0.419 . . . . 74.43 111.104 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 93.6 p 46.43 79.06 0.06 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.245 -0.434 . . . . 51.33 110.851 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.5 t -175.09 -174.89 0.8 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.126 -0.488 . . . . 62.44 111.118 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 89.4 p -98.8 164.06 12.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 73.4 110.849 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.715 HG22 ' HB2' ' A' ' 177' ' ' GLN . 3.5 p -146.31 154.02 12.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 65.33 111.111 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 66.7 t -87.35 145.31 7.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 71.11 111.071 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -49.03 122.56 5.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.134 -0.484 . . . . 71.12 110.923 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.38 -14.59 60.83 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.75 -0.738 . . . . 74.12 112.476 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.715 ' HB2' HG22 ' A' ' 173' ' ' VAL . 17.4 mm100 -90.82 -178.22 5.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.83 0.347 . . . . 72.52 110.927 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 35.1 p -161.51 148.49 14.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.224 -0.444 . . . . 74.43 110.85 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.484 HG21 HD12 ' A' ' 241' ' ' ILE . 6.7 t -106.81 -173.55 2.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.075 -0.511 . . . . 53.43 111.151 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.29 132.31 27.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.231 -0.44 . . . . 75.5 111.133 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.473 HD23 ' HB3' ' A' ' 168' ' ' PRO . 7.7 mp -105.21 143.05 33.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 72.44 110.951 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 21.9 m -110.06 142.36 41.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.217 -0.447 . . . . 72.52 111.118 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 1.087 HG13 HG22 ' A' ' 166' ' ' VAL . 18.4 t -129.34 140.24 49.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 73.33 111.13 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.64 ' HB3' ' OG1' ' A' ' 165' ' ' THR . . . -130.11 152.12 49.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.143 -0.48 . . . . 64.45 111.098 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -145.76 126.88 14.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 74.41 110.865 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.58 66.71 77.33 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.542 0.687 . . . . 73.12 110.921 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -38.37 7.91 Favored 'Trans proline' 0 N--CA 1.465 -0.155 0 C-N-CA 122.676 2.251 . . . . 73.45 112.377 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 66.92 45.68 1.77 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 71.03 110.892 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 163.74 -24.13 0.18 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.744 -0.741 . . . . 44.34 112.467 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 3.4 t -93.36 -58.99 3.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.918 0.39 . . . . 71.52 111.15 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 70.3 p 47.42 70.5 0.41 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 71.14 111.119 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -167.8 119.41 0.86 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 65.53 110.876 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.12 92.43 0.11 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 54.42 110.913 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 1.6 m -105.78 -7.08 18.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 60.32 110.831 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.776 ' CE2' HG11 ' A' ' 183' ' ' VAL . 19.2 p90 -91.34 176.35 6.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.098 -0.501 . . . . 72.43 110.913 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -163.05 171.16 16.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.459 . . . . 73.43 110.839 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 197' ' ' ALA . . . . . 0.416 ' HB3' ' HB ' ' A' ' 209' ' ' VAL . . . -120.31 168.0 11.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 72.43 111.078 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 11.3 p -175.21 151.45 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 75.0 111.108 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.7 t -77.31 150.15 35.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.126 -0.488 . . . . 53.03 110.858 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.522 ' HB2' ' HD3' ' A' ' 227' ' ' PRO . . . -86.32 -23.79 26.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 63.15 111.138 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -127.7 -52.52 1.35 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.19 -0.459 . . . . 64.34 110.831 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.24 24.39 14.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.2 -0.455 . . . . 74.44 110.91 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 35.5 p -113.37 -2.73 13.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.246 -0.433 . . . . 71.41 111.138 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 8.8 mtmm -152.59 18.53 0.62 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.251 -0.432 . . . . 74.34 110.878 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.629 ' HA ' HG23 ' A' ' 219' ' ' VAL . . . -177.22 146.61 0.5 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 73.13 111.089 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 11.9 p -107.22 159.04 16.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.174 -0.467 . . . . 50.12 111.117 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.769 HG12 HG22 ' A' ' 216' ' ' VAL . 11.2 m -141.23 141.72 30.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 53.1 111.141 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 4.3 m -148.76 108.46 4.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 72.3 110.843 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.494 HG23 HG13 ' A' ' 214' ' ' ILE . 3.5 p -87.96 143.1 11.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.132 -0.485 . . . . 74.3 111.132 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 16.7 t -172.08 123.45 0.5 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 73.33 110.841 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 55.86 47.16 80.96 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.745 -0.74 . . . . 75.14 112.488 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 2.1 mtp 63.74 16.01 9.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.853 0.359 . . . . 71.52 110.896 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 7.0 m -126.0 113.59 17.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 63.42 111.146 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.494 HG13 HG23 ' A' ' 209' ' ' VAL . 2.9 mp -110.23 113.96 45.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 75.11 111.125 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 5.0 m -88.1 132.16 34.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.45 . . . . 74.31 111.123 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.769 HG22 HG12 ' A' ' 207' ' ' VAL . 3.3 t -117.21 124.47 73.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 64.51 111.082 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -106.19 139.33 40.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 73.31 110.907 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -94.22 79.57 0.96 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.782 -0.723 . . . . 60.34 112.495 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.629 HG23 ' HA ' ' A' ' 205' ' ' ALA . 19.6 t -50.29 -55.96 4.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.792 0.329 . . . . 63.53 111.175 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -128.71 161.4 29.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 54.44 111.095 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' ALA . . . . . 0.684 ' HB2' ' HA ' ' A' ' 245' ' ' ALA . . . -61.06 140.31 57.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.215 -0.448 . . . . 71.22 111.121 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 139.41 171.21 12.15 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.743 -0.741 . . . . 74.41 112.488 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' LYS . . . . . 0.495 ' HG3' HG23 ' A' ' 242' ' ' THR . 14.3 mttt -99.46 124.56 44.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.821 0.343 . . . . 54.4 110.941 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.593 HG11 ' CB ' ' A' ' 205' ' ' ALA . 7.0 p -120.96 127.37 75.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 72.11 111.169 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 225' ' ' ASN . . . . . 0.606 ' C ' HD12 ' A' ' 226' ' ' ILE . 21.3 m120 -90.81 151.81 21.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 64.31 110.906 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.606 HD12 ' C ' ' A' ' 225' ' ' ASN . 4.4 mp -138.06 93.12 12.0 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.622 0.725 . . . . 71.12 111.125 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 227' ' ' PRO . . . . . 0.522 ' HD3' ' HB2' ' A' ' 200' ' ' ALA . 53.6 Cg_endo -69.79 -178.3 2.29 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.708 2.272 . . . . 71.22 112.34 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 90.5 t -150.09 134.78 9.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 61.21 111.137 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 80.4 t -117.08 135.59 56.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.147 -0.478 . . . . 65.23 111.161 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' SER . . . . . 0.488 ' OG ' ' HB1' ' A' ' 160' ' ' ALA . 31.0 t -122.12 116.65 24.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 74.12 110.871 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 231' ' ' GLY . . . . . 0.718 ' HA3' ' HB2' ' A' ' 160' ' ' ALA . . . 66.48 -115.04 6.98 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.729 -0.748 . . . . 63.11 112.464 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -110.54 19.23 18.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.874 0.369 . . . . 65.22 110.888 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 117.33 2.72 17.69 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.748 -0.739 . . . . 75.44 112.485 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -51.06 -70.36 0.09 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.866 0.365 . . . . 70.22 110.902 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -107.38 159.66 16.22 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.172 -0.467 . . . . 72.53 110.852 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -160.75 165.19 30.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.103 -0.499 . . . . 74.41 111.091 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -146.2 163.18 36.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 71.44 111.135 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 24.1 t -137.18 137.02 46.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.215 -0.448 . . . . 62.04 111.11 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -139.08 165.29 27.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.173 -0.467 . . . . 73.53 111.134 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' GLU . . . . . 0.419 ' O ' HD13 ' A' ' 241' ' ' ILE . 5.8 pt-20 -144.95 132.51 20.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.244 -0.434 . . . . 74.14 110.851 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 241' ' ' ILE . . . . . 0.587 HG13 HG11 ' A' ' 216' ' ' VAL . 23.5 mm -126.87 115.09 40.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.134 -0.485 . . . . 72.25 111.174 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 242' ' ' THR . . . . . 0.495 HG23 ' HG3' ' A' ' 223' ' ' LYS . 2.0 m -82.43 141.24 32.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.152 -0.476 . . . . 62.0 111.162 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 17.8 t -119.71 121.54 66.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 52.4 111.128 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' THR . . . . . 0.529 HG23 ' O ' ' A' ' 173' ' ' VAL . 7.1 p -82.28 133.0 35.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 73.42 111.17 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 245' ' ' ALA . . . . . 0.684 ' HA ' ' HB2' ' A' ' 221' ' ' ALA . . . -58.33 -22.52 53.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 34.23 111.113 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 1.4 p . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.197 -0.456 . . . . 73.3 110.866 -179.77 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 N-CA-C 112.539 -0.224 . . . . 62.4 112.539 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -112.3 159.2 18.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.821 0.343 . . . . 73.11 111.09 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 4.1 mmt -134.4 178.92 6.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 71.24 110.9 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -137.33 142.62 41.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.249 -0.432 . . . . 73.31 111.129 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.728 ' HB2' ' HA3' ' A' ' 231' ' ' GLY . . . -60.67 -64.75 0.84 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 74.02 111.09 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -177.78 -169.6 0.22 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 71.22 111.093 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -129.25 24.09 5.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.24 -0.436 . . . . 64.44 111.088 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 153.28 99.85 0.18 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.734 -0.746 . . . . 74.03 112.448 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 21.3 ttp -113.85 124.6 52.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.85 0.357 . . . . 64.55 110.872 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.648 ' OG1' ' HB3' ' A' ' 184' ' ' ALA . 51.6 p -114.58 103.32 10.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.257 -0.429 . . . . 70.42 111.147 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 1.037 HG22 HG13 ' A' ' 183' ' ' VAL . 21.7 t -97.97 131.72 44.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.192 -0.458 . . . . 75.54 111.153 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.4 m -126.46 92.38 45.39 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.545 0.688 . . . . 72.53 111.143 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.472 ' HG3' ' HB2' ' A' ' 239' ' ' ALA . 53.5 Cg_endo -69.82 -167.2 0.22 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.67 2.247 . . . . 74.11 112.321 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -85.94 -40.26 16.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 61.3 111.15 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 87.9 p 46.41 77.29 0.08 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.213 -0.449 . . . . 75.03 110.877 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.5 t -175.72 -174.82 0.71 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.12 -0.491 . . . . 73.11 111.128 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 34.6 p -100.56 162.91 12.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 72.24 110.862 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.732 HG22 ' HB2' ' A' ' 177' ' ' GLN . 3.3 p -144.27 153.03 15.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 64.53 111.12 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 63.2 t -86.58 145.26 7.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 73.42 111.152 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.1 122.3 5.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.191 -0.459 . . . . 73.34 110.899 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 100.19 -14.35 59.79 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.758 -0.734 . . . . 61.21 112.484 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.732 ' HB2' HG22 ' A' ' 173' ' ' VAL . 11.7 mm100 -90.03 -177.66 5.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.81 0.338 . . . . 60.41 110.935 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 2.2 p -160.9 148.82 15.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 43.14 110.836 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.494 HG21 HD12 ' A' ' 241' ' ' ILE . 7.5 t -109.65 -176.82 3.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 50.25 111.128 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -139.47 127.51 22.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 60.23 111.148 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.466 HD23 ' HB3' ' A' ' 168' ' ' PRO . 7.9 mp -99.89 145.71 27.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.221 -0.445 . . . . 75.54 110.902 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -114.1 143.21 45.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 64.22 111.173 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 1.037 HG13 HG22 ' A' ' 166' ' ' VAL . 25.4 t -129.47 141.9 45.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 61.24 111.146 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.648 ' HB3' ' OG1' ' A' ' 165' ' ' THR . . . -129.81 150.66 51.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 75.25 111.095 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -144.5 127.8 16.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 65.5 110.901 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.39 66.76 71.3 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.642 0.734 . . . . 74.22 110.877 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 -35.76 12.11 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.657 2.238 . . . . 74.21 112.367 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 65.61 43.8 3.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 62.31 110.885 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 166.26 -38.74 0.26 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.719 -0.753 . . . . 44.52 112.503 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 2.6 t -76.99 -56.9 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.859 0.361 . . . . 71.02 111.111 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 50.2 p 47.43 66.02 1.12 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 72.11 111.147 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -167.2 116.81 0.85 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.205 -0.452 . . . . 73.31 110.86 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.37 104.53 0.51 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 74.1 110.932 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 1.2 m -115.42 -6.14 12.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 65.2 110.843 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.777 ' CE2' HG11 ' A' ' 183' ' ' VAL . 21.9 p90 -90.31 174.45 7.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.125 -0.489 . . . . 74.32 110.878 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -165.7 151.64 9.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 73.15 110.863 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 197' ' ' ALA . . . . . 0.759 ' HB3' ' HB ' ' A' ' 209' ' ' VAL . . . -104.2 158.91 16.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 75.44 111.116 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.635 ' O ' HG23 ' A' ' 226' ' ' ILE . 6.4 m -153.04 -178.05 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 75.34 111.16 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 11.9 p -108.1 132.27 53.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 73.31 110.887 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.497 ' HB2' ' HD3' ' A' ' 227' ' ' PRO . . . -75.35 -26.01 58.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.122 -0.49 . . . . 40.01 111.14 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -129.01 -60.02 1.1 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.454 . . . . 75.41 110.884 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 63.88 35.45 10.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 45.31 110.922 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 32.7 p -118.44 -4.73 10.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.165 -0.47 . . . . 75.15 111.064 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 9.4 mtmm -152.84 18.63 0.59 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.255 -0.43 . . . . 61.53 110.907 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.663 ' HA ' HG23 ' A' ' 219' ' ' VAL . . . -171.26 144.91 2.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 71.31 111.128 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 17.0 p -107.37 130.85 54.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.249 -0.432 . . . . 64.15 111.17 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.913 HG12 HG22 ' A' ' 216' ' ' VAL . 4.8 m -118.86 138.99 47.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 71.45 111.145 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 208' ' ' SER . . . . . 0.496 ' C ' HG23 ' A' ' 214' ' ' ILE . 5.7 t -145.29 109.09 4.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 61.45 110.849 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.759 ' HB ' ' HB3' ' A' ' 197' ' ' ALA . 4.2 p -89.4 143.61 10.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.104 -0.498 . . . . 63.15 111.091 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 3.4 t -144.79 96.28 2.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.138 -0.483 . . . . 34.12 110.885 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 70.29 -81.04 0.38 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.78 -0.724 . . . . 72.43 112.507 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -138.43 8.09 2.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.882 0.373 . . . . 64.21 110.911 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -129.24 121.82 28.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 63.12 111.168 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.654 HG13 HG23 ' A' ' 209' ' ' VAL . 2.6 mp -115.3 131.79 66.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 71.24 111.131 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 1.5 m -100.63 125.71 47.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.139 -0.482 . . . . 74.22 111.152 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.913 HG22 HG12 ' A' ' 207' ' ' VAL . 2.4 t -116.64 126.66 74.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 74.2 111.165 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -112.19 138.96 48.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 63.03 110.86 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -93.4 80.98 1.04 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.768 -0.729 . . . . 54.2 112.469 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.663 HG23 ' HA ' ' A' ' 205' ' ' ALA . 19.3 t -50.26 -51.18 18.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.855 0.36 . . . . 71.12 111.099 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -137.78 162.36 34.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 53.21 111.132 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' ALA . . . . . 0.631 ' HB2' ' HA ' ' A' ' 245' ' ' ALA . . . -57.25 143.45 39.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 74.33 111.132 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 137.18 167.95 11.23 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.748 -0.739 . . . . 52.44 112.482 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 223' ' ' LYS . . . . . 0.618 ' HG3' HG23 ' A' ' 242' ' ' THR . 6.1 mttp -102.47 133.93 46.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.83 0.348 . . . . 73.55 110.893 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 13.1 p -130.49 131.66 65.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 50.55 111.118 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 225' ' ' ASN . . . . . 0.617 ' C ' HD12 ' A' ' 226' ' ' ILE . 33.3 m120 -91.33 152.45 20.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.464 . . . . 63.42 110.905 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.635 HG23 ' O ' ' A' ' 198' ' ' VAL . 4.3 mp -137.43 92.44 13.47 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.611 0.719 . . . . 61.1 111.124 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 227' ' ' PRO . . . . . 0.497 ' HD3' ' HB2' ' A' ' 200' ' ' ALA . 54.5 Cg_endo -69.71 -179.55 2.97 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.689 2.26 . . . . 75.43 112.367 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 85.9 t -150.4 134.84 9.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 34.54 111.125 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 86.9 t -116.94 136.07 55.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 74.1 111.147 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -119.77 108.83 14.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 55.43 110.844 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 231' ' ' GLY . . . . . 0.728 ' HA3' ' HB2' ' A' ' 160' ' ' ALA . . . 56.99 -116.05 7.32 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.767 -0.73 . . . . 44.51 112.503 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 17.9 p30 -95.04 19.3 10.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.836 0.351 . . . . 64.31 110.842 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 101.09 8.28 47.98 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.72 -0.752 . . . . 42.15 112.486 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -52.0 -33.81 39.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.814 0.34 . . . . 62.33 110.835 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -144.21 153.21 41.85 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.202 -0.454 . . . . 74.31 110.894 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -154.28 165.53 36.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.174 -0.466 . . . . 42.42 111.097 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -145.78 163.16 35.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.464 . . . . 64.34 111.115 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 23.3 t -136.6 135.83 48.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.251 -0.431 . . . . 74.53 111.131 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 239' ' ' ALA . . . . . 0.472 ' HB2' ' HG3' ' A' ' 168' ' ' PRO . . . -138.6 165.29 27.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 73.32 111.123 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -145.81 132.37 19.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 75.22 110.862 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 241' ' ' ILE . . . . . 0.529 HG13 HG11 ' A' ' 216' ' ' VAL . 24.5 mm -125.79 113.59 35.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.194 -0.457 . . . . 72.54 111.151 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 242' ' ' THR . . . . . 0.618 HG23 ' HG3' ' A' ' 223' ' ' LYS . 1.7 m -83.17 141.63 31.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 63.51 111.146 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 11.3 t -119.78 122.78 69.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.44 . . . . 73.02 111.17 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 244' ' ' THR . . . . . 0.51 HG23 ' O ' ' A' ' 173' ' ' VAL . 4.2 p -84.75 132.56 34.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 63.23 111.141 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 245' ' ' ALA . . . . . 0.631 ' HA ' ' HB2' ' A' ' 221' ' ' ALA . . . -58.18 -23.48 55.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 62.55 111.097 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 58.8 m . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 72.44 110.884 -179.792 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.3 0 N-CA-C 112.489 -0.245 . . . . 64.44 112.489 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -64.06 153.52 37.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.845 0.355 . . . . 62.42 111.049 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 2.0 tpt -68.14 150.48 48.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.21 -0.45 . . . . 72.04 110.907 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -114.98 123.89 50.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.269 -0.423 . . . . 75.1 111.128 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.79 ' HB2' ' HA3' ' A' ' 231' ' ' GLY . . . -82.15 -65.74 0.97 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 71.15 111.095 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -178.28 -169.14 0.18 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.251 -0.431 . . . . 72.21 111.131 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 1.9 m -128.26 24.13 5.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.261 -0.427 . . . . 61.11 111.165 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 153.41 99.04 0.17 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.701 -0.762 . . . . 73.33 112.476 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 27.9 ttp -113.18 125.34 54.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.862 0.363 . . . . 74.21 110.851 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.596 ' OG1' ' HB3' ' A' ' 184' ' ' ALA . 48.5 p -114.72 104.01 11.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 71.31 111.142 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 1.071 HG22 HG13 ' A' ' 183' ' ' VAL . 21.7 t -100.41 130.98 48.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 61.1 111.117 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 19.2 m -125.1 92.48 47.36 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.551 0.691 . . . . 75.44 111.085 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.481 ' HG3' ' HB2' ' A' ' 239' ' ' ALA . 53.7 Cg_endo -69.8 -166.75 0.2 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.649 2.233 . . . . 71.11 112.355 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -86.59 -40.59 15.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.436 . . . . 53.13 111.063 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 88.2 p 46.72 76.3 0.1 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 61.34 110.875 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.5 t -174.23 -174.9 0.93 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 73.34 111.152 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 24.5 p -100.37 162.24 13.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 51.42 110.824 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.725 HG22 ' HB2' ' A' ' 177' ' ' GLN . 2.8 p -144.27 154.06 15.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.117 -0.492 . . . . 64.21 111.127 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 79.5 t -89.29 144.48 9.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 63.05 111.142 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.78 123.76 6.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.451 . . . . 70.41 110.92 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.84 -16.14 58.84 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.788 -0.72 . . . . 60.31 112.498 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.725 ' HB2' HG22 ' A' ' 173' ' ' VAL . 9.7 mm100 -89.41 -177.89 5.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.846 0.355 . . . . 75.53 110.914 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 11.9 p -161.98 147.09 12.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.212 -0.449 . . . . 62.31 110.884 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 7.3 t -108.12 -174.69 2.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 73.12 111.132 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -140.42 132.31 27.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 75.13 111.189 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.474 HD23 ' HB3' ' A' ' 168' ' ' PRO . 7.6 mp -105.12 142.14 35.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 73.33 110.919 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 24.9 m -110.01 141.99 42.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 65.43 111.179 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 1.071 HG13 HG22 ' A' ' 166' ' ' VAL . 21.5 t -129.32 139.87 50.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.293 -0.412 . . . . 64.22 111.127 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.596 ' HB3' ' OG1' ' A' ' 165' ' ' THR . . . -130.11 151.91 50.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.124 -0.489 . . . . 73.45 111.126 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -144.24 128.69 17.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 75.42 110.889 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.25 66.69 71.66 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.582 0.706 . . . . 75.23 110.912 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 -37.38 9.22 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.68 2.253 . . . . 65.35 112.355 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 66.31 43.7 2.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 75.54 110.84 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 166.63 -29.7 0.19 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.722 -0.751 . . . . 71.15 112.468 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 2.9 t -87.16 -57.86 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.914 0.387 . . . . 75.23 111.129 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 65.2 p 47.53 69.94 0.47 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 74.05 111.135 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -170.22 118.65 0.57 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 64.44 110.883 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 9.5 mtmt -63.24 96.78 0.11 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 74.53 110.914 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 2.0 m -109.84 -6.25 15.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 73.22 110.877 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.773 ' CE2' HG11 ' A' ' 183' ' ' VAL . 20.6 p90 -90.71 175.9 6.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.073 -0.512 . . . . 62.22 110.845 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 3.1 ptt-85 -158.25 173.71 16.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.132 -0.486 . . . . 73.22 110.89 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' ALA . . . . . 0.553 ' HB3' ' HB ' ' A' ' 209' ' ' VAL . . . -124.65 167.16 14.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 42.04 111.086 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 10.0 p -174.77 152.73 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 73.44 111.131 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.7 126.75 36.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.156 -0.475 . . . . 71.32 110.878 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.526 ' HB2' ' HD3' ' A' ' 227' ' ' PRO . . . -61.68 -17.94 57.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.115 -0.493 . . . . 74.13 111.093 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -156.99 92.43 1.27 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.213 -0.449 . . . . 61.41 110.913 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 8.0 tttp -83.65 55.18 3.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 75.05 110.931 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 20.0 p -130.66 2.67 4.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.246 -0.434 . . . . 54.1 111.144 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' LYS . . . . . 0.45 ' HA ' ' HB3' ' A' ' 220' ' ' ALA . 10.8 mtmm -153.99 18.23 0.51 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 65.23 110.881 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -179.47 153.4 0.57 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.449 . . . . 65.54 111.113 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 8.4 p -117.49 131.23 56.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 73.34 111.142 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 1.05 HG12 HG22 ' A' ' 216' ' ' VAL . 4.9 m -120.1 140.33 44.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.184 -0.462 . . . . 43.3 111.112 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.16 109.0 4.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 72.42 110.868 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.553 ' HB ' ' HB3' ' A' ' 197' ' ' ALA . 3.7 p -85.45 143.08 12.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.138 -0.483 . . . . 63.2 111.173 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 17.2 p -172.19 123.85 0.5 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 62.11 110.839 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 55.4 48.05 72.15 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.752 -0.737 . . . . 43.44 112.476 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 2.4 mtp 62.5 16.47 8.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.884 0.373 . . . . 72.51 110.853 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 1.4 m -128.15 114.23 16.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.26 -0.427 . . . . 54.21 111.153 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.537 HG13 HG23 ' A' ' 209' ' ' VAL . 3.4 mp -110.24 115.61 50.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 75.25 111.076 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 1.3 m -89.99 126.91 35.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 75.43 111.118 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 1.05 HG22 HG12 ' A' ' 207' ' ' VAL . 4.8 t -112.74 128.28 69.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.216 -0.447 . . . . 72.51 111.135 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -109.56 135.69 50.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 75.41 110.921 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -84.41 66.81 3.82 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.731 -0.747 . . . . 71.2 112.507 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.418 HG12 ' N ' ' A' ' 220' ' ' ALA . 1.9 t -48.75 -53.58 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.817 0.341 . . . . 70.24 111.146 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 220' ' ' ALA . . . . . 0.45 ' HB3' ' HA ' ' A' ' 204' ' ' LYS . . . -123.96 155.33 38.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.146 -0.479 . . . . 61.33 111.114 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 221' ' ' ALA . . . . . 0.662 ' HB2' ' HA ' ' A' ' 245' ' ' ALA . . . -67.82 138.03 55.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 74.24 111.054 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 140.46 174.68 14.05 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.769 -0.729 . . . . 52.04 112.478 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' LYS . . . . . 0.551 ' HG3' HG23 ' A' ' 242' ' ' THR . 6.0 mttp -99.38 121.51 41.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.827 0.346 . . . . 72.13 110.885 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 7.6 p -120.35 128.67 76.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 73.3 111.132 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' ASN . . . . . 0.456 ' C ' HD12 ' A' ' 226' ' ' ILE . 36.1 m120 -90.52 150.2 21.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.145 -0.479 . . . . 70.41 110.863 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.456 HD12 ' C ' ' A' ' 225' ' ' ASN . 4.7 mp -133.19 92.39 25.17 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.675 0.75 . . . . 75.51 111.135 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 227' ' ' PRO . . . . . 0.526 ' HD3' ' HB2' ' A' ' 200' ' ' ALA . 54.5 Cg_endo -69.7 -179.67 3.05 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.687 2.258 . . . . 63.4 112.375 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 96.2 t -149.46 136.13 12.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 74.4 111.142 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 82.6 t -118.26 135.52 58.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.186 -0.461 . . . . 73.35 111.134 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.21 108.8 14.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 72.2 110.856 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 231' ' ' GLY . . . . . 0.79 ' HA3' ' HB2' ' A' ' 160' ' ' ALA . . . 74.06 -111.44 3.43 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.763 -0.732 . . . . 54.32 112.485 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -111.09 8.31 21.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.907 0.384 . . . . 75.35 110.948 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 127.78 3.24 6.0 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.709 -0.758 . . . . 52.22 112.456 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -51.66 -73.21 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.853 0.358 . . . . 75.33 110.899 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -102.94 156.37 17.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.468 . . . . 71.25 110.872 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -157.24 165.18 36.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.148 -0.478 . . . . 74.32 111.068 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -144.83 163.5 33.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 74.3 111.096 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 58.8 t -137.02 136.46 47.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.226 -0.443 . . . . 55.52 111.126 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 239' ' ' ALA . . . . . 0.481 ' HB2' ' HG3' ' A' ' 168' ' ' PRO . . . -138.72 165.26 27.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 72.32 111.103 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 240' ' ' GLU . . . . . 0.507 ' O ' HD13 ' A' ' 241' ' ' ILE . 1.8 pt-20 -143.15 131.49 22.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 75.11 110.888 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 241' ' ' ILE . . . . . 0.507 HD13 ' O ' ' A' ' 240' ' ' GLU . 25.8 mm -127.28 112.05 27.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.13 -0.486 . . . . 71.42 111.089 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 242' ' ' THR . . . . . 0.551 HG23 ' HG3' ' A' ' 223' ' ' LYS . 1.7 m -82.5 139.28 34.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.189 -0.46 . . . . 53.45 111.132 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 22.1 t -120.49 119.48 59.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.23 -0.441 . . . . 61.33 111.142 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 244' ' ' THR . . . . . 0.479 HG23 ' O ' ' A' ' 173' ' ' VAL . 6.8 p -81.91 132.9 35.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 74.43 111.169 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 245' ' ' ALA . . . . . 0.662 ' HA ' ' HB2' ' A' ' 221' ' ' ALA . . . -55.2 -26.19 37.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 73.03 111.051 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 9.3 t . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.234 -0.439 . . . . 62.25 110.846 -179.785 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 N-CA-C 112.48 -0.248 . . . . 42.53 112.48 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -77.98 -56.14 4.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.756 0.312 . . . . 73.11 111.109 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 20.8 mmt -90.19 130.98 36.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.242 -0.435 . . . . 55.51 110.846 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -169.19 -169.71 1.0 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 51.35 111.111 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -175.15 129.36 0.29 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 55.33 111.088 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.65 -167.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 75.32 111.106 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -125.02 32.28 5.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 61.34 111.093 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 136.87 99.7 0.55 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.72 -0.752 . . . . 65.43 112.501 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 11.6 ttp -109.75 133.04 53.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.83 0.348 . . . . 71.1 110.898 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.461 ' HG1' ' HB3' ' A' ' 184' ' ' ALA . 33.4 p -121.65 108.17 13.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 51.43 111.147 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 1.125 HG22 HG13 ' A' ' 183' ' ' VAL . 26.3 t -102.23 132.29 48.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 53.11 111.122 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.7 m -124.33 92.49 48.05 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.599 0.714 . . . . 72.5 111.143 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.483 ' HB3' HD23 ' A' ' 181' ' ' LEU . 53.7 Cg_endo -69.75 -166.43 0.19 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.709 2.273 . . . . 63.04 112.329 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -89.03 -39.49 13.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 71.0 111.133 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 98.2 p 46.32 79.33 0.06 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 53.32 110.829 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.1 t -175.55 -174.59 0.71 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.093 -0.503 . . . . 71.03 111.121 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 97.2 p -99.89 163.19 12.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.262 -0.426 . . . . 63.31 110.886 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.737 HG22 ' HB2' ' A' ' 177' ' ' GLN . 3.1 p -144.95 153.6 14.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.134 -0.484 . . . . 64.12 111.099 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 58.7 t -87.53 145.67 7.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 63.53 111.13 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.34 122.37 6.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.459 . . . . 61.3 110.919 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.7 -12.54 61.14 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.761 -0.733 . . . . 61.13 112.489 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.737 ' HB2' HG22 ' A' ' 173' ' ' VAL . 13.9 mm100 -92.64 -178.06 4.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.779 0.323 . . . . 62.04 110.928 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 23.8 p -161.5 148.83 14.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 62.22 110.878 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.424 HG21 HD12 ' A' ' 241' ' ' ILE . 9.1 t -108.74 -175.4 2.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.124 -0.489 . . . . 73.01 111.137 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -138.9 132.98 31.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 65.4 111.143 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.483 HD23 ' HB3' ' A' ' 168' ' ' PRO . 7.4 mp -106.52 143.59 34.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 74.23 110.946 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 2.2 m -111.75 142.5 44.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.462 . . . . 75.11 111.11 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 1.125 HG13 HG22 ' A' ' 166' ' ' VAL . 22.6 t -129.75 140.52 48.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 71.4 111.141 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.461 ' HB3' ' HG1' ' A' ' 165' ' ' THR . . . -132.38 152.49 51.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 44.04 111.097 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -143.77 128.7 18.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.455 . . . . 65.5 110.866 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.77 67.11 76.81 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.577 0.704 . . . . 60.25 110.896 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 -35.45 12.72 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.675 2.25 . . . . 71.35 112.357 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 65.89 38.25 5.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.241 -0.436 . . . . 71.13 110.904 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 171.65 -44.91 0.18 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.71 -0.757 . . . . 72.42 112.488 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 2.9 t -69.05 -58.18 6.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.897 0.379 . . . . 73.35 111.1 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 41.4 p 48.23 61.7 2.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 73.15 111.11 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -164.7 112.51 1.06 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.241 -0.436 . . . . 73.05 110.881 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 6.1 mtmt -52.94 105.55 0.13 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 75.14 110.888 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 59.8 m -116.76 -6.69 11.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 64.4 110.857 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.755 ' CE2' HG11 ' A' ' 183' ' ' VAL . 23.6 p90 -90.75 176.5 6.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.101 -0.499 . . . . 61.53 110.857 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.28 157.34 15.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.122 -0.49 . . . . 71.44 110.862 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -105.48 167.78 9.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.47 . . . . 55.14 111.115 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 11.6 p -164.32 151.06 2.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 72.15 111.153 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.56 121.17 29.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 53.51 110.874 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.613 ' HB2' ' HD3' ' A' ' 227' ' ' PRO . . . -65.34 -19.49 65.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.103 -0.499 . . . . 73.33 111.107 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -163.81 91.4 0.65 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.17 -0.468 . . . . 32.34 110.845 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 7.8 ttpt -83.19 55.59 3.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 70.42 110.909 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 25.0 p -128.06 -0.23 5.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.236 -0.438 . . . . 75.02 111.153 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 6.1 mtmt -156.42 19.45 0.35 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.18 -0.463 . . . . 71.24 110.9 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.611 ' HA ' HG23 ' A' ' 219' ' ' VAL . . . -179.64 149.85 0.39 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 72.33 111.162 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 4.0 p -108.51 156.22 19.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 73.11 111.12 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.611 HG12 HG22 ' A' ' 216' ' ' VAL . 15.7 m -141.27 137.56 33.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 53.33 111.161 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 60.4 p -146.04 108.01 4.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 72.32 110.879 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.545 HG23 HG13 ' A' ' 214' ' ' ILE . 3.3 p -91.18 140.94 15.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 64.5 111.147 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 17.5 p -172.38 126.71 0.53 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 55.33 110.832 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 56.49 45.44 89.58 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.782 -0.723 . . . . 73.22 112.476 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 4.2 mtp 63.51 16.15 9.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.871 0.367 . . . . 74.34 110.867 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 22.2 m -127.05 115.04 18.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.229 -0.441 . . . . 75.25 111.088 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.545 HG13 HG23 ' A' ' 209' ' ' VAL . 3.4 mp -110.44 120.25 60.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 63.44 111.141 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 1.2 m -92.18 128.84 38.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.211 -0.449 . . . . 43.34 111.168 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.634 HG11 HG13 ' A' ' 241' ' ' ILE . 3.5 t -115.34 125.58 72.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 73.44 111.125 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -110.79 138.72 46.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 74.22 110.908 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -94.99 78.53 0.88 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.765 -0.731 . . . . 31.42 112.474 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.611 HG23 ' HA ' ' A' ' 205' ' ' ALA . 19.1 t -49.71 -53.0 11.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.827 0.346 . . . . 74.12 111.11 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -131.33 161.95 31.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.461 . . . . 74.24 111.113 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' ALA . . . . . 0.679 ' HB2' ' HA ' ' A' ' 245' ' ' ALA . . . -60.74 138.62 58.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.235 -0.439 . . . . 63.31 111.085 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 142.77 171.18 13.21 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.705 -0.759 . . . . 74.13 112.486 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' LYS . . . . . 0.507 ' HG3' HG23 ' A' ' 242' ' ' THR . 13.6 mttt -101.56 125.15 48.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.84 0.352 . . . . 72.14 110.936 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.472 HG11 ' CB ' ' A' ' 205' ' ' ALA . 7.1 p -122.07 126.17 74.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.242 -0.436 . . . . 73.23 111.122 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 225' ' ' ASN . . . . . 0.591 ' C ' HD12 ' A' ' 226' ' ' ILE . 0.3 OUTLIER -90.96 155.48 18.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 73.23 110.878 -179.977 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.591 HD12 ' C ' ' A' ' 225' ' ' ASN . 4.6 mp -139.88 92.65 9.8 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.603 0.716 . . . . 62.12 111.133 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 227' ' ' PRO . . . . . 0.613 ' HD3' ' HB2' ' A' ' 200' ' ' ALA . 54.3 Cg_endo -69.75 -178.14 2.2 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.67 2.247 . . . . 71.51 112.365 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 80.4 t -150.3 143.02 17.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 70.04 111.094 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 94.8 t -123.77 134.09 67.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.182 -0.463 . . . . 72.31 111.119 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -122.3 133.68 54.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 64.15 110.846 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 52.25 -116.15 4.86 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.78 -0.724 . . . . 73.44 112.464 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -108.73 21.17 17.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.83 0.348 . . . . 51.54 110.86 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 110.41 5.87 27.77 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.7 -0.762 . . . . 45.34 112.514 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -52.9 -60.32 3.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.924 0.392 . . . . 71.45 110.885 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -113.04 166.69 11.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.103 -0.499 . . . . 75.43 110.89 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -165.06 162.2 20.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.151 -0.477 . . . . 74.24 111.129 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -140.09 163.26 33.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 41.51 111.125 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.2 p -140.17 131.66 31.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 72.24 111.191 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 239' ' ' ALA . . . . . 0.407 ' HB2' ' HG3' ' A' ' 168' ' ' PRO . . . -132.71 165.2 25.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.191 -0.459 . . . . 62.43 111.093 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 240' ' ' GLU . . . . . 0.562 ' O ' HD13 ' A' ' 241' ' ' ILE . 4.4 pt-20 -144.55 132.28 21.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.225 -0.443 . . . . 70.3 110.916 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 241' ' ' ILE . . . . . 0.634 HG13 HG11 ' A' ' 216' ' ' VAL . 27.2 mm -127.21 112.49 28.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 73.34 111.096 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 242' ' ' THR . . . . . 0.507 HG23 ' HG3' ' A' ' 223' ' ' LYS . 2.2 m -81.76 141.21 33.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.117 -0.492 . . . . 75.55 111.123 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 19.7 t -120.12 121.31 65.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.213 -0.448 . . . . 75.23 111.106 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 244' ' ' THR . . . . . 0.49 HG23 ' O ' ' A' ' 173' ' ' VAL . 6.2 p -83.69 132.77 34.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.138 -0.483 . . . . 44.41 111.126 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 245' ' ' ALA . . . . . 0.679 ' HA ' ' HB2' ' A' ' 221' ' ' ALA . . . -53.45 -28.26 29.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 72.3 111.117 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 7.9 t . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.44 . . . . 74.13 110.86 -179.766 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 N-CA-C 112.441 -0.264 . . . . 64.33 112.441 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -78.61 151.92 32.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.753 0.311 . . . . 71.11 111.091 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 15.2 ptp -113.8 66.71 0.67 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.264 -0.425 . . . . 52.32 110.873 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -135.04 177.93 7.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.266 -0.425 . . . . 64.11 111.143 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.583 ' HB2' ' HA3' ' A' ' 231' ' ' GLY . . . -108.99 -62.8 1.43 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.258 -0.428 . . . . 72.21 111.119 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -178.74 -168.6 0.14 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.246 -0.434 . . . . 63.32 111.111 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 1.6 m -134.33 30.79 3.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 63.42 111.139 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 137.27 104.97 0.71 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.739 -0.743 . . . . 72.21 112.503 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 1.5 ttp -115.84 138.5 51.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.837 0.351 . . . . 71.43 110.855 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.58 ' OG1' ' HB3' ' A' ' 184' ' ' ALA . 37.5 p -125.34 106.67 10.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 53.03 111.152 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.992 HG22 HG13 ' A' ' 183' ' ' VAL . 16.4 t -97.62 135.92 30.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 63.24 111.099 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.3 m -128.78 92.22 40.83 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.574 0.702 . . . . 63.2 111.157 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.542 ' HG3' ' HB2' ' A' ' 239' ' ' ALA . 53.5 Cg_endo -69.75 -165.03 0.14 Allowed 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.695 2.263 . . . . 73.24 112.365 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -93.0 -37.01 12.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.433 . . . . 65.21 111.124 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 88.0 p 46.85 76.92 0.09 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 71.43 110.838 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.4 t -171.22 -174.5 1.48 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 63.32 111.18 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 18.4 p -100.35 163.66 12.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 65.23 110.833 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.744 HG22 ' HB2' ' A' ' 177' ' ' GLN . 3.0 p -144.4 153.4 15.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.079 -0.51 . . . . 65.41 111.173 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 23.2 t -86.38 145.09 8.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 50.31 111.139 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.42 122.23 5.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 73.44 110.91 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 98.87 -11.08 62.49 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.696 -0.764 . . . . 64.5 112.505 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.744 ' HB2' HG22 ' A' ' 173' ' ' VAL . 19.2 mm100 -92.82 -177.53 4.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.769 0.319 . . . . 75.12 110.945 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 59.8 p -160.56 151.65 19.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.246 -0.434 . . . . 72.41 110.854 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 11.0 t -113.74 -178.71 3.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.119 -0.491 . . . . 63.45 111.16 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.02 129.71 32.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.22 -0.445 . . . . 60.53 111.12 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.448 HD23 ' HB3' ' A' ' 168' ' ' PRO . 7.7 mp -103.57 146.23 28.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 61.12 110.901 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 7.1 m -111.1 144.36 40.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 71.44 111.133 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.992 HG13 HG22 ' A' ' 166' ' ' VAL . 21.8 t -129.5 142.26 44.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 73.44 111.155 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.58 ' HB3' ' OG1' ' A' ' 165' ' ' THR . . . -129.08 152.83 48.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 63.21 111.106 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -145.77 129.23 16.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.458 . . . . 72.02 110.852 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.6 66.81 75.42 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.592 0.71 . . . . 71.42 110.878 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -37.73 8.74 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.636 2.224 . . . . 75.21 112.358 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 65.39 31.33 10.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 71.25 110.92 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 175.7 -49.13 0.12 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.766 -0.73 . . . . 52.42 112.497 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.412 HG12 ' N ' ' A' ' 191' ' ' THR . 2.3 t -63.79 -56.61 15.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.889 0.376 . . . . 73.21 111.156 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 191' ' ' THR . . . . . 0.412 ' N ' HG12 ' A' ' 190' ' ' VAL . 39.6 p 47.45 61.41 2.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.193 -0.458 . . . . 73.13 111.177 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -159.24 124.65 4.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 71.32 110.862 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -66.33 90.51 0.15 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.451 . . . . 70.34 110.906 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 1.8 t -105.5 -6.64 19.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 74.04 110.836 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.756 ' CE2' HG11 ' A' ' 183' ' ' VAL . 18.8 p90 -91.08 168.85 11.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.465 . . . . 72.23 110.905 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.08 168.8 25.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 73.43 110.889 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 197' ' ' ALA . . . . . 0.621 ' HB3' ' HB ' ' A' ' 209' ' ' VAL . . . -119.53 163.06 17.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.446 . . . . 63.1 111.144 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.608 ' O ' HG23 ' A' ' 226' ' ' ILE . 3.9 m -153.79 -178.74 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.272 -0.422 . . . . 73.25 111.121 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 199' ' ' SER . . . . . 0.45 ' HB3' HG22 ' A' ' 207' ' ' VAL . 0.9 OUTLIER -119.53 127.35 52.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.161 -0.472 . . . . 54.01 110.921 -179.903 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.405 ' HB2' ' HD3' ' A' ' 227' ' ' PRO . . . -70.82 -9.73 58.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.474 . . . . 50.34 111.153 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -166.22 99.12 0.62 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 64.32 110.867 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 14.9 tttt -91.52 41.71 1.08 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.176 -0.465 . . . . 74.3 110.892 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 4.2 p -124.93 -5.22 7.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 52.31 111.188 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 8.5 mtmm -148.05 15.09 1.04 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 64.24 110.922 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.58 ' HA ' HG23 ' A' ' 219' ' ' VAL . . . -179.67 150.11 0.39 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.44 . . . . 44.55 111.081 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 9.3 p -115.95 151.85 34.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 64.21 111.133 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.862 HG12 HG22 ' A' ' 216' ' ' VAL . 6.2 m -138.03 141.64 37.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 55.02 111.082 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -147.05 109.02 4.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 75.35 110.906 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.621 ' HB ' ' HB3' ' A' ' 197' ' ' ALA . 3.6 p -86.23 143.21 11.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.128 -0.487 . . . . 72.24 111.114 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 7.7 p -171.98 124.11 0.53 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 71.45 110.869 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 55.64 47.19 79.09 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.781 -0.723 . . . . 73.51 112.47 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 2.0 mtp 63.26 16.08 9.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.844 0.354 . . . . 72.01 110.884 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 1.9 m -127.4 114.81 18.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.24 -0.436 . . . . 71.43 111.143 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.504 HG13 HG23 ' A' ' 209' ' ' VAL . 3.0 mp -110.15 116.26 51.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 73.33 111.107 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -89.34 126.15 35.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 62.12 111.125 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.862 HG22 HG12 ' A' ' 207' ' ' VAL . 2.8 t -111.43 129.91 65.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 73.33 111.172 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -113.55 139.03 49.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.439 . . . . 70.24 110.887 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -96.73 78.02 0.71 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.738 -0.744 . . . . 73.11 112.526 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.58 HG23 ' HA ' ' A' ' 205' ' ' ALA . 17.0 t -50.22 -54.96 6.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.846 0.355 . . . . 72.31 111.151 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -128.0 160.8 30.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 71.24 111.115 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' ALA . . . . . 0.67 ' HB2' ' HA ' ' A' ' 245' ' ' ALA . . . -61.07 140.05 57.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 62.44 111.051 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 142.56 170.83 12.94 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.802 -0.713 . . . . 71.33 112.535 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' LYS . . . . . 0.463 ' HG3' HG23 ' A' ' 242' ' ' THR . 12.8 mttt -100.85 121.33 41.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.818 0.342 . . . . 72.21 110.877 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.535 HG11 ' CB ' ' A' ' 205' ' ' ALA . 7.4 p -120.57 126.96 75.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.262 -0.426 . . . . 71.42 111.139 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 225' ' ' ASN . . . . . 0.627 ' C ' HD12 ' A' ' 226' ' ' ILE . 32.7 m120 -90.67 155.97 18.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.464 . . . . 64.43 110.864 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.627 HD12 ' C ' ' A' ' 225' ' ' ASN . 3.9 mp -135.91 92.34 16.6 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.629 0.728 . . . . 60.04 111.072 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 227' ' ' PRO . . . . . 0.595 ' HG2' HG23 ' A' ' 198' ' ' VAL . 53.8 Cg_endo -69.77 179.78 3.47 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.66 2.24 . . . . 75.33 112.352 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 64.3 t -150.29 144.11 17.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.236 -0.438 . . . . 73.33 111.108 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 86.8 t -132.55 135.74 57.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.136 -0.484 . . . . 73.15 111.156 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 82.6 p -115.03 106.7 14.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.452 . . . . 64.32 110.882 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 231' ' ' GLY . . . . . 0.583 ' HA3' ' HB2' ' A' ' 160' ' ' ALA . . . 59.33 -100.26 0.18 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.746 -0.74 . . . . 74.32 112.475 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 18.0 p30 -95.09 -7.68 38.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.897 0.379 . . . . 74.0 110.899 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 112.45 13.24 11.97 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.738 -0.744 . . . . 65.43 112.462 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -52.54 -28.73 21.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.865 0.364 . . . . 74.33 110.887 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -144.66 132.53 21.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 74.24 110.85 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -134.26 164.86 26.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 72.34 111.049 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -135.38 162.98 31.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 73.02 111.088 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 58.3 t -135.82 121.94 31.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.205 -0.452 . . . . 73.35 111.114 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 239' ' ' ALA . . . . . 0.542 ' HB2' ' HG3' ' A' ' 168' ' ' PRO . . . -129.4 165.08 22.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 74.11 111.057 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 240' ' ' GLU . . . . . 0.504 ' O ' HD13 ' A' ' 241' ' ' ILE . 4.8 pt-20 -146.74 132.7 19.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 53.42 110.864 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 241' ' ' ILE . . . . . 0.598 HG13 HG11 ' A' ' 216' ' ' VAL . 23.7 mm -126.76 111.92 27.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 63.05 111.11 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 242' ' ' THR . . . . . 0.463 HG23 ' HG3' ' A' ' 223' ' ' LYS . 2.7 m -79.8 141.22 36.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 52.13 111.148 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 16.6 t -119.9 120.7 63.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.28 -0.418 . . . . 65.14 111.113 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 244' ' ' THR . . . . . 0.489 HG23 ' O ' ' A' ' 173' ' ' VAL . 7.2 p -82.36 132.85 35.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.164 -0.471 . . . . 61.14 111.117 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 245' ' ' ALA . . . . . 0.67 ' HA ' ' HB2' ' A' ' 221' ' ' ALA . . . -57.97 -23.88 55.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 51.42 111.086 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 80.4 p . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.242 -0.435 . . . . 70.44 110.875 -179.805 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.389 0 N-CA-C 112.514 -0.235 . . . . 73.43 112.514 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . 56.78 25.54 10.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.79 0.329 . . . . 73.53 111.126 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 9.0 mmt -83.74 80.54 9.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 62.04 110.912 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -171.38 -172.47 1.08 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.226 -0.443 . . . . 51.33 111.09 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -174.34 129.08 0.36 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 73.02 111.133 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.5 -168.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 61.55 111.142 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 1.1 m -124.81 32.82 5.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.263 -0.426 . . . . 74.25 111.157 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 137.28 98.68 0.5 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.751 -0.738 . . . . 32.04 112.493 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 3.8 ttp -110.23 130.29 55.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.827 0.346 . . . . 61.04 110.846 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.572 ' OG1' ' HB3' ' A' ' 184' ' ' ALA . 43.9 p -118.67 104.01 10.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 73.43 111.118 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 1.114 HG22 HG13 ' A' ' 183' ' ' VAL . 34.7 t -97.86 132.78 41.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.264 -0.425 . . . . 63.31 111.104 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.6 m -126.76 92.53 44.54 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.571 0.701 . . . . 73.14 111.179 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.517 ' HG3' ' HB2' ' A' ' 239' ' ' ALA . 53.7 Cg_endo -69.77 -166.13 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.689 2.259 . . . . 71.53 112.317 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -87.99 -39.22 14.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 54.25 111.079 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 96.1 p 46.46 78.06 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.274 -0.421 . . . . 54.4 110.844 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.6 t -175.18 -174.81 0.78 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.493 . . . . 74.55 111.212 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 94.7 p -99.78 163.25 12.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.254 -0.43 . . . . 63.03 110.841 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.768 HG22 ' HB2' ' A' ' 177' ' ' GLN . 2.8 p -144.41 152.76 15.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.125 -0.489 . . . . 75.52 111.122 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 32.2 t -85.49 145.04 8.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.179 -0.464 . . . . 64.13 111.114 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.28 121.98 5.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.18 -0.464 . . . . 74.14 110.896 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.16 -11.87 62.0 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.701 -0.761 . . . . 54.54 112.471 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.768 ' HB2' HG22 ' A' ' 173' ' ' VAL . 21.5 mm100 -91.05 -177.39 4.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.78 0.324 . . . . 72.25 110.944 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -159.3 149.99 19.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.262 -0.427 . . . . 52.15 110.84 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 11.5 t -110.99 179.64 3.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.486 . . . . 72.54 111.139 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -136.02 126.12 26.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 74.32 111.185 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.466 HD23 ' HB3' ' A' ' 168' ' ' PRO . 7.7 mp -100.32 149.35 23.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 61.14 110.88 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 2.4 m -117.54 143.55 45.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.16 -0.473 . . . . 73.44 111.149 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 1.114 HG13 HG22 ' A' ' 166' ' ' VAL . 22.0 t -129.56 140.95 47.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 72.32 111.079 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.572 ' HB3' ' OG1' ' A' ' 165' ' ' THR . . . -129.04 151.95 49.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.474 . . . . 52.42 111.088 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -146.65 130.05 16.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 74.2 110.895 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.24 66.63 75.55 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.612 0.72 . . . . 72.11 110.946 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -36.03 11.59 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.722 2.281 . . . . 64.0 112.307 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 66.18 43.07 2.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.254 -0.43 . . . . 74.4 110.902 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 166.28 -41.46 0.27 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.77 -0.729 . . . . 43.54 112.479 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 2.5 t -73.44 -55.57 12.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.927 0.394 . . . . 72.42 111.146 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER 47.29 66.45 1.01 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.175 -0.466 . . . . 50.34 111.16 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -165.75 131.34 2.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.212 -0.449 . . . . 73.33 110.893 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.27 91.68 3.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.179 -0.464 . . . . 54.51 110.907 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.82 -6.48 21.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 74.24 110.838 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.77 ' CE2' HG11 ' A' ' 183' ' ' VAL . 26.9 p90 -90.74 179.32 5.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.469 . . . . 71.54 110.897 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 2.2 ptt180 -166.45 174.48 8.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 72.1 110.867 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' ALA . . . . . 0.525 ' HB3' ' HB ' ' A' ' 209' ' ' VAL . . . -119.45 154.77 33.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.458 . . . . 44.22 111.118 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.4 ' O ' HG23 ' A' ' 226' ' ' ILE . 12.7 t -144.85 154.8 14.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.234 -0.439 . . . . 33.41 111.082 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.95 115.97 28.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.145 -0.48 . . . . 71.31 110.857 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.459 ' HB2' ' HD3' ' A' ' 227' ' ' PRO . . . -59.73 -22.14 61.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 51.31 111.133 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -161.16 92.17 0.9 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.221 -0.445 . . . . 65.22 110.895 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 5.8 tttp -85.07 54.39 3.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 62.03 110.888 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 19.1 p -129.51 1.28 5.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 71.05 111.16 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 9.0 mtmt -155.53 18.28 0.4 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 63.12 110.924 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.624 ' HA ' HG23 ' A' ' 219' ' ' VAL . . . -179.9 148.39 0.31 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 70.2 111.104 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 5.9 p -104.71 154.15 20.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 71.21 111.13 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.655 HG12 HG22 ' A' ' 216' ' ' VAL . 17.1 m -140.8 134.31 32.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.464 . . . . 74.33 111.114 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 208' ' ' SER . . . . . 0.492 ' C ' HG23 ' A' ' 214' ' ' ILE . 10.7 m -145.3 109.09 4.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 75.24 110.867 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.628 HG23 HG13 ' A' ' 214' ' ' ILE . 4.3 p -92.69 142.43 13.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 62.23 111.113 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 4.1 t -143.23 98.9 3.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.134 -0.485 . . . . 72.25 110.866 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 69.89 -81.9 0.32 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.714 -0.755 . . . . 53.13 112.489 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 1.1 mtp -139.0 9.55 2.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.851 0.358 . . . . 61.41 110.853 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 7.3 m -130.21 123.25 29.76 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.243 -0.435 . . . . 51.24 111.17 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.628 HG13 HG23 ' A' ' 209' ' ' VAL . 2.2 mp -115.26 141.19 33.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.221 -0.445 . . . . 70.34 111.17 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.41 125.4 51.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.237 -0.438 . . . . 64.13 111.139 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.655 HG22 HG12 ' A' ' 207' ' ' VAL . 2.6 t -115.33 130.77 69.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 50.14 111.085 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -116.95 138.42 51.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 73.23 110.926 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -95.21 79.72 0.85 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.768 -0.729 . . . . 71.32 112.509 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.624 HG23 ' HA ' ' A' ' 205' ' ' ALA . 16.3 t -50.82 -53.46 13.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.792 0.33 . . . . 74.13 111.129 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -130.81 162.48 29.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.447 . . . . 72.2 111.073 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' ALA . . . . . 0.672 ' HB2' ' HA ' ' A' ' 245' ' ' ALA . . . -60.92 140.45 57.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 72.12 111.12 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 142.34 171.25 13.06 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.79 -0.719 . . . . 74.35 112.528 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' LYS . . . . . 0.558 ' HG3' HG23 ' A' ' 242' ' ' THR . 5.5 mttp -103.74 121.85 43.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.85 0.357 . . . . 54.53 110.864 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.475 HG11 ' CB ' ' A' ' 205' ' ' ALA . 7.2 p -120.36 126.04 74.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 75.51 111.179 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 225' ' ' ASN . . . . . 0.619 ' C ' HD12 ' A' ' 226' ' ' ILE . 35.3 m120 -90.8 153.33 20.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 72.02 110.871 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.619 HD12 ' C ' ' A' ' 225' ' ' ASN . 4.1 mp -137.21 93.08 13.33 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.608 0.718 . . . . 74.34 111.132 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 227' ' ' PRO . . . . . 0.459 ' HD3' ' HB2' ' A' ' 200' ' ' ALA . 54.1 Cg_endo -69.73 -178.37 2.3 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.66 2.24 . . . . 71.53 112.37 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.63 ' CG2' ' HB3' ' A' ' 237' ' ' ALA . 47.0 t -147.37 139.62 18.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 72.14 111.111 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 99.8 t -120.53 135.19 61.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 74.32 111.152 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -121.46 122.51 39.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 74.44 110.878 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 56.14 -119.87 16.69 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.757 -0.735 . . . . 72.25 112.485 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -92.36 14.09 17.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.818 0.342 . . . . 70.1 110.878 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 108.17 8.6 29.1 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.705 -0.759 . . . . 52.45 112.471 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -51.97 -65.76 0.5 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.887 0.375 . . . . 74.42 110.939 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -100.54 158.98 15.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 74.12 110.904 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -157.73 160.52 37.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.165 -0.471 . . . . 64.13 111.108 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' ALA . . . . . 0.63 ' HB3' ' CG2' ' A' ' 228' ' ' VAL . . . -136.97 163.61 30.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 71.5 111.102 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 57.7 t -137.34 130.39 43.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 63.14 111.17 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 239' ' ' ALA . . . . . 0.517 ' HB2' ' HG3' ' A' ' 168' ' ' PRO . . . -137.54 163.33 31.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 73.11 111.09 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 240' ' ' GLU . . . . . 0.464 ' O ' HD13 ' A' ' 241' ' ' ILE . 5.6 pt-20 -147.35 130.37 16.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.203 -0.453 . . . . 72.45 110.903 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 241' ' ' ILE . . . . . 0.574 HG13 HG11 ' A' ' 216' ' ' VAL . 26.5 mm -124.4 112.18 31.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.13 -0.486 . . . . 64.21 111.106 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 242' ' ' THR . . . . . 0.558 HG23 ' HG3' ' A' ' 223' ' ' LYS . 1.9 m -80.66 141.51 34.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.164 -0.471 . . . . 75.3 111.151 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 15.9 t -119.98 121.84 66.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 64.3 111.134 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 244' ' ' THR . . . . . 0.469 HG23 ' O ' ' A' ' 173' ' ' VAL . 6.8 p -83.04 132.95 35.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 34.4 111.154 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 245' ' ' ALA . . . . . 0.672 ' HA ' ' HB2' ' A' ' 221' ' ' ALA . . . -57.11 -23.82 49.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.23 -0.441 . . . . 73.51 111.089 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 4.4 t . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.26 -0.427 . . . . 60.2 110.837 -179.79 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 N-CA-C 112.494 -0.243 . . . . 74.32 112.494 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -107.88 145.72 33.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.798 0.332 . . . . 74.33 111.097 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 14.6 ptt? -118.02 79.58 1.39 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 73.3 110.843 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -160.64 -169.8 2.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.445 . . . . 71.24 111.135 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -177.19 129.65 0.16 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 40.24 111.112 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -59.95 -168.76 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.455 . . . . 62.21 111.161 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -125.56 33.74 5.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.276 -0.42 . . . . 52.03 111.176 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 134.66 99.63 0.63 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.724 -0.75 . . . . 74.03 112.481 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 11.6 ttp -114.76 133.08 56.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.861 0.363 . . . . 70.24 110.918 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 28.2 p -122.26 110.88 16.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 72.13 111.124 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 1.13 HG22 HG13 ' A' ' 183' ' ' VAL . 21.5 t -100.88 134.99 39.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 60.14 111.156 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.3 m -124.98 91.77 48.78 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.56 0.695 . . . . 74.35 111.136 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.476 ' HB3' HD23 ' A' ' 181' ' ' LEU . 53.9 Cg_endo -69.73 -165.16 0.14 Allowed 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.696 2.264 . . . . 73.45 112.336 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -91.14 -38.13 12.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.452 . . . . 65.33 111.079 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 90.5 p 46.85 77.31 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 55.45 110.88 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.2 t -174.32 -174.34 0.86 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.101 -0.499 . . . . 63.44 111.12 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 90.4 p -100.33 161.75 13.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 73.12 110.866 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.755 HG22 ' HB2' ' A' ' 177' ' ' GLN . 2.9 p -142.39 153.05 17.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.131 -0.486 . . . . 73.31 111.103 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 32.3 t -85.53 145.08 8.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 74.41 111.142 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.72 122.17 6.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.47 . . . . 73.04 110.897 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.12 -10.92 62.01 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.753 -0.737 . . . . 74.43 112.49 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.755 ' HB2' HG22 ' A' ' 173' ' ' VAL . 20.3 mm100 -91.83 -177.31 4.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.836 0.35 . . . . 74.12 110.911 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.52 152.36 19.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 73.02 110.89 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 13.2 t -115.66 179.13 4.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.454 . . . . 74.31 111.124 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.05 126.16 27.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 51.14 111.131 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.476 HD23 ' HB3' ' A' ' 168' ' ' PRO . 7.4 mp -100.28 142.77 31.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 71.23 110.916 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 14.1 m -108.74 143.81 37.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 65.53 111.196 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 1.13 HG13 HG22 ' A' ' 166' ' ' VAL . 21.0 t -129.65 141.22 47.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 63.44 111.071 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -130.04 149.55 51.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 72.23 111.119 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -139.79 130.6 26.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 73.1 110.863 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -130.73 67.0 80.03 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.564 0.697 . . . . 71.42 110.864 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -36.97 9.78 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.696 2.264 . . . . 72.03 112.332 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 65.85 26.52 11.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 64.11 110.909 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -178.81 -51.13 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.735 -0.745 . . . . 52.2 112.487 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 2.2 t -60.83 -54.39 35.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.91 0.385 . . . . 61.43 111.143 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 40.0 p 47.81 62.02 2.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.166 -0.47 . . . . 73.12 111.137 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -165.7 122.21 1.39 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.192 -0.458 . . . . 74.31 110.876 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 11.7 mtpt -61.4 95.91 0.05 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 75.03 110.875 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.35 -6.99 17.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.216 -0.447 . . . . 32.32 110.828 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.769 ' CE2' HG11 ' A' ' 183' ' ' VAL . 21.8 p90 -91.04 178.46 6.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 72.34 110.882 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.9 171.47 12.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.121 -0.491 . . . . 72.33 110.854 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 197' ' ' ALA . . . . . 0.64 ' HB3' ' HB ' ' A' ' 209' ' ' VAL . . . -122.89 163.42 20.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 72.32 111.106 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.533 ' O ' HG23 ' A' ' 226' ' ' ILE . 5.8 m -153.1 -178.27 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 64.21 111.127 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.65 114.88 24.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 72.14 110.884 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.435 ' HB2' ' HD3' ' A' ' 227' ' ' PRO . . . -59.79 -20.86 59.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 71.23 111.083 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -162.24 96.73 0.99 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 54.15 110.85 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -87.95 47.85 1.56 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.485 . . . . 70.22 110.902 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 12.4 p -125.59 -4.35 7.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 74.1 111.09 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 9.0 mtmm -149.82 16.08 0.86 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.436 . . . . 73.54 110.902 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.628 ' HA ' HG23 ' A' ' 219' ' ' VAL . . . -179.67 151.24 0.44 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.448 . . . . 73.54 111.078 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 7.2 p -112.29 152.59 28.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.215 -0.448 . . . . 75.33 111.157 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.786 HG12 HG22 ' A' ' 216' ' ' VAL . 12.9 m -141.02 137.72 34.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.265 -0.425 . . . . 74.5 111.114 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.54 109.35 4.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 75.34 110.879 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.64 ' HB ' ' HB3' ' A' ' 197' ' ' ALA . 3.5 p -87.93 134.7 27.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 72.05 111.157 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 2.9 m -161.53 124.08 3.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 63.1 110.83 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 55.34 47.74 73.6 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.74 -0.743 . . . . 71.11 112.48 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 3.4 mtp 63.24 16.1 9.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.851 0.358 . . . . 74.13 110.85 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 15.9 m -126.93 110.64 13.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 75.42 111.167 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.545 HG13 HG23 ' A' ' 209' ' ' VAL . 3.1 mp -105.7 117.35 51.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 64.5 111.126 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.26 127.02 36.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 74.33 111.107 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.786 HG22 HG12 ' A' ' 207' ' ' VAL . 2.8 t -113.0 131.53 64.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 74.11 111.107 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -117.25 136.62 52.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 72.33 110.905 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -94.15 79.22 0.97 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.777 -0.725 . . . . 22.13 112.46 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.628 HG23 ' HA ' ' A' ' 205' ' ' ALA . 18.5 t -50.98 -52.25 18.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.871 0.367 . . . . 71.04 111.144 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -131.97 161.42 33.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 64.23 111.116 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' ALA . . . . . 0.68 ' HB2' ' HA ' ' A' ' 245' ' ' ALA . . . -59.96 139.12 57.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 64.34 111.122 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 142.44 170.45 12.7 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.746 -0.74 . . . . 74.23 112.522 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' LYS . . . . . 0.478 ' HG3' HG23 ' A' ' 242' ' ' THR . 13.4 mttt -99.36 123.5 43.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.819 0.343 . . . . 75.12 110.852 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 6.7 p -118.96 124.72 73.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 63.13 111.093 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 225' ' ' ASN . . . . . 0.612 ' C ' HD12 ' A' ' 226' ' ' ILE . 16.8 m120 -90.78 152.83 20.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.152 -0.476 . . . . 73.02 110.87 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.612 HD12 ' C ' ' A' ' 225' ' ' ASN . 4.3 mp -137.77 93.17 12.41 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.594 0.712 . . . . 72.32 111.136 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 227' ' ' PRO . . . . . 0.465 ' HG2' HG23 ' A' ' 198' ' ' VAL . 53.3 Cg_endo -69.81 179.74 3.51 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.676 2.251 . . . . 64.13 112.336 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.428 ' HB ' ' HB3' ' A' ' 237' ' ' ALA . 90.3 t -150.23 136.31 11.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 60.15 111.128 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 91.3 t -117.67 134.71 60.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 71.24 111.167 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -120.94 127.57 51.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 73.43 110.893 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 58.85 -117.81 12.05 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.723 -0.751 . . . . 54.13 112.496 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -108.62 21.04 17.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.878 0.37 . . . . 71.44 110.862 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 113.4 3.69 23.97 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.759 -0.734 . . . . 61.02 112.485 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -54.12 -64.39 0.84 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.907 0.384 . . . . 74.12 110.881 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -111.42 156.74 21.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 75.32 110.831 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -156.57 164.54 38.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.095 -0.502 . . . . 65.04 111.131 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' ALA . . . . . 0.428 ' HB3' ' HB ' ' A' ' 228' ' ' VAL . . . -143.2 163.29 33.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.269 -0.423 . . . . 54.22 111.113 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 13.5 p -140.49 138.72 36.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 64.14 111.154 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 239' ' ' ALA . . . . . 0.428 ' HB2' ' HG3' ' A' ' 168' ' ' PRO . . . -136.95 165.33 26.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 74.21 111.09 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 240' ' ' GLU . . . . . 0.496 ' O ' HD13 ' A' ' 241' ' ' ILE . 3.3 pt-20 -141.88 131.17 23.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.23 -0.441 . . . . 71.14 110.876 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 241' ' ' ILE . . . . . 0.573 HG13 HG11 ' A' ' 216' ' ' VAL . 25.9 mm -127.32 110.63 23.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.123 -0.49 . . . . 64.4 111.147 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 242' ' ' THR . . . . . 0.478 HG23 ' HG3' ' A' ' 223' ' ' LYS . 1.8 m -80.13 141.33 35.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.206 -0.452 . . . . 65.32 111.158 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 17.1 t -119.91 121.92 67.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 74.32 111.124 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 244' ' ' THR . . . . . 0.466 HG23 ' O ' ' A' ' 173' ' ' VAL . 7.3 p -83.36 132.86 34.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 73.35 111.136 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 245' ' ' ALA . . . . . 0.68 ' HA ' ' HB2' ' A' ' 221' ' ' ALA . . . -57.46 -24.46 55.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 61.53 111.106 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 5.2 m . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 44.15 110.836 -179.837 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 N-CA-C 112.517 -0.233 . . . . 53.02 112.517 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . 57.17 26.53 12.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.793 0.33 . . . . 73.12 111.08 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 55.4 mtp -113.76 -179.84 3.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 75.24 110.889 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -111.69 130.67 55.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 73.44 111.097 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.718 ' HB2' ' HA3' ' A' ' 231' ' ' GLY . . . -109.38 -73.09 0.7 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.244 -0.434 . . . . 61.23 111.054 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.437 ' HB1' ' HB3' ' A' ' 187' ' ' PRO . . . -173.82 -169.37 0.49 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 53.34 111.077 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -131.91 18.53 4.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.184 -0.462 . . . . 53.05 111.074 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 166.8 97.91 0.12 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.746 -0.74 . . . . 51.54 112.466 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 41.7 ttp -111.98 129.96 56.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.815 0.341 . . . . 54.12 110.886 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.592 ' OG1' ' HB3' ' A' ' 184' ' ' ALA . 46.6 p -118.82 103.03 9.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.249 -0.432 . . . . 73.4 111.141 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 1.084 HG22 HG13 ' A' ' 183' ' ' VAL . 22.8 t -97.82 132.72 42.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.208 -0.451 . . . . 74.23 111.107 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.2 m -125.11 92.9 46.58 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 121.598 0.713 . . . . 54.41 111.119 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.474 ' HB3' HD23 ' A' ' 181' ' ' LEU . 54.1 Cg_endo -69.72 -168.62 0.28 Allowed 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.685 2.257 . . . . 71.51 112.377 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -86.99 -39.82 15.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 74.04 111.062 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 95.3 p 46.43 78.5 0.07 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 70.35 110.847 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.1 t -173.86 -174.79 0.98 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.088 -0.505 . . . . 74.41 111.141 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 27.3 p -99.34 163.56 12.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.445 . . . . 55.31 110.875 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.723 HG22 ' HB2' ' A' ' 177' ' ' GLN . 3.1 p -146.38 154.32 12.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.115 -0.493 . . . . 73.53 111.135 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 57.6 t -88.39 145.43 7.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.48 . . . . 71.22 111.153 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -48.93 122.67 6.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 32.0 110.887 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.72 -14.2 60.55 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.733 -0.746 . . . . 44.13 112.463 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.723 ' HB2' HG22 ' A' ' 173' ' ' VAL . 12.2 mm100 -91.16 -177.88 5.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.836 0.35 . . . . 71.11 110.93 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 20.4 p -161.43 149.51 15.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 73.22 110.829 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 7.5 t -108.52 -173.87 2.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.113 -0.494 . . . . 64.31 111.188 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.01 131.23 26.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.45 . . . . 65.53 111.195 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.474 HD23 ' HB3' ' A' ' 168' ' ' PRO . 7.5 mp -104.87 144.25 32.04 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.244 -0.435 . . . . 72.23 110.946 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 31.3 m -111.46 144.92 39.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 73.23 111.15 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 1.084 HG13 HG22 ' A' ' 166' ' ' VAL . 21.3 t -129.32 140.07 50.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 73.41 111.112 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.592 ' HB3' ' OG1' ' A' ' 165' ' ' THR . . . -129.6 154.95 46.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.466 . . . . 73.44 111.048 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -145.28 133.8 22.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 74.12 110.879 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.83 66.33 26.28 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.596 0.712 . . . . 74.4 110.907 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.437 ' HB3' ' HB1' ' A' ' 161' ' ' ALA . 53.7 Cg_endo -69.78 -23.83 30.28 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.679 2.253 . . . . 65.52 112.388 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 70.91 33.83 2.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.453 . . . . 74.24 110.876 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 167.55 -25.42 0.13 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.719 -0.753 . . . . 75.33 112.452 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.491 HG11 ' O ' ' A' ' 160' ' ' ALA . 78.3 t -100.38 150.11 5.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.882 0.373 . . . . 43.32 111.131 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 12.7 p -143.89 35.22 1.25 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 60.44 111.167 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.475 ' H ' HG12 ' A' ' 190' ' ' VAL . 1.0 OUTLIER -113.79 127.64 56.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.254 -0.43 . . . . 75.25 110.854 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 1.9 ttpp -79.62 61.67 3.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 53.31 110.866 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 1.7 t -73.08 -7.93 53.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 61.12 110.843 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.777 ' CE2' HG11 ' A' ' 183' ' ' VAL . 14.4 p90 -91.49 163.43 14.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 75.54 110.922 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.27 172.21 18.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.471 . . . . 73.42 110.867 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 197' ' ' ALA . . . . . 0.431 ' HB3' ' HB ' ' A' ' 209' ' ' VAL . . . -117.18 168.11 10.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 61.44 111.088 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 10.6 p -173.12 152.04 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.443 . . . . 75.05 111.126 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.3 t -78.27 151.51 32.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 74.2 110.849 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.607 ' HB2' ' HD3' ' A' ' 227' ' ' PRO . . . -88.43 -23.89 23.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 63.12 111.146 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.77 -53.51 1.23 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 75.23 110.841 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.28 28.48 15.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 65.44 110.919 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 71.9 p -114.65 -3.17 12.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 75.42 111.134 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 7.6 mtmt -152.05 18.52 0.67 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 60.12 110.888 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.667 ' HA ' HG23 ' A' ' 219' ' ' VAL . . . -177.11 146.84 0.52 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 60.45 111.052 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 18.8 p -106.93 157.47 17.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 73.54 111.158 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.784 HG12 HG22 ' A' ' 216' ' ' VAL . 9.8 m -140.9 141.08 32.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.184 -0.462 . . . . 54.53 111.108 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -148.6 108.81 4.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 45.34 110.881 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.544 HG23 HG13 ' A' ' 214' ' ' ILE . 3.8 p -87.36 143.42 11.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.491 . . . . 64.01 111.158 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -171.83 123.27 0.52 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 74.14 110.855 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 55.76 47.4 78.68 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.773 -0.727 . . . . 51.34 112.471 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 1.7 mtp 63.5 15.83 9.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.867 0.365 . . . . 70.14 110.869 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 1.1 m -126.51 113.72 17.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.434 . . . . 72.23 111.178 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.544 HG13 HG23 ' A' ' 209' ' ' VAL . 3.2 mp -110.16 115.48 49.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.241 -0.436 . . . . 61.31 111.145 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 3.8 m -88.3 131.05 34.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.459 . . . . 55.44 111.116 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.784 HG22 HG12 ' A' ' 207' ' ' VAL . 2.8 t -116.88 124.56 73.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 73.44 111.136 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -107.9 137.92 45.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 64.31 110.922 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -93.22 80.74 1.06 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.767 -0.73 . . . . 74.22 112.445 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.667 HG23 ' HA ' ' A' ' 205' ' ' ALA . 19.7 t -50.49 -54.83 7.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.882 0.372 . . . . 70.44 111.116 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -130.01 162.88 27.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 71.3 111.09 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' ALA . . . . . 0.68 ' HB2' ' HA ' ' A' ' 245' ' ' ALA . . . -62.09 140.19 58.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 62.42 111.068 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 140.1 171.2 12.28 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.676 -0.773 . . . . 73.15 112.473 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' LYS . . . . . 0.424 ' HG3' HG23 ' A' ' 242' ' ' THR . 14.0 mttt -99.5 124.24 44.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.826 0.346 . . . . 64.5 110.871 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.529 HG11 ' CB ' ' A' ' 205' ' ' ALA . 7.0 p -121.02 127.08 75.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 71.55 111.149 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 225' ' ' ASN . . . . . 0.637 ' C ' HD12 ' A' ' 226' ' ' ILE . 33.2 m120 -90.88 151.72 21.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 75.1 110.851 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.637 HD12 ' C ' ' A' ' 225' ' ' ASN . 4.0 mp -136.52 93.27 14.46 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.618 0.723 . . . . 73.55 111.156 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 227' ' ' PRO . . . . . 0.607 ' HD3' ' HB2' ' A' ' 200' ' ' ALA . 54.2 Cg_endo -69.75 179.89 3.38 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.689 2.259 . . . . 73.35 112.325 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.422 ' HB ' ' HB3' ' A' ' 237' ' ' ALA . 97.2 t -150.31 141.41 16.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 72.44 111.201 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 46.5 t -124.51 138.31 54.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 73.22 111.144 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 1.7 t -122.18 108.76 13.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 61.22 110.88 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 231' ' ' GLY . . . . . 0.718 ' HA3' ' HB2' ' A' ' 160' ' ' ALA . . . 69.27 -119.35 9.37 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.732 -0.747 . . . . 75.4 112.505 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -104.56 21.14 17.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.807 0.336 . . . . 73.54 110.866 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 112.35 5.63 24.49 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.741 -0.742 . . . . 22.05 112.521 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.475 ' OE1' ' HB3' ' A' ' 160' ' ' ALA . 9.9 mt-10 -51.28 -44.03 61.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.867 0.365 . . . . 74.42 110.863 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -138.56 167.04 22.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 72.33 110.886 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -163.53 164.72 24.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 72.23 111.122 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 237' ' ' ALA . . . . . 0.422 ' HB3' ' HB ' ' A' ' 228' ' ' VAL . . . -143.84 163.18 34.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.436 . . . . 71.05 111.145 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 10.5 p -137.94 136.69 45.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 75.02 111.115 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 239' ' ' ALA . . . . . 0.427 ' HB2' ' HG3' ' A' ' 168' ' ' PRO . . . -139.16 165.17 27.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 63.45 111.102 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 240' ' ' GLU . . . . . 0.526 ' O ' HD13 ' A' ' 241' ' ' ILE . 4.3 pt-20 -143.87 132.13 21.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 73.42 110.898 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 241' ' ' ILE . . . . . 0.586 HG13 HG11 ' A' ' 216' ' ' VAL . 24.7 mm -127.2 113.93 34.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.205 -0.452 . . . . 74.21 111.145 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 242' ' ' THR . . . . . 0.424 HG23 ' HG3' ' A' ' 223' ' ' LYS . 2.8 m -82.81 141.23 32.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 54.45 111.146 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 17.0 t -120.06 120.95 64.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 75.23 111.173 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 244' ' ' THR . . . . . 0.516 HG23 ' O ' ' A' ' 173' ' ' VAL . 5.4 p -82.33 132.79 35.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 63.51 111.118 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 245' ' ' ALA . . . . . 0.68 ' HA ' ' HB2' ' A' ' 221' ' ' ALA . . . -57.41 -23.42 49.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 70.15 111.095 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 2.1 t . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 73.22 110.859 -179.769 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.475 -0.25 . . . . 74.02 112.475 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -85.42 131.57 34.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.837 0.351 . . . . 55.34 111.107 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 5.7 tpt -111.34 57.05 0.63 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 72.23 110.867 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -158.54 163.63 36.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 73.34 111.131 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.487 ' HB2' ' HA3' ' A' ' 231' ' ' GLY . . . -76.32 -66.89 0.74 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 63.32 111.103 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -178.31 -169.34 0.18 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 74.14 111.082 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -131.68 27.09 4.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.236 -0.438 . . . . 72.53 111.106 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 145.92 101.93 0.32 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.778 -0.725 . . . . 62.23 112.484 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 42.9 ttp -114.49 126.16 54.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.863 0.364 . . . . 73.2 110.829 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.574 ' OG1' ' HB3' ' A' ' 184' ' ' ALA . 43.4 p -115.65 105.69 13.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 74.41 111.154 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 1.033 HG22 HG13 ' A' ' 183' ' ' VAL . 21.5 t -101.52 130.76 50.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 64.52 111.102 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.3 m -123.82 92.42 48.54 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.549 0.69 . . . . 73.23 111.121 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.48 ' HB3' HD23 ' A' ' 181' ' ' LEU . 53.9 Cg_endo -69.78 -167.2 0.21 Allowed 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.66 2.24 . . . . 75.03 112.361 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -90.2 -40.85 11.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 62.55 111.126 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 93.0 p 46.74 79.6 0.06 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 74.03 110.839 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.5 t -175.33 -175.63 0.84 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 65.21 111.137 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 41.7 p -98.75 163.63 12.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 64.44 110.831 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.732 HG22 ' HB2' ' A' ' 177' ' ' GLN . 3.0 p -145.6 153.57 13.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.124 -0.489 . . . . 61.44 111.107 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 99.1 t -87.24 144.71 8.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 64.54 111.134 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -47.95 122.57 5.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.216 -0.447 . . . . 75.31 110.891 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.75 -13.5 60.86 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.759 -0.734 . . . . 74.52 112.473 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.732 ' HB2' HG22 ' A' ' 173' ' ' VAL . 11.0 mm100 -93.38 -179.58 5.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.776 0.322 . . . . 63.4 110.913 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 57.4 p -162.09 148.09 13.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 70.05 110.849 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.416 HG21 HD12 ' A' ' 241' ' ' ILE . 6.9 t -105.26 -173.72 2.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.136 -0.484 . . . . 74.33 111.158 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -140.11 130.53 25.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 54.51 111.165 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.48 HD23 ' HB3' ' A' ' 168' ' ' PRO . 7.6 mp -103.53 142.39 34.36 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.245 -0.434 . . . . 74.54 110.93 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 10.9 m -109.46 142.72 40.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.262 -0.426 . . . . 65.51 111.166 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 1.033 HG13 HG22 ' A' ' 166' ' ' VAL . 21.9 t -129.45 141.53 46.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.231 -0.44 . . . . 65.54 111.154 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.574 ' HB3' ' OG1' ' A' ' 165' ' ' THR . . . -132.28 151.86 51.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.463 . . . . 60.42 111.132 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -145.33 126.73 14.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.275 -0.42 . . . . 72.12 110.882 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.97 66.69 79.65 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.57 0.7 . . . . 71.15 110.889 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -38.07 8.33 Favored 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.668 2.245 . . . . 54.15 112.328 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 66.32 41.85 3.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.22 -0.446 . . . . 71.32 110.881 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 168.39 -33.52 0.19 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.741 -0.742 . . . . 63.23 112.5 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 3.2 t -82.88 -58.36 3.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.927 0.394 . . . . 71.41 111.174 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 47.7 p 47.63 67.51 0.8 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.136 -0.484 . . . . 74.45 111.163 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -164.38 122.31 1.75 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 54.03 110.838 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -65.63 90.08 0.11 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 70.11 110.897 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 47.3 t -105.4 -6.66 19.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.254 -0.43 . . . . 70.54 110.848 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.772 ' CE2' HG11 ' A' ' 183' ' ' VAL . 17.1 p90 -90.82 177.68 6.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 61.22 110.878 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.44 175.29 9.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 75.43 110.908 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 197' ' ' ALA . . . . . 0.408 ' HB3' ' HB ' ' A' ' 209' ' ' VAL . . . -122.57 168.08 12.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 73.11 111.102 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 8.7 p -173.61 153.61 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.214 -0.448 . . . . 54.03 111.121 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.66 133.42 33.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 73.44 110.908 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.664 ' HB2' ' HD3' ' A' ' 227' ' ' PRO . . . -69.26 -21.11 63.92 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.154 -0.476 . . . . 74.15 111.074 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 201' ' ' ASP . . . . . 0.607 ' O ' HG23 ' A' ' 203' ' ' THR . 0.6 OUTLIER -132.61 -46.15 0.89 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 71.13 110.858 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.11 27.45 7.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 74.23 110.93 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.607 HG23 ' O ' ' A' ' 201' ' ' ASP . 53.3 p -112.13 -13.66 13.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 73.51 111.155 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 204' ' ' LYS . . . . . 0.489 ' HA ' ' HB3' ' A' ' 220' ' ' ALA . 9.1 mtmp? -139.26 24.88 2.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 72.44 110.87 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.675 ' HA ' HG22 ' A' ' 219' ' ' VAL . . . 179.06 143.3 0.13 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 73.32 111.137 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 7.8 p -106.99 131.23 54.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.231 -0.441 . . . . 63.25 111.121 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.947 HG12 HG22 ' A' ' 216' ' ' VAL . 5.0 m -118.34 143.33 29.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 63.3 111.153 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 3.3 m -149.3 108.7 3.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.466 . . . . 50.35 110.854 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.511 HG23 HG13 ' A' ' 214' ' ' ILE . 4.1 p -83.82 143.97 10.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 62.24 111.144 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 5.3 t -171.75 122.58 0.51 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 60.21 110.878 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 54.19 50.41 55.89 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.732 -0.747 . . . . 73.55 112.464 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 1.8 mtp 61.05 17.41 7.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.834 0.35 . . . . 70.53 110.831 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 12.7 m -129.44 113.1 14.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.253 -0.43 . . . . 70.34 111.139 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.511 HG13 HG23 ' A' ' 209' ' ' VAL . 2.9 mp -108.92 114.92 48.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 73.02 111.102 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 10.2 m -88.0 128.09 35.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 71.21 111.141 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.947 HG22 HG12 ' A' ' 207' ' ' VAL . 2.8 t -114.46 121.93 67.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.46 . . . . 63.2 111.109 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -106.0 144.43 32.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 73.02 110.861 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -96.64 66.26 0.99 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.693 -0.765 . . . . 70.52 112.478 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.675 HG22 ' HA ' ' A' ' 205' ' ' ALA . 0.1 OUTLIER -50.13 -42.08 19.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.863 0.363 . . . . 71.15 111.142 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 220' ' ' ALA . . . . . 0.489 ' HB3' ' HA ' ' A' ' 204' ' ' LYS . . . -125.2 154.04 42.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.454 . . . . 54.32 111.106 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 221' ' ' ALA . . . . . 0.666 ' HB2' ' HA ' ' A' ' 245' ' ' ALA . . . -73.47 131.89 42.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.232 -0.44 . . . . 54.2 111.085 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 143.93 177.31 18.72 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.722 -0.752 . . . . 44.24 112.494 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' LYS . . . . . 0.53 ' HG3' HG23 ' A' ' 242' ' ' THR . 12.6 mttt -98.89 136.26 39.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.84 0.352 . . . . 65.34 110.885 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.589 HG11 ' HB3' ' A' ' 205' ' ' ALA . 7.6 p -137.58 133.61 45.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.223 -0.444 . . . . 74.35 111.125 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 225' ' ' ASN . . . . . 0.625 ' C ' HD12 ' A' ' 226' ' ' ILE . 36.7 m120 -90.94 154.05 19.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 71.41 110.885 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.625 HD12 ' C ' ' A' ' 225' ' ' ASN . 4.1 mp -136.83 92.54 14.44 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.58 0.705 . . . . 73.51 111.162 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 227' ' ' PRO . . . . . 0.664 ' HD3' ' HB2' ' A' ' 200' ' ' ALA . 53.6 Cg_endo -69.79 179.05 3.99 Favored 'Trans proline' 0 C--O 1.231 0.141 0 C-N-CA 122.671 2.248 . . . . 73.54 112.353 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 57.9 t -149.26 137.19 14.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.252 -0.431 . . . . 62.32 111.165 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 98.6 t -117.55 138.65 47.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 73.44 111.124 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -121.66 106.96 11.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 63.42 110.87 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 231' ' ' GLY . . . . . 0.487 ' HA3' ' HB2' ' A' ' 160' ' ' ALA . . . 56.93 -115.04 5.95 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.722 -0.751 . . . . 60.42 112.486 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -94.56 21.08 7.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.848 0.356 . . . . 74.42 110.853 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 97.49 9.19 55.44 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.756 -0.735 . . . . 63.1 112.485 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -51.94 -30.52 24.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.896 0.379 . . . . 64.04 110.871 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -145.59 163.41 34.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.153 -0.476 . . . . 72.22 110.907 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -161.71 165.26 28.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 73.22 111.078 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -143.86 163.24 33.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 75.51 111.13 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 59.2 t -136.52 132.84 48.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.264 -0.425 . . . . 64.31 111.114 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 239' ' ' ALA . . . . . 0.44 ' HB2' ' HG3' ' A' ' 168' ' ' PRO . . . -138.71 165.39 27.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 40.33 111.074 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 240' ' ' GLU . . . . . 0.472 ' O ' HD13 ' A' ' 241' ' ' ILE . 2.9 pt-20 -144.52 131.76 20.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 71.24 110.856 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 241' ' ' ILE . . . . . 0.628 HG13 HG11 ' A' ' 216' ' ' VAL . 34.8 mm -127.25 114.95 38.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.123 -0.49 . . . . 71.3 111.123 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 242' ' ' THR . . . . . 0.53 HG23 ' HG3' ' A' ' 223' ' ' LYS . 3.0 m -86.42 140.7 29.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.13 -0.487 . . . . 73.51 111.157 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 19.8 t -120.5 120.04 61.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 73.51 111.145 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 244' ' ' THR . . . . . 0.495 HG23 ' O ' ' A' ' 173' ' ' VAL . 6.4 p -81.56 132.96 35.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 61.21 111.203 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 245' ' ' ALA . . . . . 0.666 ' HA ' ' HB2' ' A' ' 221' ' ' ALA . . . -57.46 -26.67 61.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.281 -0.418 . . . . 74.54 111.138 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 15.1 m . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 73.43 110.893 -179.814 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 N-CA-C 112.485 -0.246 . . . . 73.04 112.485 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -63.43 135.06 56.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.775 0.321 . . . . 54.41 111.148 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 14.7 mmt -73.18 160.87 31.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 75.2 110.858 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -115.92 -2.0 12.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 51.13 111.114 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.82 ' HB2' ' HA3' ' A' ' 231' ' ' GLY . . . -147.0 -45.56 0.18 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.455 . . . . 73.24 111.111 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -179.58 -169.12 0.13 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.448 . . . . 72.02 111.096 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -130.08 27.2 5.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 73.44 111.148 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 146.66 100.68 0.27 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.727 -0.749 . . . . 41.52 112.446 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 45.9 ttp -111.32 130.54 55.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.807 0.337 . . . . 54.32 110.919 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.612 ' OG1' ' HB3' ' A' ' 184' ' ' ALA . 50.1 p -119.65 102.4 8.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.251 -0.431 . . . . 70.05 111.131 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 1.022 HG22 HG13 ' A' ' 183' ' ' VAL . 21.1 t -97.82 133.14 40.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 74.42 111.119 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.1 m -126.11 92.22 46.28 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.57 0.7 . . . . 43.32 111.173 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.478 ' HB3' HD23 ' A' ' 181' ' ' LEU . 53.1 Cg_endo -69.8 -166.14 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.698 2.265 . . . . 52.53 112.335 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -89.03 -42.64 11.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 44.15 111.117 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 22.9 t 49.29 79.14 0.08 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.241 -0.436 . . . . 73.3 110.899 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.5 t -175.44 -175.54 0.81 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 71.33 111.146 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 38.1 p -98.8 163.88 12.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 62.43 110.849 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.778 HG22 ' HB2' ' A' ' 177' ' ' GLN . 2.6 p -145.81 152.56 14.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 62.01 111.158 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 38.8 t -85.76 145.28 8.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 71.2 111.12 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.24 122.09 5.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 72.42 110.881 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.18 -11.18 61.95 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.745 -0.741 . . . . 74.31 112.448 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.778 ' HB2' HG22 ' A' ' 173' ' ' VAL . 20.9 mm100 -91.37 -177.21 4.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.826 0.346 . . . . 72.45 110.883 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -160.56 149.31 16.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 51.34 110.858 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 7.7 t -111.3 -177.27 3.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.124 -0.489 . . . . 61.22 111.12 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -138.07 133.62 33.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.211 -0.45 . . . . 53.32 111.176 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.478 HD23 ' HB3' ' A' ' 168' ' ' PRO . 7.8 mp -107.7 146.4 32.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.233 -0.44 . . . . 74.1 110.918 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 2.1 m -113.94 143.53 44.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.459 . . . . 61.02 111.119 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 1.022 HG13 HG22 ' A' ' 166' ' ' VAL . 21.3 t -129.33 138.18 55.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 70.23 111.163 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.612 ' HB3' ' OG1' ' A' ' 165' ' ' THR . . . -126.22 151.38 47.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 74.33 111.087 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -144.9 131.76 20.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.221 -0.445 . . . . 70.54 110.907 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.9 66.38 47.53 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.605 0.717 . . . . 70.3 110.952 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -33.58 16.35 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.653 2.235 . . . . 43.11 112.355 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 66.48 42.03 3.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.221 -0.445 . . . . 74.33 110.91 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 167.12 -46.17 0.25 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.763 -0.732 . . . . 64.1 112.474 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 2.3 t -67.58 -55.93 15.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.895 0.379 . . . . 65.22 111.147 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 44.7 p 47.96 63.61 1.97 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 71.44 111.133 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -160.89 132.43 5.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.238 -0.437 . . . . 63.22 110.867 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.72 87.1 6.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 54.12 110.898 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 14.4 m -102.3 -5.43 24.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 72.45 110.88 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.79 ' CE2' HG11 ' A' ' 183' ' ' VAL . 29.0 p90 -89.78 172.89 8.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 70.25 110.854 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.82 171.44 16.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.104 -0.498 . . . . 75.21 110.848 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 197' ' ' ALA . . . . . 0.468 ' HB3' ' HB ' ' A' ' 209' ' ' VAL . . . -114.86 168.04 10.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 60.21 111.089 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 9.6 p -159.88 152.85 5.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.25 -0.432 . . . . 73.51 111.12 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.77 119.0 28.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 74.21 110.844 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.565 ' HB2' ' HD3' ' A' ' 227' ' ' PRO . . . -62.89 -18.62 63.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 71.23 111.108 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -163.49 89.55 0.61 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 73.44 110.858 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 9.1 tmtt? -82.63 55.45 2.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.446 . . . . 74.32 110.907 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 25.9 p -129.44 1.18 5.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 45.32 111.139 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 10.6 mtmt -157.38 19.48 0.29 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 75.52 110.895 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.635 ' HA ' HG23 ' A' ' 219' ' ' VAL . . . 179.65 148.45 0.27 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 72.51 111.112 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 9.4 p -105.68 153.94 21.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.194 -0.457 . . . . 73.23 111.125 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.744 HG12 HG22 ' A' ' 216' ' ' VAL . 18.9 m -140.77 135.14 33.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.448 . . . . 73.34 111.172 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 208' ' ' SER . . . . . 0.438 ' C ' HG23 ' A' ' 214' ' ' ILE . 4.6 m -144.32 109.31 5.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 33.24 110.8 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.675 HG23 HG13 ' A' ' 214' ' ' ILE . 5.5 p -92.47 144.44 9.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 75.31 111.168 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 2.7 m -146.56 99.42 3.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 73.52 110.859 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 70.17 -81.43 0.36 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.745 -0.74 . . . . 61.14 112.482 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -139.71 9.01 2.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.826 0.346 . . . . 62.33 110.844 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 56.9 m -128.52 124.42 35.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.242 -0.435 . . . . 41.13 111.141 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.675 HG13 HG23 ' A' ' 209' ' ' VAL . 2.5 mp -117.87 135.27 58.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 71.14 111.113 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.21 128.25 51.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.461 . . . . 52.32 111.108 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.744 HG22 HG12 ' A' ' 207' ' ' VAL . 6.8 t -118.05 131.39 70.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.227 -0.442 . . . . 72.55 111.137 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -116.45 139.22 50.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 62.2 110.905 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -94.88 78.95 0.88 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.734 -0.745 . . . . 74.05 112.492 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.635 HG23 ' HA ' ' A' ' 205' ' ' ALA . 17.2 t -49.56 -54.24 7.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.827 0.346 . . . . 75.33 111.149 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -129.6 162.92 27.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 65.22 111.105 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' ALA . . . . . 0.681 ' HB2' ' HA ' ' A' ' 245' ' ' ALA . . . -61.83 138.36 58.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.447 . . . . 72.05 111.09 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 144.25 170.33 13.57 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.74 -0.743 . . . . 50.51 112.488 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' LYS . . . . . 0.567 ' HG3' HG23 ' A' ' 242' ' ' THR . 13.3 mttt -100.19 124.0 45.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.793 0.33 . . . . 73.01 110.921 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.485 HG11 ' CB ' ' A' ' 205' ' ' ALA . 6.3 p -123.76 122.98 66.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 53.22 111.091 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 225' ' ' ASN . . . . . 0.559 ' C ' HD12 ' A' ' 226' ' ' ILE . 21.2 m120 -91.19 156.27 17.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.466 . . . . 61.12 110.923 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.559 HD12 ' C ' ' A' ' 225' ' ' ASN . 4.7 mp -138.63 92.86 11.27 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.554 0.692 . . . . 65.31 111.114 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 227' ' ' PRO . . . . . 0.565 ' HD3' ' HB2' ' A' ' 200' ' ' ALA . 53.4 Cg_endo -69.88 -178.93 2.62 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.672 2.248 . . . . 74.42 112.31 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.484 ' CG2' ' HB3' ' A' ' 237' ' ' ALA . 23.5 t -146.52 149.24 16.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.455 . . . . 65.15 111.146 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 86.9 t -138.17 138.38 43.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 74.32 111.082 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -121.98 119.97 33.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 65.15 110.848 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 231' ' ' GLY . . . . . 0.82 ' HA3' ' HB2' ' A' ' 160' ' ' ALA . . . 58.08 -112.2 3.7 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.714 -0.755 . . . . 44.35 112.5 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -99.81 7.42 44.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.874 0.368 . . . . 72.53 110.892 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 114.46 16.09 7.83 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.691 -0.766 . . . . 73.43 112.495 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -51.13 -38.42 51.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.891 0.377 . . . . 64.01 110.863 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -143.07 167.04 23.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 64.14 110.911 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -162.23 165.32 26.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.113 -0.494 . . . . 74.43 111.1 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' ALA . . . . . 0.484 ' HB3' ' CG2' ' A' ' 228' ' ' VAL . . . -139.11 163.61 31.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.441 . . . . 64.54 111.135 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 61.2 t -132.46 127.2 56.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.233 -0.44 . . . . 63.34 111.095 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 239' ' ' ALA . . . . . 0.468 ' HB2' ' HG3' ' A' ' 168' ' ' PRO . . . -134.38 161.15 35.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.169 -0.469 . . . . 74.4 111.065 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 240' ' ' GLU . . . . . 0.604 ' O ' HD13 ' A' ' 241' ' ' ILE . 5.1 pt-20 -145.31 132.68 20.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 74.55 110.874 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 241' ' ' ILE . . . . . 0.604 HD13 ' O ' ' A' ' 240' ' ' GLU . 28.8 mm -126.95 112.85 30.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 72.3 111.129 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 242' ' ' THR . . . . . 0.567 HG23 ' HG3' ' A' ' 223' ' ' LYS . 1.9 m -83.06 141.49 32.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 74.11 111.179 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 14.0 t -119.92 121.6 66.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 73.24 111.156 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 244' ' ' THR . . . . . 0.408 HG23 ' O ' ' A' ' 173' ' ' VAL . 8.1 p -83.65 132.37 34.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.145 -0.479 . . . . 72.42 111.14 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 245' ' ' ALA . . . . . 0.681 ' HA ' ' HB2' ' A' ' 221' ' ' ALA . . . -53.72 -27.64 29.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 62.34 111.099 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 11.5 m . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 65.01 110.812 -179.726 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.491 -0.244 . . . . 64.31 112.491 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -121.46 163.64 18.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.792 0.33 . . . . 71.32 111.104 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 5.8 mmm -103.84 171.43 7.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 63.33 110.884 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -141.24 156.6 45.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.262 -0.426 . . . . 74.5 111.07 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.783 ' HB2' ' HA3' ' A' ' 231' ' ' GLY . . . -105.51 -66.99 0.94 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 65.33 111.125 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.442 ' HB1' ' HB3' ' A' ' 187' ' ' PRO . . . -178.46 -171.19 0.24 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.438 . . . . 64.23 111.118 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 1.1 p -119.55 3.92 11.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 65.44 111.167 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 173.74 101.73 0.15 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.741 -0.742 . . . . 73.01 112.447 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 16.3 ttp -111.84 125.17 53.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.86 0.362 . . . . 34.31 110.88 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.619 ' OG1' ' HB3' ' A' ' 184' ' ' ALA . 59.2 p -113.98 103.07 10.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.446 . . . . 72.2 111.129 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.998 HG22 HG13 ' A' ' 183' ' ' VAL . 20.7 t -99.83 131.29 47.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.215 -0.448 . . . . 73.23 111.11 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.8 m -126.81 92.57 44.37 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.565 0.697 . . . . 74.43 111.12 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.483 ' HB3' HD23 ' A' ' 181' ' ' LEU . 53.6 Cg_endo -69.81 -167.7 0.24 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.686 2.257 . . . . 73.22 112.317 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -85.38 -41.66 15.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 75.42 111.121 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 88.7 p 46.46 75.08 0.13 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.461 . . . . 55.53 110.85 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.4 t -172.32 -175.08 1.33 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.107 -0.497 . . . . 74.42 111.165 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 86.6 p -98.9 164.08 12.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.262 -0.427 . . . . 72.32 110.844 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.728 HG22 ' HB2' ' A' ' 177' ' ' GLN . 3.0 p -147.39 153.77 11.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.114 -0.494 . . . . 62.42 111.116 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 64.3 t -87.87 145.44 7.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 71.44 111.132 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.98 122.75 6.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 70.12 110.864 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 100.08 -15.33 59.33 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.782 -0.723 . . . . 42.44 112.517 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.728 ' HB2' HG22 ' A' ' 173' ' ' VAL . 11.6 mm100 -89.64 -177.97 5.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.807 0.337 . . . . 53.44 110.941 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 15.1 p -161.6 148.87 14.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 72.54 110.859 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.513 HG21 HD12 ' A' ' 241' ' ' ILE . 7.3 t -108.95 -173.86 2.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 61.02 111.133 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.41 131.87 26.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 74.22 111.13 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.483 HD23 ' HB3' ' A' ' 168' ' ' PRO . 7.6 mp -104.21 141.72 35.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 71.31 110.954 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.9 m -110.0 141.49 42.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.212 -0.449 . . . . 72.22 111.158 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.998 HG13 HG22 ' A' ' 166' ' ' VAL . 32.5 t -129.62 141.04 47.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.242 -0.435 . . . . 74.01 111.143 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.619 ' HB3' ' OG1' ' A' ' 165' ' ' THR . . . -131.53 151.46 51.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 72.22 111.114 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -143.72 129.81 19.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.249 -0.432 . . . . 73.51 110.862 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.54 66.91 58.76 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.616 0.722 . . . . 73.21 110.907 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.442 ' HB3' ' HB1' ' A' ' 161' ' ' ALA . 53.7 Cg_endo -69.72 -38.31 8.07 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.684 2.256 . . . . 55.51 112.362 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 67.17 47.89 1.28 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.181 -0.463 . . . . 74.31 110.869 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 160.9 -23.08 0.24 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.785 -0.721 . . . . 73.33 112.482 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 2.9 t -94.22 -58.65 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.916 0.388 . . . . 72.15 111.142 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 65.7 p 47.24 71.63 0.31 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.47 . . . . 74.53 111.145 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -169.68 118.23 0.62 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 52.14 110.897 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.67 104.09 0.98 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 72.12 110.919 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -117.38 -6.21 11.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 73.21 110.834 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.764 ' CE2' HG11 ' A' ' 183' ' ' VAL . 24.7 p90 -90.45 178.59 6.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 72.21 110.886 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.14 172.01 11.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 71.34 110.897 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -128.02 144.56 51.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 72.33 111.092 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 59.7 t -150.64 146.65 16.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 71.1 111.145 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 26.6 t -70.58 136.83 49.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.19 -0.459 . . . . 61.11 110.909 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.53 ' HB2' ' HD3' ' A' ' 227' ' ' PRO . . . -76.35 -8.41 57.06 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.149 -0.478 . . . . 63.03 111.092 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -142.85 -56.33 0.42 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.248 -0.433 . . . . 55.34 110.871 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 64.39 26.27 13.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.446 . . . . 74.2 110.91 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 80.6 p -114.24 -3.21 13.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 55.32 111.101 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 8.7 mtmm -149.19 16.4 0.93 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.274 -0.421 . . . . 72.24 110.859 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.708 ' HA ' HG23 ' A' ' 219' ' ' VAL . . . -177.69 146.78 0.46 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.259 -0.428 . . . . 62.33 111.139 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 15.9 p -104.81 153.37 21.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 65.14 111.136 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.924 HG12 HG22 ' A' ' 216' ' ' VAL . 35.5 m -136.88 140.96 41.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 75.04 111.115 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.98 108.3 4.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 74.14 110.865 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.53 HG23 HG13 ' A' ' 214' ' ' ILE . 3.7 p -87.95 143.46 11.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.064 -0.516 . . . . 73.11 111.139 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 3.8 t -172.13 123.14 0.49 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 53.3 110.851 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 55.71 47.8 75.73 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.773 -0.727 . . . . 64.13 112.452 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 3.8 mtp 63.19 16.27 9.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.833 0.349 . . . . 63.51 110.867 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 21.0 m -126.47 113.48 16.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.261 -0.427 . . . . 73.22 111.114 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.53 HG13 HG23 ' A' ' 209' ' ' VAL . 3.1 mp -110.46 115.54 50.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.463 . . . . 63.22 111.121 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 2.6 m -88.88 132.66 34.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.24 -0.436 . . . . 74.2 111.169 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.924 HG22 HG12 ' A' ' 207' ' ' VAL . 3.5 t -118.0 125.69 74.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.257 -0.429 . . . . 64.2 111.104 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -109.12 136.87 47.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.104 -0.498 . . . . 75.12 110.873 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -91.16 83.56 1.27 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.734 -0.746 . . . . 73.31 112.499 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.708 HG23 ' HA ' ' A' ' 205' ' ' ALA . 20.3 t -53.99 -52.52 35.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.857 0.36 . . . . 72.31 111.151 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -134.34 163.18 30.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 65.44 111.129 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 221' ' ' ALA . . . . . 0.474 ' HB2' ' HA ' ' A' ' 245' ' ' ALA . . . -56.64 144.84 30.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 75.31 111.107 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 222' ' ' GLY . . . . . 0.441 ' O ' HG23 ' A' ' 243' ' ' VAL . . . 129.92 166.29 11.81 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.791 -0.719 . . . . 71.24 112.535 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 223' ' ' LYS . . . . . 0.77 ' HG3' HG23 ' A' ' 242' ' ' THR . 2.6 mtmm -101.32 129.67 47.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.833 0.349 . . . . 70.31 110.907 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.548 HG11 ' HB3' ' A' ' 205' ' ' ALA . 7.4 p -118.58 129.68 74.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.263 -0.426 . . . . 72.21 111.149 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 225' ' ' ASN . . . . . 0.609 ' C ' HD12 ' A' ' 226' ' ' ILE . 35.2 m120 -89.71 147.4 23.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 70.22 110.889 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.609 HD12 ' C ' ' A' ' 225' ' ' ASN . 4.3 mp -137.75 93.35 12.33 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.633 0.73 . . . . 74.54 111.161 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 227' ' ' PRO . . . . . 0.53 ' HD3' ' HB2' ' A' ' 200' ' ' ALA . 53.5 Cg_endo -69.79 -176.9 1.65 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.729 2.286 . . . . 74.25 112.297 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.557 ' CG2' ' HB3' ' A' ' 237' ' ' ALA . 48.2 t -147.3 134.72 14.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 62.3 111.082 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 93.7 t -117.95 133.08 65.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.177 -0.465 . . . . 61.02 111.109 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.23 116.28 23.85 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.128 -0.487 . . . . 73.05 110.845 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 231' ' ' GLY . . . . . 0.783 ' HA3' ' HB2' ' A' ' 160' ' ' ALA . . . 61.18 -121.13 25.44 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.743 -0.742 . . . . 72.15 112.469 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -95.78 15.43 20.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.871 0.367 . . . . 72.14 110.904 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 111.13 9.96 21.3 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.747 -0.739 . . . . 52.35 112.459 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -51.11 -65.08 0.62 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.906 0.384 . . . . 64.13 110.907 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -110.78 156.03 21.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 74.11 110.894 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -153.16 164.69 37.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 63.15 111.053 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 237' ' ' ALA . . . . . 0.557 ' HB3' ' CG2' ' A' ' 228' ' ' VAL . . . -144.86 163.88 32.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.456 . . . . 75.31 111.119 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 14.1 p -137.91 134.65 45.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 75.14 111.105 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 239' ' ' ALA . . . . . 0.452 ' HB2' ' HG3' ' A' ' 168' ' ' PRO . . . -139.31 164.37 30.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.119 -0.491 . . . . 65.35 111.116 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -147.56 131.14 16.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.249 -0.432 . . . . 63.31 110.879 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 241' ' ' ILE . . . . . 0.645 HG13 HG11 ' A' ' 216' ' ' VAL . 30.7 mm -122.83 115.0 44.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 71.42 111.064 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 242' ' ' THR . . . . . 0.77 HG23 ' HG3' ' A' ' 223' ' ' LYS . 0.6 OUTLIER -83.0 141.28 32.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.179 -0.464 . . . . 63.1 111.149 179.926 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 222' ' ' GLY . 19.5 t -120.39 120.32 62.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.225 -0.443 . . . . 64.43 111.161 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 244' ' ' THR . . . . . 0.518 HG23 ' O ' ' A' ' 173' ' ' VAL . 4.9 p -82.61 132.95 35.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 75.35 111.133 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 245' ' ' ALA . . . . . 0.474 ' HA ' ' HB2' ' A' ' 221' ' ' ALA . . . -58.71 -21.67 55.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.439 . . . . 33.35 111.086 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 4.5 m . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.443 . . . . 71.43 110.883 -179.807 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 112.481 -0.247 . . . . 65.33 112.481 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -89.82 -33.16 16.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.806 0.336 . . . . 61.34 111.132 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 35.6 mtm -52.77 129.6 30.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 73.31 110.831 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -177.17 -169.37 0.24 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 52.45 111.069 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -176.67 129.61 0.19 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 73.0 111.078 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.36 -168.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 61.02 111.073 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -125.14 32.11 5.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 72.43 111.183 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 138.46 99.58 0.48 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.775 -0.726 . . . . 75.24 112.473 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 41.2 ttp -111.11 129.07 56.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.882 0.372 . . . . 64.22 110.841 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.546 ' OG1' ' HB3' ' A' ' 184' ' ' ALA . 40.4 p -118.0 105.86 12.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.194 -0.457 . . . . 71.21 111.13 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 1.086 HG22 HG13 ' A' ' 183' ' ' VAL . 21.5 t -99.87 133.64 42.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 74.32 111.167 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.3 m -126.2 92.49 45.56 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.593 0.711 . . . . 73.11 111.145 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.497 ' HG3' ' HB2' ' A' ' 239' ' ' ALA . 53.5 Cg_endo -69.77 -167.88 0.25 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.7 2.267 . . . . 65.42 112.338 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -87.15 -38.13 16.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 72.51 111.121 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 94.4 p 46.21 79.54 0.05 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 31.31 110.87 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.4 t -175.39 -174.6 0.74 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.17 -0.468 . . . . 74.33 111.164 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 33.0 p -101.06 162.0 13.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 72.22 110.875 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.738 HG22 ' HB2' ' A' ' 177' ' ' GLN . 2.6 p -144.83 154.25 14.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 74.45 111.133 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 93.2 t -89.91 144.9 8.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 75.1 111.137 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -47.75 124.11 6.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 70.11 110.922 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.69 -17.22 57.79 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.756 -0.735 . . . . 52.11 112.465 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.738 ' HB2' HG22 ' A' ' 173' ' ' VAL . 10.7 mm100 -87.99 -177.77 5.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.768 0.318 . . . . 73.33 110.956 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 1.7 p -161.86 148.91 14.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.237 -0.438 . . . . 74.41 110.875 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 9.2 t -111.04 -174.86 2.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.14 -0.482 . . . . 72.44 111.112 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.21 132.46 29.89 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.174 -0.466 . . . . 72.22 111.139 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.473 HD23 ' HB3' ' A' ' 168' ' ' PRO . 7.6 mp -106.36 143.3 34.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 73.52 110.904 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 16.3 m -110.31 143.91 39.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.451 . . . . 33.42 111.129 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 1.086 HG13 HG22 ' A' ' 166' ' ' VAL . 22.9 t -129.69 142.36 44.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.214 -0.448 . . . . 51.44 111.143 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.546 ' HB3' ' OG1' ' A' ' 165' ' ' THR . . . -131.55 150.92 51.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 70.35 111.081 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -144.47 126.45 15.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 72.11 110.881 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.22 67.23 79.61 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.565 0.698 . . . . 65.42 110.892 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -37.22 9.58 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.674 2.249 . . . . 72.14 112.387 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 66.31 40.97 3.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 71.33 110.864 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 169.29 -37.99 0.2 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.777 -0.725 . . . . 54.11 112.52 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 2.9 t -77.43 -57.75 5.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.883 0.373 . . . . 71.31 111.09 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 1.1 p 47.21 66.56 0.98 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 73.21 111.16 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -168.49 113.63 0.62 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 70.32 110.854 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 5.1 mtmt -54.39 101.45 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 74.4 110.918 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 23.0 t -115.22 -5.99 12.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 54.22 110.837 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.772 ' CE2' HG11 ' A' ' 183' ' ' VAL . 22.7 p90 -90.31 172.15 8.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.127 -0.488 . . . . 63.41 110.873 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.58 158.89 36.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 74.24 110.886 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 197' ' ' ALA . . . . . 0.606 ' HB3' ' HB ' ' A' ' 209' ' ' VAL . . . -112.83 165.97 11.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.445 . . . . 54.51 111.094 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 10.7 p -175.18 151.84 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 34.4 111.132 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.6 t -79.25 144.49 34.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 71.11 110.866 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.581 ' HB2' ' HD3' ' A' ' 227' ' ' PRO . . . -78.57 -22.6 46.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 75.52 111.073 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -127.63 -54.87 1.33 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 60.5 110.814 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 1.7 ttpm? 63.43 27.92 15.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.469 . . . . 71.2 110.885 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 44.8 p -115.76 -1.77 12.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.265 -0.425 . . . . 71.2 111.149 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 204' ' ' LYS . . . . . 0.526 ' CB ' ' HB3' ' A' ' 220' ' ' ALA . 11.2 mtmm -149.61 16.48 0.89 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 73.11 110.919 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -174.9 150.68 1.27 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 72.04 111.078 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 23.9 p -112.88 134.65 54.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 70.33 111.145 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.924 HG12 HG22 ' A' ' 216' ' ' VAL . 5.3 m -122.4 139.65 48.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.221 -0.445 . . . . 72.2 111.108 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -144.1 108.87 4.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 45.43 110.848 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.606 ' HB ' ' HB3' ' A' ' 197' ' ' ALA . 4.3 p -84.84 143.76 11.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 63.53 111.142 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 11.8 t -172.12 124.47 0.52 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 74.44 110.865 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 52.87 52.0 41.81 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.728 -0.749 . . . . 51.12 112.478 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 2.2 mtp 58.75 19.61 7.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.885 0.374 . . . . 74.21 110.914 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 1.6 m -131.56 113.21 13.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.229 -0.441 . . . . 73.44 111.164 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.569 HG13 HG23 ' A' ' 209' ' ' VAL . 3.1 mp -109.71 116.78 53.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 64.21 111.118 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 1.1 m -89.86 129.91 36.16 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.148 -0.478 . . . . 62.04 111.118 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.924 HG22 HG12 ' A' ' 207' ' ' VAL . 3.5 t -115.75 129.6 71.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 73.34 111.063 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -112.32 135.12 53.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.119 -0.491 . . . . 52.0 110.875 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -82.1 67.04 3.76 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.752 -0.737 . . . . 65.42 112.519 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.423 HG12 ' N ' ' A' ' 220' ' ' ALA . 1.4 t -48.4 -51.05 11.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.848 0.356 . . . . 65.4 111.153 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 220' ' ' ALA . . . . . 0.526 ' HB3' ' CB ' ' A' ' 204' ' ' LYS . . . -127.86 154.87 44.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 45.24 111.093 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 221' ' ' ALA . . . . . 0.655 ' HB2' ' HA ' ' A' ' 245' ' ' ALA . . . -66.63 136.36 55.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 73.42 111.078 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 139.21 171.91 12.41 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.726 -0.749 . . . . 54.01 112.487 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 223' ' ' LYS . . . . . 0.441 ' HG3' HG23 ' A' ' 242' ' ' THR . 8.3 mttm -96.02 125.19 40.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.806 0.336 . . . . 74.35 110.918 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 7.7 p -121.42 131.25 73.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.268 -0.423 . . . . 75.4 111.141 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 225' ' ' ASN . . . . . 0.615 ' C ' HD12 ' A' ' 226' ' ' ILE . 34.3 m120 -90.54 151.41 21.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 62.22 110.859 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.615 HD12 ' C ' ' A' ' 225' ' ' ASN . 4.3 mp -136.71 92.71 14.55 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.633 0.73 . . . . 64.34 111.136 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 227' ' ' PRO . . . . . 0.581 ' HD3' ' HB2' ' A' ' 200' ' ' ALA . 53.9 Cg_endo -69.82 179.92 3.39 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.664 2.243 . . . . 62.43 112.339 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 96.7 t -150.63 137.54 13.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 73.23 111.161 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 92.7 t -122.38 134.55 65.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 51.02 111.115 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -122.22 125.02 45.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.15 -0.477 . . . . 62.11 110.869 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 56.77 -117.74 10.21 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.74 -0.743 . . . . 70.12 112.468 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -94.44 8.46 42.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.865 0.364 . . . . 62.44 110.85 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 106.94 9.61 29.83 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.717 -0.754 . . . . 63.23 112.473 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -51.67 -40.66 60.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.886 0.374 . . . . 74.23 110.884 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -127.68 167.25 16.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.481 . . . . 53.21 110.873 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -166.26 165.34 17.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 70.01 111.081 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -139.33 163.19 33.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.222 -0.445 . . . . 73.45 111.103 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.0 p -135.32 127.71 47.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.441 . . . . 52.45 111.112 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 239' ' ' ALA . . . . . 0.497 ' HB2' ' HG3' ' A' ' 168' ' ' PRO . . . -130.52 163.07 27.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.13 -0.486 . . . . 61.41 111.086 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 240' ' ' GLU . . . . . 0.439 ' O ' HD13 ' A' ' 241' ' ' ILE . 2.8 pt-20 -144.31 128.29 17.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.439 . . . . 44.21 110.876 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 241' ' ' ILE . . . . . 0.467 HG13 HG11 ' A' ' 216' ' ' VAL . 26.0 mm -124.92 111.2 27.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 63.2 111.127 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 242' ' ' THR . . . . . 0.441 HG23 ' HG3' ' A' ' 223' ' ' LYS . 4.0 m -81.63 139.94 34.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 73.31 111.131 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 30.5 t -120.26 119.06 58.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 53.31 111.142 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 244' ' ' THR . . . . . 0.503 HG23 ' O ' ' A' ' 173' ' ' VAL . 5.1 p -81.12 132.87 35.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.151 -0.477 . . . . 71.14 111.102 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 245' ' ' ALA . . . . . 0.655 ' HA ' ' HB2' ' A' ' 221' ' ' ALA . . . -54.06 -27.66 33.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 61.32 111.113 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 10.2 m . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.237 -0.438 . . . . 73.52 110.875 -179.783 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.289 0 N-CA-C 112.455 -0.258 . . . . 51.14 112.455 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -81.02 114.6 20.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.769 0.319 . . . . 54.14 111.091 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 8.0 mmt -119.29 139.08 52.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.444 . . . . 62.1 110.907 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -136.38 146.3 46.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.244 -0.435 . . . . 62.54 111.132 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.621 ' O ' HG11 ' A' ' 190' ' ' VAL . . . -76.03 -75.15 0.19 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.252 -0.431 . . . . 62.01 111.107 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -174.02 -167.78 0.37 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 72.44 111.115 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 1.1 m -137.55 27.58 2.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 62.21 111.138 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 147.01 105.65 0.43 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.801 -0.714 . . . . 72.43 112.522 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 1.5 ttp -120.0 140.52 50.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.875 0.369 . . . . 63.51 110.886 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.407 ' OG1' ' HB3' ' A' ' 184' ' ' ALA . 32.8 p -126.43 109.83 12.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.445 . . . . 71.51 111.167 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 1.059 HG22 HG13 ' A' ' 183' ' ' VAL . 21.7 t -97.57 134.98 33.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 74.2 111.102 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 4.3 m -126.94 92.59 44.1 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.631 0.729 . . . . 70.51 111.168 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.468 ' HB3' HD23 ' A' ' 181' ' ' LEU . 53.8 Cg_endo -69.74 -167.65 0.23 Allowed 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.686 2.257 . . . . 73.4 112.373 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -89.88 -43.16 10.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 73.14 111.093 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 12.2 t 49.7 80.98 0.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 55.32 110.835 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.5 t -175.13 -175.46 0.85 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 75.21 111.199 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 83.3 p -98.45 161.69 13.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.436 . . . . 60.42 110.893 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.723 HG22 ' HB2' ' A' ' 177' ' ' GLN . 3.1 p -144.24 153.92 15.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 71.13 111.132 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 64.7 t -87.5 144.99 8.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 74.33 111.159 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.6 122.55 5.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.451 . . . . 74.21 110.883 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.59 -14.2 60.73 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.753 -0.737 . . . . 65.21 112.475 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.723 ' HB2' HG22 ' A' ' 173' ' ' VAL . 15.7 mm100 -91.61 -178.23 5.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.802 0.334 . . . . 75.04 110.915 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 54.3 p -161.55 146.24 13.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 75.21 110.862 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.565 HG21 HD12 ' A' ' 241' ' ' ILE . 7.0 t -103.34 -173.85 2.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.083 -0.508 . . . . 75.11 111.158 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.51 132.86 28.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.219 -0.446 . . . . 74.42 111.14 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.468 HD23 ' HB3' ' A' ' 168' ' ' PRO . 7.5 mp -106.63 145.25 32.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 53.22 110.943 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 2.2 m -113.81 145.56 41.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.238 -0.437 . . . . 62.13 111.13 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 1.059 HG13 HG22 ' A' ' 166' ' ' VAL . 21.9 t -129.48 142.18 44.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 64.31 111.124 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.407 ' HB3' ' OG1' ' A' ' 165' ' ' THR . . . -128.74 152.94 47.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 72.32 111.088 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -143.99 128.25 17.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 73.04 110.852 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -132.72 66.93 77.6 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.606 0.717 . . . . 62.44 110.9 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -26.16 27.96 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.694 2.263 . . . . 72.54 112.387 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 70.31 33.43 2.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.195 -0.457 . . . . 74.32 110.878 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 167.88 -25.66 0.13 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.713 -0.756 . . . . 45.02 112.442 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.621 HG11 ' O ' ' A' ' 160' ' ' ALA . 71.7 t -101.18 149.64 6.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.913 0.387 . . . . 74.24 111.132 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 12.4 p -140.45 38.63 1.88 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 74.22 111.158 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.531 ' H ' HG12 ' A' ' 190' ' ' VAL . 37.6 t70 -125.02 119.74 29.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.215 -0.448 . . . . 71.11 110.86 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 24.8 mtmt -74.31 74.68 1.85 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 52.1 110.894 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -75.55 -6.25 49.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 74.01 110.826 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.785 ' CE2' HG11 ' A' ' 183' ' ' VAL . 11.5 p90 -90.03 151.81 21.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 64.33 110.898 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.59 154.04 43.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.144 -0.48 . . . . 72.24 110.923 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -103.81 167.77 9.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 71.23 111.103 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 9.3 p -173.25 152.99 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 74.15 111.171 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 73.4 p -76.6 152.86 35.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 65.24 110.866 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.636 ' HB2' ' HD3' ' A' ' 227' ' ' PRO . . . -93.86 -19.54 20.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.126 -0.488 . . . . 71.43 111.135 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.84 -55.28 0.93 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 73.52 110.864 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.54 26.41 14.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 71.32 110.881 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 41.5 p -112.9 -3.92 14.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 65.43 111.152 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 10.2 mtmm -154.21 19.87 0.49 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 72.55 110.898 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.625 ' HA ' HG23 ' A' ' 219' ' ' VAL . . . -177.46 147.6 0.53 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 73.43 111.105 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 15.0 p -108.65 159.67 16.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 75.52 111.159 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.711 HG12 HG22 ' A' ' 216' ' ' VAL . 7.7 m -141.37 141.97 29.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.246 -0.434 . . . . 62.42 111.107 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 69.8 m -149.1 108.66 3.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 73.43 110.888 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.549 HG23 HG13 ' A' ' 214' ' ' ILE . 3.6 p -88.97 143.15 11.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.1 -0.5 . . . . 72.02 111.119 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 18.8 t -172.16 123.48 0.49 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.47 . . . . 64.41 110.864 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 56.04 47.02 83.24 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.719 -0.753 . . . . 64.43 112.524 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 2.4 mtp 63.85 15.94 9.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.904 0.383 . . . . 71.22 110.908 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 6.5 m -125.6 113.14 17.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.459 . . . . 51.54 111.128 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.549 HG13 HG23 ' A' ' 209' ' ' VAL . 3.0 mp -110.43 113.98 45.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 75.22 111.127 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 7.3 m -88.95 132.78 34.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.129 -0.487 . . . . 71.42 111.184 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.711 HG22 HG12 ' A' ' 207' ' ' VAL . 4.4 t -117.94 123.54 71.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.257 -0.429 . . . . 40.43 111.124 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -104.94 140.0 38.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 73.22 110.901 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -95.41 79.31 0.83 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.726 -0.749 . . . . 73.24 112.478 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.625 HG23 ' HA ' ' A' ' 205' ' ' ALA . 18.3 t -49.54 -54.67 6.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.821 0.343 . . . . 61.12 111.12 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -130.85 162.07 30.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 71.53 111.075 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 221' ' ' ALA . . . . . 0.672 ' HB2' ' HA ' ' A' ' 245' ' ' ALA . . . -60.36 141.82 55.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 73.33 111.141 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 139.4 172.05 12.5 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.757 -0.735 . . . . 51.23 112.471 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 223' ' ' LYS . . . . . 0.401 ' HG3' HG23 ' A' ' 242' ' ' THR . 5.0 mttt -99.74 120.84 40.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.824 0.345 . . . . 73.53 110.89 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.583 HG11 ' CB ' ' A' ' 205' ' ' ALA . 6.4 p -117.46 122.88 70.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.213 -0.448 . . . . 74.4 111.133 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 225' ' ' ASN . . . . . 0.652 ' C ' HD12 ' A' ' 226' ' ' ILE . 26.8 m120 -90.99 152.74 20.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.163 -0.472 . . . . 72.04 110.908 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.652 HD12 ' C ' ' A' ' 225' ' ' ASN . 3.9 mp -137.74 92.72 12.76 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.632 0.729 . . . . 64.12 111.13 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 227' ' ' PRO . . . . . 0.636 ' HD3' ' HB2' ' A' ' 200' ' ' ALA . 54.2 Cg_endo -69.7 177.1 5.88 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.67 2.247 . . . . 65.31 112.376 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.447 ' CG2' ' HB3' ' A' ' 237' ' ' ALA . 34.6 t -146.18 139.11 20.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.257 -0.429 . . . . 74.12 111.102 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 91.4 t -129.25 143.79 40.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.15 -0.477 . . . . 71.11 111.178 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 6.0 p -92.4 176.0 6.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 50.14 110.832 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -51.16 -45.97 51.41 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.761 -0.733 . . . . 73.35 112.499 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -111.48 21.08 16.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.873 0.368 . . . . 65.01 110.885 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 61.7 16.02 49.69 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.724 -0.75 . . . . 72.13 112.469 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -66.36 -44.45 83.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.894 0.378 . . . . 71.34 110.902 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -117.3 144.93 44.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.146 -0.479 . . . . 70.02 110.909 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -144.71 163.23 34.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 70.11 111.101 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 237' ' ' ALA . . . . . 0.447 ' HB3' ' CG2' ' A' ' 228' ' ' VAL . . . -142.65 163.4 32.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 63.3 111.052 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 57.3 t -139.6 136.6 40.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.215 -0.448 . . . . 55.33 111.132 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.17 165.08 27.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.466 . . . . 72.14 111.075 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 240' ' ' GLU . . . . . 0.405 ' O ' HD13 ' A' ' 241' ' ' ILE . 3.2 pt-20 -143.79 132.25 22.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 74.12 110.862 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 241' ' ' ILE . . . . . 0.565 HD12 HG21 ' A' ' 179' ' ' THR . 24.1 mm -127.27 113.28 31.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 64.41 111.156 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 242' ' ' THR . . . . . 0.401 HG23 ' HG3' ' A' ' 223' ' ' LYS . 1.7 m -81.42 141.06 34.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 52.34 111.134 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 17.2 t -119.95 122.13 67.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 73.44 111.144 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 244' ' ' THR . . . . . 0.525 HG23 ' O ' ' A' ' 173' ' ' VAL . 7.2 p -82.57 133.05 35.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 62.35 111.159 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 245' ' ' ALA . . . . . 0.672 ' HA ' ' HB2' ' A' ' 221' ' ' ALA . . . -59.14 -21.87 60.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 72.14 111.088 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 52.3 p . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 72.11 110.856 -179.782 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 N-CA-C 112.449 -0.26 . . . . 54.3 112.449 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -163.67 164.16 24.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.773 0.32 . . . . 72.41 111.096 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.26 -177.31 3.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 73.4 110.839 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -171.22 -169.55 0.75 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 73.21 111.092 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -176.48 129.38 0.2 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.441 . . . . 74.21 111.096 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.5 -168.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.242 -0.435 . . . . 35.02 111.078 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -124.6 31.96 5.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 74.41 111.109 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 138.28 99.17 0.48 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.743 -0.741 . . . . 70.45 112.486 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 35.2 ttp -109.71 130.91 55.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.822 0.344 . . . . 70.01 110.888 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.552 ' OG1' ' HB3' ' A' ' 184' ' ' ALA . 36.5 p -120.48 105.1 10.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.44 . . . . 74.35 111.182 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.994 HG22 HG13 ' A' ' 183' ' ' VAL . 21.1 t -98.26 136.11 30.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 64.51 111.171 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.3 m -127.7 91.86 44.29 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.593 0.711 . . . . 54.41 111.127 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.465 ' HG3' ' HB2' ' A' ' 239' ' ' ALA . 53.9 Cg_endo -69.72 -165.7 0.16 Allowed 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.709 2.273 . . . . 65.04 112.346 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -91.84 -39.25 11.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 74.41 111.089 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 88.5 p 46.73 79.82 0.05 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 52.22 110.897 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.6 t -175.56 -175.06 0.75 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.121 -0.491 . . . . 72.04 111.131 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 25.5 p -99.84 163.28 12.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 73.35 110.853 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.726 HG22 ' HB2' ' A' ' 177' ' ' GLN . 3.0 p -143.91 153.4 15.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.123 -0.489 . . . . 75.32 111.12 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 80.6 t -87.76 143.58 10.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 73.55 111.099 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.35 122.41 4.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 75.05 110.872 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.34 -9.88 61.18 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.735 -0.745 . . . . 72.31 112.482 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.726 ' HB2' HG22 ' A' ' 173' ' ' VAL . 11.9 mm100 -97.17 -178.68 4.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.792 0.329 . . . . 74.02 110.946 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 15.2 p -161.55 147.67 14.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 63.3 110.898 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 7.7 t -104.9 -175.82 2.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.476 . . . . 63.33 111.131 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -137.38 130.11 30.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 63.03 111.16 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.46 HD23 ' HB3' ' A' ' 168' ' ' PRO . 8.0 mp -105.43 140.39 38.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 72.21 110.937 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -109.92 145.57 36.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 75.33 111.163 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.994 HG13 HG22 ' A' ' 166' ' ' VAL . 52.1 t -129.58 142.61 43.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.453 . . . . 74.4 111.141 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.552 ' HB3' ' OG1' ' A' ' 165' ' ' THR . . . -130.13 150.76 51.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.198 -0.455 . . . . 71.51 111.084 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -144.83 126.74 15.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 74.4 110.884 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.89 67.61 80.92 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.612 0.72 . . . . 53.33 110.903 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 -33.55 16.22 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.67 2.247 . . . . 71.35 112.372 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 65.75 32.54 8.85 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.212 -0.449 . . . . 63.44 110.857 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 177.66 -50.0 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.724 -0.75 . . . . 60.24 112.457 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 2.6 t -62.72 -56.26 18.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.918 0.389 . . . . 70.51 111.155 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 38.2 p 48.21 61.7 2.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 42.12 111.114 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -166.8 120.76 1.04 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.256 -0.429 . . . . 73.12 110.844 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.35 99.82 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 73.12 110.87 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 3.3 t -111.16 -7.33 14.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 65.43 110.892 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.789 ' CE2' HG11 ' A' ' 183' ' ' VAL . 21.1 p90 -91.36 -176.29 4.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.108 -0.496 . . . . 72.2 110.878 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -166.3 175.27 8.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 65.24 110.926 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 197' ' ' ALA . . . . . 0.684 ' HB3' ' CG2' ' A' ' 209' ' ' VAL . . . -125.24 167.16 15.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 74.32 111.098 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.419 HG13 ' HG2' ' A' ' 227' ' ' PRO . 13.9 p -170.54 149.52 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 71.23 111.133 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.2 p -92.22 125.3 36.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 71.1 110.833 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.483 ' HB2' ' HD3' ' A' ' 227' ' ' PRO . . . -60.77 -18.62 56.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 73.4 111.076 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -164.25 103.52 0.86 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 73.42 110.878 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -89.61 46.78 1.4 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.169 -0.469 . . . . 72.21 110.891 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 11.9 p -120.9 -9.17 9.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 72.21 111.165 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 204' ' ' LYS . . . . . 0.697 ' HA ' ' HB3' ' A' ' 220' ' ' ALA . 11.3 mtmm -143.09 17.1 1.92 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 71.42 110.908 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.63 ' CB ' HG11 ' A' ' 224' ' ' VAL . . . 178.91 143.12 0.12 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 45.51 111.106 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 2.1 p -104.6 161.68 13.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.437 . . . . 72.45 111.165 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.598 HG12 HG22 ' A' ' 216' ' ' VAL . 17.2 m -140.85 150.17 20.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.239 -0.437 . . . . 75.32 111.138 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 22.8 m -157.69 109.71 2.35 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.474 . . . . 73.32 110.843 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.684 ' CG2' ' HB3' ' A' ' 197' ' ' ALA . 90.5 t -79.45 145.18 9.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.116 -0.493 . . . . 61.3 111.162 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 59.2 p -165.84 111.56 0.87 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.197 -0.456 . . . . 72.2 110.848 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 47.66 63.33 3.52 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.736 -0.745 . . . . 70.43 112.458 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 3.1 mtp 55.75 20.48 4.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.875 0.369 . . . . 72.54 110.891 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 1.4 m -130.97 106.5 8.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.23 -0.441 . . . . 53.32 111.14 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.531 ' H ' HD12 ' A' ' 214' ' ' ILE . 0.8 OUTLIER -101.64 122.01 53.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.264 -0.426 . . . . 72.21 111.166 179.905 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 7.3 m -92.22 123.15 35.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 73.34 111.112 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.598 HG22 HG12 ' A' ' 207' ' ' VAL . 2.4 t -108.65 123.18 64.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 62.24 111.101 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -107.63 145.1 33.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 63.53 110.87 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -99.72 64.24 0.65 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.776 -0.726 . . . . 63.33 112.526 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.611 HG22 ' HA ' ' A' ' 205' ' ' ALA . 0.0 OUTLIER -48.23 -41.59 10.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.809 0.338 . . . . 60.02 111.092 -179.925 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 220' ' ' ALA . . . . . 0.697 ' HB3' ' HA ' ' A' ' 204' ' ' LYS . . . -127.3 151.02 49.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 73.21 111.074 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 221' ' ' ALA . . . . . 0.644 ' HB2' ' HA ' ' A' ' 245' ' ' ALA . . . -66.68 138.05 57.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 50.14 111.1 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 137.72 170.15 11.81 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.747 -0.739 . . . . 64.53 112.542 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 223' ' ' LYS . . . . . 0.527 ' HG3' HG23 ' A' ' 242' ' ' THR . 7.9 mttm -93.32 127.61 39.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.846 0.355 . . . . 74.53 110.95 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.63 HG11 ' CB ' ' A' ' 205' ' ' ALA . 7.3 p -122.05 129.36 75.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.239 -0.437 . . . . 72.44 111.15 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 225' ' ' ASN . . . . . 0.578 ' C ' HD12 ' A' ' 226' ' ' ILE . 19.3 m120 -90.95 148.54 22.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 73.41 110.851 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.578 HD12 ' C ' ' A' ' 225' ' ' ASN . 4.3 mp -135.72 92.57 16.76 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.622 0.725 . . . . 64.14 111.096 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 227' ' ' PRO . . . . . 0.483 ' HD3' ' HB2' ' A' ' 200' ' ' ALA . 54.1 Cg_endo -69.77 178.63 4.38 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.66 2.24 . . . . 63.42 112.358 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 54.4 t -148.29 136.78 15.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.237 -0.438 . . . . 75.02 111.18 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 98.3 t -118.15 136.63 54.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.453 . . . . 72.13 111.133 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 22.7 t -122.17 135.51 54.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 51.24 110.87 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 52.53 -113.72 2.9 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.738 -0.744 . . . . 71.44 112.471 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -111.8 20.66 16.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.873 0.368 . . . . 64.42 110.887 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 113.14 1.94 25.02 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.719 -0.753 . . . . 74.4 112.478 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -52.92 -62.58 1.56 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.878 0.37 . . . . 74.51 110.892 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -108.37 166.13 10.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 73.24 110.867 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -166.1 165.15 17.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.128 -0.487 . . . . 52.12 111.087 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -143.41 163.27 33.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 73.01 111.061 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 14.8 p -138.25 137.64 43.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 75.33 111.157 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 239' ' ' ALA . . . . . 0.465 ' HB2' ' HG3' ' A' ' 168' ' ' PRO . . . -138.95 164.82 28.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 61.1 111.138 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 240' ' ' GLU . . . . . 0.588 ' O ' HD13 ' A' ' 241' ' ' ILE . 4.6 pt-20 -143.99 130.48 19.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 75.12 110.94 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 241' ' ' ILE . . . . . 0.589 HG13 HG11 ' A' ' 216' ' ' VAL . 32.7 mm -127.12 114.77 38.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 74.53 111.134 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 242' ' ' THR . . . . . 0.527 HG23 ' HG3' ' A' ' 223' ' ' LYS . 3.2 m -84.28 141.0 31.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 70.25 111.169 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 25.9 t -120.39 120.1 61.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.446 . . . . 72.11 111.134 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 244' ' ' THR . . . . . 0.497 HG23 ' O ' ' A' ' 173' ' ' VAL . 7.1 p -81.1 132.83 35.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.485 . . . . 53.01 111.145 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 245' ' ' ALA . . . . . 0.644 ' HA ' ' HB2' ' A' ' 221' ' ' ALA . . . -58.51 -25.16 62.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 75.15 111.073 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 40.3 t . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 71.11 110.83 -179.753 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.286 0 N-CA-C 112.516 -0.234 . . . . 52.04 112.516 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -125.43 143.62 50.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.773 0.321 . . . . 44.42 111.108 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 16.2 tpp -53.74 156.9 2.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 64.33 110.861 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -167.41 -169.88 1.33 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 72.11 111.116 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -174.38 129.75 0.36 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 70.14 111.108 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.472 ' HB1' ' HB3' ' A' ' 187' ' ' PRO . . . -59.83 -168.68 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 63.11 111.155 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 1.2 m -125.07 32.68 5.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.271 -0.422 . . . . 74.43 111.153 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 140.55 97.99 0.34 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.765 -0.731 . . . . 62.14 112.48 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.522 ' HE3' HG11 ' A' ' 228' ' ' VAL . 0.8 OUTLIER -112.95 138.1 50.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.905 0.383 . . . . 74.2 110.86 -179.965 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 34.4 p -121.52 109.8 15.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.236 -0.438 . . . . 53.3 111.18 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 1.083 HG22 HG13 ' A' ' 183' ' ' VAL . 33.5 t -98.45 132.91 42.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.429 . . . . 75.54 111.155 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.5 m -123.43 92.09 49.16 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.619 0.723 . . . . 64.3 111.179 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.463 ' HB3' HD23 ' A' ' 181' ' ' LEU . 53.6 Cg_endo -69.78 -168.41 0.27 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.666 2.244 . . . . 64.23 112.348 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -89.75 -42.7 11.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.446 . . . . 71.31 111.105 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 12.3 t 49.88 80.57 0.07 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.236 -0.438 . . . . 64.34 110.869 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.5 t -174.72 -175.09 0.87 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 75.3 111.142 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 1.5 m -98.7 162.41 13.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.444 . . . . 71.52 110.893 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.729 HG22 ' HB2' ' A' ' 177' ' ' GLN . 3.6 p -144.5 153.32 15.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.129 -0.487 . . . . 73.13 111.124 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 61.8 t -86.73 145.55 7.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 73.14 111.1 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.23 122.22 5.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.468 . . . . 73.0 110.914 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.18 -11.54 61.95 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.76 -0.734 . . . . 72.33 112.467 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.729 ' HB2' HG22 ' A' ' 173' ' ' VAL . 16.3 mm100 -94.2 -178.62 4.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.818 0.342 . . . . 74.25 110.909 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 52.2 p -161.74 148.09 13.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 51.2 110.861 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.502 HG21 HD12 ' A' ' 241' ' ' ILE . 7.0 t -106.01 -173.61 2.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.13 -0.487 . . . . 53.2 111.097 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -139.93 132.2 28.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.456 . . . . 64.11 111.166 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.463 HD23 ' HB3' ' A' ' 168' ' ' PRO . 7.6 mp -105.83 145.19 31.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.247 -0.433 . . . . 74.44 110.904 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 5.3 m -111.55 145.12 39.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.144 -0.48 . . . . 73.12 111.123 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 1.083 HG13 HG22 ' A' ' 166' ' ' VAL . 22.5 t -129.31 140.62 48.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.256 -0.429 . . . . 75.1 111.11 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -129.11 153.1 48.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.486 . . . . 44.43 111.082 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -143.91 129.28 18.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.251 -0.432 . . . . 65.03 110.864 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -132.86 66.78 77.09 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.634 0.73 . . . . 64.55 110.925 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.472 ' HB3' ' HB1' ' A' ' 161' ' ' ALA . 53.5 Cg_endo -69.77 -25.75 28.23 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.693 2.262 . . . . 74.44 112.36 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 70.21 31.51 3.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 74.45 110.873 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 169.82 -26.18 0.11 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.753 -0.736 . . . . 62.35 112.5 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.542 HG12 ' H ' ' A' ' 192' ' ' ASP . 76.4 t -99.16 149.43 5.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.96 0.409 . . . . 74.24 111.125 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 9.5 p -140.33 37.12 1.89 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.132 -0.485 . . . . 64.4 111.133 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.542 ' H ' HG12 ' A' ' 190' ' ' VAL . 9.1 m-20 -122.01 131.23 53.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.261 -0.427 . . . . 71.42 110.841 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 13.9 mtpp -81.9 74.44 8.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 71.31 110.923 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 2.2 m -78.48 -7.28 57.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 63.44 110.862 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.774 ' CE2' HG11 ' A' ' 183' ' ' VAL . 22.4 p90 -91.31 164.38 13.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 65.05 110.838 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.04 167.52 30.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.116 -0.493 . . . . 64.14 110.88 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -115.64 160.05 20.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 63.24 111.103 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.603 HG23 ' HG2' ' A' ' 227' ' ' PRO . 5.1 m -153.43 163.04 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.206 -0.452 . . . . 53.44 111.114 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.61 118.68 35.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 72.33 110.9 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.477 ' HB2' ' HD3' ' A' ' 227' ' ' PRO . . . -59.87 -21.0 60.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.141 -0.481 . . . . 63.44 111.11 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.97 96.79 1.36 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 64.24 110.84 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.89 50.18 1.92 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 72.04 110.904 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 12.0 p -128.73 -1.45 5.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.211 -0.45 . . . . 63.24 111.176 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 7.5 mtmt -154.57 18.47 0.47 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.196 -0.457 . . . . 72.53 110.829 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.589 ' HA ' HG23 ' A' ' 219' ' ' VAL . . . -179.88 153.79 0.54 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.251 -0.431 . . . . 55.12 111.085 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 11.7 p -117.32 156.05 28.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.214 -0.448 . . . . 71.12 111.131 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.817 HG12 HG22 ' A' ' 216' ' ' VAL . 33.8 m -137.19 141.17 40.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 63.23 111.136 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 50.9 m -147.86 107.87 4.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 71.43 110.845 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.446 ' HA ' ' HA ' ' A' ' 214' ' ' ILE . 3.0 p -88.31 142.87 12.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 63.23 111.11 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.2 m -171.56 122.89 0.53 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.188 -0.46 . . . . 64.03 110.861 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 55.6 47.23 78.55 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.726 -0.75 . . . . 44.51 112.481 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 3.3 mtp 64.06 16.38 9.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.848 0.356 . . . . 70.04 110.854 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 18.8 m -125.67 112.65 16.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 63.43 111.151 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.446 ' HA ' ' HA ' ' A' ' 209' ' ' VAL . 2.6 mp -109.69 113.75 45.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 64.12 111.105 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 6.3 m -87.45 133.92 33.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.206 -0.452 . . . . 55.21 111.181 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.817 HG22 HG12 ' A' ' 207' ' ' VAL . 2.9 t -118.18 123.17 71.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.27 -0.423 . . . . 53.51 111.09 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -106.33 139.57 40.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.474 . . . . 75.11 110.857 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -96.9 78.3 0.69 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.719 -0.753 . . . . 63.11 112.48 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.589 HG23 ' HA ' ' A' ' 205' ' ' ALA . 16.2 t -50.13 -55.29 5.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.83 0.347 . . . . 71.44 111.112 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -126.38 161.63 27.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 72.14 111.122 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 221' ' ' ALA . . . . . 0.677 ' HB2' ' HA ' ' A' ' 245' ' ' ALA . . . -62.61 139.97 58.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.243 -0.435 . . . . 73.35 111.104 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 142.24 172.84 13.86 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.732 -0.747 . . . . 45.43 112.503 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 223' ' ' LYS . . . . . 0.409 ' HG3' HG23 ' A' ' 242' ' ' THR . 12.7 mttt -102.18 120.81 41.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.837 0.351 . . . . 60.52 110.886 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.533 HG11 ' CB ' ' A' ' 205' ' ' ALA . 7.3 p -119.13 126.89 75.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 50.34 111.143 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 225' ' ' ASN . . . . . 0.597 ' C ' HD12 ' A' ' 226' ' ' ILE . 33.5 m120 -90.55 156.05 18.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 65.25 110.864 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.597 HD12 ' C ' ' A' ' 225' ' ' ASN . 4.4 mp -138.13 92.43 12.33 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.634 0.731 . . . . 75.31 111.127 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 227' ' ' PRO . . . . . 0.603 ' HG2' HG23 ' A' ' 198' ' ' VAL . 53.3 Cg_endo -69.77 -179.26 2.79 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.679 2.253 . . . . 45.21 112.345 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.522 HG11 ' HE3' ' A' ' 164' ' ' MET . 61.3 t -150.11 140.6 16.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 74.44 111.16 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 89.9 t -124.06 138.53 53.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 72.02 111.137 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 1.5 m -118.94 106.67 12.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.191 -0.459 . . . . 65.22 110.862 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 57.74 -110.86 2.59 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.701 -0.761 . . . . 74.21 112.486 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -81.01 -7.39 59.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.865 0.364 . . . . 65.31 110.889 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 109.76 10.01 23.76 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.743 -0.741 . . . . 61.43 112.424 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -50.72 -47.1 59.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.874 0.369 . . . . 64.22 110.879 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -117.51 147.52 42.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 63.55 110.884 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -149.72 165.23 33.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 73.23 111.11 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 237' ' ' ALA . . . . . 0.429 ' HB3' ' CG2' ' A' ' 228' ' ' VAL . . . -136.95 163.3 31.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.441 . . . . 73.42 111.109 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.4 p -136.36 125.59 38.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.188 -0.46 . . . . 73.43 111.139 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 239' ' ' ALA . . . . . 0.409 ' HB2' ' HG3' ' A' ' 168' ' ' PRO . . . -132.79 162.13 32.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 52.41 111.15 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 240' ' ' GLU . . . . . 0.413 ' O ' HD13 ' A' ' 241' ' ' ILE . 6.3 pt-20 -144.16 132.1 21.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.268 -0.424 . . . . 55.53 110.886 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 241' ' ' ILE . . . . . 0.621 HG13 HG11 ' A' ' 216' ' ' VAL . 26.3 mm -126.81 112.73 30.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.124 -0.489 . . . . 63.01 111.142 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 242' ' ' THR . . . . . 0.409 HG23 ' HG3' ' A' ' 223' ' ' LYS . 2.7 m -80.82 141.28 34.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 65.24 111.165 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 17.1 t -120.08 121.0 64.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.236 -0.438 . . . . 73.33 111.116 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 244' ' ' THR . . . . . 0.506 HG23 ' O ' ' A' ' 173' ' ' VAL . 7.3 p -82.28 132.75 35.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.144 -0.48 . . . . 73.01 111.146 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 245' ' ' ALA . . . . . 0.677 ' HA ' ' HB2' ' A' ' 221' ' ' ALA . . . -56.92 -24.63 53.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.462 . . . . 74.24 111.113 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.26 -0.427 . . . . 71.23 110.847 -179.791 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.266 0 N-CA-C 112.493 -0.243 . . . . 72.02 112.493 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . 62.19 24.8 14.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.789 0.328 . . . . 61.23 111.084 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.87 75.58 1.62 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 43.12 110.873 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -128.45 -169.46 2.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.268 -0.424 . . . . 74.25 111.097 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -172.48 129.48 0.55 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.449 . . . . 51.32 111.101 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.494 ' HB1' ' HB3' ' A' ' 187' ' ' PRO . . . -60.05 -168.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 73.24 111.07 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -124.9 30.85 5.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.161 -0.472 . . . . 64.14 111.096 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 146.24 96.7 0.19 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.722 -0.751 . . . . 73.15 112.466 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.607 ' SD ' HG23 ' A' ' 166' ' ' VAL . 2.1 tmm? -106.09 143.71 33.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.845 0.355 . . . . 65.01 110.897 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.515 ' OG1' ' HB3' ' A' ' 184' ' ' ALA . 44.7 p -133.87 103.33 5.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.274 -0.421 . . . . 71.34 111.169 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 1.13 HG22 HG13 ' A' ' 183' ' ' VAL . 89.0 t -97.19 133.98 36.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 74.41 111.103 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 40.8 m -123.86 92.01 48.99 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.517 0.675 . . . . 74.54 111.115 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.465 ' HB3' HD23 ' A' ' 181' ' ' LEU . 53.9 Cg_endo -69.78 -167.33 0.22 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.636 2.224 . . . . 73.3 112.331 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -90.75 -43.75 9.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.459 . . . . 64.22 111.089 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 8.0 t 49.48 80.12 0.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 75.14 110.861 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.6 t -173.68 -176.11 1.2 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.135 -0.484 . . . . 75.32 111.128 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 10.0 p -97.27 162.19 13.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 54.15 110.837 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.734 HG22 ' HB2' ' A' ' 177' ' ' GLN . 3.3 p -145.37 153.18 14.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.479 . . . . 63.41 111.142 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 66.6 t -87.52 145.21 7.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.116 -0.493 . . . . 72.54 111.12 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.64 122.42 5.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 72.42 110.837 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.81 -12.87 61.0 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.741 -0.742 . . . . 73.24 112.501 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.734 ' HB2' HG22 ' A' ' 173' ' ' VAL . 11.6 mm100 -92.91 -178.32 4.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.811 0.339 . . . . 61.11 110.931 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 39.1 p -161.37 149.45 15.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.214 -0.448 . . . . 74.04 110.894 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.533 HG21 HD12 ' A' ' 241' ' ' ILE . 6.8 t -107.11 -173.92 2.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 71.04 111.186 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.73 132.39 27.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.258 -0.428 . . . . 72.12 111.184 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.465 HD23 ' HB3' ' A' ' 168' ' ' PRO . 7.6 mp -106.56 145.54 31.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 74.3 110.873 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 4.1 m -113.75 146.42 39.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 72.31 111.144 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 1.13 HG13 HG22 ' A' ' 166' ' ' VAL . 47.4 t -128.7 140.84 48.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 75.13 111.136 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.515 ' HB3' ' OG1' ' A' ' 165' ' ' THR . . . -129.9 155.98 45.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 72.32 111.123 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -148.93 131.28 15.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.257 -0.428 . . . . 73.11 110.9 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.05 67.35 73.52 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.634 0.73 . . . . 74.01 110.919 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.494 ' HB3' ' HB1' ' A' ' 161' ' ' ALA . 53.6 Cg_endo -69.75 -25.38 28.72 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.703 2.268 . . . . 65.0 112.343 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 70.66 30.45 3.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.21 -0.45 . . . . 72.51 110.885 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 171.16 -27.11 0.1 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.761 -0.733 . . . . 74.13 112.491 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.523 HG12 ' H ' ' A' ' 192' ' ' ASP . 76.8 t -98.14 149.14 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.898 0.38 . . . . 64.44 111.11 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 7.0 p -140.98 35.13 1.75 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 72.54 111.129 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.523 ' H ' HG12 ' A' ' 190' ' ' VAL . 1.4 p30 -115.88 136.29 53.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.236 -0.438 . . . . 62.43 110.882 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 6.1 mtpm? -91.4 67.58 5.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 52.43 110.907 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 21.8 t -74.51 -7.24 52.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 65.53 110.864 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.772 ' CE2' HG11 ' A' ' 183' ' ' VAL . 21.8 p90 -91.28 163.64 14.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.131 -0.486 . . . . 64.23 110.897 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.9 173.19 16.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 74.24 110.878 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -112.66 168.14 9.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 73.32 111.068 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.436 HG13 ' HG2' ' A' ' 227' ' ' PRO . 14.5 p -167.62 149.7 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 75.32 111.101 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.03 130.03 36.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.139 -0.482 . . . . 65.03 110.881 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.492 ' HB2' ' HD3' ' A' ' 227' ' ' PRO . . . -68.08 -17.61 64.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.095 -0.502 . . . . 72.01 111.106 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -162.93 95.7 0.88 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.224 -0.443 . . . . 64.11 110.891 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 18.6 tttt -84.99 53.06 2.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 71.13 110.935 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 18.0 p -128.82 0.37 5.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 73.32 111.142 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 204' ' ' LYS . . . . . 0.415 ' HG2' ' HB3' ' A' ' 220' ' ' ALA . 3.7 mtmm -155.29 18.24 0.41 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 74.3 110.887 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.613 ' HA ' HG23 ' A' ' 219' ' ' VAL . . . -179.96 149.16 0.33 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.277 -0.419 . . . . 73.32 111.107 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 7.0 p -109.92 156.69 20.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.166 -0.47 . . . . 74.24 111.118 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.856 HG12 HG22 ' A' ' 216' ' ' VAL . 17.6 m -140.42 140.86 33.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 72.12 111.112 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -148.15 109.0 4.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 72.54 110.879 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.544 HG23 HG13 ' A' ' 214' ' ' ILE . 3.6 p -89.21 143.01 12.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.465 . . . . 74.34 111.106 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.7 m -171.82 123.43 0.52 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 72.0 110.91 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 56.2 46.67 85.33 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.715 -0.755 . . . . 74.23 112.466 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 4.1 mtp 64.2 15.78 9.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.827 0.346 . . . . 64.43 110.892 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 13.6 m -125.13 113.01 17.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.246 -0.434 . . . . 71.03 111.112 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.544 HG13 HG23 ' A' ' 209' ' ' VAL . 3.1 mp -110.48 113.8 45.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 73.41 111.154 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 5.8 m -88.93 132.05 34.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 73.51 111.12 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.856 HG22 HG12 ' A' ' 207' ' ' VAL . 3.9 t -117.02 124.28 72.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.187 -0.46 . . . . 55.1 111.101 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -106.03 138.67 41.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 75.32 110.95 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -94.73 78.55 0.91 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.676 -0.773 . . . . 72.32 112.505 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.613 HG23 ' HA ' ' A' ' 205' ' ' ALA . 20.6 t -49.75 -55.52 4.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.823 0.344 . . . . 72.44 111.134 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 220' ' ' ALA . . . . . 0.415 ' HB3' ' HG2' ' A' ' 204' ' ' LYS . . . -127.19 161.75 27.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 64.05 111.111 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 221' ' ' ALA . . . . . 0.682 ' HB2' ' HA ' ' A' ' 245' ' ' ALA . . . -62.22 139.93 58.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 70.24 111.068 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 142.27 171.72 13.27 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.752 -0.737 . . . . 73.23 112.496 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 223' ' ' LYS . . . . . 0.464 ' HG3' HG23 ' A' ' 242' ' ' THR . 2.1 mttt -101.12 121.19 41.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.783 0.325 . . . . 75.42 110.929 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.501 HG11 ' CB ' ' A' ' 205' ' ' ALA . 7.1 p -120.46 125.46 74.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.259 -0.428 . . . . 64.23 111.102 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 225' ' ' ASN . . . . . 0.558 ' C ' HD12 ' A' ' 226' ' ' ILE . 21.0 m120 -90.98 152.45 20.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.468 . . . . 72.33 110.888 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.558 HD12 ' C ' ' A' ' 225' ' ' ASN . 4.3 mp -135.24 92.71 17.59 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.667 0.746 . . . . 75.33 111.166 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 227' ' ' PRO . . . . . 0.492 ' HD3' ' HB2' ' A' ' 200' ' ' ALA . 53.9 Cg_endo -69.76 -176.44 1.49 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.689 2.26 . . . . 74.25 112.329 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.505 ' CG2' ' HB3' ' A' ' 237' ' ' ALA . 59.5 t -149.4 137.04 13.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.444 . . . . 72.44 111.127 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 84.0 t -118.4 133.18 66.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.158 -0.474 . . . . 74.41 111.135 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 5.7 t -122.32 126.21 47.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 72.32 110.881 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 55.53 -121.86 24.43 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.717 -0.754 . . . . 75.12 112.519 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -98.17 21.03 11.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.87 0.367 . . . . 55.13 110.911 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 106.77 6.9 34.54 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.702 -0.761 . . . . 71.42 112.507 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -53.26 -62.66 1.51 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.85 0.357 . . . . 74.32 110.887 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -105.99 166.02 10.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 73.42 110.879 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -167.15 165.41 15.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 70.04 111.053 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 237' ' ' ALA . . . . . 0.505 ' HB3' ' CG2' ' A' ' 228' ' ' VAL . . . -142.33 163.16 33.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 75.11 111.099 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 8.0 p -136.58 131.15 47.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.243 -0.435 . . . . 74.41 111.149 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 239' ' ' ALA . . . . . 0.42 ' HB2' ' HG3' ' A' ' 168' ' ' PRO . . . -139.3 165.22 27.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 63.22 111.157 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -147.7 133.32 18.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 74.22 110.919 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 241' ' ' ILE . . . . . 0.533 HD12 HG21 ' A' ' 179' ' ' THR . 25.1 mm -126.7 115.13 40.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.475 . . . . 54.34 111.11 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 242' ' ' THR . . . . . 0.464 HG23 ' HG3' ' A' ' 223' ' ' LYS . 2.4 m -82.91 141.11 32.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 73.45 111.146 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 21.2 t -120.01 121.06 64.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.243 -0.435 . . . . 74.23 111.121 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 244' ' ' THR . . . . . 0.443 HG23 ' O ' ' A' ' 173' ' ' VAL . 9.2 p -82.92 132.78 35.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.138 -0.483 . . . . 75.54 111.124 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 245' ' ' ALA . . . . . 0.682 ' HA ' ' HB2' ' A' ' 221' ' ' ALA . . . -54.39 -27.18 34.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 71.22 111.089 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 46.9 t . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 54.13 110.906 -179.811 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 N-CA-C 112.499 -0.24 . . . . 72.11 112.499 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -64.06 165.87 8.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.792 0.33 . . . . 73.14 111.126 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 67.5 mmm -104.78 177.01 4.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.247 -0.433 . . . . 55.41 110.887 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -126.19 129.06 48.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 75.35 111.106 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.669 ' HB2' ' HB3' ' A' ' 194' ' ' SER . . . -73.62 -71.06 0.34 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.211 -0.449 . . . . 33.55 111.072 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.458 ' HB1' ' HB3' ' A' ' 187' ' ' PRO . . . -178.48 -174.45 0.39 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.205 -0.452 . . . . 70.12 111.081 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.508 HG22 ' HA ' ' A' ' 187' ' ' PRO . 10.8 t -127.24 15.99 7.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 60.31 111.132 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -176.71 81.28 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.764 -0.731 . . . . 74.11 112.493 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 30.5 ttp -102.95 123.19 46.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.895 0.378 . . . . 70.22 110.867 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.53 ' OG1' ' HB3' ' A' ' 184' ' ' ALA . 51.6 p -111.52 104.97 13.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.236 -0.438 . . . . 72.35 111.159 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 1.07 HG22 HG13 ' A' ' 183' ' ' VAL . 60.9 t -97.2 131.92 42.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.455 . . . . 74.44 111.141 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 38.5 m -124.55 92.29 48.18 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.534 0.683 . . . . 62.2 111.147 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.456 ' HB3' HD23 ' A' ' 181' ' ' LEU . 54.1 Cg_endo -69.74 -167.26 0.22 Allowed 'Trans proline' 0 C--N 1.341 0.132 0 C-N-CA 122.674 2.249 . . . . 75.42 112.35 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -90.92 -39.27 12.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.444 . . . . 63.45 111.114 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 4.8 p 45.86 79.96 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 71.11 110.87 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.6 t -175.44 -175.69 0.83 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.477 . . . . 63.35 111.126 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 1.7 m -97.42 164.42 12.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.443 . . . . 65.12 110.908 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.737 HG22 ' HB2' ' A' ' 177' ' ' GLN . 3.4 p -146.22 153.18 13.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.469 . . . . 62.34 111.137 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 59.2 t -86.1 145.48 7.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 64.31 111.125 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.27 122.32 5.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.443 . . . . 74.55 110.905 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.15 -12.79 62.06 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.771 -0.728 . . . . 44.4 112.53 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.737 ' HB2' HG22 ' A' ' 173' ' ' VAL . 17.9 mm100 -92.35 -178.8 5.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.796 0.331 . . . . 74.3 110.914 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 60.6 p -161.69 148.63 14.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 71.32 110.879 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.466 HG21 HD12 ' A' ' 241' ' ' ILE . 6.7 t -105.75 -174.46 2.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 75.31 111.145 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -140.29 127.09 20.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.256 -0.429 . . . . 75.53 111.139 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.456 HD23 ' HB3' ' A' ' 168' ' ' PRO . 7.5 mp -100.81 141.01 34.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.183 -0.462 . . . . 71.53 110.93 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 6.1 m -109.17 144.61 37.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 65.02 111.152 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 1.07 HG13 HG22 ' A' ' 166' ' ' VAL . 23.1 t -129.43 141.56 46.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 75.54 111.104 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.53 ' HB3' ' OG1' ' A' ' 165' ' ' THR . . . -130.89 156.87 44.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 73.31 111.111 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -147.09 133.37 19.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 74.14 110.894 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.62 67.18 23.96 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.634 0.731 . . . . 70.05 110.915 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.508 ' HA ' HG22 ' A' ' 162' ' ' THR . 53.6 Cg_endo -69.74 -23.87 30.39 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.676 2.251 . . . . 73.33 112.369 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 71.58 38.07 1.04 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 65.42 110.865 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 163.32 -23.36 0.18 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.754 -0.736 . . . . 22.13 112.478 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.51 HG12 ' H ' ' A' ' 192' ' ' ASP . 73.0 t -104.07 148.34 9.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.877 0.37 . . . . 74.03 111.109 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 16.6 p -139.72 38.0 2.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 41.31 111.134 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.51 ' H ' HG12 ' A' ' 190' ' ' VAL . 11.7 m-20 -121.14 123.12 41.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 72.11 110.868 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 10.3 mtmm -85.31 73.11 10.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.474 . . . . 72.51 110.87 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' SER . . . . . 0.669 ' HB3' ' HB2' ' A' ' 160' ' ' ALA . 0.3 OUTLIER -77.45 -3.98 43.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.253 -0.431 . . . . 65.22 110.831 -179.854 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.806 ' CE2' HG11 ' A' ' 183' ' ' VAL . 14.9 p90 -88.05 168.58 12.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.074 -0.512 . . . . 62.44 110.858 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -164.38 162.07 21.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 64.32 110.868 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 197' ' ' ALA . . . . . 0.684 ' HB3' ' CG2' ' A' ' 209' ' ' VAL . . . -104.03 157.69 16.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.467 . . . . 75.03 111.107 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 91.9 t -150.25 145.14 17.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.257 -0.429 . . . . 74.13 111.126 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -83.83 122.78 29.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 74.11 110.826 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.471 ' HB2' ' HD3' ' A' ' 227' ' ' PRO . . . -72.98 -8.25 54.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 74.15 111.088 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -164.21 98.58 0.83 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.259 -0.428 . . . . 63.12 110.899 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.64 41.4 1.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 61.32 110.89 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 4.3 p -124.51 -5.3 7.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.249 -0.432 . . . . 71.01 111.144 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 9.7 mtmm -148.45 16.27 1.02 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.462 . . . . 73.33 110.921 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.572 ' HA ' HG23 ' A' ' 219' ' ' VAL . . . -179.2 154.35 0.65 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 25.14 111.124 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 11.2 p -117.62 158.42 24.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.209 -0.45 . . . . 74.24 111.153 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 10.7 m -134.74 144.4 34.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 71.11 111.093 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 1.9 t -150.93 109.21 3.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 74.24 110.886 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.684 ' CG2' ' HB3' ' A' ' 197' ' ' ALA . 80.9 t -84.16 145.71 7.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 74.15 111.123 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 3.3 t -171.09 117.58 0.46 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.147 -0.479 . . . . 53.14 110.849 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 48.52 61.32 5.19 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.738 -0.744 . . . . 53.02 112.496 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 2.3 mtp 54.09 21.97 3.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.887 0.375 . . . . 74.11 110.904 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 1.7 m -130.59 110.33 11.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 71.45 111.2 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.493 HG23 HG22 ' A' ' 209' ' ' VAL . 0.8 OUTLIER -104.65 121.36 56.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.253 -0.43 . . . . 74.03 111.158 179.905 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 21.0 m -91.9 129.19 37.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.146 -0.479 . . . . 55.3 111.16 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.589 HG11 HG13 ' A' ' 241' ' ' ILE . 2.3 t -115.54 120.94 66.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 62.12 111.15 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -105.47 140.33 38.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 72.22 110.872 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -96.47 78.54 0.73 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.767 -0.73 . . . . 52.24 112.491 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.572 HG23 ' HA ' ' A' ' 205' ' ' ALA . 19.5 t -50.81 -56.67 3.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.837 0.351 . . . . 70.22 111.115 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -123.86 161.21 25.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.148 -0.478 . . . . 74.54 111.103 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 221' ' ' ALA . . . . . 0.669 ' HB2' ' HA ' ' A' ' 245' ' ' ALA . . . -63.15 138.7 58.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.256 -0.429 . . . . 72.54 111.099 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 141.37 168.49 11.53 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.713 -0.756 . . . . 62.4 112.458 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 223' ' ' LYS . . . . . 0.588 ' HG3' HG23 ' A' ' 242' ' ' THR . 5.6 mttp -95.68 120.2 35.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.804 0.335 . . . . 71.11 110.915 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.562 HG11 ' CB ' ' A' ' 205' ' ' ALA . 6.6 p -117.99 123.15 71.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.272 -0.422 . . . . 72.14 111.177 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 225' ' ' ASN . . . . . 0.634 ' C ' HD12 ' A' ' 226' ' ' ILE . 58.7 m-80 -90.72 153.18 20.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.458 . . . . 71.33 110.864 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.634 HD12 ' C ' ' A' ' 225' ' ' ASN . 4.2 mp -138.38 93.19 11.47 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.645 0.736 . . . . 53.43 111.139 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 227' ' ' PRO . . . . . 0.471 ' HD3' ' HB2' ' A' ' 200' ' ' ALA . 53.9 Cg_endo -69.73 -177.41 1.85 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.73 2.287 . . . . 70.34 112.339 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 62.4 t -149.01 142.04 18.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 65.23 111.126 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 91.0 t -121.42 137.09 56.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.157 -0.474 . . . . 73.01 111.141 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.34 130.09 52.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 70.22 110.884 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 53.37 -114.09 3.53 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.74 -0.743 . . . . 72.13 112.513 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -111.17 21.22 16.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.807 0.337 . . . . 74.35 110.831 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 114.39 1.76 23.23 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.76 -0.733 . . . . 62.33 112.512 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 44.1 mm-40 -51.75 -62.96 1.3 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.9 0.381 . . . . 61.4 110.899 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -112.46 162.93 15.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 75.52 110.929 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -165.71 164.8 18.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 74.35 111.065 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -143.01 163.05 33.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 50.01 111.084 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 10.9 p -137.77 136.34 45.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 70.34 111.172 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -139.23 165.51 26.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 65.31 111.086 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -145.11 132.34 20.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 64.34 110.88 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 241' ' ' ILE . . . . . 0.589 HG13 HG11 ' A' ' 216' ' ' VAL . 36.3 mm -127.21 116.89 45.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 73.23 111.155 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 242' ' ' THR . . . . . 0.588 HG23 ' HG3' ' A' ' 223' ' ' LYS . 2.1 m -84.22 141.68 30.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.192 -0.458 . . . . 53.53 111.138 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 21.5 t -120.0 121.5 66.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.243 -0.435 . . . . 42.32 111.127 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 244' ' ' THR . . . . . 0.502 HG23 ' O ' ' A' ' 173' ' ' VAL . 7.6 p -82.58 132.8 35.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 70.31 111.166 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 245' ' ' ALA . . . . . 0.669 ' HA ' ' HB2' ' A' ' 221' ' ' ALA . . . -55.78 -25.29 40.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 61.13 111.082 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 9.7 t . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 74.31 110.857 -179.774 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 N-CA-C 112.448 -0.261 . . . . 61.34 112.448 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -86.49 -33.97 20.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.801 0.334 . . . . 74.21 111.098 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 14.5 mtm -135.85 176.62 8.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 73.12 110.86 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -151.36 176.42 11.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 75.3 111.152 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.737 ' HB2' ' HA3' ' A' ' 231' ' ' GLY . . . -110.05 -70.14 0.83 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.255 -0.43 . . . . 63.13 111.132 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -179.28 -174.46 0.32 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.469 . . . . 43.31 111.089 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 2.3 m -124.89 13.93 8.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.243 -0.435 . . . . 74.52 111.139 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 163.26 104.71 0.19 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.715 -0.755 . . . . 45.25 112.504 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 21.5 ttp -110.62 134.48 52.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.839 0.352 . . . . 74.13 110.9 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.651 ' OG1' ' HB3' ' A' ' 184' ' ' ALA . 1.8 p -119.62 95.44 4.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.256 -0.429 . . . . 64.33 111.173 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 1.02 HG22 HG13 ' A' ' 183' ' ' VAL . 21.8 t -97.21 117.9 42.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.439 . . . . 73.41 111.168 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 60.8 m -112.72 91.61 17.93 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.574 0.702 . . . . 74.14 111.17 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.472 ' HB3' HD23 ' A' ' 181' ' ' LEU . 53.7 Cg_endo -69.8 -168.23 0.26 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.638 2.226 . . . . 71.54 112.361 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -86.6 -44.57 11.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.438 . . . . 61.53 111.104 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 37.8 t 49.82 76.93 0.12 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.257 -0.429 . . . . 50.03 110.887 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.4 t -175.05 -174.91 0.8 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.111 -0.495 . . . . 71.04 111.14 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 33.3 p -99.15 158.42 15.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 64.13 110.856 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.738 HG22 ' HB2' ' A' ' 177' ' ' GLN . 3.3 p -140.22 152.37 21.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.103 -0.499 . . . . 73.15 111.096 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 95.5 t -84.6 143.66 11.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.166 -0.47 . . . . 72.41 111.093 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -48.04 122.5 5.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 73.55 110.917 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.85 -14.6 60.15 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.712 -0.756 . . . . 53.53 112.473 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.738 ' HB2' HG22 ' A' ' 173' ' ' VAL . 16.7 mm100 -90.63 -178.31 5.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.824 0.345 . . . . 73.11 110.889 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 27.4 p -161.52 149.14 14.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 55.53 110.825 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 7.3 t -108.21 -173.68 2.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.481 . . . . 73.43 111.136 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -140.47 132.1 27.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.451 . . . . 42.13 111.161 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.472 HD23 ' HB3' ' A' ' 168' ' ' PRO . 7.3 mp -105.37 142.02 35.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.246 -0.434 . . . . 75.03 110.918 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 3.6 m -108.42 142.12 39.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 74.32 111.128 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 1.02 HG13 HG22 ' A' ' 166' ' ' VAL . 16.5 t -129.79 136.37 59.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 63.34 111.13 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.651 ' HB3' ' OG1' ' A' ' 165' ' ' THR . . . -124.33 155.86 37.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.243 -0.435 . . . . 70.44 111.076 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -142.83 125.25 15.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 71.21 110.884 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.48 63.06 46.34 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.557 0.694 . . . . 62.13 110.903 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 -43.16 2.85 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.668 2.245 . . . . 74.34 112.317 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 69.77 49.39 0.53 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 64.21 110.871 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 157.53 -20.67 0.39 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.716 -0.754 . . . . 44.13 112.495 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.46 HG11 ' O ' ' A' ' 160' ' ' ALA . 2.7 t -98.16 -59.68 3.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.928 0.394 . . . . 64.42 111.125 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 48.26 72.34 0.28 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.181 -0.463 . . . . 73.53 111.131 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -157.26 138.68 13.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 75.41 110.848 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.17 70.71 7.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 64.34 110.866 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 1.1 m -93.79 -5.3 48.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 75.5 110.886 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.75 ' CE2' HG11 ' A' ' 183' ' ' VAL . 7.2 p90 -89.77 171.87 9.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.107 -0.497 . . . . 71.05 110.873 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.68 167.17 17.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.141 -0.481 . . . . 74.51 110.852 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 197' ' ' ALA . . . . . 0.421 ' HB3' ' HB ' ' A' ' 209' ' ' VAL . . . -113.19 167.84 10.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.178 -0.464 . . . . 73.55 111.077 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 10.5 p -173.65 151.52 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 75.23 111.168 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.8 t -78.44 152.55 32.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 71.43 110.852 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.567 ' HB2' ' HD3' ' A' ' 227' ' ' PRO . . . -89.97 -21.61 22.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 63.45 111.122 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -129.14 -54.63 1.19 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 74.21 110.906 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 3.0 ttpp 63.63 25.52 14.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 75.34 110.915 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 32.3 p -112.59 -4.85 14.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.469 . . . . 51.45 111.11 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 9.1 mtmm -151.94 18.28 0.68 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 71.53 110.947 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.63 ' HA ' HG23 ' A' ' 219' ' ' VAL . . . -174.91 147.36 0.97 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 65.05 111.122 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 16.7 p -108.59 157.78 18.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 71.25 111.101 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.779 HG12 HG22 ' A' ' 216' ' ' VAL . 12.3 m -140.6 140.85 33.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 54.45 111.133 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 10.0 m -148.68 108.77 4.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 52.12 110.863 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.463 ' HA ' ' HA ' ' A' ' 214' ' ' ILE . 3.2 p -87.07 135.43 25.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.154 -0.475 . . . . 70.5 111.148 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 3.3 m -161.31 121.96 2.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 32.51 110.858 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 54.72 49.08 62.95 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.752 -0.737 . . . . 64.42 112.511 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER 63.3 16.38 9.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.853 0.359 . . . . 70.5 110.877 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 3.3 m -126.46 109.41 12.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 72.04 111.167 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.463 ' HA ' ' HA ' ' A' ' 209' ' ' VAL . 2.1 mp -105.18 114.09 43.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 75.33 111.11 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 6.2 m -87.9 130.51 34.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 75.03 111.124 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.779 HG22 HG12 ' A' ' 207' ' ' VAL . 2.8 t -115.93 123.91 71.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.449 . . . . 71.54 111.144 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -106.78 139.74 40.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 75.53 110.864 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -94.79 79.8 0.89 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.804 -0.712 . . . . 63.4 112.45 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.63 HG23 ' HA ' ' A' ' 205' ' ' ALA . 18.5 t -50.75 -55.63 6.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.858 0.361 . . . . 74.24 111.112 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -129.36 163.87 24.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 60.41 111.125 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 221' ' ' ALA . . . . . 0.673 ' HB2' ' HA ' ' A' ' 245' ' ' ALA . . . -63.17 142.26 58.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 51.15 111.085 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 139.04 171.56 12.23 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.78 -0.724 . . . . 70.42 112.495 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 223' ' ' LYS . . . . . 0.614 ' HG3' HG23 ' A' ' 242' ' ' THR . 14.9 mttt -100.73 121.57 41.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.788 0.328 . . . . 62.11 110.88 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.6 HG11 ' CB ' ' A' ' 205' ' ' ALA . 7.4 p -120.62 126.23 75.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 74.13 111.124 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 225' ' ' ASN . . . . . 0.627 ' C ' HD12 ' A' ' 226' ' ' ILE . 30.0 m120 -90.66 154.3 19.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.127 -0.488 . . . . 71.05 110.908 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.627 HD12 ' C ' ' A' ' 225' ' ' ASN . 4.1 mp -137.02 93.16 13.55 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.619 0.723 . . . . 73.43 111.102 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 227' ' ' PRO . . . . . 0.567 ' HD3' ' HB2' ' A' ' 200' ' ' ALA . 54.1 Cg_endo -69.81 -178.61 2.44 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.723 2.282 . . . . 74.54 112.305 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 99.4 t -150.29 138.32 14.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.169 -0.468 . . . . 72.23 111.069 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 66.6 t -121.47 139.39 48.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.166 -0.47 . . . . 64.41 111.124 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 7.4 m -122.45 125.53 46.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 71.5 110.851 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 231' ' ' GLY . . . . . 0.737 ' HA3' ' HB2' ' A' ' 160' ' ' ALA . . . 55.54 -115.35 5.75 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.716 -0.754 . . . . 72.13 112.474 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -103.29 17.42 24.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.896 0.379 . . . . 72.05 110.897 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 114.01 9.73 15.37 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.778 -0.725 . . . . 72.32 112.513 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -52.01 -73.44 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.874 0.368 . . . . 71.22 110.921 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -104.15 162.48 13.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 72.11 110.879 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -158.93 165.1 34.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.469 . . . . 44.04 111.097 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -144.1 163.36 33.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 45.25 111.099 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 11.5 p -138.0 135.38 45.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.201 -0.454 . . . . 54.12 111.125 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.84 164.26 30.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 71.42 111.071 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 240' ' ' GLU . . . . . 0.52 ' O ' HD13 ' A' ' 241' ' ' ILE . 2.3 pt-20 -141.55 131.85 25.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 74.45 110.921 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 241' ' ' ILE . . . . . 0.607 HG13 HG11 ' A' ' 216' ' ' VAL . 23.9 mm -127.43 110.64 22.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.154 -0.476 . . . . 43.53 111.161 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 242' ' ' THR . . . . . 0.614 HG23 ' HG3' ' A' ' 223' ' ' LYS . 1.4 m -81.32 141.43 34.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 62.52 111.139 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 15.7 t -120.13 122.78 69.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 53.22 111.137 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 14.6 p -82.41 133.62 35.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 52.05 111.14 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 245' ' ' ALA . . . . . 0.673 ' HA ' ' HB2' ' A' ' 221' ' ' ALA . . . -59.16 -21.88 60.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 72.42 111.058 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 67.0 m . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.239 -0.437 . . . . 74.42 110.859 -179.732 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 N-CA-C 112.466 -0.253 . . . . 51.33 112.466 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -118.35 -66.61 1.06 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.797 0.332 . . . . 62.14 111.095 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 8.7 mtt -114.08 119.64 37.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 73.24 110.851 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -176.62 -170.15 0.32 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 72.14 111.112 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -173.21 129.09 0.46 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 54.0 111.11 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.32 -168.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.438 . . . . 73.31 111.075 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.88 32.94 5.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.233 -0.44 . . . . 73.22 111.148 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 135.27 99.63 0.6 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.721 -0.752 . . . . 45.42 112.51 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 18.8 ttp -110.88 128.15 55.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.824 0.345 . . . . 70.24 110.907 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.481 ' OG1' ' HB3' ' A' ' 184' ' ' ALA . 38.9 p -116.29 107.4 14.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 71.31 111.116 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 1.063 HG22 HG13 ' A' ' 183' ' ' VAL . 21.2 t -102.24 131.1 50.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.246 -0.434 . . . . 71.2 111.141 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -123.58 91.86 49.3 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.554 0.693 . . . . 64.05 111.189 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.485 ' HB3' HD23 ' A' ' 181' ' ' LEU . 53.3 Cg_endo -69.77 -167.05 0.21 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.653 2.235 . . . . 74.43 112.34 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -92.55 -45.19 8.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.45 . . . . 42.4 111.117 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 73.1 m 48.08 85.42 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 75.14 110.905 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 8.4 t -176.0 -176.01 0.78 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 74.14 111.173 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 75.8 p -97.07 153.49 17.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 70.33 110.852 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.711 HG22 ' HB2' ' A' ' 177' ' ' GLN . 3.3 p -139.07 153.54 24.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.139 -0.482 . . . . 54.14 111.127 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 67.2 t -87.6 145.05 8.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.167 -0.47 . . . . 71.43 111.151 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -48.42 122.66 5.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 72.01 110.914 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.98 -15.35 59.45 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.756 -0.735 . . . . 71.31 112.487 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.711 ' HB2' HG22 ' A' ' 173' ' ' VAL . 11.8 mm100 -90.62 -178.63 5.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.781 0.324 . . . . 72.44 110.943 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 65.4 p -161.96 149.7 14.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 63.34 110.838 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.409 HG21 HD12 ' A' ' 241' ' ' ILE . 7.8 t -107.19 -173.89 2.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.105 -0.498 . . . . 74.33 111.115 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.76 132.25 28.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.201 -0.454 . . . . 74.53 111.111 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.485 HD23 ' HB3' ' A' ' 168' ' ' PRO . 7.6 mp -105.8 143.66 33.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.186 -0.461 . . . . 72.14 110.933 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 4.0 m -111.35 142.98 42.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.444 . . . . 63.31 111.133 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 1.063 HG13 HG22 ' A' ' 166' ' ' VAL . 21.8 t -129.69 143.41 41.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.255 -0.429 . . . . 70.24 111.185 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.481 ' HB3' ' OG1' ' A' ' 165' ' ' THR . . . -134.48 152.06 51.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 44.44 111.106 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -144.88 126.53 15.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 70.42 110.878 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.81 67.77 68.93 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.594 0.712 . . . . 75.03 110.877 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.79 -40.44 5.27 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.657 2.238 . . . . 62.33 112.333 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 67.01 42.35 2.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 73.22 110.896 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 163.11 -40.56 0.34 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.807 -0.711 . . . . 62.33 112.507 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.423 ' O ' ' C ' ' A' ' 191' ' ' THR . 2.2 t -78.02 -48.2 23.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.864 0.364 . . . . 65.54 111.165 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 191' ' ' THR . . . . . 0.423 ' C ' ' O ' ' A' ' 190' ' ' VAL . 1.6 t 35.82 71.96 0.11 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 74.44 111.139 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -164.52 116.75 1.29 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.205 -0.452 . . . . 73.35 110.887 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt -58.15 98.43 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.44 . . . . 71.51 110.874 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 2.6 t -111.61 -6.8 14.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 74.42 110.878 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.769 ' CE2' HG11 ' A' ' 183' ' ' VAL . 20.0 p90 -90.97 174.58 7.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.15 -0.477 . . . . 74.52 110.899 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -165.81 154.95 11.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 65.22 110.861 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -103.89 165.63 10.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 73.03 111.076 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 10.4 p -169.17 152.17 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 65.24 111.122 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.4 p -81.93 140.22 34.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 74.43 110.863 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.506 ' HB2' ' HD3' ' A' ' 227' ' ' PRO . . . -76.52 -23.34 53.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.107 -0.497 . . . . 72.13 111.069 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -134.82 -53.61 0.81 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.436 . . . . 74.34 110.845 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 2.8 ttpp 63.66 33.85 12.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.44 . . . . 75.3 110.918 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 50.8 p -116.65 -3.26 11.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.196 -0.456 . . . . 74.34 111.121 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 204' ' ' LYS . . . . . 0.412 ' HG2' ' HB3' ' A' ' 220' ' ' ALA . 8.0 mtmm -153.19 18.75 0.57 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 73.35 110.854 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.642 ' HA ' HG23 ' A' ' 219' ' ' VAL . . . -172.42 148.09 2.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 72.52 111.083 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 17.1 p -111.69 142.37 44.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 74.1 111.192 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.905 HG12 HG22 ' A' ' 216' ' ' VAL . 16.2 m -126.7 140.15 49.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.267 -0.424 . . . . 71.42 111.146 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 28.4 m -146.68 108.99 4.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 74.33 110.846 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.535 HG23 HG13 ' A' ' 214' ' ' ILE . 3.7 p -86.87 143.27 11.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.08 -0.509 . . . . 74.2 111.112 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 43.7 t -171.45 123.57 0.56 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.152 -0.477 . . . . 75.23 110.881 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 55.14 48.29 69.05 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.73 -0.748 . . . . 71.34 112.479 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 1.8 mtp 62.5 16.59 8.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.834 0.35 . . . . 55.04 110.889 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 2.3 m -127.55 113.55 16.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 74.21 111.175 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.535 HG13 HG23 ' A' ' 209' ' ' VAL . 3.0 mp -109.9 115.96 51.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.241 -0.436 . . . . 73.52 111.15 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 3.4 m -89.1 130.83 35.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.439 . . . . 65.42 111.127 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.905 HG22 HG12 ' A' ' 207' ' ' VAL . 3.0 t -116.24 121.06 66.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.24 -0.436 . . . . 72.43 111.124 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -104.79 139.83 38.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 65.15 110.863 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -94.28 79.65 0.95 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.729 -0.748 . . . . 42.33 112.502 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.642 HG23 ' HA ' ' A' ' 205' ' ' ALA . 19.7 t -49.95 -56.39 3.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.837 0.351 . . . . 64.12 111.154 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 220' ' ' ALA . . . . . 0.412 ' HB3' ' HG2' ' A' ' 204' ' ' LYS . . . -127.77 163.35 24.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 42.02 111.07 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 221' ' ' ALA . . . . . 0.678 ' HB2' ' HA ' ' A' ' 245' ' ' ALA . . . -63.45 137.75 58.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 62.24 111.092 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 142.4 167.53 11.42 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.74 -0.743 . . . . 70.44 112.515 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 223' ' ' LYS . . . . . 0.606 ' HG3' HG23 ' A' ' 242' ' ' THR . 6.2 mttp -98.72 124.58 43.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.876 0.369 . . . . 62.22 110.874 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.497 HG11 ' CB ' ' A' ' 205' ' ' ALA . 7.4 p -121.96 129.76 75.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.218 -0.446 . . . . 71.43 111.119 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 225' ' ' ASN . . . . . 0.626 ' C ' HD12 ' A' ' 226' ' ' ILE . 27.4 m120 -90.62 152.48 20.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 61.5 110.876 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.626 HD12 ' C ' ' A' ' 225' ' ' ASN . 4.2 mp -138.2 92.83 11.97 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.611 0.72 . . . . 71.02 111.12 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 227' ' ' PRO . . . . . 0.506 ' HD3' ' HB2' ' A' ' 200' ' ' ALA . 53.6 Cg_endo -69.73 -177.79 2.03 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.658 2.239 . . . . 51.22 112.379 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.506 ' CG2' ' HB3' ' A' ' 237' ' ' ALA . 99.7 t -150.08 137.82 13.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 64.04 111.084 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 88.1 t -117.94 132.82 66.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 71.22 111.12 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -121.72 137.52 54.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 74.2 110.858 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 51.91 -118.88 7.78 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.707 -0.758 . . . . 42.32 112.51 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -105.5 21.09 17.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.918 0.39 . . . . 52.41 110.933 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 107.27 12.01 24.41 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.706 -0.759 . . . . 62.33 112.49 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -63.14 -58.97 5.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.842 0.353 . . . . 62.41 110.901 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -105.58 167.22 9.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.464 . . . . 74.33 110.89 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -166.13 165.04 17.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.165 -0.471 . . . . 51.34 111.115 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 237' ' ' ALA . . . . . 0.506 ' HB3' ' CG2' ' A' ' 228' ' ' VAL . . . -139.52 163.2 33.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 73.42 111.064 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 52.4 t -137.52 132.11 44.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.441 . . . . 61.42 111.137 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 239' ' ' ALA . . . . . 0.448 ' HB2' ' HG3' ' A' ' 168' ' ' PRO . . . -139.23 162.48 34.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 71.12 111.094 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -145.51 124.37 12.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 75.22 110.898 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 241' ' ' ILE . . . . . 0.662 HG13 HG11 ' A' ' 216' ' ' VAL . 29.6 mm -119.1 109.13 25.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.12 -0.491 . . . . 72.02 111.135 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 242' ' ' THR . . . . . 0.606 HG23 ' HG3' ' A' ' 223' ' ' LYS . 4.2 m -80.31 141.83 35.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 73.01 111.12 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 18.5 t -119.22 121.1 65.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 75.54 111.18 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 244' ' ' THR . . . . . 0.502 HG23 ' O ' ' A' ' 173' ' ' VAL . 6.7 p -81.67 132.85 35.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.188 -0.46 . . . . 70.35 111.185 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 245' ' ' ALA . . . . . 0.678 ' HA ' ' HB2' ' A' ' 221' ' ' ALA . . . -58.46 -21.7 52.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.226 -0.443 . . . . 70.54 111.076 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 76.5 p . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.224 -0.444 . . . . 40.52 110.83 -179.769 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 N-CA-C 112.475 -0.25 . . . . 31.24 112.475 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -165.05 110.49 0.93 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.804 0.335 . . . . 74.55 111.075 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 8.6 mtt -83.31 178.11 8.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 62.12 110.879 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -135.69 -175.26 3.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 74.45 111.062 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -175.3 129.53 0.28 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.15 -0.477 . . . . 63.43 111.101 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -59.81 -169.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 75.44 111.105 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.735 HG22 ' HA ' ' A' ' 187' ' ' PRO . 4.7 t -120.69 22.37 11.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 71.23 111.171 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 147.23 100.38 0.25 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.775 -0.726 . . . . 74.21 112.524 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -110.04 136.5 49.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.88 0.371 . . . . 74.42 110.876 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.646 ' OG1' ' HB3' ' A' ' 184' ' ' ALA . 68.6 p -116.11 105.65 12.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 71.25 111.147 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 1.069 HG22 HG13 ' A' ' 183' ' ' VAL . 45.7 t -98.48 130.14 47.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.198 -0.456 . . . . 74.22 111.094 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 8.9 m -126.66 92.72 44.26 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.537 0.684 . . . . 72.01 111.128 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.532 ' HG3' ' HB2' ' A' ' 239' ' ' ALA . 54.1 Cg_endo -69.72 -166.07 0.17 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.67 2.246 . . . . 74.32 112.352 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -87.05 -40.13 14.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 64.42 111.114 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 99.5 p 46.47 78.81 0.06 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.439 . . . . 70.44 110.876 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.5 t -175.27 -174.96 0.78 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.11 -0.496 . . . . 64.35 111.174 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 99.1 p -99.79 162.94 12.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.261 -0.427 . . . . 42.32 110.85 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.79 HG22 ' HB2' ' A' ' 177' ' ' GLN . 1.9 p -147.06 151.68 13.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 73.32 111.114 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 69.3 t -87.62 145.35 7.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.475 . . . . 62.33 111.116 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.31 123.1 6.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 71.41 110.92 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 100.49 -15.87 58.34 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.758 -0.734 . . . . 65.41 112.526 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.79 ' HB2' HG22 ' A' ' 173' ' ' VAL . 12.9 mm100 -86.51 -177.09 6.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.819 0.343 . . . . 63.21 110.921 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 1.4 p -161.02 149.31 15.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 63.2 110.838 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 8.9 t -113.26 -178.25 3.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.09 -0.504 . . . . 71.05 111.113 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -138.61 128.89 25.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.203 -0.453 . . . . 55.41 111.16 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.457 HD23 ' HB3' ' A' ' 168' ' ' PRO . 7.6 mp -101.69 147.96 25.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 73.4 110.866 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 7.4 m -115.23 142.79 46.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.198 -0.456 . . . . 71.41 111.135 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 1.069 HG13 HG22 ' A' ' 166' ' ' VAL . 30.0 t -129.72 142.56 43.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 71.42 111.139 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.646 ' HB3' ' OG1' ' A' ' 165' ' ' THR . . . -130.41 152.94 49.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 35.23 111.078 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -146.4 131.85 18.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 52.32 110.885 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -127.71 68.05 73.95 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.544 0.688 . . . . 72.42 110.931 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.735 ' HA ' HG22 ' A' ' 162' ' ' THR . 53.4 Cg_endo -69.75 -33.93 15.63 Favored 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.692 2.262 . . . . 64.21 112.345 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 60.31 19.84 9.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 73.13 110.871 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -177.92 -54.34 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.752 -0.737 . . . . 42.54 112.491 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.418 HG12 ' N ' ' A' ' 191' ' ' THR . 1.4 t -54.62 -50.4 59.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.947 0.403 . . . . 61.34 111.135 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 191' ' ' THR . . . . . 0.418 ' N ' HG12 ' A' ' 190' ' ' VAL . 44.0 p 47.04 62.17 2.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.187 -0.46 . . . . 53.32 111.125 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -157.6 146.61 19.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 74.22 110.865 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.16 76.6 6.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.197 -0.456 . . . . 73.33 110.918 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 4.9 m -86.07 -6.48 59.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.258 -0.428 . . . . 53.12 110.86 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.775 ' CE2' HG11 ' A' ' 183' ' ' VAL . 20.2 p90 -90.74 173.4 8.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.129 -0.487 . . . . 63.13 110.867 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 23.4 ptt180 -163.04 172.56 14.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.138 -0.483 . . . . 71.13 110.874 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 197' ' ' ALA . . . . . 0.549 ' HB3' ' HB ' ' A' ' 209' ' ' VAL . . . -121.38 167.86 12.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 75.45 111.074 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 8.3 p -174.05 153.82 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 74.15 111.089 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.49 129.14 38.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.121 -0.491 . . . . 72.32 110.834 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.445 ' HB2' ' HD3' ' A' ' 227' ' ' PRO . . . -65.92 -21.86 66.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.114 -0.494 . . . . 64.34 111.078 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -155.45 86.85 1.09 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.245 -0.434 . . . . 43.14 110.869 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 24.4 ttmt -79.23 58.46 2.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.44 . . . . 71.42 110.905 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 27.6 p -132.89 3.68 3.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 74.4 111.123 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 204' ' ' LYS . . . . . 0.444 ' HA ' ' HB3' ' A' ' 220' ' ' ALA . 12.9 mtmm -154.22 16.51 0.48 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.238 -0.437 . . . . 60.33 110.918 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.4 ' HA ' ' H ' ' A' ' 219' ' ' VAL . . . -179.96 152.96 0.49 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.436 . . . . 72.34 111.068 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 12.1 p -107.9 154.13 22.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 74.33 111.17 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.73 HG12 HG22 ' A' ' 216' ' ' VAL . 13.3 m -140.58 136.36 35.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 74.34 111.124 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 208' ' ' SER . . . . . 0.527 ' C ' HG23 ' A' ' 214' ' ' ILE . 1.2 t -144.99 108.44 4.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.459 . . . . 62.31 110.85 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.637 HG23 HG13 ' A' ' 214' ' ' ILE . 4.4 p -91.01 143.68 10.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 72.52 111.139 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 7.8 t -144.97 98.16 3.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 65.12 110.843 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 70.24 -81.63 0.36 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.748 -0.739 . . . . 74.12 112.497 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -138.78 7.68 2.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.838 0.351 . . . . 63.43 110.86 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 1.6 m -129.16 123.03 31.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.444 . . . . 74.14 111.185 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.637 HG13 HG23 ' A' ' 209' ' ' VAL . 2.4 mp -114.6 140.49 35.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 64.24 111.17 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.0 128.59 54.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 62.41 111.087 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.73 HG22 HG12 ' A' ' 207' ' ' VAL . 2.6 t -118.72 134.24 62.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 73.45 111.125 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -119.27 137.19 53.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 65.4 110.923 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -85.7 68.88 3.32 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.778 -0.725 . . . . 54.52 112.491 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.425 HG12 ' N ' ' A' ' 220' ' ' ALA . 1.9 t -49.45 -53.98 7.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.812 0.339 . . . . 63.1 111.116 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 220' ' ' ALA . . . . . 0.444 ' HB3' ' HA ' ' A' ' 204' ' ' LYS . . . -123.71 155.2 38.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 73.31 111.134 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 221' ' ' ALA . . . . . 0.664 ' HB2' ' HA ' ' A' ' 245' ' ' ALA . . . -67.27 137.11 55.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.238 -0.437 . . . . 65.43 111.106 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 141.32 175.09 14.67 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.703 -0.76 . . . . 70.12 112.503 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 223' ' ' LYS . . . . . 0.495 ' HG3' HG23 ' A' ' 242' ' ' THR . 5.1 mttp -98.86 122.24 41.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.787 0.327 . . . . 72.21 110.926 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 6.4 p -119.15 127.35 75.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 53.22 111.123 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 225' ' ' ASN . . . . . 0.418 ' C ' HD12 ' A' ' 226' ' ' ILE . 30.6 m120 -90.7 145.4 24.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 64.03 110.916 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.418 HD12 ' C ' ' A' ' 225' ' ' ASN . 4.8 mp -131.12 92.56 32.8 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.657 0.742 . . . . 72.35 111.126 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 227' ' ' PRO . . . . . 0.445 ' HD3' ' HB2' ' A' ' 200' ' ' ALA . 53.6 Cg_endo -69.75 179.21 3.85 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.705 2.27 . . . . 74.2 112.338 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.456 ' HB ' ' HB3' ' A' ' 237' ' ' ALA . 58.0 t -148.36 137.27 15.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 61.01 111.155 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 46.1 t -116.93 135.91 55.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 74.13 111.123 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.25 107.37 12.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 74.02 110.844 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 74.94 -118.23 5.6 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.752 -0.737 . . . . 52.21 112.492 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -108.06 19.95 19.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.851 0.357 . . . . 74.55 110.867 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 116.49 2.87 19.29 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.733 -0.746 . . . . 55.01 112.52 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -51.47 -71.47 0.06 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.876 0.37 . . . . 65.43 110.88 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -109.32 151.63 26.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 70.31 110.86 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -149.46 161.73 41.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 40.14 111.138 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 237' ' ' ALA . . . . . 0.456 ' HB3' ' HB ' ' A' ' 228' ' ' VAL . . . -139.61 163.15 33.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.246 -0.434 . . . . 73.54 111.149 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 43.0 t -136.58 139.58 44.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.281 -0.418 . . . . 73.21 111.117 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 239' ' ' ALA . . . . . 0.532 ' HB2' ' HG3' ' A' ' 168' ' ' PRO . . . -139.26 164.37 29.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.237 -0.438 . . . . 74.2 111.109 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 240' ' ' GLU . . . . . 0.448 ' O ' HD13 ' A' ' 241' ' ' ILE . 1.7 pt-20 -143.71 128.72 18.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.239 -0.437 . . . . 54.53 110.861 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 241' ' ' ILE . . . . . 0.448 HD13 ' O ' ' A' ' 240' ' ' GLU . 29.1 mm -125.2 110.85 25.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 72.52 111.156 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 242' ' ' THR . . . . . 0.495 HG23 ' HG3' ' A' ' 223' ' ' LYS . 1.5 m -80.75 138.82 36.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 73.35 111.191 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 18.3 t -120.07 117.82 54.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.24 -0.436 . . . . 65.24 111.152 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 244' ' ' THR . . . . . 0.481 HG23 ' O ' ' A' ' 173' ' ' VAL . 4.3 p -81.86 132.94 35.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 54.44 111.149 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 245' ' ' ALA . . . . . 0.664 ' HA ' ' HB2' ' A' ' 221' ' ' ALA . . . -53.24 -28.52 27.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 71.03 111.106 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 1.4 t . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 61.14 110.845 -179.789 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.903 0.382 . . . . 75.329999999999998 111.051 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -127.6 24.34 6.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 51.119999999999997 111.155 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 151.54 99.08 0.18 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.776 -0.726 . . . . 42.119999999999997 112.551 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 43.8 ttp -113.13 125.5 54.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.846 0.355 . . . . 72.420000000000002 110.901 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.64 ' OG1' ' HB3' ' A' ' 184' ' ' ALA . 51.6 p -114.47 103.62 11.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 61.219999999999999 111.153 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 1.087 HG22 HG13 ' A' ' 183' ' ' VAL . 21.4 t -99.7 130.48 48.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.256 -0.429 . . . . 73.349999999999994 111.117 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.3 m -125.0 92.88 46.81 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.593 0.711 . . . . 73.200000000000003 111.113 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.473 ' HB3' HD23 ' A' ' 181' ' ' LEU . 53.7 Cg_endo -69.74 -168.85 0.29 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.668 2.245 . . . . 65.010000000000005 112.381 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -86.73 -40.84 14.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.279 -0.419 . . . . 74.430000000000007 111.104 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 93.6 p 46.43 79.06 0.06 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.245 -0.434 . . . . 51.329999999999998 110.851 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.5 t -175.09 -174.89 0.8 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.126 -0.488 . . . . 62.439999999999998 111.118 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 89.4 p -98.8 164.06 12.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 73.400000000000006 110.849 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.715 HG22 ' HB2' ' A' ' 177' ' ' GLN . 3.5 p -146.31 154.02 12.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 65.329999999999998 111.111 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 66.7 t -87.35 145.31 7.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 71.109999999999999 111.071 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -49.03 122.56 5.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.134 -0.484 . . . . 71.120000000000005 110.923 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.38 -14.59 60.83 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.75 -0.738 . . . . 74.120000000000005 112.476 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . 0.715 ' HB2' HG22 ' A' ' 173' ' ' VAL . 17.4 mm100 -90.82 -178.22 5.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.83 0.347 . . . . 72.519999999999996 110.927 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 35.1 p -161.51 148.49 14.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.224 -0.444 . . . . 74.430000000000007 110.85 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.484 HG21 HD12 ' A' ' 241' ' ' ILE . 6.7 t -106.81 -173.55 2.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.075 -0.511 . . . . 53.43 111.151 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.29 132.31 27.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.231 -0.44 . . . . 75.5 111.133 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.473 HD23 ' HB3' ' A' ' 168' ' ' PRO . 7.7 mp -105.21 143.05 33.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 72.439999999999998 110.951 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 21.9 m -110.06 142.36 41.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.217 -0.447 . . . . 72.519999999999996 111.118 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 1.087 HG13 HG22 ' A' ' 166' ' ' VAL . 18.4 t -129.34 140.24 49.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 73.329999999999998 111.13 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.64 ' HB3' ' OG1' ' A' ' 165' ' ' THR . . . -130.11 152.12 49.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.143 -0.48 . . . . 64.450000000000003 111.098 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -145.76 126.88 14.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 74.409999999999997 110.865 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.58 66.71 77.33 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.542 0.687 . . . . 73.120000000000005 110.921 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo . . . . . 0 N--CA 1.465 -0.155 0 C-N-CA 122.676 2.251 . . . . 73.450000000000003 112.377 179.975 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 7.2 t0 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.865 0.364 . . . . 65.530000000000001 110.876 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.12 92.43 0.11 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 54.420000000000002 110.913 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 1.6 m -105.78 -7.08 18.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 60.32 110.831 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.776 ' CE2' HG11 ' A' ' 183' ' ' VAL . 19.2 p90 -91.34 176.35 6.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.098 -0.501 . . . . 72.430000000000007 110.913 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -163.05 171.16 16.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.459 . . . . 73.430000000000007 110.839 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . 0.416 ' HB3' ' HB ' ' A' ' 209' ' ' VAL . . . -120.31 168.0 11.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 72.430000000000007 111.078 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 11.3 p -175.21 151.45 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 75.0 111.108 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.7 t -77.31 150.15 35.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.126 -0.488 . . . . 53.030000000000001 110.858 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.522 ' HB2' ' HD3' ' A' ' 227' ' ' PRO . . . -86.32 -23.79 26.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 63.149999999999999 111.138 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -127.7 -52.52 1.35 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.19 -0.459 . . . . 64.340000000000003 110.831 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.24 24.39 14.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.2 -0.455 . . . . 74.439999999999998 110.91 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 35.5 p -113.37 -2.73 13.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.246 -0.433 . . . . 71.409999999999997 111.138 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 8.8 mtmm -152.59 18.53 0.62 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.251 -0.432 . . . . 74.340000000000003 110.878 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.629 ' HA ' HG23 ' A' ' 219' ' ' VAL . . . -177.22 146.61 0.5 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 73.129999999999995 111.089 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 11.9 p -107.22 159.04 16.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.174 -0.467 . . . . 50.119999999999997 111.117 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.769 HG12 HG22 ' A' ' 216' ' ' VAL . 11.2 m -141.23 141.72 30.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 53.100000000000001 111.141 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 4.3 m -148.76 108.46 4.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 72.299999999999997 110.843 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.494 HG23 HG13 ' A' ' 214' ' ' ILE . 3.5 p -87.96 143.1 11.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.132 -0.485 . . . . 74.299999999999997 111.132 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 16.7 t -172.08 123.45 0.5 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 73.329999999999998 110.841 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 55.86 47.16 80.96 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.745 -0.74 . . . . 75.140000000000001 112.488 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 2.1 mtp 63.74 16.01 9.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.853 0.359 . . . . 71.519999999999996 110.896 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 7.0 m -126.0 113.59 17.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 63.420000000000002 111.146 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.494 HG13 HG23 ' A' ' 209' ' ' VAL . 2.9 mp -110.23 113.96 45.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 75.109999999999999 111.125 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 5.0 m -88.1 132.16 34.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.45 . . . . 74.310000000000002 111.123 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.769 HG22 HG12 ' A' ' 207' ' ' VAL . 3.3 t -117.21 124.47 73.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 64.510000000000005 111.082 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -106.19 139.33 40.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 73.310000000000002 110.907 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -94.22 79.57 0.96 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.782 -0.723 . . . . 60.340000000000003 112.495 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.629 HG23 ' HA ' ' A' ' 205' ' ' ALA . 19.6 t -50.29 -55.96 4.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.792 0.329 . . . . 63.530000000000001 111.175 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -128.71 161.4 29.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 54.439999999999998 111.095 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . 0.684 ' HB2' ' HA ' ' A' ' 245' ' ' ALA . . . -61.06 140.31 57.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.215 -0.448 . . . . 71.219999999999999 111.121 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 139.41 171.21 12.15 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.743 -0.741 . . . . 74.409999999999997 112.488 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . 0.495 ' HG3' HG23 ' A' ' 242' ' ' THR . 14.3 mttt -99.46 124.56 44.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.821 0.343 . . . . 54.399999999999999 110.941 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.593 HG11 ' CB ' ' A' ' 205' ' ' ALA . 7.0 p -120.96 127.37 75.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 72.109999999999999 111.169 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . 0.606 ' C ' HD12 ' A' ' 226' ' ' ILE . 21.3 m120 -90.81 151.81 21.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 64.310000000000002 110.906 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.606 HD12 ' C ' ' A' ' 225' ' ' ASN . 4.4 mp -138.06 93.12 12.0 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.622 0.725 . . . . 71.120000000000005 111.125 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' PRO . . . . . 0.522 ' HD3' ' HB2' ' A' ' 200' ' ' ALA . 53.6 Cg_endo -69.79 -178.3 2.29 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.708 2.272 . . . . 71.219999999999999 112.34 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 90.5 t -150.09 134.78 9.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 61.210000000000001 111.137 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 80.4 t -117.08 135.59 56.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.147 -0.478 . . . . 65.230000000000004 111.161 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 31.0 t -122.12 116.65 24.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 74.120000000000005 110.871 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 66.48 -115.04 6.98 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.729 -0.748 . . . . 63.109999999999999 112.464 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -110.54 19.23 18.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.874 0.369 . . . . 65.219999999999999 110.888 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 117.33 2.72 17.69 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.748 -0.739 . . . . 75.439999999999998 112.485 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -51.06 -70.36 0.09 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.866 0.365 . . . . 70.219999999999999 110.902 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -107.38 159.66 16.22 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.172 -0.467 . . . . 72.530000000000001 110.852 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -160.75 165.19 30.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.103 -0.499 . . . . 74.409999999999997 111.091 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -146.2 163.18 36.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 71.439999999999998 111.135 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 24.1 t -137.18 137.02 46.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.215 -0.448 . . . . 62.039999999999999 111.11 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -139.08 165.29 27.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.173 -0.467 . . . . 73.530000000000001 111.134 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . 0.419 ' O ' HD13 ' A' ' 241' ' ' ILE . 5.8 pt-20 -144.95 132.51 20.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.244 -0.434 . . . . 74.140000000000001 110.851 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' ILE . . . . . 0.587 HG13 HG11 ' A' ' 216' ' ' VAL . 23.5 mm -126.87 115.09 40.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.134 -0.485 . . . . 72.25 111.174 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' THR . . . . . 0.495 HG23 ' HG3' ' A' ' 223' ' ' LYS . 2.0 m -82.43 141.24 32.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.152 -0.476 . . . . 62.0 111.162 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 17.8 t -119.71 121.54 66.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 52.399999999999999 111.128 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' THR . . . . . 0.529 HG23 ' O ' ' A' ' 173' ' ' VAL . 7.1 p -82.28 133.0 35.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 73.420000000000002 111.17 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' ALA . . . . . 0.684 ' HA ' ' HB2' ' A' ' 221' ' ' ALA . . . -58.33 -22.52 53.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 34.229999999999997 111.113 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 1.4 p . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.197 -0.456 . . . . 73.299999999999997 110.866 -179.77 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.859 0.361 . . . . 71.219999999999999 111.093 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -129.25 24.09 5.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.24 -0.436 . . . . 64.439999999999998 111.088 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 153.28 99.85 0.18 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.734 -0.746 . . . . 74.030000000000001 112.448 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 21.3 ttp -113.85 124.6 52.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.85 0.357 . . . . 64.549999999999997 110.872 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.648 ' OG1' ' HB3' ' A' ' 184' ' ' ALA . 51.6 p -114.58 103.32 10.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.257 -0.429 . . . . 70.420000000000002 111.147 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 1.037 HG22 HG13 ' A' ' 183' ' ' VAL . 21.7 t -97.97 131.72 44.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.192 -0.458 . . . . 75.540000000000006 111.153 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.4 m -126.46 92.38 45.39 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.545 0.688 . . . . 72.530000000000001 111.143 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.472 ' HG3' ' HB2' ' A' ' 239' ' ' ALA . 53.5 Cg_endo -69.82 -167.2 0.22 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.67 2.247 . . . . 74.109999999999999 112.321 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -85.94 -40.26 16.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 61.299999999999997 111.15 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 87.9 p 46.41 77.29 0.08 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.213 -0.449 . . . . 75.030000000000001 110.877 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.5 t -175.72 -174.82 0.71 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.12 -0.491 . . . . 73.109999999999999 111.128 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 34.6 p -100.56 162.91 12.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 72.239999999999995 110.862 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.732 HG22 ' HB2' ' A' ' 177' ' ' GLN . 3.3 p -144.27 153.03 15.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 64.530000000000001 111.12 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 63.2 t -86.58 145.26 7.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 73.420000000000002 111.152 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.1 122.3 5.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.191 -0.459 . . . . 73.340000000000003 110.899 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 100.19 -14.35 59.79 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.758 -0.734 . . . . 61.210000000000001 112.484 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . 0.732 ' HB2' HG22 ' A' ' 173' ' ' VAL . 11.7 mm100 -90.03 -177.66 5.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.81 0.338 . . . . 60.409999999999997 110.935 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 2.2 p -160.9 148.82 15.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 43.140000000000001 110.836 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.494 HG21 HD12 ' A' ' 241' ' ' ILE . 7.5 t -109.65 -176.82 3.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 50.25 111.128 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -139.47 127.51 22.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 60.229999999999997 111.148 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.466 HD23 ' HB3' ' A' ' 168' ' ' PRO . 7.9 mp -99.89 145.71 27.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.221 -0.445 . . . . 75.540000000000006 110.902 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -114.1 143.21 45.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 64.219999999999999 111.173 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 1.037 HG13 HG22 ' A' ' 166' ' ' VAL . 25.4 t -129.47 141.9 45.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 61.240000000000002 111.146 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.648 ' HB3' ' OG1' ' A' ' 165' ' ' THR . . . -129.81 150.66 51.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 75.25 111.095 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -144.5 127.8 16.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 65.5 110.901 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.39 66.76 71.3 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.642 0.734 . . . . 74.219999999999999 110.877 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo . . . . . 0 C--N 1.342 0.21 0 C-N-CA 122.657 2.238 . . . . 74.209999999999994 112.367 179.943 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 2.7 t70 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.854 0.359 . . . . 73.310000000000002 110.86 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.37 104.53 0.51 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 74.099999999999994 110.932 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 1.2 m -115.42 -6.14 12.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 65.200000000000003 110.843 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.777 ' CE2' HG11 ' A' ' 183' ' ' VAL . 21.9 p90 -90.31 174.45 7.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.125 -0.489 . . . . 74.319999999999993 110.878 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -165.7 151.64 9.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 73.150000000000006 110.863 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . 0.759 ' HB3' ' HB ' ' A' ' 209' ' ' VAL . . . -104.2 158.91 16.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 75.439999999999998 111.116 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.635 ' O ' HG23 ' A' ' 226' ' ' ILE . 6.4 m -153.04 -178.05 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 75.340000000000003 111.16 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 11.9 p -108.1 132.27 53.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 73.310000000000002 110.887 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.497 ' HB2' ' HD3' ' A' ' 227' ' ' PRO . . . -75.35 -26.01 58.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.122 -0.49 . . . . 40.009999999999998 111.14 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -129.01 -60.02 1.1 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.454 . . . . 75.409999999999997 110.884 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 63.88 35.45 10.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 45.310000000000002 110.922 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 32.7 p -118.44 -4.73 10.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.165 -0.47 . . . . 75.150000000000006 111.064 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 9.4 mtmm -152.84 18.63 0.59 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.255 -0.43 . . . . 61.530000000000001 110.907 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.663 ' HA ' HG23 ' A' ' 219' ' ' VAL . . . -171.26 144.91 2.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 71.310000000000002 111.128 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 17.0 p -107.37 130.85 54.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.249 -0.432 . . . . 64.150000000000006 111.17 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.913 HG12 HG22 ' A' ' 216' ' ' VAL . 4.8 m -118.86 138.99 47.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 71.450000000000003 111.145 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . 0.496 ' C ' HG23 ' A' ' 214' ' ' ILE . 5.7 t -145.29 109.09 4.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 61.450000000000003 110.849 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.759 ' HB ' ' HB3' ' A' ' 197' ' ' ALA . 4.2 p -89.4 143.61 10.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.104 -0.498 . . . . 63.149999999999999 111.091 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 3.4 t -144.79 96.28 2.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.138 -0.483 . . . . 34.119999999999997 110.885 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 70.29 -81.04 0.38 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.78 -0.724 . . . . 72.430000000000007 112.507 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -138.43 8.09 2.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.882 0.373 . . . . 64.209999999999994 110.911 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -129.24 121.82 28.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 63.119999999999997 111.168 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.654 HG13 HG23 ' A' ' 209' ' ' VAL . 2.6 mp -115.3 131.79 66.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 71.239999999999995 111.131 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 1.5 m -100.63 125.71 47.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.139 -0.482 . . . . 74.219999999999999 111.152 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.913 HG22 HG12 ' A' ' 207' ' ' VAL . 2.4 t -116.64 126.66 74.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 74.200000000000003 111.165 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -112.19 138.96 48.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 63.030000000000001 110.86 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -93.4 80.98 1.04 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.768 -0.729 . . . . 54.200000000000003 112.469 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.663 HG23 ' HA ' ' A' ' 205' ' ' ALA . 19.3 t -50.26 -51.18 18.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.855 0.36 . . . . 71.120000000000005 111.099 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -137.78 162.36 34.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 53.210000000000001 111.132 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . 0.631 ' HB2' ' HA ' ' A' ' 245' ' ' ALA . . . -57.25 143.45 39.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 74.329999999999998 111.132 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 137.18 167.95 11.23 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.748 -0.739 . . . . 52.439999999999998 112.482 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . 0.618 ' HG3' HG23 ' A' ' 242' ' ' THR . 6.1 mttp -102.47 133.93 46.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.83 0.348 . . . . 73.549999999999997 110.893 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 13.1 p -130.49 131.66 65.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 50.549999999999997 111.118 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . 0.617 ' C ' HD12 ' A' ' 226' ' ' ILE . 33.3 m120 -91.33 152.45 20.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.464 . . . . 63.420000000000002 110.905 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.635 HG23 ' O ' ' A' ' 198' ' ' VAL . 4.3 mp -137.43 92.44 13.47 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.611 0.719 . . . . 61.100000000000001 111.124 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' PRO . . . . . 0.497 ' HD3' ' HB2' ' A' ' 200' ' ' ALA . 54.5 Cg_endo -69.71 -179.55 2.97 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.689 2.26 . . . . 75.430000000000007 112.367 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 85.9 t -150.4 134.84 9.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 34.539999999999999 111.125 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 86.9 t -116.94 136.07 55.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 74.099999999999994 111.147 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -119.77 108.83 14.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 55.43 110.844 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 56.99 -116.05 7.32 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.767 -0.73 . . . . 44.509999999999998 112.503 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 17.9 p30 -95.04 19.3 10.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.836 0.351 . . . . 64.310000000000002 110.842 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 101.09 8.28 47.98 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.72 -0.752 . . . . 42.149999999999999 112.486 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -52.0 -33.81 39.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.814 0.34 . . . . 62.329999999999998 110.835 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -144.21 153.21 41.85 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.202 -0.454 . . . . 74.310000000000002 110.894 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -154.28 165.53 36.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.174 -0.466 . . . . 42.420000000000002 111.097 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -145.78 163.16 35.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.464 . . . . 64.340000000000003 111.115 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 23.3 t -136.6 135.83 48.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.251 -0.431 . . . . 74.530000000000001 111.131 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' ALA . . . . . 0.472 ' HB2' ' HG3' ' A' ' 168' ' ' PRO . . . -138.6 165.29 27.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 73.319999999999993 111.123 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -145.81 132.37 19.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 75.219999999999999 110.862 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' ILE . . . . . 0.529 HG13 HG11 ' A' ' 216' ' ' VAL . 24.5 mm -125.79 113.59 35.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.194 -0.457 . . . . 72.540000000000006 111.151 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' THR . . . . . 0.618 HG23 ' HG3' ' A' ' 223' ' ' LYS . 1.7 m -83.17 141.63 31.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 63.509999999999998 111.146 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 11.3 t -119.78 122.78 69.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.44 . . . . 73.019999999999996 111.17 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' THR . . . . . 0.51 HG23 ' O ' ' A' ' 173' ' ' VAL . 4.2 p -84.75 132.56 34.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 63.229999999999997 111.141 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' ALA . . . . . 0.631 ' HA ' ' HB2' ' A' ' 221' ' ' ALA . . . -58.18 -23.48 55.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 62.549999999999997 111.097 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 58.8 m . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 72.439999999999998 110.884 -179.792 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.869 0.366 . . . . 72.209999999999994 111.131 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 1.9 m -128.26 24.13 5.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.261 -0.427 . . . . 61.109999999999999 111.165 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 153.41 99.04 0.17 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.701 -0.762 . . . . 73.329999999999998 112.476 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 27.9 ttp -113.18 125.34 54.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.862 0.363 . . . . 74.209999999999994 110.851 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.596 ' OG1' ' HB3' ' A' ' 184' ' ' ALA . 48.5 p -114.72 104.01 11.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 71.310000000000002 111.142 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 1.071 HG22 HG13 ' A' ' 183' ' ' VAL . 21.7 t -100.41 130.98 48.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 61.100000000000001 111.117 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 19.2 m -125.1 92.48 47.36 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.551 0.691 . . . . 75.439999999999998 111.085 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.481 ' HG3' ' HB2' ' A' ' 239' ' ' ALA . 53.7 Cg_endo -69.8 -166.75 0.2 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.649 2.233 . . . . 71.109999999999999 112.355 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -86.59 -40.59 15.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.436 . . . . 53.130000000000003 111.063 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 88.2 p 46.72 76.3 0.1 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 61.340000000000003 110.875 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.5 t -174.23 -174.9 0.93 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 73.340000000000003 111.152 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 24.5 p -100.37 162.24 13.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 51.420000000000002 110.824 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.725 HG22 ' HB2' ' A' ' 177' ' ' GLN . 2.8 p -144.27 154.06 15.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.117 -0.492 . . . . 64.209999999999994 111.127 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 79.5 t -89.29 144.48 9.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 63.049999999999997 111.142 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.78 123.76 6.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.451 . . . . 70.409999999999997 110.92 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.84 -16.14 58.84 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.788 -0.72 . . . . 60.310000000000002 112.498 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . 0.725 ' HB2' HG22 ' A' ' 173' ' ' VAL . 9.7 mm100 -89.41 -177.89 5.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.846 0.355 . . . . 75.530000000000001 110.914 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 11.9 p -161.98 147.09 12.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.212 -0.449 . . . . 62.310000000000002 110.884 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 7.3 t -108.12 -174.69 2.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 73.120000000000005 111.132 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -140.42 132.31 27.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 75.129999999999995 111.189 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.474 HD23 ' HB3' ' A' ' 168' ' ' PRO . 7.6 mp -105.12 142.14 35.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 73.329999999999998 110.919 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 24.9 m -110.01 141.99 42.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 65.430000000000007 111.179 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 1.071 HG13 HG22 ' A' ' 166' ' ' VAL . 21.5 t -129.32 139.87 50.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.293 -0.412 . . . . 64.219999999999999 111.127 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.596 ' HB3' ' OG1' ' A' ' 165' ' ' THR . . . -130.11 151.91 50.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.124 -0.489 . . . . 73.450000000000003 111.126 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -144.24 128.69 17.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 75.420000000000002 110.889 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.25 66.69 71.66 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.582 0.706 . . . . 75.230000000000004 110.912 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo . . . . . 0 C--N 1.341 0.162 0 C-N-CA 122.68 2.253 . . . . 65.349999999999994 112.355 179.999 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 13.5 t0 . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.877 0.37 . . . . 64.439999999999998 110.883 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 9.5 mtmt -63.24 96.78 0.11 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 74.530000000000001 110.914 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 2.0 m -109.84 -6.25 15.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 73.219999999999999 110.877 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.773 ' CE2' HG11 ' A' ' 183' ' ' VAL . 20.6 p90 -90.71 175.9 6.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.073 -0.512 . . . . 62.219999999999999 110.845 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 3.1 ptt-85 -158.25 173.71 16.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.132 -0.486 . . . . 73.219999999999999 110.89 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . 0.553 ' HB3' ' HB ' ' A' ' 209' ' ' VAL . . . -124.65 167.16 14.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 42.039999999999999 111.086 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 10.0 p -174.77 152.73 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 73.439999999999998 111.131 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.7 126.75 36.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.156 -0.475 . . . . 71.319999999999993 110.878 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.526 ' HB2' ' HD3' ' A' ' 227' ' ' PRO . . . -61.68 -17.94 57.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.115 -0.493 . . . . 74.129999999999995 111.093 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -156.99 92.43 1.27 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.213 -0.449 . . . . 61.409999999999997 110.913 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 8.0 tttp -83.65 55.18 3.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 75.049999999999997 110.931 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 20.0 p -130.66 2.67 4.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.246 -0.434 . . . . 54.100000000000001 111.144 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . 0.45 ' HA ' ' HB3' ' A' ' 220' ' ' ALA . 10.8 mtmm -153.99 18.23 0.51 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 65.230000000000004 110.881 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -179.47 153.4 0.57 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.449 . . . . 65.540000000000006 111.113 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 8.4 p -117.49 131.23 56.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 73.340000000000003 111.142 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 1.05 HG12 HG22 ' A' ' 216' ' ' VAL . 4.9 m -120.1 140.33 44.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.184 -0.462 . . . . 43.299999999999997 111.112 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.16 109.0 4.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 72.420000000000002 110.868 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.553 ' HB ' ' HB3' ' A' ' 197' ' ' ALA . 3.7 p -85.45 143.08 12.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.138 -0.483 . . . . 63.200000000000003 111.173 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 17.2 p -172.19 123.85 0.5 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 62.109999999999999 110.839 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 55.4 48.05 72.15 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.752 -0.737 . . . . 43.439999999999998 112.476 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 2.4 mtp 62.5 16.47 8.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.884 0.373 . . . . 72.510000000000005 110.853 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 1.4 m -128.15 114.23 16.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.26 -0.427 . . . . 54.210000000000001 111.153 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.537 HG13 HG23 ' A' ' 209' ' ' VAL . 3.4 mp -110.24 115.61 50.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 75.25 111.076 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 1.3 m -89.99 126.91 35.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 75.430000000000007 111.118 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 1.05 HG22 HG12 ' A' ' 207' ' ' VAL . 4.8 t -112.74 128.28 69.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.216 -0.447 . . . . 72.510000000000005 111.135 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -109.56 135.69 50.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 75.409999999999997 110.921 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -84.41 66.81 3.82 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.731 -0.747 . . . . 71.200000000000003 112.507 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.418 HG12 ' N ' ' A' ' 220' ' ' ALA . 1.9 t -48.75 -53.58 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.817 0.341 . . . . 70.239999999999995 111.146 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . 0.45 ' HB3' ' HA ' ' A' ' 204' ' ' LYS . . . -123.96 155.33 38.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.146 -0.479 . . . . 61.329999999999998 111.114 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . 0.662 ' HB2' ' HA ' ' A' ' 245' ' ' ALA . . . -67.82 138.03 55.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 74.239999999999995 111.054 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 140.46 174.68 14.05 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.769 -0.729 . . . . 52.039999999999999 112.478 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . 0.551 ' HG3' HG23 ' A' ' 242' ' ' THR . 6.0 mttp -99.38 121.51 41.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.827 0.346 . . . . 72.129999999999995 110.885 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 7.6 p -120.35 128.67 76.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 73.299999999999997 111.132 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . 0.456 ' C ' HD12 ' A' ' 226' ' ' ILE . 36.1 m120 -90.52 150.2 21.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.145 -0.479 . . . . 70.409999999999997 110.863 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.456 HD12 ' C ' ' A' ' 225' ' ' ASN . 4.7 mp -133.19 92.39 25.17 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.675 0.75 . . . . 75.510000000000005 111.135 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' PRO . . . . . 0.526 ' HD3' ' HB2' ' A' ' 200' ' ' ALA . 54.5 Cg_endo -69.7 -179.67 3.05 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.687 2.258 . . . . 63.399999999999999 112.375 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 96.2 t -149.46 136.13 12.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 74.400000000000006 111.142 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 82.6 t -118.26 135.52 58.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.186 -0.461 . . . . 73.349999999999994 111.134 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.21 108.8 14.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 72.200000000000003 110.856 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 74.06 -111.44 3.43 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.763 -0.732 . . . . 54.32 112.485 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -111.09 8.31 21.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.907 0.384 . . . . 75.349999999999994 110.948 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 127.78 3.24 6.0 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.709 -0.758 . . . . 52.219999999999999 112.456 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -51.66 -73.21 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.853 0.358 . . . . 75.329999999999998 110.899 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -102.94 156.37 17.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.468 . . . . 71.25 110.872 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -157.24 165.18 36.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.148 -0.478 . . . . 74.319999999999993 111.068 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -144.83 163.5 33.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 74.299999999999997 111.096 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 58.8 t -137.02 136.46 47.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.226 -0.443 . . . . 55.520000000000003 111.126 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' ALA . . . . . 0.481 ' HB2' ' HG3' ' A' ' 168' ' ' PRO . . . -138.72 165.26 27.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 72.319999999999993 111.103 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . 0.507 ' O ' HD13 ' A' ' 241' ' ' ILE . 1.8 pt-20 -143.15 131.49 22.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 75.109999999999999 110.888 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' ILE . . . . . 0.507 HD13 ' O ' ' A' ' 240' ' ' GLU . 25.8 mm -127.28 112.05 27.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.13 -0.486 . . . . 71.420000000000002 111.089 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' THR . . . . . 0.551 HG23 ' HG3' ' A' ' 223' ' ' LYS . 1.7 m -82.5 139.28 34.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.189 -0.46 . . . . 53.450000000000003 111.132 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 22.1 t -120.49 119.48 59.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.23 -0.441 . . . . 61.329999999999998 111.142 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' THR . . . . . 0.479 HG23 ' O ' ' A' ' 173' ' ' VAL . 6.8 p -81.91 132.9 35.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 74.430000000000007 111.169 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' ALA . . . . . 0.662 ' HA ' ' HB2' ' A' ' 221' ' ' ALA . . . -55.2 -26.19 37.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 73.030000000000001 111.051 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 9.3 t . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.234 -0.439 . . . . 62.25 110.846 -179.785 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.835 0.35 . . . . 75.319999999999993 111.106 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -125.02 32.28 5.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 61.340000000000003 111.093 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 136.87 99.7 0.55 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.72 -0.752 . . . . 65.430000000000007 112.501 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 11.6 ttp -109.75 133.04 53.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.83 0.348 . . . . 71.099999999999994 110.898 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.461 ' HG1' ' HB3' ' A' ' 184' ' ' ALA . 33.4 p -121.65 108.17 13.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 51.43 111.147 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 1.125 HG22 HG13 ' A' ' 183' ' ' VAL . 26.3 t -102.23 132.29 48.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 53.109999999999999 111.122 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.7 m -124.33 92.49 48.05 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.599 0.714 . . . . 72.5 111.143 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.483 ' HB3' HD23 ' A' ' 181' ' ' LEU . 53.7 Cg_endo -69.75 -166.43 0.19 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.709 2.273 . . . . 63.039999999999999 112.329 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -89.03 -39.49 13.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 71.0 111.133 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 98.2 p 46.32 79.33 0.06 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 53.32 110.829 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.1 t -175.55 -174.59 0.71 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.093 -0.503 . . . . 71.030000000000001 111.121 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 97.2 p -99.89 163.19 12.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.262 -0.426 . . . . 63.310000000000002 110.886 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.737 HG22 ' HB2' ' A' ' 177' ' ' GLN . 3.1 p -144.95 153.6 14.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.134 -0.484 . . . . 64.120000000000005 111.099 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 58.7 t -87.53 145.67 7.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 63.530000000000001 111.13 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.34 122.37 6.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.459 . . . . 61.299999999999997 110.919 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.7 -12.54 61.14 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.761 -0.733 . . . . 61.130000000000003 112.489 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . 0.737 ' HB2' HG22 ' A' ' 173' ' ' VAL . 13.9 mm100 -92.64 -178.06 4.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.779 0.323 . . . . 62.039999999999999 110.928 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 23.8 p -161.5 148.83 14.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 62.219999999999999 110.878 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.424 HG21 HD12 ' A' ' 241' ' ' ILE . 9.1 t -108.74 -175.4 2.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.124 -0.489 . . . . 73.010000000000005 111.137 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -138.9 132.98 31.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 65.400000000000006 111.143 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.483 HD23 ' HB3' ' A' ' 168' ' ' PRO . 7.4 mp -106.52 143.59 34.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 74.230000000000004 110.946 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 2.2 m -111.75 142.5 44.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.462 . . . . 75.109999999999999 111.11 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 1.125 HG13 HG22 ' A' ' 166' ' ' VAL . 22.6 t -129.75 140.52 48.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 71.400000000000006 111.141 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.461 ' HB3' ' HG1' ' A' ' 165' ' ' THR . . . -132.38 152.49 51.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 44.039999999999999 111.097 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -143.77 128.7 18.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.455 . . . . 65.5 110.866 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.77 67.11 76.81 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.577 0.704 . . . . 60.25 110.896 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo . . . . . 0 C--N 1.342 0.185 0 C-N-CA 122.675 2.25 . . . . 71.349999999999994 112.357 179.95 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.877 0.37 . . . . 73.049999999999997 110.881 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 6.1 mtmt -52.94 105.55 0.13 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 75.140000000000001 110.888 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 59.8 m -116.76 -6.69 11.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 64.400000000000006 110.857 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.755 ' CE2' HG11 ' A' ' 183' ' ' VAL . 23.6 p90 -90.75 176.5 6.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.101 -0.499 . . . . 61.530000000000001 110.857 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.28 157.34 15.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.122 -0.49 . . . . 71.439999999999998 110.862 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -105.48 167.78 9.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.47 . . . . 55.140000000000001 111.115 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 11.6 p -164.32 151.06 2.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 72.150000000000006 111.153 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.56 121.17 29.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 53.509999999999998 110.874 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.613 ' HB2' ' HD3' ' A' ' 227' ' ' PRO . . . -65.34 -19.49 65.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.103 -0.499 . . . . 73.329999999999998 111.107 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -163.81 91.4 0.65 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.17 -0.468 . . . . 32.340000000000003 110.845 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 7.8 ttpt -83.19 55.59 3.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 70.420000000000002 110.909 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 25.0 p -128.06 -0.23 5.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.236 -0.438 . . . . 75.019999999999996 111.153 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 6.1 mtmt -156.42 19.45 0.35 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.18 -0.463 . . . . 71.239999999999995 110.9 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.611 ' HA ' HG23 ' A' ' 219' ' ' VAL . . . -179.64 149.85 0.39 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 72.329999999999998 111.162 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 4.0 p -108.51 156.22 19.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 73.109999999999999 111.12 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.611 HG12 HG22 ' A' ' 216' ' ' VAL . 15.7 m -141.27 137.56 33.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 53.329999999999998 111.161 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 60.4 p -146.04 108.01 4.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 72.319999999999993 110.879 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.545 HG23 HG13 ' A' ' 214' ' ' ILE . 3.3 p -91.18 140.94 15.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 64.5 111.147 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 17.5 p -172.38 126.71 0.53 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 55.329999999999998 110.832 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 56.49 45.44 89.58 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.782 -0.723 . . . . 73.219999999999999 112.476 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 4.2 mtp 63.51 16.15 9.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.871 0.367 . . . . 74.340000000000003 110.867 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 22.2 m -127.05 115.04 18.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.229 -0.441 . . . . 75.25 111.088 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.545 HG13 HG23 ' A' ' 209' ' ' VAL . 3.4 mp -110.44 120.25 60.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 63.439999999999998 111.141 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 1.2 m -92.18 128.84 38.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.211 -0.449 . . . . 43.340000000000003 111.168 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.634 HG11 HG13 ' A' ' 241' ' ' ILE . 3.5 t -115.34 125.58 72.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 73.439999999999998 111.125 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -110.79 138.72 46.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 74.219999999999999 110.908 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -94.99 78.53 0.88 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.765 -0.731 . . . . 31.420000000000002 112.474 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.611 HG23 ' HA ' ' A' ' 205' ' ' ALA . 19.1 t -49.71 -53.0 11.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.827 0.346 . . . . 74.120000000000005 111.11 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -131.33 161.95 31.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.461 . . . . 74.239999999999995 111.113 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . 0.679 ' HB2' ' HA ' ' A' ' 245' ' ' ALA . . . -60.74 138.62 58.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.235 -0.439 . . . . 63.310000000000002 111.085 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 142.77 171.18 13.21 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.705 -0.759 . . . . 74.129999999999995 112.486 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . 0.507 ' HG3' HG23 ' A' ' 242' ' ' THR . 13.6 mttt -101.56 125.15 48.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.84 0.352 . . . . 72.140000000000001 110.936 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.472 HG11 ' CB ' ' A' ' 205' ' ' ALA . 7.1 p -122.07 126.17 74.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.242 -0.436 . . . . 73.230000000000004 111.122 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . 0.591 ' C ' HD12 ' A' ' 226' ' ' ILE . 0.3 OUTLIER -90.96 155.48 18.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 73.230000000000004 110.878 -179.977 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.591 HD12 ' C ' ' A' ' 225' ' ' ASN . 4.6 mp -139.88 92.65 9.8 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.603 0.716 . . . . 62.119999999999997 111.133 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' PRO . . . . . 0.613 ' HD3' ' HB2' ' A' ' 200' ' ' ALA . 54.3 Cg_endo -69.75 -178.14 2.2 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.67 2.247 . . . . 71.510000000000005 112.365 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 80.4 t -150.3 143.02 17.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 70.040000000000006 111.094 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 94.8 t -123.77 134.09 67.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.182 -0.463 . . . . 72.310000000000002 111.119 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -122.3 133.68 54.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 64.150000000000006 110.846 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 52.25 -116.15 4.86 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.78 -0.724 . . . . 73.439999999999998 112.464 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -108.73 21.17 17.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.83 0.348 . . . . 51.539999999999999 110.86 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 110.41 5.87 27.77 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.7 -0.762 . . . . 45.340000000000003 112.514 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -52.9 -60.32 3.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.924 0.392 . . . . 71.450000000000003 110.885 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -113.04 166.69 11.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.103 -0.499 . . . . 75.430000000000007 110.89 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -165.06 162.2 20.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.151 -0.477 . . . . 74.239999999999995 111.129 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -140.09 163.26 33.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 41.509999999999998 111.125 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.2 p -140.17 131.66 31.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 72.239999999999995 111.191 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' ALA . . . . . 0.407 ' HB2' ' HG3' ' A' ' 168' ' ' PRO . . . -132.71 165.2 25.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.191 -0.459 . . . . 62.43 111.093 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . 0.562 ' O ' HD13 ' A' ' 241' ' ' ILE . 4.4 pt-20 -144.55 132.28 21.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.225 -0.443 . . . . 70.299999999999997 110.916 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' ILE . . . . . 0.634 HG13 HG11 ' A' ' 216' ' ' VAL . 27.2 mm -127.21 112.49 28.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 73.340000000000003 111.096 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' THR . . . . . 0.507 HG23 ' HG3' ' A' ' 223' ' ' LYS . 2.2 m -81.76 141.21 33.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.117 -0.492 . . . . 75.549999999999997 111.123 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 19.7 t -120.12 121.31 65.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.213 -0.448 . . . . 75.230000000000004 111.106 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' THR . . . . . 0.49 HG23 ' O ' ' A' ' 173' ' ' VAL . 6.2 p -83.69 132.77 34.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.138 -0.483 . . . . 44.409999999999997 111.126 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' ALA . . . . . 0.679 ' HA ' ' HB2' ' A' ' 221' ' ' ALA . . . -53.45 -28.26 29.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 72.299999999999997 111.117 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 7.9 t . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.44 . . . . 74.129999999999995 110.86 -179.766 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.874 0.369 . . . . 63.32 111.111 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 1.6 m -134.33 30.79 3.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 63.420000000000002 111.139 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 137.27 104.97 0.71 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.739 -0.743 . . . . 72.209999999999994 112.503 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 1.5 ttp -115.84 138.5 51.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.837 0.351 . . . . 71.430000000000007 110.855 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.691 HG23 HE22 ' A' ' 186' ' ' GLN . 37.5 p -125.34 106.67 10.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 53.030000000000001 111.152 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.992 HG22 HG13 ' A' ' 183' ' ' VAL . 16.4 t -97.62 135.92 30.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 63.240000000000002 111.099 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.3 m -128.78 92.22 40.83 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.574 0.702 . . . . 63.200000000000003 111.157 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.542 ' HG3' ' HB2' ' A' ' 239' ' ' ALA . 53.5 Cg_endo -69.75 -165.03 0.14 Allowed 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.695 2.263 . . . . 73.239999999999995 112.365 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -93.0 -37.01 12.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.433 . . . . 65.209999999999994 111.124 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 88.0 p 46.85 76.92 0.09 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 71.430000000000007 110.838 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.4 t -171.22 -174.5 1.48 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 63.32 111.18 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 18.4 p -100.35 163.66 12.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 65.230000000000004 110.833 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.744 HG22 ' HB2' ' A' ' 177' ' ' GLN . 3.0 p -144.4 153.4 15.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.079 -0.51 . . . . 65.409999999999997 111.173 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 23.2 t -86.38 145.09 8.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 50.310000000000002 111.139 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.42 122.23 5.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 73.439999999999998 110.91 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 98.87 -11.08 62.49 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.696 -0.764 . . . . 64.5 112.505 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . 0.744 ' HB2' HG22 ' A' ' 173' ' ' VAL . 19.2 mm100 -92.82 -177.53 4.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.769 0.319 . . . . 75.120000000000005 110.945 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 59.8 p -160.56 151.65 19.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.246 -0.434 . . . . 72.409999999999997 110.854 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 11.0 t -113.74 -178.71 3.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.119 -0.491 . . . . 63.450000000000003 111.16 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.02 129.71 32.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.22 -0.445 . . . . 60.530000000000001 111.12 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.448 HD23 ' HB3' ' A' ' 168' ' ' PRO . 7.7 mp -103.57 146.23 28.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 61.119999999999997 110.901 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 7.1 m -111.1 144.36 40.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 71.439999999999998 111.133 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.992 HG13 HG22 ' A' ' 166' ' ' VAL . 21.8 t -129.5 142.26 44.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 73.439999999999998 111.155 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.58 ' HB3' ' OG1' ' A' ' 165' ' ' THR . . . -129.08 152.83 48.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 63.210000000000001 111.106 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -145.77 129.23 16.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.458 . . . . 72.019999999999996 110.852 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' GLN . . . . . 0.691 HE22 HG23 ' A' ' 165' ' ' THR . 0.0 OUTLIER -128.6 66.81 75.42 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.592 0.71 . . . . 71.420000000000002 110.878 -179.885 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--N 1.342 0.197 0 C-N-CA 122.636 2.224 . . . . 75.209999999999994 112.358 179.97 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.919 0.39 . . . . 71.319999999999993 110.862 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -66.33 90.51 0.15 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.451 . . . . 70.340000000000003 110.906 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 1.8 t -105.5 -6.64 19.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 74.040000000000006 110.836 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.756 ' CE2' HG11 ' A' ' 183' ' ' VAL . 18.8 p90 -91.08 168.85 11.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.465 . . . . 72.230000000000004 110.905 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.08 168.8 25.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 73.430000000000007 110.889 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . 0.621 ' HB3' ' HB ' ' A' ' 209' ' ' VAL . . . -119.53 163.06 17.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.446 . . . . 63.100000000000001 111.144 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.608 ' O ' HG23 ' A' ' 226' ' ' ILE . 3.9 m -153.79 -178.74 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.272 -0.422 . . . . 73.25 111.121 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . 0.45 ' HB3' HG22 ' A' ' 207' ' ' VAL . 0.9 OUTLIER -119.53 127.35 52.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.161 -0.472 . . . . 54.009999999999998 110.921 -179.903 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.405 ' HB2' ' HD3' ' A' ' 227' ' ' PRO . . . -70.82 -9.73 58.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.474 . . . . 50.340000000000003 111.153 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -166.22 99.12 0.62 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 64.319999999999993 110.867 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 14.9 tttt -91.52 41.71 1.08 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.176 -0.465 . . . . 74.299999999999997 110.892 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 4.2 p -124.93 -5.22 7.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 52.310000000000002 111.188 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 8.5 mtmm -148.05 15.09 1.04 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 64.239999999999995 110.922 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.58 ' HA ' HG23 ' A' ' 219' ' ' VAL . . . -179.67 150.11 0.39 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.44 . . . . 44.549999999999997 111.081 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 9.3 p -115.95 151.85 34.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 64.209999999999994 111.133 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.862 HG12 HG22 ' A' ' 216' ' ' VAL . 6.2 m -138.03 141.64 37.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 55.020000000000003 111.082 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -147.05 109.02 4.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 75.349999999999994 110.906 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.621 ' HB ' ' HB3' ' A' ' 197' ' ' ALA . 3.6 p -86.23 143.21 11.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.128 -0.487 . . . . 72.239999999999995 111.114 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 7.7 p -171.98 124.11 0.53 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 71.450000000000003 110.869 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 55.64 47.19 79.09 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.781 -0.723 . . . . 73.510000000000005 112.47 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 2.0 mtp 63.26 16.08 9.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.844 0.354 . . . . 72.010000000000005 110.884 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 1.9 m -127.4 114.81 18.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.24 -0.436 . . . . 71.430000000000007 111.143 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.504 HG13 HG23 ' A' ' 209' ' ' VAL . 3.0 mp -110.15 116.26 51.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 73.329999999999998 111.107 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -89.34 126.15 35.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 62.119999999999997 111.125 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.862 HG22 HG12 ' A' ' 207' ' ' VAL . 2.8 t -111.43 129.91 65.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 73.329999999999998 111.172 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -113.55 139.03 49.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.439 . . . . 70.239999999999995 110.887 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -96.73 78.02 0.71 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.738 -0.744 . . . . 73.109999999999999 112.526 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.58 HG23 ' HA ' ' A' ' 205' ' ' ALA . 17.0 t -50.22 -54.96 6.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.846 0.355 . . . . 72.310000000000002 111.151 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -128.0 160.8 30.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 71.239999999999995 111.115 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . 0.67 ' HB2' ' HA ' ' A' ' 245' ' ' ALA . . . -61.07 140.05 57.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 62.439999999999998 111.051 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 142.56 170.83 12.94 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.802 -0.713 . . . . 71.329999999999998 112.535 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . 0.463 ' HG3' HG23 ' A' ' 242' ' ' THR . 12.8 mttt -100.85 121.33 41.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.818 0.342 . . . . 72.209999999999994 110.877 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.535 HG11 ' CB ' ' A' ' 205' ' ' ALA . 7.4 p -120.57 126.96 75.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.262 -0.426 . . . . 71.420000000000002 111.139 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . 0.627 ' C ' HD12 ' A' ' 226' ' ' ILE . 32.7 m120 -90.67 155.97 18.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.464 . . . . 64.430000000000007 110.864 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.627 HD12 ' C ' ' A' ' 225' ' ' ASN . 3.9 mp -135.91 92.34 16.6 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.629 0.728 . . . . 60.039999999999999 111.072 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' PRO . . . . . 0.595 ' HG2' HG23 ' A' ' 198' ' ' VAL . 53.8 Cg_endo -69.77 179.78 3.47 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.66 2.24 . . . . 75.329999999999998 112.352 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 64.3 t -150.29 144.11 17.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.236 -0.438 . . . . 73.329999999999998 111.108 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 86.8 t -132.55 135.74 57.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.136 -0.484 . . . . 73.150000000000006 111.156 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 82.6 p -115.03 106.7 14.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.452 . . . . 64.319999999999993 110.882 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 59.33 -100.26 0.18 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.746 -0.74 . . . . 74.319999999999993 112.475 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 18.0 p30 -95.09 -7.68 38.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.897 0.379 . . . . 74.0 110.899 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 112.45 13.24 11.97 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.738 -0.744 . . . . 65.430000000000007 112.462 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -52.54 -28.73 21.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.865 0.364 . . . . 74.329999999999998 110.887 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -144.66 132.53 21.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 74.239999999999995 110.85 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -134.26 164.86 26.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 72.340000000000003 111.049 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -135.38 162.98 31.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 73.019999999999996 111.088 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 58.3 t -135.82 121.94 31.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.205 -0.452 . . . . 73.349999999999994 111.114 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' ALA . . . . . 0.542 ' HB2' ' HG3' ' A' ' 168' ' ' PRO . . . -129.4 165.08 22.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 74.109999999999999 111.057 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . 0.504 ' O ' HD13 ' A' ' 241' ' ' ILE . 4.8 pt-20 -146.74 132.7 19.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 53.420000000000002 110.864 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' ILE . . . . . 0.598 HG13 HG11 ' A' ' 216' ' ' VAL . 23.7 mm -126.76 111.92 27.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 63.049999999999997 111.11 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' THR . . . . . 0.463 HG23 ' HG3' ' A' ' 223' ' ' LYS . 2.7 m -79.8 141.22 36.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 52.130000000000003 111.148 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 16.6 t -119.9 120.7 63.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.28 -0.418 . . . . 65.140000000000001 111.113 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' THR . . . . . 0.489 HG23 ' O ' ' A' ' 173' ' ' VAL . 7.2 p -82.36 132.85 35.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.164 -0.471 . . . . 61.140000000000001 111.117 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' ALA . . . . . 0.67 ' HA ' ' HB2' ' A' ' 221' ' ' ALA . . . -57.97 -23.88 55.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 51.420000000000002 111.086 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 80.4 p . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.242 -0.435 . . . . 70.439999999999998 110.875 -179.805 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.836 0.351 . . . . 61.549999999999997 111.142 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 1.1 m -124.81 32.82 5.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.263 -0.426 . . . . 74.25 111.157 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 137.28 98.68 0.5 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.751 -0.738 . . . . 32.039999999999999 112.493 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 3.8 ttp -110.23 130.29 55.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.827 0.346 . . . . 61.039999999999999 110.846 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.572 ' OG1' ' HB3' ' A' ' 184' ' ' ALA . 43.9 p -118.67 104.01 10.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 73.430000000000007 111.118 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 1.114 HG22 HG13 ' A' ' 183' ' ' VAL . 34.7 t -97.86 132.78 41.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.264 -0.425 . . . . 63.310000000000002 111.104 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.6 m -126.76 92.53 44.54 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.571 0.701 . . . . 73.140000000000001 111.179 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.517 ' HG3' ' HB2' ' A' ' 239' ' ' ALA . 53.7 Cg_endo -69.77 -166.13 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.689 2.259 . . . . 71.530000000000001 112.317 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -87.99 -39.22 14.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 54.25 111.079 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 96.1 p 46.46 78.06 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.274 -0.421 . . . . 54.399999999999999 110.844 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.6 t -175.18 -174.81 0.78 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.493 . . . . 74.549999999999997 111.212 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 94.7 p -99.78 163.25 12.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.254 -0.43 . . . . 63.030000000000001 110.841 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.768 HG22 ' HB2' ' A' ' 177' ' ' GLN . 2.8 p -144.41 152.76 15.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.125 -0.489 . . . . 75.519999999999996 111.122 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 32.2 t -85.49 145.04 8.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.179 -0.464 . . . . 64.129999999999995 111.114 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.28 121.98 5.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.18 -0.464 . . . . 74.140000000000001 110.896 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.16 -11.87 62.0 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.701 -0.761 . . . . 54.539999999999999 112.471 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . 0.768 ' HB2' HG22 ' A' ' 173' ' ' VAL . 21.5 mm100 -91.05 -177.39 4.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.78 0.324 . . . . 72.25 110.944 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -159.3 149.99 19.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.262 -0.427 . . . . 52.149999999999999 110.84 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 11.5 t -110.99 179.64 3.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.486 . . . . 72.540000000000006 111.139 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -136.02 126.12 26.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 74.319999999999993 111.185 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.466 HD23 ' HB3' ' A' ' 168' ' ' PRO . 7.7 mp -100.32 149.35 23.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 61.140000000000001 110.88 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 2.4 m -117.54 143.55 45.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.16 -0.473 . . . . 73.439999999999998 111.149 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 1.114 HG13 HG22 ' A' ' 166' ' ' VAL . 22.0 t -129.56 140.95 47.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 72.319999999999993 111.079 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.572 ' HB3' ' OG1' ' A' ' 165' ' ' THR . . . -129.04 151.95 49.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.474 . . . . 52.420000000000002 111.088 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -146.65 130.05 16.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 74.200000000000003 110.895 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.24 66.63 75.55 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.612 0.72 . . . . 72.109999999999999 110.946 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--N 1.341 0.169 0 C-N-CA 122.722 2.281 . . . . 64.0 112.307 -179.988 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 18.3 t70 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.899 0.381 . . . . 73.329999999999998 110.893 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.27 91.68 3.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.179 -0.464 . . . . 54.509999999999998 110.907 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.82 -6.48 21.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 74.239999999999995 110.838 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.77 ' CE2' HG11 ' A' ' 183' ' ' VAL . 26.9 p90 -90.74 179.32 5.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.469 . . . . 71.540000000000006 110.897 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 2.2 ptt180 -166.45 174.48 8.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 72.099999999999994 110.867 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . 0.525 ' HB3' ' HB ' ' A' ' 209' ' ' VAL . . . -119.45 154.77 33.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.458 . . . . 44.219999999999999 111.118 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.4 ' O ' HG23 ' A' ' 226' ' ' ILE . 12.7 t -144.85 154.8 14.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.234 -0.439 . . . . 33.409999999999997 111.082 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.95 115.97 28.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.145 -0.48 . . . . 71.310000000000002 110.857 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.459 ' HB2' ' HD3' ' A' ' 227' ' ' PRO . . . -59.73 -22.14 61.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 51.310000000000002 111.133 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -161.16 92.17 0.9 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.221 -0.445 . . . . 65.219999999999999 110.895 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 5.8 tttp -85.07 54.39 3.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 62.030000000000001 110.888 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 19.1 p -129.51 1.28 5.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 71.049999999999997 111.16 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 9.0 mtmt -155.53 18.28 0.4 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 63.119999999999997 110.924 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.624 ' HA ' HG23 ' A' ' 219' ' ' VAL . . . -179.9 148.39 0.31 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 70.200000000000003 111.104 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 5.9 p -104.71 154.15 20.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 71.209999999999994 111.13 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.655 HG12 HG22 ' A' ' 216' ' ' VAL . 17.1 m -140.8 134.31 32.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.464 . . . . 74.329999999999998 111.114 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . 0.492 ' C ' HG23 ' A' ' 214' ' ' ILE . 10.7 m -145.3 109.09 4.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 75.239999999999995 110.867 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.628 HG23 HG13 ' A' ' 214' ' ' ILE . 4.3 p -92.69 142.43 13.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 62.229999999999997 111.113 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 4.1 t -143.23 98.9 3.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.134 -0.485 . . . . 72.25 110.866 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 69.89 -81.9 0.32 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.714 -0.755 . . . . 53.130000000000003 112.489 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 1.1 mtp -139.0 9.55 2.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.851 0.358 . . . . 61.409999999999997 110.853 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 7.3 m -130.21 123.25 29.76 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.243 -0.435 . . . . 51.240000000000002 111.17 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.628 HG13 HG23 ' A' ' 209' ' ' VAL . 2.2 mp -115.26 141.19 33.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.221 -0.445 . . . . 70.340000000000003 111.17 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.41 125.4 51.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.237 -0.438 . . . . 64.129999999999995 111.139 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.655 HG22 HG12 ' A' ' 207' ' ' VAL . 2.6 t -115.33 130.77 69.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 50.140000000000001 111.085 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -116.95 138.42 51.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 73.230000000000004 110.926 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -95.21 79.72 0.85 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.768 -0.729 . . . . 71.319999999999993 112.509 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.624 HG23 ' HA ' ' A' ' 205' ' ' ALA . 16.3 t -50.82 -53.46 13.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.792 0.33 . . . . 74.129999999999995 111.129 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -130.81 162.48 29.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.447 . . . . 72.200000000000003 111.073 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . 0.672 ' HB2' ' HA ' ' A' ' 245' ' ' ALA . . . -60.92 140.45 57.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 72.120000000000005 111.12 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 142.34 171.25 13.06 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.79 -0.719 . . . . 74.349999999999994 112.528 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . 0.558 ' HG3' HG23 ' A' ' 242' ' ' THR . 5.5 mttp -103.74 121.85 43.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.85 0.357 . . . . 54.530000000000001 110.864 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.475 HG11 ' CB ' ' A' ' 205' ' ' ALA . 7.2 p -120.36 126.04 74.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 75.510000000000005 111.179 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . 0.619 ' C ' HD12 ' A' ' 226' ' ' ILE . 35.3 m120 -90.8 153.33 20.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 72.019999999999996 110.871 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.619 HD12 ' C ' ' A' ' 225' ' ' ASN . 4.1 mp -137.21 93.08 13.33 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.608 0.718 . . . . 74.340000000000003 111.132 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' PRO . . . . . 0.459 ' HD3' ' HB2' ' A' ' 200' ' ' ALA . 54.1 Cg_endo -69.73 -178.37 2.3 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.66 2.24 . . . . 71.530000000000001 112.37 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.63 ' CG2' ' HB3' ' A' ' 237' ' ' ALA . 47.0 t -147.37 139.62 18.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 72.140000000000001 111.111 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 99.8 t -120.53 135.19 61.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 74.319999999999993 111.152 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -121.46 122.51 39.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 74.439999999999998 110.878 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 56.14 -119.87 16.69 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.757 -0.735 . . . . 72.25 112.485 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -92.36 14.09 17.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.818 0.342 . . . . 70.099999999999994 110.878 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 108.17 8.6 29.1 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.705 -0.759 . . . . 52.450000000000003 112.471 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -51.97 -65.76 0.5 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.887 0.375 . . . . 74.420000000000002 110.939 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -100.54 158.98 15.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 74.120000000000005 110.904 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -157.73 160.52 37.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.165 -0.471 . . . . 64.129999999999995 111.108 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . 0.63 ' HB3' ' CG2' ' A' ' 228' ' ' VAL . . . -136.97 163.61 30.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 71.5 111.102 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 57.7 t -137.34 130.39 43.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 63.140000000000001 111.17 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' ALA . . . . . 0.517 ' HB2' ' HG3' ' A' ' 168' ' ' PRO . . . -137.54 163.33 31.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 73.109999999999999 111.09 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . 0.464 ' O ' HD13 ' A' ' 241' ' ' ILE . 5.6 pt-20 -147.35 130.37 16.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.203 -0.453 . . . . 72.450000000000003 110.903 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' ILE . . . . . 0.574 HG13 HG11 ' A' ' 216' ' ' VAL . 26.5 mm -124.4 112.18 31.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.13 -0.486 . . . . 64.209999999999994 111.106 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' THR . . . . . 0.558 HG23 ' HG3' ' A' ' 223' ' ' LYS . 1.9 m -80.66 141.51 34.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.164 -0.471 . . . . 75.299999999999997 111.151 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 15.9 t -119.98 121.84 66.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 64.299999999999997 111.134 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' THR . . . . . 0.469 HG23 ' O ' ' A' ' 173' ' ' VAL . 6.8 p -83.04 132.95 35.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 34.399999999999999 111.154 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' ALA . . . . . 0.672 ' HA ' ' HB2' ' A' ' 221' ' ' ALA . . . -57.11 -23.82 49.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.23 -0.441 . . . . 73.510000000000005 111.089 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 4.4 t . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.26 -0.427 . . . . 60.200000000000003 110.837 -179.79 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.824 0.345 . . . . 62.210000000000001 111.161 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -125.56 33.74 5.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.276 -0.42 . . . . 52.030000000000001 111.176 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 134.66 99.63 0.63 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.724 -0.75 . . . . 74.030000000000001 112.481 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 11.6 ttp -114.76 133.08 56.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.861 0.363 . . . . 70.239999999999995 110.918 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.662 HG23 HE22 ' A' ' 186' ' ' GLN . 28.2 p -122.26 110.88 16.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 72.129999999999995 111.124 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 1.13 HG22 HG13 ' A' ' 183' ' ' VAL . 21.5 t -100.88 134.99 39.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 60.140000000000001 111.156 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.3 m -124.98 91.77 48.78 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.56 0.695 . . . . 74.349999999999994 111.136 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.476 ' HB3' HD23 ' A' ' 181' ' ' LEU . 53.9 Cg_endo -69.73 -165.16 0.14 Allowed 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.696 2.264 . . . . 73.450000000000003 112.336 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -91.14 -38.13 12.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.452 . . . . 65.329999999999998 111.079 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 90.5 p 46.85 77.31 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 55.450000000000003 110.88 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.2 t -174.32 -174.34 0.86 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.101 -0.499 . . . . 63.439999999999998 111.12 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 90.4 p -100.33 161.75 13.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 73.120000000000005 110.866 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.755 HG22 ' HB2' ' A' ' 177' ' ' GLN . 2.9 p -142.39 153.05 17.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.131 -0.486 . . . . 73.310000000000002 111.103 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 32.3 t -85.53 145.08 8.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 74.409999999999997 111.142 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.72 122.17 6.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.47 . . . . 73.040000000000006 110.897 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.12 -10.92 62.01 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.753 -0.737 . . . . 74.430000000000007 112.49 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . 0.755 ' HB2' HG22 ' A' ' 173' ' ' VAL . 20.3 mm100 -91.83 -177.31 4.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.836 0.35 . . . . 74.120000000000005 110.911 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.52 152.36 19.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 73.019999999999996 110.89 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 13.2 t -115.66 179.13 4.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.454 . . . . 74.310000000000002 111.124 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.05 126.16 27.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 51.140000000000001 111.131 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.476 HD23 ' HB3' ' A' ' 168' ' ' PRO . 7.4 mp -100.28 142.77 31.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 71.230000000000004 110.916 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 14.1 m -108.74 143.81 37.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 65.530000000000001 111.196 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 1.13 HG13 HG22 ' A' ' 166' ' ' VAL . 21.0 t -129.65 141.22 47.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 63.439999999999998 111.071 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -130.04 149.55 51.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 72.230000000000004 111.119 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -139.79 130.6 26.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 73.099999999999994 110.863 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' GLN . . . . . 0.662 HE22 HG23 ' A' ' 165' ' ' THR . 0.0 OUTLIER -130.73 67.0 80.03 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.564 0.697 . . . . 71.420000000000002 110.864 -179.919 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--N 1.341 0.177 0 C-N-CA 122.696 2.264 . . . . 72.030000000000001 112.332 179.966 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 7.9 t70 . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.853 0.359 . . . . 74.310000000000002 110.876 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 11.7 mtpt -61.4 95.91 0.05 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 75.030000000000001 110.875 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.35 -6.99 17.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.216 -0.447 . . . . 32.32 110.828 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.769 ' CE2' HG11 ' A' ' 183' ' ' VAL . 21.8 p90 -91.04 178.46 6.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 72.340000000000003 110.882 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.9 171.47 12.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.121 -0.491 . . . . 72.329999999999998 110.854 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . 0.64 ' HB3' ' HB ' ' A' ' 209' ' ' VAL . . . -122.89 163.42 20.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 72.319999999999993 111.106 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.533 ' O ' HG23 ' A' ' 226' ' ' ILE . 5.8 m -153.1 -178.27 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 64.209999999999994 111.127 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.65 114.88 24.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 72.140000000000001 110.884 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.435 ' HB2' ' HD3' ' A' ' 227' ' ' PRO . . . -59.79 -20.86 59.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 71.230000000000004 111.083 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -162.24 96.73 0.99 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 54.149999999999999 110.85 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -87.95 47.85 1.56 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.485 . . . . 70.219999999999999 110.902 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 12.4 p -125.59 -4.35 7.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 74.099999999999994 111.09 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 9.0 mtmm -149.82 16.08 0.86 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.436 . . . . 73.540000000000006 110.902 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.628 ' HA ' HG23 ' A' ' 219' ' ' VAL . . . -179.67 151.24 0.44 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.448 . . . . 73.540000000000006 111.078 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 7.2 p -112.29 152.59 28.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.215 -0.448 . . . . 75.329999999999998 111.157 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.786 HG12 HG22 ' A' ' 216' ' ' VAL . 12.9 m -141.02 137.72 34.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.265 -0.425 . . . . 74.5 111.114 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.54 109.35 4.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 75.340000000000003 110.879 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.64 ' HB ' ' HB3' ' A' ' 197' ' ' ALA . 3.5 p -87.93 134.7 27.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 72.049999999999997 111.157 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 2.9 m -161.53 124.08 3.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 63.100000000000001 110.83 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 55.34 47.74 73.6 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.74 -0.743 . . . . 71.109999999999999 112.48 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 3.4 mtp 63.24 16.1 9.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.851 0.358 . . . . 74.129999999999995 110.85 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 15.9 m -126.93 110.64 13.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 75.420000000000002 111.167 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.545 HG13 HG23 ' A' ' 209' ' ' VAL . 3.1 mp -105.7 117.35 51.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 64.5 111.126 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.26 127.02 36.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 74.329999999999998 111.107 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.786 HG22 HG12 ' A' ' 207' ' ' VAL . 2.8 t -113.0 131.53 64.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 74.109999999999999 111.107 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -117.25 136.62 52.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 72.329999999999998 110.905 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -94.15 79.22 0.97 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.777 -0.725 . . . . 22.129999999999999 112.46 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.628 HG23 ' HA ' ' A' ' 205' ' ' ALA . 18.5 t -50.98 -52.25 18.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.871 0.367 . . . . 71.040000000000006 111.144 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -131.97 161.42 33.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 64.230000000000004 111.116 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . 0.68 ' HB2' ' HA ' ' A' ' 245' ' ' ALA . . . -59.96 139.12 57.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 64.340000000000003 111.122 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 142.44 170.45 12.7 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.746 -0.74 . . . . 74.230000000000004 112.522 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . 0.478 ' HG3' HG23 ' A' ' 242' ' ' THR . 13.4 mttt -99.36 123.5 43.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.819 0.343 . . . . 75.120000000000005 110.852 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 6.7 p -118.96 124.72 73.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 63.130000000000003 111.093 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . 0.612 ' C ' HD12 ' A' ' 226' ' ' ILE . 16.8 m120 -90.78 152.83 20.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.152 -0.476 . . . . 73.019999999999996 110.87 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.612 HD12 ' C ' ' A' ' 225' ' ' ASN . 4.3 mp -137.77 93.17 12.41 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.594 0.712 . . . . 72.319999999999993 111.136 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' PRO . . . . . 0.465 ' HG2' HG23 ' A' ' 198' ' ' VAL . 53.3 Cg_endo -69.81 179.74 3.51 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.676 2.251 . . . . 64.129999999999995 112.336 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.428 ' HB ' ' HB3' ' A' ' 237' ' ' ALA . 90.3 t -150.23 136.31 11.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 60.149999999999999 111.128 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 91.3 t -117.67 134.71 60.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 71.239999999999995 111.167 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -120.94 127.57 51.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 73.430000000000007 110.893 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 58.85 -117.81 12.05 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.723 -0.751 . . . . 54.130000000000003 112.496 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -108.62 21.04 17.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.878 0.37 . . . . 71.439999999999998 110.862 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 113.4 3.69 23.97 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.759 -0.734 . . . . 61.020000000000003 112.485 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -54.12 -64.39 0.84 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.907 0.384 . . . . 74.120000000000005 110.881 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -111.42 156.74 21.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 75.319999999999993 110.831 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -156.57 164.54 38.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.095 -0.502 . . . . 65.040000000000006 111.131 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . 0.428 ' HB3' ' HB ' ' A' ' 228' ' ' VAL . . . -143.2 163.29 33.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.269 -0.423 . . . . 54.219999999999999 111.113 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 13.5 p -140.49 138.72 36.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 64.140000000000001 111.154 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' ALA . . . . . 0.428 ' HB2' ' HG3' ' A' ' 168' ' ' PRO . . . -136.95 165.33 26.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 74.209999999999994 111.09 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . 0.496 ' O ' HD13 ' A' ' 241' ' ' ILE . 3.3 pt-20 -141.88 131.17 23.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.23 -0.441 . . . . 71.140000000000001 110.876 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' ILE . . . . . 0.573 HG13 HG11 ' A' ' 216' ' ' VAL . 25.9 mm -127.32 110.63 23.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.123 -0.49 . . . . 64.400000000000006 111.147 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' THR . . . . . 0.478 HG23 ' HG3' ' A' ' 223' ' ' LYS . 1.8 m -80.13 141.33 35.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.206 -0.452 . . . . 65.319999999999993 111.158 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 17.1 t -119.91 121.92 67.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 74.319999999999993 111.124 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' THR . . . . . 0.466 HG23 ' O ' ' A' ' 173' ' ' VAL . 7.3 p -83.36 132.86 34.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 73.349999999999994 111.136 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' ALA . . . . . 0.68 ' HA ' ' HB2' ' A' ' 221' ' ' ALA . . . -57.46 -24.46 55.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 61.530000000000001 111.106 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 5.2 m . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 44.149999999999999 110.836 -179.837 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.437 ' HB1' ' HB3' ' A' ' 187' ' ' PRO . . . . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.885 0.374 . . . . 53.340000000000003 111.077 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -131.91 18.53 4.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.184 -0.462 . . . . 53.049999999999997 111.074 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 166.8 97.91 0.12 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.746 -0.74 . . . . 51.539999999999999 112.466 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 41.7 ttp -111.98 129.96 56.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.815 0.341 . . . . 54.119999999999997 110.886 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.592 ' OG1' ' HB3' ' A' ' 184' ' ' ALA . 46.6 p -118.82 103.03 9.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.249 -0.432 . . . . 73.400000000000006 111.141 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 1.084 HG22 HG13 ' A' ' 183' ' ' VAL . 22.8 t -97.82 132.72 42.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.208 -0.451 . . . . 74.230000000000004 111.107 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.2 m -125.11 92.9 46.58 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 121.598 0.713 . . . . 54.409999999999997 111.119 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.474 ' HB3' HD23 ' A' ' 181' ' ' LEU . 54.1 Cg_endo -69.72 -168.62 0.28 Allowed 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.685 2.257 . . . . 71.510000000000005 112.377 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -86.99 -39.82 15.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 74.040000000000006 111.062 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 95.3 p 46.43 78.5 0.07 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 70.349999999999994 110.847 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.1 t -173.86 -174.79 0.98 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.088 -0.505 . . . . 74.409999999999997 111.141 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 27.3 p -99.34 163.56 12.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.445 . . . . 55.310000000000002 110.875 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.723 HG22 ' HB2' ' A' ' 177' ' ' GLN . 3.1 p -146.38 154.32 12.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.115 -0.493 . . . . 73.530000000000001 111.135 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 57.6 t -88.39 145.43 7.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.48 . . . . 71.219999999999999 111.153 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -48.93 122.67 6.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 32.0 110.887 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.72 -14.2 60.55 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.733 -0.746 . . . . 44.130000000000003 112.463 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . 0.723 ' HB2' HG22 ' A' ' 173' ' ' VAL . 12.2 mm100 -91.16 -177.88 5.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.836 0.35 . . . . 71.109999999999999 110.93 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 20.4 p -161.43 149.51 15.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 73.219999999999999 110.829 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 7.5 t -108.52 -173.87 2.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.113 -0.494 . . . . 64.310000000000002 111.188 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.01 131.23 26.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.45 . . . . 65.530000000000001 111.195 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.474 HD23 ' HB3' ' A' ' 168' ' ' PRO . 7.5 mp -104.87 144.25 32.04 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.244 -0.435 . . . . 72.230000000000004 110.946 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 31.3 m -111.46 144.92 39.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 73.230000000000004 111.15 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 1.084 HG13 HG22 ' A' ' 166' ' ' VAL . 21.3 t -129.32 140.07 50.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 73.409999999999997 111.112 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.592 ' HB3' ' OG1' ' A' ' 165' ' ' THR . . . -129.6 154.95 46.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.466 . . . . 73.439999999999998 111.048 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -145.28 133.8 22.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 74.120000000000005 110.879 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.83 66.33 26.28 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.596 0.712 . . . . 74.400000000000006 110.907 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.437 ' HB3' ' HB1' ' A' ' 161' ' ' ALA . 53.7 Cg_endo . . . . . 0 C--N 1.341 0.172 0 C-N-CA 122.679 2.253 . . . . 65.519999999999996 112.388 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.886 0.374 . . . . 75.25 110.854 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 1.9 ttpp -79.62 61.67 3.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 53.310000000000002 110.866 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 1.7 t -73.08 -7.93 53.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 61.119999999999997 110.843 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.777 ' CE2' HG11 ' A' ' 183' ' ' VAL . 14.4 p90 -91.49 163.43 14.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 75.540000000000006 110.922 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.27 172.21 18.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.471 . . . . 73.420000000000002 110.867 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . 0.431 ' HB3' ' HB ' ' A' ' 209' ' ' VAL . . . -117.18 168.11 10.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 61.439999999999998 111.088 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 10.6 p -173.12 152.04 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.443 . . . . 75.049999999999997 111.126 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.3 t -78.27 151.51 32.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 74.200000000000003 110.849 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.607 ' HB2' ' HD3' ' A' ' 227' ' ' PRO . . . -88.43 -23.89 23.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 63.119999999999997 111.146 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.77 -53.51 1.23 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 75.230000000000004 110.841 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.28 28.48 15.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 65.439999999999998 110.919 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 71.9 p -114.65 -3.17 12.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 75.420000000000002 111.134 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 7.6 mtmt -152.05 18.52 0.67 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 60.119999999999997 110.888 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.667 ' HA ' HG23 ' A' ' 219' ' ' VAL . . . -177.11 146.84 0.52 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 60.450000000000003 111.052 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 18.8 p -106.93 157.47 17.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 73.540000000000006 111.158 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.784 HG12 HG22 ' A' ' 216' ' ' VAL . 9.8 m -140.9 141.08 32.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.184 -0.462 . . . . 54.530000000000001 111.108 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -148.6 108.81 4.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 45.340000000000003 110.881 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.544 HG23 HG13 ' A' ' 214' ' ' ILE . 3.8 p -87.36 143.42 11.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.491 . . . . 64.010000000000005 111.158 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -171.83 123.27 0.52 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 74.140000000000001 110.855 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 55.76 47.4 78.68 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.773 -0.727 . . . . 51.340000000000003 112.471 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 1.7 mtp 63.5 15.83 9.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.867 0.365 . . . . 70.140000000000001 110.869 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 1.1 m -126.51 113.72 17.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.434 . . . . 72.230000000000004 111.178 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.544 HG13 HG23 ' A' ' 209' ' ' VAL . 3.2 mp -110.16 115.48 49.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.241 -0.436 . . . . 61.310000000000002 111.145 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 3.8 m -88.3 131.05 34.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.459 . . . . 55.439999999999998 111.116 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.784 HG22 HG12 ' A' ' 207' ' ' VAL . 2.8 t -116.88 124.56 73.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 73.439999999999998 111.136 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -107.9 137.92 45.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 64.310000000000002 110.922 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -93.22 80.74 1.06 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.767 -0.73 . . . . 74.219999999999999 112.445 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.667 HG23 ' HA ' ' A' ' 205' ' ' ALA . 19.7 t -50.49 -54.83 7.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.882 0.372 . . . . 70.439999999999998 111.116 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -130.01 162.88 27.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 71.299999999999997 111.09 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . 0.68 ' HB2' ' HA ' ' A' ' 245' ' ' ALA . . . -62.09 140.19 58.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 62.420000000000002 111.068 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 140.1 171.2 12.28 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.676 -0.773 . . . . 73.150000000000006 112.473 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . 0.424 ' HG3' HG23 ' A' ' 242' ' ' THR . 14.0 mttt -99.5 124.24 44.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.826 0.346 . . . . 64.5 110.871 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.529 HG11 ' CB ' ' A' ' 205' ' ' ALA . 7.0 p -121.02 127.08 75.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 71.549999999999997 111.149 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . 0.637 ' C ' HD12 ' A' ' 226' ' ' ILE . 33.2 m120 -90.88 151.72 21.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 75.099999999999994 110.851 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.637 HD12 ' C ' ' A' ' 225' ' ' ASN . 4.0 mp -136.52 93.27 14.46 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.618 0.723 . . . . 73.549999999999997 111.156 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' PRO . . . . . 0.607 ' HD3' ' HB2' ' A' ' 200' ' ' ALA . 54.2 Cg_endo -69.75 179.89 3.38 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.689 2.259 . . . . 73.349999999999994 112.325 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.422 ' HB ' ' HB3' ' A' ' 237' ' ' ALA . 97.2 t -150.31 141.41 16.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 72.439999999999998 111.201 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 46.5 t -124.51 138.31 54.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 73.219999999999999 111.144 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 1.7 t -122.18 108.76 13.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 61.219999999999999 110.88 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 69.27 -119.35 9.37 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.732 -0.747 . . . . 75.400000000000006 112.505 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -104.56 21.14 17.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.807 0.336 . . . . 73.540000000000006 110.866 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 112.35 5.63 24.49 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.741 -0.742 . . . . 22.050000000000001 112.521 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -51.28 -44.03 61.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.867 0.365 . . . . 74.420000000000002 110.863 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -138.56 167.04 22.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 72.329999999999998 110.886 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -163.53 164.72 24.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 72.230000000000004 111.122 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . 0.422 ' HB3' ' HB ' ' A' ' 228' ' ' VAL . . . -143.84 163.18 34.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.436 . . . . 71.049999999999997 111.145 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 10.5 p -137.94 136.69 45.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 75.019999999999996 111.115 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' ALA . . . . . 0.427 ' HB2' ' HG3' ' A' ' 168' ' ' PRO . . . -139.16 165.17 27.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 63.450000000000003 111.102 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . 0.526 ' O ' HD13 ' A' ' 241' ' ' ILE . 4.3 pt-20 -143.87 132.13 21.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 73.420000000000002 110.898 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' ILE . . . . . 0.586 HG13 HG11 ' A' ' 216' ' ' VAL . 24.7 mm -127.2 113.93 34.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.205 -0.452 . . . . 74.209999999999994 111.145 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' THR . . . . . 0.424 HG23 ' HG3' ' A' ' 223' ' ' LYS . 2.8 m -82.81 141.23 32.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 54.450000000000003 111.146 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 17.0 t -120.06 120.95 64.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 75.230000000000004 111.173 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' THR . . . . . 0.516 HG23 ' O ' ' A' ' 173' ' ' VAL . 5.4 p -82.33 132.79 35.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 63.509999999999998 111.118 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' ALA . . . . . 0.68 ' HA ' ' HB2' ' A' ' 221' ' ' ALA . . . -57.41 -23.42 49.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 70.150000000000006 111.095 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 2.1 t . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 73.219999999999999 110.859 -179.769 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.175 0 CA-C-O 120.896 0.379 . . . . 74.140000000000001 111.082 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -131.68 27.09 4.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.236 -0.438 . . . . 72.530000000000001 111.106 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 145.92 101.93 0.32 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.778 -0.725 . . . . 62.229999999999997 112.484 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 42.9 ttp -114.49 126.16 54.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.863 0.364 . . . . 73.200000000000003 110.829 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.574 ' OG1' ' HB3' ' A' ' 184' ' ' ALA . 43.4 p -115.65 105.69 13.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 74.409999999999997 111.154 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 1.033 HG22 HG13 ' A' ' 183' ' ' VAL . 21.5 t -101.52 130.76 50.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 64.519999999999996 111.102 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.3 m -123.82 92.42 48.54 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.549 0.69 . . . . 73.230000000000004 111.121 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.48 ' HB3' HD23 ' A' ' 181' ' ' LEU . 53.9 Cg_endo -69.78 -167.2 0.21 Allowed 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.66 2.24 . . . . 75.030000000000001 112.361 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -90.2 -40.85 11.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 62.549999999999997 111.126 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 93.0 p 46.74 79.6 0.06 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 74.030000000000001 110.839 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.5 t -175.33 -175.63 0.84 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 65.209999999999994 111.137 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 41.7 p -98.75 163.63 12.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 64.439999999999998 110.831 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.732 HG22 ' HB2' ' A' ' 177' ' ' GLN . 3.0 p -145.6 153.57 13.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.124 -0.489 . . . . 61.439999999999998 111.107 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 99.1 t -87.24 144.71 8.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 64.540000000000006 111.134 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -47.95 122.57 5.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.216 -0.447 . . . . 75.310000000000002 110.891 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.75 -13.5 60.86 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.759 -0.734 . . . . 74.519999999999996 112.473 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . 0.732 ' HB2' HG22 ' A' ' 173' ' ' VAL . 11.0 mm100 -93.38 -179.58 5.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.776 0.322 . . . . 63.399999999999999 110.913 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 57.4 p -162.09 148.09 13.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 70.049999999999997 110.849 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.416 HG21 HD12 ' A' ' 241' ' ' ILE . 6.9 t -105.26 -173.72 2.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.136 -0.484 . . . . 74.329999999999998 111.158 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -140.11 130.53 25.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 54.509999999999998 111.165 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.48 HD23 ' HB3' ' A' ' 168' ' ' PRO . 7.6 mp -103.53 142.39 34.36 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.245 -0.434 . . . . 74.540000000000006 110.93 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 10.9 m -109.46 142.72 40.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.262 -0.426 . . . . 65.510000000000005 111.166 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 1.033 HG13 HG22 ' A' ' 166' ' ' VAL . 21.9 t -129.45 141.53 46.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.231 -0.44 . . . . 65.540000000000006 111.154 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.574 ' HB3' ' OG1' ' A' ' 165' ' ' THR . . . -132.28 151.86 51.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.463 . . . . 60.420000000000002 111.132 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -145.33 126.73 14.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.275 -0.42 . . . . 72.120000000000005 110.882 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.97 66.69 79.65 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.57 0.7 . . . . 71.150000000000006 110.889 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--N 1.341 0.138 0 C-N-CA 122.668 2.245 . . . . 54.149999999999999 112.328 -179.993 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.903 0.382 . . . . 54.030000000000001 110.838 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -65.63 90.08 0.11 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 70.109999999999999 110.897 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 47.3 t -105.4 -6.66 19.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.254 -0.43 . . . . 70.540000000000006 110.848 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.772 ' CE2' HG11 ' A' ' 183' ' ' VAL . 17.1 p90 -90.82 177.68 6.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 61.219999999999999 110.878 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.44 175.29 9.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 75.430000000000007 110.908 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . 0.408 ' HB3' ' HB ' ' A' ' 209' ' ' VAL . . . -122.57 168.08 12.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 73.109999999999999 111.102 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 8.7 p -173.61 153.61 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.214 -0.448 . . . . 54.030000000000001 111.121 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.66 133.42 33.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 73.439999999999998 110.908 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.664 ' HB2' ' HD3' ' A' ' 227' ' ' PRO . . . -69.26 -21.11 63.92 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.154 -0.476 . . . . 74.150000000000006 111.074 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . 0.607 ' O ' HG23 ' A' ' 203' ' ' THR . 0.6 OUTLIER -132.61 -46.15 0.89 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 71.129999999999995 110.858 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.11 27.45 7.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 74.230000000000004 110.93 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.607 HG23 ' O ' ' A' ' 201' ' ' ASP . 53.3 p -112.13 -13.66 13.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 73.510000000000005 111.155 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . 0.489 ' HA ' ' HB3' ' A' ' 220' ' ' ALA . 9.1 mtmp? -139.26 24.88 2.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 72.439999999999998 110.87 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.675 ' HA ' HG22 ' A' ' 219' ' ' VAL . . . 179.06 143.3 0.13 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 73.319999999999993 111.137 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 7.8 p -106.99 131.23 54.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.231 -0.441 . . . . 63.25 111.121 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.947 HG12 HG22 ' A' ' 216' ' ' VAL . 5.0 m -118.34 143.33 29.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 63.299999999999997 111.153 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 3.3 m -149.3 108.7 3.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.466 . . . . 50.350000000000001 110.854 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.511 HG23 HG13 ' A' ' 214' ' ' ILE . 4.1 p -83.82 143.97 10.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 62.240000000000002 111.144 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 5.3 t -171.75 122.58 0.51 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 60.210000000000001 110.878 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 54.19 50.41 55.89 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.732 -0.747 . . . . 73.549999999999997 112.464 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 1.8 mtp 61.05 17.41 7.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.834 0.35 . . . . 70.530000000000001 110.831 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 12.7 m -129.44 113.1 14.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.253 -0.43 . . . . 70.340000000000003 111.139 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.511 HG13 HG23 ' A' ' 209' ' ' VAL . 2.9 mp -108.92 114.92 48.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 73.019999999999996 111.102 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 10.2 m -88.0 128.09 35.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 71.209999999999994 111.141 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.947 HG22 HG12 ' A' ' 207' ' ' VAL . 2.8 t -114.46 121.93 67.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.46 . . . . 63.200000000000003 111.109 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -106.0 144.43 32.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 73.019999999999996 110.861 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -96.64 66.26 0.99 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.693 -0.765 . . . . 70.519999999999996 112.478 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.675 HG22 ' HA ' ' A' ' 205' ' ' ALA . 0.1 OUTLIER -50.13 -42.08 19.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.863 0.363 . . . . 71.150000000000006 111.142 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . 0.489 ' HB3' ' HA ' ' A' ' 204' ' ' LYS . . . -125.2 154.04 42.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.454 . . . . 54.32 111.106 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . 0.666 ' HB2' ' HA ' ' A' ' 245' ' ' ALA . . . -73.47 131.89 42.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.232 -0.44 . . . . 54.200000000000003 111.085 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 143.93 177.31 18.72 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.722 -0.752 . . . . 44.240000000000002 112.494 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . 0.53 ' HG3' HG23 ' A' ' 242' ' ' THR . 12.6 mttt -98.89 136.26 39.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.84 0.352 . . . . 65.340000000000003 110.885 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.589 HG11 ' HB3' ' A' ' 205' ' ' ALA . 7.6 p -137.58 133.61 45.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.223 -0.444 . . . . 74.349999999999994 111.125 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . 0.625 ' C ' HD12 ' A' ' 226' ' ' ILE . 36.7 m120 -90.94 154.05 19.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 71.409999999999997 110.885 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.625 HD12 ' C ' ' A' ' 225' ' ' ASN . 4.1 mp -136.83 92.54 14.44 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.58 0.705 . . . . 73.510000000000005 111.162 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' PRO . . . . . 0.664 ' HD3' ' HB2' ' A' ' 200' ' ' ALA . 53.6 Cg_endo -69.79 179.05 3.99 Favored 'Trans proline' 0 C--O 1.231 0.141 0 C-N-CA 122.671 2.248 . . . . 73.540000000000006 112.353 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 57.9 t -149.26 137.19 14.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.252 -0.431 . . . . 62.32 111.165 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 98.6 t -117.55 138.65 47.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 73.439999999999998 111.124 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -121.66 106.96 11.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 63.420000000000002 110.87 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 56.93 -115.04 5.95 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.722 -0.751 . . . . 60.420000000000002 112.486 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -94.56 21.08 7.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.848 0.356 . . . . 74.420000000000002 110.853 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 97.49 9.19 55.44 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.756 -0.735 . . . . 63.100000000000001 112.485 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -51.94 -30.52 24.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.896 0.379 . . . . 64.040000000000006 110.871 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -145.59 163.41 34.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.153 -0.476 . . . . 72.219999999999999 110.907 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -161.71 165.26 28.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 73.219999999999999 111.078 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -143.86 163.24 33.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 75.510000000000005 111.13 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 59.2 t -136.52 132.84 48.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.264 -0.425 . . . . 64.310000000000002 111.114 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' ALA . . . . . 0.44 ' HB2' ' HG3' ' A' ' 168' ' ' PRO . . . -138.71 165.39 27.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 40.329999999999998 111.074 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . 0.472 ' O ' HD13 ' A' ' 241' ' ' ILE . 2.9 pt-20 -144.52 131.76 20.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 71.239999999999995 110.856 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' ILE . . . . . 0.628 HG13 HG11 ' A' ' 216' ' ' VAL . 34.8 mm -127.25 114.95 38.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.123 -0.49 . . . . 71.299999999999997 111.123 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' THR . . . . . 0.53 HG23 ' HG3' ' A' ' 223' ' ' LYS . 3.0 m -86.42 140.7 29.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.13 -0.487 . . . . 73.510000000000005 111.157 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 19.8 t -120.5 120.04 61.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 73.510000000000005 111.145 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' THR . . . . . 0.495 HG23 ' O ' ' A' ' 173' ' ' VAL . 6.4 p -81.56 132.96 35.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 61.210000000000001 111.203 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' ALA . . . . . 0.666 ' HA ' ' HB2' ' A' ' 221' ' ' ALA . . . -57.46 -26.67 61.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.281 -0.418 . . . . 74.540000000000006 111.138 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 15.1 m . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 73.430000000000007 110.893 -179.814 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.888 0.375 . . . . 72.019999999999996 111.096 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -130.08 27.2 5.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 73.439999999999998 111.148 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 146.66 100.68 0.27 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.727 -0.749 . . . . 41.520000000000003 112.446 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 45.9 ttp -111.32 130.54 55.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.807 0.337 . . . . 54.32 110.919 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.612 ' OG1' ' HB3' ' A' ' 184' ' ' ALA . 50.1 p -119.65 102.4 8.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.251 -0.431 . . . . 70.049999999999997 111.131 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 1.022 HG22 HG13 ' A' ' 183' ' ' VAL . 21.1 t -97.82 133.14 40.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 74.420000000000002 111.119 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.1 m -126.11 92.22 46.28 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.57 0.7 . . . . 43.32 111.173 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.478 ' HB3' HD23 ' A' ' 181' ' ' LEU . 53.1 Cg_endo -69.8 -166.14 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.698 2.265 . . . . 52.530000000000001 112.335 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -89.03 -42.64 11.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 44.149999999999999 111.117 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 22.9 t 49.29 79.14 0.08 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.241 -0.436 . . . . 73.299999999999997 110.899 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.5 t -175.44 -175.54 0.81 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 71.329999999999998 111.146 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 38.1 p -98.8 163.88 12.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 62.43 110.849 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.778 HG22 ' HB2' ' A' ' 177' ' ' GLN . 2.6 p -145.81 152.56 14.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 62.009999999999998 111.158 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 38.8 t -85.76 145.28 8.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 71.200000000000003 111.12 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.24 122.09 5.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 72.420000000000002 110.881 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.18 -11.18 61.95 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.745 -0.741 . . . . 74.310000000000002 112.448 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . 0.778 ' HB2' HG22 ' A' ' 173' ' ' VAL . 20.9 mm100 -91.37 -177.21 4.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.826 0.346 . . . . 72.450000000000003 110.883 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -160.56 149.31 16.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 51.340000000000003 110.858 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 7.7 t -111.3 -177.27 3.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.124 -0.489 . . . . 61.219999999999999 111.12 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -138.07 133.62 33.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.211 -0.45 . . . . 53.32 111.176 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.478 HD23 ' HB3' ' A' ' 168' ' ' PRO . 7.8 mp -107.7 146.4 32.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.233 -0.44 . . . . 74.099999999999994 110.918 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 2.1 m -113.94 143.53 44.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.459 . . . . 61.020000000000003 111.119 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 1.022 HG13 HG22 ' A' ' 166' ' ' VAL . 21.3 t -129.33 138.18 55.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 70.230000000000004 111.163 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.612 ' HB3' ' OG1' ' A' ' 165' ' ' THR . . . -126.22 151.38 47.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 74.329999999999998 111.087 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -144.9 131.76 20.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.221 -0.445 . . . . 70.540000000000006 110.907 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.9 66.38 47.53 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.605 0.717 . . . . 70.299999999999997 110.952 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo . . . . . 0 C--N 1.342 0.186 0 C-N-CA 122.653 2.235 . . . . 43.109999999999999 112.355 -179.991 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 37.5 t0 . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.881 0.372 . . . . 63.219999999999999 110.867 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.72 87.1 6.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 54.119999999999997 110.898 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 14.4 m -102.3 -5.43 24.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 72.450000000000003 110.88 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.79 ' CE2' HG11 ' A' ' 183' ' ' VAL . 29.0 p90 -89.78 172.89 8.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 70.25 110.854 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.82 171.44 16.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.104 -0.498 . . . . 75.209999999999994 110.848 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . 0.468 ' HB3' ' HB ' ' A' ' 209' ' ' VAL . . . -114.86 168.04 10.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 60.210000000000001 111.089 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 9.6 p -159.88 152.85 5.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.25 -0.432 . . . . 73.510000000000005 111.12 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.77 119.0 28.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 74.209999999999994 110.844 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.565 ' HB2' ' HD3' ' A' ' 227' ' ' PRO . . . -62.89 -18.62 63.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 71.230000000000004 111.108 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -163.49 89.55 0.61 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 73.439999999999998 110.858 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 9.1 tmtt? -82.63 55.45 2.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.446 . . . . 74.319999999999993 110.907 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 25.9 p -129.44 1.18 5.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 45.32 111.139 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 10.6 mtmt -157.38 19.48 0.29 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 75.519999999999996 110.895 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.635 ' HA ' HG23 ' A' ' 219' ' ' VAL . . . 179.65 148.45 0.27 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 72.510000000000005 111.112 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 9.4 p -105.68 153.94 21.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.194 -0.457 . . . . 73.230000000000004 111.125 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.744 HG12 HG22 ' A' ' 216' ' ' VAL . 18.9 m -140.77 135.14 33.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.448 . . . . 73.340000000000003 111.172 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . 0.438 ' C ' HG23 ' A' ' 214' ' ' ILE . 4.6 m -144.32 109.31 5.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 33.240000000000002 110.8 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.675 HG23 HG13 ' A' ' 214' ' ' ILE . 5.5 p -92.47 144.44 9.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 75.310000000000002 111.168 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 2.7 m -146.56 99.42 3.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 73.519999999999996 110.859 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 70.17 -81.43 0.36 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.745 -0.74 . . . . 61.140000000000001 112.482 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -139.71 9.01 2.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.826 0.346 . . . . 62.329999999999998 110.844 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 56.9 m -128.52 124.42 35.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.242 -0.435 . . . . 41.130000000000003 111.141 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.675 HG13 HG23 ' A' ' 209' ' ' VAL . 2.5 mp -117.87 135.27 58.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 71.140000000000001 111.113 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.21 128.25 51.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.461 . . . . 52.32 111.108 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.744 HG22 HG12 ' A' ' 207' ' ' VAL . 6.8 t -118.05 131.39 70.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.227 -0.442 . . . . 72.549999999999997 111.137 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -116.45 139.22 50.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 62.200000000000003 110.905 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -94.88 78.95 0.88 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.734 -0.745 . . . . 74.049999999999997 112.492 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.635 HG23 ' HA ' ' A' ' 205' ' ' ALA . 17.2 t -49.56 -54.24 7.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.827 0.346 . . . . 75.329999999999998 111.149 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -129.6 162.92 27.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 65.219999999999999 111.105 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . 0.681 ' HB2' ' HA ' ' A' ' 245' ' ' ALA . . . -61.83 138.36 58.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.447 . . . . 72.049999999999997 111.09 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 144.25 170.33 13.57 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.74 -0.743 . . . . 50.509999999999998 112.488 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . 0.567 ' HG3' HG23 ' A' ' 242' ' ' THR . 13.3 mttt -100.19 124.0 45.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.793 0.33 . . . . 73.010000000000005 110.921 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.485 HG11 ' CB ' ' A' ' 205' ' ' ALA . 6.3 p -123.76 122.98 66.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 53.219999999999999 111.091 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . 0.559 ' C ' HD12 ' A' ' 226' ' ' ILE . 21.2 m120 -91.19 156.27 17.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.466 . . . . 61.119999999999997 110.923 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.559 HD12 ' C ' ' A' ' 225' ' ' ASN . 4.7 mp -138.63 92.86 11.27 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.554 0.692 . . . . 65.310000000000002 111.114 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' PRO . . . . . 0.565 ' HD3' ' HB2' ' A' ' 200' ' ' ALA . 53.4 Cg_endo -69.88 -178.93 2.62 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.672 2.248 . . . . 74.420000000000002 112.31 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.484 ' CG2' ' HB3' ' A' ' 237' ' ' ALA . 23.5 t -146.52 149.24 16.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.455 . . . . 65.150000000000006 111.146 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 86.9 t -138.17 138.38 43.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 74.319999999999993 111.082 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -121.98 119.97 33.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 65.150000000000006 110.848 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 58.08 -112.2 3.7 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.714 -0.755 . . . . 44.350000000000001 112.5 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -99.81 7.42 44.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.874 0.368 . . . . 72.530000000000001 110.892 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 114.46 16.09 7.83 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.691 -0.766 . . . . 73.430000000000007 112.495 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -51.13 -38.42 51.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.891 0.377 . . . . 64.010000000000005 110.863 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -143.07 167.04 23.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 64.140000000000001 110.911 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -162.23 165.32 26.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.113 -0.494 . . . . 74.430000000000007 111.1 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . 0.484 ' HB3' ' CG2' ' A' ' 228' ' ' VAL . . . -139.11 163.61 31.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.441 . . . . 64.540000000000006 111.135 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 61.2 t -132.46 127.2 56.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.233 -0.44 . . . . 63.340000000000003 111.095 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' ALA . . . . . 0.468 ' HB2' ' HG3' ' A' ' 168' ' ' PRO . . . -134.38 161.15 35.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.169 -0.469 . . . . 74.400000000000006 111.065 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . 0.604 ' O ' HD13 ' A' ' 241' ' ' ILE . 5.1 pt-20 -145.31 132.68 20.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 74.549999999999997 110.874 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' ILE . . . . . 0.604 HD13 ' O ' ' A' ' 240' ' ' GLU . 28.8 mm -126.95 112.85 30.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 72.299999999999997 111.129 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' THR . . . . . 0.567 HG23 ' HG3' ' A' ' 223' ' ' LYS . 1.9 m -83.06 141.49 32.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 74.109999999999999 111.179 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 14.0 t -119.92 121.6 66.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 73.239999999999995 111.156 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' THR . . . . . 0.408 HG23 ' O ' ' A' ' 173' ' ' VAL . 8.1 p -83.65 132.37 34.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.145 -0.479 . . . . 72.420000000000002 111.14 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' ALA . . . . . 0.681 ' HA ' ' HB2' ' A' ' 221' ' ' ALA . . . -53.72 -27.64 29.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 62.340000000000003 111.099 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 11.5 m . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 65.010000000000005 110.812 -179.726 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.442 ' HB1' ' HB3' ' A' ' 187' ' ' PRO . . . . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.855 0.36 . . . . 64.230000000000004 111.118 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 1.1 p -119.55 3.92 11.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 65.439999999999998 111.167 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 173.74 101.73 0.15 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.741 -0.742 . . . . 73.010000000000005 112.447 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 16.3 ttp -111.84 125.17 53.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.86 0.362 . . . . 34.310000000000002 110.88 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.619 ' OG1' ' HB3' ' A' ' 184' ' ' ALA . 59.2 p -113.98 103.07 10.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.446 . . . . 72.200000000000003 111.129 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.998 HG22 HG13 ' A' ' 183' ' ' VAL . 20.7 t -99.83 131.29 47.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.215 -0.448 . . . . 73.230000000000004 111.11 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.8 m -126.81 92.57 44.37 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.565 0.697 . . . . 74.430000000000007 111.12 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.483 ' HB3' HD23 ' A' ' 181' ' ' LEU . 53.6 Cg_endo -69.81 -167.7 0.24 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.686 2.257 . . . . 73.219999999999999 112.317 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -85.38 -41.66 15.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 75.420000000000002 111.121 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 88.7 p 46.46 75.08 0.13 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.461 . . . . 55.530000000000001 110.85 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.4 t -172.32 -175.08 1.33 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.107 -0.497 . . . . 74.420000000000002 111.165 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 86.6 p -98.9 164.08 12.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.262 -0.427 . . . . 72.319999999999993 110.844 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.728 HG22 ' HB2' ' A' ' 177' ' ' GLN . 3.0 p -147.39 153.77 11.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.114 -0.494 . . . . 62.420000000000002 111.116 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 64.3 t -87.87 145.44 7.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 71.439999999999998 111.132 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.98 122.75 6.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 70.120000000000005 110.864 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 100.08 -15.33 59.33 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.782 -0.723 . . . . 42.439999999999998 112.517 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . 0.728 ' HB2' HG22 ' A' ' 173' ' ' VAL . 11.6 mm100 -89.64 -177.97 5.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.807 0.337 . . . . 53.439999999999998 110.941 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 15.1 p -161.6 148.87 14.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 72.540000000000006 110.859 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.513 HG21 HD12 ' A' ' 241' ' ' ILE . 7.3 t -108.95 -173.86 2.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 61.020000000000003 111.133 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.41 131.87 26.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 74.219999999999999 111.13 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.483 HD23 ' HB3' ' A' ' 168' ' ' PRO . 7.6 mp -104.21 141.72 35.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 71.310000000000002 110.954 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.9 m -110.0 141.49 42.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.212 -0.449 . . . . 72.219999999999999 111.158 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.998 HG13 HG22 ' A' ' 166' ' ' VAL . 32.5 t -129.62 141.04 47.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.242 -0.435 . . . . 74.010000000000005 111.143 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.619 ' HB3' ' OG1' ' A' ' 165' ' ' THR . . . -131.53 151.46 51.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 72.219999999999999 111.114 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -143.72 129.81 19.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.249 -0.432 . . . . 73.510000000000005 110.862 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.54 66.91 58.76 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.616 0.722 . . . . 73.209999999999994 110.907 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.442 ' HB3' ' HB1' ' A' ' 161' ' ' ALA . 53.7 Cg_endo . . . . . 0 C--N 1.341 0.163 0 C-N-CA 122.684 2.256 . . . . 55.509999999999998 112.362 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.859 0.362 . . . . 52.140000000000001 110.897 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.67 104.09 0.98 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 72.120000000000005 110.919 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -117.38 -6.21 11.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 73.209999999999994 110.834 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.764 ' CE2' HG11 ' A' ' 183' ' ' VAL . 24.7 p90 -90.45 178.59 6.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 72.209999999999994 110.886 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.14 172.01 11.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 71.340000000000003 110.897 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -128.02 144.56 51.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 72.329999999999998 111.092 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 59.7 t -150.64 146.65 16.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 71.099999999999994 111.145 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 26.6 t -70.58 136.83 49.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.19 -0.459 . . . . 61.109999999999999 110.909 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.53 ' HB2' ' HD3' ' A' ' 227' ' ' PRO . . . -76.35 -8.41 57.06 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.149 -0.478 . . . . 63.030000000000001 111.092 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -142.85 -56.33 0.42 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.248 -0.433 . . . . 55.340000000000003 110.871 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 64.39 26.27 13.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.446 . . . . 74.200000000000003 110.91 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 80.6 p -114.24 -3.21 13.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 55.32 111.101 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 8.7 mtmm -149.19 16.4 0.93 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.274 -0.421 . . . . 72.239999999999995 110.859 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.708 ' HA ' HG23 ' A' ' 219' ' ' VAL . . . -177.69 146.78 0.46 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.259 -0.428 . . . . 62.329999999999998 111.139 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 15.9 p -104.81 153.37 21.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 65.140000000000001 111.136 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.924 HG12 HG22 ' A' ' 216' ' ' VAL . 35.5 m -136.88 140.96 41.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 75.040000000000006 111.115 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.98 108.3 4.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 74.140000000000001 110.865 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.53 HG23 HG13 ' A' ' 214' ' ' ILE . 3.7 p -87.95 143.46 11.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.064 -0.516 . . . . 73.109999999999999 111.139 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 3.8 t -172.13 123.14 0.49 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 53.299999999999997 110.851 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 55.71 47.8 75.73 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.773 -0.727 . . . . 64.129999999999995 112.452 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 3.8 mtp 63.19 16.27 9.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.833 0.349 . . . . 63.509999999999998 110.867 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 21.0 m -126.47 113.48 16.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.261 -0.427 . . . . 73.219999999999999 111.114 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.53 HG13 HG23 ' A' ' 209' ' ' VAL . 3.1 mp -110.46 115.54 50.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.463 . . . . 63.219999999999999 111.121 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 2.6 m -88.88 132.66 34.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.24 -0.436 . . . . 74.200000000000003 111.169 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.924 HG22 HG12 ' A' ' 207' ' ' VAL . 3.5 t -118.0 125.69 74.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.257 -0.429 . . . . 64.200000000000003 111.104 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -109.12 136.87 47.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.104 -0.498 . . . . 75.120000000000005 110.873 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -91.16 83.56 1.27 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.734 -0.746 . . . . 73.310000000000002 112.499 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.708 HG23 ' HA ' ' A' ' 205' ' ' ALA . 20.3 t -53.99 -52.52 35.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.857 0.36 . . . . 72.310000000000002 111.151 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -134.34 163.18 30.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 65.439999999999998 111.129 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . 0.474 ' HB2' ' HA ' ' A' ' 245' ' ' ALA . . . -56.64 144.84 30.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 75.310000000000002 111.107 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . 0.441 ' O ' HG23 ' A' ' 243' ' ' VAL . . . 129.92 166.29 11.81 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.791 -0.719 . . . . 71.239999999999995 112.535 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . 0.77 ' HG3' HG23 ' A' ' 242' ' ' THR . 2.6 mtmm -101.32 129.67 47.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.833 0.349 . . . . 70.310000000000002 110.907 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.548 HG11 ' HB3' ' A' ' 205' ' ' ALA . 7.4 p -118.58 129.68 74.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.263 -0.426 . . . . 72.209999999999994 111.149 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . 0.609 ' C ' HD12 ' A' ' 226' ' ' ILE . 35.2 m120 -89.71 147.4 23.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 70.219999999999999 110.889 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.609 HD12 ' C ' ' A' ' 225' ' ' ASN . 4.3 mp -137.75 93.35 12.33 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.633 0.73 . . . . 74.540000000000006 111.161 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' PRO . . . . . 0.53 ' HD3' ' HB2' ' A' ' 200' ' ' ALA . 53.5 Cg_endo -69.79 -176.9 1.65 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.729 2.286 . . . . 74.25 112.297 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.557 ' CG2' ' HB3' ' A' ' 237' ' ' ALA . 48.2 t -147.3 134.72 14.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 62.299999999999997 111.082 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 93.7 t -117.95 133.08 65.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.177 -0.465 . . . . 61.020000000000003 111.109 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.23 116.28 23.85 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.128 -0.487 . . . . 73.049999999999997 110.845 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 61.18 -121.13 25.44 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.743 -0.742 . . . . 72.150000000000006 112.469 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -95.78 15.43 20.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.871 0.367 . . . . 72.140000000000001 110.904 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 111.13 9.96 21.3 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.747 -0.739 . . . . 52.350000000000001 112.459 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -51.11 -65.08 0.62 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.906 0.384 . . . . 64.129999999999995 110.907 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -110.78 156.03 21.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 74.109999999999999 110.894 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -153.16 164.69 37.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 63.149999999999999 111.053 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . 0.557 ' HB3' ' CG2' ' A' ' 228' ' ' VAL . . . -144.86 163.88 32.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.456 . . . . 75.310000000000002 111.119 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 14.1 p -137.91 134.65 45.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 75.140000000000001 111.105 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' ALA . . . . . 0.452 ' HB2' ' HG3' ' A' ' 168' ' ' PRO . . . -139.31 164.37 30.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.119 -0.491 . . . . 65.349999999999994 111.116 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -147.56 131.14 16.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.249 -0.432 . . . . 63.310000000000002 110.879 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' ILE . . . . . 0.645 HG13 HG11 ' A' ' 216' ' ' VAL . 30.7 mm -122.83 115.0 44.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 71.420000000000002 111.064 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 242' ' ' THR . . . . . 0.77 HG23 ' HG3' ' A' ' 223' ' ' LYS . 0.6 OUTLIER -83.0 141.28 32.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.179 -0.464 . . . . 63.100000000000001 111.149 179.926 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 222' ' ' GLY . 19.5 t -120.39 120.32 62.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.225 -0.443 . . . . 64.430000000000007 111.161 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 244' ' ' THR . . . . . 0.518 HG23 ' O ' ' A' ' 173' ' ' VAL . 4.9 p -82.61 132.95 35.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 75.349999999999994 111.133 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 245' ' ' ALA . . . . . 0.474 ' HA ' ' HB2' ' A' ' 221' ' ' ALA . . . -58.71 -21.67 55.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.439 . . . . 33.350000000000001 111.086 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 4.5 m . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.443 . . . . 71.430000000000007 110.883 -179.807 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.889 0.376 . . . . 61.020000000000003 111.073 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -125.14 32.11 5.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 72.430000000000007 111.183 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 138.46 99.58 0.48 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.775 -0.726 . . . . 75.239999999999995 112.473 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 41.2 ttp -111.11 129.07 56.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.882 0.372 . . . . 64.219999999999999 110.841 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.546 ' OG1' ' HB3' ' A' ' 184' ' ' ALA . 40.4 p -118.0 105.86 12.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.194 -0.457 . . . . 71.209999999999994 111.13 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 1.086 HG22 HG13 ' A' ' 183' ' ' VAL . 21.5 t -99.87 133.64 42.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 74.319999999999993 111.167 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.3 m -126.2 92.49 45.56 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.593 0.711 . . . . 73.109999999999999 111.145 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.497 ' HG3' ' HB2' ' A' ' 239' ' ' ALA . 53.5 Cg_endo -69.77 -167.88 0.25 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.7 2.267 . . . . 65.420000000000002 112.338 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -87.15 -38.13 16.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 72.510000000000005 111.121 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 94.4 p 46.21 79.54 0.05 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 31.309999999999999 110.87 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.4 t -175.39 -174.6 0.74 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.17 -0.468 . . . . 74.329999999999998 111.164 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 33.0 p -101.06 162.0 13.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 72.219999999999999 110.875 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.738 HG22 ' HB2' ' A' ' 177' ' ' GLN . 2.6 p -144.83 154.25 14.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 74.450000000000003 111.133 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 93.2 t -89.91 144.9 8.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 75.099999999999994 111.137 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -47.75 124.11 6.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 70.109999999999999 110.922 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.69 -17.22 57.79 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.756 -0.735 . . . . 52.109999999999999 112.465 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . 0.738 ' HB2' HG22 ' A' ' 173' ' ' VAL . 10.7 mm100 -87.99 -177.77 5.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.768 0.318 . . . . 73.329999999999998 110.956 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 1.7 p -161.86 148.91 14.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.237 -0.438 . . . . 74.409999999999997 110.875 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 9.2 t -111.04 -174.86 2.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.14 -0.482 . . . . 72.439999999999998 111.112 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.21 132.46 29.89 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.174 -0.466 . . . . 72.219999999999999 111.139 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.473 HD23 ' HB3' ' A' ' 168' ' ' PRO . 7.6 mp -106.36 143.3 34.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 73.519999999999996 110.904 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 16.3 m -110.31 143.91 39.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.451 . . . . 33.420000000000002 111.129 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 1.086 HG13 HG22 ' A' ' 166' ' ' VAL . 22.9 t -129.69 142.36 44.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.214 -0.448 . . . . 51.439999999999998 111.143 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.546 ' HB3' ' OG1' ' A' ' 165' ' ' THR . . . -131.55 150.92 51.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 70.349999999999994 111.081 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -144.47 126.45 15.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 72.109999999999999 110.881 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.22 67.23 79.61 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.565 0.698 . . . . 65.420000000000002 110.892 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--N 1.341 0.174 0 C-N-CA 122.674 2.249 . . . . 72.140000000000001 112.387 179.962 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.886 0.374 . . . . 70.319999999999993 110.854 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 5.1 mtmt -54.39 101.45 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 74.400000000000006 110.918 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 23.0 t -115.22 -5.99 12.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 54.219999999999999 110.837 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.772 ' CE2' HG11 ' A' ' 183' ' ' VAL . 22.7 p90 -90.31 172.15 8.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.127 -0.488 . . . . 63.409999999999997 110.873 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.58 158.89 36.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 74.239999999999995 110.886 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . 0.606 ' HB3' ' HB ' ' A' ' 209' ' ' VAL . . . -112.83 165.97 11.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.445 . . . . 54.509999999999998 111.094 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 10.7 p -175.18 151.84 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 34.399999999999999 111.132 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.6 t -79.25 144.49 34.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 71.109999999999999 110.866 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.581 ' HB2' ' HD3' ' A' ' 227' ' ' PRO . . . -78.57 -22.6 46.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 75.519999999999996 111.073 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -127.63 -54.87 1.33 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 60.5 110.814 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 1.7 ttpm? 63.43 27.92 15.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.469 . . . . 71.200000000000003 110.885 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 44.8 p -115.76 -1.77 12.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.265 -0.425 . . . . 71.200000000000003 111.149 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . 0.526 ' CB ' ' HB3' ' A' ' 220' ' ' ALA . 11.2 mtmm -149.61 16.48 0.89 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 73.109999999999999 110.919 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -174.9 150.68 1.27 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 72.040000000000006 111.078 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 23.9 p -112.88 134.65 54.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 70.329999999999998 111.145 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.924 HG12 HG22 ' A' ' 216' ' ' VAL . 5.3 m -122.4 139.65 48.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.221 -0.445 . . . . 72.200000000000003 111.108 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -144.1 108.87 4.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 45.43 110.848 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.606 ' HB ' ' HB3' ' A' ' 197' ' ' ALA . 4.3 p -84.84 143.76 11.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 63.530000000000001 111.142 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 11.8 t -172.12 124.47 0.52 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 74.439999999999998 110.865 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 52.87 52.0 41.81 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.728 -0.749 . . . . 51.119999999999997 112.478 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 2.2 mtp 58.75 19.61 7.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.885 0.374 . . . . 74.209999999999994 110.914 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 1.6 m -131.56 113.21 13.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.229 -0.441 . . . . 73.439999999999998 111.164 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.569 HG13 HG23 ' A' ' 209' ' ' VAL . 3.1 mp -109.71 116.78 53.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 64.209999999999994 111.118 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 1.1 m -89.86 129.91 36.16 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.148 -0.478 . . . . 62.039999999999999 111.118 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.924 HG22 HG12 ' A' ' 207' ' ' VAL . 3.5 t -115.75 129.6 71.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 73.340000000000003 111.063 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -112.32 135.12 53.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.119 -0.491 . . . . 52.0 110.875 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -82.1 67.04 3.76 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.752 -0.737 . . . . 65.420000000000002 112.519 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.423 HG12 ' N ' ' A' ' 220' ' ' ALA . 1.4 t -48.4 -51.05 11.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.848 0.356 . . . . 65.400000000000006 111.153 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . 0.526 ' HB3' ' CB ' ' A' ' 204' ' ' LYS . . . -127.86 154.87 44.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 45.240000000000002 111.093 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . 0.655 ' HB2' ' HA ' ' A' ' 245' ' ' ALA . . . -66.63 136.36 55.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 73.420000000000002 111.078 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 139.21 171.91 12.41 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.726 -0.749 . . . . 54.009999999999998 112.487 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . 0.441 ' HG3' HG23 ' A' ' 242' ' ' THR . 8.3 mttm -96.02 125.19 40.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.806 0.336 . . . . 74.349999999999994 110.918 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 7.7 p -121.42 131.25 73.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.268 -0.423 . . . . 75.400000000000006 111.141 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . 0.615 ' C ' HD12 ' A' ' 226' ' ' ILE . 34.3 m120 -90.54 151.41 21.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 62.219999999999999 110.859 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.615 HD12 ' C ' ' A' ' 225' ' ' ASN . 4.3 mp -136.71 92.71 14.55 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.633 0.73 . . . . 64.340000000000003 111.136 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' PRO . . . . . 0.581 ' HD3' ' HB2' ' A' ' 200' ' ' ALA . 53.9 Cg_endo -69.82 179.92 3.39 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.664 2.243 . . . . 62.43 112.339 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 96.7 t -150.63 137.54 13.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 73.230000000000004 111.161 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 92.7 t -122.38 134.55 65.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 51.020000000000003 111.115 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -122.22 125.02 45.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.15 -0.477 . . . . 62.109999999999999 110.869 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 56.77 -117.74 10.21 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.74 -0.743 . . . . 70.120000000000005 112.468 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -94.44 8.46 42.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.865 0.364 . . . . 62.439999999999998 110.85 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 106.94 9.61 29.83 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.717 -0.754 . . . . 63.229999999999997 112.473 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -51.67 -40.66 60.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.886 0.374 . . . . 74.230000000000004 110.884 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -127.68 167.25 16.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.481 . . . . 53.210000000000001 110.873 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -166.26 165.34 17.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 70.010000000000005 111.081 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -139.33 163.19 33.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.222 -0.445 . . . . 73.450000000000003 111.103 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.0 p -135.32 127.71 47.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.441 . . . . 52.450000000000003 111.112 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' ALA . . . . . 0.497 ' HB2' ' HG3' ' A' ' 168' ' ' PRO . . . -130.52 163.07 27.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.13 -0.486 . . . . 61.409999999999997 111.086 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . 0.439 ' O ' HD13 ' A' ' 241' ' ' ILE . 2.8 pt-20 -144.31 128.29 17.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.439 . . . . 44.210000000000001 110.876 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' ILE . . . . . 0.467 HG13 HG11 ' A' ' 216' ' ' VAL . 26.0 mm -124.92 111.2 27.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 63.200000000000003 111.127 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 242' ' ' THR . . . . . 0.441 HG23 ' HG3' ' A' ' 223' ' ' LYS . 4.0 m -81.63 139.94 34.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 73.310000000000002 111.131 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 30.5 t -120.26 119.06 58.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 53.310000000000002 111.142 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 244' ' ' THR . . . . . 0.503 HG23 ' O ' ' A' ' 173' ' ' VAL . 5.1 p -81.12 132.87 35.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.151 -0.477 . . . . 71.140000000000001 111.102 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 245' ' ' ALA . . . . . 0.655 ' HA ' ' HB2' ' A' ' 221' ' ' ALA . . . -54.06 -27.66 33.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 61.32 111.113 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 10.2 m . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.237 -0.438 . . . . 73.519999999999996 110.875 -179.783 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.842 0.354 . . . . 72.439999999999998 111.115 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 1.1 m -137.55 27.58 2.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 62.210000000000001 111.138 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 147.01 105.65 0.43 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.801 -0.714 . . . . 72.430000000000007 112.522 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 1.5 ttp -120.0 140.52 50.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.875 0.369 . . . . 63.509999999999998 110.886 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.628 HG23 HE22 ' A' ' 186' ' ' GLN . 32.8 p -126.43 109.83 12.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.445 . . . . 71.510000000000005 111.167 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 1.059 HG22 HG13 ' A' ' 183' ' ' VAL . 21.7 t -97.57 134.98 33.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 74.200000000000003 111.102 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 4.3 m -126.94 92.59 44.1 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.631 0.729 . . . . 70.510000000000005 111.168 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.468 ' HB3' HD23 ' A' ' 181' ' ' LEU . 53.8 Cg_endo -69.74 -167.65 0.23 Allowed 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.686 2.257 . . . . 73.400000000000006 112.373 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -89.88 -43.16 10.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 73.140000000000001 111.093 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 12.2 t 49.7 80.98 0.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 55.32 110.835 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.5 t -175.13 -175.46 0.85 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 75.209999999999994 111.199 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 83.3 p -98.45 161.69 13.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.436 . . . . 60.420000000000002 110.893 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.723 HG22 ' HB2' ' A' ' 177' ' ' GLN . 3.1 p -144.24 153.92 15.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 71.129999999999995 111.132 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 64.7 t -87.5 144.99 8.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 74.329999999999998 111.159 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.6 122.55 5.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.451 . . . . 74.209999999999994 110.883 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.59 -14.2 60.73 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.753 -0.737 . . . . 65.209999999999994 112.475 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . 0.723 ' HB2' HG22 ' A' ' 173' ' ' VAL . 15.7 mm100 -91.61 -178.23 5.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.802 0.334 . . . . 75.040000000000006 110.915 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 54.3 p -161.55 146.24 13.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 75.209999999999994 110.862 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.565 HG21 HD12 ' A' ' 241' ' ' ILE . 7.0 t -103.34 -173.85 2.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.083 -0.508 . . . . 75.109999999999999 111.158 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.51 132.86 28.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.219 -0.446 . . . . 74.420000000000002 111.14 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.468 HD23 ' HB3' ' A' ' 168' ' ' PRO . 7.5 mp -106.63 145.25 32.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 53.219999999999999 110.943 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 2.2 m -113.81 145.56 41.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.238 -0.437 . . . . 62.130000000000003 111.13 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 1.059 HG13 HG22 ' A' ' 166' ' ' VAL . 21.9 t -129.48 142.18 44.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 64.310000000000002 111.124 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.407 ' HB3' ' OG1' ' A' ' 165' ' ' THR . . . -128.74 152.94 47.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 72.319999999999993 111.088 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -143.99 128.25 17.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 73.040000000000006 110.852 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' GLN . . . . . 0.628 HE22 HG23 ' A' ' 165' ' ' THR . 0.0 OUTLIER -132.72 66.93 77.6 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.606 0.717 . . . . 62.439999999999998 110.9 -179.935 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--N 1.341 0.159 0 C-N-CA 122.694 2.263 . . . . 72.540000000000006 112.387 179.972 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 37.6 t70 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.918 0.389 . . . . 71.109999999999999 110.86 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 24.8 mtmt -74.31 74.68 1.85 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 52.100000000000001 110.894 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -75.55 -6.25 49.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 74.010000000000005 110.826 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.785 ' CE2' HG11 ' A' ' 183' ' ' VAL . 11.5 p90 -90.03 151.81 21.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 64.329999999999998 110.898 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.59 154.04 43.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.144 -0.48 . . . . 72.239999999999995 110.923 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -103.81 167.77 9.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 71.230000000000004 111.103 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 9.3 p -173.25 152.99 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 74.150000000000006 111.171 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 73.4 p -76.6 152.86 35.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 65.239999999999995 110.866 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.636 ' HB2' ' HD3' ' A' ' 227' ' ' PRO . . . -93.86 -19.54 20.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.126 -0.488 . . . . 71.430000000000007 111.135 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.84 -55.28 0.93 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 73.519999999999996 110.864 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.54 26.41 14.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 71.319999999999993 110.881 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 41.5 p -112.9 -3.92 14.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 65.430000000000007 111.152 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 10.2 mtmm -154.21 19.87 0.49 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 72.549999999999997 110.898 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.625 ' HA ' HG23 ' A' ' 219' ' ' VAL . . . -177.46 147.6 0.53 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 73.430000000000007 111.105 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 15.0 p -108.65 159.67 16.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 75.519999999999996 111.159 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.711 HG12 HG22 ' A' ' 216' ' ' VAL . 7.7 m -141.37 141.97 29.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.246 -0.434 . . . . 62.420000000000002 111.107 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 69.8 m -149.1 108.66 3.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 73.430000000000007 110.888 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.549 HG23 HG13 ' A' ' 214' ' ' ILE . 3.6 p -88.97 143.15 11.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.1 -0.5 . . . . 72.019999999999996 111.119 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 18.8 t -172.16 123.48 0.49 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.47 . . . . 64.409999999999997 110.864 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 56.04 47.02 83.24 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.719 -0.753 . . . . 64.430000000000007 112.524 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 2.4 mtp 63.85 15.94 9.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.904 0.383 . . . . 71.219999999999999 110.908 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 6.5 m -125.6 113.14 17.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.459 . . . . 51.539999999999999 111.128 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.549 HG13 HG23 ' A' ' 209' ' ' VAL . 3.0 mp -110.43 113.98 45.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 75.219999999999999 111.127 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 7.3 m -88.95 132.78 34.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.129 -0.487 . . . . 71.420000000000002 111.184 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.711 HG22 HG12 ' A' ' 207' ' ' VAL . 4.4 t -117.94 123.54 71.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.257 -0.429 . . . . 40.43 111.124 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -104.94 140.0 38.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 73.219999999999999 110.901 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -95.41 79.31 0.83 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.726 -0.749 . . . . 73.239999999999995 112.478 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.625 HG23 ' HA ' ' A' ' 205' ' ' ALA . 18.3 t -49.54 -54.67 6.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.821 0.343 . . . . 61.119999999999997 111.12 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -130.85 162.07 30.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 71.530000000000001 111.075 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . 0.672 ' HB2' ' HA ' ' A' ' 245' ' ' ALA . . . -60.36 141.82 55.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 73.329999999999998 111.141 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 139.4 172.05 12.5 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.757 -0.735 . . . . 51.229999999999997 112.471 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . 0.401 ' HG3' HG23 ' A' ' 242' ' ' THR . 5.0 mttt -99.74 120.84 40.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.824 0.345 . . . . 73.530000000000001 110.89 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.583 HG11 ' CB ' ' A' ' 205' ' ' ALA . 6.4 p -117.46 122.88 70.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.213 -0.448 . . . . 74.400000000000006 111.133 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . 0.652 ' C ' HD12 ' A' ' 226' ' ' ILE . 26.8 m120 -90.99 152.74 20.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.163 -0.472 . . . . 72.040000000000006 110.908 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.652 HD12 ' C ' ' A' ' 225' ' ' ASN . 3.9 mp -137.74 92.72 12.76 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.632 0.729 . . . . 64.120000000000005 111.13 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' PRO . . . . . 0.636 ' HD3' ' HB2' ' A' ' 200' ' ' ALA . 54.2 Cg_endo -69.7 177.1 5.88 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.67 2.247 . . . . 65.310000000000002 112.376 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.447 ' CG2' ' HB3' ' A' ' 237' ' ' ALA . 34.6 t -146.18 139.11 20.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.257 -0.429 . . . . 74.120000000000005 111.102 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 91.4 t -129.25 143.79 40.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.15 -0.477 . . . . 71.109999999999999 111.178 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 6.0 p -92.4 176.0 6.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 50.140000000000001 110.832 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -51.16 -45.97 51.41 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.761 -0.733 . . . . 73.349999999999994 112.499 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 20.2 t30 -111.48 21.08 16.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.873 0.368 . . . . 65.010000000000005 110.885 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 61.7 16.02 49.69 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.724 -0.75 . . . . 72.129999999999995 112.469 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -66.36 -44.45 83.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.894 0.378 . . . . 71.340000000000003 110.902 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -117.3 144.93 44.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.146 -0.479 . . . . 70.019999999999996 110.909 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -144.71 163.23 34.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 70.109999999999999 111.101 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . 0.447 ' HB3' ' CG2' ' A' ' 228' ' ' VAL . . . -142.65 163.4 32.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 63.299999999999997 111.052 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 57.3 t -139.6 136.6 40.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.215 -0.448 . . . . 55.329999999999998 111.132 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.17 165.08 27.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.466 . . . . 72.140000000000001 111.075 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . 0.405 ' O ' HD13 ' A' ' 241' ' ' ILE . 3.2 pt-20 -143.79 132.25 22.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 74.120000000000005 110.862 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' ILE . . . . . 0.565 HD12 HG21 ' A' ' 179' ' ' THR . 24.1 mm -127.27 113.28 31.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 64.409999999999997 111.156 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 242' ' ' THR . . . . . 0.401 HG23 ' HG3' ' A' ' 223' ' ' LYS . 1.7 m -81.42 141.06 34.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 52.340000000000003 111.134 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 17.2 t -119.95 122.13 67.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 73.439999999999998 111.144 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 244' ' ' THR . . . . . 0.525 HG23 ' O ' ' A' ' 173' ' ' VAL . 7.2 p -82.57 133.05 35.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 62.350000000000001 111.159 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 245' ' ' ALA . . . . . 0.672 ' HA ' ' HB2' ' A' ' 221' ' ' ALA . . . -59.14 -21.87 60.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 72.140000000000001 111.088 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 52.3 p . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 72.109999999999999 110.856 -179.782 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.905 0.384 . . . . 35.020000000000003 111.078 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -124.6 31.96 5.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 74.409999999999997 111.109 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 138.28 99.17 0.48 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.743 -0.741 . . . . 70.450000000000003 112.486 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 35.2 ttp -109.71 130.91 55.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.822 0.344 . . . . 70.010000000000005 110.888 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.552 ' OG1' ' HB3' ' A' ' 184' ' ' ALA . 36.5 p -120.48 105.1 10.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.44 . . . . 74.349999999999994 111.182 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.994 HG22 HG13 ' A' ' 183' ' ' VAL . 21.1 t -98.26 136.11 30.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 64.510000000000005 111.171 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.3 m -127.7 91.86 44.29 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.593 0.711 . . . . 54.409999999999997 111.127 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.465 ' HG3' ' HB2' ' A' ' 239' ' ' ALA . 53.9 Cg_endo -69.72 -165.7 0.16 Allowed 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.709 2.273 . . . . 65.040000000000006 112.346 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -91.84 -39.25 11.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 74.409999999999997 111.089 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 88.5 p 46.73 79.82 0.05 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 52.219999999999999 110.897 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.6 t -175.56 -175.06 0.75 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.121 -0.491 . . . . 72.040000000000006 111.131 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 25.5 p -99.84 163.28 12.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 73.349999999999994 110.853 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.726 HG22 ' HB2' ' A' ' 177' ' ' GLN . 3.0 p -143.91 153.4 15.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.123 -0.489 . . . . 75.319999999999993 111.12 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 80.6 t -87.76 143.58 10.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 73.549999999999997 111.099 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.35 122.41 4.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 75.049999999999997 110.872 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.34 -9.88 61.18 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.735 -0.745 . . . . 72.310000000000002 112.482 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . 0.726 ' HB2' HG22 ' A' ' 173' ' ' VAL . 11.9 mm100 -97.17 -178.68 4.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.792 0.329 . . . . 74.019999999999996 110.946 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 15.2 p -161.55 147.67 14.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 63.299999999999997 110.898 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 7.7 t -104.9 -175.82 2.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.476 . . . . 63.329999999999998 111.131 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -137.38 130.11 30.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 63.030000000000001 111.16 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.46 HD23 ' HB3' ' A' ' 168' ' ' PRO . 8.0 mp -105.43 140.39 38.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 72.209999999999994 110.937 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -109.92 145.57 36.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 75.329999999999998 111.163 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.994 HG13 HG22 ' A' ' 166' ' ' VAL . 52.1 t -129.58 142.61 43.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.453 . . . . 74.400000000000006 111.141 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.552 ' HB3' ' OG1' ' A' ' 165' ' ' THR . . . -130.13 150.76 51.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.198 -0.455 . . . . 71.510000000000005 111.084 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -144.83 126.74 15.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 74.400000000000006 110.884 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.89 67.61 80.92 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.612 0.72 . . . . 53.329999999999998 110.903 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--N 1.342 0.202 0 C-N-CA 122.67 2.247 . . . . 71.349999999999994 112.372 -179.996 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.889 0.376 . . . . 73.120000000000005 110.844 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.35 99.82 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 73.120000000000005 110.87 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 3.3 t -111.16 -7.33 14.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 65.430000000000007 110.892 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.789 ' CE2' HG11 ' A' ' 183' ' ' VAL . 21.1 p90 -91.36 -176.29 4.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.108 -0.496 . . . . 72.200000000000003 110.878 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -166.3 175.27 8.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 65.239999999999995 110.926 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . 0.684 ' HB3' ' CG2' ' A' ' 209' ' ' VAL . . . -125.24 167.16 15.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 74.319999999999993 111.098 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.419 HG13 ' HG2' ' A' ' 227' ' ' PRO . 13.9 p -170.54 149.52 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 71.230000000000004 111.133 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.2 p -92.22 125.3 36.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 71.099999999999994 110.833 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.483 ' HB2' ' HD3' ' A' ' 227' ' ' PRO . . . -60.77 -18.62 56.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 73.400000000000006 111.076 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -164.25 103.52 0.86 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 73.420000000000002 110.878 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -89.61 46.78 1.4 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.169 -0.469 . . . . 72.209999999999994 110.891 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 11.9 p -120.9 -9.17 9.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 72.209999999999994 111.165 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . 0.697 ' HA ' ' HB3' ' A' ' 220' ' ' ALA . 11.3 mtmm -143.09 17.1 1.92 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 71.420000000000002 110.908 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.63 ' CB ' HG11 ' A' ' 224' ' ' VAL . . . 178.91 143.12 0.12 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 45.509999999999998 111.106 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 2.1 p -104.6 161.68 13.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.437 . . . . 72.450000000000003 111.165 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.598 HG12 HG22 ' A' ' 216' ' ' VAL . 17.2 m -140.85 150.17 20.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.239 -0.437 . . . . 75.319999999999993 111.138 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 22.8 m -157.69 109.71 2.35 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.474 . . . . 73.319999999999993 110.843 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.684 ' CG2' ' HB3' ' A' ' 197' ' ' ALA . 90.5 t -79.45 145.18 9.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.116 -0.493 . . . . 61.299999999999997 111.162 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 59.2 p -165.84 111.56 0.87 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.197 -0.456 . . . . 72.200000000000003 110.848 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 47.66 63.33 3.52 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.736 -0.745 . . . . 70.430000000000007 112.458 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 3.1 mtp 55.75 20.48 4.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.875 0.369 . . . . 72.540000000000006 110.891 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 1.4 m -130.97 106.5 8.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.23 -0.441 . . . . 53.32 111.14 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.531 ' H ' HD12 ' A' ' 214' ' ' ILE . 0.8 OUTLIER -101.64 122.01 53.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.264 -0.426 . . . . 72.209999999999994 111.166 179.905 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 7.3 m -92.22 123.15 35.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 73.340000000000003 111.112 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.598 HG22 HG12 ' A' ' 207' ' ' VAL . 2.4 t -108.65 123.18 64.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 62.240000000000002 111.101 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -107.63 145.1 33.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 63.530000000000001 110.87 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -99.72 64.24 0.65 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.776 -0.726 . . . . 63.329999999999998 112.526 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.611 HG22 ' HA ' ' A' ' 205' ' ' ALA . 0.0 OUTLIER -48.23 -41.59 10.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.809 0.338 . . . . 60.020000000000003 111.092 -179.925 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . 0.697 ' HB3' ' HA ' ' A' ' 204' ' ' LYS . . . -127.3 151.02 49.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 73.209999999999994 111.074 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . 0.644 ' HB2' ' HA ' ' A' ' 245' ' ' ALA . . . -66.68 138.05 57.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 50.140000000000001 111.1 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 137.72 170.15 11.81 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.747 -0.739 . . . . 64.530000000000001 112.542 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . 0.527 ' HG3' HG23 ' A' ' 242' ' ' THR . 7.9 mttm -93.32 127.61 39.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.846 0.355 . . . . 74.530000000000001 110.95 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.63 HG11 ' CB ' ' A' ' 205' ' ' ALA . 7.3 p -122.05 129.36 75.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.239 -0.437 . . . . 72.439999999999998 111.15 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . 0.578 ' C ' HD12 ' A' ' 226' ' ' ILE . 19.3 m120 -90.95 148.54 22.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 73.409999999999997 110.851 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.578 HD12 ' C ' ' A' ' 225' ' ' ASN . 4.3 mp -135.72 92.57 16.76 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.622 0.725 . . . . 64.140000000000001 111.096 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' PRO . . . . . 0.483 ' HD3' ' HB2' ' A' ' 200' ' ' ALA . 54.1 Cg_endo -69.77 178.63 4.38 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.66 2.24 . . . . 63.420000000000002 112.358 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 54.4 t -148.29 136.78 15.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.237 -0.438 . . . . 75.019999999999996 111.18 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 98.3 t -118.15 136.63 54.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.453 . . . . 72.129999999999995 111.133 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 22.7 t -122.17 135.51 54.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 51.240000000000002 110.87 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 52.53 -113.72 2.9 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.738 -0.744 . . . . 71.439999999999998 112.471 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -111.8 20.66 16.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.873 0.368 . . . . 64.420000000000002 110.887 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 113.14 1.94 25.02 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.719 -0.753 . . . . 74.400000000000006 112.478 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -52.92 -62.58 1.56 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.878 0.37 . . . . 74.510000000000005 110.892 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -108.37 166.13 10.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 73.239999999999995 110.867 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -166.1 165.15 17.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.128 -0.487 . . . . 52.119999999999997 111.087 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -143.41 163.27 33.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 73.010000000000005 111.061 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 14.8 p -138.25 137.64 43.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 75.329999999999998 111.157 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' ALA . . . . . 0.465 ' HB2' ' HG3' ' A' ' 168' ' ' PRO . . . -138.95 164.82 28.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 61.100000000000001 111.138 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . 0.588 ' O ' HD13 ' A' ' 241' ' ' ILE . 4.6 pt-20 -143.99 130.48 19.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 75.120000000000005 110.94 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' ILE . . . . . 0.589 HG13 HG11 ' A' ' 216' ' ' VAL . 32.7 mm -127.12 114.77 38.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 74.530000000000001 111.134 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 242' ' ' THR . . . . . 0.527 HG23 ' HG3' ' A' ' 223' ' ' LYS . 3.2 m -84.28 141.0 31.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 70.25 111.169 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 25.9 t -120.39 120.1 61.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.446 . . . . 72.109999999999999 111.134 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 244' ' ' THR . . . . . 0.497 HG23 ' O ' ' A' ' 173' ' ' VAL . 7.1 p -81.1 132.83 35.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.485 . . . . 53.009999999999998 111.145 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 245' ' ' ALA . . . . . 0.644 ' HA ' ' HB2' ' A' ' 221' ' ' ALA . . . -58.51 -25.16 62.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 75.150000000000006 111.073 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 40.3 t . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 71.109999999999999 110.83 -179.753 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.472 ' HB1' ' HB3' ' A' ' 187' ' ' PRO . . . . . . . . 0 C--O 1.232 0.174 0 CA-C-O 120.825 0.345 . . . . 63.109999999999999 111.155 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 1.2 m -125.07 32.68 5.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.271 -0.422 . . . . 74.430000000000007 111.153 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 140.55 97.99 0.34 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.765 -0.731 . . . . 62.140000000000001 112.48 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.522 ' HE3' HG11 ' A' ' 228' ' ' VAL . 0.8 OUTLIER -112.95 138.1 50.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.905 0.383 . . . . 74.200000000000003 110.86 -179.965 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.642 HG23 HE22 ' A' ' 186' ' ' GLN . 34.4 p -121.52 109.8 15.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.236 -0.438 . . . . 53.299999999999997 111.18 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 1.083 HG22 HG13 ' A' ' 183' ' ' VAL . 33.5 t -98.45 132.91 42.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.429 . . . . 75.540000000000006 111.155 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.5 m -123.43 92.09 49.16 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.619 0.723 . . . . 64.299999999999997 111.179 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.463 ' HB3' HD23 ' A' ' 181' ' ' LEU . 53.6 Cg_endo -69.78 -168.41 0.27 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.666 2.244 . . . . 64.230000000000004 112.348 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -89.75 -42.7 11.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.446 . . . . 71.310000000000002 111.105 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 12.3 t 49.88 80.57 0.07 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.236 -0.438 . . . . 64.340000000000003 110.869 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.5 t -174.72 -175.09 0.87 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 75.299999999999997 111.142 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 1.5 m -98.7 162.41 13.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.444 . . . . 71.519999999999996 110.893 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.729 HG22 ' HB2' ' A' ' 177' ' ' GLN . 3.6 p -144.5 153.32 15.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.129 -0.487 . . . . 73.129999999999995 111.124 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 61.8 t -86.73 145.55 7.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 73.140000000000001 111.1 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.23 122.22 5.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.468 . . . . 73.0 110.914 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.18 -11.54 61.95 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.76 -0.734 . . . . 72.329999999999998 112.467 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . 0.729 ' HB2' HG22 ' A' ' 173' ' ' VAL . 16.3 mm100 -94.2 -178.62 4.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.818 0.342 . . . . 74.25 110.909 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 52.2 p -161.74 148.09 13.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 51.200000000000003 110.861 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.502 HG21 HD12 ' A' ' 241' ' ' ILE . 7.0 t -106.01 -173.61 2.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.13 -0.487 . . . . 53.200000000000003 111.097 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -139.93 132.2 28.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.456 . . . . 64.109999999999999 111.166 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.463 HD23 ' HB3' ' A' ' 168' ' ' PRO . 7.6 mp -105.83 145.19 31.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.247 -0.433 . . . . 74.439999999999998 110.904 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 5.3 m -111.55 145.12 39.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.144 -0.48 . . . . 73.120000000000005 111.123 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 1.083 HG13 HG22 ' A' ' 166' ' ' VAL . 22.5 t -129.31 140.62 48.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.256 -0.429 . . . . 75.099999999999994 111.11 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -129.11 153.1 48.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.486 . . . . 44.43 111.082 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -143.91 129.28 18.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.251 -0.432 . . . . 65.030000000000001 110.864 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' GLN . . . . . 0.642 HE22 HG23 ' A' ' 165' ' ' THR . 0.0 OUTLIER -132.86 66.78 77.09 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.634 0.73 . . . . 64.549999999999997 110.925 -179.975 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.472 ' HB3' ' HB1' ' A' ' 161' ' ' ALA . 53.5 Cg_endo . . . . . 0 C--N 1.342 0.219 0 C-N-CA 122.693 2.262 . . . . 74.439999999999998 112.36 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.881 0.372 . . . . 71.420000000000002 110.841 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 13.9 mtpp -81.9 74.44 8.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 71.310000000000002 110.923 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 2.2 m -78.48 -7.28 57.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 63.439999999999998 110.862 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.774 ' CE2' HG11 ' A' ' 183' ' ' VAL . 22.4 p90 -91.31 164.38 13.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 65.049999999999997 110.838 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.04 167.52 30.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.116 -0.493 . . . . 64.140000000000001 110.88 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -115.64 160.05 20.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 63.240000000000002 111.103 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.603 HG23 ' HG2' ' A' ' 227' ' ' PRO . 5.1 m -153.43 163.04 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.206 -0.452 . . . . 53.439999999999998 111.114 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.61 118.68 35.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 72.329999999999998 110.9 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.477 ' HB2' ' HD3' ' A' ' 227' ' ' PRO . . . -59.87 -21.0 60.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.141 -0.481 . . . . 63.439999999999998 111.11 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.97 96.79 1.36 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 64.239999999999995 110.84 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.89 50.18 1.92 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 72.040000000000006 110.904 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 12.0 p -128.73 -1.45 5.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.211 -0.45 . . . . 63.240000000000002 111.176 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 7.5 mtmt -154.57 18.47 0.47 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.196 -0.457 . . . . 72.530000000000001 110.829 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.589 ' HA ' HG23 ' A' ' 219' ' ' VAL . . . -179.88 153.79 0.54 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.251 -0.431 . . . . 55.119999999999997 111.085 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 11.7 p -117.32 156.05 28.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.214 -0.448 . . . . 71.120000000000005 111.131 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.817 HG12 HG22 ' A' ' 216' ' ' VAL . 33.8 m -137.19 141.17 40.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 63.229999999999997 111.136 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 50.9 m -147.86 107.87 4.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 71.430000000000007 110.845 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.446 ' HA ' ' HA ' ' A' ' 214' ' ' ILE . 3.0 p -88.31 142.87 12.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 63.229999999999997 111.11 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.2 m -171.56 122.89 0.53 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.188 -0.46 . . . . 64.030000000000001 110.861 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 55.6 47.23 78.55 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.726 -0.75 . . . . 44.509999999999998 112.481 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 3.3 mtp 64.06 16.38 9.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.848 0.356 . . . . 70.040000000000006 110.854 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 18.8 m -125.67 112.65 16.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 63.43 111.151 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.446 ' HA ' ' HA ' ' A' ' 209' ' ' VAL . 2.6 mp -109.69 113.75 45.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 64.120000000000005 111.105 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 6.3 m -87.45 133.92 33.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.206 -0.452 . . . . 55.210000000000001 111.181 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.817 HG22 HG12 ' A' ' 207' ' ' VAL . 2.9 t -118.18 123.17 71.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.27 -0.423 . . . . 53.509999999999998 111.09 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -106.33 139.57 40.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.474 . . . . 75.109999999999999 110.857 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -96.9 78.3 0.69 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.719 -0.753 . . . . 63.109999999999999 112.48 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.589 HG23 ' HA ' ' A' ' 205' ' ' ALA . 16.2 t -50.13 -55.29 5.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.83 0.347 . . . . 71.439999999999998 111.112 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -126.38 161.63 27.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 72.140000000000001 111.122 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . 0.677 ' HB2' ' HA ' ' A' ' 245' ' ' ALA . . . -62.61 139.97 58.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.243 -0.435 . . . . 73.349999999999994 111.104 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 142.24 172.84 13.86 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.732 -0.747 . . . . 45.43 112.503 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . 0.409 ' HG3' HG23 ' A' ' 242' ' ' THR . 12.7 mttt -102.18 120.81 41.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.837 0.351 . . . . 60.520000000000003 110.886 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.533 HG11 ' CB ' ' A' ' 205' ' ' ALA . 7.3 p -119.13 126.89 75.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 50.340000000000003 111.143 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . 0.597 ' C ' HD12 ' A' ' 226' ' ' ILE . 33.5 m120 -90.55 156.05 18.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 65.25 110.864 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.597 HD12 ' C ' ' A' ' 225' ' ' ASN . 4.4 mp -138.13 92.43 12.33 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.634 0.731 . . . . 75.310000000000002 111.127 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' PRO . . . . . 0.603 ' HG2' HG23 ' A' ' 198' ' ' VAL . 53.3 Cg_endo -69.77 -179.26 2.79 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.679 2.253 . . . . 45.210000000000001 112.345 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.522 HG11 ' HE3' ' A' ' 164' ' ' MET . 61.3 t -150.11 140.6 16.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 74.439999999999998 111.16 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 89.9 t -124.06 138.53 53.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 72.019999999999996 111.137 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 1.5 m -118.94 106.67 12.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.191 -0.459 . . . . 65.219999999999999 110.862 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 57.74 -110.86 2.59 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.701 -0.761 . . . . 74.209999999999994 112.486 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -81.01 -7.39 59.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.865 0.364 . . . . 65.310000000000002 110.889 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 109.76 10.01 23.76 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.743 -0.741 . . . . 61.43 112.424 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -50.72 -47.1 59.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.874 0.369 . . . . 64.219999999999999 110.879 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -117.51 147.52 42.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 63.549999999999997 110.884 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -149.72 165.23 33.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 73.230000000000004 111.11 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . 0.429 ' HB3' ' CG2' ' A' ' 228' ' ' VAL . . . -136.95 163.3 31.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.441 . . . . 73.420000000000002 111.109 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.4 p -136.36 125.59 38.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.188 -0.46 . . . . 73.430000000000007 111.139 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' ALA . . . . . 0.409 ' HB2' ' HG3' ' A' ' 168' ' ' PRO . . . -132.79 162.13 32.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 52.409999999999997 111.15 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . 0.413 ' O ' HD13 ' A' ' 241' ' ' ILE . 6.3 pt-20 -144.16 132.1 21.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.268 -0.424 . . . . 55.530000000000001 110.886 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 241' ' ' ILE . . . . . 0.621 HG13 HG11 ' A' ' 216' ' ' VAL . 26.3 mm -126.81 112.73 30.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.124 -0.489 . . . . 63.009999999999998 111.142 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 242' ' ' THR . . . . . 0.409 HG23 ' HG3' ' A' ' 223' ' ' LYS . 2.7 m -80.82 141.28 34.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 65.239999999999995 111.165 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 17.1 t -120.08 121.0 64.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.236 -0.438 . . . . 73.329999999999998 111.116 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 244' ' ' THR . . . . . 0.506 HG23 ' O ' ' A' ' 173' ' ' VAL . 7.3 p -82.28 132.75 35.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.144 -0.48 . . . . 73.010000000000005 111.146 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 245' ' ' ALA . . . . . 0.677 ' HA ' ' HB2' ' A' ' 221' ' ' ALA . . . -56.92 -24.63 53.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.462 . . . . 74.239999999999995 111.113 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.26 -0.427 . . . . 71.230000000000004 110.847 -179.791 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.494 ' HB1' ' HB3' ' A' ' 187' ' ' PRO . . . . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.922 0.391 . . . . 73.239999999999995 111.07 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -124.9 30.85 5.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.161 -0.472 . . . . 64.140000000000001 111.096 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 146.24 96.7 0.19 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.722 -0.751 . . . . 73.150000000000006 112.466 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.607 ' SD ' HG23 ' A' ' 166' ' ' VAL . 2.1 tmm? -106.09 143.71 33.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.845 0.355 . . . . 65.010000000000005 110.897 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.515 ' OG1' ' HB3' ' A' ' 184' ' ' ALA . 44.7 p -133.87 103.33 5.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.274 -0.421 . . . . 71.340000000000003 111.169 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 1.13 HG22 HG13 ' A' ' 183' ' ' VAL . 89.0 t -97.19 133.98 36.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 74.409999999999997 111.103 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 40.8 m -123.86 92.01 48.99 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.517 0.675 . . . . 74.540000000000006 111.115 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.465 ' HB3' HD23 ' A' ' 181' ' ' LEU . 53.9 Cg_endo -69.78 -167.33 0.22 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.636 2.224 . . . . 73.299999999999997 112.331 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -90.75 -43.75 9.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.459 . . . . 64.219999999999999 111.089 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 8.0 t 49.48 80.12 0.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 75.140000000000001 110.861 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.6 t -173.68 -176.11 1.2 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.135 -0.484 . . . . 75.319999999999993 111.128 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 10.0 p -97.27 162.19 13.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 54.149999999999999 110.837 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.734 HG22 ' HB2' ' A' ' 177' ' ' GLN . 3.3 p -145.37 153.18 14.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.479 . . . . 63.409999999999997 111.142 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 66.6 t -87.52 145.21 7.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.116 -0.493 . . . . 72.540000000000006 111.12 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.64 122.42 5.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 72.420000000000002 110.837 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.81 -12.87 61.0 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.741 -0.742 . . . . 73.239999999999995 112.501 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . 0.734 ' HB2' HG22 ' A' ' 173' ' ' VAL . 11.6 mm100 -92.91 -178.32 4.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.811 0.339 . . . . 61.109999999999999 110.931 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 39.1 p -161.37 149.45 15.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.214 -0.448 . . . . 74.040000000000006 110.894 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.533 HG21 HD12 ' A' ' 241' ' ' ILE . 6.8 t -107.11 -173.92 2.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 71.040000000000006 111.186 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.73 132.39 27.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.258 -0.428 . . . . 72.120000000000005 111.184 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.465 HD23 ' HB3' ' A' ' 168' ' ' PRO . 7.6 mp -106.56 145.54 31.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 74.299999999999997 110.873 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 4.1 m -113.75 146.42 39.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 72.310000000000002 111.144 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 1.13 HG13 HG22 ' A' ' 166' ' ' VAL . 47.4 t -128.7 140.84 48.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 75.129999999999995 111.136 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.515 ' HB3' ' OG1' ' A' ' 165' ' ' THR . . . -129.9 155.98 45.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 72.319999999999993 111.123 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -148.93 131.28 15.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.257 -0.428 . . . . 73.109999999999999 110.9 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.05 67.35 73.52 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.634 0.73 . . . . 74.010000000000005 110.919 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.494 ' HB3' ' HB1' ' A' ' 161' ' ' ALA . 53.6 Cg_endo . . . . . 0 C--N 1.342 0.22 0 C-N-CA 122.703 2.268 . . . . 65.0 112.343 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 1.4 p30 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.863 0.364 . . . . 62.43 110.882 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 6.1 mtpm? -91.4 67.58 5.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 52.43 110.907 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 21.8 t -74.51 -7.24 52.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 65.530000000000001 110.864 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.772 ' CE2' HG11 ' A' ' 183' ' ' VAL . 21.8 p90 -91.28 163.64 14.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.131 -0.486 . . . . 64.230000000000004 110.897 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.9 173.19 16.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 74.239999999999995 110.878 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -112.66 168.14 9.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 73.319999999999993 111.068 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.436 HG13 ' HG2' ' A' ' 227' ' ' PRO . 14.5 p -167.62 149.7 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 75.319999999999993 111.101 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.03 130.03 36.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.139 -0.482 . . . . 65.030000000000001 110.881 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.492 ' HB2' ' HD3' ' A' ' 227' ' ' PRO . . . -68.08 -17.61 64.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.095 -0.502 . . . . 72.010000000000005 111.106 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -162.93 95.7 0.88 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.224 -0.443 . . . . 64.109999999999999 110.891 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 18.6 tttt -84.99 53.06 2.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 71.129999999999995 110.935 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 18.0 p -128.82 0.37 5.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 73.319999999999993 111.142 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . 0.415 ' HG2' ' HB3' ' A' ' 220' ' ' ALA . 3.7 mtmm -155.29 18.24 0.41 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 74.299999999999997 110.887 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.613 ' HA ' HG23 ' A' ' 219' ' ' VAL . . . -179.96 149.16 0.33 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.277 -0.419 . . . . 73.319999999999993 111.107 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 7.0 p -109.92 156.69 20.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.166 -0.47 . . . . 74.239999999999995 111.118 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.856 HG12 HG22 ' A' ' 216' ' ' VAL . 17.6 m -140.42 140.86 33.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 72.120000000000005 111.112 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -148.15 109.0 4.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 72.540000000000006 110.879 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.544 HG23 HG13 ' A' ' 214' ' ' ILE . 3.6 p -89.21 143.01 12.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.465 . . . . 74.340000000000003 111.106 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.7 m -171.82 123.43 0.52 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 72.0 110.91 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 56.2 46.67 85.33 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.715 -0.755 . . . . 74.230000000000004 112.466 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 4.1 mtp 64.2 15.78 9.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.827 0.346 . . . . 64.430000000000007 110.892 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 13.6 m -125.13 113.01 17.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.246 -0.434 . . . . 71.030000000000001 111.112 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.544 HG13 HG23 ' A' ' 209' ' ' VAL . 3.1 mp -110.48 113.8 45.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 73.409999999999997 111.154 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 5.8 m -88.93 132.05 34.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 73.510000000000005 111.12 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.856 HG22 HG12 ' A' ' 207' ' ' VAL . 3.9 t -117.02 124.28 72.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.187 -0.46 . . . . 55.100000000000001 111.101 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -106.03 138.67 41.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 75.319999999999993 110.95 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -94.73 78.55 0.91 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.676 -0.773 . . . . 72.319999999999993 112.505 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.613 HG23 ' HA ' ' A' ' 205' ' ' ALA . 20.6 t -49.75 -55.52 4.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.823 0.344 . . . . 72.439999999999998 111.134 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . 0.415 ' HB3' ' HG2' ' A' ' 204' ' ' LYS . . . -127.19 161.75 27.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 64.049999999999997 111.111 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . 0.682 ' HB2' ' HA ' ' A' ' 245' ' ' ALA . . . -62.22 139.93 58.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 70.239999999999995 111.068 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 142.27 171.72 13.27 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.752 -0.737 . . . . 73.230000000000004 112.496 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . 0.464 ' HG3' HG23 ' A' ' 242' ' ' THR . 2.1 mttt -101.12 121.19 41.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.783 0.325 . . . . 75.420000000000002 110.929 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.501 HG11 ' CB ' ' A' ' 205' ' ' ALA . 7.1 p -120.46 125.46 74.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.259 -0.428 . . . . 64.230000000000004 111.102 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . 0.558 ' C ' HD12 ' A' ' 226' ' ' ILE . 21.0 m120 -90.98 152.45 20.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.468 . . . . 72.329999999999998 110.888 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.558 HD12 ' C ' ' A' ' 225' ' ' ASN . 4.3 mp -135.24 92.71 17.59 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.667 0.746 . . . . 75.329999999999998 111.166 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 227' ' ' PRO . . . . . 0.492 ' HD3' ' HB2' ' A' ' 200' ' ' ALA . 53.9 Cg_endo -69.76 -176.44 1.49 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.689 2.26 . . . . 74.25 112.329 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.505 ' CG2' ' HB3' ' A' ' 237' ' ' ALA . 59.5 t -149.4 137.04 13.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.444 . . . . 72.439999999999998 111.127 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 84.0 t -118.4 133.18 66.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.158 -0.474 . . . . 74.409999999999997 111.135 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 5.7 t -122.32 126.21 47.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 72.319999999999993 110.881 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 55.53 -121.86 24.43 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.717 -0.754 . . . . 75.120000000000005 112.519 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -98.17 21.03 11.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.87 0.367 . . . . 55.130000000000003 110.911 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 106.77 6.9 34.54 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.702 -0.761 . . . . 71.420000000000002 112.507 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -53.26 -62.66 1.51 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.85 0.357 . . . . 74.319999999999993 110.887 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -105.99 166.02 10.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 73.420000000000002 110.879 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -167.15 165.41 15.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 70.040000000000006 111.053 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . 0.505 ' HB3' ' CG2' ' A' ' 228' ' ' VAL . . . -142.33 163.16 33.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 75.109999999999999 111.099 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 8.0 p -136.58 131.15 47.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.243 -0.435 . . . . 74.409999999999997 111.149 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 239' ' ' ALA . . . . . 0.42 ' HB2' ' HG3' ' A' ' 168' ' ' PRO . . . -139.3 165.22 27.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 63.219999999999999 111.157 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -147.7 133.32 18.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 74.219999999999999 110.919 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 241' ' ' ILE . . . . . 0.533 HD12 HG21 ' A' ' 179' ' ' THR . 25.1 mm -126.7 115.13 40.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.475 . . . . 54.340000000000003 111.11 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 242' ' ' THR . . . . . 0.464 HG23 ' HG3' ' A' ' 223' ' ' LYS . 2.4 m -82.91 141.11 32.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 73.450000000000003 111.146 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 21.2 t -120.01 121.06 64.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.243 -0.435 . . . . 74.230000000000004 111.121 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 244' ' ' THR . . . . . 0.443 HG23 ' O ' ' A' ' 173' ' ' VAL . 9.2 p -82.92 132.78 35.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.138 -0.483 . . . . 75.540000000000006 111.124 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 245' ' ' ALA . . . . . 0.682 ' HA ' ' HB2' ' A' ' 221' ' ' ALA . . . -54.39 -27.18 34.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 71.219999999999999 111.089 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 46.9 t . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 54.130000000000003 110.906 -179.811 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.458 ' HB1' ' HB3' ' A' ' 187' ' ' PRO . . . . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.885 0.374 . . . . 70.120000000000005 111.081 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.508 HG22 ' HA ' ' A' ' 187' ' ' PRO . 10.8 t -127.24 15.99 7.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 60.310000000000002 111.132 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -176.71 81.28 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.764 -0.731 . . . . 74.109999999999999 112.493 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 30.5 ttp -102.95 123.19 46.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.895 0.378 . . . . 70.219999999999999 110.867 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.53 ' OG1' ' HB3' ' A' ' 184' ' ' ALA . 51.6 p -111.52 104.97 13.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.236 -0.438 . . . . 72.349999999999994 111.159 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 1.07 HG22 HG13 ' A' ' 183' ' ' VAL . 60.9 t -97.2 131.92 42.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.455 . . . . 74.439999999999998 111.141 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 38.5 m -124.55 92.29 48.18 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.534 0.683 . . . . 62.200000000000003 111.147 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.456 ' HB3' HD23 ' A' ' 181' ' ' LEU . 54.1 Cg_endo -69.74 -167.26 0.22 Allowed 'Trans proline' 0 C--N 1.341 0.132 0 C-N-CA 122.674 2.249 . . . . 75.420000000000002 112.35 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -90.92 -39.27 12.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.444 . . . . 63.450000000000003 111.114 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 4.8 p 45.86 79.96 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 71.109999999999999 110.87 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.6 t -175.44 -175.69 0.83 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.477 . . . . 63.350000000000001 111.126 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 1.7 m -97.42 164.42 12.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.443 . . . . 65.120000000000005 110.908 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.737 HG22 ' HB2' ' A' ' 177' ' ' GLN . 3.4 p -146.22 153.18 13.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.469 . . . . 62.340000000000003 111.137 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 59.2 t -86.1 145.48 7.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 64.310000000000002 111.125 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.27 122.32 5.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.443 . . . . 74.549999999999997 110.905 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.15 -12.79 62.06 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.771 -0.728 . . . . 44.399999999999999 112.53 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . 0.737 ' HB2' HG22 ' A' ' 173' ' ' VAL . 17.9 mm100 -92.35 -178.8 5.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.796 0.331 . . . . 74.299999999999997 110.914 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 60.6 p -161.69 148.63 14.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 71.319999999999993 110.879 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.466 HG21 HD12 ' A' ' 241' ' ' ILE . 6.7 t -105.75 -174.46 2.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 75.310000000000002 111.145 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -140.29 127.09 20.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.256 -0.429 . . . . 75.530000000000001 111.139 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.456 HD23 ' HB3' ' A' ' 168' ' ' PRO . 7.5 mp -100.81 141.01 34.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.183 -0.462 . . . . 71.530000000000001 110.93 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 6.1 m -109.17 144.61 37.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 65.019999999999996 111.152 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 1.07 HG13 HG22 ' A' ' 166' ' ' VAL . 23.1 t -129.43 141.56 46.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 75.540000000000006 111.104 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.53 ' HB3' ' OG1' ' A' ' 165' ' ' THR . . . -130.89 156.87 44.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 73.310000000000002 111.111 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -147.09 133.37 19.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 74.140000000000001 110.894 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.62 67.18 23.96 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.634 0.731 . . . . 70.049999999999997 110.915 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.508 ' HA ' HG22 ' A' ' 162' ' ' THR . 53.6 Cg_endo . . . . . 0 C--N 1.341 0.169 0 C-N-CA 122.676 2.251 . . . . 73.329999999999998 112.369 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.858 0.361 . . . . 72.109999999999999 110.868 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 10.3 mtmm -85.31 73.11 10.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.474 . . . . 72.510000000000005 110.87 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.45 -3.98 43.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.253 -0.431 . . . . 65.219999999999999 110.831 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.806 ' CE2' HG11 ' A' ' 183' ' ' VAL . 14.9 p90 -88.05 168.58 12.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.074 -0.512 . . . . 62.439999999999998 110.858 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -164.38 162.07 21.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 64.319999999999993 110.868 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . 0.684 ' HB3' ' CG2' ' A' ' 209' ' ' VAL . . . -104.03 157.69 16.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.467 . . . . 75.030000000000001 111.107 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 91.9 t -150.25 145.14 17.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.257 -0.429 . . . . 74.129999999999995 111.126 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -83.83 122.78 29.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 74.109999999999999 110.826 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.471 ' HB2' ' HD3' ' A' ' 227' ' ' PRO . . . -72.98 -8.25 54.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 74.150000000000006 111.088 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -164.21 98.58 0.83 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.259 -0.428 . . . . 63.119999999999997 110.899 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.64 41.4 1.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 61.32 110.89 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 4.3 p -124.51 -5.3 7.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.249 -0.432 . . . . 71.010000000000005 111.144 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 9.7 mtmm -148.45 16.27 1.02 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.462 . . . . 73.329999999999998 110.921 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.572 ' HA ' HG23 ' A' ' 219' ' ' VAL . . . -179.2 154.35 0.65 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 25.140000000000001 111.124 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 11.2 p -117.62 158.42 24.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.209 -0.45 . . . . 74.239999999999995 111.153 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 10.7 m -134.74 144.4 34.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 71.109999999999999 111.093 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 1.9 t -150.93 109.21 3.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 74.239999999999995 110.886 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.684 ' CG2' ' HB3' ' A' ' 197' ' ' ALA . 80.9 t -84.16 145.71 7.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 74.150000000000006 111.123 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 3.3 t -171.09 117.58 0.46 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.147 -0.479 . . . . 53.140000000000001 110.849 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 48.52 61.32 5.19 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.738 -0.744 . . . . 53.020000000000003 112.496 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 2.3 mtp 54.09 21.97 3.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.887 0.375 . . . . 74.109999999999999 110.904 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 1.7 m -130.59 110.33 11.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 71.450000000000003 111.2 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.493 HG23 HG22 ' A' ' 209' ' ' VAL . 0.8 OUTLIER -104.65 121.36 56.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.253 -0.43 . . . . 74.030000000000001 111.158 179.905 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 21.0 m -91.9 129.19 37.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.146 -0.479 . . . . 55.299999999999997 111.16 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.589 HG11 HG13 ' A' ' 241' ' ' ILE . 2.3 t -115.54 120.94 66.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 62.119999999999997 111.15 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -105.47 140.33 38.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 72.219999999999999 110.872 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -96.47 78.54 0.73 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.767 -0.73 . . . . 52.240000000000002 112.491 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.572 HG23 ' HA ' ' A' ' 205' ' ' ALA . 19.5 t -50.81 -56.67 3.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.837 0.351 . . . . 70.219999999999999 111.115 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -123.86 161.21 25.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.148 -0.478 . . . . 74.540000000000006 111.103 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . 0.669 ' HB2' ' HA ' ' A' ' 245' ' ' ALA . . . -63.15 138.7 58.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.256 -0.429 . . . . 72.540000000000006 111.099 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 141.37 168.49 11.53 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.713 -0.756 . . . . 62.399999999999999 112.458 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . 0.588 ' HG3' HG23 ' A' ' 242' ' ' THR . 5.6 mttp -95.68 120.2 35.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.804 0.335 . . . . 71.109999999999999 110.915 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.562 HG11 ' CB ' ' A' ' 205' ' ' ALA . 6.6 p -117.99 123.15 71.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.272 -0.422 . . . . 72.140000000000001 111.177 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . 0.634 ' C ' HD12 ' A' ' 226' ' ' ILE . 31.5 m120 -90.72 153.18 20.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.458 . . . . 71.329999999999998 110.864 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.634 HD12 ' C ' ' A' ' 225' ' ' ASN . 4.2 mp -138.38 93.19 11.47 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.645 0.736 . . . . 53.43 111.139 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 227' ' ' PRO . . . . . 0.471 ' HD3' ' HB2' ' A' ' 200' ' ' ALA . 53.9 Cg_endo -69.73 -177.41 1.85 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.73 2.287 . . . . 70.340000000000003 112.339 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 62.4 t -149.01 142.04 18.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 65.230000000000004 111.126 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 91.0 t -121.42 137.09 56.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.157 -0.474 . . . . 73.010000000000005 111.141 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.34 130.09 52.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 70.219999999999999 110.884 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 53.37 -114.09 3.53 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.74 -0.743 . . . . 72.129999999999995 112.513 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -111.17 21.22 16.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.807 0.337 . . . . 74.349999999999994 110.831 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 114.39 1.76 23.23 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.76 -0.733 . . . . 62.329999999999998 112.512 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 44.1 mm-40 -51.75 -62.96 1.3 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.9 0.381 . . . . 61.399999999999999 110.899 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -112.46 162.93 15.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 75.519999999999996 110.929 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -165.71 164.8 18.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 74.349999999999994 111.065 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -143.01 163.05 33.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 50.009999999999998 111.084 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 10.9 p -137.77 136.34 45.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 70.340000000000003 111.172 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -139.23 165.51 26.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 65.310000000000002 111.086 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -145.11 132.34 20.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 64.340000000000003 110.88 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 241' ' ' ILE . . . . . 0.589 HG13 HG11 ' A' ' 216' ' ' VAL . 36.3 mm -127.21 116.89 45.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 73.230000000000004 111.155 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 242' ' ' THR . . . . . 0.588 HG23 ' HG3' ' A' ' 223' ' ' LYS . 2.1 m -84.22 141.68 30.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.192 -0.458 . . . . 53.530000000000001 111.138 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 21.5 t -120.0 121.5 66.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.243 -0.435 . . . . 42.32 111.127 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 244' ' ' THR . . . . . 0.502 HG23 ' O ' ' A' ' 173' ' ' VAL . 7.6 p -82.58 132.8 35.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 70.310000000000002 111.166 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 245' ' ' ALA . . . . . 0.669 ' HA ' ' HB2' ' A' ' 221' ' ' ALA . . . -55.78 -25.29 40.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 61.130000000000003 111.082 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 9.7 t . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 74.310000000000002 110.857 -179.774 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.892 0.377 . . . . 43.310000000000002 111.089 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 2.3 m -124.89 13.93 8.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.243 -0.435 . . . . 74.519999999999996 111.139 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 163.26 104.71 0.19 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.715 -0.755 . . . . 45.25 112.504 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 21.5 ttp -110.62 134.48 52.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.839 0.352 . . . . 74.129999999999995 110.9 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.651 ' OG1' ' HB3' ' A' ' 184' ' ' ALA . 1.8 p -119.62 95.44 4.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.256 -0.429 . . . . 64.329999999999998 111.173 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 1.02 HG22 HG13 ' A' ' 183' ' ' VAL . 21.8 t -97.21 117.9 42.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.439 . . . . 73.409999999999997 111.168 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 60.8 m -112.72 91.61 17.93 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.574 0.702 . . . . 74.140000000000001 111.17 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.472 ' HB3' HD23 ' A' ' 181' ' ' LEU . 53.7 Cg_endo -69.8 -168.23 0.26 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.638 2.226 . . . . 71.540000000000006 112.361 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -86.6 -44.57 11.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.438 . . . . 61.530000000000001 111.104 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 37.8 t 49.82 76.93 0.12 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.257 -0.429 . . . . 50.030000000000001 110.887 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.4 t -175.05 -174.91 0.8 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.111 -0.495 . . . . 71.040000000000006 111.14 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 33.3 p -99.15 158.42 15.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 64.129999999999995 110.856 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.738 HG22 ' HB2' ' A' ' 177' ' ' GLN . 3.3 p -140.22 152.37 21.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.103 -0.499 . . . . 73.150000000000006 111.096 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 95.5 t -84.6 143.66 11.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.166 -0.47 . . . . 72.409999999999997 111.093 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -48.04 122.5 5.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 73.549999999999997 110.917 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.85 -14.6 60.15 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.712 -0.756 . . . . 53.530000000000001 112.473 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . 0.738 ' HB2' HG22 ' A' ' 173' ' ' VAL . 16.7 mm100 -90.63 -178.31 5.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.824 0.345 . . . . 73.109999999999999 110.889 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 27.4 p -161.52 149.14 14.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 55.530000000000001 110.825 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 7.3 t -108.21 -173.68 2.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.481 . . . . 73.430000000000007 111.136 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -140.47 132.1 27.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.451 . . . . 42.130000000000003 111.161 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.472 HD23 ' HB3' ' A' ' 168' ' ' PRO . 7.3 mp -105.37 142.02 35.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.246 -0.434 . . . . 75.030000000000001 110.918 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 3.6 m -108.42 142.12 39.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 74.319999999999993 111.128 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 1.02 HG13 HG22 ' A' ' 166' ' ' VAL . 16.5 t -129.79 136.37 59.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 63.340000000000003 111.13 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.651 ' HB3' ' OG1' ' A' ' 165' ' ' THR . . . -124.33 155.86 37.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.243 -0.435 . . . . 70.439999999999998 111.076 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -142.83 125.25 15.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 71.209999999999994 110.884 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.48 63.06 46.34 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.557 0.694 . . . . 62.130000000000003 110.903 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--N 1.342 0.194 0 C-N-CA 122.668 2.245 . . . . 74.340000000000003 112.317 179.99 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.856 0.36 . . . . 75.409999999999997 110.848 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.17 70.71 7.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 64.340000000000003 110.866 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 1.1 m -93.79 -5.3 48.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 75.5 110.886 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.75 ' CE2' HG11 ' A' ' 183' ' ' VAL . 7.2 p90 -89.77 171.87 9.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.107 -0.497 . . . . 71.049999999999997 110.873 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.68 167.17 17.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.141 -0.481 . . . . 74.510000000000005 110.852 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . 0.421 ' HB3' ' HB ' ' A' ' 209' ' ' VAL . . . -113.19 167.84 10.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.178 -0.464 . . . . 73.549999999999997 111.077 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 10.5 p -173.65 151.52 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 75.230000000000004 111.168 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.8 t -78.44 152.55 32.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 71.430000000000007 110.852 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.567 ' HB2' ' HD3' ' A' ' 227' ' ' PRO . . . -89.97 -21.61 22.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 63.450000000000003 111.122 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -129.14 -54.63 1.19 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 74.209999999999994 110.906 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 3.0 ttpp 63.63 25.52 14.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 75.340000000000003 110.915 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 32.3 p -112.59 -4.85 14.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.469 . . . . 51.450000000000003 111.11 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 9.1 mtmm -151.94 18.28 0.68 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 71.530000000000001 110.947 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.63 ' HA ' HG23 ' A' ' 219' ' ' VAL . . . -174.91 147.36 0.97 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 65.049999999999997 111.122 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 16.7 p -108.59 157.78 18.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 71.25 111.101 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.779 HG12 HG22 ' A' ' 216' ' ' VAL . 12.3 m -140.6 140.85 33.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 54.450000000000003 111.133 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 10.0 m -148.68 108.77 4.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 52.119999999999997 110.863 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.463 ' HA ' ' HA ' ' A' ' 214' ' ' ILE . 3.2 p -87.07 135.43 25.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.154 -0.475 . . . . 70.5 111.148 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 3.3 m -161.31 121.96 2.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 32.509999999999998 110.858 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 54.72 49.08 62.95 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.752 -0.737 . . . . 64.420000000000002 112.511 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER 63.3 16.38 9.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.853 0.359 . . . . 70.5 110.877 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 3.3 m -126.46 109.41 12.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 72.040000000000006 111.167 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.463 ' HA ' ' HA ' ' A' ' 209' ' ' VAL . 2.1 mp -105.18 114.09 43.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 75.329999999999998 111.11 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 6.2 m -87.9 130.51 34.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 75.030000000000001 111.124 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.779 HG22 HG12 ' A' ' 207' ' ' VAL . 2.8 t -115.93 123.91 71.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.449 . . . . 71.540000000000006 111.144 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -106.78 139.74 40.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 75.530000000000001 110.864 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -94.79 79.8 0.89 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.804 -0.712 . . . . 63.399999999999999 112.45 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.63 HG23 ' HA ' ' A' ' 205' ' ' ALA . 18.5 t -50.75 -55.63 6.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.858 0.361 . . . . 74.239999999999995 111.112 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -129.36 163.87 24.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 60.409999999999997 111.125 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . 0.673 ' HB2' ' HA ' ' A' ' 245' ' ' ALA . . . -63.17 142.26 58.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 51.149999999999999 111.085 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 139.04 171.56 12.23 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.78 -0.724 . . . . 70.420000000000002 112.495 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . 0.614 ' HG3' HG23 ' A' ' 242' ' ' THR . 14.9 mttt -100.73 121.57 41.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.788 0.328 . . . . 62.109999999999999 110.88 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.6 HG11 ' CB ' ' A' ' 205' ' ' ALA . 7.4 p -120.62 126.23 75.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 74.129999999999995 111.124 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . 0.627 ' C ' HD12 ' A' ' 226' ' ' ILE . 30.0 m120 -90.66 154.3 19.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.127 -0.488 . . . . 71.049999999999997 110.908 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.627 HD12 ' C ' ' A' ' 225' ' ' ASN . 4.1 mp -137.02 93.16 13.55 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.619 0.723 . . . . 73.430000000000007 111.102 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 227' ' ' PRO . . . . . 0.567 ' HD3' ' HB2' ' A' ' 200' ' ' ALA . 54.1 Cg_endo -69.81 -178.61 2.44 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.723 2.282 . . . . 74.540000000000006 112.305 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 99.4 t -150.29 138.32 14.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.169 -0.468 . . . . 72.230000000000004 111.069 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 66.6 t -121.47 139.39 48.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.166 -0.47 . . . . 64.409999999999997 111.124 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 7.4 m -122.45 125.53 46.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 71.5 110.851 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 55.54 -115.35 5.75 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.716 -0.754 . . . . 72.129999999999995 112.474 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -103.29 17.42 24.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.896 0.379 . . . . 72.049999999999997 110.897 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 114.01 9.73 15.37 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.778 -0.725 . . . . 72.319999999999993 112.513 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -52.01 -73.44 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.874 0.368 . . . . 71.219999999999999 110.921 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -104.15 162.48 13.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 72.109999999999999 110.879 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -158.93 165.1 34.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.469 . . . . 44.039999999999999 111.097 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -144.1 163.36 33.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 45.25 111.099 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 11.5 p -138.0 135.38 45.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.201 -0.454 . . . . 54.119999999999997 111.125 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.84 164.26 30.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 71.420000000000002 111.071 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . 0.52 ' O ' HD13 ' A' ' 241' ' ' ILE . 2.3 pt-20 -141.55 131.85 25.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 74.450000000000003 110.921 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 241' ' ' ILE . . . . . 0.607 HG13 HG11 ' A' ' 216' ' ' VAL . 23.9 mm -127.43 110.64 22.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.154 -0.476 . . . . 43.530000000000001 111.161 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 242' ' ' THR . . . . . 0.614 HG23 ' HG3' ' A' ' 223' ' ' LYS . 1.4 m -81.32 141.43 34.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 62.520000000000003 111.139 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 15.7 t -120.13 122.78 69.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 53.219999999999999 111.137 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 14.6 p -82.41 133.62 35.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 52.049999999999997 111.14 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 245' ' ' ALA . . . . . 0.673 ' HA ' ' HB2' ' A' ' 221' ' ' ALA . . . -59.16 -21.88 60.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 72.420000000000002 111.058 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 67.0 m . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.239 -0.437 . . . . 74.420000000000002 110.859 -179.732 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.182 0 CA-C-O 120.902 0.382 . . . . 73.310000000000002 111.075 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.88 32.94 5.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.233 -0.44 . . . . 73.219999999999999 111.148 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 135.27 99.63 0.6 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.721 -0.752 . . . . 45.420000000000002 112.51 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 18.8 ttp -110.88 128.15 55.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.824 0.345 . . . . 70.239999999999995 110.907 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.481 ' OG1' ' HB3' ' A' ' 184' ' ' ALA . 38.9 p -116.29 107.4 14.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 71.310000000000002 111.116 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 1.063 HG22 HG13 ' A' ' 183' ' ' VAL . 21.2 t -102.24 131.1 50.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.246 -0.434 . . . . 71.200000000000003 111.141 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -123.58 91.86 49.3 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.554 0.693 . . . . 64.049999999999997 111.189 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.485 ' HB3' HD23 ' A' ' 181' ' ' LEU . 53.3 Cg_endo -69.77 -167.05 0.21 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.653 2.235 . . . . 74.430000000000007 112.34 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -92.55 -45.19 8.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.45 . . . . 42.399999999999999 111.117 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 73.1 m 48.08 85.42 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 75.140000000000001 110.905 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 8.4 t -176.0 -176.01 0.78 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 74.140000000000001 111.173 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 75.8 p -97.07 153.49 17.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 70.329999999999998 110.852 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.711 HG22 ' HB2' ' A' ' 177' ' ' GLN . 3.3 p -139.07 153.54 24.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.139 -0.482 . . . . 54.140000000000001 111.127 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 67.2 t -87.6 145.05 8.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.167 -0.47 . . . . 71.430000000000007 111.151 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -48.42 122.66 5.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 72.010000000000005 110.914 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.98 -15.35 59.45 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.756 -0.735 . . . . 71.310000000000002 112.487 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . 0.711 ' HB2' HG22 ' A' ' 173' ' ' VAL . 11.8 mm100 -90.62 -178.63 5.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.781 0.324 . . . . 72.439999999999998 110.943 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 65.4 p -161.96 149.7 14.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 63.340000000000003 110.838 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.409 HG21 HD12 ' A' ' 241' ' ' ILE . 7.8 t -107.19 -173.89 2.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.105 -0.498 . . . . 74.329999999999998 111.115 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.76 132.25 28.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.201 -0.454 . . . . 74.530000000000001 111.111 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.485 HD23 ' HB3' ' A' ' 168' ' ' PRO . 7.6 mp -105.8 143.66 33.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.186 -0.461 . . . . 72.140000000000001 110.933 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 4.0 m -111.35 142.98 42.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.444 . . . . 63.310000000000002 111.133 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 1.063 HG13 HG22 ' A' ' 166' ' ' VAL . 21.8 t -129.69 143.41 41.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.255 -0.429 . . . . 70.239999999999995 111.185 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.481 ' HB3' ' OG1' ' A' ' 165' ' ' THR . . . -134.48 152.06 51.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 44.439999999999998 111.106 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -144.88 126.53 15.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 70.420000000000002 110.878 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.81 67.77 68.93 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.594 0.712 . . . . 75.030000000000001 110.877 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo . . . . . 0 C--N 1.342 0.187 0 C-N-CA 122.657 2.238 . . . . 62.329999999999998 112.333 179.983 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 2.2 t70 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.849 0.357 . . . . 73.349999999999994 110.887 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt -58.15 98.43 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.44 . . . . 71.510000000000005 110.874 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 2.6 t -111.61 -6.8 14.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 74.420000000000002 110.878 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.769 ' CE2' HG11 ' A' ' 183' ' ' VAL . 20.0 p90 -90.97 174.58 7.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.15 -0.477 . . . . 74.519999999999996 110.899 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -165.81 154.95 11.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 65.219999999999999 110.861 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -103.89 165.63 10.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 73.030000000000001 111.076 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 10.4 p -169.17 152.17 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 65.239999999999995 111.122 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.4 p -81.93 140.22 34.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 74.430000000000007 110.863 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.506 ' HB2' ' HD3' ' A' ' 227' ' ' PRO . . . -76.52 -23.34 53.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.107 -0.497 . . . . 72.129999999999995 111.069 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -134.82 -53.61 0.81 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.436 . . . . 74.340000000000003 110.845 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 2.8 ttpp 63.66 33.85 12.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.44 . . . . 75.299999999999997 110.918 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 50.8 p -116.65 -3.26 11.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.196 -0.456 . . . . 74.340000000000003 111.121 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . 0.412 ' HG2' ' HB3' ' A' ' 220' ' ' ALA . 8.0 mtmm -153.19 18.75 0.57 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 73.349999999999994 110.854 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.642 ' HA ' HG23 ' A' ' 219' ' ' VAL . . . -172.42 148.09 2.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 72.519999999999996 111.083 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 17.1 p -111.69 142.37 44.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 74.099999999999994 111.192 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.905 HG12 HG22 ' A' ' 216' ' ' VAL . 16.2 m -126.7 140.15 49.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.267 -0.424 . . . . 71.420000000000002 111.146 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 28.4 m -146.68 108.99 4.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 74.329999999999998 110.846 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.535 HG23 HG13 ' A' ' 214' ' ' ILE . 3.7 p -86.87 143.27 11.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.08 -0.509 . . . . 74.200000000000003 111.112 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 43.7 t -171.45 123.57 0.56 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.152 -0.477 . . . . 75.230000000000004 110.881 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 55.14 48.29 69.05 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.73 -0.748 . . . . 71.340000000000003 112.479 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 1.8 mtp 62.5 16.59 8.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.834 0.35 . . . . 55.039999999999999 110.889 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 2.3 m -127.55 113.55 16.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 74.209999999999994 111.175 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.535 HG13 HG23 ' A' ' 209' ' ' VAL . 3.0 mp -109.9 115.96 51.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.241 -0.436 . . . . 73.519999999999996 111.15 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 3.4 m -89.1 130.83 35.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.439 . . . . 65.420000000000002 111.127 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.905 HG22 HG12 ' A' ' 207' ' ' VAL . 3.0 t -116.24 121.06 66.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.24 -0.436 . . . . 72.430000000000007 111.124 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -104.79 139.83 38.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 65.150000000000006 110.863 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -94.28 79.65 0.95 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.729 -0.748 . . . . 42.329999999999998 112.502 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.642 HG23 ' HA ' ' A' ' 205' ' ' ALA . 19.7 t -49.95 -56.39 3.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.837 0.351 . . . . 64.120000000000005 111.154 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . 0.412 ' HB3' ' HG2' ' A' ' 204' ' ' LYS . . . -127.77 163.35 24.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 42.020000000000003 111.07 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . 0.678 ' HB2' ' HA ' ' A' ' 245' ' ' ALA . . . -63.45 137.75 58.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 62.240000000000002 111.092 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 142.4 167.53 11.42 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.74 -0.743 . . . . 70.439999999999998 112.515 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . 0.606 ' HG3' HG23 ' A' ' 242' ' ' THR . 6.2 mttp -98.72 124.58 43.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.876 0.369 . . . . 62.219999999999999 110.874 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.497 HG11 ' CB ' ' A' ' 205' ' ' ALA . 7.4 p -121.96 129.76 75.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.218 -0.446 . . . . 71.430000000000007 111.119 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . 0.626 ' C ' HD12 ' A' ' 226' ' ' ILE . 27.4 m120 -90.62 152.48 20.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 61.5 110.876 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.626 HD12 ' C ' ' A' ' 225' ' ' ASN . 4.2 mp -138.2 92.83 11.97 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.611 0.72 . . . . 71.019999999999996 111.12 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 227' ' ' PRO . . . . . 0.506 ' HD3' ' HB2' ' A' ' 200' ' ' ALA . 53.6 Cg_endo -69.73 -177.79 2.03 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.658 2.239 . . . . 51.219999999999999 112.379 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.506 ' CG2' ' HB3' ' A' ' 237' ' ' ALA . 99.7 t -150.08 137.82 13.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 64.040000000000006 111.084 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 88.1 t -117.94 132.82 66.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 71.219999999999999 111.12 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -121.72 137.52 54.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 74.200000000000003 110.858 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 51.91 -118.88 7.78 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.707 -0.758 . . . . 42.32 112.51 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -105.5 21.09 17.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.918 0.39 . . . . 52.409999999999997 110.933 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 107.27 12.01 24.41 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.706 -0.759 . . . . 62.329999999999998 112.49 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -63.14 -58.97 5.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.842 0.353 . . . . 62.409999999999997 110.901 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -105.58 167.22 9.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.464 . . . . 74.329999999999998 110.89 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -166.13 165.04 17.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.165 -0.471 . . . . 51.340000000000003 111.115 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . 0.506 ' HB3' ' CG2' ' A' ' 228' ' ' VAL . . . -139.52 163.2 33.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 73.420000000000002 111.064 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 52.4 t -137.52 132.11 44.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.441 . . . . 61.420000000000002 111.137 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 239' ' ' ALA . . . . . 0.448 ' HB2' ' HG3' ' A' ' 168' ' ' PRO . . . -139.23 162.48 34.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 71.120000000000005 111.094 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -145.51 124.37 12.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 75.219999999999999 110.898 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 241' ' ' ILE . . . . . 0.662 HG13 HG11 ' A' ' 216' ' ' VAL . 29.6 mm -119.1 109.13 25.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.12 -0.491 . . . . 72.019999999999996 111.135 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 242' ' ' THR . . . . . 0.606 HG23 ' HG3' ' A' ' 223' ' ' LYS . 4.2 m -80.31 141.83 35.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 73.010000000000005 111.12 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 18.5 t -119.22 121.1 65.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 75.540000000000006 111.18 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 244' ' ' THR . . . . . 0.502 HG23 ' O ' ' A' ' 173' ' ' VAL . 6.7 p -81.67 132.85 35.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.188 -0.46 . . . . 70.349999999999994 111.185 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 245' ' ' ALA . . . . . 0.678 ' HA ' ' HB2' ' A' ' 221' ' ' ALA . . . -58.46 -21.7 52.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.226 -0.443 . . . . 70.540000000000006 111.076 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 76.5 p . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.224 -0.444 . . . . 40.520000000000003 110.83 -179.769 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.826 0.346 . . . . 75.439999999999998 111.105 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.735 HG22 ' HA ' ' A' ' 187' ' ' PRO . 4.7 t -120.69 22.37 11.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 71.230000000000004 111.171 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 147.23 100.38 0.25 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.775 -0.726 . . . . 74.209999999999994 112.524 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -110.04 136.5 49.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.88 0.371 . . . . 74.420000000000002 110.876 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.646 ' OG1' ' HB3' ' A' ' 184' ' ' ALA . 68.6 p -116.11 105.65 12.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 71.25 111.147 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 1.069 HG22 HG13 ' A' ' 183' ' ' VAL . 45.7 t -98.48 130.14 47.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.198 -0.456 . . . . 74.219999999999999 111.094 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 8.9 m -126.66 92.72 44.26 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.537 0.684 . . . . 72.010000000000005 111.128 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.532 ' HG3' ' HB2' ' A' ' 239' ' ' ALA . 54.1 Cg_endo -69.72 -166.07 0.17 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.67 2.246 . . . . 74.319999999999993 112.352 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -87.05 -40.13 14.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 64.420000000000002 111.114 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 99.5 p 46.47 78.81 0.06 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.439 . . . . 70.439999999999998 110.876 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.5 t -175.27 -174.96 0.78 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.11 -0.496 . . . . 64.349999999999994 111.174 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 99.1 p -99.79 162.94 12.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.261 -0.427 . . . . 42.32 110.85 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.79 HG22 ' HB2' ' A' ' 177' ' ' GLN . 1.9 p -147.06 151.68 13.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 73.319999999999993 111.114 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 69.3 t -87.62 145.35 7.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.475 . . . . 62.329999999999998 111.116 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.31 123.1 6.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 71.409999999999997 110.92 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 100.49 -15.87 58.34 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.758 -0.734 . . . . 65.409999999999997 112.526 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . 0.79 ' HB2' HG22 ' A' ' 173' ' ' VAL . 12.9 mm100 -86.51 -177.09 6.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.819 0.343 . . . . 63.210000000000001 110.921 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 1.4 p -161.02 149.31 15.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 63.200000000000003 110.838 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 8.9 t -113.26 -178.25 3.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.09 -0.504 . . . . 71.049999999999997 111.113 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -138.61 128.89 25.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.203 -0.453 . . . . 55.409999999999997 111.16 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.457 HD23 ' HB3' ' A' ' 168' ' ' PRO . 7.6 mp -101.69 147.96 25.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 73.400000000000006 110.866 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 7.4 m -115.23 142.79 46.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.198 -0.456 . . . . 71.409999999999997 111.135 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 1.069 HG13 HG22 ' A' ' 166' ' ' VAL . 30.0 t -129.72 142.56 43.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 71.420000000000002 111.139 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.646 ' HB3' ' OG1' ' A' ' 165' ' ' THR . . . -130.41 152.94 49.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 35.229999999999997 111.078 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -146.4 131.85 18.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 52.32 110.885 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' GLN . . . . . 0.571 HE22 HG23 ' A' ' 165' ' ' THR . 0.0 OUTLIER -127.71 68.05 73.95 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.544 0.688 . . . . 72.420000000000002 110.931 -179.952 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.735 ' HA ' HG22 ' A' ' 162' ' ' THR . 53.4 Cg_endo . . . . . 0 C--O 1.231 0.136 0 C-N-CA 122.692 2.262 . . . . 64.209999999999994 112.345 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 15.2 t0 . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.9 0.381 . . . . 74.219999999999999 110.865 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.16 76.6 6.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.197 -0.456 . . . . 73.329999999999998 110.918 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 4.9 m -86.07 -6.48 59.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.258 -0.428 . . . . 53.119999999999997 110.86 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.775 ' CE2' HG11 ' A' ' 183' ' ' VAL . 20.2 p90 -90.74 173.4 8.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.129 -0.487 . . . . 63.130000000000003 110.867 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 23.4 ptt180 -163.04 172.56 14.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.138 -0.483 . . . . 71.129999999999995 110.874 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . 0.549 ' HB3' ' HB ' ' A' ' 209' ' ' VAL . . . -121.38 167.86 12.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 75.450000000000003 111.074 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 8.3 p -174.05 153.82 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 74.150000000000006 111.089 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.49 129.14 38.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.121 -0.491 . . . . 72.319999999999993 110.834 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.445 ' HB2' ' HD3' ' A' ' 227' ' ' PRO . . . -65.92 -21.86 66.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.114 -0.494 . . . . 64.340000000000003 111.078 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -155.45 86.85 1.09 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.245 -0.434 . . . . 43.140000000000001 110.869 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 24.4 ttmt -79.23 58.46 2.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.44 . . . . 71.420000000000002 110.905 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 27.6 p -132.89 3.68 3.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 74.400000000000006 111.123 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . 0.444 ' HA ' ' HB3' ' A' ' 220' ' ' ALA . 12.9 mtmm -154.22 16.51 0.48 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.238 -0.437 . . . . 60.329999999999998 110.918 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.4 ' HA ' ' H ' ' A' ' 219' ' ' VAL . . . -179.96 152.96 0.49 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.436 . . . . 72.340000000000003 111.068 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 12.1 p -107.9 154.13 22.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 74.329999999999998 111.17 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.73 HG12 HG22 ' A' ' 216' ' ' VAL . 13.3 m -140.58 136.36 35.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 74.340000000000003 111.124 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . 0.527 ' C ' HG23 ' A' ' 214' ' ' ILE . 1.2 t -144.99 108.44 4.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.459 . . . . 62.310000000000002 110.85 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.637 HG23 HG13 ' A' ' 214' ' ' ILE . 4.4 p -91.01 143.68 10.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 72.519999999999996 111.139 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 7.8 t -144.97 98.16 3.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 65.120000000000005 110.843 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 70.24 -81.63 0.36 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.748 -0.739 . . . . 74.120000000000005 112.497 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -138.78 7.68 2.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.838 0.351 . . . . 63.43 110.86 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 1.6 m -129.16 123.03 31.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.444 . . . . 74.140000000000001 111.185 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.637 HG13 HG23 ' A' ' 209' ' ' VAL . 2.4 mp -114.6 140.49 35.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 64.239999999999995 111.17 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.0 128.59 54.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 62.409999999999997 111.087 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.73 HG22 HG12 ' A' ' 207' ' ' VAL . 2.6 t -118.72 134.24 62.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 73.450000000000003 111.125 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -119.27 137.19 53.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 65.400000000000006 110.923 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -85.7 68.88 3.32 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.778 -0.725 . . . . 54.520000000000003 112.491 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.425 HG12 ' N ' ' A' ' 220' ' ' ALA . 1.9 t -49.45 -53.98 7.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.812 0.339 . . . . 63.100000000000001 111.116 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . 0.444 ' HB3' ' HA ' ' A' ' 204' ' ' LYS . . . -123.71 155.2 38.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 73.310000000000002 111.134 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . 0.664 ' HB2' ' HA ' ' A' ' 245' ' ' ALA . . . -67.27 137.11 55.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.238 -0.437 . . . . 65.430000000000007 111.106 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 141.32 175.09 14.67 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.703 -0.76 . . . . 70.120000000000005 112.503 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 223' ' ' LYS . . . . . 0.495 ' HG3' HG23 ' A' ' 242' ' ' THR . 5.1 mttp -98.86 122.24 41.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.787 0.327 . . . . 72.209999999999994 110.926 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 6.4 p -119.15 127.35 75.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 53.219999999999999 111.123 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . 0.418 ' C ' HD12 ' A' ' 226' ' ' ILE . 30.6 m120 -90.7 145.4 24.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 64.030000000000001 110.916 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.418 HD12 ' C ' ' A' ' 225' ' ' ASN . 4.8 mp -131.12 92.56 32.8 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.657 0.742 . . . . 72.349999999999994 111.126 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 227' ' ' PRO . . . . . 0.445 ' HD3' ' HB2' ' A' ' 200' ' ' ALA . 53.6 Cg_endo -69.75 179.21 3.85 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.705 2.27 . . . . 74.200000000000003 112.338 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.456 ' HB ' ' HB3' ' A' ' 237' ' ' ALA . 58.0 t -148.36 137.27 15.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 61.009999999999998 111.155 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 46.1 t -116.93 135.91 55.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 74.129999999999995 111.123 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.25 107.37 12.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 74.019999999999996 110.844 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 74.94 -118.23 5.6 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.752 -0.737 . . . . 52.210000000000001 112.492 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -108.06 19.95 19.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.851 0.357 . . . . 74.549999999999997 110.867 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 116.49 2.87 19.29 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.733 -0.746 . . . . 55.009999999999998 112.52 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -51.47 -71.47 0.06 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.876 0.37 . . . . 65.430000000000007 110.88 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -109.32 151.63 26.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 70.310000000000002 110.86 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -149.46 161.73 41.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 40.140000000000001 111.138 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . 0.456 ' HB3' ' HB ' ' A' ' 228' ' ' VAL . . . -139.61 163.15 33.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.246 -0.434 . . . . 73.540000000000006 111.149 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 43.0 t -136.58 139.58 44.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.281 -0.418 . . . . 73.209999999999994 111.117 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 239' ' ' ALA . . . . . 0.532 ' HB2' ' HG3' ' A' ' 168' ' ' PRO . . . -139.26 164.37 29.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.237 -0.438 . . . . 74.200000000000003 111.109 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 240' ' ' GLU . . . . . 0.448 ' O ' HD13 ' A' ' 241' ' ' ILE . 1.7 pt-20 -143.71 128.72 18.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.239 -0.437 . . . . 54.530000000000001 110.861 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 241' ' ' ILE . . . . . 0.448 HD13 ' O ' ' A' ' 240' ' ' GLU . 29.1 mm -125.2 110.85 25.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 72.519999999999996 111.156 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 242' ' ' THR . . . . . 0.495 HG23 ' HG3' ' A' ' 223' ' ' LYS . 1.5 m -80.75 138.82 36.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 73.349999999999994 111.191 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 18.3 t -120.07 117.82 54.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.24 -0.436 . . . . 65.239999999999995 111.152 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 244' ' ' THR . . . . . 0.481 HG23 ' O ' ' A' ' 173' ' ' VAL . 4.3 p -81.86 132.94 35.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 54.439999999999998 111.149 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 245' ' ' ALA . . . . . 0.664 ' HA ' ' HB2' ' A' ' 221' ' ' ALA . . . -53.24 -28.52 27.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 71.030000000000001 111.106 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 1.4 t . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 61.140000000000001 110.845 -179.789 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 N-CA-C 112.507 -0.237 . . . . 50.340000000000003 112.507 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -95.23 90.48 5.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.744 0.306 . . . . 74.120000000000005 111.059 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 7.7 mtt -151.26 174.43 13.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.235 -0.439 . . . . 74.230000000000004 110.903 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -122.54 128.15 50.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.255 -0.43 . . . . 65.310000000000002 111.104 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.718 ' HB2' ' HA3' ' A' ' 231' ' ' GLY . . . -64.08 -70.01 0.25 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.251 -0.431 . . . . 75.450000000000003 111.119 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -178.55 -169.16 0.17 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.449 . . . . 75.329999999999998 111.051 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -127.6 24.34 6.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 51.119999999999997 111.155 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 151.54 99.08 0.18 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.776 -0.726 . . . . 42.119999999999997 112.551 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 43.8 ttp -113.13 125.5 54.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.846 0.355 . . . . 72.420000000000002 110.901 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.64 ' OG1' ' HB3' ' A' ' 184' ' ' ALA . 51.6 p -114.47 103.62 11.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 61.219999999999999 111.153 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 1.087 HG22 HG13 ' A' ' 183' ' ' VAL . 21.4 t -99.7 130.48 48.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.256 -0.429 . . . . 73.349999999999994 111.117 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.3 m -125.0 92.88 46.81 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.593 0.711 . . . . 73.200000000000003 111.113 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.473 ' HB3' HD23 ' A' ' 181' ' ' LEU . 53.7 Cg_endo -69.74 -168.85 0.29 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.668 2.245 . . . . 65.010000000000005 112.381 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -86.73 -40.84 14.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.279 -0.419 . . . . 74.430000000000007 111.104 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 93.6 p 46.43 79.06 0.06 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.245 -0.434 . . . . 51.329999999999998 110.851 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.5 t -175.09 -174.89 0.8 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.126 -0.488 . . . . 62.439999999999998 111.118 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 89.4 p -98.8 164.06 12.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 73.400000000000006 110.849 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.715 HG22 ' HB2' ' A' ' 177' ' ' GLN . 3.5 p -146.31 154.02 12.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 65.329999999999998 111.111 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 66.7 t -87.35 145.31 7.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 71.109999999999999 111.071 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -49.03 122.56 5.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.134 -0.484 . . . . 71.120000000000005 110.923 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.38 -14.59 60.83 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.75 -0.738 . . . . 74.120000000000005 112.476 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.715 ' HB2' HG22 ' A' ' 173' ' ' VAL . 17.4 mm100 -90.82 -178.22 5.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.83 0.347 . . . . 72.519999999999996 110.927 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 35.1 p -161.51 148.49 14.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.224 -0.444 . . . . 74.430000000000007 110.85 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.484 HG21 HD12 ' A' ' 241' ' ' ILE . 6.7 t -106.81 -173.55 2.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.075 -0.511 . . . . 53.43 111.151 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.29 132.31 27.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.231 -0.44 . . . . 75.5 111.133 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.473 HD23 ' HB3' ' A' ' 168' ' ' PRO . 7.7 mp -105.21 143.05 33.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 72.439999999999998 110.951 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 21.9 m -110.06 142.36 41.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.217 -0.447 . . . . 72.519999999999996 111.118 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 1.087 HG13 HG22 ' A' ' 166' ' ' VAL . 18.4 t -129.34 140.24 49.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 73.329999999999998 111.13 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.64 ' HB3' ' OG1' ' A' ' 165' ' ' THR . . . -130.11 152.12 49.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.143 -0.48 . . . . 64.450000000000003 111.098 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -145.76 126.88 14.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 74.409999999999997 110.865 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.58 66.71 77.33 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.542 0.687 . . . . 73.120000000000005 110.921 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -38.37 7.91 Favored 'Trans proline' 0 N--CA 1.465 -0.155 0 C-N-CA 122.676 2.251 . . . . 73.450000000000003 112.377 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 66.92 45.68 1.77 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 71.030000000000001 110.892 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 163.74 -24.13 0.18 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.744 -0.741 . . . . 44.340000000000003 112.467 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 3.4 t -93.36 -58.99 3.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.918 0.39 . . . . 71.519999999999996 111.15 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 70.3 p 47.42 70.5 0.41 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 71.140000000000001 111.119 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -167.8 119.41 0.86 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 65.530000000000001 110.876 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.12 92.43 0.11 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 54.420000000000002 110.913 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 1.6 m -105.78 -7.08 18.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 60.32 110.831 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.776 ' CE2' HG11 ' A' ' 183' ' ' VAL . 19.2 p90 -91.34 176.35 6.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.098 -0.501 . . . . 72.430000000000007 110.913 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -163.05 171.16 16.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.459 . . . . 73.430000000000007 110.839 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . 0.416 ' HB3' ' HB ' ' A' ' 209' ' ' VAL . . . -120.31 168.0 11.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 72.430000000000007 111.078 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 11.3 p -175.21 151.45 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 75.0 111.108 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.7 t -77.31 150.15 35.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.126 -0.488 . . . . 53.030000000000001 110.858 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.522 ' HB2' ' HD3' ' A' ' 227' ' ' PRO . . . -86.32 -23.79 26.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 63.149999999999999 111.138 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -127.7 -52.52 1.35 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.19 -0.459 . . . . 64.340000000000003 110.831 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.24 24.39 14.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.2 -0.455 . . . . 74.439999999999998 110.91 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 35.5 p -113.37 -2.73 13.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.246 -0.433 . . . . 71.409999999999997 111.138 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 8.8 mtmm -152.59 18.53 0.62 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.251 -0.432 . . . . 74.340000000000003 110.878 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.629 ' HA ' HG23 ' A' ' 219' ' ' VAL . . . -177.22 146.61 0.5 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 73.129999999999995 111.089 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 11.9 p -107.22 159.04 16.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.174 -0.467 . . . . 50.119999999999997 111.117 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.769 HG12 HG22 ' A' ' 216' ' ' VAL . 11.2 m -141.23 141.72 30.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 53.100000000000001 111.141 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 4.3 m -148.76 108.46 4.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 72.299999999999997 110.843 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.494 HG23 HG13 ' A' ' 214' ' ' ILE . 3.5 p -87.96 143.1 11.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.132 -0.485 . . . . 74.299999999999997 111.132 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 16.7 t -172.08 123.45 0.5 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 73.329999999999998 110.841 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 55.86 47.16 80.96 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.745 -0.74 . . . . 75.140000000000001 112.488 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 2.1 mtp 63.74 16.01 9.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.853 0.359 . . . . 71.519999999999996 110.896 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 7.0 m -126.0 113.59 17.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 63.420000000000002 111.146 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.494 HG13 HG23 ' A' ' 209' ' ' VAL . 2.9 mp -110.23 113.96 45.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 75.109999999999999 111.125 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 5.0 m -88.1 132.16 34.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.45 . . . . 74.310000000000002 111.123 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.769 HG22 HG12 ' A' ' 207' ' ' VAL . 3.3 t -117.21 124.47 73.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 64.510000000000005 111.082 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -106.19 139.33 40.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 73.310000000000002 110.907 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -94.22 79.57 0.96 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.782 -0.723 . . . . 60.340000000000003 112.495 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.629 HG23 ' HA ' ' A' ' 205' ' ' ALA . 19.6 t -50.29 -55.96 4.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.792 0.329 . . . . 63.530000000000001 111.175 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -128.71 161.4 29.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 54.439999999999998 111.095 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . 0.684 ' HB2' ' HA ' ' A' ' 245' ' ' ALA . . . -61.06 140.31 57.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.215 -0.448 . . . . 71.219999999999999 111.121 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 139.41 171.21 12.15 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.743 -0.741 . . . . 74.409999999999997 112.488 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . 0.495 ' HG3' HG23 ' A' ' 242' ' ' THR . 14.3 mttt -99.46 124.56 44.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.821 0.343 . . . . 54.399999999999999 110.941 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.593 HG11 ' CB ' ' A' ' 205' ' ' ALA . 7.0 p -120.96 127.37 75.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 72.109999999999999 111.169 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.606 ' C ' HD12 ' A' ' 226' ' ' ILE . 21.3 m120 -90.81 151.81 21.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 64.310000000000002 110.906 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.606 HD12 ' C ' ' A' ' 225' ' ' ASN . 4.4 mp -138.06 93.12 12.0 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.622 0.725 . . . . 71.120000000000005 111.125 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' PRO . . . . . 0.522 ' HD3' ' HB2' ' A' ' 200' ' ' ALA . 53.6 Cg_endo -69.79 -178.3 2.29 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.708 2.272 . . . . 71.219999999999999 112.34 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 90.5 t -150.09 134.78 9.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 61.210000000000001 111.137 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 80.4 t -117.08 135.59 56.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.147 -0.478 . . . . 65.230000000000004 111.161 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . 0.488 ' OG ' ' HB1' ' A' ' 160' ' ' ALA . 31.0 t -122.12 116.65 24.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 74.120000000000005 110.871 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . 0.718 ' HA3' ' HB2' ' A' ' 160' ' ' ALA . . . 66.48 -115.04 6.98 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.729 -0.748 . . . . 63.109999999999999 112.464 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -110.54 19.23 18.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.874 0.369 . . . . 65.219999999999999 110.888 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 117.33 2.72 17.69 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.748 -0.739 . . . . 75.439999999999998 112.485 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -51.06 -70.36 0.09 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.866 0.365 . . . . 70.219999999999999 110.902 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -107.38 159.66 16.22 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.172 -0.467 . . . . 72.530000000000001 110.852 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -160.75 165.19 30.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.103 -0.499 . . . . 74.409999999999997 111.091 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -146.2 163.18 36.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 71.439999999999998 111.135 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 24.1 t -137.18 137.02 46.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.215 -0.448 . . . . 62.039999999999999 111.11 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -139.08 165.29 27.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.173 -0.467 . . . . 73.530000000000001 111.134 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . 0.419 ' O ' HD13 ' A' ' 241' ' ' ILE . 5.8 pt-20 -144.95 132.51 20.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.244 -0.434 . . . . 74.140000000000001 110.851 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' ILE . . . . . 0.587 HG13 HG11 ' A' ' 216' ' ' VAL . 23.5 mm -126.87 115.09 40.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.134 -0.485 . . . . 72.25 111.174 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' THR . . . . . 0.495 HG23 ' HG3' ' A' ' 223' ' ' LYS . 2.0 m -82.43 141.24 32.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.152 -0.476 . . . . 62.0 111.162 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 17.8 t -119.71 121.54 66.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 52.399999999999999 111.128 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' THR . . . . . 0.529 HG23 ' O ' ' A' ' 173' ' ' VAL . 7.1 p -82.28 133.0 35.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 73.420000000000002 111.17 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' ALA . . . . . 0.684 ' HA ' ' HB2' ' A' ' 221' ' ' ALA . . . -58.33 -22.52 53.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 34.229999999999997 111.113 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 1.4 p . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.197 -0.456 . . . . 73.299999999999997 110.866 -179.77 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 N-CA-C 112.539 -0.224 . . . . 62.399999999999999 112.539 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -112.3 159.2 18.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.821 0.343 . . . . 73.109999999999999 111.09 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 4.1 mmt -134.4 178.92 6.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 71.239999999999995 110.9 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -137.33 142.62 41.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.249 -0.432 . . . . 73.310000000000002 111.129 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.728 ' HB2' ' HA3' ' A' ' 231' ' ' GLY . . . -60.67 -64.75 0.84 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 74.019999999999996 111.09 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -177.78 -169.6 0.22 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 71.219999999999999 111.093 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -129.25 24.09 5.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.24 -0.436 . . . . 64.439999999999998 111.088 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 153.28 99.85 0.18 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.734 -0.746 . . . . 74.030000000000001 112.448 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 21.3 ttp -113.85 124.6 52.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.85 0.357 . . . . 64.549999999999997 110.872 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.648 ' OG1' ' HB3' ' A' ' 184' ' ' ALA . 51.6 p -114.58 103.32 10.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.257 -0.429 . . . . 70.420000000000002 111.147 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 1.037 HG22 HG13 ' A' ' 183' ' ' VAL . 21.7 t -97.97 131.72 44.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.192 -0.458 . . . . 75.540000000000006 111.153 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.4 m -126.46 92.38 45.39 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.545 0.688 . . . . 72.530000000000001 111.143 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.472 ' HG3' ' HB2' ' A' ' 239' ' ' ALA . 53.5 Cg_endo -69.82 -167.2 0.22 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.67 2.247 . . . . 74.109999999999999 112.321 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -85.94 -40.26 16.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 61.299999999999997 111.15 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 87.9 p 46.41 77.29 0.08 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.213 -0.449 . . . . 75.030000000000001 110.877 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.5 t -175.72 -174.82 0.71 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.12 -0.491 . . . . 73.109999999999999 111.128 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 34.6 p -100.56 162.91 12.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 72.239999999999995 110.862 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.732 HG22 ' HB2' ' A' ' 177' ' ' GLN . 3.3 p -144.27 153.03 15.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 64.530000000000001 111.12 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 63.2 t -86.58 145.26 7.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 73.420000000000002 111.152 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.1 122.3 5.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.191 -0.459 . . . . 73.340000000000003 110.899 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 100.19 -14.35 59.79 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.758 -0.734 . . . . 61.210000000000001 112.484 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.732 ' HB2' HG22 ' A' ' 173' ' ' VAL . 11.7 mm100 -90.03 -177.66 5.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.81 0.338 . . . . 60.409999999999997 110.935 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 2.2 p -160.9 148.82 15.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 43.140000000000001 110.836 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.494 HG21 HD12 ' A' ' 241' ' ' ILE . 7.5 t -109.65 -176.82 3.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 50.25 111.128 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -139.47 127.51 22.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 60.229999999999997 111.148 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.466 HD23 ' HB3' ' A' ' 168' ' ' PRO . 7.9 mp -99.89 145.71 27.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.221 -0.445 . . . . 75.540000000000006 110.902 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -114.1 143.21 45.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 64.219999999999999 111.173 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 1.037 HG13 HG22 ' A' ' 166' ' ' VAL . 25.4 t -129.47 141.9 45.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 61.240000000000002 111.146 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.648 ' HB3' ' OG1' ' A' ' 165' ' ' THR . . . -129.81 150.66 51.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 75.25 111.095 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -144.5 127.8 16.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 65.5 110.901 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.39 66.76 71.3 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.642 0.734 . . . . 74.219999999999999 110.877 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 -35.76 12.11 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.657 2.238 . . . . 74.209999999999994 112.367 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 65.61 43.8 3.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 62.310000000000002 110.885 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 166.26 -38.74 0.26 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.719 -0.753 . . . . 44.520000000000003 112.503 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 2.6 t -76.99 -56.9 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.859 0.361 . . . . 71.019999999999996 111.111 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 50.2 p 47.43 66.02 1.12 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 72.109999999999999 111.147 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -167.2 116.81 0.85 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.205 -0.452 . . . . 73.310000000000002 110.86 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.37 104.53 0.51 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 74.099999999999994 110.932 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 1.2 m -115.42 -6.14 12.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 65.200000000000003 110.843 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.777 ' CE2' HG11 ' A' ' 183' ' ' VAL . 21.9 p90 -90.31 174.45 7.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.125 -0.489 . . . . 74.319999999999993 110.878 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -165.7 151.64 9.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 73.150000000000006 110.863 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . 0.759 ' HB3' ' HB ' ' A' ' 209' ' ' VAL . . . -104.2 158.91 16.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 75.439999999999998 111.116 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.635 ' O ' HG23 ' A' ' 226' ' ' ILE . 6.4 m -153.04 -178.05 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 75.340000000000003 111.16 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 11.9 p -108.1 132.27 53.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 73.310000000000002 110.887 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.497 ' HB2' ' HD3' ' A' ' 227' ' ' PRO . . . -75.35 -26.01 58.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.122 -0.49 . . . . 40.009999999999998 111.14 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -129.01 -60.02 1.1 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.454 . . . . 75.409999999999997 110.884 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 63.88 35.45 10.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 45.310000000000002 110.922 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 32.7 p -118.44 -4.73 10.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.165 -0.47 . . . . 75.150000000000006 111.064 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 9.4 mtmm -152.84 18.63 0.59 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.255 -0.43 . . . . 61.530000000000001 110.907 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.663 ' HA ' HG23 ' A' ' 219' ' ' VAL . . . -171.26 144.91 2.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 71.310000000000002 111.128 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 17.0 p -107.37 130.85 54.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.249 -0.432 . . . . 64.150000000000006 111.17 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.913 HG12 HG22 ' A' ' 216' ' ' VAL . 4.8 m -118.86 138.99 47.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 71.450000000000003 111.145 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . 0.496 ' C ' HG23 ' A' ' 214' ' ' ILE . 5.7 t -145.29 109.09 4.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 61.450000000000003 110.849 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.759 ' HB ' ' HB3' ' A' ' 197' ' ' ALA . 4.2 p -89.4 143.61 10.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.104 -0.498 . . . . 63.149999999999999 111.091 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 3.4 t -144.79 96.28 2.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.138 -0.483 . . . . 34.119999999999997 110.885 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 70.29 -81.04 0.38 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.78 -0.724 . . . . 72.430000000000007 112.507 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -138.43 8.09 2.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.882 0.373 . . . . 64.209999999999994 110.911 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -129.24 121.82 28.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 63.119999999999997 111.168 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.654 HG13 HG23 ' A' ' 209' ' ' VAL . 2.6 mp -115.3 131.79 66.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 71.239999999999995 111.131 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 1.5 m -100.63 125.71 47.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.139 -0.482 . . . . 74.219999999999999 111.152 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.913 HG22 HG12 ' A' ' 207' ' ' VAL . 2.4 t -116.64 126.66 74.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 74.200000000000003 111.165 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -112.19 138.96 48.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 63.030000000000001 110.86 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -93.4 80.98 1.04 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.768 -0.729 . . . . 54.200000000000003 112.469 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.663 HG23 ' HA ' ' A' ' 205' ' ' ALA . 19.3 t -50.26 -51.18 18.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.855 0.36 . . . . 71.120000000000005 111.099 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -137.78 162.36 34.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 53.210000000000001 111.132 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . 0.631 ' HB2' ' HA ' ' A' ' 245' ' ' ALA . . . -57.25 143.45 39.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 74.329999999999998 111.132 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 137.18 167.95 11.23 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.748 -0.739 . . . . 52.439999999999998 112.482 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . 0.618 ' HG3' HG23 ' A' ' 242' ' ' THR . 6.1 mttp -102.47 133.93 46.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.83 0.348 . . . . 73.549999999999997 110.893 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 13.1 p -130.49 131.66 65.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 50.549999999999997 111.118 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.617 ' C ' HD12 ' A' ' 226' ' ' ILE . 33.3 m120 -91.33 152.45 20.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.464 . . . . 63.420000000000002 110.905 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.635 HG23 ' O ' ' A' ' 198' ' ' VAL . 4.3 mp -137.43 92.44 13.47 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.611 0.719 . . . . 61.100000000000001 111.124 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' PRO . . . . . 0.497 ' HD3' ' HB2' ' A' ' 200' ' ' ALA . 54.5 Cg_endo -69.71 -179.55 2.97 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.689 2.26 . . . . 75.430000000000007 112.367 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 85.9 t -150.4 134.84 9.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 34.539999999999999 111.125 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 86.9 t -116.94 136.07 55.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 74.099999999999994 111.147 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -119.77 108.83 14.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 55.43 110.844 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . 0.728 ' HA3' ' HB2' ' A' ' 160' ' ' ALA . . . 56.99 -116.05 7.32 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.767 -0.73 . . . . 44.509999999999998 112.503 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 17.9 p30 -95.04 19.3 10.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.836 0.351 . . . . 64.310000000000002 110.842 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 101.09 8.28 47.98 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.72 -0.752 . . . . 42.149999999999999 112.486 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -52.0 -33.81 39.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.814 0.34 . . . . 62.329999999999998 110.835 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -144.21 153.21 41.85 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.202 -0.454 . . . . 74.310000000000002 110.894 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -154.28 165.53 36.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.174 -0.466 . . . . 42.420000000000002 111.097 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -145.78 163.16 35.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.464 . . . . 64.340000000000003 111.115 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 23.3 t -136.6 135.83 48.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.251 -0.431 . . . . 74.530000000000001 111.131 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . 0.472 ' HB2' ' HG3' ' A' ' 168' ' ' PRO . . . -138.6 165.29 27.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 73.319999999999993 111.123 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -145.81 132.37 19.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 75.219999999999999 110.862 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' ILE . . . . . 0.529 HG13 HG11 ' A' ' 216' ' ' VAL . 24.5 mm -125.79 113.59 35.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.194 -0.457 . . . . 72.540000000000006 111.151 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' THR . . . . . 0.618 HG23 ' HG3' ' A' ' 223' ' ' LYS . 1.7 m -83.17 141.63 31.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 63.509999999999998 111.146 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 11.3 t -119.78 122.78 69.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.44 . . . . 73.019999999999996 111.17 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' THR . . . . . 0.51 HG23 ' O ' ' A' ' 173' ' ' VAL . 4.2 p -84.75 132.56 34.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 63.229999999999997 111.141 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' ALA . . . . . 0.631 ' HA ' ' HB2' ' A' ' 221' ' ' ALA . . . -58.18 -23.48 55.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 62.549999999999997 111.097 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 58.8 m . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 72.439999999999998 110.884 -179.792 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.3 0 N-CA-C 112.489 -0.245 . . . . 64.439999999999998 112.489 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -64.06 153.52 37.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.845 0.355 . . . . 62.420000000000002 111.049 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 2.0 tpt -68.14 150.48 48.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.21 -0.45 . . . . 72.040000000000006 110.907 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -114.98 123.89 50.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.269 -0.423 . . . . 75.099999999999994 111.128 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.79 ' HB2' ' HA3' ' A' ' 231' ' ' GLY . . . -82.15 -65.74 0.97 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 71.150000000000006 111.095 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -178.28 -169.14 0.18 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.251 -0.431 . . . . 72.209999999999994 111.131 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 1.9 m -128.26 24.13 5.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.261 -0.427 . . . . 61.109999999999999 111.165 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 153.41 99.04 0.17 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.701 -0.762 . . . . 73.329999999999998 112.476 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 27.9 ttp -113.18 125.34 54.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.862 0.363 . . . . 74.209999999999994 110.851 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.596 ' OG1' ' HB3' ' A' ' 184' ' ' ALA . 48.5 p -114.72 104.01 11.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 71.310000000000002 111.142 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 1.071 HG22 HG13 ' A' ' 183' ' ' VAL . 21.7 t -100.41 130.98 48.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 61.100000000000001 111.117 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 19.2 m -125.1 92.48 47.36 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.551 0.691 . . . . 75.439999999999998 111.085 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.481 ' HG3' ' HB2' ' A' ' 239' ' ' ALA . 53.7 Cg_endo -69.8 -166.75 0.2 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.649 2.233 . . . . 71.109999999999999 112.355 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -86.59 -40.59 15.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.436 . . . . 53.130000000000003 111.063 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 88.2 p 46.72 76.3 0.1 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 61.340000000000003 110.875 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.5 t -174.23 -174.9 0.93 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 73.340000000000003 111.152 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 24.5 p -100.37 162.24 13.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 51.420000000000002 110.824 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.725 HG22 ' HB2' ' A' ' 177' ' ' GLN . 2.8 p -144.27 154.06 15.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.117 -0.492 . . . . 64.209999999999994 111.127 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 79.5 t -89.29 144.48 9.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 63.049999999999997 111.142 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.78 123.76 6.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.451 . . . . 70.409999999999997 110.92 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.84 -16.14 58.84 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.788 -0.72 . . . . 60.310000000000002 112.498 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.725 ' HB2' HG22 ' A' ' 173' ' ' VAL . 9.7 mm100 -89.41 -177.89 5.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.846 0.355 . . . . 75.530000000000001 110.914 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 11.9 p -161.98 147.09 12.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.212 -0.449 . . . . 62.310000000000002 110.884 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 7.3 t -108.12 -174.69 2.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 73.120000000000005 111.132 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -140.42 132.31 27.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 75.129999999999995 111.189 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.474 HD23 ' HB3' ' A' ' 168' ' ' PRO . 7.6 mp -105.12 142.14 35.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 73.329999999999998 110.919 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 24.9 m -110.01 141.99 42.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 65.430000000000007 111.179 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 1.071 HG13 HG22 ' A' ' 166' ' ' VAL . 21.5 t -129.32 139.87 50.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.293 -0.412 . . . . 64.219999999999999 111.127 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.596 ' HB3' ' OG1' ' A' ' 165' ' ' THR . . . -130.11 151.91 50.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.124 -0.489 . . . . 73.450000000000003 111.126 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -144.24 128.69 17.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 75.420000000000002 110.889 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.25 66.69 71.66 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.582 0.706 . . . . 75.230000000000004 110.912 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 -37.38 9.22 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.68 2.253 . . . . 65.349999999999994 112.355 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 66.31 43.7 2.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 75.540000000000006 110.84 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 166.63 -29.7 0.19 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.722 -0.751 . . . . 71.150000000000006 112.468 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 2.9 t -87.16 -57.86 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.914 0.387 . . . . 75.230000000000004 111.129 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 65.2 p 47.53 69.94 0.47 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 74.049999999999997 111.135 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -170.22 118.65 0.57 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 64.439999999999998 110.883 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 9.5 mtmt -63.24 96.78 0.11 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 74.530000000000001 110.914 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 2.0 m -109.84 -6.25 15.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 73.219999999999999 110.877 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.773 ' CE2' HG11 ' A' ' 183' ' ' VAL . 20.6 p90 -90.71 175.9 6.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.073 -0.512 . . . . 62.219999999999999 110.845 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 3.1 ptt-85 -158.25 173.71 16.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.132 -0.486 . . . . 73.219999999999999 110.89 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . 0.553 ' HB3' ' HB ' ' A' ' 209' ' ' VAL . . . -124.65 167.16 14.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 42.039999999999999 111.086 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 10.0 p -174.77 152.73 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 73.439999999999998 111.131 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.7 126.75 36.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.156 -0.475 . . . . 71.319999999999993 110.878 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.526 ' HB2' ' HD3' ' A' ' 227' ' ' PRO . . . -61.68 -17.94 57.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.115 -0.493 . . . . 74.129999999999995 111.093 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -156.99 92.43 1.27 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.213 -0.449 . . . . 61.409999999999997 110.913 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 8.0 tttp -83.65 55.18 3.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 75.049999999999997 110.931 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 20.0 p -130.66 2.67 4.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.246 -0.434 . . . . 54.100000000000001 111.144 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . 0.45 ' HA ' ' HB3' ' A' ' 220' ' ' ALA . 10.8 mtmm -153.99 18.23 0.51 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 65.230000000000004 110.881 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -179.47 153.4 0.57 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.449 . . . . 65.540000000000006 111.113 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 8.4 p -117.49 131.23 56.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 73.340000000000003 111.142 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 1.05 HG12 HG22 ' A' ' 216' ' ' VAL . 4.9 m -120.1 140.33 44.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.184 -0.462 . . . . 43.299999999999997 111.112 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.16 109.0 4.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 72.420000000000002 110.868 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.553 ' HB ' ' HB3' ' A' ' 197' ' ' ALA . 3.7 p -85.45 143.08 12.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.138 -0.483 . . . . 63.200000000000003 111.173 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 17.2 p -172.19 123.85 0.5 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 62.109999999999999 110.839 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 55.4 48.05 72.15 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.752 -0.737 . . . . 43.439999999999998 112.476 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 2.4 mtp 62.5 16.47 8.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.884 0.373 . . . . 72.510000000000005 110.853 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 1.4 m -128.15 114.23 16.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.26 -0.427 . . . . 54.210000000000001 111.153 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.537 HG13 HG23 ' A' ' 209' ' ' VAL . 3.4 mp -110.24 115.61 50.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 75.25 111.076 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 1.3 m -89.99 126.91 35.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 75.430000000000007 111.118 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 1.05 HG22 HG12 ' A' ' 207' ' ' VAL . 4.8 t -112.74 128.28 69.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.216 -0.447 . . . . 72.510000000000005 111.135 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -109.56 135.69 50.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 75.409999999999997 110.921 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -84.41 66.81 3.82 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.731 -0.747 . . . . 71.200000000000003 112.507 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.418 HG12 ' N ' ' A' ' 220' ' ' ALA . 1.9 t -48.75 -53.58 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.817 0.341 . . . . 70.239999999999995 111.146 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . 0.45 ' HB3' ' HA ' ' A' ' 204' ' ' LYS . . . -123.96 155.33 38.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.146 -0.479 . . . . 61.329999999999998 111.114 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . 0.662 ' HB2' ' HA ' ' A' ' 245' ' ' ALA . . . -67.82 138.03 55.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 74.239999999999995 111.054 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 140.46 174.68 14.05 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.769 -0.729 . . . . 52.039999999999999 112.478 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . 0.551 ' HG3' HG23 ' A' ' 242' ' ' THR . 6.0 mttp -99.38 121.51 41.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.827 0.346 . . . . 72.129999999999995 110.885 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 7.6 p -120.35 128.67 76.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 73.299999999999997 111.132 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.456 ' C ' HD12 ' A' ' 226' ' ' ILE . 36.1 m120 -90.52 150.2 21.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.145 -0.479 . . . . 70.409999999999997 110.863 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.456 HD12 ' C ' ' A' ' 225' ' ' ASN . 4.7 mp -133.19 92.39 25.17 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.675 0.75 . . . . 75.510000000000005 111.135 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' PRO . . . . . 0.526 ' HD3' ' HB2' ' A' ' 200' ' ' ALA . 54.5 Cg_endo -69.7 -179.67 3.05 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.687 2.258 . . . . 63.399999999999999 112.375 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 96.2 t -149.46 136.13 12.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 74.400000000000006 111.142 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 82.6 t -118.26 135.52 58.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.186 -0.461 . . . . 73.349999999999994 111.134 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.21 108.8 14.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 72.200000000000003 110.856 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . 0.79 ' HA3' ' HB2' ' A' ' 160' ' ' ALA . . . 74.06 -111.44 3.43 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.763 -0.732 . . . . 54.32 112.485 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -111.09 8.31 21.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.907 0.384 . . . . 75.349999999999994 110.948 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 127.78 3.24 6.0 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.709 -0.758 . . . . 52.219999999999999 112.456 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -51.66 -73.21 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.853 0.358 . . . . 75.329999999999998 110.899 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -102.94 156.37 17.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.468 . . . . 71.25 110.872 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -157.24 165.18 36.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.148 -0.478 . . . . 74.319999999999993 111.068 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -144.83 163.5 33.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 74.299999999999997 111.096 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 58.8 t -137.02 136.46 47.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.226 -0.443 . . . . 55.520000000000003 111.126 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . 0.481 ' HB2' ' HG3' ' A' ' 168' ' ' PRO . . . -138.72 165.26 27.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 72.319999999999993 111.103 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . 0.507 ' O ' HD13 ' A' ' 241' ' ' ILE . 1.8 pt-20 -143.15 131.49 22.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 75.109999999999999 110.888 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' ILE . . . . . 0.507 HD13 ' O ' ' A' ' 240' ' ' GLU . 25.8 mm -127.28 112.05 27.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.13 -0.486 . . . . 71.420000000000002 111.089 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' THR . . . . . 0.551 HG23 ' HG3' ' A' ' 223' ' ' LYS . 1.7 m -82.5 139.28 34.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.189 -0.46 . . . . 53.450000000000003 111.132 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 22.1 t -120.49 119.48 59.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.23 -0.441 . . . . 61.329999999999998 111.142 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' THR . . . . . 0.479 HG23 ' O ' ' A' ' 173' ' ' VAL . 6.8 p -81.91 132.9 35.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 74.430000000000007 111.169 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' ALA . . . . . 0.662 ' HA ' ' HB2' ' A' ' 221' ' ' ALA . . . -55.2 -26.19 37.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 73.030000000000001 111.051 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 9.3 t . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.234 -0.439 . . . . 62.25 110.846 -179.785 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 N-CA-C 112.48 -0.248 . . . . 42.530000000000001 112.48 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -77.98 -56.14 4.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.756 0.312 . . . . 73.109999999999999 111.109 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 20.8 mmt -90.19 130.98 36.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.242 -0.435 . . . . 55.509999999999998 110.846 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -169.19 -169.71 1.0 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 51.350000000000001 111.111 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -175.15 129.36 0.29 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 55.329999999999998 111.088 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.65 -167.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 75.319999999999993 111.106 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -125.02 32.28 5.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 61.340000000000003 111.093 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 136.87 99.7 0.55 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.72 -0.752 . . . . 65.430000000000007 112.501 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 11.6 ttp -109.75 133.04 53.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.83 0.348 . . . . 71.099999999999994 110.898 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.461 ' HG1' ' HB3' ' A' ' 184' ' ' ALA . 33.4 p -121.65 108.17 13.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 51.43 111.147 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 1.125 HG22 HG13 ' A' ' 183' ' ' VAL . 26.3 t -102.23 132.29 48.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 53.109999999999999 111.122 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.7 m -124.33 92.49 48.05 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.599 0.714 . . . . 72.5 111.143 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.483 ' HB3' HD23 ' A' ' 181' ' ' LEU . 53.7 Cg_endo -69.75 -166.43 0.19 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.709 2.273 . . . . 63.039999999999999 112.329 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -89.03 -39.49 13.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 71.0 111.133 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 98.2 p 46.32 79.33 0.06 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 53.32 110.829 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.1 t -175.55 -174.59 0.71 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.093 -0.503 . . . . 71.030000000000001 111.121 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 97.2 p -99.89 163.19 12.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.262 -0.426 . . . . 63.310000000000002 110.886 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.737 HG22 ' HB2' ' A' ' 177' ' ' GLN . 3.1 p -144.95 153.6 14.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.134 -0.484 . . . . 64.120000000000005 111.099 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 58.7 t -87.53 145.67 7.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 63.530000000000001 111.13 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.34 122.37 6.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.459 . . . . 61.299999999999997 110.919 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.7 -12.54 61.14 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.761 -0.733 . . . . 61.130000000000003 112.489 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.737 ' HB2' HG22 ' A' ' 173' ' ' VAL . 13.9 mm100 -92.64 -178.06 4.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.779 0.323 . . . . 62.039999999999999 110.928 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 23.8 p -161.5 148.83 14.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 62.219999999999999 110.878 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.424 HG21 HD12 ' A' ' 241' ' ' ILE . 9.1 t -108.74 -175.4 2.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.124 -0.489 . . . . 73.010000000000005 111.137 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -138.9 132.98 31.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 65.400000000000006 111.143 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.483 HD23 ' HB3' ' A' ' 168' ' ' PRO . 7.4 mp -106.52 143.59 34.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 74.230000000000004 110.946 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 2.2 m -111.75 142.5 44.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.462 . . . . 75.109999999999999 111.11 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 1.125 HG13 HG22 ' A' ' 166' ' ' VAL . 22.6 t -129.75 140.52 48.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 71.400000000000006 111.141 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.461 ' HB3' ' HG1' ' A' ' 165' ' ' THR . . . -132.38 152.49 51.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 44.039999999999999 111.097 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -143.77 128.7 18.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.455 . . . . 65.5 110.866 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.77 67.11 76.81 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.577 0.704 . . . . 60.25 110.896 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 -35.45 12.72 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.675 2.25 . . . . 71.349999999999994 112.357 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 65.89 38.25 5.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.241 -0.436 . . . . 71.129999999999995 110.904 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 171.65 -44.91 0.18 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.71 -0.757 . . . . 72.420000000000002 112.488 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 2.9 t -69.05 -58.18 6.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.897 0.379 . . . . 73.349999999999994 111.1 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 41.4 p 48.23 61.7 2.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 73.150000000000006 111.11 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -164.7 112.51 1.06 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.241 -0.436 . . . . 73.049999999999997 110.881 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 6.1 mtmt -52.94 105.55 0.13 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 75.140000000000001 110.888 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 59.8 m -116.76 -6.69 11.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 64.400000000000006 110.857 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.755 ' CE2' HG11 ' A' ' 183' ' ' VAL . 23.6 p90 -90.75 176.5 6.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.101 -0.499 . . . . 61.530000000000001 110.857 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.28 157.34 15.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.122 -0.49 . . . . 71.439999999999998 110.862 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -105.48 167.78 9.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.47 . . . . 55.140000000000001 111.115 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 11.6 p -164.32 151.06 2.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 72.150000000000006 111.153 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.56 121.17 29.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 53.509999999999998 110.874 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.613 ' HB2' ' HD3' ' A' ' 227' ' ' PRO . . . -65.34 -19.49 65.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.103 -0.499 . . . . 73.329999999999998 111.107 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -163.81 91.4 0.65 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.17 -0.468 . . . . 32.340000000000003 110.845 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 7.8 ttpt -83.19 55.59 3.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 70.420000000000002 110.909 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 25.0 p -128.06 -0.23 5.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.236 -0.438 . . . . 75.019999999999996 111.153 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 6.1 mtmt -156.42 19.45 0.35 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.18 -0.463 . . . . 71.239999999999995 110.9 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.611 ' HA ' HG23 ' A' ' 219' ' ' VAL . . . -179.64 149.85 0.39 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 72.329999999999998 111.162 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 4.0 p -108.51 156.22 19.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 73.109999999999999 111.12 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.611 HG12 HG22 ' A' ' 216' ' ' VAL . 15.7 m -141.27 137.56 33.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 53.329999999999998 111.161 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 60.4 p -146.04 108.01 4.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 72.319999999999993 110.879 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.545 HG23 HG13 ' A' ' 214' ' ' ILE . 3.3 p -91.18 140.94 15.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 64.5 111.147 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 17.5 p -172.38 126.71 0.53 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 55.329999999999998 110.832 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 56.49 45.44 89.58 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.782 -0.723 . . . . 73.219999999999999 112.476 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 4.2 mtp 63.51 16.15 9.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.871 0.367 . . . . 74.340000000000003 110.867 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 22.2 m -127.05 115.04 18.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.229 -0.441 . . . . 75.25 111.088 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.545 HG13 HG23 ' A' ' 209' ' ' VAL . 3.4 mp -110.44 120.25 60.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 63.439999999999998 111.141 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 1.2 m -92.18 128.84 38.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.211 -0.449 . . . . 43.340000000000003 111.168 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.634 HG11 HG13 ' A' ' 241' ' ' ILE . 3.5 t -115.34 125.58 72.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 73.439999999999998 111.125 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -110.79 138.72 46.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 74.219999999999999 110.908 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -94.99 78.53 0.88 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.765 -0.731 . . . . 31.420000000000002 112.474 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.611 HG23 ' HA ' ' A' ' 205' ' ' ALA . 19.1 t -49.71 -53.0 11.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.827 0.346 . . . . 74.120000000000005 111.11 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -131.33 161.95 31.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.461 . . . . 74.239999999999995 111.113 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . 0.679 ' HB2' ' HA ' ' A' ' 245' ' ' ALA . . . -60.74 138.62 58.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.235 -0.439 . . . . 63.310000000000002 111.085 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 142.77 171.18 13.21 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.705 -0.759 . . . . 74.129999999999995 112.486 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . 0.507 ' HG3' HG23 ' A' ' 242' ' ' THR . 13.6 mttt -101.56 125.15 48.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.84 0.352 . . . . 72.140000000000001 110.936 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.472 HG11 ' CB ' ' A' ' 205' ' ' ALA . 7.1 p -122.07 126.17 74.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.242 -0.436 . . . . 73.230000000000004 111.122 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.591 ' C ' HD12 ' A' ' 226' ' ' ILE . 0.3 OUTLIER -90.96 155.48 18.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 73.230000000000004 110.878 -179.977 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.591 HD12 ' C ' ' A' ' 225' ' ' ASN . 4.6 mp -139.88 92.65 9.8 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.603 0.716 . . . . 62.119999999999997 111.133 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' PRO . . . . . 0.613 ' HD3' ' HB2' ' A' ' 200' ' ' ALA . 54.3 Cg_endo -69.75 -178.14 2.2 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.67 2.247 . . . . 71.510000000000005 112.365 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 80.4 t -150.3 143.02 17.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 70.040000000000006 111.094 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 94.8 t -123.77 134.09 67.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.182 -0.463 . . . . 72.310000000000002 111.119 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -122.3 133.68 54.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 64.150000000000006 110.846 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 52.25 -116.15 4.86 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.78 -0.724 . . . . 73.439999999999998 112.464 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -108.73 21.17 17.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.83 0.348 . . . . 51.539999999999999 110.86 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 110.41 5.87 27.77 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.7 -0.762 . . . . 45.340000000000003 112.514 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -52.9 -60.32 3.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.924 0.392 . . . . 71.450000000000003 110.885 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -113.04 166.69 11.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.103 -0.499 . . . . 75.430000000000007 110.89 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -165.06 162.2 20.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.151 -0.477 . . . . 74.239999999999995 111.129 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -140.09 163.26 33.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 41.509999999999998 111.125 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.2 p -140.17 131.66 31.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 72.239999999999995 111.191 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . 0.407 ' HB2' ' HG3' ' A' ' 168' ' ' PRO . . . -132.71 165.2 25.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.191 -0.459 . . . . 62.43 111.093 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . 0.562 ' O ' HD13 ' A' ' 241' ' ' ILE . 4.4 pt-20 -144.55 132.28 21.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.225 -0.443 . . . . 70.299999999999997 110.916 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' ILE . . . . . 0.634 HG13 HG11 ' A' ' 216' ' ' VAL . 27.2 mm -127.21 112.49 28.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 73.340000000000003 111.096 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' THR . . . . . 0.507 HG23 ' HG3' ' A' ' 223' ' ' LYS . 2.2 m -81.76 141.21 33.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.117 -0.492 . . . . 75.549999999999997 111.123 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 19.7 t -120.12 121.31 65.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.213 -0.448 . . . . 75.230000000000004 111.106 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' THR . . . . . 0.49 HG23 ' O ' ' A' ' 173' ' ' VAL . 6.2 p -83.69 132.77 34.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.138 -0.483 . . . . 44.409999999999997 111.126 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' ALA . . . . . 0.679 ' HA ' ' HB2' ' A' ' 221' ' ' ALA . . . -53.45 -28.26 29.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 72.299999999999997 111.117 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 7.9 t . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.44 . . . . 74.129999999999995 110.86 -179.766 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 N-CA-C 112.441 -0.264 . . . . 64.329999999999998 112.441 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -78.61 151.92 32.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.753 0.311 . . . . 71.109999999999999 111.091 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 15.2 ptp -113.8 66.71 0.67 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.264 -0.425 . . . . 52.32 110.873 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -135.04 177.93 7.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.266 -0.425 . . . . 64.109999999999999 111.143 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.583 ' HB2' ' HA3' ' A' ' 231' ' ' GLY . . . -108.99 -62.8 1.43 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.258 -0.428 . . . . 72.209999999999994 111.119 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -178.74 -168.6 0.14 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.246 -0.434 . . . . 63.32 111.111 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 1.6 m -134.33 30.79 3.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 63.420000000000002 111.139 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 137.27 104.97 0.71 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.739 -0.743 . . . . 72.209999999999994 112.503 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 1.5 ttp -115.84 138.5 51.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.837 0.351 . . . . 71.430000000000007 110.855 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.691 HG23 HE22 ' A' ' 186' ' ' GLN . 37.5 p -125.34 106.67 10.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 53.030000000000001 111.152 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.992 HG22 HG13 ' A' ' 183' ' ' VAL . 16.4 t -97.62 135.92 30.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 63.240000000000002 111.099 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.3 m -128.78 92.22 40.83 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.574 0.702 . . . . 63.200000000000003 111.157 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.542 ' HG3' ' HB2' ' A' ' 239' ' ' ALA . 53.5 Cg_endo -69.75 -165.03 0.14 Allowed 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.695 2.263 . . . . 73.239999999999995 112.365 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -93.0 -37.01 12.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.433 . . . . 65.209999999999994 111.124 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 88.0 p 46.85 76.92 0.09 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 71.430000000000007 110.838 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.4 t -171.22 -174.5 1.48 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 63.32 111.18 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 18.4 p -100.35 163.66 12.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 65.230000000000004 110.833 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.744 HG22 ' HB2' ' A' ' 177' ' ' GLN . 3.0 p -144.4 153.4 15.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.079 -0.51 . . . . 65.409999999999997 111.173 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 23.2 t -86.38 145.09 8.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 50.310000000000002 111.139 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.42 122.23 5.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 73.439999999999998 110.91 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 98.87 -11.08 62.49 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.696 -0.764 . . . . 64.5 112.505 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.744 ' HB2' HG22 ' A' ' 173' ' ' VAL . 19.2 mm100 -92.82 -177.53 4.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.769 0.319 . . . . 75.120000000000005 110.945 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 59.8 p -160.56 151.65 19.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.246 -0.434 . . . . 72.409999999999997 110.854 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 11.0 t -113.74 -178.71 3.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.119 -0.491 . . . . 63.450000000000003 111.16 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.02 129.71 32.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.22 -0.445 . . . . 60.530000000000001 111.12 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.448 HD23 ' HB3' ' A' ' 168' ' ' PRO . 7.7 mp -103.57 146.23 28.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 61.119999999999997 110.901 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 7.1 m -111.1 144.36 40.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 71.439999999999998 111.133 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.992 HG13 HG22 ' A' ' 166' ' ' VAL . 21.8 t -129.5 142.26 44.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 73.439999999999998 111.155 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.58 ' HB3' ' OG1' ' A' ' 165' ' ' THR . . . -129.08 152.83 48.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 63.210000000000001 111.106 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -145.77 129.23 16.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.458 . . . . 72.019999999999996 110.852 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . 0.691 HE22 HG23 ' A' ' 165' ' ' THR . 0.0 OUTLIER -128.6 66.81 75.42 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.592 0.71 . . . . 71.420000000000002 110.878 -179.885 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -37.73 8.74 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.636 2.224 . . . . 75.209999999999994 112.358 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 65.39 31.33 10.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 71.25 110.92 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 175.7 -49.13 0.12 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.766 -0.73 . . . . 52.420000000000002 112.497 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.412 HG12 ' N ' ' A' ' 191' ' ' THR . 2.3 t -63.79 -56.61 15.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.889 0.376 . . . . 73.209999999999994 111.156 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . 0.412 ' N ' HG12 ' A' ' 190' ' ' VAL . 39.6 p 47.45 61.41 2.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.193 -0.458 . . . . 73.129999999999995 111.177 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -159.24 124.65 4.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 71.319999999999993 110.862 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -66.33 90.51 0.15 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.451 . . . . 70.340000000000003 110.906 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 1.8 t -105.5 -6.64 19.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 74.040000000000006 110.836 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.756 ' CE2' HG11 ' A' ' 183' ' ' VAL . 18.8 p90 -91.08 168.85 11.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.465 . . . . 72.230000000000004 110.905 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.08 168.8 25.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 73.430000000000007 110.889 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . 0.621 ' HB3' ' HB ' ' A' ' 209' ' ' VAL . . . -119.53 163.06 17.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.446 . . . . 63.100000000000001 111.144 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.608 ' O ' HG23 ' A' ' 226' ' ' ILE . 3.9 m -153.79 -178.74 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.272 -0.422 . . . . 73.25 111.121 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . 0.45 ' HB3' HG22 ' A' ' 207' ' ' VAL . 0.9 OUTLIER -119.53 127.35 52.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.161 -0.472 . . . . 54.009999999999998 110.921 -179.903 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.405 ' HB2' ' HD3' ' A' ' 227' ' ' PRO . . . -70.82 -9.73 58.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.474 . . . . 50.340000000000003 111.153 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -166.22 99.12 0.62 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 64.319999999999993 110.867 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 14.9 tttt -91.52 41.71 1.08 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.176 -0.465 . . . . 74.299999999999997 110.892 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 4.2 p -124.93 -5.22 7.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 52.310000000000002 111.188 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 8.5 mtmm -148.05 15.09 1.04 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 64.239999999999995 110.922 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.58 ' HA ' HG23 ' A' ' 219' ' ' VAL . . . -179.67 150.11 0.39 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.44 . . . . 44.549999999999997 111.081 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 9.3 p -115.95 151.85 34.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 64.209999999999994 111.133 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.862 HG12 HG22 ' A' ' 216' ' ' VAL . 6.2 m -138.03 141.64 37.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 55.020000000000003 111.082 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -147.05 109.02 4.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 75.349999999999994 110.906 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.621 ' HB ' ' HB3' ' A' ' 197' ' ' ALA . 3.6 p -86.23 143.21 11.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.128 -0.487 . . . . 72.239999999999995 111.114 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 7.7 p -171.98 124.11 0.53 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 71.450000000000003 110.869 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 55.64 47.19 79.09 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.781 -0.723 . . . . 73.510000000000005 112.47 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 2.0 mtp 63.26 16.08 9.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.844 0.354 . . . . 72.010000000000005 110.884 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 1.9 m -127.4 114.81 18.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.24 -0.436 . . . . 71.430000000000007 111.143 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.504 HG13 HG23 ' A' ' 209' ' ' VAL . 3.0 mp -110.15 116.26 51.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 73.329999999999998 111.107 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -89.34 126.15 35.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 62.119999999999997 111.125 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.862 HG22 HG12 ' A' ' 207' ' ' VAL . 2.8 t -111.43 129.91 65.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 73.329999999999998 111.172 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -113.55 139.03 49.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.439 . . . . 70.239999999999995 110.887 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -96.73 78.02 0.71 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.738 -0.744 . . . . 73.109999999999999 112.526 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.58 HG23 ' HA ' ' A' ' 205' ' ' ALA . 17.0 t -50.22 -54.96 6.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.846 0.355 . . . . 72.310000000000002 111.151 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -128.0 160.8 30.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 71.239999999999995 111.115 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . 0.67 ' HB2' ' HA ' ' A' ' 245' ' ' ALA . . . -61.07 140.05 57.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 62.439999999999998 111.051 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 142.56 170.83 12.94 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.802 -0.713 . . . . 71.329999999999998 112.535 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . 0.463 ' HG3' HG23 ' A' ' 242' ' ' THR . 12.8 mttt -100.85 121.33 41.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.818 0.342 . . . . 72.209999999999994 110.877 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.535 HG11 ' CB ' ' A' ' 205' ' ' ALA . 7.4 p -120.57 126.96 75.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.262 -0.426 . . . . 71.420000000000002 111.139 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.627 ' C ' HD12 ' A' ' 226' ' ' ILE . 32.7 m120 -90.67 155.97 18.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.464 . . . . 64.430000000000007 110.864 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.627 HD12 ' C ' ' A' ' 225' ' ' ASN . 3.9 mp -135.91 92.34 16.6 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.629 0.728 . . . . 60.039999999999999 111.072 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' PRO . . . . . 0.595 ' HG2' HG23 ' A' ' 198' ' ' VAL . 53.8 Cg_endo -69.77 179.78 3.47 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.66 2.24 . . . . 75.329999999999998 112.352 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 64.3 t -150.29 144.11 17.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.236 -0.438 . . . . 73.329999999999998 111.108 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 86.8 t -132.55 135.74 57.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.136 -0.484 . . . . 73.150000000000006 111.156 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 82.6 p -115.03 106.7 14.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.452 . . . . 64.319999999999993 110.882 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . 0.583 ' HA3' ' HB2' ' A' ' 160' ' ' ALA . . . 59.33 -100.26 0.18 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.746 -0.74 . . . . 74.319999999999993 112.475 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 18.0 p30 -95.09 -7.68 38.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.897 0.379 . . . . 74.0 110.899 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 112.45 13.24 11.97 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.738 -0.744 . . . . 65.430000000000007 112.462 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -52.54 -28.73 21.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.865 0.364 . . . . 74.329999999999998 110.887 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -144.66 132.53 21.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 74.239999999999995 110.85 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -134.26 164.86 26.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 72.340000000000003 111.049 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -135.38 162.98 31.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 73.019999999999996 111.088 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 58.3 t -135.82 121.94 31.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.205 -0.452 . . . . 73.349999999999994 111.114 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . 0.542 ' HB2' ' HG3' ' A' ' 168' ' ' PRO . . . -129.4 165.08 22.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 74.109999999999999 111.057 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . 0.504 ' O ' HD13 ' A' ' 241' ' ' ILE . 4.8 pt-20 -146.74 132.7 19.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 53.420000000000002 110.864 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' ILE . . . . . 0.598 HG13 HG11 ' A' ' 216' ' ' VAL . 23.7 mm -126.76 111.92 27.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 63.049999999999997 111.11 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' THR . . . . . 0.463 HG23 ' HG3' ' A' ' 223' ' ' LYS . 2.7 m -79.8 141.22 36.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 52.130000000000003 111.148 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 16.6 t -119.9 120.7 63.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.28 -0.418 . . . . 65.140000000000001 111.113 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' THR . . . . . 0.489 HG23 ' O ' ' A' ' 173' ' ' VAL . 7.2 p -82.36 132.85 35.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.164 -0.471 . . . . 61.140000000000001 111.117 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' ALA . . . . . 0.67 ' HA ' ' HB2' ' A' ' 221' ' ' ALA . . . -57.97 -23.88 55.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 51.420000000000002 111.086 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 80.4 p . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.242 -0.435 . . . . 70.439999999999998 110.875 -179.805 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.389 0 N-CA-C 112.514 -0.235 . . . . 73.430000000000007 112.514 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . 56.78 25.54 10.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.79 0.329 . . . . 73.530000000000001 111.126 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 9.0 mmt -83.74 80.54 9.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 62.039999999999999 110.912 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -171.38 -172.47 1.08 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.226 -0.443 . . . . 51.329999999999998 111.09 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -174.34 129.08 0.36 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 73.019999999999996 111.133 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.5 -168.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 61.549999999999997 111.142 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 1.1 m -124.81 32.82 5.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.263 -0.426 . . . . 74.25 111.157 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 137.28 98.68 0.5 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.751 -0.738 . . . . 32.039999999999999 112.493 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 3.8 ttp -110.23 130.29 55.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.827 0.346 . . . . 61.039999999999999 110.846 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.572 ' OG1' ' HB3' ' A' ' 184' ' ' ALA . 43.9 p -118.67 104.01 10.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 73.430000000000007 111.118 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 1.114 HG22 HG13 ' A' ' 183' ' ' VAL . 34.7 t -97.86 132.78 41.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.264 -0.425 . . . . 63.310000000000002 111.104 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.6 m -126.76 92.53 44.54 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.571 0.701 . . . . 73.140000000000001 111.179 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.517 ' HG3' ' HB2' ' A' ' 239' ' ' ALA . 53.7 Cg_endo -69.77 -166.13 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.689 2.259 . . . . 71.530000000000001 112.317 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -87.99 -39.22 14.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 54.25 111.079 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 96.1 p 46.46 78.06 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.274 -0.421 . . . . 54.399999999999999 110.844 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.6 t -175.18 -174.81 0.78 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.493 . . . . 74.549999999999997 111.212 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 94.7 p -99.78 163.25 12.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.254 -0.43 . . . . 63.030000000000001 110.841 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.768 HG22 ' HB2' ' A' ' 177' ' ' GLN . 2.8 p -144.41 152.76 15.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.125 -0.489 . . . . 75.519999999999996 111.122 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 32.2 t -85.49 145.04 8.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.179 -0.464 . . . . 64.129999999999995 111.114 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.28 121.98 5.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.18 -0.464 . . . . 74.140000000000001 110.896 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.16 -11.87 62.0 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.701 -0.761 . . . . 54.539999999999999 112.471 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.768 ' HB2' HG22 ' A' ' 173' ' ' VAL . 21.5 mm100 -91.05 -177.39 4.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.78 0.324 . . . . 72.25 110.944 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -159.3 149.99 19.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.262 -0.427 . . . . 52.149999999999999 110.84 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 11.5 t -110.99 179.64 3.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.486 . . . . 72.540000000000006 111.139 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -136.02 126.12 26.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 74.319999999999993 111.185 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.466 HD23 ' HB3' ' A' ' 168' ' ' PRO . 7.7 mp -100.32 149.35 23.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 61.140000000000001 110.88 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 2.4 m -117.54 143.55 45.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.16 -0.473 . . . . 73.439999999999998 111.149 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 1.114 HG13 HG22 ' A' ' 166' ' ' VAL . 22.0 t -129.56 140.95 47.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 72.319999999999993 111.079 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.572 ' HB3' ' OG1' ' A' ' 165' ' ' THR . . . -129.04 151.95 49.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.474 . . . . 52.420000000000002 111.088 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -146.65 130.05 16.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 74.200000000000003 110.895 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.24 66.63 75.55 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.612 0.72 . . . . 72.109999999999999 110.946 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -36.03 11.59 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.722 2.281 . . . . 64.0 112.307 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 66.18 43.07 2.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.254 -0.43 . . . . 74.400000000000006 110.902 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 166.28 -41.46 0.27 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.77 -0.729 . . . . 43.539999999999999 112.479 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 2.5 t -73.44 -55.57 12.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.927 0.394 . . . . 72.420000000000002 111.146 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER 47.29 66.45 1.01 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.175 -0.466 . . . . 50.340000000000003 111.16 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -165.75 131.34 2.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.212 -0.449 . . . . 73.329999999999998 110.893 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.27 91.68 3.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.179 -0.464 . . . . 54.509999999999998 110.907 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.82 -6.48 21.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 74.239999999999995 110.838 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.77 ' CE2' HG11 ' A' ' 183' ' ' VAL . 26.9 p90 -90.74 179.32 5.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.469 . . . . 71.540000000000006 110.897 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 2.2 ptt180 -166.45 174.48 8.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 72.099999999999994 110.867 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . 0.525 ' HB3' ' HB ' ' A' ' 209' ' ' VAL . . . -119.45 154.77 33.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.458 . . . . 44.219999999999999 111.118 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.4 ' O ' HG23 ' A' ' 226' ' ' ILE . 12.7 t -144.85 154.8 14.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.234 -0.439 . . . . 33.409999999999997 111.082 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.95 115.97 28.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.145 -0.48 . . . . 71.310000000000002 110.857 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.459 ' HB2' ' HD3' ' A' ' 227' ' ' PRO . . . -59.73 -22.14 61.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 51.310000000000002 111.133 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -161.16 92.17 0.9 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.221 -0.445 . . . . 65.219999999999999 110.895 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 5.8 tttp -85.07 54.39 3.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 62.030000000000001 110.888 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 19.1 p -129.51 1.28 5.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 71.049999999999997 111.16 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 9.0 mtmt -155.53 18.28 0.4 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 63.119999999999997 110.924 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.624 ' HA ' HG23 ' A' ' 219' ' ' VAL . . . -179.9 148.39 0.31 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 70.200000000000003 111.104 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 5.9 p -104.71 154.15 20.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 71.209999999999994 111.13 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.655 HG12 HG22 ' A' ' 216' ' ' VAL . 17.1 m -140.8 134.31 32.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.464 . . . . 74.329999999999998 111.114 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . 0.492 ' C ' HG23 ' A' ' 214' ' ' ILE . 10.7 m -145.3 109.09 4.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 75.239999999999995 110.867 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.628 HG23 HG13 ' A' ' 214' ' ' ILE . 4.3 p -92.69 142.43 13.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 62.229999999999997 111.113 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 4.1 t -143.23 98.9 3.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.134 -0.485 . . . . 72.25 110.866 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 69.89 -81.9 0.32 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.714 -0.755 . . . . 53.130000000000003 112.489 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 1.1 mtp -139.0 9.55 2.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.851 0.358 . . . . 61.409999999999997 110.853 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 7.3 m -130.21 123.25 29.76 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.243 -0.435 . . . . 51.240000000000002 111.17 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.628 HG13 HG23 ' A' ' 209' ' ' VAL . 2.2 mp -115.26 141.19 33.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.221 -0.445 . . . . 70.340000000000003 111.17 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.41 125.4 51.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.237 -0.438 . . . . 64.129999999999995 111.139 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.655 HG22 HG12 ' A' ' 207' ' ' VAL . 2.6 t -115.33 130.77 69.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 50.140000000000001 111.085 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -116.95 138.42 51.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 73.230000000000004 110.926 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -95.21 79.72 0.85 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.768 -0.729 . . . . 71.319999999999993 112.509 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.624 HG23 ' HA ' ' A' ' 205' ' ' ALA . 16.3 t -50.82 -53.46 13.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.792 0.33 . . . . 74.129999999999995 111.129 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -130.81 162.48 29.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.447 . . . . 72.200000000000003 111.073 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . 0.672 ' HB2' ' HA ' ' A' ' 245' ' ' ALA . . . -60.92 140.45 57.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 72.120000000000005 111.12 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 142.34 171.25 13.06 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.79 -0.719 . . . . 74.349999999999994 112.528 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . 0.558 ' HG3' HG23 ' A' ' 242' ' ' THR . 5.5 mttp -103.74 121.85 43.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.85 0.357 . . . . 54.530000000000001 110.864 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.475 HG11 ' CB ' ' A' ' 205' ' ' ALA . 7.2 p -120.36 126.04 74.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 75.510000000000005 111.179 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.619 ' C ' HD12 ' A' ' 226' ' ' ILE . 35.3 m120 -90.8 153.33 20.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 72.019999999999996 110.871 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.619 HD12 ' C ' ' A' ' 225' ' ' ASN . 4.1 mp -137.21 93.08 13.33 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.608 0.718 . . . . 74.340000000000003 111.132 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' PRO . . . . . 0.459 ' HD3' ' HB2' ' A' ' 200' ' ' ALA . 54.1 Cg_endo -69.73 -178.37 2.3 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.66 2.24 . . . . 71.530000000000001 112.37 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.63 ' CG2' ' HB3' ' A' ' 237' ' ' ALA . 47.0 t -147.37 139.62 18.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 72.140000000000001 111.111 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 99.8 t -120.53 135.19 61.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 74.319999999999993 111.152 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -121.46 122.51 39.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 74.439999999999998 110.878 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 56.14 -119.87 16.69 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.757 -0.735 . . . . 72.25 112.485 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -92.36 14.09 17.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.818 0.342 . . . . 70.099999999999994 110.878 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 108.17 8.6 29.1 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.705 -0.759 . . . . 52.450000000000003 112.471 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -51.97 -65.76 0.5 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.887 0.375 . . . . 74.420000000000002 110.939 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -100.54 158.98 15.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 74.120000000000005 110.904 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -157.73 160.52 37.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.165 -0.471 . . . . 64.129999999999995 111.108 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . 0.63 ' HB3' ' CG2' ' A' ' 228' ' ' VAL . . . -136.97 163.61 30.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 71.5 111.102 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 57.7 t -137.34 130.39 43.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 63.140000000000001 111.17 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . 0.517 ' HB2' ' HG3' ' A' ' 168' ' ' PRO . . . -137.54 163.33 31.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 73.109999999999999 111.09 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . 0.464 ' O ' HD13 ' A' ' 241' ' ' ILE . 5.6 pt-20 -147.35 130.37 16.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.203 -0.453 . . . . 72.450000000000003 110.903 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' ILE . . . . . 0.574 HG13 HG11 ' A' ' 216' ' ' VAL . 26.5 mm -124.4 112.18 31.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.13 -0.486 . . . . 64.209999999999994 111.106 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' THR . . . . . 0.558 HG23 ' HG3' ' A' ' 223' ' ' LYS . 1.9 m -80.66 141.51 34.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.164 -0.471 . . . . 75.299999999999997 111.151 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 15.9 t -119.98 121.84 66.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 64.299999999999997 111.134 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' THR . . . . . 0.469 HG23 ' O ' ' A' ' 173' ' ' VAL . 6.8 p -83.04 132.95 35.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 34.399999999999999 111.154 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' ALA . . . . . 0.672 ' HA ' ' HB2' ' A' ' 221' ' ' ALA . . . -57.11 -23.82 49.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.23 -0.441 . . . . 73.510000000000005 111.089 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 4.4 t . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.26 -0.427 . . . . 60.200000000000003 110.837 -179.79 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 N-CA-C 112.494 -0.243 . . . . 74.319999999999993 112.494 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -107.88 145.72 33.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.798 0.332 . . . . 74.329999999999998 111.097 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 14.6 ptt? -118.02 79.58 1.39 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 73.299999999999997 110.843 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -160.64 -169.8 2.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.445 . . . . 71.239999999999995 111.135 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -177.19 129.65 0.16 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 40.240000000000002 111.112 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -59.95 -168.76 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.455 . . . . 62.210000000000001 111.161 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -125.56 33.74 5.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.276 -0.42 . . . . 52.030000000000001 111.176 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 134.66 99.63 0.63 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.724 -0.75 . . . . 74.030000000000001 112.481 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 11.6 ttp -114.76 133.08 56.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.861 0.363 . . . . 70.239999999999995 110.918 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.662 HG23 HE22 ' A' ' 186' ' ' GLN . 28.2 p -122.26 110.88 16.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 72.129999999999995 111.124 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 1.13 HG22 HG13 ' A' ' 183' ' ' VAL . 21.5 t -100.88 134.99 39.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 60.140000000000001 111.156 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.3 m -124.98 91.77 48.78 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.56 0.695 . . . . 74.349999999999994 111.136 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.476 ' HB3' HD23 ' A' ' 181' ' ' LEU . 53.9 Cg_endo -69.73 -165.16 0.14 Allowed 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.696 2.264 . . . . 73.450000000000003 112.336 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -91.14 -38.13 12.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.452 . . . . 65.329999999999998 111.079 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 90.5 p 46.85 77.31 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 55.450000000000003 110.88 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.2 t -174.32 -174.34 0.86 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.101 -0.499 . . . . 63.439999999999998 111.12 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 90.4 p -100.33 161.75 13.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 73.120000000000005 110.866 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.755 HG22 ' HB2' ' A' ' 177' ' ' GLN . 2.9 p -142.39 153.05 17.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.131 -0.486 . . . . 73.310000000000002 111.103 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 32.3 t -85.53 145.08 8.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 74.409999999999997 111.142 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.72 122.17 6.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.47 . . . . 73.040000000000006 110.897 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.12 -10.92 62.01 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.753 -0.737 . . . . 74.430000000000007 112.49 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.755 ' HB2' HG22 ' A' ' 173' ' ' VAL . 20.3 mm100 -91.83 -177.31 4.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.836 0.35 . . . . 74.120000000000005 110.911 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.52 152.36 19.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 73.019999999999996 110.89 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 13.2 t -115.66 179.13 4.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.454 . . . . 74.310000000000002 111.124 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.05 126.16 27.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 51.140000000000001 111.131 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.476 HD23 ' HB3' ' A' ' 168' ' ' PRO . 7.4 mp -100.28 142.77 31.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 71.230000000000004 110.916 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 14.1 m -108.74 143.81 37.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 65.530000000000001 111.196 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 1.13 HG13 HG22 ' A' ' 166' ' ' VAL . 21.0 t -129.65 141.22 47.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 63.439999999999998 111.071 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -130.04 149.55 51.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 72.230000000000004 111.119 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -139.79 130.6 26.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 73.099999999999994 110.863 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . 0.662 HE22 HG23 ' A' ' 165' ' ' THR . 0.0 OUTLIER -130.73 67.0 80.03 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.564 0.697 . . . . 71.420000000000002 110.864 -179.919 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -36.97 9.78 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.696 2.264 . . . . 72.030000000000001 112.332 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 65.85 26.52 11.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 64.109999999999999 110.909 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -178.81 -51.13 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.735 -0.745 . . . . 52.200000000000003 112.487 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 2.2 t -60.83 -54.39 35.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.91 0.385 . . . . 61.43 111.143 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 40.0 p 47.81 62.02 2.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.166 -0.47 . . . . 73.120000000000005 111.137 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -165.7 122.21 1.39 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.192 -0.458 . . . . 74.310000000000002 110.876 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 11.7 mtpt -61.4 95.91 0.05 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 75.030000000000001 110.875 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.35 -6.99 17.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.216 -0.447 . . . . 32.32 110.828 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.769 ' CE2' HG11 ' A' ' 183' ' ' VAL . 21.8 p90 -91.04 178.46 6.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 72.340000000000003 110.882 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.9 171.47 12.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.121 -0.491 . . . . 72.329999999999998 110.854 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . 0.64 ' HB3' ' HB ' ' A' ' 209' ' ' VAL . . . -122.89 163.42 20.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 72.319999999999993 111.106 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.533 ' O ' HG23 ' A' ' 226' ' ' ILE . 5.8 m -153.1 -178.27 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 64.209999999999994 111.127 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.65 114.88 24.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 72.140000000000001 110.884 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.435 ' HB2' ' HD3' ' A' ' 227' ' ' PRO . . . -59.79 -20.86 59.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 71.230000000000004 111.083 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -162.24 96.73 0.99 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 54.149999999999999 110.85 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -87.95 47.85 1.56 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.485 . . . . 70.219999999999999 110.902 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 12.4 p -125.59 -4.35 7.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 74.099999999999994 111.09 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 9.0 mtmm -149.82 16.08 0.86 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.436 . . . . 73.540000000000006 110.902 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.628 ' HA ' HG23 ' A' ' 219' ' ' VAL . . . -179.67 151.24 0.44 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.448 . . . . 73.540000000000006 111.078 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 7.2 p -112.29 152.59 28.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.215 -0.448 . . . . 75.329999999999998 111.157 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.786 HG12 HG22 ' A' ' 216' ' ' VAL . 12.9 m -141.02 137.72 34.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.265 -0.425 . . . . 74.5 111.114 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.54 109.35 4.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 75.340000000000003 110.879 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.64 ' HB ' ' HB3' ' A' ' 197' ' ' ALA . 3.5 p -87.93 134.7 27.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 72.049999999999997 111.157 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 2.9 m -161.53 124.08 3.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 63.100000000000001 110.83 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 55.34 47.74 73.6 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.74 -0.743 . . . . 71.109999999999999 112.48 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 3.4 mtp 63.24 16.1 9.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.851 0.358 . . . . 74.129999999999995 110.85 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 15.9 m -126.93 110.64 13.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 75.420000000000002 111.167 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.545 HG13 HG23 ' A' ' 209' ' ' VAL . 3.1 mp -105.7 117.35 51.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 64.5 111.126 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.26 127.02 36.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 74.329999999999998 111.107 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.786 HG22 HG12 ' A' ' 207' ' ' VAL . 2.8 t -113.0 131.53 64.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 74.109999999999999 111.107 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -117.25 136.62 52.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 72.329999999999998 110.905 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -94.15 79.22 0.97 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.777 -0.725 . . . . 22.129999999999999 112.46 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.628 HG23 ' HA ' ' A' ' 205' ' ' ALA . 18.5 t -50.98 -52.25 18.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.871 0.367 . . . . 71.040000000000006 111.144 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -131.97 161.42 33.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 64.230000000000004 111.116 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . 0.68 ' HB2' ' HA ' ' A' ' 245' ' ' ALA . . . -59.96 139.12 57.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 64.340000000000003 111.122 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 142.44 170.45 12.7 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.746 -0.74 . . . . 74.230000000000004 112.522 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . 0.478 ' HG3' HG23 ' A' ' 242' ' ' THR . 13.4 mttt -99.36 123.5 43.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.819 0.343 . . . . 75.120000000000005 110.852 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 6.7 p -118.96 124.72 73.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 63.130000000000003 111.093 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.612 ' C ' HD12 ' A' ' 226' ' ' ILE . 16.8 m120 -90.78 152.83 20.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.152 -0.476 . . . . 73.019999999999996 110.87 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.612 HD12 ' C ' ' A' ' 225' ' ' ASN . 4.3 mp -137.77 93.17 12.41 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.594 0.712 . . . . 72.319999999999993 111.136 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' PRO . . . . . 0.465 ' HG2' HG23 ' A' ' 198' ' ' VAL . 53.3 Cg_endo -69.81 179.74 3.51 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.676 2.251 . . . . 64.129999999999995 112.336 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.428 ' HB ' ' HB3' ' A' ' 237' ' ' ALA . 90.3 t -150.23 136.31 11.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 60.149999999999999 111.128 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 91.3 t -117.67 134.71 60.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 71.239999999999995 111.167 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -120.94 127.57 51.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 73.430000000000007 110.893 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 58.85 -117.81 12.05 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.723 -0.751 . . . . 54.130000000000003 112.496 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -108.62 21.04 17.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.878 0.37 . . . . 71.439999999999998 110.862 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 113.4 3.69 23.97 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.759 -0.734 . . . . 61.020000000000003 112.485 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -54.12 -64.39 0.84 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.907 0.384 . . . . 74.120000000000005 110.881 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -111.42 156.74 21.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 75.319999999999993 110.831 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -156.57 164.54 38.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.095 -0.502 . . . . 65.040000000000006 111.131 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . 0.428 ' HB3' ' HB ' ' A' ' 228' ' ' VAL . . . -143.2 163.29 33.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.269 -0.423 . . . . 54.219999999999999 111.113 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 13.5 p -140.49 138.72 36.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 64.140000000000001 111.154 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . 0.428 ' HB2' ' HG3' ' A' ' 168' ' ' PRO . . . -136.95 165.33 26.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 74.209999999999994 111.09 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . 0.496 ' O ' HD13 ' A' ' 241' ' ' ILE . 3.3 pt-20 -141.88 131.17 23.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.23 -0.441 . . . . 71.140000000000001 110.876 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' ILE . . . . . 0.573 HG13 HG11 ' A' ' 216' ' ' VAL . 25.9 mm -127.32 110.63 23.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.123 -0.49 . . . . 64.400000000000006 111.147 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' THR . . . . . 0.478 HG23 ' HG3' ' A' ' 223' ' ' LYS . 1.8 m -80.13 141.33 35.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.206 -0.452 . . . . 65.319999999999993 111.158 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 17.1 t -119.91 121.92 67.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 74.319999999999993 111.124 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' THR . . . . . 0.466 HG23 ' O ' ' A' ' 173' ' ' VAL . 7.3 p -83.36 132.86 34.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 73.349999999999994 111.136 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' ALA . . . . . 0.68 ' HA ' ' HB2' ' A' ' 221' ' ' ALA . . . -57.46 -24.46 55.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 61.530000000000001 111.106 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 5.2 m . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 44.149999999999999 110.836 -179.837 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 N-CA-C 112.517 -0.233 . . . . 53.020000000000003 112.517 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . 57.17 26.53 12.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.793 0.33 . . . . 73.120000000000005 111.08 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 55.4 mtp -113.76 -179.84 3.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 75.239999999999995 110.889 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -111.69 130.67 55.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 73.439999999999998 111.097 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.718 ' HB2' ' HA3' ' A' ' 231' ' ' GLY . . . -109.38 -73.09 0.7 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.244 -0.434 . . . . 61.229999999999997 111.054 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.437 ' HB1' ' HB3' ' A' ' 187' ' ' PRO . . . -173.82 -169.37 0.49 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 53.340000000000003 111.077 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -131.91 18.53 4.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.184 -0.462 . . . . 53.049999999999997 111.074 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 166.8 97.91 0.12 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.746 -0.74 . . . . 51.539999999999999 112.466 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 41.7 ttp -111.98 129.96 56.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.815 0.341 . . . . 54.119999999999997 110.886 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.592 ' OG1' ' HB3' ' A' ' 184' ' ' ALA . 46.6 p -118.82 103.03 9.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.249 -0.432 . . . . 73.400000000000006 111.141 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 1.084 HG22 HG13 ' A' ' 183' ' ' VAL . 22.8 t -97.82 132.72 42.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.208 -0.451 . . . . 74.230000000000004 111.107 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.2 m -125.11 92.9 46.58 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 121.598 0.713 . . . . 54.409999999999997 111.119 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.474 ' HB3' HD23 ' A' ' 181' ' ' LEU . 54.1 Cg_endo -69.72 -168.62 0.28 Allowed 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.685 2.257 . . . . 71.510000000000005 112.377 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -86.99 -39.82 15.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 74.040000000000006 111.062 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 95.3 p 46.43 78.5 0.07 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 70.349999999999994 110.847 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.1 t -173.86 -174.79 0.98 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.088 -0.505 . . . . 74.409999999999997 111.141 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 27.3 p -99.34 163.56 12.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.445 . . . . 55.310000000000002 110.875 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.723 HG22 ' HB2' ' A' ' 177' ' ' GLN . 3.1 p -146.38 154.32 12.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.115 -0.493 . . . . 73.530000000000001 111.135 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 57.6 t -88.39 145.43 7.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.48 . . . . 71.219999999999999 111.153 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -48.93 122.67 6.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 32.0 110.887 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.72 -14.2 60.55 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.733 -0.746 . . . . 44.130000000000003 112.463 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.723 ' HB2' HG22 ' A' ' 173' ' ' VAL . 12.2 mm100 -91.16 -177.88 5.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.836 0.35 . . . . 71.109999999999999 110.93 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 20.4 p -161.43 149.51 15.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 73.219999999999999 110.829 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 7.5 t -108.52 -173.87 2.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.113 -0.494 . . . . 64.310000000000002 111.188 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.01 131.23 26.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.45 . . . . 65.530000000000001 111.195 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.474 HD23 ' HB3' ' A' ' 168' ' ' PRO . 7.5 mp -104.87 144.25 32.04 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.244 -0.435 . . . . 72.230000000000004 110.946 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 31.3 m -111.46 144.92 39.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 73.230000000000004 111.15 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 1.084 HG13 HG22 ' A' ' 166' ' ' VAL . 21.3 t -129.32 140.07 50.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 73.409999999999997 111.112 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.592 ' HB3' ' OG1' ' A' ' 165' ' ' THR . . . -129.6 154.95 46.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.466 . . . . 73.439999999999998 111.048 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -145.28 133.8 22.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 74.120000000000005 110.879 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.83 66.33 26.28 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.596 0.712 . . . . 74.400000000000006 110.907 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.437 ' HB3' ' HB1' ' A' ' 161' ' ' ALA . 53.7 Cg_endo -69.78 -23.83 30.28 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.679 2.253 . . . . 65.519999999999996 112.388 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 70.91 33.83 2.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.453 . . . . 74.239999999999995 110.876 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 167.55 -25.42 0.13 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.719 -0.753 . . . . 75.329999999999998 112.452 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.491 HG11 ' O ' ' A' ' 160' ' ' ALA . 78.3 t -100.38 150.11 5.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.882 0.373 . . . . 43.32 111.131 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 12.7 p -143.89 35.22 1.25 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 60.439999999999998 111.167 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.475 ' H ' HG12 ' A' ' 190' ' ' VAL . 1.0 OUTLIER -113.79 127.64 56.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.254 -0.43 . . . . 75.25 110.854 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 1.9 ttpp -79.62 61.67 3.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 53.310000000000002 110.866 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 1.7 t -73.08 -7.93 53.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 61.119999999999997 110.843 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.777 ' CE2' HG11 ' A' ' 183' ' ' VAL . 14.4 p90 -91.49 163.43 14.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 75.540000000000006 110.922 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.27 172.21 18.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.471 . . . . 73.420000000000002 110.867 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . 0.431 ' HB3' ' HB ' ' A' ' 209' ' ' VAL . . . -117.18 168.11 10.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 61.439999999999998 111.088 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 10.6 p -173.12 152.04 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.443 . . . . 75.049999999999997 111.126 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.3 t -78.27 151.51 32.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 74.200000000000003 110.849 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.607 ' HB2' ' HD3' ' A' ' 227' ' ' PRO . . . -88.43 -23.89 23.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 63.119999999999997 111.146 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.77 -53.51 1.23 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 75.230000000000004 110.841 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.28 28.48 15.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 65.439999999999998 110.919 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 71.9 p -114.65 -3.17 12.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 75.420000000000002 111.134 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 7.6 mtmt -152.05 18.52 0.67 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 60.119999999999997 110.888 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.667 ' HA ' HG23 ' A' ' 219' ' ' VAL . . . -177.11 146.84 0.52 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 60.450000000000003 111.052 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 18.8 p -106.93 157.47 17.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 73.540000000000006 111.158 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.784 HG12 HG22 ' A' ' 216' ' ' VAL . 9.8 m -140.9 141.08 32.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.184 -0.462 . . . . 54.530000000000001 111.108 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -148.6 108.81 4.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 45.340000000000003 110.881 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.544 HG23 HG13 ' A' ' 214' ' ' ILE . 3.8 p -87.36 143.42 11.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.491 . . . . 64.010000000000005 111.158 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -171.83 123.27 0.52 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 74.140000000000001 110.855 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 55.76 47.4 78.68 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.773 -0.727 . . . . 51.340000000000003 112.471 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 1.7 mtp 63.5 15.83 9.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.867 0.365 . . . . 70.140000000000001 110.869 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 1.1 m -126.51 113.72 17.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.434 . . . . 72.230000000000004 111.178 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.544 HG13 HG23 ' A' ' 209' ' ' VAL . 3.2 mp -110.16 115.48 49.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.241 -0.436 . . . . 61.310000000000002 111.145 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 3.8 m -88.3 131.05 34.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.459 . . . . 55.439999999999998 111.116 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.784 HG22 HG12 ' A' ' 207' ' ' VAL . 2.8 t -116.88 124.56 73.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 73.439999999999998 111.136 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -107.9 137.92 45.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 64.310000000000002 110.922 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -93.22 80.74 1.06 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.767 -0.73 . . . . 74.219999999999999 112.445 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.667 HG23 ' HA ' ' A' ' 205' ' ' ALA . 19.7 t -50.49 -54.83 7.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.882 0.372 . . . . 70.439999999999998 111.116 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -130.01 162.88 27.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 71.299999999999997 111.09 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . 0.68 ' HB2' ' HA ' ' A' ' 245' ' ' ALA . . . -62.09 140.19 58.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 62.420000000000002 111.068 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 140.1 171.2 12.28 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.676 -0.773 . . . . 73.150000000000006 112.473 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . 0.424 ' HG3' HG23 ' A' ' 242' ' ' THR . 14.0 mttt -99.5 124.24 44.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.826 0.346 . . . . 64.5 110.871 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.529 HG11 ' CB ' ' A' ' 205' ' ' ALA . 7.0 p -121.02 127.08 75.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 71.549999999999997 111.149 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.637 ' C ' HD12 ' A' ' 226' ' ' ILE . 33.2 m120 -90.88 151.72 21.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 75.099999999999994 110.851 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.637 HD12 ' C ' ' A' ' 225' ' ' ASN . 4.0 mp -136.52 93.27 14.46 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.618 0.723 . . . . 73.549999999999997 111.156 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' PRO . . . . . 0.607 ' HD3' ' HB2' ' A' ' 200' ' ' ALA . 54.2 Cg_endo -69.75 179.89 3.38 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.689 2.259 . . . . 73.349999999999994 112.325 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.422 ' HB ' ' HB3' ' A' ' 237' ' ' ALA . 97.2 t -150.31 141.41 16.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 72.439999999999998 111.201 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 46.5 t -124.51 138.31 54.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 73.219999999999999 111.144 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 1.7 t -122.18 108.76 13.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 61.219999999999999 110.88 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . 0.718 ' HA3' ' HB2' ' A' ' 160' ' ' ALA . . . 69.27 -119.35 9.37 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.732 -0.747 . . . . 75.400000000000006 112.505 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -104.56 21.14 17.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.807 0.336 . . . . 73.540000000000006 110.866 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 112.35 5.63 24.49 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.741 -0.742 . . . . 22.050000000000001 112.521 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.475 ' OE1' ' HB3' ' A' ' 160' ' ' ALA . 9.9 mt-10 -51.28 -44.03 61.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.867 0.365 . . . . 74.420000000000002 110.863 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -138.56 167.04 22.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 72.329999999999998 110.886 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -163.53 164.72 24.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 72.230000000000004 111.122 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . 0.422 ' HB3' ' HB ' ' A' ' 228' ' ' VAL . . . -143.84 163.18 34.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.436 . . . . 71.049999999999997 111.145 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 10.5 p -137.94 136.69 45.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 75.019999999999996 111.115 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . 0.427 ' HB2' ' HG3' ' A' ' 168' ' ' PRO . . . -139.16 165.17 27.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 63.450000000000003 111.102 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . 0.526 ' O ' HD13 ' A' ' 241' ' ' ILE . 4.3 pt-20 -143.87 132.13 21.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 73.420000000000002 110.898 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' ILE . . . . . 0.586 HG13 HG11 ' A' ' 216' ' ' VAL . 24.7 mm -127.2 113.93 34.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.205 -0.452 . . . . 74.209999999999994 111.145 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' THR . . . . . 0.424 HG23 ' HG3' ' A' ' 223' ' ' LYS . 2.8 m -82.81 141.23 32.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 54.450000000000003 111.146 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 17.0 t -120.06 120.95 64.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 75.230000000000004 111.173 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' THR . . . . . 0.516 HG23 ' O ' ' A' ' 173' ' ' VAL . 5.4 p -82.33 132.79 35.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 63.509999999999998 111.118 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' ALA . . . . . 0.68 ' HA ' ' HB2' ' A' ' 221' ' ' ALA . . . -57.41 -23.42 49.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 70.150000000000006 111.095 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 2.1 t . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 73.219999999999999 110.859 -179.769 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.475 -0.25 . . . . 74.019999999999996 112.475 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -85.42 131.57 34.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.837 0.351 . . . . 55.340000000000003 111.107 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 5.7 tpt -111.34 57.05 0.63 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 72.230000000000004 110.867 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -158.54 163.63 36.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 73.340000000000003 111.131 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.487 ' HB2' ' HA3' ' A' ' 231' ' ' GLY . . . -76.32 -66.89 0.74 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 63.32 111.103 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -178.31 -169.34 0.18 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 74.140000000000001 111.082 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -131.68 27.09 4.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.236 -0.438 . . . . 72.530000000000001 111.106 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 145.92 101.93 0.32 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.778 -0.725 . . . . 62.229999999999997 112.484 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 42.9 ttp -114.49 126.16 54.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.863 0.364 . . . . 73.200000000000003 110.829 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.574 ' OG1' ' HB3' ' A' ' 184' ' ' ALA . 43.4 p -115.65 105.69 13.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 74.409999999999997 111.154 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 1.033 HG22 HG13 ' A' ' 183' ' ' VAL . 21.5 t -101.52 130.76 50.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 64.519999999999996 111.102 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.3 m -123.82 92.42 48.54 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.549 0.69 . . . . 73.230000000000004 111.121 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.48 ' HB3' HD23 ' A' ' 181' ' ' LEU . 53.9 Cg_endo -69.78 -167.2 0.21 Allowed 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.66 2.24 . . . . 75.030000000000001 112.361 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -90.2 -40.85 11.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 62.549999999999997 111.126 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 93.0 p 46.74 79.6 0.06 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 74.030000000000001 110.839 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.5 t -175.33 -175.63 0.84 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 65.209999999999994 111.137 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 41.7 p -98.75 163.63 12.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 64.439999999999998 110.831 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.732 HG22 ' HB2' ' A' ' 177' ' ' GLN . 3.0 p -145.6 153.57 13.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.124 -0.489 . . . . 61.439999999999998 111.107 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 99.1 t -87.24 144.71 8.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 64.540000000000006 111.134 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -47.95 122.57 5.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.216 -0.447 . . . . 75.310000000000002 110.891 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.75 -13.5 60.86 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.759 -0.734 . . . . 74.519999999999996 112.473 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.732 ' HB2' HG22 ' A' ' 173' ' ' VAL . 11.0 mm100 -93.38 -179.58 5.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.776 0.322 . . . . 63.399999999999999 110.913 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 57.4 p -162.09 148.09 13.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 70.049999999999997 110.849 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.416 HG21 HD12 ' A' ' 241' ' ' ILE . 6.9 t -105.26 -173.72 2.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.136 -0.484 . . . . 74.329999999999998 111.158 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -140.11 130.53 25.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 54.509999999999998 111.165 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.48 HD23 ' HB3' ' A' ' 168' ' ' PRO . 7.6 mp -103.53 142.39 34.36 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.245 -0.434 . . . . 74.540000000000006 110.93 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 10.9 m -109.46 142.72 40.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.262 -0.426 . . . . 65.510000000000005 111.166 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 1.033 HG13 HG22 ' A' ' 166' ' ' VAL . 21.9 t -129.45 141.53 46.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.231 -0.44 . . . . 65.540000000000006 111.154 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.574 ' HB3' ' OG1' ' A' ' 165' ' ' THR . . . -132.28 151.86 51.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.463 . . . . 60.420000000000002 111.132 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -145.33 126.73 14.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.275 -0.42 . . . . 72.120000000000005 110.882 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.97 66.69 79.65 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.57 0.7 . . . . 71.150000000000006 110.889 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -38.07 8.33 Favored 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.668 2.245 . . . . 54.149999999999999 112.328 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 66.32 41.85 3.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.22 -0.446 . . . . 71.319999999999993 110.881 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 168.39 -33.52 0.19 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.741 -0.742 . . . . 63.229999999999997 112.5 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 3.2 t -82.88 -58.36 3.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.927 0.394 . . . . 71.409999999999997 111.174 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 47.7 p 47.63 67.51 0.8 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.136 -0.484 . . . . 74.450000000000003 111.163 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -164.38 122.31 1.75 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 54.030000000000001 110.838 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -65.63 90.08 0.11 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 70.109999999999999 110.897 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 47.3 t -105.4 -6.66 19.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.254 -0.43 . . . . 70.540000000000006 110.848 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.772 ' CE2' HG11 ' A' ' 183' ' ' VAL . 17.1 p90 -90.82 177.68 6.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 61.219999999999999 110.878 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.44 175.29 9.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 75.430000000000007 110.908 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . 0.408 ' HB3' ' HB ' ' A' ' 209' ' ' VAL . . . -122.57 168.08 12.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 73.109999999999999 111.102 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 8.7 p -173.61 153.61 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.214 -0.448 . . . . 54.030000000000001 111.121 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.66 133.42 33.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 73.439999999999998 110.908 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.664 ' HB2' ' HD3' ' A' ' 227' ' ' PRO . . . -69.26 -21.11 63.92 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.154 -0.476 . . . . 74.150000000000006 111.074 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . 0.607 ' O ' HG23 ' A' ' 203' ' ' THR . 0.6 OUTLIER -132.61 -46.15 0.89 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 71.129999999999995 110.858 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.11 27.45 7.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 74.230000000000004 110.93 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.607 HG23 ' O ' ' A' ' 201' ' ' ASP . 53.3 p -112.13 -13.66 13.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 73.510000000000005 111.155 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . 0.489 ' HA ' ' HB3' ' A' ' 220' ' ' ALA . 9.1 mtmp? -139.26 24.88 2.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 72.439999999999998 110.87 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.675 ' HA ' HG22 ' A' ' 219' ' ' VAL . . . 179.06 143.3 0.13 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 73.319999999999993 111.137 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 7.8 p -106.99 131.23 54.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.231 -0.441 . . . . 63.25 111.121 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.947 HG12 HG22 ' A' ' 216' ' ' VAL . 5.0 m -118.34 143.33 29.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 63.299999999999997 111.153 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 3.3 m -149.3 108.7 3.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.466 . . . . 50.350000000000001 110.854 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.511 HG23 HG13 ' A' ' 214' ' ' ILE . 4.1 p -83.82 143.97 10.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 62.240000000000002 111.144 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 5.3 t -171.75 122.58 0.51 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 60.210000000000001 110.878 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 54.19 50.41 55.89 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.732 -0.747 . . . . 73.549999999999997 112.464 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 1.8 mtp 61.05 17.41 7.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.834 0.35 . . . . 70.530000000000001 110.831 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 12.7 m -129.44 113.1 14.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.253 -0.43 . . . . 70.340000000000003 111.139 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.511 HG13 HG23 ' A' ' 209' ' ' VAL . 2.9 mp -108.92 114.92 48.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 73.019999999999996 111.102 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 10.2 m -88.0 128.09 35.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 71.209999999999994 111.141 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.947 HG22 HG12 ' A' ' 207' ' ' VAL . 2.8 t -114.46 121.93 67.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.46 . . . . 63.200000000000003 111.109 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -106.0 144.43 32.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 73.019999999999996 110.861 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -96.64 66.26 0.99 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.693 -0.765 . . . . 70.519999999999996 112.478 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.675 HG22 ' HA ' ' A' ' 205' ' ' ALA . 0.1 OUTLIER -50.13 -42.08 19.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.863 0.363 . . . . 71.150000000000006 111.142 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . 0.489 ' HB3' ' HA ' ' A' ' 204' ' ' LYS . . . -125.2 154.04 42.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.454 . . . . 54.32 111.106 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . 0.666 ' HB2' ' HA ' ' A' ' 245' ' ' ALA . . . -73.47 131.89 42.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.232 -0.44 . . . . 54.200000000000003 111.085 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 143.93 177.31 18.72 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.722 -0.752 . . . . 44.240000000000002 112.494 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . 0.53 ' HG3' HG23 ' A' ' 242' ' ' THR . 12.6 mttt -98.89 136.26 39.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.84 0.352 . . . . 65.340000000000003 110.885 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.589 HG11 ' HB3' ' A' ' 205' ' ' ALA . 7.6 p -137.58 133.61 45.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.223 -0.444 . . . . 74.349999999999994 111.125 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.625 ' C ' HD12 ' A' ' 226' ' ' ILE . 36.7 m120 -90.94 154.05 19.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 71.409999999999997 110.885 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.625 HD12 ' C ' ' A' ' 225' ' ' ASN . 4.1 mp -136.83 92.54 14.44 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.58 0.705 . . . . 73.510000000000005 111.162 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' PRO . . . . . 0.664 ' HD3' ' HB2' ' A' ' 200' ' ' ALA . 53.6 Cg_endo -69.79 179.05 3.99 Favored 'Trans proline' 0 C--O 1.231 0.141 0 C-N-CA 122.671 2.248 . . . . 73.540000000000006 112.353 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 57.9 t -149.26 137.19 14.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.252 -0.431 . . . . 62.32 111.165 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 98.6 t -117.55 138.65 47.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 73.439999999999998 111.124 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -121.66 106.96 11.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 63.420000000000002 110.87 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . 0.487 ' HA3' ' HB2' ' A' ' 160' ' ' ALA . . . 56.93 -115.04 5.95 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.722 -0.751 . . . . 60.420000000000002 112.486 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -94.56 21.08 7.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.848 0.356 . . . . 74.420000000000002 110.853 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 97.49 9.19 55.44 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.756 -0.735 . . . . 63.100000000000001 112.485 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -51.94 -30.52 24.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.896 0.379 . . . . 64.040000000000006 110.871 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -145.59 163.41 34.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.153 -0.476 . . . . 72.219999999999999 110.907 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -161.71 165.26 28.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 73.219999999999999 111.078 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -143.86 163.24 33.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 75.510000000000005 111.13 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 59.2 t -136.52 132.84 48.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.264 -0.425 . . . . 64.310000000000002 111.114 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . 0.44 ' HB2' ' HG3' ' A' ' 168' ' ' PRO . . . -138.71 165.39 27.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 40.329999999999998 111.074 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . 0.472 ' O ' HD13 ' A' ' 241' ' ' ILE . 2.9 pt-20 -144.52 131.76 20.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 71.239999999999995 110.856 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' ILE . . . . . 0.628 HG13 HG11 ' A' ' 216' ' ' VAL . 34.8 mm -127.25 114.95 38.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.123 -0.49 . . . . 71.299999999999997 111.123 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' THR . . . . . 0.53 HG23 ' HG3' ' A' ' 223' ' ' LYS . 3.0 m -86.42 140.7 29.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.13 -0.487 . . . . 73.510000000000005 111.157 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 19.8 t -120.5 120.04 61.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 73.510000000000005 111.145 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' THR . . . . . 0.495 HG23 ' O ' ' A' ' 173' ' ' VAL . 6.4 p -81.56 132.96 35.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 61.210000000000001 111.203 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' ALA . . . . . 0.666 ' HA ' ' HB2' ' A' ' 221' ' ' ALA . . . -57.46 -26.67 61.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.281 -0.418 . . . . 74.540000000000006 111.138 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 15.1 m . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 73.430000000000007 110.893 -179.814 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 N-CA-C 112.485 -0.246 . . . . 73.040000000000006 112.485 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -63.43 135.06 56.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.775 0.321 . . . . 54.409999999999997 111.148 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 14.7 mmt -73.18 160.87 31.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 75.200000000000003 110.858 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -115.92 -2.0 12.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 51.130000000000003 111.114 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.82 ' HB2' ' HA3' ' A' ' 231' ' ' GLY . . . -147.0 -45.56 0.18 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.455 . . . . 73.239999999999995 111.111 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -179.58 -169.12 0.13 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.448 . . . . 72.019999999999996 111.096 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -130.08 27.2 5.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 73.439999999999998 111.148 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 146.66 100.68 0.27 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.727 -0.749 . . . . 41.520000000000003 112.446 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 45.9 ttp -111.32 130.54 55.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.807 0.337 . . . . 54.32 110.919 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.612 ' OG1' ' HB3' ' A' ' 184' ' ' ALA . 50.1 p -119.65 102.4 8.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.251 -0.431 . . . . 70.049999999999997 111.131 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 1.022 HG22 HG13 ' A' ' 183' ' ' VAL . 21.1 t -97.82 133.14 40.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 74.420000000000002 111.119 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.1 m -126.11 92.22 46.28 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.57 0.7 . . . . 43.32 111.173 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.478 ' HB3' HD23 ' A' ' 181' ' ' LEU . 53.1 Cg_endo -69.8 -166.14 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.698 2.265 . . . . 52.530000000000001 112.335 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -89.03 -42.64 11.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 44.149999999999999 111.117 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 22.9 t 49.29 79.14 0.08 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.241 -0.436 . . . . 73.299999999999997 110.899 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.5 t -175.44 -175.54 0.81 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 71.329999999999998 111.146 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 38.1 p -98.8 163.88 12.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 62.43 110.849 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.778 HG22 ' HB2' ' A' ' 177' ' ' GLN . 2.6 p -145.81 152.56 14.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 62.009999999999998 111.158 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 38.8 t -85.76 145.28 8.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 71.200000000000003 111.12 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.24 122.09 5.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 72.420000000000002 110.881 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.18 -11.18 61.95 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.745 -0.741 . . . . 74.310000000000002 112.448 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.778 ' HB2' HG22 ' A' ' 173' ' ' VAL . 20.9 mm100 -91.37 -177.21 4.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.826 0.346 . . . . 72.450000000000003 110.883 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -160.56 149.31 16.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 51.340000000000003 110.858 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 7.7 t -111.3 -177.27 3.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.124 -0.489 . . . . 61.219999999999999 111.12 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -138.07 133.62 33.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.211 -0.45 . . . . 53.32 111.176 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.478 HD23 ' HB3' ' A' ' 168' ' ' PRO . 7.8 mp -107.7 146.4 32.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.233 -0.44 . . . . 74.099999999999994 110.918 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 2.1 m -113.94 143.53 44.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.459 . . . . 61.020000000000003 111.119 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 1.022 HG13 HG22 ' A' ' 166' ' ' VAL . 21.3 t -129.33 138.18 55.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 70.230000000000004 111.163 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.612 ' HB3' ' OG1' ' A' ' 165' ' ' THR . . . -126.22 151.38 47.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 74.329999999999998 111.087 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -144.9 131.76 20.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.221 -0.445 . . . . 70.540000000000006 110.907 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.9 66.38 47.53 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.605 0.717 . . . . 70.299999999999997 110.952 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -33.58 16.35 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.653 2.235 . . . . 43.109999999999999 112.355 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 66.48 42.03 3.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.221 -0.445 . . . . 74.329999999999998 110.91 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 167.12 -46.17 0.25 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.763 -0.732 . . . . 64.099999999999994 112.474 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 2.3 t -67.58 -55.93 15.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.895 0.379 . . . . 65.219999999999999 111.147 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 44.7 p 47.96 63.61 1.97 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 71.439999999999998 111.133 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -160.89 132.43 5.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.238 -0.437 . . . . 63.219999999999999 110.867 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.72 87.1 6.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 54.119999999999997 110.898 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 14.4 m -102.3 -5.43 24.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 72.450000000000003 110.88 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.79 ' CE2' HG11 ' A' ' 183' ' ' VAL . 29.0 p90 -89.78 172.89 8.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 70.25 110.854 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.82 171.44 16.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.104 -0.498 . . . . 75.209999999999994 110.848 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . 0.468 ' HB3' ' HB ' ' A' ' 209' ' ' VAL . . . -114.86 168.04 10.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 60.210000000000001 111.089 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 9.6 p -159.88 152.85 5.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.25 -0.432 . . . . 73.510000000000005 111.12 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.77 119.0 28.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 74.209999999999994 110.844 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.565 ' HB2' ' HD3' ' A' ' 227' ' ' PRO . . . -62.89 -18.62 63.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 71.230000000000004 111.108 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -163.49 89.55 0.61 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 73.439999999999998 110.858 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 9.1 tmtt? -82.63 55.45 2.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.446 . . . . 74.319999999999993 110.907 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 25.9 p -129.44 1.18 5.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 45.32 111.139 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 10.6 mtmt -157.38 19.48 0.29 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 75.519999999999996 110.895 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.635 ' HA ' HG23 ' A' ' 219' ' ' VAL . . . 179.65 148.45 0.27 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 72.510000000000005 111.112 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 9.4 p -105.68 153.94 21.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.194 -0.457 . . . . 73.230000000000004 111.125 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.744 HG12 HG22 ' A' ' 216' ' ' VAL . 18.9 m -140.77 135.14 33.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.448 . . . . 73.340000000000003 111.172 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . 0.438 ' C ' HG23 ' A' ' 214' ' ' ILE . 4.6 m -144.32 109.31 5.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 33.240000000000002 110.8 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.675 HG23 HG13 ' A' ' 214' ' ' ILE . 5.5 p -92.47 144.44 9.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 75.310000000000002 111.168 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 2.7 m -146.56 99.42 3.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 73.519999999999996 110.859 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 70.17 -81.43 0.36 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.745 -0.74 . . . . 61.140000000000001 112.482 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -139.71 9.01 2.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.826 0.346 . . . . 62.329999999999998 110.844 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 56.9 m -128.52 124.42 35.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.242 -0.435 . . . . 41.130000000000003 111.141 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.675 HG13 HG23 ' A' ' 209' ' ' VAL . 2.5 mp -117.87 135.27 58.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 71.140000000000001 111.113 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.21 128.25 51.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.461 . . . . 52.32 111.108 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.744 HG22 HG12 ' A' ' 207' ' ' VAL . 6.8 t -118.05 131.39 70.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.227 -0.442 . . . . 72.549999999999997 111.137 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -116.45 139.22 50.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 62.200000000000003 110.905 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -94.88 78.95 0.88 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.734 -0.745 . . . . 74.049999999999997 112.492 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.635 HG23 ' HA ' ' A' ' 205' ' ' ALA . 17.2 t -49.56 -54.24 7.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.827 0.346 . . . . 75.329999999999998 111.149 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -129.6 162.92 27.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 65.219999999999999 111.105 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . 0.681 ' HB2' ' HA ' ' A' ' 245' ' ' ALA . . . -61.83 138.36 58.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.447 . . . . 72.049999999999997 111.09 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 144.25 170.33 13.57 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.74 -0.743 . . . . 50.509999999999998 112.488 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . 0.567 ' HG3' HG23 ' A' ' 242' ' ' THR . 13.3 mttt -100.19 124.0 45.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.793 0.33 . . . . 73.010000000000005 110.921 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.485 HG11 ' CB ' ' A' ' 205' ' ' ALA . 6.3 p -123.76 122.98 66.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 53.219999999999999 111.091 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.559 ' C ' HD12 ' A' ' 226' ' ' ILE . 21.2 m120 -91.19 156.27 17.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.466 . . . . 61.119999999999997 110.923 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.559 HD12 ' C ' ' A' ' 225' ' ' ASN . 4.7 mp -138.63 92.86 11.27 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.554 0.692 . . . . 65.310000000000002 111.114 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' PRO . . . . . 0.565 ' HD3' ' HB2' ' A' ' 200' ' ' ALA . 53.4 Cg_endo -69.88 -178.93 2.62 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.672 2.248 . . . . 74.420000000000002 112.31 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.484 ' CG2' ' HB3' ' A' ' 237' ' ' ALA . 23.5 t -146.52 149.24 16.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.455 . . . . 65.150000000000006 111.146 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 86.9 t -138.17 138.38 43.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 74.319999999999993 111.082 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -121.98 119.97 33.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 65.150000000000006 110.848 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . 0.82 ' HA3' ' HB2' ' A' ' 160' ' ' ALA . . . 58.08 -112.2 3.7 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.714 -0.755 . . . . 44.350000000000001 112.5 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -99.81 7.42 44.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.874 0.368 . . . . 72.530000000000001 110.892 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 114.46 16.09 7.83 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.691 -0.766 . . . . 73.430000000000007 112.495 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -51.13 -38.42 51.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.891 0.377 . . . . 64.010000000000005 110.863 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -143.07 167.04 23.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 64.140000000000001 110.911 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -162.23 165.32 26.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.113 -0.494 . . . . 74.430000000000007 111.1 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . 0.484 ' HB3' ' CG2' ' A' ' 228' ' ' VAL . . . -139.11 163.61 31.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.441 . . . . 64.540000000000006 111.135 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 61.2 t -132.46 127.2 56.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.233 -0.44 . . . . 63.340000000000003 111.095 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . 0.468 ' HB2' ' HG3' ' A' ' 168' ' ' PRO . . . -134.38 161.15 35.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.169 -0.469 . . . . 74.400000000000006 111.065 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . 0.604 ' O ' HD13 ' A' ' 241' ' ' ILE . 5.1 pt-20 -145.31 132.68 20.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 74.549999999999997 110.874 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' ILE . . . . . 0.604 HD13 ' O ' ' A' ' 240' ' ' GLU . 28.8 mm -126.95 112.85 30.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 72.299999999999997 111.129 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' THR . . . . . 0.567 HG23 ' HG3' ' A' ' 223' ' ' LYS . 1.9 m -83.06 141.49 32.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 74.109999999999999 111.179 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 14.0 t -119.92 121.6 66.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 73.239999999999995 111.156 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' THR . . . . . 0.408 HG23 ' O ' ' A' ' 173' ' ' VAL . 8.1 p -83.65 132.37 34.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.145 -0.479 . . . . 72.420000000000002 111.14 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' ALA . . . . . 0.681 ' HA ' ' HB2' ' A' ' 221' ' ' ALA . . . -53.72 -27.64 29.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 62.340000000000003 111.099 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 11.5 m . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 65.010000000000005 110.812 -179.726 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.491 -0.244 . . . . 64.310000000000002 112.491 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -121.46 163.64 18.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.792 0.33 . . . . 71.319999999999993 111.104 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 5.8 mmm -103.84 171.43 7.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 63.329999999999998 110.884 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -141.24 156.6 45.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.262 -0.426 . . . . 74.5 111.07 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.783 ' HB2' ' HA3' ' A' ' 231' ' ' GLY . . . -105.51 -66.99 0.94 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 65.329999999999998 111.125 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.442 ' HB1' ' HB3' ' A' ' 187' ' ' PRO . . . -178.46 -171.19 0.24 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.438 . . . . 64.230000000000004 111.118 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 1.1 p -119.55 3.92 11.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 65.439999999999998 111.167 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 173.74 101.73 0.15 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.741 -0.742 . . . . 73.010000000000005 112.447 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 16.3 ttp -111.84 125.17 53.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.86 0.362 . . . . 34.310000000000002 110.88 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.619 ' OG1' ' HB3' ' A' ' 184' ' ' ALA . 59.2 p -113.98 103.07 10.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.446 . . . . 72.200000000000003 111.129 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.998 HG22 HG13 ' A' ' 183' ' ' VAL . 20.7 t -99.83 131.29 47.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.215 -0.448 . . . . 73.230000000000004 111.11 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.8 m -126.81 92.57 44.37 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.565 0.697 . . . . 74.430000000000007 111.12 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.483 ' HB3' HD23 ' A' ' 181' ' ' LEU . 53.6 Cg_endo -69.81 -167.7 0.24 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.686 2.257 . . . . 73.219999999999999 112.317 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -85.38 -41.66 15.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 75.420000000000002 111.121 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 88.7 p 46.46 75.08 0.13 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.461 . . . . 55.530000000000001 110.85 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.4 t -172.32 -175.08 1.33 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.107 -0.497 . . . . 74.420000000000002 111.165 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 86.6 p -98.9 164.08 12.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.262 -0.427 . . . . 72.319999999999993 110.844 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.728 HG22 ' HB2' ' A' ' 177' ' ' GLN . 3.0 p -147.39 153.77 11.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.114 -0.494 . . . . 62.420000000000002 111.116 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 64.3 t -87.87 145.44 7.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 71.439999999999998 111.132 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.98 122.75 6.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 70.120000000000005 110.864 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 100.08 -15.33 59.33 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.782 -0.723 . . . . 42.439999999999998 112.517 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.728 ' HB2' HG22 ' A' ' 173' ' ' VAL . 11.6 mm100 -89.64 -177.97 5.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.807 0.337 . . . . 53.439999999999998 110.941 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 15.1 p -161.6 148.87 14.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 72.540000000000006 110.859 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.513 HG21 HD12 ' A' ' 241' ' ' ILE . 7.3 t -108.95 -173.86 2.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 61.020000000000003 111.133 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.41 131.87 26.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 74.219999999999999 111.13 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.483 HD23 ' HB3' ' A' ' 168' ' ' PRO . 7.6 mp -104.21 141.72 35.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 71.310000000000002 110.954 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.9 m -110.0 141.49 42.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.212 -0.449 . . . . 72.219999999999999 111.158 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.998 HG13 HG22 ' A' ' 166' ' ' VAL . 32.5 t -129.62 141.04 47.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.242 -0.435 . . . . 74.010000000000005 111.143 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.619 ' HB3' ' OG1' ' A' ' 165' ' ' THR . . . -131.53 151.46 51.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 72.219999999999999 111.114 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -143.72 129.81 19.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.249 -0.432 . . . . 73.510000000000005 110.862 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.54 66.91 58.76 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.616 0.722 . . . . 73.209999999999994 110.907 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.442 ' HB3' ' HB1' ' A' ' 161' ' ' ALA . 53.7 Cg_endo -69.72 -38.31 8.07 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.684 2.256 . . . . 55.509999999999998 112.362 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 67.17 47.89 1.28 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.181 -0.463 . . . . 74.310000000000002 110.869 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 160.9 -23.08 0.24 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.785 -0.721 . . . . 73.329999999999998 112.482 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 2.9 t -94.22 -58.65 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.916 0.388 . . . . 72.150000000000006 111.142 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 65.7 p 47.24 71.63 0.31 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.47 . . . . 74.530000000000001 111.145 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -169.68 118.23 0.62 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 52.140000000000001 110.897 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.67 104.09 0.98 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 72.120000000000005 110.919 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -117.38 -6.21 11.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 73.209999999999994 110.834 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.764 ' CE2' HG11 ' A' ' 183' ' ' VAL . 24.7 p90 -90.45 178.59 6.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 72.209999999999994 110.886 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.14 172.01 11.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 71.340000000000003 110.897 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -128.02 144.56 51.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 72.329999999999998 111.092 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 59.7 t -150.64 146.65 16.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 71.099999999999994 111.145 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 26.6 t -70.58 136.83 49.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.19 -0.459 . . . . 61.109999999999999 110.909 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.53 ' HB2' ' HD3' ' A' ' 227' ' ' PRO . . . -76.35 -8.41 57.06 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.149 -0.478 . . . . 63.030000000000001 111.092 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -142.85 -56.33 0.42 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.248 -0.433 . . . . 55.340000000000003 110.871 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 64.39 26.27 13.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.446 . . . . 74.200000000000003 110.91 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 80.6 p -114.24 -3.21 13.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 55.32 111.101 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 8.7 mtmm -149.19 16.4 0.93 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.274 -0.421 . . . . 72.239999999999995 110.859 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.708 ' HA ' HG23 ' A' ' 219' ' ' VAL . . . -177.69 146.78 0.46 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.259 -0.428 . . . . 62.329999999999998 111.139 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 15.9 p -104.81 153.37 21.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 65.140000000000001 111.136 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.924 HG12 HG22 ' A' ' 216' ' ' VAL . 35.5 m -136.88 140.96 41.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 75.040000000000006 111.115 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.98 108.3 4.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 74.140000000000001 110.865 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.53 HG23 HG13 ' A' ' 214' ' ' ILE . 3.7 p -87.95 143.46 11.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.064 -0.516 . . . . 73.109999999999999 111.139 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 3.8 t -172.13 123.14 0.49 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 53.299999999999997 110.851 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 55.71 47.8 75.73 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.773 -0.727 . . . . 64.129999999999995 112.452 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 3.8 mtp 63.19 16.27 9.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.833 0.349 . . . . 63.509999999999998 110.867 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 21.0 m -126.47 113.48 16.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.261 -0.427 . . . . 73.219999999999999 111.114 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.53 HG13 HG23 ' A' ' 209' ' ' VAL . 3.1 mp -110.46 115.54 50.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.463 . . . . 63.219999999999999 111.121 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 2.6 m -88.88 132.66 34.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.24 -0.436 . . . . 74.200000000000003 111.169 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.924 HG22 HG12 ' A' ' 207' ' ' VAL . 3.5 t -118.0 125.69 74.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.257 -0.429 . . . . 64.200000000000003 111.104 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -109.12 136.87 47.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.104 -0.498 . . . . 75.120000000000005 110.873 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -91.16 83.56 1.27 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.734 -0.746 . . . . 73.310000000000002 112.499 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.708 HG23 ' HA ' ' A' ' 205' ' ' ALA . 20.3 t -53.99 -52.52 35.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.857 0.36 . . . . 72.310000000000002 111.151 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -134.34 163.18 30.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 65.439999999999998 111.129 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . 0.474 ' HB2' ' HA ' ' A' ' 245' ' ' ALA . . . -56.64 144.84 30.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 75.310000000000002 111.107 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . 0.441 ' O ' HG23 ' A' ' 243' ' ' VAL . . . 129.92 166.29 11.81 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.791 -0.719 . . . . 71.239999999999995 112.535 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . 0.77 ' HG3' HG23 ' A' ' 242' ' ' THR . 2.6 mtmm -101.32 129.67 47.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.833 0.349 . . . . 70.310000000000002 110.907 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.548 HG11 ' HB3' ' A' ' 205' ' ' ALA . 7.4 p -118.58 129.68 74.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.263 -0.426 . . . . 72.209999999999994 111.149 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.609 ' C ' HD12 ' A' ' 226' ' ' ILE . 35.2 m120 -89.71 147.4 23.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 70.219999999999999 110.889 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.609 HD12 ' C ' ' A' ' 225' ' ' ASN . 4.3 mp -137.75 93.35 12.33 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.633 0.73 . . . . 74.540000000000006 111.161 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' PRO . . . . . 0.53 ' HD3' ' HB2' ' A' ' 200' ' ' ALA . 53.5 Cg_endo -69.79 -176.9 1.65 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.729 2.286 . . . . 74.25 112.297 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.557 ' CG2' ' HB3' ' A' ' 237' ' ' ALA . 48.2 t -147.3 134.72 14.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 62.299999999999997 111.082 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 93.7 t -117.95 133.08 65.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.177 -0.465 . . . . 61.020000000000003 111.109 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.23 116.28 23.85 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.128 -0.487 . . . . 73.049999999999997 110.845 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . 0.783 ' HA3' ' HB2' ' A' ' 160' ' ' ALA . . . 61.18 -121.13 25.44 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.743 -0.742 . . . . 72.150000000000006 112.469 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -95.78 15.43 20.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.871 0.367 . . . . 72.140000000000001 110.904 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 111.13 9.96 21.3 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.747 -0.739 . . . . 52.350000000000001 112.459 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -51.11 -65.08 0.62 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.906 0.384 . . . . 64.129999999999995 110.907 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -110.78 156.03 21.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 74.109999999999999 110.894 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -153.16 164.69 37.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 63.149999999999999 111.053 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . 0.557 ' HB3' ' CG2' ' A' ' 228' ' ' VAL . . . -144.86 163.88 32.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.456 . . . . 75.310000000000002 111.119 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 14.1 p -137.91 134.65 45.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 75.140000000000001 111.105 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . 0.452 ' HB2' ' HG3' ' A' ' 168' ' ' PRO . . . -139.31 164.37 30.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.119 -0.491 . . . . 65.349999999999994 111.116 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -147.56 131.14 16.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.249 -0.432 . . . . 63.310000000000002 110.879 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' ILE . . . . . 0.645 HG13 HG11 ' A' ' 216' ' ' VAL . 30.7 mm -122.83 115.0 44.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 71.420000000000002 111.064 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' THR . . . . . 0.77 HG23 ' HG3' ' A' ' 223' ' ' LYS . 0.6 OUTLIER -83.0 141.28 32.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.179 -0.464 . . . . 63.100000000000001 111.149 179.926 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 222' ' ' GLY . 19.5 t -120.39 120.32 62.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.225 -0.443 . . . . 64.430000000000007 111.161 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' THR . . . . . 0.518 HG23 ' O ' ' A' ' 173' ' ' VAL . 4.9 p -82.61 132.95 35.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 75.349999999999994 111.133 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' ALA . . . . . 0.474 ' HA ' ' HB2' ' A' ' 221' ' ' ALA . . . -58.71 -21.67 55.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.439 . . . . 33.350000000000001 111.086 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 4.5 m . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.443 . . . . 71.430000000000007 110.883 -179.807 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 112.481 -0.247 . . . . 65.329999999999998 112.481 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -89.82 -33.16 16.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.806 0.336 . . . . 61.340000000000003 111.132 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 35.6 mtm -52.77 129.6 30.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 73.310000000000002 110.831 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -177.17 -169.37 0.24 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 52.450000000000003 111.069 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -176.67 129.61 0.19 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 73.0 111.078 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.36 -168.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 61.020000000000003 111.073 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -125.14 32.11 5.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 72.430000000000007 111.183 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 138.46 99.58 0.48 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.775 -0.726 . . . . 75.239999999999995 112.473 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 41.2 ttp -111.11 129.07 56.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.882 0.372 . . . . 64.219999999999999 110.841 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.546 ' OG1' ' HB3' ' A' ' 184' ' ' ALA . 40.4 p -118.0 105.86 12.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.194 -0.457 . . . . 71.209999999999994 111.13 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 1.086 HG22 HG13 ' A' ' 183' ' ' VAL . 21.5 t -99.87 133.64 42.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 74.319999999999993 111.167 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.3 m -126.2 92.49 45.56 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.593 0.711 . . . . 73.109999999999999 111.145 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.497 ' HG3' ' HB2' ' A' ' 239' ' ' ALA . 53.5 Cg_endo -69.77 -167.88 0.25 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.7 2.267 . . . . 65.420000000000002 112.338 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -87.15 -38.13 16.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 72.510000000000005 111.121 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 94.4 p 46.21 79.54 0.05 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 31.309999999999999 110.87 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.4 t -175.39 -174.6 0.74 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.17 -0.468 . . . . 74.329999999999998 111.164 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 33.0 p -101.06 162.0 13.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 72.219999999999999 110.875 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.738 HG22 ' HB2' ' A' ' 177' ' ' GLN . 2.6 p -144.83 154.25 14.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 74.450000000000003 111.133 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 93.2 t -89.91 144.9 8.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 75.099999999999994 111.137 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -47.75 124.11 6.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 70.109999999999999 110.922 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.69 -17.22 57.79 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.756 -0.735 . . . . 52.109999999999999 112.465 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.738 ' HB2' HG22 ' A' ' 173' ' ' VAL . 10.7 mm100 -87.99 -177.77 5.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.768 0.318 . . . . 73.329999999999998 110.956 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 1.7 p -161.86 148.91 14.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.237 -0.438 . . . . 74.409999999999997 110.875 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 9.2 t -111.04 -174.86 2.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.14 -0.482 . . . . 72.439999999999998 111.112 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.21 132.46 29.89 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.174 -0.466 . . . . 72.219999999999999 111.139 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.473 HD23 ' HB3' ' A' ' 168' ' ' PRO . 7.6 mp -106.36 143.3 34.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 73.519999999999996 110.904 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 16.3 m -110.31 143.91 39.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.451 . . . . 33.420000000000002 111.129 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 1.086 HG13 HG22 ' A' ' 166' ' ' VAL . 22.9 t -129.69 142.36 44.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.214 -0.448 . . . . 51.439999999999998 111.143 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.546 ' HB3' ' OG1' ' A' ' 165' ' ' THR . . . -131.55 150.92 51.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 70.349999999999994 111.081 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -144.47 126.45 15.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 72.109999999999999 110.881 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.22 67.23 79.61 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.565 0.698 . . . . 65.420000000000002 110.892 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -37.22 9.58 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.674 2.249 . . . . 72.140000000000001 112.387 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 66.31 40.97 3.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 71.329999999999998 110.864 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 169.29 -37.99 0.2 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.777 -0.725 . . . . 54.109999999999999 112.52 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 2.9 t -77.43 -57.75 5.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.883 0.373 . . . . 71.310000000000002 111.09 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 1.1 p 47.21 66.56 0.98 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 73.209999999999994 111.16 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -168.49 113.63 0.62 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 70.319999999999993 110.854 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 5.1 mtmt -54.39 101.45 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 74.400000000000006 110.918 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 23.0 t -115.22 -5.99 12.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 54.219999999999999 110.837 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.772 ' CE2' HG11 ' A' ' 183' ' ' VAL . 22.7 p90 -90.31 172.15 8.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.127 -0.488 . . . . 63.409999999999997 110.873 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.58 158.89 36.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 74.239999999999995 110.886 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . 0.606 ' HB3' ' HB ' ' A' ' 209' ' ' VAL . . . -112.83 165.97 11.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.445 . . . . 54.509999999999998 111.094 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 10.7 p -175.18 151.84 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 34.399999999999999 111.132 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.6 t -79.25 144.49 34.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 71.109999999999999 110.866 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.581 ' HB2' ' HD3' ' A' ' 227' ' ' PRO . . . -78.57 -22.6 46.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 75.519999999999996 111.073 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -127.63 -54.87 1.33 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 60.5 110.814 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 1.7 ttpm? 63.43 27.92 15.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.469 . . . . 71.200000000000003 110.885 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 44.8 p -115.76 -1.77 12.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.265 -0.425 . . . . 71.200000000000003 111.149 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . 0.526 ' CB ' ' HB3' ' A' ' 220' ' ' ALA . 11.2 mtmm -149.61 16.48 0.89 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 73.109999999999999 110.919 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -174.9 150.68 1.27 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 72.040000000000006 111.078 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 23.9 p -112.88 134.65 54.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 70.329999999999998 111.145 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.924 HG12 HG22 ' A' ' 216' ' ' VAL . 5.3 m -122.4 139.65 48.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.221 -0.445 . . . . 72.200000000000003 111.108 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -144.1 108.87 4.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 45.43 110.848 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.606 ' HB ' ' HB3' ' A' ' 197' ' ' ALA . 4.3 p -84.84 143.76 11.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 63.530000000000001 111.142 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 11.8 t -172.12 124.47 0.52 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 74.439999999999998 110.865 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 52.87 52.0 41.81 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.728 -0.749 . . . . 51.119999999999997 112.478 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 2.2 mtp 58.75 19.61 7.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.885 0.374 . . . . 74.209999999999994 110.914 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 1.6 m -131.56 113.21 13.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.229 -0.441 . . . . 73.439999999999998 111.164 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.569 HG13 HG23 ' A' ' 209' ' ' VAL . 3.1 mp -109.71 116.78 53.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 64.209999999999994 111.118 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 1.1 m -89.86 129.91 36.16 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.148 -0.478 . . . . 62.039999999999999 111.118 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.924 HG22 HG12 ' A' ' 207' ' ' VAL . 3.5 t -115.75 129.6 71.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 73.340000000000003 111.063 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -112.32 135.12 53.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.119 -0.491 . . . . 52.0 110.875 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -82.1 67.04 3.76 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.752 -0.737 . . . . 65.420000000000002 112.519 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.423 HG12 ' N ' ' A' ' 220' ' ' ALA . 1.4 t -48.4 -51.05 11.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.848 0.356 . . . . 65.400000000000006 111.153 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . 0.526 ' HB3' ' CB ' ' A' ' 204' ' ' LYS . . . -127.86 154.87 44.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 45.240000000000002 111.093 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . 0.655 ' HB2' ' HA ' ' A' ' 245' ' ' ALA . . . -66.63 136.36 55.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 73.420000000000002 111.078 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 139.21 171.91 12.41 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.726 -0.749 . . . . 54.009999999999998 112.487 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . 0.441 ' HG3' HG23 ' A' ' 242' ' ' THR . 8.3 mttm -96.02 125.19 40.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.806 0.336 . . . . 74.349999999999994 110.918 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 7.7 p -121.42 131.25 73.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.268 -0.423 . . . . 75.400000000000006 111.141 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.615 ' C ' HD12 ' A' ' 226' ' ' ILE . 34.3 m120 -90.54 151.41 21.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 62.219999999999999 110.859 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.615 HD12 ' C ' ' A' ' 225' ' ' ASN . 4.3 mp -136.71 92.71 14.55 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.633 0.73 . . . . 64.340000000000003 111.136 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' PRO . . . . . 0.581 ' HD3' ' HB2' ' A' ' 200' ' ' ALA . 53.9 Cg_endo -69.82 179.92 3.39 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.664 2.243 . . . . 62.43 112.339 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 96.7 t -150.63 137.54 13.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 73.230000000000004 111.161 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 92.7 t -122.38 134.55 65.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 51.020000000000003 111.115 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -122.22 125.02 45.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.15 -0.477 . . . . 62.109999999999999 110.869 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 56.77 -117.74 10.21 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.74 -0.743 . . . . 70.120000000000005 112.468 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -94.44 8.46 42.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.865 0.364 . . . . 62.439999999999998 110.85 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 106.94 9.61 29.83 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.717 -0.754 . . . . 63.229999999999997 112.473 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -51.67 -40.66 60.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.886 0.374 . . . . 74.230000000000004 110.884 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -127.68 167.25 16.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.481 . . . . 53.210000000000001 110.873 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -166.26 165.34 17.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 70.010000000000005 111.081 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -139.33 163.19 33.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.222 -0.445 . . . . 73.450000000000003 111.103 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.0 p -135.32 127.71 47.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.441 . . . . 52.450000000000003 111.112 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . 0.497 ' HB2' ' HG3' ' A' ' 168' ' ' PRO . . . -130.52 163.07 27.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.13 -0.486 . . . . 61.409999999999997 111.086 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . 0.439 ' O ' HD13 ' A' ' 241' ' ' ILE . 2.8 pt-20 -144.31 128.29 17.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.439 . . . . 44.210000000000001 110.876 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' ILE . . . . . 0.467 HG13 HG11 ' A' ' 216' ' ' VAL . 26.0 mm -124.92 111.2 27.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 63.200000000000003 111.127 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' THR . . . . . 0.441 HG23 ' HG3' ' A' ' 223' ' ' LYS . 4.0 m -81.63 139.94 34.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 73.310000000000002 111.131 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 30.5 t -120.26 119.06 58.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 53.310000000000002 111.142 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' THR . . . . . 0.503 HG23 ' O ' ' A' ' 173' ' ' VAL . 5.1 p -81.12 132.87 35.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.151 -0.477 . . . . 71.140000000000001 111.102 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' ALA . . . . . 0.655 ' HA ' ' HB2' ' A' ' 221' ' ' ALA . . . -54.06 -27.66 33.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 61.32 111.113 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 10.2 m . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.237 -0.438 . . . . 73.519999999999996 110.875 -179.783 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.289 0 N-CA-C 112.455 -0.258 . . . . 51.140000000000001 112.455 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -81.02 114.6 20.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.769 0.319 . . . . 54.140000000000001 111.091 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 8.0 mmt -119.29 139.08 52.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.444 . . . . 62.100000000000001 110.907 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -136.38 146.3 46.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.244 -0.435 . . . . 62.539999999999999 111.132 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.621 ' O ' HG11 ' A' ' 190' ' ' VAL . . . -76.03 -75.15 0.19 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.252 -0.431 . . . . 62.009999999999998 111.107 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -174.02 -167.78 0.37 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 72.439999999999998 111.115 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 1.1 m -137.55 27.58 2.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 62.210000000000001 111.138 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 147.01 105.65 0.43 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.801 -0.714 . . . . 72.430000000000007 112.522 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 1.5 ttp -120.0 140.52 50.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.875 0.369 . . . . 63.509999999999998 110.886 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.628 HG23 HE22 ' A' ' 186' ' ' GLN . 32.8 p -126.43 109.83 12.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.445 . . . . 71.510000000000005 111.167 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 1.059 HG22 HG13 ' A' ' 183' ' ' VAL . 21.7 t -97.57 134.98 33.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 74.200000000000003 111.102 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 4.3 m -126.94 92.59 44.1 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.631 0.729 . . . . 70.510000000000005 111.168 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.468 ' HB3' HD23 ' A' ' 181' ' ' LEU . 53.8 Cg_endo -69.74 -167.65 0.23 Allowed 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.686 2.257 . . . . 73.400000000000006 112.373 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -89.88 -43.16 10.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 73.140000000000001 111.093 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 12.2 t 49.7 80.98 0.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 55.32 110.835 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.5 t -175.13 -175.46 0.85 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 75.209999999999994 111.199 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 83.3 p -98.45 161.69 13.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.436 . . . . 60.420000000000002 110.893 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.723 HG22 ' HB2' ' A' ' 177' ' ' GLN . 3.1 p -144.24 153.92 15.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 71.129999999999995 111.132 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 64.7 t -87.5 144.99 8.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 74.329999999999998 111.159 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.6 122.55 5.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.451 . . . . 74.209999999999994 110.883 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.59 -14.2 60.73 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.753 -0.737 . . . . 65.209999999999994 112.475 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.723 ' HB2' HG22 ' A' ' 173' ' ' VAL . 15.7 mm100 -91.61 -178.23 5.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.802 0.334 . . . . 75.040000000000006 110.915 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 54.3 p -161.55 146.24 13.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 75.209999999999994 110.862 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.565 HG21 HD12 ' A' ' 241' ' ' ILE . 7.0 t -103.34 -173.85 2.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.083 -0.508 . . . . 75.109999999999999 111.158 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.51 132.86 28.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.219 -0.446 . . . . 74.420000000000002 111.14 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.468 HD23 ' HB3' ' A' ' 168' ' ' PRO . 7.5 mp -106.63 145.25 32.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 53.219999999999999 110.943 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 2.2 m -113.81 145.56 41.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.238 -0.437 . . . . 62.130000000000003 111.13 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 1.059 HG13 HG22 ' A' ' 166' ' ' VAL . 21.9 t -129.48 142.18 44.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 64.310000000000002 111.124 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.407 ' HB3' ' OG1' ' A' ' 165' ' ' THR . . . -128.74 152.94 47.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 72.319999999999993 111.088 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -143.99 128.25 17.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 73.040000000000006 110.852 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . 0.628 HE22 HG23 ' A' ' 165' ' ' THR . 0.0 OUTLIER -132.72 66.93 77.6 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.606 0.717 . . . . 62.439999999999998 110.9 -179.935 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -26.16 27.96 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.694 2.263 . . . . 72.540000000000006 112.387 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 70.31 33.43 2.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.195 -0.457 . . . . 74.319999999999993 110.878 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 167.88 -25.66 0.13 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.713 -0.756 . . . . 45.020000000000003 112.442 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.621 HG11 ' O ' ' A' ' 160' ' ' ALA . 71.7 t -101.18 149.64 6.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.913 0.387 . . . . 74.239999999999995 111.132 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 12.4 p -140.45 38.63 1.88 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 74.219999999999999 111.158 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.531 ' H ' HG12 ' A' ' 190' ' ' VAL . 37.6 t70 -125.02 119.74 29.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.215 -0.448 . . . . 71.109999999999999 110.86 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 24.8 mtmt -74.31 74.68 1.85 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 52.100000000000001 110.894 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -75.55 -6.25 49.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 74.010000000000005 110.826 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.785 ' CE2' HG11 ' A' ' 183' ' ' VAL . 11.5 p90 -90.03 151.81 21.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 64.329999999999998 110.898 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.59 154.04 43.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.144 -0.48 . . . . 72.239999999999995 110.923 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -103.81 167.77 9.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 71.230000000000004 111.103 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 9.3 p -173.25 152.99 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 74.150000000000006 111.171 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 73.4 p -76.6 152.86 35.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 65.239999999999995 110.866 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.636 ' HB2' ' HD3' ' A' ' 227' ' ' PRO . . . -93.86 -19.54 20.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.126 -0.488 . . . . 71.430000000000007 111.135 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.84 -55.28 0.93 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 73.519999999999996 110.864 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.54 26.41 14.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 71.319999999999993 110.881 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 41.5 p -112.9 -3.92 14.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 65.430000000000007 111.152 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 10.2 mtmm -154.21 19.87 0.49 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 72.549999999999997 110.898 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.625 ' HA ' HG23 ' A' ' 219' ' ' VAL . . . -177.46 147.6 0.53 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 73.430000000000007 111.105 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 15.0 p -108.65 159.67 16.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 75.519999999999996 111.159 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.711 HG12 HG22 ' A' ' 216' ' ' VAL . 7.7 m -141.37 141.97 29.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.246 -0.434 . . . . 62.420000000000002 111.107 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 69.8 m -149.1 108.66 3.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 73.430000000000007 110.888 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.549 HG23 HG13 ' A' ' 214' ' ' ILE . 3.6 p -88.97 143.15 11.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.1 -0.5 . . . . 72.019999999999996 111.119 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 18.8 t -172.16 123.48 0.49 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.47 . . . . 64.409999999999997 110.864 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 56.04 47.02 83.24 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.719 -0.753 . . . . 64.430000000000007 112.524 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 2.4 mtp 63.85 15.94 9.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.904 0.383 . . . . 71.219999999999999 110.908 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 6.5 m -125.6 113.14 17.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.459 . . . . 51.539999999999999 111.128 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.549 HG13 HG23 ' A' ' 209' ' ' VAL . 3.0 mp -110.43 113.98 45.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 75.219999999999999 111.127 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 7.3 m -88.95 132.78 34.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.129 -0.487 . . . . 71.420000000000002 111.184 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.711 HG22 HG12 ' A' ' 207' ' ' VAL . 4.4 t -117.94 123.54 71.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.257 -0.429 . . . . 40.43 111.124 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -104.94 140.0 38.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 73.219999999999999 110.901 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -95.41 79.31 0.83 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.726 -0.749 . . . . 73.239999999999995 112.478 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.625 HG23 ' HA ' ' A' ' 205' ' ' ALA . 18.3 t -49.54 -54.67 6.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.821 0.343 . . . . 61.119999999999997 111.12 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -130.85 162.07 30.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 71.530000000000001 111.075 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . 0.672 ' HB2' ' HA ' ' A' ' 245' ' ' ALA . . . -60.36 141.82 55.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 73.329999999999998 111.141 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 139.4 172.05 12.5 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.757 -0.735 . . . . 51.229999999999997 112.471 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . 0.401 ' HG3' HG23 ' A' ' 242' ' ' THR . 5.0 mttt -99.74 120.84 40.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.824 0.345 . . . . 73.530000000000001 110.89 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.583 HG11 ' CB ' ' A' ' 205' ' ' ALA . 6.4 p -117.46 122.88 70.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.213 -0.448 . . . . 74.400000000000006 111.133 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.652 ' C ' HD12 ' A' ' 226' ' ' ILE . 26.8 m120 -90.99 152.74 20.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.163 -0.472 . . . . 72.040000000000006 110.908 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.652 HD12 ' C ' ' A' ' 225' ' ' ASN . 3.9 mp -137.74 92.72 12.76 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.632 0.729 . . . . 64.120000000000005 111.13 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' PRO . . . . . 0.636 ' HD3' ' HB2' ' A' ' 200' ' ' ALA . 54.2 Cg_endo -69.7 177.1 5.88 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.67 2.247 . . . . 65.310000000000002 112.376 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.447 ' CG2' ' HB3' ' A' ' 237' ' ' ALA . 34.6 t -146.18 139.11 20.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.257 -0.429 . . . . 74.120000000000005 111.102 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 91.4 t -129.25 143.79 40.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.15 -0.477 . . . . 71.109999999999999 111.178 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 6.0 p -92.4 176.0 6.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 50.140000000000001 110.832 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -51.16 -45.97 51.41 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.761 -0.733 . . . . 73.349999999999994 112.499 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 20.2 t30 -111.48 21.08 16.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.873 0.368 . . . . 65.010000000000005 110.885 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 61.7 16.02 49.69 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.724 -0.75 . . . . 72.129999999999995 112.469 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -66.36 -44.45 83.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.894 0.378 . . . . 71.340000000000003 110.902 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -117.3 144.93 44.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.146 -0.479 . . . . 70.019999999999996 110.909 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -144.71 163.23 34.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 70.109999999999999 111.101 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . 0.447 ' HB3' ' CG2' ' A' ' 228' ' ' VAL . . . -142.65 163.4 32.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 63.299999999999997 111.052 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 57.3 t -139.6 136.6 40.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.215 -0.448 . . . . 55.329999999999998 111.132 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.17 165.08 27.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.466 . . . . 72.140000000000001 111.075 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . 0.405 ' O ' HD13 ' A' ' 241' ' ' ILE . 3.2 pt-20 -143.79 132.25 22.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 74.120000000000005 110.862 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' ILE . . . . . 0.565 HD12 HG21 ' A' ' 179' ' ' THR . 24.1 mm -127.27 113.28 31.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 64.409999999999997 111.156 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' THR . . . . . 0.401 HG23 ' HG3' ' A' ' 223' ' ' LYS . 1.7 m -81.42 141.06 34.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 52.340000000000003 111.134 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 17.2 t -119.95 122.13 67.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 73.439999999999998 111.144 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' THR . . . . . 0.525 HG23 ' O ' ' A' ' 173' ' ' VAL . 7.2 p -82.57 133.05 35.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 62.350000000000001 111.159 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' ALA . . . . . 0.672 ' HA ' ' HB2' ' A' ' 221' ' ' ALA . . . -59.14 -21.87 60.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 72.140000000000001 111.088 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 52.3 p . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 72.109999999999999 110.856 -179.782 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 N-CA-C 112.449 -0.26 . . . . 54.299999999999997 112.449 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -163.67 164.16 24.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.773 0.32 . . . . 72.409999999999997 111.096 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.26 -177.31 3.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 73.400000000000006 110.839 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -171.22 -169.55 0.75 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 73.209999999999994 111.092 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -176.48 129.38 0.2 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.441 . . . . 74.209999999999994 111.096 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.5 -168.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.242 -0.435 . . . . 35.020000000000003 111.078 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -124.6 31.96 5.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 74.409999999999997 111.109 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 138.28 99.17 0.48 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.743 -0.741 . . . . 70.450000000000003 112.486 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 35.2 ttp -109.71 130.91 55.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.822 0.344 . . . . 70.010000000000005 110.888 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.552 ' OG1' ' HB3' ' A' ' 184' ' ' ALA . 36.5 p -120.48 105.1 10.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.44 . . . . 74.349999999999994 111.182 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.994 HG22 HG13 ' A' ' 183' ' ' VAL . 21.1 t -98.26 136.11 30.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 64.510000000000005 111.171 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.3 m -127.7 91.86 44.29 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.593 0.711 . . . . 54.409999999999997 111.127 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.465 ' HG3' ' HB2' ' A' ' 239' ' ' ALA . 53.9 Cg_endo -69.72 -165.7 0.16 Allowed 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.709 2.273 . . . . 65.040000000000006 112.346 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -91.84 -39.25 11.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 74.409999999999997 111.089 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 88.5 p 46.73 79.82 0.05 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 52.219999999999999 110.897 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.6 t -175.56 -175.06 0.75 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.121 -0.491 . . . . 72.040000000000006 111.131 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 25.5 p -99.84 163.28 12.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 73.349999999999994 110.853 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.726 HG22 ' HB2' ' A' ' 177' ' ' GLN . 3.0 p -143.91 153.4 15.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.123 -0.489 . . . . 75.319999999999993 111.12 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 80.6 t -87.76 143.58 10.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 73.549999999999997 111.099 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.35 122.41 4.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 75.049999999999997 110.872 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.34 -9.88 61.18 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.735 -0.745 . . . . 72.310000000000002 112.482 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.726 ' HB2' HG22 ' A' ' 173' ' ' VAL . 11.9 mm100 -97.17 -178.68 4.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.792 0.329 . . . . 74.019999999999996 110.946 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 15.2 p -161.55 147.67 14.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 63.299999999999997 110.898 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 7.7 t -104.9 -175.82 2.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.476 . . . . 63.329999999999998 111.131 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -137.38 130.11 30.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 63.030000000000001 111.16 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.46 HD23 ' HB3' ' A' ' 168' ' ' PRO . 8.0 mp -105.43 140.39 38.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 72.209999999999994 110.937 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -109.92 145.57 36.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 75.329999999999998 111.163 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.994 HG13 HG22 ' A' ' 166' ' ' VAL . 52.1 t -129.58 142.61 43.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.453 . . . . 74.400000000000006 111.141 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.552 ' HB3' ' OG1' ' A' ' 165' ' ' THR . . . -130.13 150.76 51.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.198 -0.455 . . . . 71.510000000000005 111.084 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -144.83 126.74 15.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 74.400000000000006 110.884 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.89 67.61 80.92 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.612 0.72 . . . . 53.329999999999998 110.903 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 -33.55 16.22 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.67 2.247 . . . . 71.349999999999994 112.372 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 65.75 32.54 8.85 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.212 -0.449 . . . . 63.439999999999998 110.857 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 177.66 -50.0 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.724 -0.75 . . . . 60.240000000000002 112.457 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 2.6 t -62.72 -56.26 18.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.918 0.389 . . . . 70.510000000000005 111.155 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 38.2 p 48.21 61.7 2.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 42.119999999999997 111.114 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -166.8 120.76 1.04 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.256 -0.429 . . . . 73.120000000000005 110.844 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.35 99.82 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 73.120000000000005 110.87 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 3.3 t -111.16 -7.33 14.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 65.430000000000007 110.892 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.789 ' CE2' HG11 ' A' ' 183' ' ' VAL . 21.1 p90 -91.36 -176.29 4.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.108 -0.496 . . . . 72.200000000000003 110.878 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -166.3 175.27 8.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 65.239999999999995 110.926 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . 0.684 ' HB3' ' CG2' ' A' ' 209' ' ' VAL . . . -125.24 167.16 15.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 74.319999999999993 111.098 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.419 HG13 ' HG2' ' A' ' 227' ' ' PRO . 13.9 p -170.54 149.52 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 71.230000000000004 111.133 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.2 p -92.22 125.3 36.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 71.099999999999994 110.833 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.483 ' HB2' ' HD3' ' A' ' 227' ' ' PRO . . . -60.77 -18.62 56.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 73.400000000000006 111.076 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -164.25 103.52 0.86 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 73.420000000000002 110.878 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -89.61 46.78 1.4 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.169 -0.469 . . . . 72.209999999999994 110.891 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 11.9 p -120.9 -9.17 9.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 72.209999999999994 111.165 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . 0.697 ' HA ' ' HB3' ' A' ' 220' ' ' ALA . 11.3 mtmm -143.09 17.1 1.92 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 71.420000000000002 110.908 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.63 ' CB ' HG11 ' A' ' 224' ' ' VAL . . . 178.91 143.12 0.12 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 45.509999999999998 111.106 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 2.1 p -104.6 161.68 13.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.437 . . . . 72.450000000000003 111.165 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.598 HG12 HG22 ' A' ' 216' ' ' VAL . 17.2 m -140.85 150.17 20.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.239 -0.437 . . . . 75.319999999999993 111.138 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 22.8 m -157.69 109.71 2.35 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.474 . . . . 73.319999999999993 110.843 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.684 ' CG2' ' HB3' ' A' ' 197' ' ' ALA . 90.5 t -79.45 145.18 9.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.116 -0.493 . . . . 61.299999999999997 111.162 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 59.2 p -165.84 111.56 0.87 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.197 -0.456 . . . . 72.200000000000003 110.848 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 47.66 63.33 3.52 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.736 -0.745 . . . . 70.430000000000007 112.458 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 3.1 mtp 55.75 20.48 4.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.875 0.369 . . . . 72.540000000000006 110.891 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 1.4 m -130.97 106.5 8.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.23 -0.441 . . . . 53.32 111.14 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.531 ' H ' HD12 ' A' ' 214' ' ' ILE . 0.8 OUTLIER -101.64 122.01 53.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.264 -0.426 . . . . 72.209999999999994 111.166 179.905 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 7.3 m -92.22 123.15 35.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 73.340000000000003 111.112 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.598 HG22 HG12 ' A' ' 207' ' ' VAL . 2.4 t -108.65 123.18 64.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 62.240000000000002 111.101 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -107.63 145.1 33.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 63.530000000000001 110.87 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -99.72 64.24 0.65 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.776 -0.726 . . . . 63.329999999999998 112.526 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.611 HG22 ' HA ' ' A' ' 205' ' ' ALA . 0.0 OUTLIER -48.23 -41.59 10.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.809 0.338 . . . . 60.020000000000003 111.092 -179.925 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . 0.697 ' HB3' ' HA ' ' A' ' 204' ' ' LYS . . . -127.3 151.02 49.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 73.209999999999994 111.074 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . 0.644 ' HB2' ' HA ' ' A' ' 245' ' ' ALA . . . -66.68 138.05 57.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 50.140000000000001 111.1 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 137.72 170.15 11.81 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.747 -0.739 . . . . 64.530000000000001 112.542 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . 0.527 ' HG3' HG23 ' A' ' 242' ' ' THR . 7.9 mttm -93.32 127.61 39.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.846 0.355 . . . . 74.530000000000001 110.95 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.63 HG11 ' CB ' ' A' ' 205' ' ' ALA . 7.3 p -122.05 129.36 75.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.239 -0.437 . . . . 72.439999999999998 111.15 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.578 ' C ' HD12 ' A' ' 226' ' ' ILE . 19.3 m120 -90.95 148.54 22.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 73.409999999999997 110.851 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.578 HD12 ' C ' ' A' ' 225' ' ' ASN . 4.3 mp -135.72 92.57 16.76 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.622 0.725 . . . . 64.140000000000001 111.096 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' PRO . . . . . 0.483 ' HD3' ' HB2' ' A' ' 200' ' ' ALA . 54.1 Cg_endo -69.77 178.63 4.38 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.66 2.24 . . . . 63.420000000000002 112.358 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 54.4 t -148.29 136.78 15.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.237 -0.438 . . . . 75.019999999999996 111.18 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 98.3 t -118.15 136.63 54.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.453 . . . . 72.129999999999995 111.133 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 22.7 t -122.17 135.51 54.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 51.240000000000002 110.87 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 52.53 -113.72 2.9 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.738 -0.744 . . . . 71.439999999999998 112.471 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -111.8 20.66 16.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.873 0.368 . . . . 64.420000000000002 110.887 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 113.14 1.94 25.02 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.719 -0.753 . . . . 74.400000000000006 112.478 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -52.92 -62.58 1.56 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.878 0.37 . . . . 74.510000000000005 110.892 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -108.37 166.13 10.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 73.239999999999995 110.867 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -166.1 165.15 17.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.128 -0.487 . . . . 52.119999999999997 111.087 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -143.41 163.27 33.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 73.010000000000005 111.061 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 14.8 p -138.25 137.64 43.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 75.329999999999998 111.157 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . 0.465 ' HB2' ' HG3' ' A' ' 168' ' ' PRO . . . -138.95 164.82 28.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 61.100000000000001 111.138 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . 0.588 ' O ' HD13 ' A' ' 241' ' ' ILE . 4.6 pt-20 -143.99 130.48 19.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 75.120000000000005 110.94 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' ILE . . . . . 0.589 HG13 HG11 ' A' ' 216' ' ' VAL . 32.7 mm -127.12 114.77 38.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 74.530000000000001 111.134 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' THR . . . . . 0.527 HG23 ' HG3' ' A' ' 223' ' ' LYS . 3.2 m -84.28 141.0 31.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 70.25 111.169 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 25.9 t -120.39 120.1 61.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.446 . . . . 72.109999999999999 111.134 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' THR . . . . . 0.497 HG23 ' O ' ' A' ' 173' ' ' VAL . 7.1 p -81.1 132.83 35.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.485 . . . . 53.009999999999998 111.145 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' ALA . . . . . 0.644 ' HA ' ' HB2' ' A' ' 221' ' ' ALA . . . -58.51 -25.16 62.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 75.150000000000006 111.073 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 40.3 t . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 71.109999999999999 110.83 -179.753 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.286 0 N-CA-C 112.516 -0.234 . . . . 52.039999999999999 112.516 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -125.43 143.62 50.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.773 0.321 . . . . 44.420000000000002 111.108 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 16.2 tpp -53.74 156.9 2.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 64.329999999999998 110.861 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -167.41 -169.88 1.33 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 72.109999999999999 111.116 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -174.38 129.75 0.36 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 70.140000000000001 111.108 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.472 ' HB1' ' HB3' ' A' ' 187' ' ' PRO . . . -59.83 -168.68 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 63.109999999999999 111.155 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 1.2 m -125.07 32.68 5.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.271 -0.422 . . . . 74.430000000000007 111.153 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 140.55 97.99 0.34 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.765 -0.731 . . . . 62.140000000000001 112.48 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.522 ' HE3' HG11 ' A' ' 228' ' ' VAL . 0.8 OUTLIER -112.95 138.1 50.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.905 0.383 . . . . 74.200000000000003 110.86 -179.965 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.642 HG23 HE22 ' A' ' 186' ' ' GLN . 34.4 p -121.52 109.8 15.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.236 -0.438 . . . . 53.299999999999997 111.18 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 1.083 HG22 HG13 ' A' ' 183' ' ' VAL . 33.5 t -98.45 132.91 42.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.429 . . . . 75.540000000000006 111.155 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.5 m -123.43 92.09 49.16 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.619 0.723 . . . . 64.299999999999997 111.179 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.463 ' HB3' HD23 ' A' ' 181' ' ' LEU . 53.6 Cg_endo -69.78 -168.41 0.27 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.666 2.244 . . . . 64.230000000000004 112.348 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -89.75 -42.7 11.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.446 . . . . 71.310000000000002 111.105 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 12.3 t 49.88 80.57 0.07 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.236 -0.438 . . . . 64.340000000000003 110.869 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.5 t -174.72 -175.09 0.87 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 75.299999999999997 111.142 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 1.5 m -98.7 162.41 13.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.444 . . . . 71.519999999999996 110.893 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.729 HG22 ' HB2' ' A' ' 177' ' ' GLN . 3.6 p -144.5 153.32 15.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.129 -0.487 . . . . 73.129999999999995 111.124 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 61.8 t -86.73 145.55 7.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 73.140000000000001 111.1 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.23 122.22 5.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.468 . . . . 73.0 110.914 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.18 -11.54 61.95 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.76 -0.734 . . . . 72.329999999999998 112.467 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.729 ' HB2' HG22 ' A' ' 173' ' ' VAL . 16.3 mm100 -94.2 -178.62 4.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.818 0.342 . . . . 74.25 110.909 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 52.2 p -161.74 148.09 13.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 51.200000000000003 110.861 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.502 HG21 HD12 ' A' ' 241' ' ' ILE . 7.0 t -106.01 -173.61 2.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.13 -0.487 . . . . 53.200000000000003 111.097 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -139.93 132.2 28.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.456 . . . . 64.109999999999999 111.166 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.463 HD23 ' HB3' ' A' ' 168' ' ' PRO . 7.6 mp -105.83 145.19 31.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.247 -0.433 . . . . 74.439999999999998 110.904 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 5.3 m -111.55 145.12 39.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.144 -0.48 . . . . 73.120000000000005 111.123 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 1.083 HG13 HG22 ' A' ' 166' ' ' VAL . 22.5 t -129.31 140.62 48.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.256 -0.429 . . . . 75.099999999999994 111.11 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -129.11 153.1 48.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.486 . . . . 44.43 111.082 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -143.91 129.28 18.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.251 -0.432 . . . . 65.030000000000001 110.864 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . 0.642 HE22 HG23 ' A' ' 165' ' ' THR . 0.0 OUTLIER -132.86 66.78 77.09 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.634 0.73 . . . . 64.549999999999997 110.925 -179.975 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.472 ' HB3' ' HB1' ' A' ' 161' ' ' ALA . 53.5 Cg_endo -69.77 -25.75 28.23 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.693 2.262 . . . . 74.439999999999998 112.36 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 70.21 31.51 3.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 74.450000000000003 110.873 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 169.82 -26.18 0.11 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.753 -0.736 . . . . 62.350000000000001 112.5 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.542 HG12 ' H ' ' A' ' 192' ' ' ASP . 76.4 t -99.16 149.43 5.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.96 0.409 . . . . 74.239999999999995 111.125 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 9.5 p -140.33 37.12 1.89 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.132 -0.485 . . . . 64.400000000000006 111.133 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.542 ' H ' HG12 ' A' ' 190' ' ' VAL . 9.1 m-20 -122.01 131.23 53.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.261 -0.427 . . . . 71.420000000000002 110.841 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 13.9 mtpp -81.9 74.44 8.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 71.310000000000002 110.923 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 2.2 m -78.48 -7.28 57.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 63.439999999999998 110.862 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.774 ' CE2' HG11 ' A' ' 183' ' ' VAL . 22.4 p90 -91.31 164.38 13.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 65.049999999999997 110.838 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.04 167.52 30.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.116 -0.493 . . . . 64.140000000000001 110.88 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -115.64 160.05 20.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 63.240000000000002 111.103 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.603 HG23 ' HG2' ' A' ' 227' ' ' PRO . 5.1 m -153.43 163.04 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.206 -0.452 . . . . 53.439999999999998 111.114 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.61 118.68 35.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 72.329999999999998 110.9 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.477 ' HB2' ' HD3' ' A' ' 227' ' ' PRO . . . -59.87 -21.0 60.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.141 -0.481 . . . . 63.439999999999998 111.11 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.97 96.79 1.36 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 64.239999999999995 110.84 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.89 50.18 1.92 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 72.040000000000006 110.904 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 12.0 p -128.73 -1.45 5.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.211 -0.45 . . . . 63.240000000000002 111.176 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 7.5 mtmt -154.57 18.47 0.47 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.196 -0.457 . . . . 72.530000000000001 110.829 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.589 ' HA ' HG23 ' A' ' 219' ' ' VAL . . . -179.88 153.79 0.54 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.251 -0.431 . . . . 55.119999999999997 111.085 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 11.7 p -117.32 156.05 28.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.214 -0.448 . . . . 71.120000000000005 111.131 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.817 HG12 HG22 ' A' ' 216' ' ' VAL . 33.8 m -137.19 141.17 40.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 63.229999999999997 111.136 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 50.9 m -147.86 107.87 4.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 71.430000000000007 110.845 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.446 ' HA ' ' HA ' ' A' ' 214' ' ' ILE . 3.0 p -88.31 142.87 12.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 63.229999999999997 111.11 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.2 m -171.56 122.89 0.53 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.188 -0.46 . . . . 64.030000000000001 110.861 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 55.6 47.23 78.55 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.726 -0.75 . . . . 44.509999999999998 112.481 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 3.3 mtp 64.06 16.38 9.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.848 0.356 . . . . 70.040000000000006 110.854 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 18.8 m -125.67 112.65 16.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 63.43 111.151 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.446 ' HA ' ' HA ' ' A' ' 209' ' ' VAL . 2.6 mp -109.69 113.75 45.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 64.120000000000005 111.105 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 6.3 m -87.45 133.92 33.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.206 -0.452 . . . . 55.210000000000001 111.181 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.817 HG22 HG12 ' A' ' 207' ' ' VAL . 2.9 t -118.18 123.17 71.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.27 -0.423 . . . . 53.509999999999998 111.09 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -106.33 139.57 40.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.474 . . . . 75.109999999999999 110.857 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -96.9 78.3 0.69 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.719 -0.753 . . . . 63.109999999999999 112.48 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.589 HG23 ' HA ' ' A' ' 205' ' ' ALA . 16.2 t -50.13 -55.29 5.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.83 0.347 . . . . 71.439999999999998 111.112 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -126.38 161.63 27.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 72.140000000000001 111.122 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . 0.677 ' HB2' ' HA ' ' A' ' 245' ' ' ALA . . . -62.61 139.97 58.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.243 -0.435 . . . . 73.349999999999994 111.104 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 142.24 172.84 13.86 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.732 -0.747 . . . . 45.43 112.503 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . 0.409 ' HG3' HG23 ' A' ' 242' ' ' THR . 12.7 mttt -102.18 120.81 41.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.837 0.351 . . . . 60.520000000000003 110.886 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.533 HG11 ' CB ' ' A' ' 205' ' ' ALA . 7.3 p -119.13 126.89 75.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 50.340000000000003 111.143 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.597 ' C ' HD12 ' A' ' 226' ' ' ILE . 33.5 m120 -90.55 156.05 18.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 65.25 110.864 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.597 HD12 ' C ' ' A' ' 225' ' ' ASN . 4.4 mp -138.13 92.43 12.33 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.634 0.731 . . . . 75.310000000000002 111.127 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' PRO . . . . . 0.603 ' HG2' HG23 ' A' ' 198' ' ' VAL . 53.3 Cg_endo -69.77 -179.26 2.79 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.679 2.253 . . . . 45.210000000000001 112.345 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.522 HG11 ' HE3' ' A' ' 164' ' ' MET . 61.3 t -150.11 140.6 16.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 74.439999999999998 111.16 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 89.9 t -124.06 138.53 53.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 72.019999999999996 111.137 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 1.5 m -118.94 106.67 12.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.191 -0.459 . . . . 65.219999999999999 110.862 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 57.74 -110.86 2.59 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.701 -0.761 . . . . 74.209999999999994 112.486 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -81.01 -7.39 59.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.865 0.364 . . . . 65.310000000000002 110.889 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 109.76 10.01 23.76 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.743 -0.741 . . . . 61.43 112.424 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -50.72 -47.1 59.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.874 0.369 . . . . 64.219999999999999 110.879 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -117.51 147.52 42.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 63.549999999999997 110.884 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -149.72 165.23 33.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 73.230000000000004 111.11 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . 0.429 ' HB3' ' CG2' ' A' ' 228' ' ' VAL . . . -136.95 163.3 31.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.441 . . . . 73.420000000000002 111.109 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 7.4 p -136.36 125.59 38.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.188 -0.46 . . . . 73.430000000000007 111.139 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . 0.409 ' HB2' ' HG3' ' A' ' 168' ' ' PRO . . . -132.79 162.13 32.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 52.409999999999997 111.15 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . 0.413 ' O ' HD13 ' A' ' 241' ' ' ILE . 6.3 pt-20 -144.16 132.1 21.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.268 -0.424 . . . . 55.530000000000001 110.886 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' ILE . . . . . 0.621 HG13 HG11 ' A' ' 216' ' ' VAL . 26.3 mm -126.81 112.73 30.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.124 -0.489 . . . . 63.009999999999998 111.142 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' THR . . . . . 0.409 HG23 ' HG3' ' A' ' 223' ' ' LYS . 2.7 m -80.82 141.28 34.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 65.239999999999995 111.165 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 17.1 t -120.08 121.0 64.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.236 -0.438 . . . . 73.329999999999998 111.116 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' THR . . . . . 0.506 HG23 ' O ' ' A' ' 173' ' ' VAL . 7.3 p -82.28 132.75 35.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.144 -0.48 . . . . 73.010000000000005 111.146 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' ALA . . . . . 0.677 ' HA ' ' HB2' ' A' ' 221' ' ' ALA . . . -56.92 -24.63 53.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.462 . . . . 74.239999999999995 111.113 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.26 -0.427 . . . . 71.230000000000004 110.847 -179.791 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.266 0 N-CA-C 112.493 -0.243 . . . . 72.019999999999996 112.493 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . 62.19 24.8 14.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.789 0.328 . . . . 61.229999999999997 111.084 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.87 75.58 1.62 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 43.119999999999997 110.873 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -128.45 -169.46 2.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.268 -0.424 . . . . 74.25 111.097 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -172.48 129.48 0.55 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.449 . . . . 51.32 111.101 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.494 ' HB1' ' HB3' ' A' ' 187' ' ' PRO . . . -60.05 -168.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 73.239999999999995 111.07 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -124.9 30.85 5.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.161 -0.472 . . . . 64.140000000000001 111.096 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 146.24 96.7 0.19 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.722 -0.751 . . . . 73.150000000000006 112.466 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.607 ' SD ' HG23 ' A' ' 166' ' ' VAL . 2.1 tmm? -106.09 143.71 33.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.845 0.355 . . . . 65.010000000000005 110.897 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.515 ' OG1' ' HB3' ' A' ' 184' ' ' ALA . 44.7 p -133.87 103.33 5.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.274 -0.421 . . . . 71.340000000000003 111.169 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 1.13 HG22 HG13 ' A' ' 183' ' ' VAL . 89.0 t -97.19 133.98 36.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 74.409999999999997 111.103 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 40.8 m -123.86 92.01 48.99 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.517 0.675 . . . . 74.540000000000006 111.115 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.465 ' HB3' HD23 ' A' ' 181' ' ' LEU . 53.9 Cg_endo -69.78 -167.33 0.22 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.636 2.224 . . . . 73.299999999999997 112.331 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -90.75 -43.75 9.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.459 . . . . 64.219999999999999 111.089 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 8.0 t 49.48 80.12 0.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 75.140000000000001 110.861 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.6 t -173.68 -176.11 1.2 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.135 -0.484 . . . . 75.319999999999993 111.128 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 10.0 p -97.27 162.19 13.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 54.149999999999999 110.837 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.734 HG22 ' HB2' ' A' ' 177' ' ' GLN . 3.3 p -145.37 153.18 14.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.479 . . . . 63.409999999999997 111.142 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 66.6 t -87.52 145.21 7.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.116 -0.493 . . . . 72.540000000000006 111.12 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.64 122.42 5.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 72.420000000000002 110.837 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.81 -12.87 61.0 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.741 -0.742 . . . . 73.239999999999995 112.501 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.734 ' HB2' HG22 ' A' ' 173' ' ' VAL . 11.6 mm100 -92.91 -178.32 4.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.811 0.339 . . . . 61.109999999999999 110.931 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 39.1 p -161.37 149.45 15.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.214 -0.448 . . . . 74.040000000000006 110.894 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.533 HG21 HD12 ' A' ' 241' ' ' ILE . 6.8 t -107.11 -173.92 2.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 71.040000000000006 111.186 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.73 132.39 27.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.258 -0.428 . . . . 72.120000000000005 111.184 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.465 HD23 ' HB3' ' A' ' 168' ' ' PRO . 7.6 mp -106.56 145.54 31.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 74.299999999999997 110.873 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 4.1 m -113.75 146.42 39.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 72.310000000000002 111.144 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 1.13 HG13 HG22 ' A' ' 166' ' ' VAL . 47.4 t -128.7 140.84 48.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 75.129999999999995 111.136 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.515 ' HB3' ' OG1' ' A' ' 165' ' ' THR . . . -129.9 155.98 45.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 72.319999999999993 111.123 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -148.93 131.28 15.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.257 -0.428 . . . . 73.109999999999999 110.9 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.05 67.35 73.52 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.634 0.73 . . . . 74.010000000000005 110.919 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.494 ' HB3' ' HB1' ' A' ' 161' ' ' ALA . 53.6 Cg_endo -69.75 -25.38 28.72 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.703 2.268 . . . . 65.0 112.343 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 70.66 30.45 3.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.21 -0.45 . . . . 72.510000000000005 110.885 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 171.16 -27.11 0.1 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.761 -0.733 . . . . 74.129999999999995 112.491 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.523 HG12 ' H ' ' A' ' 192' ' ' ASP . 76.8 t -98.14 149.14 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.898 0.38 . . . . 64.439999999999998 111.11 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 7.0 p -140.98 35.13 1.75 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 72.540000000000006 111.129 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.523 ' H ' HG12 ' A' ' 190' ' ' VAL . 1.4 p30 -115.88 136.29 53.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.236 -0.438 . . . . 62.43 110.882 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 6.1 mtpm? -91.4 67.58 5.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 52.43 110.907 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 21.8 t -74.51 -7.24 52.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 65.530000000000001 110.864 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.772 ' CE2' HG11 ' A' ' 183' ' ' VAL . 21.8 p90 -91.28 163.64 14.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.131 -0.486 . . . . 64.230000000000004 110.897 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.9 173.19 16.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 74.239999999999995 110.878 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -112.66 168.14 9.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 73.319999999999993 111.068 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.436 HG13 ' HG2' ' A' ' 227' ' ' PRO . 14.5 p -167.62 149.7 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 75.319999999999993 111.101 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.03 130.03 36.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.139 -0.482 . . . . 65.030000000000001 110.881 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.492 ' HB2' ' HD3' ' A' ' 227' ' ' PRO . . . -68.08 -17.61 64.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.095 -0.502 . . . . 72.010000000000005 111.106 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -162.93 95.7 0.88 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.224 -0.443 . . . . 64.109999999999999 110.891 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 18.6 tttt -84.99 53.06 2.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 71.129999999999995 110.935 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 18.0 p -128.82 0.37 5.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 73.319999999999993 111.142 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . 0.415 ' HG2' ' HB3' ' A' ' 220' ' ' ALA . 3.7 mtmm -155.29 18.24 0.41 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 74.299999999999997 110.887 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.613 ' HA ' HG23 ' A' ' 219' ' ' VAL . . . -179.96 149.16 0.33 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.277 -0.419 . . . . 73.319999999999993 111.107 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 7.0 p -109.92 156.69 20.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.166 -0.47 . . . . 74.239999999999995 111.118 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.856 HG12 HG22 ' A' ' 216' ' ' VAL . 17.6 m -140.42 140.86 33.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 72.120000000000005 111.112 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -148.15 109.0 4.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 72.540000000000006 110.879 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.544 HG23 HG13 ' A' ' 214' ' ' ILE . 3.6 p -89.21 143.01 12.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.465 . . . . 74.340000000000003 111.106 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.7 m -171.82 123.43 0.52 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 72.0 110.91 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 56.2 46.67 85.33 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.715 -0.755 . . . . 74.230000000000004 112.466 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 4.1 mtp 64.2 15.78 9.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.827 0.346 . . . . 64.430000000000007 110.892 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 13.6 m -125.13 113.01 17.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.246 -0.434 . . . . 71.030000000000001 111.112 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.544 HG13 HG23 ' A' ' 209' ' ' VAL . 3.1 mp -110.48 113.8 45.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 73.409999999999997 111.154 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 5.8 m -88.93 132.05 34.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 73.510000000000005 111.12 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.856 HG22 HG12 ' A' ' 207' ' ' VAL . 3.9 t -117.02 124.28 72.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.187 -0.46 . . . . 55.100000000000001 111.101 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -106.03 138.67 41.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 75.319999999999993 110.95 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -94.73 78.55 0.91 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.676 -0.773 . . . . 72.319999999999993 112.505 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.613 HG23 ' HA ' ' A' ' 205' ' ' ALA . 20.6 t -49.75 -55.52 4.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.823 0.344 . . . . 72.439999999999998 111.134 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . 0.415 ' HB3' ' HG2' ' A' ' 204' ' ' LYS . . . -127.19 161.75 27.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 64.049999999999997 111.111 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . 0.682 ' HB2' ' HA ' ' A' ' 245' ' ' ALA . . . -62.22 139.93 58.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 70.239999999999995 111.068 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 142.27 171.72 13.27 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.752 -0.737 . . . . 73.230000000000004 112.496 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . 0.464 ' HG3' HG23 ' A' ' 242' ' ' THR . 2.1 mttt -101.12 121.19 41.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.783 0.325 . . . . 75.420000000000002 110.929 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.501 HG11 ' CB ' ' A' ' 205' ' ' ALA . 7.1 p -120.46 125.46 74.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.259 -0.428 . . . . 64.230000000000004 111.102 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.558 ' C ' HD12 ' A' ' 226' ' ' ILE . 21.0 m120 -90.98 152.45 20.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.468 . . . . 72.329999999999998 110.888 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.558 HD12 ' C ' ' A' ' 225' ' ' ASN . 4.3 mp -135.24 92.71 17.59 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.667 0.746 . . . . 75.329999999999998 111.166 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' PRO . . . . . 0.492 ' HD3' ' HB2' ' A' ' 200' ' ' ALA . 53.9 Cg_endo -69.76 -176.44 1.49 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.689 2.26 . . . . 74.25 112.329 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.505 ' CG2' ' HB3' ' A' ' 237' ' ' ALA . 59.5 t -149.4 137.04 13.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.444 . . . . 72.439999999999998 111.127 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 84.0 t -118.4 133.18 66.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.158 -0.474 . . . . 74.409999999999997 111.135 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 5.7 t -122.32 126.21 47.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 72.319999999999993 110.881 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 55.53 -121.86 24.43 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.717 -0.754 . . . . 75.120000000000005 112.519 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -98.17 21.03 11.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.87 0.367 . . . . 55.130000000000003 110.911 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 106.77 6.9 34.54 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.702 -0.761 . . . . 71.420000000000002 112.507 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -53.26 -62.66 1.51 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.85 0.357 . . . . 74.319999999999993 110.887 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -105.99 166.02 10.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 73.420000000000002 110.879 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -167.15 165.41 15.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 70.040000000000006 111.053 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . 0.505 ' HB3' ' CG2' ' A' ' 228' ' ' VAL . . . -142.33 163.16 33.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 75.109999999999999 111.099 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 8.0 p -136.58 131.15 47.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.243 -0.435 . . . . 74.409999999999997 111.149 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . 0.42 ' HB2' ' HG3' ' A' ' 168' ' ' PRO . . . -139.3 165.22 27.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 63.219999999999999 111.157 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -147.7 133.32 18.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 74.219999999999999 110.919 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' ILE . . . . . 0.533 HD12 HG21 ' A' ' 179' ' ' THR . 25.1 mm -126.7 115.13 40.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.475 . . . . 54.340000000000003 111.11 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' THR . . . . . 0.464 HG23 ' HG3' ' A' ' 223' ' ' LYS . 2.4 m -82.91 141.11 32.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 73.450000000000003 111.146 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 21.2 t -120.01 121.06 64.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.243 -0.435 . . . . 74.230000000000004 111.121 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' THR . . . . . 0.443 HG23 ' O ' ' A' ' 173' ' ' VAL . 9.2 p -82.92 132.78 35.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.138 -0.483 . . . . 75.540000000000006 111.124 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' ALA . . . . . 0.682 ' HA ' ' HB2' ' A' ' 221' ' ' ALA . . . -54.39 -27.18 34.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 71.219999999999999 111.089 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 46.9 t . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 54.130000000000003 110.906 -179.811 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 N-CA-C 112.499 -0.24 . . . . 72.109999999999999 112.499 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -64.06 165.87 8.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.792 0.33 . . . . 73.140000000000001 111.126 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 67.5 mmm -104.78 177.01 4.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.247 -0.433 . . . . 55.409999999999997 110.887 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -126.19 129.06 48.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 75.349999999999994 111.106 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.669 ' HB2' ' HB3' ' A' ' 194' ' ' SER . . . -73.62 -71.06 0.34 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.211 -0.449 . . . . 33.549999999999997 111.072 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.458 ' HB1' ' HB3' ' A' ' 187' ' ' PRO . . . -178.48 -174.45 0.39 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.205 -0.452 . . . . 70.120000000000005 111.081 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.508 HG22 ' HA ' ' A' ' 187' ' ' PRO . 10.8 t -127.24 15.99 7.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 60.310000000000002 111.132 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -176.71 81.28 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.764 -0.731 . . . . 74.109999999999999 112.493 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 30.5 ttp -102.95 123.19 46.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.895 0.378 . . . . 70.219999999999999 110.867 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.53 ' OG1' ' HB3' ' A' ' 184' ' ' ALA . 51.6 p -111.52 104.97 13.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.236 -0.438 . . . . 72.349999999999994 111.159 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 1.07 HG22 HG13 ' A' ' 183' ' ' VAL . 60.9 t -97.2 131.92 42.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.455 . . . . 74.439999999999998 111.141 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 38.5 m -124.55 92.29 48.18 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.534 0.683 . . . . 62.200000000000003 111.147 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.456 ' HB3' HD23 ' A' ' 181' ' ' LEU . 54.1 Cg_endo -69.74 -167.26 0.22 Allowed 'Trans proline' 0 C--N 1.341 0.132 0 C-N-CA 122.674 2.249 . . . . 75.420000000000002 112.35 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -90.92 -39.27 12.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.444 . . . . 63.450000000000003 111.114 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 4.8 p 45.86 79.96 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 71.109999999999999 110.87 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.6 t -175.44 -175.69 0.83 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.477 . . . . 63.350000000000001 111.126 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 1.7 m -97.42 164.42 12.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.443 . . . . 65.120000000000005 110.908 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.737 HG22 ' HB2' ' A' ' 177' ' ' GLN . 3.4 p -146.22 153.18 13.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.469 . . . . 62.340000000000003 111.137 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 59.2 t -86.1 145.48 7.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 64.310000000000002 111.125 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.27 122.32 5.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.443 . . . . 74.549999999999997 110.905 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.15 -12.79 62.06 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.771 -0.728 . . . . 44.399999999999999 112.53 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.737 ' HB2' HG22 ' A' ' 173' ' ' VAL . 17.9 mm100 -92.35 -178.8 5.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.796 0.331 . . . . 74.299999999999997 110.914 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 60.6 p -161.69 148.63 14.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 71.319999999999993 110.879 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.466 HG21 HD12 ' A' ' 241' ' ' ILE . 6.7 t -105.75 -174.46 2.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 75.310000000000002 111.145 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -140.29 127.09 20.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.256 -0.429 . . . . 75.530000000000001 111.139 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.456 HD23 ' HB3' ' A' ' 168' ' ' PRO . 7.5 mp -100.81 141.01 34.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.183 -0.462 . . . . 71.530000000000001 110.93 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 6.1 m -109.17 144.61 37.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 65.019999999999996 111.152 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 1.07 HG13 HG22 ' A' ' 166' ' ' VAL . 23.1 t -129.43 141.56 46.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 75.540000000000006 111.104 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.53 ' HB3' ' OG1' ' A' ' 165' ' ' THR . . . -130.89 156.87 44.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 73.310000000000002 111.111 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -147.09 133.37 19.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 74.140000000000001 110.894 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.62 67.18 23.96 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.634 0.731 . . . . 70.049999999999997 110.915 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.508 ' HA ' HG22 ' A' ' 162' ' ' THR . 53.6 Cg_endo -69.74 -23.87 30.39 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.676 2.251 . . . . 73.329999999999998 112.369 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 71.58 38.07 1.04 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 65.420000000000002 110.865 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 163.32 -23.36 0.18 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.754 -0.736 . . . . 22.129999999999999 112.478 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.51 HG12 ' H ' ' A' ' 192' ' ' ASP . 73.0 t -104.07 148.34 9.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.877 0.37 . . . . 74.030000000000001 111.109 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 16.6 p -139.72 38.0 2.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 41.310000000000002 111.134 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.51 ' H ' HG12 ' A' ' 190' ' ' VAL . 11.7 m-20 -121.14 123.12 41.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 72.109999999999999 110.868 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 10.3 mtmm -85.31 73.11 10.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.474 . . . . 72.510000000000005 110.87 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . 0.669 ' HB3' ' HB2' ' A' ' 160' ' ' ALA . 0.3 OUTLIER -77.45 -3.98 43.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.253 -0.431 . . . . 65.219999999999999 110.831 -179.854 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.806 ' CE2' HG11 ' A' ' 183' ' ' VAL . 14.9 p90 -88.05 168.58 12.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.074 -0.512 . . . . 62.439999999999998 110.858 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -164.38 162.07 21.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 64.319999999999993 110.868 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . 0.684 ' HB3' ' CG2' ' A' ' 209' ' ' VAL . . . -104.03 157.69 16.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.467 . . . . 75.030000000000001 111.107 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 91.9 t -150.25 145.14 17.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.257 -0.429 . . . . 74.129999999999995 111.126 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -83.83 122.78 29.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 74.109999999999999 110.826 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.471 ' HB2' ' HD3' ' A' ' 227' ' ' PRO . . . -72.98 -8.25 54.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 74.150000000000006 111.088 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -164.21 98.58 0.83 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.259 -0.428 . . . . 63.119999999999997 110.899 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.64 41.4 1.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 61.32 110.89 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 4.3 p -124.51 -5.3 7.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.249 -0.432 . . . . 71.010000000000005 111.144 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 9.7 mtmm -148.45 16.27 1.02 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.462 . . . . 73.329999999999998 110.921 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.572 ' HA ' HG23 ' A' ' 219' ' ' VAL . . . -179.2 154.35 0.65 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 25.140000000000001 111.124 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 11.2 p -117.62 158.42 24.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.209 -0.45 . . . . 74.239999999999995 111.153 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 10.7 m -134.74 144.4 34.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 71.109999999999999 111.093 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 1.9 t -150.93 109.21 3.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 74.239999999999995 110.886 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.684 ' CG2' ' HB3' ' A' ' 197' ' ' ALA . 80.9 t -84.16 145.71 7.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 74.150000000000006 111.123 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 3.3 t -171.09 117.58 0.46 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.147 -0.479 . . . . 53.140000000000001 110.849 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 48.52 61.32 5.19 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.738 -0.744 . . . . 53.020000000000003 112.496 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 2.3 mtp 54.09 21.97 3.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.887 0.375 . . . . 74.109999999999999 110.904 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 1.7 m -130.59 110.33 11.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 71.450000000000003 111.2 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.493 HG23 HG22 ' A' ' 209' ' ' VAL . 0.8 OUTLIER -104.65 121.36 56.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.253 -0.43 . . . . 74.030000000000001 111.158 179.905 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 21.0 m -91.9 129.19 37.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.146 -0.479 . . . . 55.299999999999997 111.16 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.589 HG11 HG13 ' A' ' 241' ' ' ILE . 2.3 t -115.54 120.94 66.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 62.119999999999997 111.15 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -105.47 140.33 38.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 72.219999999999999 110.872 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -96.47 78.54 0.73 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.767 -0.73 . . . . 52.240000000000002 112.491 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.572 HG23 ' HA ' ' A' ' 205' ' ' ALA . 19.5 t -50.81 -56.67 3.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.837 0.351 . . . . 70.219999999999999 111.115 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -123.86 161.21 25.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.148 -0.478 . . . . 74.540000000000006 111.103 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . 0.669 ' HB2' ' HA ' ' A' ' 245' ' ' ALA . . . -63.15 138.7 58.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.256 -0.429 . . . . 72.540000000000006 111.099 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 141.37 168.49 11.53 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.713 -0.756 . . . . 62.399999999999999 112.458 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . 0.588 ' HG3' HG23 ' A' ' 242' ' ' THR . 5.6 mttp -95.68 120.2 35.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.804 0.335 . . . . 71.109999999999999 110.915 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.562 HG11 ' CB ' ' A' ' 205' ' ' ALA . 6.6 p -117.99 123.15 71.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.272 -0.422 . . . . 72.140000000000001 111.177 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.634 ' C ' HD12 ' A' ' 226' ' ' ILE . 31.5 m120 -90.72 153.18 20.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.458 . . . . 71.329999999999998 110.864 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.634 HD12 ' C ' ' A' ' 225' ' ' ASN . 4.2 mp -138.38 93.19 11.47 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.645 0.736 . . . . 53.43 111.139 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' PRO . . . . . 0.471 ' HD3' ' HB2' ' A' ' 200' ' ' ALA . 53.9 Cg_endo -69.73 -177.41 1.85 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.73 2.287 . . . . 70.340000000000003 112.339 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 62.4 t -149.01 142.04 18.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 65.230000000000004 111.126 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 91.0 t -121.42 137.09 56.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.157 -0.474 . . . . 73.010000000000005 111.141 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.34 130.09 52.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 70.219999999999999 110.884 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 53.37 -114.09 3.53 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.74 -0.743 . . . . 72.129999999999995 112.513 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -111.17 21.22 16.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.807 0.337 . . . . 74.349999999999994 110.831 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 114.39 1.76 23.23 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.76 -0.733 . . . . 62.329999999999998 112.512 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 44.1 mm-40 -51.75 -62.96 1.3 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.9 0.381 . . . . 61.399999999999999 110.899 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -112.46 162.93 15.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 75.519999999999996 110.929 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -165.71 164.8 18.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 74.349999999999994 111.065 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -143.01 163.05 33.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 50.009999999999998 111.084 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 10.9 p -137.77 136.34 45.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 70.340000000000003 111.172 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -139.23 165.51 26.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 65.310000000000002 111.086 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -145.11 132.34 20.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 64.340000000000003 110.88 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' ILE . . . . . 0.589 HG13 HG11 ' A' ' 216' ' ' VAL . 36.3 mm -127.21 116.89 45.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 73.230000000000004 111.155 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' THR . . . . . 0.588 HG23 ' HG3' ' A' ' 223' ' ' LYS . 2.1 m -84.22 141.68 30.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.192 -0.458 . . . . 53.530000000000001 111.138 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 21.5 t -120.0 121.5 66.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.243 -0.435 . . . . 42.32 111.127 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' THR . . . . . 0.502 HG23 ' O ' ' A' ' 173' ' ' VAL . 7.6 p -82.58 132.8 35.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 70.310000000000002 111.166 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' ALA . . . . . 0.669 ' HA ' ' HB2' ' A' ' 221' ' ' ALA . . . -55.78 -25.29 40.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 61.130000000000003 111.082 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 9.7 t . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 74.310000000000002 110.857 -179.774 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 N-CA-C 112.448 -0.261 . . . . 61.340000000000003 112.448 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -86.49 -33.97 20.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.801 0.334 . . . . 74.209999999999994 111.098 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 14.5 mtm -135.85 176.62 8.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 73.120000000000005 110.86 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -151.36 176.42 11.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 75.299999999999997 111.152 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.737 ' HB2' ' HA3' ' A' ' 231' ' ' GLY . . . -110.05 -70.14 0.83 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.255 -0.43 . . . . 63.130000000000003 111.132 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -179.28 -174.46 0.32 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.469 . . . . 43.310000000000002 111.089 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 2.3 m -124.89 13.93 8.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.243 -0.435 . . . . 74.519999999999996 111.139 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 163.26 104.71 0.19 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.715 -0.755 . . . . 45.25 112.504 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 21.5 ttp -110.62 134.48 52.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.839 0.352 . . . . 74.129999999999995 110.9 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.651 ' OG1' ' HB3' ' A' ' 184' ' ' ALA . 1.8 p -119.62 95.44 4.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.256 -0.429 . . . . 64.329999999999998 111.173 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 1.02 HG22 HG13 ' A' ' 183' ' ' VAL . 21.8 t -97.21 117.9 42.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.439 . . . . 73.409999999999997 111.168 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 60.8 m -112.72 91.61 17.93 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.574 0.702 . . . . 74.140000000000001 111.17 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.472 ' HB3' HD23 ' A' ' 181' ' ' LEU . 53.7 Cg_endo -69.8 -168.23 0.26 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.638 2.226 . . . . 71.540000000000006 112.361 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -86.6 -44.57 11.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.438 . . . . 61.530000000000001 111.104 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 37.8 t 49.82 76.93 0.12 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.257 -0.429 . . . . 50.030000000000001 110.887 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.4 t -175.05 -174.91 0.8 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.111 -0.495 . . . . 71.040000000000006 111.14 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 33.3 p -99.15 158.42 15.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 64.129999999999995 110.856 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.738 HG22 ' HB2' ' A' ' 177' ' ' GLN . 3.3 p -140.22 152.37 21.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.103 -0.499 . . . . 73.150000000000006 111.096 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 95.5 t -84.6 143.66 11.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.166 -0.47 . . . . 72.409999999999997 111.093 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -48.04 122.5 5.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 73.549999999999997 110.917 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.85 -14.6 60.15 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.712 -0.756 . . . . 53.530000000000001 112.473 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.738 ' HB2' HG22 ' A' ' 173' ' ' VAL . 16.7 mm100 -90.63 -178.31 5.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.824 0.345 . . . . 73.109999999999999 110.889 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 27.4 p -161.52 149.14 14.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 55.530000000000001 110.825 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 7.3 t -108.21 -173.68 2.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.481 . . . . 73.430000000000007 111.136 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -140.47 132.1 27.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.451 . . . . 42.130000000000003 111.161 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.472 HD23 ' HB3' ' A' ' 168' ' ' PRO . 7.3 mp -105.37 142.02 35.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.246 -0.434 . . . . 75.030000000000001 110.918 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 3.6 m -108.42 142.12 39.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 74.319999999999993 111.128 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 1.02 HG13 HG22 ' A' ' 166' ' ' VAL . 16.5 t -129.79 136.37 59.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 63.340000000000003 111.13 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.651 ' HB3' ' OG1' ' A' ' 165' ' ' THR . . . -124.33 155.86 37.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.243 -0.435 . . . . 70.439999999999998 111.076 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -142.83 125.25 15.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 71.209999999999994 110.884 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.48 63.06 46.34 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.557 0.694 . . . . 62.130000000000003 110.903 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 -43.16 2.85 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.668 2.245 . . . . 74.340000000000003 112.317 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 69.77 49.39 0.53 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 64.209999999999994 110.871 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 157.53 -20.67 0.39 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.716 -0.754 . . . . 44.130000000000003 112.495 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.46 HG11 ' O ' ' A' ' 160' ' ' ALA . 2.7 t -98.16 -59.68 3.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.928 0.394 . . . . 64.420000000000002 111.125 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 48.26 72.34 0.28 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.181 -0.463 . . . . 73.530000000000001 111.131 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -157.26 138.68 13.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 75.409999999999997 110.848 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.17 70.71 7.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 64.340000000000003 110.866 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 1.1 m -93.79 -5.3 48.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 75.5 110.886 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.75 ' CE2' HG11 ' A' ' 183' ' ' VAL . 7.2 p90 -89.77 171.87 9.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.107 -0.497 . . . . 71.049999999999997 110.873 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.68 167.17 17.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.141 -0.481 . . . . 74.510000000000005 110.852 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . 0.421 ' HB3' ' HB ' ' A' ' 209' ' ' VAL . . . -113.19 167.84 10.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.178 -0.464 . . . . 73.549999999999997 111.077 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 10.5 p -173.65 151.52 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 75.230000000000004 111.168 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.8 t -78.44 152.55 32.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 71.430000000000007 110.852 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.567 ' HB2' ' HD3' ' A' ' 227' ' ' PRO . . . -89.97 -21.61 22.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 63.450000000000003 111.122 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -129.14 -54.63 1.19 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 74.209999999999994 110.906 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 3.0 ttpp 63.63 25.52 14.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 75.340000000000003 110.915 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 32.3 p -112.59 -4.85 14.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.469 . . . . 51.450000000000003 111.11 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 9.1 mtmm -151.94 18.28 0.68 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 71.530000000000001 110.947 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.63 ' HA ' HG23 ' A' ' 219' ' ' VAL . . . -174.91 147.36 0.97 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 65.049999999999997 111.122 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 16.7 p -108.59 157.78 18.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 71.25 111.101 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.779 HG12 HG22 ' A' ' 216' ' ' VAL . 12.3 m -140.6 140.85 33.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 54.450000000000003 111.133 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 10.0 m -148.68 108.77 4.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 52.119999999999997 110.863 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.463 ' HA ' ' HA ' ' A' ' 214' ' ' ILE . 3.2 p -87.07 135.43 25.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.154 -0.475 . . . . 70.5 111.148 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 3.3 m -161.31 121.96 2.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 32.509999999999998 110.858 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 54.72 49.08 62.95 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.752 -0.737 . . . . 64.420000000000002 112.511 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER 63.3 16.38 9.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.853 0.359 . . . . 70.5 110.877 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 3.3 m -126.46 109.41 12.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 72.040000000000006 111.167 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.463 ' HA ' ' HA ' ' A' ' 209' ' ' VAL . 2.1 mp -105.18 114.09 43.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 75.329999999999998 111.11 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 6.2 m -87.9 130.51 34.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 75.030000000000001 111.124 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.779 HG22 HG12 ' A' ' 207' ' ' VAL . 2.8 t -115.93 123.91 71.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.449 . . . . 71.540000000000006 111.144 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -106.78 139.74 40.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 75.530000000000001 110.864 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -94.79 79.8 0.89 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.804 -0.712 . . . . 63.399999999999999 112.45 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.63 HG23 ' HA ' ' A' ' 205' ' ' ALA . 18.5 t -50.75 -55.63 6.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.858 0.361 . . . . 74.239999999999995 111.112 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -129.36 163.87 24.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 60.409999999999997 111.125 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . 0.673 ' HB2' ' HA ' ' A' ' 245' ' ' ALA . . . -63.17 142.26 58.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 51.149999999999999 111.085 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 139.04 171.56 12.23 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.78 -0.724 . . . . 70.420000000000002 112.495 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . 0.614 ' HG3' HG23 ' A' ' 242' ' ' THR . 14.9 mttt -100.73 121.57 41.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.788 0.328 . . . . 62.109999999999999 110.88 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.6 HG11 ' CB ' ' A' ' 205' ' ' ALA . 7.4 p -120.62 126.23 75.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 74.129999999999995 111.124 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.627 ' C ' HD12 ' A' ' 226' ' ' ILE . 30.0 m120 -90.66 154.3 19.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.127 -0.488 . . . . 71.049999999999997 110.908 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.627 HD12 ' C ' ' A' ' 225' ' ' ASN . 4.1 mp -137.02 93.16 13.55 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.619 0.723 . . . . 73.430000000000007 111.102 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' PRO . . . . . 0.567 ' HD3' ' HB2' ' A' ' 200' ' ' ALA . 54.1 Cg_endo -69.81 -178.61 2.44 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.723 2.282 . . . . 74.540000000000006 112.305 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 99.4 t -150.29 138.32 14.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.169 -0.468 . . . . 72.230000000000004 111.069 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 66.6 t -121.47 139.39 48.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.166 -0.47 . . . . 64.409999999999997 111.124 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 7.4 m -122.45 125.53 46.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 71.5 110.851 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . 0.737 ' HA3' ' HB2' ' A' ' 160' ' ' ALA . . . 55.54 -115.35 5.75 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.716 -0.754 . . . . 72.129999999999995 112.474 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -103.29 17.42 24.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.896 0.379 . . . . 72.049999999999997 110.897 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 114.01 9.73 15.37 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.778 -0.725 . . . . 72.319999999999993 112.513 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -52.01 -73.44 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.874 0.368 . . . . 71.219999999999999 110.921 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -104.15 162.48 13.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 72.109999999999999 110.879 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -158.93 165.1 34.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.469 . . . . 44.039999999999999 111.097 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -144.1 163.36 33.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 45.25 111.099 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 11.5 p -138.0 135.38 45.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.201 -0.454 . . . . 54.119999999999997 111.125 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.84 164.26 30.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 71.420000000000002 111.071 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . 0.52 ' O ' HD13 ' A' ' 241' ' ' ILE . 2.3 pt-20 -141.55 131.85 25.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 74.450000000000003 110.921 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' ILE . . . . . 0.607 HG13 HG11 ' A' ' 216' ' ' VAL . 23.9 mm -127.43 110.64 22.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.154 -0.476 . . . . 43.530000000000001 111.161 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' THR . . . . . 0.614 HG23 ' HG3' ' A' ' 223' ' ' LYS . 1.4 m -81.32 141.43 34.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 62.520000000000003 111.139 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 15.7 t -120.13 122.78 69.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 53.219999999999999 111.137 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 14.6 p -82.41 133.62 35.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 52.049999999999997 111.14 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' ALA . . . . . 0.673 ' HA ' ' HB2' ' A' ' 221' ' ' ALA . . . -59.16 -21.88 60.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 72.420000000000002 111.058 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 67.0 m . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.239 -0.437 . . . . 74.420000000000002 110.859 -179.732 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 N-CA-C 112.466 -0.253 . . . . 51.329999999999998 112.466 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -118.35 -66.61 1.06 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.797 0.332 . . . . 62.140000000000001 111.095 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 8.7 mtt -114.08 119.64 37.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 73.239999999999995 110.851 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -176.62 -170.15 0.32 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 72.140000000000001 111.112 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -173.21 129.09 0.46 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 54.0 111.11 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.32 -168.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.438 . . . . 73.310000000000002 111.075 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.88 32.94 5.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.233 -0.44 . . . . 73.219999999999999 111.148 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 135.27 99.63 0.6 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.721 -0.752 . . . . 45.420000000000002 112.51 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 18.8 ttp -110.88 128.15 55.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.824 0.345 . . . . 70.239999999999995 110.907 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.481 ' OG1' ' HB3' ' A' ' 184' ' ' ALA . 38.9 p -116.29 107.4 14.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 71.310000000000002 111.116 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 1.063 HG22 HG13 ' A' ' 183' ' ' VAL . 21.2 t -102.24 131.1 50.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.246 -0.434 . . . . 71.200000000000003 111.141 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -123.58 91.86 49.3 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.554 0.693 . . . . 64.049999999999997 111.189 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.485 ' HB3' HD23 ' A' ' 181' ' ' LEU . 53.3 Cg_endo -69.77 -167.05 0.21 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.653 2.235 . . . . 74.430000000000007 112.34 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -92.55 -45.19 8.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.45 . . . . 42.399999999999999 111.117 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 73.1 m 48.08 85.42 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 75.140000000000001 110.905 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 8.4 t -176.0 -176.01 0.78 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 74.140000000000001 111.173 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 75.8 p -97.07 153.49 17.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 70.329999999999998 110.852 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.711 HG22 ' HB2' ' A' ' 177' ' ' GLN . 3.3 p -139.07 153.54 24.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.139 -0.482 . . . . 54.140000000000001 111.127 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 67.2 t -87.6 145.05 8.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.167 -0.47 . . . . 71.430000000000007 111.151 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -48.42 122.66 5.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 72.010000000000005 110.914 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.98 -15.35 59.45 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.756 -0.735 . . . . 71.310000000000002 112.487 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.711 ' HB2' HG22 ' A' ' 173' ' ' VAL . 11.8 mm100 -90.62 -178.63 5.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.781 0.324 . . . . 72.439999999999998 110.943 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 65.4 p -161.96 149.7 14.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 63.340000000000003 110.838 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.409 HG21 HD12 ' A' ' 241' ' ' ILE . 7.8 t -107.19 -173.89 2.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.105 -0.498 . . . . 74.329999999999998 111.115 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.76 132.25 28.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.201 -0.454 . . . . 74.530000000000001 111.111 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.485 HD23 ' HB3' ' A' ' 168' ' ' PRO . 7.6 mp -105.8 143.66 33.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.186 -0.461 . . . . 72.140000000000001 110.933 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 4.0 m -111.35 142.98 42.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.444 . . . . 63.310000000000002 111.133 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 1.063 HG13 HG22 ' A' ' 166' ' ' VAL . 21.8 t -129.69 143.41 41.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.255 -0.429 . . . . 70.239999999999995 111.185 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.481 ' HB3' ' OG1' ' A' ' 165' ' ' THR . . . -134.48 152.06 51.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 44.439999999999998 111.106 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -144.88 126.53 15.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 70.420000000000002 110.878 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.81 67.77 68.93 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.594 0.712 . . . . 75.030000000000001 110.877 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.79 -40.44 5.27 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.657 2.238 . . . . 62.329999999999998 112.333 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 67.01 42.35 2.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 73.219999999999999 110.896 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 163.11 -40.56 0.34 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.807 -0.711 . . . . 62.329999999999998 112.507 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.423 ' O ' ' C ' ' A' ' 191' ' ' THR . 2.2 t -78.02 -48.2 23.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.864 0.364 . . . . 65.540000000000006 111.165 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . 0.423 ' C ' ' O ' ' A' ' 190' ' ' VAL . 1.6 t 35.82 71.96 0.11 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 74.439999999999998 111.139 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -164.52 116.75 1.29 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.205 -0.452 . . . . 73.349999999999994 110.887 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt -58.15 98.43 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.44 . . . . 71.510000000000005 110.874 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 2.6 t -111.61 -6.8 14.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 74.420000000000002 110.878 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.769 ' CE2' HG11 ' A' ' 183' ' ' VAL . 20.0 p90 -90.97 174.58 7.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.15 -0.477 . . . . 74.519999999999996 110.899 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -165.81 154.95 11.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 65.219999999999999 110.861 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -103.89 165.63 10.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 73.030000000000001 111.076 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 10.4 p -169.17 152.17 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 65.239999999999995 111.122 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.4 p -81.93 140.22 34.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 74.430000000000007 110.863 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.506 ' HB2' ' HD3' ' A' ' 227' ' ' PRO . . . -76.52 -23.34 53.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.107 -0.497 . . . . 72.129999999999995 111.069 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -134.82 -53.61 0.81 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.436 . . . . 74.340000000000003 110.845 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 2.8 ttpp 63.66 33.85 12.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.44 . . . . 75.299999999999997 110.918 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 50.8 p -116.65 -3.26 11.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.196 -0.456 . . . . 74.340000000000003 111.121 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . 0.412 ' HG2' ' HB3' ' A' ' 220' ' ' ALA . 8.0 mtmm -153.19 18.75 0.57 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 73.349999999999994 110.854 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.642 ' HA ' HG23 ' A' ' 219' ' ' VAL . . . -172.42 148.09 2.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 72.519999999999996 111.083 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 17.1 p -111.69 142.37 44.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 74.099999999999994 111.192 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.905 HG12 HG22 ' A' ' 216' ' ' VAL . 16.2 m -126.7 140.15 49.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.267 -0.424 . . . . 71.420000000000002 111.146 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 28.4 m -146.68 108.99 4.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 74.329999999999998 110.846 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.535 HG23 HG13 ' A' ' 214' ' ' ILE . 3.7 p -86.87 143.27 11.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.08 -0.509 . . . . 74.200000000000003 111.112 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 43.7 t -171.45 123.57 0.56 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.152 -0.477 . . . . 75.230000000000004 110.881 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 55.14 48.29 69.05 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.73 -0.748 . . . . 71.340000000000003 112.479 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 1.8 mtp 62.5 16.59 8.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.834 0.35 . . . . 55.039999999999999 110.889 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 2.3 m -127.55 113.55 16.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 74.209999999999994 111.175 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.535 HG13 HG23 ' A' ' 209' ' ' VAL . 3.0 mp -109.9 115.96 51.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.241 -0.436 . . . . 73.519999999999996 111.15 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 3.4 m -89.1 130.83 35.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.439 . . . . 65.420000000000002 111.127 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.905 HG22 HG12 ' A' ' 207' ' ' VAL . 3.0 t -116.24 121.06 66.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.24 -0.436 . . . . 72.430000000000007 111.124 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -104.79 139.83 38.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 65.150000000000006 110.863 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -94.28 79.65 0.95 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.729 -0.748 . . . . 42.329999999999998 112.502 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.642 HG23 ' HA ' ' A' ' 205' ' ' ALA . 19.7 t -49.95 -56.39 3.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.837 0.351 . . . . 64.120000000000005 111.154 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . 0.412 ' HB3' ' HG2' ' A' ' 204' ' ' LYS . . . -127.77 163.35 24.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 42.020000000000003 111.07 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . 0.678 ' HB2' ' HA ' ' A' ' 245' ' ' ALA . . . -63.45 137.75 58.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 62.240000000000002 111.092 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 142.4 167.53 11.42 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.74 -0.743 . . . . 70.439999999999998 112.515 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . 0.606 ' HG3' HG23 ' A' ' 242' ' ' THR . 6.2 mttp -98.72 124.58 43.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.876 0.369 . . . . 62.219999999999999 110.874 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.497 HG11 ' CB ' ' A' ' 205' ' ' ALA . 7.4 p -121.96 129.76 75.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.218 -0.446 . . . . 71.430000000000007 111.119 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.626 ' C ' HD12 ' A' ' 226' ' ' ILE . 27.4 m120 -90.62 152.48 20.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 61.5 110.876 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.626 HD12 ' C ' ' A' ' 225' ' ' ASN . 4.2 mp -138.2 92.83 11.97 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.611 0.72 . . . . 71.019999999999996 111.12 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' PRO . . . . . 0.506 ' HD3' ' HB2' ' A' ' 200' ' ' ALA . 53.6 Cg_endo -69.73 -177.79 2.03 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.658 2.239 . . . . 51.219999999999999 112.379 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.506 ' CG2' ' HB3' ' A' ' 237' ' ' ALA . 99.7 t -150.08 137.82 13.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 64.040000000000006 111.084 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 88.1 t -117.94 132.82 66.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 71.219999999999999 111.12 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -121.72 137.52 54.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 74.200000000000003 110.858 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 51.91 -118.88 7.78 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.707 -0.758 . . . . 42.32 112.51 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -105.5 21.09 17.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.918 0.39 . . . . 52.409999999999997 110.933 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 107.27 12.01 24.41 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.706 -0.759 . . . . 62.329999999999998 112.49 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -63.14 -58.97 5.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.842 0.353 . . . . 62.409999999999997 110.901 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -105.58 167.22 9.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.464 . . . . 74.329999999999998 110.89 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -166.13 165.04 17.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.165 -0.471 . . . . 51.340000000000003 111.115 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . 0.506 ' HB3' ' CG2' ' A' ' 228' ' ' VAL . . . -139.52 163.2 33.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 73.420000000000002 111.064 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 52.4 t -137.52 132.11 44.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.441 . . . . 61.420000000000002 111.137 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . 0.448 ' HB2' ' HG3' ' A' ' 168' ' ' PRO . . . -139.23 162.48 34.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 71.120000000000005 111.094 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -145.51 124.37 12.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 75.219999999999999 110.898 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' ILE . . . . . 0.662 HG13 HG11 ' A' ' 216' ' ' VAL . 29.6 mm -119.1 109.13 25.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.12 -0.491 . . . . 72.019999999999996 111.135 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' THR . . . . . 0.606 HG23 ' HG3' ' A' ' 223' ' ' LYS . 4.2 m -80.31 141.83 35.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 73.010000000000005 111.12 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 18.5 t -119.22 121.1 65.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 75.540000000000006 111.18 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' THR . . . . . 0.502 HG23 ' O ' ' A' ' 173' ' ' VAL . 6.7 p -81.67 132.85 35.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.188 -0.46 . . . . 70.349999999999994 111.185 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' ALA . . . . . 0.678 ' HA ' ' HB2' ' A' ' 221' ' ' ALA . . . -58.46 -21.7 52.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.226 -0.443 . . . . 70.540000000000006 111.076 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 76.5 p . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.224 -0.444 . . . . 40.520000000000003 110.83 -179.769 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 N-CA-C 112.475 -0.25 . . . . 31.239999999999998 112.475 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -165.05 110.49 0.93 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.804 0.335 . . . . 74.549999999999997 111.075 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 8.6 mtt -83.31 178.11 8.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 62.119999999999997 110.879 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -135.69 -175.26 3.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 74.450000000000003 111.062 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -175.3 129.53 0.28 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.15 -0.477 . . . . 63.43 111.101 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -59.81 -169.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 75.439999999999998 111.105 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.735 HG22 ' HA ' ' A' ' 187' ' ' PRO . 4.7 t -120.69 22.37 11.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 71.230000000000004 111.171 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 147.23 100.38 0.25 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.775 -0.726 . . . . 74.209999999999994 112.524 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -110.04 136.5 49.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.88 0.371 . . . . 74.420000000000002 110.876 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.646 ' OG1' ' HB3' ' A' ' 184' ' ' ALA . 68.6 p -116.11 105.65 12.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 71.25 111.147 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 1.069 HG22 HG13 ' A' ' 183' ' ' VAL . 45.7 t -98.48 130.14 47.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.198 -0.456 . . . . 74.219999999999999 111.094 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 8.9 m -126.66 92.72 44.26 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.537 0.684 . . . . 72.010000000000005 111.128 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.532 ' HG3' ' HB2' ' A' ' 239' ' ' ALA . 54.1 Cg_endo -69.72 -166.07 0.17 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.67 2.246 . . . . 74.319999999999993 112.352 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -87.05 -40.13 14.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 64.420000000000002 111.114 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 99.5 p 46.47 78.81 0.06 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.439 . . . . 70.439999999999998 110.876 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 7.5 t -175.27 -174.96 0.78 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.11 -0.496 . . . . 64.349999999999994 111.174 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 99.1 p -99.79 162.94 12.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.261 -0.427 . . . . 42.32 110.85 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.79 HG22 ' HB2' ' A' ' 177' ' ' GLN . 1.9 p -147.06 151.68 13.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 73.319999999999993 111.114 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 69.3 t -87.62 145.35 7.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.475 . . . . 62.329999999999998 111.116 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.31 123.1 6.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 71.409999999999997 110.92 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 100.49 -15.87 58.34 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.758 -0.734 . . . . 65.409999999999997 112.526 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.79 ' HB2' HG22 ' A' ' 173' ' ' VAL . 12.9 mm100 -86.51 -177.09 6.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.819 0.343 . . . . 63.210000000000001 110.921 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 1.4 p -161.02 149.31 15.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 63.200000000000003 110.838 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 8.9 t -113.26 -178.25 3.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.09 -0.504 . . . . 71.049999999999997 111.113 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -138.61 128.89 25.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.203 -0.453 . . . . 55.409999999999997 111.16 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.457 HD23 ' HB3' ' A' ' 168' ' ' PRO . 7.6 mp -101.69 147.96 25.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 73.400000000000006 110.866 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 7.4 m -115.23 142.79 46.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.198 -0.456 . . . . 71.409999999999997 111.135 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 1.069 HG13 HG22 ' A' ' 166' ' ' VAL . 30.0 t -129.72 142.56 43.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 71.420000000000002 111.139 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.646 ' HB3' ' OG1' ' A' ' 165' ' ' THR . . . -130.41 152.94 49.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 35.229999999999997 111.078 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -146.4 131.85 18.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 52.32 110.885 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . 0.571 HE22 HG23 ' A' ' 165' ' ' THR . 0.0 OUTLIER -127.71 68.05 73.95 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.544 0.688 . . . . 72.420000000000002 110.931 -179.952 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.735 ' HA ' HG22 ' A' ' 162' ' ' THR . 53.4 Cg_endo -69.75 -33.93 15.63 Favored 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.692 2.262 . . . . 64.209999999999994 112.345 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 60.31 19.84 9.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 73.129999999999995 110.871 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -177.92 -54.34 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.752 -0.737 . . . . 42.539999999999999 112.491 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.418 HG12 ' N ' ' A' ' 191' ' ' THR . 1.4 t -54.62 -50.4 59.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.947 0.403 . . . . 61.340000000000003 111.135 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . 0.418 ' N ' HG12 ' A' ' 190' ' ' VAL . 44.0 p 47.04 62.17 2.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.187 -0.46 . . . . 53.32 111.125 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -157.6 146.61 19.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 74.219999999999999 110.865 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.16 76.6 6.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.197 -0.456 . . . . 73.329999999999998 110.918 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 4.9 m -86.07 -6.48 59.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.258 -0.428 . . . . 53.119999999999997 110.86 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.775 ' CE2' HG11 ' A' ' 183' ' ' VAL . 20.2 p90 -90.74 173.4 8.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.129 -0.487 . . . . 63.130000000000003 110.867 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 23.4 ptt180 -163.04 172.56 14.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.138 -0.483 . . . . 71.129999999999995 110.874 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . 0.549 ' HB3' ' HB ' ' A' ' 209' ' ' VAL . . . -121.38 167.86 12.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 75.450000000000003 111.074 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 8.3 p -174.05 153.82 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 74.150000000000006 111.089 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.49 129.14 38.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.121 -0.491 . . . . 72.319999999999993 110.834 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.445 ' HB2' ' HD3' ' A' ' 227' ' ' PRO . . . -65.92 -21.86 66.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.114 -0.494 . . . . 64.340000000000003 111.078 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -155.45 86.85 1.09 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.245 -0.434 . . . . 43.140000000000001 110.869 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 24.4 ttmt -79.23 58.46 2.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.44 . . . . 71.420000000000002 110.905 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 27.6 p -132.89 3.68 3.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 74.400000000000006 111.123 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . 0.444 ' HA ' ' HB3' ' A' ' 220' ' ' ALA . 12.9 mtmm -154.22 16.51 0.48 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.238 -0.437 . . . . 60.329999999999998 110.918 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.4 ' HA ' ' H ' ' A' ' 219' ' ' VAL . . . -179.96 152.96 0.49 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.436 . . . . 72.340000000000003 111.068 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 12.1 p -107.9 154.13 22.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 74.329999999999998 111.17 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.73 HG12 HG22 ' A' ' 216' ' ' VAL . 13.3 m -140.58 136.36 35.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 74.340000000000003 111.124 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . 0.527 ' C ' HG23 ' A' ' 214' ' ' ILE . 1.2 t -144.99 108.44 4.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.459 . . . . 62.310000000000002 110.85 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.637 HG23 HG13 ' A' ' 214' ' ' ILE . 4.4 p -91.01 143.68 10.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 72.519999999999996 111.139 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 7.8 t -144.97 98.16 3.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 65.120000000000005 110.843 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 70.24 -81.63 0.36 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.748 -0.739 . . . . 74.120000000000005 112.497 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -138.78 7.68 2.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.838 0.351 . . . . 63.43 110.86 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 1.6 m -129.16 123.03 31.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.444 . . . . 74.140000000000001 111.185 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.637 HG13 HG23 ' A' ' 209' ' ' VAL . 2.4 mp -114.6 140.49 35.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 64.239999999999995 111.17 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.0 128.59 54.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 62.409999999999997 111.087 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.73 HG22 HG12 ' A' ' 207' ' ' VAL . 2.6 t -118.72 134.24 62.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 73.450000000000003 111.125 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -119.27 137.19 53.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 65.400000000000006 110.923 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -85.7 68.88 3.32 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.778 -0.725 . . . . 54.520000000000003 112.491 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.425 HG12 ' N ' ' A' ' 220' ' ' ALA . 1.9 t -49.45 -53.98 7.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.812 0.339 . . . . 63.100000000000001 111.116 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . 0.444 ' HB3' ' HA ' ' A' ' 204' ' ' LYS . . . -123.71 155.2 38.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 73.310000000000002 111.134 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . 0.664 ' HB2' ' HA ' ' A' ' 245' ' ' ALA . . . -67.27 137.11 55.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.238 -0.437 . . . . 65.430000000000007 111.106 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 141.32 175.09 14.67 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.703 -0.76 . . . . 70.120000000000005 112.503 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . 0.495 ' HG3' HG23 ' A' ' 242' ' ' THR . 5.1 mttp -98.86 122.24 41.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.787 0.327 . . . . 72.209999999999994 110.926 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 6.4 p -119.15 127.35 75.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 53.219999999999999 111.123 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.418 ' C ' HD12 ' A' ' 226' ' ' ILE . 30.6 m120 -90.7 145.4 24.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 64.030000000000001 110.916 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.418 HD12 ' C ' ' A' ' 225' ' ' ASN . 4.8 mp -131.12 92.56 32.8 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.657 0.742 . . . . 72.349999999999994 111.126 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' PRO . . . . . 0.445 ' HD3' ' HB2' ' A' ' 200' ' ' ALA . 53.6 Cg_endo -69.75 179.21 3.85 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.705 2.27 . . . . 74.200000000000003 112.338 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.456 ' HB ' ' HB3' ' A' ' 237' ' ' ALA . 58.0 t -148.36 137.27 15.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 61.009999999999998 111.155 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 46.1 t -116.93 135.91 55.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 74.129999999999995 111.123 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.25 107.37 12.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 74.019999999999996 110.844 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 74.94 -118.23 5.6 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.752 -0.737 . . . . 52.210000000000001 112.492 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -108.06 19.95 19.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.851 0.357 . . . . 74.549999999999997 110.867 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 116.49 2.87 19.29 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.733 -0.746 . . . . 55.009999999999998 112.52 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -51.47 -71.47 0.06 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.876 0.37 . . . . 65.430000000000007 110.88 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -109.32 151.63 26.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 70.310000000000002 110.86 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -149.46 161.73 41.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 40.140000000000001 111.138 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . 0.456 ' HB3' ' HB ' ' A' ' 228' ' ' VAL . . . -139.61 163.15 33.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.246 -0.434 . . . . 73.540000000000006 111.149 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 43.0 t -136.58 139.58 44.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.281 -0.418 . . . . 73.209999999999994 111.117 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . 0.532 ' HB2' ' HG3' ' A' ' 168' ' ' PRO . . . -139.26 164.37 29.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.237 -0.438 . . . . 74.200000000000003 111.109 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . 0.448 ' O ' HD13 ' A' ' 241' ' ' ILE . 1.7 pt-20 -143.71 128.72 18.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.239 -0.437 . . . . 54.530000000000001 110.861 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' ILE . . . . . 0.448 HD13 ' O ' ' A' ' 240' ' ' GLU . 29.1 mm -125.2 110.85 25.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 72.519999999999996 111.156 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' THR . . . . . 0.495 HG23 ' HG3' ' A' ' 223' ' ' LYS . 1.5 m -80.75 138.82 36.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 73.349999999999994 111.191 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 18.3 t -120.07 117.82 54.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.24 -0.436 . . . . 65.239999999999995 111.152 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' THR . . . . . 0.481 HG23 ' O ' ' A' ' 173' ' ' VAL . 4.3 p -81.86 132.94 35.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 54.439999999999998 111.149 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' ALA . . . . . 0.664 ' HA ' ' HB2' ' A' ' 221' ' ' ALA . . . -53.24 -28.52 27.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 71.030000000000001 111.106 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 1.4 t . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 61.140000000000001 110.845 -179.789 . . . . . . . . 0 0 . 1 stop_ save_